sampleID	ABSOLUTE_Ploidy	ABSOLUTE_Purity	AKT1	ALK_translocation	BRAF	CBL	CTNNB1	Canonical_mut_in_KRAS_EGFR_ALK	Cnncl_mt_n_KRAS_EGFR_ALK_RET_ROS1_BRAF_ERBB2_HRAS_NRAS_AKT1_MAP2	EGFR	ERBB2	ERBB4	Estimated_allele_fraction_of_a_clonal_varnt_prsnt_t_1_cpy_pr_cll	Expression_Subtype	HRAS	KRAS	MAP2K1	MET	NRAS	PIK3CA	PTPN11	Pathology	Pathology_Updated	RET_translocation	ROS1_translocation	STK11	WGS_as_of_20120731_0_no_1_yes	_INTEGRATION	_PANCAN_CNA_PANCAN_K8	_PANCAN_Cluster_Cluster_PANCAN	_PANCAN_DNAMethyl_LUAD	_PANCAN_DNAMethyl_PANCAN	_PANCAN_RPPA_PANCAN_K8	_PANCAN_UNC_RNAseq_PANCAN_K16	_PANCAN_miRNA_PANCAN	_PANCAN_mirna_LUAD	_PANCAN_mutation_PANCAN	_PATIENT	_cohort	_primary_disease	_primary_site	additional_pharmaceutical_therapy	additional_radiation_therapy	additional_surgery_locoregional_procedure	additional_surgery_metastatic_procedure	age_at_initial_pathologic_diagnosis	anatomic_neoplasm_subdivision	anatomic_neoplasm_subdivision_other	bcr_followup_barcode	bcr_patient_barcode	bcr_sample_barcode	days_to_additional_surgery_locoregional_procedure	days_to_additional_surgery_metastatic_procedure	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_new_tumor_event_after_initial_treatment	disease_code	dlco_predictive_percent	eastern_cancer_oncology_group	egfr_mutation_performed	egfr_mutation_result	eml4_alk_translocation_method	eml4_alk_translocation_performed	followup_case_report_form_submission_reason	followup_treatment_success	form_completion_date	gender	histological_type	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	initial_weight	intermediate_dimension	is_ffpe	karnofsky_performance_score	kras_gene_analysis_performed	kras_mutation_found	kras_mutation_result	location_in_lung_parenchyma	longest_dimension	lost_follow_up	new_neoplasm_event_type	new_tumor_event_after_initial_treatment	number_pack_years_smoked	oct_embedded	other_dx	pathologic_M	pathologic_N	pathologic_T	pathologic_stage	pathology_report_file_name	patient_id	performance_status_scale_timing	person_neoplasm_cancer_status	post_bronchodilator_fev1_fvc_percent	post_bronchodilator_fev1_percent	pre_bronchodilator_fev1_fvc_percent	pre_bronchodilator_fev1_percent	primary_therapy_outcome_success	progression_determined_by	project_code	pulmonary_function_test_performed	radiation_therapy	residual_tumor	sample_type	sample_type_id	shortest_dimension	stopped_smoking_year	system_version	targeted_molecular_therapy	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tobacco_smoking_history	tobacco_smoking_history_indicator	tumor_tissue_site	vial_number	vital_status	year_of_initial_pathologic_diagnosis	year_of_tobacco_smoking_onset	_GENOMIC_ID_TCGA_LUAD_mutation	_GENOMIC_ID_TCGA_LUAD_mutation_curated_broad_gene	_GENOMIC_ID_TCGA_LUAD_PDMarray	_GENOMIC_ID_TCGA_LUAD_exp_HiSeqV2	_GENOMIC_ID_TCGA_LUAD_G4502A_07_3	_GENOMIC_ID_TCGA_LUAD_hMethyl27	_GENOMIC_ID_data/public/TCGA/LUAD/miRNA_GA_gene	_GENOMIC_ID_TCGA_LUAD_gistic2	_GENOMIC_ID_TCGA_LUAD_hMethyl450	_GENOMIC_ID_TCGA_LUAD_PDMRNAseqCNV	_GENOMIC_ID_TCGA_LUAD_gistic2thd	_GENOMIC_ID_TCGA_LUAD_PDMarrayCNV	_GENOMIC_ID_TCGA_LUAD_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_LUAD_miRNA_HiSeq	_GENOMIC_ID_TCGA_LUAD_RPPA_RBN	_GENOMIC_ID_TCGA_LUAD_exp_HiSeqV2_PANCAN	_GENOMIC_ID_TCGA_LUAD_PDMRNAseq	_GENOMIC_ID_TCGA_LUAD_RPPA	_GENOMIC_ID_TCGA_LUAD_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_LUAD_mutation_broad_gene	_GENOMIC_ID_data/public/TCGA/LUAD/miRNA_HiSeq_gene	_GENOMIC_ID_TCGA_LUAD_miRNA_GA
TCGA-05-4244-01																												TCGA-05-4244-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 12	TCGA-05-4244	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	R-Lower			TCGA-05-4244	TCGA-05-4244-01A			-25752			0	0											2010-7-22	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.9	NO					Peripheral Lung	1.1				38		No	M1	N2	T2	Stage IV	TCGA-05-4244.3a844132-f813-4d8e-8f7d-dbae0b23d7fd.pdf	4244		TUMOR FREE										RX	Primary Tumor	01	0.3		6th		NO	YES	05	4		Lung	A	LIVING	2009		TCGA-05-4244-01A-01D-1105-08		TCGA-05-4244-01	e6a101b9-61f9-4ed1-a59f-d9db3fdb4555	TCGA-05-4244-01A-01R-1107-07	TCGA-05-4244-01A-01D-1104-05	TCGA-05-4244-01	TCGA-05-4244-01A-01D-1877-01		TCGA-05-4244-01	TCGA-05-4244-01A-01D-1877-01	TCGA-05-4244-01	e6a101b9-61f9-4ed1-a59f-d9db3fdb4555		TCGA-05-4244-01A-21-2190-20	e6a101b9-61f9-4ed1-a59f-d9db3fdb4555	TCGA-05-4244-01	59881fe3-70f4-4fa0-9355-f50250872752	e6a101b9-61f9-4ed1-a59f-d9db3fdb4555	TCGA-05-4244-01A-01D-1105-08		TCGA-05-4244-01
TCGA-05-4249-01	3.77	0.46	none		p.A762E	none	none	Y	Y	none	none	none	0.16	Bronchioid	none	p.G12C	none	none	none	p.E545K	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-05-4249-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 1	mutation cluster 1	TCGA-05-4249	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					67	R-Lower		TCGA-05-4249-F36327	TCGA-05-4249	TCGA-05-4249-01A			-24532			0	1523									Scheduled Follow-up Submission	Complete Remission/Response	2012-10-29	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.8	NO					Peripheral Lung	1.4	NO		NO	52		No	M0	N0	T2	Stage IB	TCGA-05-4249.7e920317-d5c2-4160-9e2b-ef0101eb5a23.pdf	4249		TUMOR FREE									NO	R0	Primary Tumor	01	0.4		6th	NO	NO	YES	05	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2007		TCGA-05-4249-01A-01D-1105-08	TCGA-05-4249-01A-01D-1105-08	TCGA-05-4249-01	d1a8d88d-1708-4959-9695-6f2e67853bd5	TCGA-05-4249-01A-01R-1107-07	TCGA-05-4249-01A-01D-1104-05	TCGA-05-4249-01	TCGA-05-4249-01A-01D-1877-01		TCGA-05-4249-01	TCGA-05-4249-01A-01D-1877-01	TCGA-05-4249-01	d1a8d88d-1708-4959-9695-6f2e67853bd5		TCGA-05-4249-01A-21-2190-20	d1a8d88d-1708-4959-9695-6f2e67853bd5	TCGA-05-4249-01	5b46a235-49a6-43ea-91b6-82a384702477	d1a8d88d-1708-4959-9695-6f2e67853bd5	TCGA-05-4249-01A-01D-1105-08		TCGA-05-4249-01
TCGA-05-4250-01																												TCGA-05-4250-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 12	TCGA-05-4250	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					79	R-Lower			TCGA-05-4250	TCGA-05-4250-01A			-29068		121	0												2010-7-22	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.7	NO						1.2				47		No	M0	N1	T3	Stage IIIA	TCGA-05-4250.5574f2f8-f247-40e6-a285-7793edcf5358.pdf	4250												R2	Primary Tumor	01	0.3		6th		NO	YES	05	4		Lung	A	DECEASED	2007		TCGA-05-4250-01A-01D-1105-08		TCGA-05-4250-01	bba9333a-09f7-4585-b22e-e4ae4049f7da	TCGA-05-4250-01A-01R-1107-07	TCGA-05-4250-01A-01D-1104-05	TCGA-05-4250-01	TCGA-05-4250-01A-01D-1877-01		TCGA-05-4250-01	TCGA-05-4250-01A-01D-1877-01	TCGA-05-4250-01	bba9333a-09f7-4585-b22e-e4ae4049f7da		TCGA-05-4250-01A-21-2190-20	bba9333a-09f7-4585-b22e-e4ae4049f7da	TCGA-05-4250-01	3f069d62-c371-4f30-bdb4-c58093bbb1d7	bba9333a-09f7-4585-b22e-e4ae4049f7da	TCGA-05-4250-01A-01D-1105-08		TCGA-05-4250-01
TCGA-05-4382-01			none		p.L613F	none	none	N	N	p.R222L, p.E545Q	none	p.D922E		Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-05-4382-01	High	C1-LUAD-enriched		Cluster 5		LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 11	TCGA-05-4382	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung		YES			68	L-Upper		TCGA-05-4382-F36329	TCGA-05-4382				-24868			0	607	334								Scheduled Follow-up Submission	Complete Remission/Response	2012-10-29	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES										NO	Distant Metastasis	YES	62		Yes	M0	N0	T2	Stage IB		4382		TUMOR FREE					Complete Remission/Response				YES	R0	Primary Tumor	01			6th	NO	NO	YES	05	4	Current reformed smoker for < or = 15 years	Lung		LIVING	2009		TCGA-05-4382-01A-01D-1265-08	TCGA-05-4382-01A-01D-1265-08		e4177b01-6898-4bb7-b38d-0c09f85c5668		TCGA-05-4382-01A-01D-1205-05	TCGA-05-4382-01	TCGA-05-4382-01A-01D-1204-01		TCGA-05-4382-01	TCGA-05-4382-01A-01D-1204-01		e4177b01-6898-4bb7-b38d-0c09f85c5668			e4177b01-6898-4bb7-b38d-0c09f85c5668	TCGA-05-4382-01		e4177b01-6898-4bb7-b38d-0c09f85c5668	TCGA-05-4382-01A-01D-1931-08		TCGA-05-4382-01
TCGA-05-4384-01	2.04	0.48	none		none	none	p.F777S	N	N	none	p.S633_splice	none	0.24	Bronchioid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-05-4384-01	Iq	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation cluster 5	TCGA-05-4384	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung		YES			66	R-Lower		TCGA-05-4384-F36330	TCGA-05-4384	TCGA-05-4384-01A			-24411			0	426	183								Scheduled Follow-up Submission	Progressive Disease	2012-10-29	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.8	NO						0.8	NO	Distant Metastasis	YES	20		Yes	M0	N2	T2	Stage IIIA	TCGA-05-4384.b70e95c5-2e6c-4409-8bbd-80e03e302b4c.pdf	4384		WITH TUMOR					Progressive Disease				YES	RX	Primary Tumor	01	0.4	1987	6th	YES	NO	YES	05	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2009	1963	TCGA-05-4384-01A-01D-1753-08	TCGA-05-4384-01A-01D-1753-08		7d6cf896-b04a-431a-a192-aaf540eeaf77				TCGA-05-4384-01A-01D-1752-01	TCGA-05-4384-01A-01D-1756-05	TCGA-05-4384-01	TCGA-05-4384-01A-01D-1752-01		7d6cf896-b04a-431a-a192-aaf540eeaf77	TCGA-05-4384-01	TCGA-05-4384-01A-21-2190-20	7d6cf896-b04a-431a-a192-aaf540eeaf77	TCGA-05-4384-01	5e735c28-5f2b-47ec-98fb-2f57cc8a5d6a	7d6cf896-b04a-431a-a192-aaf540eeaf77	TCGA-05-4384-01A-01D-1753-08	TCGA-05-4384-01	
TCGA-05-4389-01	3.29	0.48	none		p.G469V	none	p.T41A	N	Y	none	none	none	0.18	Magnoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	1	TCGA-05-4389-01	High	C1-LUAD-enriched		Cluster 5		LUAD-like c10	miRNA cluster 4	cluster 2	mutation c1uster 9	TCGA-05-4389	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	R-Upper		TCGA-05-4389-F36455	TCGA-05-4389				-25660			0	1369									Scheduled Follow-up Submission	Complete Remission/Response	2012-10-31	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES										NO		NO	43		No	M0	N0	T1	Stage IA		4389		TUMOR FREE									NO	R0	Primary Tumor	01			5th	NO	NO	YES	05	3	Current reformed smoker for > 15 years	Lung		LIVING	2005		TCGA-05-4389-01A-01D-1265-08	TCGA-05-4389-01A-01D-1265-08		a588764f-f972-4d3a-b8f8-d0209fc7d2a1		TCGA-05-4389-01A-01D-1205-05	TCGA-05-4389-01	TCGA-05-4389-01A-01D-1204-01		TCGA-05-4389-01	TCGA-05-4389-01A-01D-1204-01		a588764f-f972-4d3a-b8f8-d0209fc7d2a1			a588764f-f972-4d3a-b8f8-d0209fc7d2a1	TCGA-05-4389-01		a588764f-f972-4d3a-b8f8-d0209fc7d2a1	TCGA-05-4389-01A-01D-1265-08		TCGA-05-4389-01
TCGA-05-4390-01	3.99	0.57	none		none	none	none	Y	Y	none	none	none	0.18	Magnoid	none	p.G12V	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-05-4390-01	COAD-READ	C1-LUAD-enriched	cluster 2	Cluster 6		LUAD-like c10	miRNA cluster 6	cluster 1	mutation cluster 12	TCGA-05-4390	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					58	R-Upper		TCGA-05-4390-F36456	TCGA-05-4390	TCGA-05-4390-01A			-21430			0	1126	395								Scheduled Follow-up Submission	Complete Remission/Response	2012-10-31	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.9	NO						1.8	NO		YES	15		No	M0	N0	T2	Stage IB	TCGA-05-4390.2e3faad1-3a5e-4efb-96ea-8c44839fec6e.pdf	4390		TUMOR FREE					Progressive Disease				NO	R0	Primary Tumor	01	0.3	1996	5th	YES	NO	YES	05	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2005	1966	TCGA-05-4390-01A-02D-1753-08	TCGA-05-4390-01A-02D-1753-08		6b6d7855-8621-45f8-98c9-5ad5b924b15e				TCGA-05-4390-01A-02D-1752-01	TCGA-05-4390-01A-02D-1756-05	TCGA-05-4390-01	TCGA-05-4390-01A-02D-1752-01		6b6d7855-8621-45f8-98c9-5ad5b924b15e	TCGA-05-4390-01		6b6d7855-8621-45f8-98c9-5ad5b924b15e	TCGA-05-4390-01		6b6d7855-8621-45f8-98c9-5ad5b924b15e	TCGA-05-4390-01A-02D-1753-08	TCGA-05-4390-01	
TCGA-05-4395-01	3.24	0.61	none		none	none	none	Y	Y	none	none	none	0.22	Squamoid	none	p.G12V	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			p.G56W	0	TCGA-05-4395-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 6		LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 2	TCGA-05-4395	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					76	L-Upper			TCGA-05-4395	TCGA-05-4395-01A			-27971		0	0												2010-7-22	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.4	NO						1						No	M0	N2	T4	Stage IIIB	TCGA-05-4395.601b48ca-e99c-4d4b-854e-4aa923b63237.pdf	4395		TUMOR FREE										R0	Primary Tumor	01	0.4	1983	5th		NO	YES	05	3	Lifelong Non-smoker	Lung	A	DECEASED	2006		TCGA-05-4395-01A-01D-1265-08	TCGA-05-4395-01A-01D-1265-08		3ae6f6d4-ae90-4572-9bd5-ed8700570b96		TCGA-05-4395-01A-01D-1205-05	TCGA-05-4395-01	TCGA-05-4395-01A-01D-1204-01		TCGA-05-4395-01	TCGA-05-4395-01A-01D-1204-01		3ae6f6d4-ae90-4572-9bd5-ed8700570b96			3ae6f6d4-ae90-4572-9bd5-ed8700570b96	TCGA-05-4395-01		3ae6f6d4-ae90-4572-9bd5-ed8700570b96	TCGA-05-4395-01A-01D-1265-08		TCGA-05-4395-01
TCGA-05-4396-01	1.86	0.74	none		none	none	none	N	N	none	none	none	0.39	Magnoid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-05-4396-01	Squamous	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 6	cluster 1	mutation cluster 11	TCGA-05-4396	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					76	R-Lower			TCGA-05-4396	TCGA-05-4396-01A			-28094		303	0												2010-7-22	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.9	NO						1.6				19		Yes	M0	N1	T4	Stage IIIB	TCGA-05-4396.96f3b48a-c5c4-40c3-a3d1-64477499c6e6.pdf	4396												R0	Primary Tumor	01	0.5	1984	5th		NO	YES	05	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2006	1947	TCGA-05-4396-01A-21D-1855-08	TCGA-05-4396-01A-21D-1855-08		82b154a5-b4d5-4737-8f79-10d252741963				TCGA-05-4396-01A-21D-1854-01	TCGA-05-4396-01A-21D-1856-05	TCGA-05-4396-01	TCGA-05-4396-01A-21D-1854-01		82b154a5-b4d5-4737-8f79-10d252741963	TCGA-05-4396-01	TCGA-05-4396-01A-22-2190-20	82b154a5-b4d5-4737-8f79-10d252741963	TCGA-05-4396-01	b7cb4257-cc52-4219-8e7b-0a6e881532af	82b154a5-b4d5-4737-8f79-10d252741963	TCGA-05-4396-01A-21D-1855-08	TCGA-05-4396-01	
TCGA-05-4397-01																												TCGA-05-4397-01	Squamous	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 7		mutation cluster 8	TCGA-05-4397	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					65	R-Middle			TCGA-05-4397				-23833		731	0												2010-7-22	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.2	8255/3	C34.2	YES													45		No	M0	N1	T2	Stage IIB		4397												R0	Primary Tumor	01			5th		NO	YES	05	2		Lung		DECEASED	2006		TCGA-05-4397-01A-01D-1265-08			e8fb125c-3249-44f4-9bc7-5cd086011d89		TCGA-05-4397-01A-01D-1205-05	TCGA-05-4397-01	TCGA-05-4397-01A-01D-1204-01		TCGA-05-4397-01	TCGA-05-4397-01A-01D-1204-01		e8fb125c-3249-44f4-9bc7-5cd086011d89		TCGA-05-4397-01A-21-2190-20	e8fb125c-3249-44f4-9bc7-5cd086011d89	TCGA-05-4397-01	e2c7eef9-5765-4ee9-92dd-a632be207eba	e8fb125c-3249-44f4-9bc7-5cd086011d89	TCGA-05-4397-01A-01D-1265-08		TCGA-05-4397-01
TCGA-05-4398-01	4.86	0.33	none		none	none	none	N	N	none	none	none	0.11	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	1	TCGA-05-4398-01	Squamous	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-05-4398	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					47	R-Upper		TCGA-05-4398-F36462	TCGA-05-4398	TCGA-05-4398-01A			-17471			0	1431									Scheduled Follow-up Submission	Complete Remission/Response	2012-10-31	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.9	NO						1.5	NO		NO	72		No	M0	N3	T4	Stage IIIB	TCGA-05-4398.37d9ee69-f24e-4dda-a283-078243db1fa8.pdf	4398		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.4		5th	YES	NO	YES	05	2	Current smoker	Lung	A	LIVING	2006		TCGA-05-4398-01A-01D-1265-08	TCGA-05-4398-01A-01D-1265-08		8835ae28-831e-49da-a046-a1a43b626a4e		TCGA-05-4398-01A-01D-1205-05	TCGA-05-4398-01	TCGA-05-4398-01A-01D-1204-01		TCGA-05-4398-01	TCGA-05-4398-01A-01D-1204-01		8835ae28-831e-49da-a046-a1a43b626a4e		TCGA-05-4398-01A-21-2190-20	8835ae28-831e-49da-a046-a1a43b626a4e	TCGA-05-4398-01	33467565-286d-4be1-a430-d1a74a5752f0	8835ae28-831e-49da-a046-a1a43b626a4e	TCGA-05-4398-01A-01D-1265-08		TCGA-05-4398-01
TCGA-05-4402-01	3.24	0.44	none		none	none	none	Y	Y	p.TSPKANKE751del	none	none	0.17	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-05-4402-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4	mutation cluster 8	TCGA-05-4402	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					57	R-Lower		TCGA-05-4402-F36466	TCGA-05-4402	TCGA-05-4402-01A			-20819		244	0										Scheduled Follow-up Submission	Complete Remission/Response	2012-10-31	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.6	NO						1.6	NO		NO			Yes	M1	NX	T2	Stage IV	TCGA-05-4402.8099c860-5c8d-4200-8c8f-07f9e1b71780.pdf	4402		TUMOR FREE					Complete Remission/Response				NO	R2	Primary Tumor	01	0.2		6th	YES	NO	YES	05	1	Lifelong Non-smoker	Lung	A	DECEASED	2007		TCGA-05-4402-01A-01D-1265-08	TCGA-05-4402-01A-01D-1265-08		86973b83-4077-414a-ad8d-dbf32b6707d1		TCGA-05-4402-01A-01D-1205-05	TCGA-05-4402-01	TCGA-05-4402-01A-01D-1204-01		TCGA-05-4402-01	TCGA-05-4402-01A-01D-1204-01		86973b83-4077-414a-ad8d-dbf32b6707d1		TCGA-05-4402-01A-21-2190-20	86973b83-4077-414a-ad8d-dbf32b6707d1	TCGA-05-4402-01	4e5d6d6d-af25-4b7c-bb75-357b90e36434	86973b83-4077-414a-ad8d-dbf32b6707d1	TCGA-05-4402-01A-01D-1265-08		TCGA-05-4402-01
TCGA-05-4403-01	2.06	0.46	none		none	none	none	Y	Y	none	none	none	0.23	Bronchioid	none	p.G12C	none	p.H476Y	none	none	none	Invasive mucinous	Invasive mucinous			none	0	TCGA-05-4403-01	Kirc+	C1-LUAD-enriched		Cluster 6		LUAD-like c10	miRNA cluster 8	cluster 1	mutation cluster 12	TCGA-05-4403	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					76	R-Upper			TCGA-05-4403	TCGA-05-4403-01A			-27881			0	578											2010-7-22	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		1	NO						1.5						No	M0	N0	T2	Stage IB	TCGA-05-4403.96181bb6-7944-4674-83ba-5268ef8b10a5.pdf	4403												R0	Primary Tumor	01	0.4	1975	5th		NO	YES	05	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2006		TCGA-05-4403-01A-01D-1265-08	TCGA-05-4403-01A-01D-1265-08		89059faf-e38c-49d0-890e-47c455f19dc7		TCGA-05-4403-01A-01D-1205-05	TCGA-05-4403-01	TCGA-05-4403-01A-01D-1204-01		TCGA-05-4403-01	TCGA-05-4403-01A-01D-1204-01		89059faf-e38c-49d0-890e-47c455f19dc7			89059faf-e38c-49d0-890e-47c455f19dc7	TCGA-05-4403-01		89059faf-e38c-49d0-890e-47c455f19dc7	TCGA-05-4403-01A-01D-1265-08		TCGA-05-4403-01
TCGA-05-4405-01	3.34	0.38	none		none	none	none	N	N	none	none	none	0.15	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-05-4405-01	High	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 2	TCGA-05-4405	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	R-Lower		TCGA-05-4405-F36494	TCGA-05-4405	TCGA-05-4405-01A			-27241			0	610									Scheduled Follow-up Submission	Complete Remission/Response	2012-10-31	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.7	NO						0.9	NO		NO	65		Yes	M0	N0	T2	Stage IB	TCGA-05-4405.AB2C32B2-3CB1-4977-8C79-7B19F9022DFB.pdf	4405		TUMOR FREE									NO	R0	Primary Tumor	01	0.3	1994	5th	NO	NO	YES	05	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2006	1951	TCGA-05-4405-01A-21D-1855-08	TCGA-05-4405-01A-21D-1855-08		a1510fc9-aff1-4cc2-8d8e-9aafce9319f7				TCGA-05-4405-01A-21D-1854-01	TCGA-05-4405-01A-21D-1856-05	TCGA-05-4405-01	TCGA-05-4405-01A-21D-1854-01		a1510fc9-aff1-4cc2-8d8e-9aafce9319f7	TCGA-05-4405-01	TCGA-05-4405-01A-22-2190-20	a1510fc9-aff1-4cc2-8d8e-9aafce9319f7	TCGA-05-4405-01	86533c79-3f76-4293-ac1e-cbe3482a1765	a1510fc9-aff1-4cc2-8d8e-9aafce9319f7	TCGA-05-4405-01A-21D-1855-08	TCGA-05-4405-01	
TCGA-05-4410-01			none		p.G466V	none	none	N	Y	p.R377S	none	none		Bronchioid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-05-4410-01	High	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 11	TCGA-05-4410	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					62	L-Upper			TCGA-05-4410	TCGA-05-4410-01A			-22888			0	0											2010-7-22	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.8	NO						1				98		Yes	M0	N0	T2	Stage IB	TCGA-05-4410.13c40632-79e2-485c-9ef2-da6d075b054c.pdf	4410												RX	Primary Tumor	01	0.4	2007	6th		NO	YES	05	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2007	1958	TCGA-05-4410-01A-21D-1855-08	TCGA-05-4410-01A-21D-1855-08		149e2d5d-3d6c-410e-b435-7e37b3f96661				TCGA-05-4410-01A-21D-1854-01	TCGA-05-4410-01A-21D-1856-05	TCGA-05-4410-01	TCGA-05-4410-01A-21D-1854-01		149e2d5d-3d6c-410e-b435-7e37b3f96661	TCGA-05-4410-01	TCGA-05-4410-01A-22-2190-20	149e2d5d-3d6c-410e-b435-7e37b3f96661	TCGA-05-4410-01	b5ff5d37-3c6b-4fdb-9d52-668269d77d4c	149e2d5d-3d6c-410e-b435-7e37b3f96661	TCGA-05-4410-01A-21D-1855-08	TCGA-05-4410-01	
TCGA-05-4415-01	3.65	0.65	none		none	none	none	Y	Y	none	none	none	0.21	Magnoid	none	p.G12C	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			p.G227fs	0	TCGA-05-4415-01	GBM	C1-LUAD-enriched	cluster 3	Cluster 5		LUAD-like c10	miRNA cluster 4	cluster 5	mutation cluster 12	TCGA-05-4415	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					57	L-Lower		TCGA-05-4415-F36499	TCGA-05-4415	TCGA-05-4415-01A			-20880		91	0		60								Scheduled Follow-up Submission	Progressive Disease	2012-10-31	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		1	NO						1.1	NO		YES	29		No	M0	N2	T4	Stage IIIB	TCGA-05-4415.e8871f29-3623-4975-be19-bda98dbbc33b.pdf	4415		WITH TUMOR					Progressive Disease				NO	R0	Primary Tumor	01	0.4	2007	6th	NO	NO	YES	05	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2008	1997	TCGA-05-4415-01A-22D-1855-08	TCGA-05-4415-01A-22D-1855-08		7f9f381e-edb1-4a5e-b5f7-c31b2a769912				TCGA-05-4415-01A-22D-1854-01	TCGA-05-4415-01A-22D-1856-05	TCGA-05-4415-01	TCGA-05-4415-01A-22D-1854-01		7f9f381e-edb1-4a5e-b5f7-c31b2a769912	TCGA-05-4415-01		7f9f381e-edb1-4a5e-b5f7-c31b2a769912	TCGA-05-4415-01		7f9f381e-edb1-4a5e-b5f7-c31b2a769912	TCGA-05-4415-01A-22D-1855-08	TCGA-05-4415-01	
TCGA-05-4417-01	2.96	0.39	none		none	none	none	Y	Y	none	none	none	0.16	Magnoid	none	p.G12C	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			p.H168R	0	TCGA-05-4417-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 12	TCGA-05-4417	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					51	R-Upper		TCGA-05-4417-F36502	TCGA-05-4417	TCGA-05-4417-01A			-18780			0	455									Scheduled Follow-up Submission	Partial Remission/Response	2012-10-31	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.8	NO						1.4	NO		NO	56		No	M0	N0	T2	Stage IB	TCGA-05-4417.0b795830-d3bf-4a94-8355-b76a5f4469a5.pdf	4417		TUMOR FREE					Partial Remission/Response				NO	R0	Primary Tumor	01	0.3	2008	6th	NO	NO	YES	05	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2008	1971	TCGA-05-4417-01A-22D-1855-08	TCGA-05-4417-01A-22D-1855-08		c5c76768-3b14-4d6e-9455-13783631d796				TCGA-05-4417-01A-22D-1854-01	TCGA-05-4417-01A-22D-1856-05	TCGA-05-4417-01	TCGA-05-4417-01A-22D-1854-01		c5c76768-3b14-4d6e-9455-13783631d796	TCGA-05-4417-01	TCGA-05-4417-01A-23-2190-20	c5c76768-3b14-4d6e-9455-13783631d796	TCGA-05-4417-01	9d52cd8c-4ff7-44fb-8abc-441150545c46	c5c76768-3b14-4d6e-9455-13783631d796	TCGA-05-4417-01A-22D-1855-08	TCGA-05-4417-01	
TCGA-05-4418-01	2.01	0.53	none		none	none	none	Y	Y	none	none	none	0.26	Magnoid	none	p.G12C	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-05-4418-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA c1uster 9	cluster 4	mutation cluster 12	TCGA-05-4418	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	L-Lower			TCGA-05-4418	TCGA-05-4418-01A			-25417		274	0												2010-7-22	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		1	NO						1.2				25		Yes	M0	N2	T3	Stage IIIA	TCGA-05-4418.4d77e536-98f2-4e34-9e76-adb4bc79bf5e.pdf	4418												R0	Primary Tumor	01	0.4		6th		NO	YES	05	2	Current smoker	Lung	A	DECEASED	2008		TCGA-05-4418-01A-01D-1265-08	TCGA-05-4418-01A-01D-1265-08		271766c9-819e-4555-89d7-dc7a52203386		TCGA-05-4418-01A-01D-1205-05	TCGA-05-4418-01	TCGA-05-4418-01A-01D-1204-01		TCGA-05-4418-01	TCGA-05-4418-01A-01D-1204-01		271766c9-819e-4555-89d7-dc7a52203386		TCGA-05-4418-01A-21-2190-20	271766c9-819e-4555-89d7-dc7a52203386	TCGA-05-4418-01	51411ac1-143c-428b-8a13-22ececc4d2f0	271766c9-819e-4555-89d7-dc7a52203386	TCGA-05-4418-01A-01D-1265-08		TCGA-05-4418-01
TCGA-05-4420-01	3.53	0.6	none		none	none	none	N	Y	none	none	none	0.21	Magnoid	p.Q61L	none	none	none	none	none	none	Invasive mucinous	Invasive mucinous			none	1	TCGA-05-4420-01	High	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 6	cluster 1	mutation cluster 3	TCGA-05-4420	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					41	R-Lower		TCGA-05-4420-F36531	TCGA-05-4420	TCGA-05-4420-01A			-15159			0	912									Scheduled Follow-up Submission	Complete Remission/Response	2012-11-1	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.8	NO						0.8	NO		NO	38		No	M0	N0	T2	Stage IB	TCGA-05-4420.682a1fdc-41dd-441b-831c-fe3cf834638e.pdf	4420		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.3		6th	NO	NO	YES	05	2	Current smoker	Lung	A	LIVING	2008		TCGA-05-4420-01A-01D-1265-08	TCGA-05-4420-01A-01D-1265-08		89dda3b6-2905-4577-9b74-965fb7f77c98		TCGA-05-4420-01A-01D-1205-05	TCGA-05-4420-01	TCGA-05-4420-01A-01D-1204-01		TCGA-05-4420-01	TCGA-05-4420-01A-01D-1204-01		89dda3b6-2905-4577-9b74-965fb7f77c98		TCGA-05-4420-01A-21-2190-20	89dda3b6-2905-4577-9b74-965fb7f77c98	TCGA-05-4420-01	17a82652-9990-4947-998e-ac10b35923d2	89dda3b6-2905-4577-9b74-965fb7f77c98	TCGA-05-4420-01A-01D-1265-08		TCGA-05-4420-01
TCGA-05-4422-01	2.09	0.63	none		none	none	p.S37F	N	N	none	none	none	0.31	Magnoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			p.G251V	1	TCGA-05-4422-01	COAD-READ	C1-LUAD-enriched		Low purity c2	squamous c3	LUAD-like c10	miRNA cluster 7	cluster 4	mutation c1uster 9	TCGA-05-4422	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					68	L-Lower			TCGA-05-4422	TCGA-05-4422-01A			-24837			0	365											2010-7-22	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.8	NO						1.5				147		No	M0	N0	T2	Stage IB	TCGA-05-4422.b51045ca-f7ae-459f-90b7-631683d84e0f.pdf	4422												R0	Primary Tumor	01	0.4		6th		NO	YES	05	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2008		TCGA-05-4422-01A-01D-1265-08	TCGA-05-4422-01A-01D-1265-08		2662f59e-0959-4fbf-a8bf-6ad639e44005		TCGA-05-4422-01A-01D-1205-05	TCGA-05-4422-01	TCGA-05-4422-01A-01D-1204-01		TCGA-05-4422-01	TCGA-05-4422-01A-01D-1204-01		2662f59e-0959-4fbf-a8bf-6ad639e44005		TCGA-05-4422-01A-21-2190-20	2662f59e-0959-4fbf-a8bf-6ad639e44005	TCGA-05-4422-01	6fd0d313-a9a6-46e2-b37f-d2bc537bed19	2662f59e-0959-4fbf-a8bf-6ad639e44005	TCGA-05-4422-01A-01D-1265-08		TCGA-05-4422-01
TCGA-05-4424-01			none		none	none	none	N	N	none	none	none		Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-05-4424-01	High	C1-LUAD-enriched	cluster 3	Low purity c2		LUAD-like c10	miRNA cluster 5	cluster 5	mutation cluster 2	TCGA-05-4424	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung		YES			70	R-Upper		TCGA-05-4424-F36536	TCGA-05-4424				-25689			0	913	153								Scheduled Follow-up Submission	Partial Remission/Response	2012-11-1	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES										NO	Distant Metastasis	YES	50		No	M0	N0	T3	Stage IIB		4424		WITH TUMOR					Progressive Disease				YES	R1	Primary Tumor	01		2007	6th	YES	NO	YES	05	4	Current reformed smoker for < or = 15 years	Lung		LIVING	2008	1957	TCGA-05-4424-01A-22D-1855-08	TCGA-05-4424-01A-22D-1855-08		c4da944d-4055-493e-bb87-7ccd1e5d1a87				TCGA-05-4424-01A-22D-1854-01	TCGA-05-4424-01A-22D-1856-05	TCGA-05-4424-01	TCGA-05-4424-01A-22D-1854-01		c4da944d-4055-493e-bb87-7ccd1e5d1a87	TCGA-05-4424-01		c4da944d-4055-493e-bb87-7ccd1e5d1a87	TCGA-05-4424-01		c4da944d-4055-493e-bb87-7ccd1e5d1a87	TCGA-05-4424-01A-22D-1855-08	TCGA-05-4424-01	
TCGA-05-4425-01	1.96	0.61	none		none	none	p.S45F	N	N	none	none	none	0.31	Squamoid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-05-4425-01	Kirc+	C1-LUAD-enriched	cluster 1	Cluster 6		LUAD-like c10	miRNA cluster 4	cluster 1	mutation c1uster 9	TCGA-05-4425	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	R-Middle			TCGA-05-4425				-25902			0	669											2010-7-22	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.2	8255/3	C34.2	YES													28		No	M1	N0	T2	Stage IV		4425												R1	Primary Tumor	01			6th		NO	YES	05	3	Current reformed smoker for > 15 years	Lung		LIVING	2008		TCGA-05-4425-01A-01D-1753-08	TCGA-05-4425-01A-01D-1753-08		ac9dd948-4352-4869-85a1-639151a4bffb				TCGA-05-4425-01A-01D-1752-01	TCGA-05-4425-01A-01D-1756-05	TCGA-05-4425-01	TCGA-05-4425-01A-01D-1752-01		ac9dd948-4352-4869-85a1-639151a4bffb	TCGA-05-4425-01		ac9dd948-4352-4869-85a1-639151a4bffb	TCGA-05-4425-01		ac9dd948-4352-4869-85a1-639151a4bffb		TCGA-05-4425-01	
TCGA-05-4426-01	1.99	0.71	none		none	none	none	N	Y	none	none	none	0.36	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc		Y	none	0	TCGA-05-4426-01	Kirc+	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 5	TCGA-05-4426	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	L-Lower		TCGA-05-4426-F36562	TCGA-05-4426				-26084			0	791	457								Scheduled Follow-up Submission	Complete Remission/Response	2012-11-2	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES										NO		YES	20		No	M0	N0	T2	Stage IB		4426		TUMOR FREE					Complete Remission/Response					R0	Primary Tumor	01			6th		NO	YES	05	3	Current reformed smoker for > 15 years	Lung		LIVING	2008		TCGA-05-4426-01A-01D-1265-08	TCGA-05-4426-01A-01D-1265-08		b2aba2a6-3b30-41bb-a4cc-74f36b60a114		TCGA-05-4426-01A-01D-1205-05	TCGA-05-4426-01	TCGA-05-4426-01A-01D-1204-01		TCGA-05-4426-01	TCGA-05-4426-01A-01D-1204-01		b2aba2a6-3b30-41bb-a4cc-74f36b60a114		TCGA-05-4426-01A-21-2190-20	b2aba2a6-3b30-41bb-a4cc-74f36b60a114	TCGA-05-4426-01	c737047d-6c28-4463-84b6-dd585bb960fc	b2aba2a6-3b30-41bb-a4cc-74f36b60a114	TCGA-05-4426-01A-01D-1265-08		TCGA-05-4426-01
TCGA-05-4427-01																												TCGA-05-4427-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 11	TCGA-05-4427	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					65	L-Upper		TCGA-05-4427-F36564	TCGA-05-4427	TCGA-05-4427-01A			-23893			0	791									Scheduled Follow-up Submission	Complete Remission/Response	2012-11-2	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.6	NO						1.7	NO		NO	8		Yes	M0	N1	T2	Stage IIB	TCGA-05-4427.06c7cdb1-5048-4c75-9002-090997275eff.pdf	4427		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.3	2008	6th	YES	NO	YES	05	4		Lung	A	LIVING	2008	1993	TCGA-05-4427-01A-21D-1855-08			fd4a3155-ca05-464c-b8d9-816103de489d				TCGA-05-4427-01A-21D-1854-01	TCGA-05-4427-01A-21D-1856-05	TCGA-05-4427-01	TCGA-05-4427-01A-21D-1854-01		fd4a3155-ca05-464c-b8d9-816103de489d	TCGA-05-4427-01	TCGA-05-4427-01A-22-2190-20	fd4a3155-ca05-464c-b8d9-816103de489d	TCGA-05-4427-01	8d0744f3-398b-485e-a564-092cc3d1a268	fd4a3155-ca05-464c-b8d9-816103de489d	TCGA-05-4427-01A-21D-1855-08	TCGA-05-4427-01	
TCGA-05-4430-01	3.44	0.2	none		none	none	none	N	N	none	none	none	0.09	Bronchioid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-05-4430-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 2	TCGA-05-4430	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					59	L-Lower		TCGA-05-4430-F36427	TCGA-05-4430				-21884			0	761									Scheduled Follow-up Submission	Complete Remission/Response	2012-10-30	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES										NO		NO	80		No	M0	N0	T2	Stage IB		4430		TUMOR FREE										R0	Primary Tumor	01			6th		NO	YES	05	4	Current reformed smoker for < or = 15 years	Lung		LIVING	2008		TCGA-05-4430-01A-02D-1265-08	TCGA-05-4430-01A-02D-1265-08		bda96534-9900-4f6f-ab17-a09f52dfada4		TCGA-05-4430-01A-02D-1205-05	TCGA-05-4430-01	TCGA-05-4430-01A-02D-1204-01		TCGA-05-4430-01	TCGA-05-4430-01A-02D-1204-01		bda96534-9900-4f6f-ab17-a09f52dfada4		TCGA-05-4430-01A-11-2190-20	bda96534-9900-4f6f-ab17-a09f52dfada4	TCGA-05-4430-01	c4a810c3-91fc-4010-a669-cb616238d295	bda96534-9900-4f6f-ab17-a09f52dfada4	TCGA-05-4430-01A-02D-1265-08		TCGA-05-4430-01
TCGA-05-4432-01	3.33	0.37	none		none	none	none	N	N	none	none	p.P1206L	0.15	Magnoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			p.137_138QE>H*	1	TCGA-05-4432-01	High	C1-LUAD-enriched		Low purity c2		LUAD-like c10	miRNA cluster 7	cluster 4	mutation cluster 2	TCGA-05-4432	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					66	R-Upper		TCGA-05-4432-F36424	TCGA-05-4432	TCGA-05-4432-01A			-24350			0	761									Scheduled Follow-up Submission	Complete Remission/Response	2012-10-30	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.7	NO						1	NO		NO	58		No	M0	N1	T2	Stage IIB	TCGA-05-4432.f99933b1-6f7b-4e5e-87a4-4f902d031c76.pdf	4432		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.3		6th	YES	NO	YES	05	2	Current smoker	Lung	A	LIVING	2008		TCGA-05-4432-01A-01D-1265-08	TCGA-05-4432-01A-01D-1265-08		31769d4d-64f5-4a2b-b8da-d5b2252badb3		TCGA-05-4432-01A-01D-1205-05	TCGA-05-4432-01	TCGA-05-4432-01A-01D-1204-01		TCGA-05-4432-01	TCGA-05-4432-01A-01D-1204-01		31769d4d-64f5-4a2b-b8da-d5b2252badb3			31769d4d-64f5-4a2b-b8da-d5b2252badb3	TCGA-05-4432-01		31769d4d-64f5-4a2b-b8da-d5b2252badb3	TCGA-05-4432-01A-01D-1265-08		TCGA-05-4432-01
TCGA-05-4433-01	1.9	0.61	none		none	none	none	Y	Y	none	none	none	0.31	Bronchioid	none	p.G12V	none	none	none	none	none	Invasive mucinous	Invasive mucinous			none	0	TCGA-05-4433-01	Squamous	C1-LUAD-enriched	cluster 2	Cluster 5		LUAD-like c10	miRNA cluster 4	cluster 1	mutation cluster 2	TCGA-05-4433	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					82	L-Lower		TCGA-05-4433-F36530	TCGA-05-4433	TCGA-05-4433-01A			-30194			0	730									Scheduled Follow-up Submission	Complete Remission/Response	2012-11-1	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		1	NO						1.1	NO		NO	1		No	M0	N0	T2	Stage IB	TCGA-05-4433.eeae318d-a517-48b6-9a21-5c72dc4bd510.pdf	4433		TUMOR FREE										R0	Primary Tumor	01	0.3	1948	6th		NO	YES	05	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2008	1946	TCGA-05-4433-01A-22D-1855-08	TCGA-05-4433-01A-22D-1855-08		013f7a4f-eec9-4ba8-8473-6515cdc9be68				TCGA-05-4433-01A-22D-1854-01	TCGA-05-4433-01A-22D-1856-05	TCGA-05-4433-01	TCGA-05-4433-01A-22D-1854-01		013f7a4f-eec9-4ba8-8473-6515cdc9be68	TCGA-05-4433-01		013f7a4f-eec9-4ba8-8473-6515cdc9be68	TCGA-05-4433-01		013f7a4f-eec9-4ba8-8473-6515cdc9be68	TCGA-05-4433-01A-22D-1855-08	TCGA-05-4433-01	
TCGA-05-4434-01																												TCGA-05-4434-01	Kirc+	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4		mutation c1uster 9	TCGA-05-4434	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					67	R-Lower			TCGA-05-4434	TCGA-05-4434-01A			-24472		457	0												2010-7-22	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.8	NO						1.3				15		Yes	M1	N1	T4	Stage IV	TCGA-05-4434.0e9e74b2-7fd5-47b0-adf5-83c83b0c2d3d.pdf	4434												R2	Primary Tumor	01	0.3		6th		NO	YES	05	2		Lung	A	DECEASED	2008		TCGA-05-4434-01A-01D-1265-08			49511397-f9b7-4946-98b7-d26f9a2ec0c2		TCGA-05-4434-01A-01D-1205-05	TCGA-05-4434-01	TCGA-05-4434-01A-01D-1204-01		TCGA-05-4434-01	TCGA-05-4434-01A-01D-1204-01		49511397-f9b7-4946-98b7-d26f9a2ec0c2		TCGA-05-4434-01A-21-2190-20	49511397-f9b7-4946-98b7-d26f9a2ec0c2	TCGA-05-4434-01	a1067628-2a22-4bbf-8978-7ae9b7953e39	49511397-f9b7-4946-98b7-d26f9a2ec0c2	TCGA-05-4434-01A-01D-1265-08		TCGA-05-4434-01
TCGA-05-5420-01	1.83	0.25	none		none	none	none	N	N	none	none	none	0.13	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-05-5420-01	High	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-05-5420	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					67	L-Upper		TCGA-05-5420-F36422	TCGA-05-5420	TCGA-05-5420-01A			-24472			0	457	245								Scheduled Follow-up Submission	Progressive Disease	2012-10-30	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES		0.9	NO						1	NO		YES	40		Yes	M0	N2	T2	Stage IIIA	TCGA-05-5420.0777F8E7-46DF-4C9C-8CE9-B9B6E36DBAF5.pdf	5420		WITH TUMOR					Progressive Disease					R0	Primary Tumor	01	0.3	2001	6th		NO	YES	05	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2008	1961	TCGA-05-5420-01A-01D-1625-08	TCGA-05-5420-01A-01D-1625-08		8d78dad5-81bc-41d5-83db-10bec2cf114e				TCGA-05-5420-01A-01D-1624-01	TCGA-05-5420-01A-01D-1626-05	TCGA-05-5420-01	TCGA-05-5420-01A-01D-1624-01		8d78dad5-81bc-41d5-83db-10bec2cf114e		TCGA-05-5420-01A-21-2190-20	8d78dad5-81bc-41d5-83db-10bec2cf114e	TCGA-05-5420-01	24209db7-f1fb-41fd-9f5e-de3f6480a606	8d78dad5-81bc-41d5-83db-10bec2cf114e	TCGA-05-5420-01A-01D-1625-08		
TCGA-05-5420-11	1.83	0.25	none		none	none	none	N	N	none	none	none	0.13	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-05-5420-11		C1-LUAD-enriched							mutation c1uster 9	TCGA-05-5420	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					67	L-Upper		TCGA-05-5420-F36422	TCGA-05-5420	TCGA-05-5420-11A			-24472			0	457	245								Scheduled Follow-up Submission	Progressive Disease	2012-10-30	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES		0.9	NO						0.9	NO		YES	40		Yes	M0	N2	T2	Stage IIIA		5420		WITH TUMOR					Progressive Disease					R0	Solid Tissue Normal	11	0.9	2001	6th		NO	YES	05	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2008	1961									TCGA-05-5420-11A-01D-1626-05													
TCGA-05-5423-01	2.36	0.6	none		none	none	none	Y	Y	p.L833F, p.L861Q	none	none	0.27	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-05-5423-01	High	C1-LUAD-enriched	cluster 3	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4	mutation cluster 8	TCGA-05-5423	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					65	L-Upper			TCGA-05-5423	TCGA-05-5423-01A			-23863			0	151											2011-3-22	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.9	8255/3	C34.9	YES		0.8	NO						1.4				72		No	M0	N1	T2	Stage IIB	TCGA-05-5423.37823CCB-824B-4761-A520-A9F2C8D457EF.pdf	5423		TUMOR FREE										R0	Primary Tumor	01	0.3	1980	6th		NO	YES	05	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2006	1956	TCGA-05-5423-01A-01D-1625-08	TCGA-05-5423-01A-01D-1625-08		44d80508-53d8-4ba3-b263-8c31e4b58096				TCGA-05-5423-01A-01D-1624-01	TCGA-05-5423-01A-01D-1626-05	TCGA-05-5423-01	TCGA-05-5423-01A-01D-1624-01		44d80508-53d8-4ba3-b263-8c31e4b58096	TCGA-05-5423-01	TCGA-05-5423-01A-21-2190-20	44d80508-53d8-4ba3-b263-8c31e4b58096	TCGA-05-5423-01	4c1ed504-6b5d-49d4-bc1d-5844ae2e7f8b	44d80508-53d8-4ba3-b263-8c31e4b58096	TCGA-05-5423-01A-01D-1625-08	TCGA-05-5423-01	
TCGA-05-5425-01																												TCGA-05-5425-01	High	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4		mutation c1uster 9	TCGA-05-5425	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					68	R-Upper		TCGA-05-5425-F36403	TCGA-05-5425	TCGA-05-5425-01A			-25020			0	882	486								Scheduled Follow-up Submission	Progressive Disease	2012-10-30	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.9	8255/3	C34.9	YES		0.9	NO						1.2	NO		YES	40		No	M0	N1	T2b	Stage IIB	TCGA-05-5425.6367B293-BF9C-4651-9B73-7B9D1764948D.pdf	5425		WITH TUMOR									YES	R0	Primary Tumor	01	0.4	1985	7th	YES	NO	YES	05	3		Lung	A	LIVING	2009	1965	TCGA-05-5425-01A-02D-1625-08			46b786be-8c30-4025-aa29-708c76bb4bcf				TCGA-05-5425-01A-02D-1624-01	TCGA-05-5425-01A-02D-1626-05	TCGA-05-5425-01	TCGA-05-5425-01A-02D-1624-01		46b786be-8c30-4025-aa29-708c76bb4bcf	TCGA-05-5425-01	TCGA-05-5425-01A-11-2190-20	46b786be-8c30-4025-aa29-708c76bb4bcf	TCGA-05-5425-01	591cdbcf-f93b-4ae6-b1ad-7cc69a11862b	46b786be-8c30-4025-aa29-708c76bb4bcf	TCGA-05-5425-01A-02D-1625-08	TCGA-05-5425-01	
TCGA-05-5428-01	3.37	0.63	none		p.D594N	none	none	N	Y	none	none	none	0.22	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-05-5428-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 1	Cluster 6		LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 8	TCGA-05-5428	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					57	R-Upper		TCGA-05-5428-F36401	TCGA-05-5428	TCGA-05-5428-01A			-21061			0	670									Scheduled Follow-up Submission	Complete Remission/Response	2012-10-30	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.9	8255/3	C34.9	YES		0.8	NO						1	NO		NO	30		No	M0	N1	T1b	Stage IIA	TCGA-05-5428.E5422AE1-E0E5-470E-A6E2-E66BF61B157B.pdf	5428		TUMOR FREE					Complete Remission/Response				YES	R0	Primary Tumor	01	0.2	1993	7th	YES	NO	YES	05	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2010	1969	TCGA-05-5428-01A-01D-1625-08	TCGA-05-5428-01A-01D-1625-08		7dfdb65a-8f75-4223-8e5c-bb13f1d8eb3b				TCGA-05-5428-01A-01D-1624-01	TCGA-05-5428-01A-01D-1626-05	TCGA-05-5428-01	TCGA-05-5428-01A-01D-1624-01		7dfdb65a-8f75-4223-8e5c-bb13f1d8eb3b	TCGA-05-5428-01		7dfdb65a-8f75-4223-8e5c-bb13f1d8eb3b	TCGA-05-5428-01		7dfdb65a-8f75-4223-8e5c-bb13f1d8eb3b	TCGA-05-5428-01A-01D-1625-08	TCGA-05-5428-01	
TCGA-05-5429-01	2.07	0.47	none		none	none	none	N	N	none	none	none	0.23	Magnoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-05-5429-01	Iq	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 8	cluster 1	mutation c1uster 9	TCGA-05-5429	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					60	L-Upper		TCGA-05-5429-F36396	TCGA-05-5429	TCGA-05-5429-01A			-22066		275	0	30									Scheduled Follow-up Submission		2012-10-30	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES		0.9	NO						1	NO					No	M0	N2	T3	Stage IIIA	TCGA-05-5429.087C433B-9B20-439A-932C-4C852341A052.pdf	5429		TUMOR FREE										R0	Primary Tumor	01	0.3		7th		NO	YES	05	1	Lifelong Non-smoker	Lung	A	DECEASED	2010		TCGA-05-5429-01A-01D-1625-08	TCGA-05-5429-01A-01D-1625-08		33f213fa-6fa4-48ed-bd7e-a63ed8c3a8da				TCGA-05-5429-01A-01D-1624-01	TCGA-05-5429-01A-01D-1626-05	TCGA-05-5429-01	TCGA-05-5429-01A-01D-1624-01		33f213fa-6fa4-48ed-bd7e-a63ed8c3a8da	TCGA-05-5429-01	TCGA-05-5429-01A-21-2190-20	33f213fa-6fa4-48ed-bd7e-a63ed8c3a8da	TCGA-05-5429-01	88f95b94-582d-4db9-82d1-f6253c6c9837	33f213fa-6fa4-48ed-bd7e-a63ed8c3a8da	TCGA-05-5429-01A-01D-1625-08	TCGA-05-5429-01	
TCGA-05-5715-01	1.82	0.74	none		none	none	none	N	Y	none	p.774_775insAYVM	none	0.4	Bronchioid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-05-5715-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 2	Cluster 6	KIRC-like c1	LUAD-like c10	miRNA c1uster 10	cluster 5	mutation c1uster 10	TCGA-05-5715	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	L-Upper			TCGA-05-5715	TCGA-05-5715-01A			-25383			0	62											2011-3-22	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.6	NO						0.9						No	M0	N0	T2a	Stage IB	TCGA-05-5715.b764fced-b638-48c6-82a6-4d3663bb2168.pdf	5715		TUMOR FREE										R0	Primary Tumor	01	0.6		7th		NO	YES	05	1	Lifelong Non-smoker	Lung	A	LIVING	2010		TCGA-05-5715-01A-01D-1625-08	TCGA-05-5715-01A-01D-1625-08		a9c81a18-bc29-4fac-83b2-bbd8047599bd				TCGA-05-5715-01A-01D-1624-01	TCGA-05-5715-01A-01D-1626-05	TCGA-05-5715-01	TCGA-05-5715-01A-01D-1624-01		a9c81a18-bc29-4fac-83b2-bbd8047599bd	TCGA-05-5715-01	TCGA-05-5715-01A-41-2191-20	a9c81a18-bc29-4fac-83b2-bbd8047599bd	TCGA-05-5715-01	4f36ddf4-4d4a-4733-9809-d4fd53d8457a	a9c81a18-bc29-4fac-83b2-bbd8047599bd	TCGA-05-5715-01A-01D-1625-08	TCGA-05-5715-01	
TCGA-17-Z000-01																												TCGA-17-Z000-01				Cluster 5					mutation c1uster 9	TCGA-17-Z000	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z000-01A-01W-0746-08					TCGA-17-Z000-01A-01D-0752-05														TCGA-17-Z000-01A-01W-0746-08		
TCGA-17-Z001-01																												TCGA-17-Z001-01				Cluster 5					mutation cluster 8	TCGA-17-Z001	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z001-01A-01W-0746-08					TCGA-17-Z001-01A-01D-0752-05														TCGA-17-Z001-01A-01W-0746-08		
TCGA-17-Z002-01																												TCGA-17-Z002-01				Cluster 6						TCGA-17-Z002	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																										TCGA-17-Z002-01A-01D-0752-05														TCGA-17-Z002-01A-01W-0746-08		
TCGA-17-Z003-01																												TCGA-17-Z003-01				Cluster 5					mutation cluster 5	TCGA-17-Z003	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z003-01A-01W-0746-08					TCGA-17-Z003-01A-01D-0752-05														TCGA-17-Z003-01A-01W-0746-08		
TCGA-17-Z004-01																												TCGA-17-Z004-01				Low purity c2					mutation c1uster 9	TCGA-17-Z004	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z004-01A-01W-0746-08					TCGA-17-Z004-01A-01D-0752-05														TCGA-17-Z004-01A-01W-0746-08		
TCGA-17-Z005-01																												TCGA-17-Z005-01				Cluster 6					mutation cluster 5	TCGA-17-Z005	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z005-01A-01W-0746-08					TCGA-17-Z005-01A-01D-0752-05														TCGA-17-Z005-01A-01W-0746-08		
TCGA-17-Z006-01																												TCGA-17-Z006-01				Cluster 5						TCGA-17-Z006	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																										TCGA-17-Z006-01A-01D-0752-05																
TCGA-17-Z007-01																												TCGA-17-Z007-01				COADREAD non-CIMP c11					mutation cluster 5	TCGA-17-Z007	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z007-01A-01W-0746-08					TCGA-17-Z007-01A-01D-0752-05														TCGA-17-Z007-01A-01W-0746-08		
TCGA-17-Z008-01																												TCGA-17-Z008-01				Cluster 5					mutation cluster 7	TCGA-17-Z008	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z008-01A-01W-0746-08					TCGA-17-Z008-01A-01D-0752-05																
TCGA-17-Z009-01																												TCGA-17-Z009-01				Low purity c2					mutation cluster 14	TCGA-17-Z009	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z009-01A-01W-0746-08					TCGA-17-Z009-01A-01D-0752-05														TCGA-17-Z009-01A-01W-0746-08		
TCGA-17-Z010-01																												TCGA-17-Z010-01				Cluster 6					mutation cluster 7	TCGA-17-Z010	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z010-01A-01W-0746-08					TCGA-17-Z010-01A-01D-0752-05														TCGA-17-Z010-01A-01W-0746-08		
TCGA-17-Z011-01																												TCGA-17-Z011-01				Cluster 5					mutation c1uster 9	TCGA-17-Z011	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z011-01A-01W-0746-08					TCGA-17-Z011-01A-01D-0752-05														TCGA-17-Z011-01A-01W-0746-08		
TCGA-17-Z012-01																												TCGA-17-Z012-01				Cluster 5					mutation cluster 5	TCGA-17-Z012	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z012-01A-01W-0746-08					TCGA-17-Z012-01A-01D-0752-05																
TCGA-17-Z013-01																												TCGA-17-Z013-01				Cluster 5					mutation c1uster 9	TCGA-17-Z013	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z013-01A-01W-0746-08					TCGA-17-Z013-01A-01D-0752-05														TCGA-17-Z013-01A-01W-0746-08		
TCGA-17-Z014-01																												TCGA-17-Z014-01				Cluster 6					mutation cluster 12	TCGA-17-Z014	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z014-01A-01W-0746-08					TCGA-17-Z014-01A-01D-0752-05														TCGA-17-Z014-01A-01W-0746-08		
TCGA-17-Z015-01																												TCGA-17-Z015-01				Cluster 6					mutation cluster 8	TCGA-17-Z015	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z015-01A-01W-0746-08					TCGA-17-Z015-01A-01D-0752-05														TCGA-17-Z015-01A-01W-0746-08		
TCGA-17-Z016-01																												TCGA-17-Z016-01				Cluster 5					mutation cluster 12	TCGA-17-Z016	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z016-01A-01W-0746-08					TCGA-17-Z016-01A-01D-0752-05														TCGA-17-Z016-01A-01W-0746-08		
TCGA-17-Z017-01																												TCGA-17-Z017-01				Cluster 6					mutation cluster 2	TCGA-17-Z017	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z017-01A-01W-0746-08					TCGA-17-Z017-01A-01D-0752-05														TCGA-17-Z017-01A-01W-0746-08		
TCGA-17-Z018-01																												TCGA-17-Z018-01				Cluster 5					mutation cluster 6	TCGA-17-Z018	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z018-01A-01W-0746-08					TCGA-17-Z018-01A-01D-0752-05														TCGA-17-Z018-01A-01W-0746-08		
TCGA-17-Z019-01																												TCGA-17-Z019-01				Cluster 5						TCGA-17-Z019	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																										TCGA-17-Z019-01A-01D-0752-05														TCGA-17-Z019-01A-01W-0746-08		
TCGA-17-Z020-01																												TCGA-17-Z020-01				Cluster 5					mutation cluster 2	TCGA-17-Z020	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z020-01A-01W-0746-08					TCGA-17-Z020-01A-01D-0752-05														TCGA-17-Z020-01A-01W-0746-08		
TCGA-17-Z021-01																												TCGA-17-Z021-01				Cluster 5					mutation cluster 5	TCGA-17-Z021	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z021-01A-01W-0746-08					TCGA-17-Z021-01A-01D-0752-05														TCGA-17-Z021-01A-01W-0746-08		
TCGA-17-Z022-01																												TCGA-17-Z022-01				Cluster 5					mutation cluster 11	TCGA-17-Z022	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z022-01A-01W-0746-08					TCGA-17-Z022-01A-01D-0752-05														TCGA-17-Z022-01A-01W-0746-08		
TCGA-17-Z023-01																												TCGA-17-Z023-01				Low purity c2					mutation cluster 2	TCGA-17-Z023	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z023-01A-01W-0746-08					TCGA-17-Z023-01A-01D-0752-05														TCGA-17-Z023-01A-01W-0746-08		
TCGA-17-Z024-01																												TCGA-17-Z024-01				Cluster 5						TCGA-17-Z024	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																										TCGA-17-Z024-01A-01D-0752-05																
TCGA-17-Z025-01																												TCGA-17-Z025-01				Cluster 6					mutation cluster 12	TCGA-17-Z025	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z025-01A-01W-0746-08					TCGA-17-Z025-01A-01D-0752-05														TCGA-17-Z025-01A-01W-0746-08		
TCGA-17-Z026-01																												TCGA-17-Z026-01				Cluster 5					mutation cluster 11	TCGA-17-Z026	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z026-01A-01W-0746-08					TCGA-17-Z026-01A-01D-0752-05														TCGA-17-Z026-01A-01W-0746-08		
TCGA-17-Z027-01																												TCGA-17-Z027-01				Cluster 5					mutation cluster 8	TCGA-17-Z027	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z027-01A-01W-0746-08					TCGA-17-Z027-01A-01D-0752-05														TCGA-17-Z027-01A-01W-0746-08		
TCGA-17-Z028-01																												TCGA-17-Z028-01				Cluster 5					mutation cluster 8	TCGA-17-Z028	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z028-01A-01W-0746-08					TCGA-17-Z028-01A-01D-0752-05														TCGA-17-Z028-01A-01W-0746-08		
TCGA-17-Z029-01																												TCGA-17-Z029-01				Low purity c2						TCGA-17-Z029	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																										TCGA-17-Z029-01A-01D-0752-05																
TCGA-17-Z030-01																												TCGA-17-Z030-01				Cluster 5					mutation cluster 11	TCGA-17-Z030	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z030-01A-01W-0746-08					TCGA-17-Z030-01A-01D-0752-05														TCGA-17-Z030-01A-01W-0746-08		
TCGA-17-Z031-01																												TCGA-17-Z031-01				Cluster 6					mutation cluster 11	TCGA-17-Z031	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z031-01A-01W-0746-08					TCGA-17-Z031-01A-01D-0752-05														TCGA-17-Z031-01A-01W-0746-08		
TCGA-17-Z032-01																												TCGA-17-Z032-01				Cluster 5					mutation cluster 14	TCGA-17-Z032	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z032-01A-01W-0746-08					TCGA-17-Z032-01A-01D-0752-05														TCGA-17-Z032-01A-01W-0746-08		
TCGA-17-Z033-01																												TCGA-17-Z033-01				Cluster 6					mutation cluster 12	TCGA-17-Z033	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z033-01A-01W-0746-08					TCGA-17-Z033-01A-01D-0752-05														TCGA-17-Z033-01A-01W-0746-08		
TCGA-17-Z034-01																												TCGA-17-Z034-01				Low purity c2						TCGA-17-Z034	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																										TCGA-17-Z034-01A-01D-0752-05																
TCGA-17-Z035-01																												TCGA-17-Z035-01				Cluster 5					mutation cluster 8	TCGA-17-Z035	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z035-01A-01W-0746-08					TCGA-17-Z035-01A-01D-0752-05																
TCGA-17-Z036-01																												TCGA-17-Z036-01				Cluster 5					mutation cluster 12	TCGA-17-Z036	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z036-01A-01W-0746-08					TCGA-17-Z036-01A-01D-0752-05														TCGA-17-Z036-01A-01W-0746-08		
TCGA-17-Z037-01																												TCGA-17-Z037-01				COADREAD non-CIMP c11					mutation cluster 2	TCGA-17-Z037	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z037-01A-01W-0746-08					TCGA-17-Z037-01A-01D-0752-05														TCGA-17-Z037-01A-01W-0746-08		
TCGA-17-Z038-01																												TCGA-17-Z038-01				Cluster 5					mutation c1uster 9	TCGA-17-Z038	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z038-01A-01W-0746-08					TCGA-17-Z038-01A-01D-0752-05																
TCGA-17-Z039-01																												TCGA-17-Z039-01				Low purity c2					mutation c1uster 9	TCGA-17-Z039	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z039-01A-01W-0746-08					TCGA-17-Z039-01A-01D-0752-05																
TCGA-17-Z040-01																												TCGA-17-Z040-01				Cluster 5					mutation c1uster 9	TCGA-17-Z040	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z040-01A-01W-0746-08					TCGA-17-Z040-01A-01D-0752-05																
TCGA-17-Z041-01																												TCGA-17-Z041-01				Cluster 5					mutation c1uster 9	TCGA-17-Z041	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z041-01A-01W-0746-08					TCGA-17-Z041-01A-01D-0752-05														TCGA-17-Z041-01A-01W-0746-08		
TCGA-17-Z042-01																												TCGA-17-Z042-01				Cluster 6					mutation cluster 11	TCGA-17-Z042	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z042-01A-01W-0746-08					TCGA-17-Z042-01A-01D-0752-05														TCGA-17-Z042-01A-01W-0746-08		
TCGA-17-Z043-01																												TCGA-17-Z043-01				Cluster 5					mutation cluster 5	TCGA-17-Z043	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z043-01A-01W-0746-08					TCGA-17-Z043-01A-01D-0752-05														TCGA-17-Z043-01A-01W-0746-08		
TCGA-17-Z044-01																												TCGA-17-Z044-01				Cluster 5					mutation cluster 8	TCGA-17-Z044	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z044-01A-01W-0746-08					TCGA-17-Z044-01A-01D-0752-05														TCGA-17-Z044-01A-01W-0746-08		
TCGA-17-Z045-01																												TCGA-17-Z045-01				Cluster 5					mutation cluster 2	TCGA-17-Z045	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z045-01A-01W-0746-08					TCGA-17-Z045-01A-01D-0752-05														TCGA-17-Z045-01A-01W-0746-08		
TCGA-17-Z046-01																												TCGA-17-Z046-01				Cluster 6					mutation cluster 11	TCGA-17-Z046	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z046-01A-01W-0746-08					TCGA-17-Z046-01A-01D-0752-05																
TCGA-17-Z047-01																												TCGA-17-Z047-01				Cluster 5					mutation cluster 8	TCGA-17-Z047	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z047-01A-01W-0747-08					TCGA-17-Z047-01A-01D-0752-05														TCGA-17-Z047-01A-01W-0747-08		
TCGA-17-Z048-01																												TCGA-17-Z048-01				Cluster 5					mutation cluster 14	TCGA-17-Z048	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z048-01A-01W-0746-08					TCGA-17-Z048-01A-01D-0752-05														TCGA-17-Z048-01A-01W-0746-08		
TCGA-17-Z049-01																												TCGA-17-Z049-01				Cluster 5					mutation cluster 2	TCGA-17-Z049	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z049-01A-01W-0746-08					TCGA-17-Z049-01A-01D-0752-05														TCGA-17-Z049-01A-01W-0746-08		
TCGA-17-Z050-01																												TCGA-17-Z050-01				Cluster 6					mutation cluster 7	TCGA-17-Z050	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z050-01A-01W-0747-08					TCGA-17-Z050-01A-01D-0752-05														TCGA-17-Z050-01A-01W-0747-08		
TCGA-17-Z051-01																												TCGA-17-Z051-01				Cluster 5					mutation c1uster 9	TCGA-17-Z051	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z051-01A-01W-0747-08					TCGA-17-Z051-01A-01D-0752-05														TCGA-17-Z051-01A-01W-0747-08		
TCGA-17-Z052-01																												TCGA-17-Z052-01				Low purity c2					mutation cluster 5	TCGA-17-Z052	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z052-01A-01W-0747-08					TCGA-17-Z052-01A-01D-0752-05														TCGA-17-Z052-01A-01W-0747-08		
TCGA-17-Z053-01																												TCGA-17-Z053-01				Cluster 13 (HNSC-LUSC)					mutation cluster 2	TCGA-17-Z053	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z053-01A-01W-0747-08					TCGA-17-Z053-01A-01D-0752-05														TCGA-17-Z053-01A-01W-0747-08		
TCGA-17-Z054-01																												TCGA-17-Z054-01				Cluster 5					mutation c1uster 9	TCGA-17-Z054	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z054-01A-01W-0747-08					TCGA-17-Z054-01A-01D-0752-05														TCGA-17-Z054-01A-01W-0747-08		
TCGA-17-Z055-01																												TCGA-17-Z055-01									mutation cluster 2	TCGA-17-Z055	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z055-01A-01W-0747-08																			TCGA-17-Z055-01A-01W-0747-08		
TCGA-17-Z056-01																												TCGA-17-Z056-01				Cluster 5					mutation cluster 8	TCGA-17-Z056	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z056-01A-01W-0747-08					TCGA-17-Z056-01A-01D-0752-05														TCGA-17-Z056-01A-01W-0747-08		
TCGA-17-Z057-01																												TCGA-17-Z057-01									mutation cluster 5	TCGA-17-Z057	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z057-01A-01W-0747-08																			TCGA-17-Z057-01A-01W-0747-08		
TCGA-17-Z058-01																												TCGA-17-Z058-01				Cluster 5					mutation cluster 12	TCGA-17-Z058	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z058-01A-01W-0747-08					TCGA-17-Z058-01A-01D-0752-05														TCGA-17-Z058-01A-01W-0747-08		
TCGA-17-Z059-01																												TCGA-17-Z059-01				Cluster 6					mutation c1uster 9	TCGA-17-Z059	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z059-01A-01W-0747-08					TCGA-17-Z059-01A-01D-0752-05														TCGA-17-Z059-01A-01W-0747-08		
TCGA-17-Z060-01																												TCGA-17-Z060-01				Cluster 5					mutation cluster 12	TCGA-17-Z060	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z060-01A-01W-0747-08					TCGA-17-Z060-01A-01D-0752-05														TCGA-17-Z060-01A-01W-0747-08		
TCGA-17-Z061-01																												TCGA-17-Z061-01				Cluster 5					mutation cluster 13	TCGA-17-Z061	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z061-01A-01W-0747-08					TCGA-17-Z061-01A-01D-0752-05														TCGA-17-Z061-01A-01W-0747-08		
TCGA-17-Z062-01																												TCGA-17-Z062-01				Cluster 5					mutation cluster 11	TCGA-17-Z062	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung																																																																																					TCGA-17-Z062-01A-01W-0747-08					TCGA-17-Z062-01A-01D-0752-05														TCGA-17-Z062-01A-01W-0747-08		
TCGA-35-3615-01	2.07	0.68	none		none	none	none	Y	Y	none	none	none	0.33	Magnoid	none	p.G12C	none	none	none	none	none	Lepidic predominant Adc	Lepidic predominant Adc			p.L245_splice	0	TCGA-35-3615-01	Iq	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 7	cluster 4	mutation cluster 12	TCGA-35-3615	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					57	R-Upper		TCGA-35-3615-F68919	TCGA-35-3615				-21076			0	14					NO			NO	Scheduled Follow-up Submission		2015-8-24	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO			Peripheral Lung		YES					No	M0	N0	T2	Stage IB		3615		TUMOR FREE										R0	Primary Tumor	01					NO	YES	35	1	Lifelong Non-smoker	Lung		LIVING	2007		TCGA-35-3615-01	TCGA-35-3615-01A-01D-1040-01	TCGA-35-3615-01	c3fb15e3-4fca-413f-86e8-24cb073ef3f1	TCGA-35-3615-01A-01R-0946-07	TCGA-35-3615-01A-01D-0945-05	TCGA-35-3615-01	TCGA-35-3615-01A-01D-0944-01		TCGA-35-3615-01	TCGA-35-3615-01A-01D-0944-01	TCGA-35-3615-01	c3fb15e3-4fca-413f-86e8-24cb073ef3f1		TCGA-35-3615-01A-21-2190-20	c3fb15e3-4fca-413f-86e8-24cb073ef3f1	TCGA-35-3615-01	f47527bd-86b0-4807-818c-6b4971222e06	c3fb15e3-4fca-413f-86e8-24cb073ef3f1	TCGA-35-3615-01A-01W-0928-08,TCGA-35-3615-01A-01D-1040-01		TCGA-35-3615-01
TCGA-35-3621-01																												TCGA-35-3621-01										TCGA-35-3621	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung										TCGA-35-3621-01A																											0.4	NO						0.8																									Primary Tumor	01	0.3										A				TCGA-35-3621-01A-01D-0969-08				TCGA-35-3621-01A-01R-1107-07	TCGA-35-3621-01A-01D-1104-05																
TCGA-35-4122-01																												TCGA-35-4122-01	High	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 5	TCGA-35-4122	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	L-Upper		TCGA-35-4122-F68915	TCGA-35-4122	TCGA-35-4122-01A			-25491			0	225				1	NO			NO	Scheduled Follow-up Submission		2014-12-23	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO	80	NO			Peripheral Lung	1	YES			45		No	M0	N0	T1	Stage IA	TCGA-35-4122.a970d363-3ea8-4f28-a3a5-81c28dcb799f.pdf	4122	Preoperative	TUMOR FREE								YES		R0	Primary Tumor	01	0.5	2010	7th		NO	YES	35	4		Lung	A	LIVING	2010	1965	TCGA-35-4122-01A-01D-1105-08		TCGA-35-4122-01	9d983613-1588-48a2-a515-7afae7aafc92	TCGA-35-4122-01A-01R-1107-07	TCGA-35-4122-01A-01D-1104-05	TCGA-35-4122-01	TCGA-35-4122-01A-01D-1877-01		TCGA-35-4122-01	TCGA-35-4122-01A-01D-1877-01	TCGA-35-4122-01	9d983613-1588-48a2-a515-7afae7aafc92		TCGA-35-4122-01A-21-2190-20	9d983613-1588-48a2-a515-7afae7aafc92	TCGA-35-4122-01	a0dded2b-3083-4aea-a9b1-c8376ddf0db1	9d983613-1588-48a2-a515-7afae7aafc92	TCGA-35-4122-01A-01D-1105-08		TCGA-35-4122-01
TCGA-35-4123-01																												TCGA-35-4123-01	Squamous	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 3	TCGA-35-4123	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					38	R-Upper		TCGA-35-4123-F68918	TCGA-35-4123	TCGA-35-4123-01A			-14064			0	182				1	NO			NO	Scheduled Follow-up Submission		2014-12-23	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.4	NO	90	NO			Peripheral Lung	0.9	YES			20		No	M0	N0	T1	Stage IA	TCGA-35-4123.7f74ee3b-0ecf-468d-9280-d30686d67d3a.pdf	4123	Preoperative	TUMOR FREE								YES		R0	Primary Tumor	01	0.3	2010	7th		NO	YES	35	4		Lung	A	LIVING	2010	1990	TCGA-35-4123-01A-01D-1105-08		TCGA-35-4123-01	2ef846b1-a0f9-412e-a72e-6dab6543d41f	TCGA-35-4123-01A-01R-1107-07	TCGA-35-4123-01A-01D-1104-05	TCGA-35-4123-01	TCGA-35-4123-01A-01D-1877-01		TCGA-35-4123-01	TCGA-35-4123-01A-01D-1877-01	TCGA-35-4123-01	2ef846b1-a0f9-412e-a72e-6dab6543d41f		TCGA-35-4123-01A-21-2190-20	2ef846b1-a0f9-412e-a72e-6dab6543d41f	TCGA-35-4123-01	b3627ae3-6960-4e37-b443-bc30986e9d0d	2ef846b1-a0f9-412e-a72e-6dab6543d41f	TCGA-35-4123-01A-01D-1105-08		TCGA-35-4123-01
TCGA-35-5375-01																												TCGA-35-5375-01	High	C2-Squamous-like		BRCA CIMP c7	squamous c3	squamous-like c4	miRNA cluster 12		mutation cluster 11	TCGA-35-5375	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	L-Upper		TCGA-35-5375-F68920	TCGA-35-5375	TCGA-35-5375-01A			-22628			0	264				1					Scheduled Follow-up Submission		2015-8-24	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO	90				Peripheral Lung	1.3	YES			35		No	M0	N2	T2	Stage IIIA	TCGA-35-5375.a93477c8-5ebe-436b-978a-61b573f65471.pdf	5375	Post-Adjuvant Therapy	TUMOR FREE										R0	Primary Tumor	01	0.3	2006			NO	YES	35	4		Lung	A	LIVING	2010	1971	TCGA-35-5375-01A-01D-1625-08			ab215c47-4678-4ca9-8cd3-ac6e3e804c05				TCGA-35-5375-01A-01D-1624-01	TCGA-35-5375-01A-01D-1626-05	TCGA-35-5375-01	TCGA-35-5375-01A-01D-1624-01		ab215c47-4678-4ca9-8cd3-ac6e3e804c05	TCGA-35-5375-01	TCGA-35-5375-01A-21-2190-20	ab215c47-4678-4ca9-8cd3-ac6e3e804c05	TCGA-35-5375-01	1dec822b-8282-4b95-8d3b-76bd5ed3fbe0	ab215c47-4678-4ca9-8cd3-ac6e3e804c05	TCGA-35-5375-01A-01D-1625-08	TCGA-35-5375-01	
TCGA-38-4625-01																												TCGA-38-4625-01	Squamous	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA c1uster 9		mutation cluster 13	TCGA-38-4625	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					66	R-Upper		TCGA-38-4625-F33407	TCGA-38-4625				-24241			0	2973			68		NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2012-7-26	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO			Peripheral Lung		YES			50		No	M0	N0	T2a	Stage IB		4625			66	66	68	64				YES		R0	Primary Tumor	01			5th		NO	YES	38	2		Lung		LIVING	2002	1952	TCGA-38-4625-01A-01D-1553-08			bc6c762f-727f-43c8-a4bc-4c41351c7f13		TCGA-38-4625-01A-01D-1205-05	TCGA-38-4625-01	TCGA-38-4625-01A-01D-1204-01		TCGA-38-4625-01	TCGA-38-4625-01A-01D-1204-01		bc6c762f-727f-43c8-a4bc-4c41351c7f13		TCGA-38-4625-01A-21-2190-20	bc6c762f-727f-43c8-a4bc-4c41351c7f13	TCGA-38-4625-01	f5f1b4e7-6b05-4d28-a55b-8719ebb6a9c0	bc6c762f-727f-43c8-a4bc-4c41351c7f13	TCGA-38-4625-01A-01D-1553-08		TCGA-38-4625-01
TCGA-38-4625-11																												TCGA-38-4625-11		C1-LUAD-enriched							mutation cluster 13	TCGA-38-4625	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					66	R-Upper		TCGA-38-4625-F33407	TCGA-38-4625	TCGA-38-4625-11A			-24241			0	2973			68		NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2012-7-26	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO		NO			Peripheral Lung	0.9	YES			50		No	M0	N0	T2a	Stage IB		4625			66	66	68	64				YES		R0	Solid Tissue Normal	11	0.2		5th		NO	YES	38	2		Lung	A	LIVING	2002	1952				cc556dfb-6bd4-4d53-a33b-6dae9407d7c4									cc556dfb-6bd4-4d53-a33b-6dae9407d7c4			cc556dfb-6bd4-4d53-a33b-6dae9407d7c4			cc556dfb-6bd4-4d53-a33b-6dae9407d7c4			
TCGA-38-4626-01			none		none	none	none	Y	Y	none	none	none		Bronchioid	none	p.G12V	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-38-4626-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA c1uster 9	cluster 4	mutation cluster 12	TCGA-38-4626	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		57	L-Upper		TCGA-38-4626-F33409	TCGA-38-4626				-20903			0	3674	2518		57						Scheduled Follow-up Submission	Complete Remission/Response	2012-7-26	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES								Central Lung		NO	New Primary Tumor	YES	40		No	M0	N0	T2b	[Discrepancy]		4626		TUMOR FREE	68	85	71	85	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			6th	NO	NO	YES	38	2	Current smoker	Lung		LIVING	2003	1962	TCGA-38-4626-01A-01D-1553-08	TCGA-38-4626-01A-01D-1553-08		abc25621-f98e-4bce-968b-df64793b2daf		TCGA-38-4626-01A-01D-1205-05	TCGA-38-4626-01	TCGA-38-4626-01A-01D-1204-01		TCGA-38-4626-01	TCGA-38-4626-01A-01D-1204-01		abc25621-f98e-4bce-968b-df64793b2daf		TCGA-38-4626-01A-21-2190-20	abc25621-f98e-4bce-968b-df64793b2daf	TCGA-38-4626-01	f1a33481-d34e-4a5b-8b60-9bb49b4584b1	abc25621-f98e-4bce-968b-df64793b2daf	TCGA-38-4626-01A-01D-1553-08		TCGA-38-4626-01
TCGA-38-4626-11			none		none	none	none	Y	Y	none	none	none		Bronchioid	none	p.G12V	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-38-4626-11		C1-LUAD-enriched							mutation cluster 12	TCGA-38-4626	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		57	L-Upper		TCGA-38-4626-F33409	TCGA-38-4626	TCGA-38-4626-11A			-20903			0	3674	2518		57						Scheduled Follow-up Submission	Complete Remission/Response	2012-7-26	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO					Central Lung	0.6	NO	New Primary Tumor	YES	40		No	M0	N0	T2b	[Discrepancy]		4626		TUMOR FREE	68	85	71	85	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11	0.3		6th	NO	NO	YES	38	2	Current smoker	Lung	A	LIVING	2003	1962				aad6bc48-5020-41e4-a2d0-f994c08170a9									aad6bc48-5020-41e4-a2d0-f994c08170a9			aad6bc48-5020-41e4-a2d0-f994c08170a9			aad6bc48-5020-41e4-a2d0-f994c08170a9			
TCGA-38-4627-01			none		none	none	none	Y	Y	p.L62R, p.L858R	none	none		Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-38-4627-01	Quiet	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA c1uster 9	cluster 2	mutation cluster 14	TCGA-38-4627	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					64	R-Upper		TCGA-38-4627-F4508	TCGA-38-4627				-23510		1147	0												2010-12-8	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES								Central Lung							No	M0	N1	T1b	Stage IIA		4627							Complete Remission/Response				NO	R0	Primary Tumor	01				NO	NO	YES	38	4	Current reformed smoker for < or = 15 years	Lung		DECEASED	2003		TCGA-38-4627-01A-01D-1553-08	TCGA-38-4627-01A-01D-1553-08		ca296fb4-2d1e-4ce9-acc8-81bd4cd11e58		TCGA-38-4627-01A-01D-1205-05	TCGA-38-4627-01	TCGA-38-4627-01A-01D-1549-01		TCGA-38-4627-01	TCGA-38-4627-01A-01D-1549-01		ca296fb4-2d1e-4ce9-acc8-81bd4cd11e58		TCGA-38-4627-01A-21-2190-20	ca296fb4-2d1e-4ce9-acc8-81bd4cd11e58	TCGA-38-4627-01	a7ef03a9-2a95-43d7-8dc4-3e98decdb223	ca296fb4-2d1e-4ce9-acc8-81bd4cd11e58	TCGA-38-4627-01A-01D-1553-08		TCGA-38-4627-01
TCGA-38-4627-11			none		none	none	none	Y	Y	p.L62R, p.L858R	none	none		Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-38-4627-11		C1-LUAD-enriched							mutation cluster 14	TCGA-38-4627	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					64	R-Upper		TCGA-38-4627-F4508	TCGA-38-4627	TCGA-38-4627-11A			-23510		1147	0												2010-12-8	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO					Central Lung	1						No	M0	N1	T1b	Stage IIA		4627							Complete Remission/Response				NO	R0	Solid Tissue Normal	11	0.1			NO	NO	YES	38	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2003					90a1abbc-6287-48f9-a669-10033380c9db									90a1abbc-6287-48f9-a669-10033380c9db			90a1abbc-6287-48f9-a669-10033380c9db			90a1abbc-6287-48f9-a669-10033380c9db			
TCGA-38-4628-01	5.05	0.5	none		none	none	none	Y	Y	p.ELREA746del	none	none	0.14	Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	1	TCGA-38-4628-01	High	C1-LUAD-enriched		Cluster 6		LUAD-like c10	miRNA cluster 4	cluster 5	mutation cluster 14	TCGA-38-4628	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	YES	65	R-Upper		TCGA-38-4628-F4676	TCGA-38-4628	TCGA-38-4628-01A		1118	-24057		1492	0		1083		72		NO			NO		Stable Disease	2010-12-9	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.5	NO		NO			Central Lung	0.8			YES			No	M0	N1	T2	Stage IIB	TCGA-38-4628.0a4269d2-d168-4750-ab8c-3c27907c45ef.pdf	4628		WITH TUMOR	78	85	74	86	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.2		5th	NO	NO	YES	38	1	Lifelong Non-smoker	Lung	A	DECEASED	2002		TCGA-38-4628-01A-01D-1265-08	TCGA-38-4628-01A-01D-1265-08		20c29e50-f961-465c-aa22-12e9ab187e71		TCGA-38-4628-01A-01D-1205-05	TCGA-38-4628-01	TCGA-38-4628-01A-01D-1204-01		TCGA-38-4628-01	TCGA-38-4628-01A-01D-1204-01		20c29e50-f961-465c-aa22-12e9ab187e71			20c29e50-f961-465c-aa22-12e9ab187e71	TCGA-38-4628-01		20c29e50-f961-465c-aa22-12e9ab187e71	TCGA-38-4628-01A-01D-1265-08		TCGA-38-4628-01
TCGA-38-4628-11	5.05	0.5	none		none	none	none	Y	Y	p.ELREA746del	none	none	0.14	Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	1	TCGA-38-4628-11		C1-LUAD-enriched							mutation cluster 14	TCGA-38-4628	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	YES	65	R-Upper		TCGA-38-4628-F4676	TCGA-38-4628	TCGA-38-4628-11A		1118	-24057		1492	0		1083		72		NO			NO		Stable Disease	2010-12-9	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.9	NO		NO			Central Lung	1			YES			No	M0	N1	T2	Stage IIB		4628		WITH TUMOR	78	85	74	86	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11	0.4		5th	NO	NO	YES	38	1	Lifelong Non-smoker	Lung	A	DECEASED	2002							TCGA-38-4628-11A-01D-1205-05																
TCGA-38-4629-01																												TCGA-38-4629-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 11	TCGA-38-4629	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	68	R-Upper		TCGA-38-4629-F4887	TCGA-38-4629	TCGA-38-4629-01A			-25104		864	0		379				NO			NO			2010-12-14	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO		NO			Peripheral Lung	1.3			YES	100		Yes	M0	N0	T3	Stage IIB	TCGA-38-4629.9546e974-686d-4d97-b5bd-771972cb4b82.pdf	4629		WITH TUMOR					Complete Remission/Response				NO	R0	Primary Tumor	01	0.2	2003		NO	NO	YES	38	4		Lung	A	DECEASED	2003		TCGA-38-4629-01A-02D-1265-08			6ed236e4-faf1-4d23-bccd-341688b034c3		TCGA-38-4629-01A-02D-1205-05		TCGA-38-4629-01A-02D-1204-01		TCGA-38-4629-01	TCGA-38-4629-01A-02D-1204-01		6ed236e4-faf1-4d23-bccd-341688b034c3		TCGA-38-4629-01A-11-2190-20	6ed236e4-faf1-4d23-bccd-341688b034c3	TCGA-38-4629-01	b78fa417-a0aa-4ebf-b75f-6891c541fb6d	6ed236e4-faf1-4d23-bccd-341688b034c3	TCGA-38-4629-01A-02D-1265-08		
TCGA-38-4629-11																												TCGA-38-4629-11		C1-LUAD-enriched							mutation cluster 11	TCGA-38-4629	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	68	R-Upper		TCGA-38-4629-F4887	TCGA-38-4629	TCGA-38-4629-11A			-25104		864	0		379				NO			NO			2010-12-14	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO		NO			Peripheral Lung	1			YES	100		Yes	M0	N0	T3	Stage IIB		4629		WITH TUMOR					Complete Remission/Response				NO	R0	Solid Tissue Normal	11	0.1	2003		NO	NO	YES	38	4		Lung	A	DECEASED	2003							TCGA-38-4629-11A-01D-1205-05																
TCGA-38-4630-01																												TCGA-38-4630-01	High	C6-UCEC		UCEC Serous c4		UCEC-like c11	miRNA c1uster 10		mutation cluster 5	TCGA-38-4630	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	75	R-Upper		TCGA-38-4630-F4972	TCGA-38-4630	TCGA-38-4630-01A			-27667		1073	0		836				NO			NO		Stable Disease	2010-12-16	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES		0.8	NO		NO			Peripheral Lung	1.6			YES			Yes	M0	N0	T2	Stage IB	TCGA-38-4630.63d133eb-0aa7-4c76-bf48-b9206df8975f.pdf	4630		WITH TUMOR					Complete Remission/Response			NO	NO	R1	Primary Tumor	01	0.3		6th	NO	NO	YES	38	1		Lung	A	DECEASED	2000		TCGA-38-4630-01A-01D-1265-08			09a88dca-7503-4fcb-b42a-ac5af9fdbca7		TCGA-38-4630-01A-01D-1205-05		TCGA-38-4630-01A-01D-1204-01		TCGA-38-4630-01	TCGA-38-4630-01A-01D-1204-01		09a88dca-7503-4fcb-b42a-ac5af9fdbca7			09a88dca-7503-4fcb-b42a-ac5af9fdbca7	TCGA-38-4630-01		09a88dca-7503-4fcb-b42a-ac5af9fdbca7	TCGA-38-4630-01A-01D-1265-08		
TCGA-38-4630-11																												TCGA-38-4630-11		C6-UCEC							mutation cluster 5	TCGA-38-4630	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	75	R-Upper		TCGA-38-4630-F4972	TCGA-38-4630	TCGA-38-4630-11A			-27667		1073	0		836				NO			NO		Stable Disease	2010-12-16	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES		0.7	NO		NO			Peripheral Lung	1.2			YES			Yes	M0	N0	T2	Stage IB		4630		WITH TUMOR					Complete Remission/Response			NO	NO	R1	Solid Tissue Normal	11	0.2		6th	NO	NO	YES	38	1		Lung	A	DECEASED	2000							TCGA-38-4630-11A-01D-1205-05																
TCGA-38-4631-01			none		none	none	none	N	N	none	none	p.P610T		Magnoid	none	none	none	none	none	none	none	NSCLC, favor Adeno	NSCLC, favor Adeno			none	0	TCGA-38-4631-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5		LUAD-like c10	miRNA cluster 5	cluster 5	mutation cluster 5	TCGA-38-4631	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	72	L-Upper		TCGA-38-4631-F4892	TCGA-38-4631				-26538		354	0						NO			NO			2010-12-14	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO			Peripheral Lung				YES	40		Yes	M0	N0	T2	Stage IB		4631		WITH TUMOR					Progressive Disease				NO	R0	Primary Tumor	01				NO	NO	YES	38	4	Current reformed smoker for < or = 15 years	Lung		DECEASED	1997		TCGA-38-4631-01A-01D-1753-08	TCGA-38-4631-01A-01D-1753-08		c436fa86-ae7e-490e-a52c-5004a8643b50				TCGA-38-4631-01A-01D-1752-01	TCGA-38-4631-01A-01D-1756-05	TCGA-38-4631-01	TCGA-38-4631-01A-01D-1752-01		c436fa86-ae7e-490e-a52c-5004a8643b50	TCGA-38-4631-01		c436fa86-ae7e-490e-a52c-5004a8643b50	TCGA-38-4631-01		c436fa86-ae7e-490e-a52c-5004a8643b50	TCGA-38-4631-01A-01D-1753-08	TCGA-38-4631-01	
TCGA-38-4631-11			none		none	none	none	N	N	none	none	p.P610T		Magnoid	none	none	none	none	none	none	none	NSCLC, favor Adeno	NSCLC, favor Adeno			none	0	TCGA-38-4631-11		C1-LUAD-enriched							mutation cluster 5	TCGA-38-4631	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	72	L-Upper		TCGA-38-4631-F4892	TCGA-38-4631	TCGA-38-4631-11A			-26538		354	0						NO			NO			2010-12-14	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO		NO			Peripheral Lung	1.1			YES	40		Yes	M0	N0	T2	Stage IB		4631		WITH TUMOR					Progressive Disease				NO	R0	Solid Tissue Normal	11	0.3			NO	NO	YES	38	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	1997										TCGA-38-4631-11A-01D-1756-05													
TCGA-38-4632-01			none		none	none	none	N	Y	none	none	none		Squamoid	none	none	none	none	p.Q61L	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-38-4632-01	High	C1-LUAD-enriched	cluster 1	Cluster 6		LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 11	TCGA-38-4632	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	42	L-Upper		TCGA-38-4632-F4842	TCGA-38-4632				-15418		1357	0		925				NO			NO		Progressive Disease	2010-12-13	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO			Peripheral Lung				YES	10		No	M1	N1	T2	Stage IV		4632		WITH TUMOR					Complete Remission/Response			NO	NO	R0	Primary Tumor	01		1991	5th	NO	NO	YES	38	4	Current reformed smoker for < or = 15 years	Lung		DECEASED	1998		TCGA-38-4632-01A-01D-1753-08	TCGA-38-4632-01A-01D-1753-08		b3cb327b-b0d4-478f-8dac-75abdb6365eb				TCGA-38-4632-01A-01D-1752-01	TCGA-38-4632-01A-01D-1756-05	TCGA-38-4632-01	TCGA-38-4632-01A-01D-1752-01		b3cb327b-b0d4-478f-8dac-75abdb6365eb	TCGA-38-4632-01		b3cb327b-b0d4-478f-8dac-75abdb6365eb	TCGA-38-4632-01		b3cb327b-b0d4-478f-8dac-75abdb6365eb	TCGA-38-4632-01A-01D-1753-08	TCGA-38-4632-01	
TCGA-38-4632-11			none		none	none	none	N	Y	none	none	none		Squamoid	none	none	none	none	p.Q61L	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-38-4632-11		C1-LUAD-enriched							mutation cluster 11	TCGA-38-4632	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	42	L-Upper		TCGA-38-4632-F4842	TCGA-38-4632	TCGA-38-4632-11A			-15418		1357	0		925				NO			NO		Progressive Disease	2010-12-13	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO		NO			Peripheral Lung	1.6			YES	10		No	M1	N1	T2	Stage IV		4632		WITH TUMOR					Complete Remission/Response			NO	NO	R0	Solid Tissue Normal	11	0.4	1991	5th	NO	NO	YES	38	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	1998					190cca34-43f6-4d87-93fc-e36220f1782f					TCGA-38-4632-11A-01D-1756-05				190cca34-43f6-4d87-93fc-e36220f1782f			190cca34-43f6-4d87-93fc-e36220f1782f			190cca34-43f6-4d87-93fc-e36220f1782f			
TCGA-38-6178-01	3.91	0.33	none		none	none	none	Y	Y	p.ELREA746del	none	none	0.13	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-38-6178-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation cluster 8	TCGA-38-6178	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	L-Upper		TCGA-38-6178-F22078	TCGA-38-6178	TCGA-38-6178-01A			-25593			0	448					YES	Exon 19 Deletion		NO	Scheduled Follow-up Submission		2012-2-23	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO		YES	NO		Central Lung	1.5			NO			Yes		N2	T2b	Stage IIIA	TCGA-38-6178.c2b33805-c417-4d5b-97ff-ec0d93afee8c.pdf	6178		WITH TUMOR					Stable Disease				NO	R1	Primary Tumor	01	0.3			YES	YES	NO	38	1	Lifelong Non-smoker	Lung	A	LIVING	2010		TCGA-38-6178-01A-11D-1753-08	TCGA-38-6178-01A-11D-1753-08		b73f5912-d163-4812-995c-0a273f543af1				TCGA-38-6178-01A-11D-1752-01	TCGA-38-6178-01A-11D-1756-05	TCGA-38-6178-01	TCGA-38-6178-01A-11D-1752-01		b73f5912-d163-4812-995c-0a273f543af1	TCGA-38-6178-01	TCGA-38-6178-01A-13-2191-20	b73f5912-d163-4812-995c-0a273f543af1	TCGA-38-6178-01	672018b4-22a2-4763-8ce7-19bff0256138	b73f5912-d163-4812-995c-0a273f543af1	TCGA-38-6178-01A-11D-1753-08	TCGA-38-6178-01	
TCGA-38-7271-01																												TCGA-38-7271-01	Iq			Cluster 5		LUAD-like c10	miRNA cluster 5			TCGA-38-7271	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	72	R-Upper		TCGA-38-7271-F18312	TCGA-38-7271	TCGA-38-7271-01A			-26440		800	0		633		76		NO			NO	Additional New Tumor Event	Progressive Disease	2011-11-10	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO		NO				1.1			YES	25		Yes	M0	N0	T1	Stage IA	TCGA-38-7271.7eb95f4d-3fb0-4312-89d1-4d5ec9f4f677.pdf	7271		WITH TUMOR	46	45	43	40				YES		R0	Primary Tumor	01	0.5	1999	6th		NO	YES	38	4		Lung	A	DECEASED	2006	1971				8d895d3d-9598-459b-813e-3fc84dd3efe8				TCGA-38-7271-01A-11D-2035-01	TCGA-38-7271-01A-11D-2037-05	TCGA-38-7271-01	TCGA-38-7271-01A-11D-2035-01		8d895d3d-9598-459b-813e-3fc84dd3efe8	TCGA-38-7271-01		8d895d3d-9598-459b-813e-3fc84dd3efe8	TCGA-38-7271-01		8d895d3d-9598-459b-813e-3fc84dd3efe8	TCGA-38-7271-01A-11D-2036-08	TCGA-38-7271-01	
TCGA-38-A44F-01																												TCGA-38-A44F-01										TCGA-38-A44F	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					80	R-Upper		TCGA-38-A44F-F47557	TCGA-38-A44F	TCGA-38-A44F-01A			-29534	127		0	133			35		NO		FISH	YES	Scheduled Follow-up Submission		2013-8-26	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8550/3	C34.1	YES	580		NO		NO			Peripheral Lung		YES		NO	12	false	No	M0	N0	T2a	Stage IB	TCGA-38-A44F.FC3ACA4F-AA49-47F4-9BA3-7B18C56F64AD.pdf	A44F		TUMOR FREE	71		72	52	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1977	7th	NO	YES	NO	38	3		Lung	A	LIVING	2012	1965				c8762ae1-49de-496d-a00f-4cde20bbd3af				TCGA-38-A44F-01A-11D-A24C-01	TCGA-38-A44F-01A-11D-A24I-05	TCGA-38-A44F-01	TCGA-38-A44F-01A-11D-A24C-01		c8762ae1-49de-496d-a00f-4cde20bbd3af	TCGA-38-A44F-01		c8762ae1-49de-496d-a00f-4cde20bbd3af	TCGA-38-A44F-01	C59BEC58-FE3B-4F16-B6A0-169F621575B5	c8762ae1-49de-496d-a00f-4cde20bbd3af	TCGA-38-A44F-01A-11D-A24D-08	TCGA-38-A44F-01	
TCGA-44-2655-01	2.05	0.3	none		none	none	none	N	N	none	none	none	0.15	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-44-2655-01	Iq	C1-LUAD-enriched		Cluster 5		LUAD-like c10	miRNA cluster 5	cluster 4	mutation c1uster 9	TCGA-44-2655	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	65	R-Upper		TCGA-44-2655-F39289	TCGA-44-2655	TCGA-44-2655-01A			-23854			0	1324	1009		73	0					Scheduled Follow-up Submission	Complete Remission/Response	2013-1-16	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.5	NO		NO				0.5	NO	New Primary Tumor	YES	30		Yes	M0	N0	T1	Stage IA	TCGA-44-2655.ebae1e0e-18fb-48c8-b2f3-282dab7352d4.pdf	2655	Pre-Adjuvant Therapy	TUMOR FREE			100	91	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.3	1988	6th	NO	YES	NO	44	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2009	1958	TCGA-44-2655-01	TCGA-44-2655-01A-01D-1553-08	TCGA-44-2655-01	785a76b0-7ae7-44ed-a8a6-519fe6e15f04	TCGA-44-2655-01A-01R-0946-07	TCGA-44-2655-01A-01D-0945-05	TCGA-44-2655-01	TCGA-44-2655-01A-01D-0944-01		TCGA-44-2655-01	TCGA-44-2655-01A-01D-0944-01	TCGA-44-2655-01	785a76b0-7ae7-44ed-a8a6-519fe6e15f04			785a76b0-7ae7-44ed-a8a6-519fe6e15f04	TCGA-44-2655-01		785a76b0-7ae7-44ed-a8a6-519fe6e15f04	TCGA-44-2655-01A-01W-0928-08,TCGA-44-2655-01A-01D-1553-08		TCGA-44-2655-01
TCGA-44-2655-11	2.05	0.3	none		none	none	none	N	N	none	none	none	0.15	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-44-2655-11		C1-LUAD-enriched							mutation c1uster 9	TCGA-44-2655	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	65	R-Upper		TCGA-44-2655-F39289	TCGA-44-2655				-23854			0	1324	1009		73	0					Scheduled Follow-up Submission	Complete Remission/Response	2013-1-16	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO					NO	New Primary Tumor	YES	30		Yes	M0	N0	T1	Stage IA		2655	Pre-Adjuvant Therapy	TUMOR FREE			100	91	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11		1988	6th	NO	YES	NO	44	3	Current reformed smoker for > 15 years	Lung		LIVING	2009	1958				e218db14-8225-450d-92b1-865d46ab59bf					TCGA-44-2655-11A-01D-1551-05				e218db14-8225-450d-92b1-865d46ab59bf	TCGA-44-2655-11		e218db14-8225-450d-92b1-865d46ab59bf			e218db14-8225-450d-92b1-865d46ab59bf		TCGA-44-2655-11	
TCGA-44-2656-01	3.14	0.31	none		none	none	none	N	Y	none	p.S310F	none	0.13	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-2656-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 11	TCGA-44-2656	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES			59	R-Upper		TCGA-44-2656-F39934	TCGA-44-2656	TCGA-44-2656-01A			-21766			0	1429	568	FPPP	72	0					Scheduled Follow-up Submission	Complete Remission/Response	2013-2-6	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	50	0.8	NO		NO				0.8	NO	New Primary Tumor	YES	23		No	M0	N0	T2	Stage IB	TCGA-44-2656.3c7e7f0d-f1b6-42cf-895e-df6cc52f4c2a.pdf	2656	Pre-Adjuvant Therapy	TUMOR FREE	86	84	86	79	Complete Remission/Response	Biopsy with Histologic Confirmation	TCGA	YES	NO		Primary Tumor	01	0.4	2009	6th	NO	YES	NO	44	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2009	1994	TCGA-44-2656-01	TCGA-44-2656-01A-02W-0928-08	TCGA-44-2656-01	7b9dc578-8869-4322-a705-bfb9942d9b65	TCGA-44-2656-01A-02R-0946-07	TCGA-44-2656-01A-02D-0945-05	TCGA-44-2656-01	TCGA-44-2656-01A-02D-A273-01	TCGA-44-2656-01A-02D-A276-05,TCGA-44-2656-01B-06D-A276-05	TCGA-44-2656-01	TCGA-44-2656-01A-02D-A273-01	TCGA-44-2656-01	7b9dc578-8869-4322-a705-bfb9942d9b65		TCGA-44-2656-01A-11-2190-20	7b9dc578-8869-4322-a705-bfb9942d9b65	TCGA-44-2656-01	84750167-98a3-4be6-a407-39a6c9629a14	7b9dc578-8869-4322-a705-bfb9942d9b65	TCGA-44-2656-01A-02W-0928-08,TCGA-44-2656-01A-02D-0969-08		TCGA-44-2656-01
TCGA-44-2656-11	3.14	0.31	none		none	none	none	N	Y	none	p.S310F	none	0.13	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-2656-11		C1-LUAD-enriched							mutation cluster 11	TCGA-44-2656	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES			59	R-Upper		TCGA-44-2656-F39934	TCGA-44-2656	TCGA-44-2656-11A			-21766			0	1429	568	FPPP	72	0					Scheduled Follow-up Submission	Complete Remission/Response	2013-2-6	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	530	0.9	NO		NO				2	NO	New Primary Tumor	YES	23		No	M0	N0	T2	Stage IB		2656	Pre-Adjuvant Therapy	TUMOR FREE	86	84	86	79	Complete Remission/Response	Biopsy with Histologic Confirmation	TCGA	YES	NO		Solid Tissue Normal	11	0.9	2009	6th	NO	YES	NO	44	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2009	1994									TCGA-44-2656-11A-01D-1551-05													
TCGA-44-2657-01	1.74	0.33	none		none	none	none	N	N	none	none	none	0.17	Bronchioid	none	none	none	p.N315S	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-44-2657-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 7	cluster 4	mutation c1uster 10	TCGA-44-2657	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	L-Upper		TCGA-44-2657-F39296	TCGA-44-2657	TCGA-44-2657-01A			-27298			0	1351			96	0					Scheduled Follow-up Submission	Complete Remission/Response	2013-1-16	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO		NO				1	NO		NO	25		No	M0	NX	T2	Stage IB	TCGA-44-2657.d31fa48b-949c-48b7-bc78-6954ede98172.pdf	2657	Pre-Adjuvant Therapy	TUMOR FREE	87	147	78	120	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.3	2006	6th	NO	YES	NO	44	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2009	1959	TCGA-44-2657-01A-01D-1105-08	TCGA-44-2657-01A-01D-1105-08	TCGA-44-2657-01	e1a6b655-0a09-4a79-b86b-8ff65b2bbceb	TCGA-44-2657-01A-01R-1107-07	TCGA-44-2657-01A-01D-1104-05	TCGA-44-2657-01	TCGA-44-2657-01A-01D-1877-01		TCGA-44-2657-01	TCGA-44-2657-01A-01D-1877-01	TCGA-44-2657-01	e1a6b655-0a09-4a79-b86b-8ff65b2bbceb		TCGA-44-2657-01A-21-2190-20	e1a6b655-0a09-4a79-b86b-8ff65b2bbceb	TCGA-44-2657-01	54935339-ba0b-4d0e-ae3a-5805916ef135	e1a6b655-0a09-4a79-b86b-8ff65b2bbceb	TCGA-44-2657-01A-01D-1105-08		TCGA-44-2657-01
TCGA-44-2657-11	1.74	0.33	none		none	none	none	N	N	none	none	none	0.17	Bronchioid	none	none	none	p.N315S	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-44-2657-11		C1-LUAD-enriched							mutation c1uster 10	TCGA-44-2657	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	L-Upper		TCGA-44-2657-F39296	TCGA-44-2657				-27298			0	1351			96	0					Scheduled Follow-up Submission	Complete Remission/Response	2013-1-16	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO					NO		NO	25		No	M0	NX	T2	Stage IB		2657	Pre-Adjuvant Therapy	TUMOR FREE	87	147	78	120	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11		2006	6th	NO	YES	NO	44	4	Current reformed smoker for < or = 15 years	Lung		LIVING	2009	1959				ca16fef9-9795-4a33-899f-9bf111ee093e									ca16fef9-9795-4a33-899f-9bf111ee093e	TCGA-44-2657-11		ca16fef9-9795-4a33-899f-9bf111ee093e			ca16fef9-9795-4a33-899f-9bf111ee093e		TCGA-44-2657-11	
TCGA-44-2659-01	3.6	0.41	none		none	none	none	N	N	none	none	none	0.15	Bronchioid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	1	TCGA-44-2659-01	BRCA-LUAD+					LUAD-like c10	miRNA cluster 7	cluster 4	mutation cluster 5	TCGA-44-2659	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					65	[Discrepancy]		TCGA-44-2659-F40300	TCGA-44-2659	TCGA-44-2659-01A			-23808			0	1367			67	1					Scheduled Follow-up Submission	Complete Remission/Response	2013-2-15	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.8	NO		NO				1.3	NO		NO	57		No	M0	N1	T1	Stage IIB	TCGA-44-2659.9015ab9c-ad9f-44f1-af94-3c7bf34f12fd.pdf	2659	Other	TUMOR FREE	87	73	77	64	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.3	2003	6th	YES	YES	NO	44	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2009	1965	TCGA-44-2659-01	TCGA-44-2659-01A-01D-0969-08	TCGA-44-2659-01	6f748364-2a6a-4fd4-af87-3de643719577	TCGA-44-2659-01A-01R-0946-07		TCGA-44-2659-01	TCGA-44-2659-01A-01D-0944-01		TCGA-44-2659-01	TCGA-44-2659-01A-01D-0944-01	TCGA-44-2659-01	6f748364-2a6a-4fd4-af87-3de643719577			6f748364-2a6a-4fd4-af87-3de643719577	TCGA-44-2659-01		6f748364-2a6a-4fd4-af87-3de643719577	TCGA-44-2659-01A-01W-0928-08,TCGA-44-2659-01A-01D-0969-08		TCGA-44-2659-01
TCGA-44-2659-11	3.6	0.41	none		none	none	none	N	N	none	none	none	0.15	Bronchioid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	1	TCGA-44-2659-11									mutation cluster 5	TCGA-44-2659	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					65	[Discrepancy]		TCGA-44-2659-F40300	TCGA-44-2659	TCGA-44-2659-11A			-23808			0	1367			67	1					Scheduled Follow-up Submission	Complete Remission/Response	2013-2-15	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.9	NO		NO				1.5	NO		NO	57		No	M0	N1	T1	Stage IIB		2659	Other	TUMOR FREE	87	73	77	64	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11	0.7	2003	6th	YES	YES	NO	44	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2009	1965									TCGA-44-2659-11A-01D-1551-05													
TCGA-44-2661-01	1.86	0.27	none		none	none	none	Y	Y	p.ELREA746del	none	none	0.14	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-44-2661-01	Kirc+	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4	mutation cluster 14	TCGA-44-2661	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	L-Upper		TCGA-44-2661-F41293	TCGA-44-2661	TCGA-44-2661-01A			-25313			0	1159				1					Scheduled Follow-up Submission	Complete Remission/Response	2013-3-14	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO		NO				1.5	NO		NO			Yes	M0	N0	T1	Stage IA	TCGA-44-2661.17e596f5-74fe-46cc-bee2-fa1355b01721.pdf	2661	Pre-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.4		6th	NO	YES	NO	44	1	Lifelong Non-smoker	Lung	A	LIVING	2009		TCGA-44-2661-01A-01D-1105-08	TCGA-44-2661-01A-01D-1105-08	TCGA-44-2661-01	847f00ce-5f09-4e12-90c5-ebdf7612d707	TCGA-44-2661-01A-01R-1107-07	TCGA-44-2661-01A-01D-1104-05		TCGA-44-2661-01A-01D-1877-01		TCGA-44-2661-01	TCGA-44-2661-01A-01D-1877-01	TCGA-44-2661-01	847f00ce-5f09-4e12-90c5-ebdf7612d707		TCGA-44-2661-01A-21-2190-20	847f00ce-5f09-4e12-90c5-ebdf7612d707	TCGA-44-2661-01	39162d9a-aa2f-4aa6-a495-9d3d5f159771	847f00ce-5f09-4e12-90c5-ebdf7612d707	TCGA-44-2661-01A-01D-1105-08		
TCGA-44-2661-11	1.86	0.27	none		none	none	none	Y	Y	p.ELREA746del	none	none	0.14	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-44-2661-11		C1-LUAD-enriched							mutation cluster 14	TCGA-44-2661	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	L-Upper		TCGA-44-2661-F41293	TCGA-44-2661	TCGA-44-2661-11A			-25313			0	1159				1					Scheduled Follow-up Submission	Complete Remission/Response	2013-3-14	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.9	NO		NO				1.3	NO		NO			Yes	M0	N0	T1	Stage IA		2661	Pre-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11	0.4		6th	NO	YES	NO	44	1	Lifelong Non-smoker	Lung	A	LIVING	2009					90b503db-13ca-4257-bda3-31d4e7bc69b4									90b503db-13ca-4257-bda3-31d4e7bc69b4			90b503db-13ca-4257-bda3-31d4e7bc69b4			90b503db-13ca-4257-bda3-31d4e7bc69b4			
TCGA-44-2662-01	3.33	0.25	none		p.N581S	none	none	N	N	none	none	none	0.11	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-2662-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5		LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 2	TCGA-44-2662	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		65	R-Upper		TCGA-44-2662-F39415	TCGA-44-2662	TCGA-44-2662-01A			-24014			0	1280		FPPP	78						Scheduled Follow-up Submission	Complete Remission/Response	2013-1-22	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.9	NO		NO				1	NO		NO	56		Yes	M0	N0	T2	Stage IB	TCGA-44-2662.76bab538-e95a-48a6-9f83-36b9a472252b.pdf	2662		TUMOR FREE	94	73	88	67	Progressive Disease		TCGA	YES	NO	R0	Primary Tumor	01	0.2	1984	6th	YES	YES	NO	44	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2009	1956	TCGA-44-2662-01	TCGA-44-2662-01A-01D-0969-08	TCGA-44-2662-01	5ec48286-3f47-49eb-83ba-a1169f734bba	TCGA-44-2662-01A-01R-0946-07	TCGA-44-2662-01A-01D-0945-05	TCGA-44-2662-01	TCGA-44-2662-01A-01D-A273-01		TCGA-44-2662-01	TCGA-44-2662-01A-01D-A273-01	TCGA-44-2662-01	5ec48286-3f47-49eb-83ba-a1169f734bba			5ec48286-3f47-49eb-83ba-a1169f734bba	TCGA-44-2662-01		5ec48286-3f47-49eb-83ba-a1169f734bba	TCGA-44-2662-01A-01W-0928-08,TCGA-44-2662-01A-01D-0969-08		TCGA-44-2662-01
TCGA-44-2662-11	3.33	0.25	none		p.N581S	none	none	N	N	none	none	none	0.11	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-2662-11		C1-LUAD-enriched							mutation cluster 2	TCGA-44-2662	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		65	R-Upper		TCGA-44-2662-F39415	TCGA-44-2662	TCGA-44-2662-11A			-24014			0	1280		FPPP	78						Scheduled Follow-up Submission	Complete Remission/Response	2013-1-22	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO		NO				1	NO		NO	56		Yes	M0	N0	T2	Stage IB		2662		TUMOR FREE	94	73	88	67	Progressive Disease		TCGA	YES	NO	R0	Solid Tissue Normal	11	0.4	1984	6th	YES	YES	NO	44	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2009	1956				b548a64b-0275-4beb-9b67-ce8bad3ccd63					TCGA-44-2662-11A-01D-1551-05				b548a64b-0275-4beb-9b67-ce8bad3ccd63			b548a64b-0275-4beb-9b67-ce8bad3ccd63			b548a64b-0275-4beb-9b67-ce8bad3ccd63			
TCGA-44-2664-01																												TCGA-44-2664-01					squamous c3					TCGA-44-2664	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO		66	R-Lower		TCGA-44-2664-F34138	TCGA-44-2664	TCGA-44-2664-01A			-24468			0	1251	832		74	2					Additional New Tumor Event	Complete Remission/Response	2012-7-30	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.6	NO		NO				1	NO	Locoregional Recurrence	YES	23		No	M0	N0	T1	Stage IA	TCGA-44-2664.8ac6aec3-d709-411f-9233-f264bac80972.pdf	2664	Other	TUMOR FREE			109	113	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01	0.4		6th	NO	YES	NO	44	2		Lung	A	LIVING	2009	1964															TCGA-44-2664-01A-21-2190-20			d81b36d5-1923-49b3-8881-306793fb7c77				
TCGA-44-2665-01	2.12	0.44	none		none	none	none	N	Y	none	none	none	0.21	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc		Y	none	1	TCGA-44-2665-01	Iq	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation c1uster 9	TCGA-44-2665	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					55	R-Upper		TCGA-44-2665-F40281	TCGA-44-2665	TCGA-44-2665-01A			-20349			0	1301		FPPP	71	0					Scheduled Follow-up Submission	Complete Remission/Response	2013-2-15	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO		NO				1.1	NO		NO			No	M0	N1	T2	Stage IIB	TCGA-44-2665.262e300a-7b16-4f2b-80bf-29decfe84d33.pdf	2665	Other	TUMOR FREE	79	105	79	114	Stable Disease		TCGA	YES	NO	R0	Primary Tumor	01	0.3		6th	YES	YES	NO	44	1	Lifelong Non-smoker	Lung	A	LIVING	2009		TCGA-44-2665-01	TCGA-44-2665-01A-01D-1040-01	TCGA-44-2665-01	9a6962a2-0a32-44d5-a2bf-c28c5f1a9cd0	TCGA-44-2665-01A-01R-0946-07	TCGA-44-2665-01A-01D-0945-05	TCGA-44-2665-01	TCGA-44-2665-01A-01D-A273-01	TCGA-44-2665-01B-06D-A276-05,TCGA-44-2665-01A-01D-A276-05	TCGA-44-2665-01	TCGA-44-2665-01A-01D-A273-01	TCGA-44-2665-01	9a6962a2-0a32-44d5-a2bf-c28c5f1a9cd0		TCGA-44-2665-01A-21-2190-20	9a6962a2-0a32-44d5-a2bf-c28c5f1a9cd0	TCGA-44-2665-01	80b4100c-7cdf-42f6-a01f-056acc9f2244	9a6962a2-0a32-44d5-a2bf-c28c5f1a9cd0	TCGA-44-2665-01A-01W-0928-08,TCGA-44-2665-01A-01D-1040-01		TCGA-44-2665-01
TCGA-44-2665-11	2.12	0.44	none		none	none	none	N	Y	none	none	none	0.21	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc		Y	none	1	TCGA-44-2665-11		C1-LUAD-enriched							mutation c1uster 9	TCGA-44-2665	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					55	R-Upper		TCGA-44-2665-F40281	TCGA-44-2665	TCGA-44-2665-11A			-20349			0	1301		FPPP	71	0					Scheduled Follow-up Submission	Complete Remission/Response	2013-2-15	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO		NO				1.9	NO		NO			No	M0	N1	T2	Stage IIB		2665	Other	TUMOR FREE	79	105	79	114	Stable Disease		TCGA	YES	NO	R0	Solid Tissue Normal	11	0.6		6th	YES	YES	NO	44	1	Lifelong Non-smoker	Lung	A	LIVING	2009					756942cf-3ba1-456e-8086-57f710247b8e					TCGA-44-2665-11A-01D-1551-05				756942cf-3ba1-456e-8086-57f710247b8e	TCGA-44-2665-11		756942cf-3ba1-456e-8086-57f710247b8e			756942cf-3ba1-456e-8086-57f710247b8e		TCGA-44-2665-11	
TCGA-44-2666-01	1.94	0.58	none		p.V600E	none	none	N	Y	none	none	none	0.3	Bronchioid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	1	TCGA-44-2666-01	Kirc+	C1-LUAD-enriched		Cluster 6		LUAD-like c10	miRNA cluster 5	cluster 4	mutation cluster 5	TCGA-44-2666	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	43	R-Upper		TCGA-44-2666-F5304	TCGA-44-2666				-15970		97	0	97		FPPP	66								2010-10-12	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO							NO	30		No	M0	N0	T2	Stage IB		2666		WITH TUMOR			86	87			TCGA	YES	NO	R0	Primary Tumor	01			6th	NO	YES	NO	44	2	Current smoker	Lung		DECEASED	2009	1979	TCGA-44-2666-01	TCGA-44-2666-01A-01D-1489-08	TCGA-44-2666-01	bfad522f-6130-424d-8497-99cac9714966	TCGA-44-2666-01A-01R-0946-07	TCGA-44-2666-01A-01D-0945-05	TCGA-44-2666-01	TCGA-44-2666-01A-01D-A273-01	TCGA-44-2666-01B-02D-A276-05,TCGA-44-2666-01A-01D-A276-05	TCGA-44-2666-01	TCGA-44-2666-01A-01D-A273-01	TCGA-44-2666-01	bfad522f-6130-424d-8497-99cac9714966			bfad522f-6130-424d-8497-99cac9714966	TCGA-44-2666-01		bfad522f-6130-424d-8497-99cac9714966	TCGA-44-2666-01A-01W-0928-08,TCGA-44-2666-01A-01D-1489-08		TCGA-44-2666-01
TCGA-44-2668-01																												TCGA-44-2668-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 2	TCGA-44-2668	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung		YES	YES	NO	51	R-Upper		TCGA-44-2668-F18688	TCGA-44-2668	TCGA-44-2668-01A	453		-18856		761	0	246	433	FPPP	53	0					Additional New Tumor Event	Progressive Disease	2011-11-22	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO		NO				1.2			YES	60		No	M0	N0	T2	Stage IB	TCGA-44-2668.d5ebaec8-79c6-493b-ae2a-bbc96e6e5ddc.pdf	2668	Other	WITH TUMOR			104	82			TCGA	YES		R0	Primary Tumor	01	0.3	2009	6th		YES	NO	44	4		Lung	A	DECEASED	2009	1979	TCGA-44-2668-01		TCGA-44-2668-01	4c5c1c05-b9d1-4073-9d91-5c4e552928ae	TCGA-44-2668-01A-01R-0946-07	TCGA-44-2668-01A-01D-0945-05	TCGA-44-2668-01	TCGA-44-2668-01A-01D-A273-01	TCGA-44-2668-01B-02D-A276-05,TCGA-44-2668-01A-01D-A276-05	TCGA-44-2668-01	TCGA-44-2668-01A-01D-A273-01	TCGA-44-2668-01	4c5c1c05-b9d1-4073-9d91-5c4e552928ae		TCGA-44-2668-01A-21-2190-20	4c5c1c05-b9d1-4073-9d91-5c4e552928ae	TCGA-44-2668-01	2e058de2-768c-4a90-9105-a30e5a3cd627	4c5c1c05-b9d1-4073-9d91-5c4e552928ae	TCGA-44-2668-01A-01W-0928-08,TCGA-44-2668-01A-01D-0969-08		TCGA-44-2668-01
TCGA-44-2668-11																												TCGA-44-2668-11		C1-LUAD-enriched							mutation cluster 2	TCGA-44-2668	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung		YES	YES	NO	51	R-Upper		TCGA-44-2668-F18688	TCGA-44-2668	TCGA-44-2668-11A	453		-18856		761	0	246	433	FPPP	53	0					Additional New Tumor Event	Progressive Disease	2011-11-22	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO		NO				1.5			YES	60		No	M0	N0	T2	Stage IB		2668	Other	WITH TUMOR			104	82			TCGA	YES		R0	Solid Tissue Normal	11	0.5	2009	6th		YES	NO	44	4		Lung	A	DECEASED	2009	1979				2170c29a-1256-45eb-b08e-e1192dad3560					TCGA-44-2668-11A-01D-1551-05				2170c29a-1256-45eb-b08e-e1192dad3560	TCGA-44-2668-11		2170c29a-1256-45eb-b08e-e1192dad3560			2170c29a-1256-45eb-b08e-e1192dad3560		TCGA-44-2668-11	
TCGA-44-3396-01			none		none	none	none	N	N	none	none	none		Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-3396-01	Kirc+	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 7	cluster 4	mutation cluster 5	TCGA-44-3396	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	[Discrepancy]		TCGA-44-3396-F39080	TCGA-44-3396	TCGA-44-3396-01A			-27073			0	1130			48	1					Scheduled Follow-up Submission	Complete Remission/Response	2013-1-11	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO	80	NO				1.3	NO		NO	50		No	M0	N2	T2	Stage IIIA	TCGA-44-3396.6a7ec9e8-ea86-4c3b-9d0e-9564e41311b5.pdf	3396	Other	TUMOR FREE			98	89	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.4		7th	YES	YES	NO	44	2	Current smoker	Lung	A	LIVING	2009	1959	TCGA-44-3396-01A-01D-1265-08	TCGA-44-3396-01A-01D-1265-08		8b0a1ab6-e7ea-45f9-9e3a-bd98b3f59972		TCGA-44-3396-01A-01D-1205-05	TCGA-44-3396-01	TCGA-44-3396-01A-01D-1204-01		TCGA-44-3396-01	TCGA-44-3396-01A-01D-1204-01		8b0a1ab6-e7ea-45f9-9e3a-bd98b3f59972		TCGA-44-3396-01A-31-2190-20	8b0a1ab6-e7ea-45f9-9e3a-bd98b3f59972	TCGA-44-3396-01	a9183121-98c3-4e97-942d-85eb5b1255f5	8b0a1ab6-e7ea-45f9-9e3a-bd98b3f59972	TCGA-44-3396-01A-01D-1553-08		TCGA-44-3396-01
TCGA-44-3396-11			none		none	none	none	N	N	none	none	none		Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-3396-11		C1-LUAD-enriched							mutation cluster 5	TCGA-44-3396	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	[Discrepancy]		TCGA-44-3396-F39080	TCGA-44-3396				-27073			0	1130			48	1					Scheduled Follow-up Submission	Complete Remission/Response	2013-1-11	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES				80	NO					NO		NO	50		No	M0	N2	T2	Stage IIIA		3396	Other	TUMOR FREE			98	89	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11			7th	YES	YES	NO	44	2	Current smoker	Lung		LIVING	2009	1959				f879b84d-a2e7-4189-bcf6-9286b52e19dd									f879b84d-a2e7-4189-bcf6-9286b52e19dd	TCGA-44-3396-11		f879b84d-a2e7-4189-bcf6-9286b52e19dd			f879b84d-a2e7-4189-bcf6-9286b52e19dd		TCGA-44-3396-11	
TCGA-44-3398-01																												TCGA-44-3398-01	Kirc+	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4		mutation c1uster 9	TCGA-44-3398	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					77	R-Lower		TCGA-44-3398-F38762	TCGA-44-3398	TCGA-44-3398-01A			-28392			0	1163			60						Scheduled Follow-up Submission	Complete Remission/Response	2012-12-21	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.9	NO		NO				1.7	NO		NO	60		No	M0	N0	T1b	Stage IA	TCGA-44-3398.7dc9c668-3304-47d8-9c33-5b72352672db.pdf	3398		TUMOR FREE	89	96	84	87	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.5	2009	6th	NO	YES	NO	44	4		Lung	A	LIVING	2009	1959	TCGA-44-3398-01A-01D-1105-08		TCGA-44-3398-01	c63e6cf3-936d-4d14-ab87-11aa4ef51242	TCGA-44-3398-01A-01R-1107-07	TCGA-44-3398-01A-01D-1104-05	TCGA-44-3398-01	TCGA-44-3398-01A-01D-1877-01		TCGA-44-3398-01	TCGA-44-3398-01A-01D-1877-01	TCGA-44-3398-01	c63e6cf3-936d-4d14-ab87-11aa4ef51242		TCGA-44-3398-01A-31-2190-20	c63e6cf3-936d-4d14-ab87-11aa4ef51242	TCGA-44-3398-01	16bb1a7a-a8b2-44a0-bccc-574b6e418d1c	c63e6cf3-936d-4d14-ab87-11aa4ef51242	TCGA-44-3398-01A-01D-1105-08		TCGA-44-3398-01
TCGA-44-3398-11																												TCGA-44-3398-11		C1-LUAD-enriched							mutation c1uster 9	TCGA-44-3398	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					77	R-Lower		TCGA-44-3398-F38762	TCGA-44-3398	TCGA-44-3398-11B			-28392			0	1163			60						Scheduled Follow-up Submission	Complete Remission/Response	2012-12-21	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.8	NO		NO				1.8	NO		NO	60		No	M0	N0	T1b	Stage IA		3398		TUMOR FREE	89	96	84	87	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11	0.8	2009	6th	NO	YES	NO	44	4		Lung	B	LIVING	2009	1959				453cdfcc-52a8-4ab0-80ac-ce1dc1bc1bf8									453cdfcc-52a8-4ab0-80ac-ce1dc1bc1bf8	TCGA-44-3398-11		453cdfcc-52a8-4ab0-80ac-ce1dc1bc1bf8			453cdfcc-52a8-4ab0-80ac-ce1dc1bc1bf8		TCGA-44-3398-11	
TCGA-44-3917-01																												TCGA-44-3917-01					squamous c3					TCGA-44-3917	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					33	R-Upper		TCGA-44-3917-F38799	TCGA-44-3917	TCGA-44-3917-01A			-12179			0	1183		FPPP	83						Scheduled Follow-up Submission	Complete Remission/Response	2012-12-24	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO	100	NO				1.2	NO		NO	16		No	M0	N0	T2	Stage IB	TCGA-44-3917.240f6268-ffef-488e-855d-9c39e3969c65.pdf	3917	Post-Adjuvant Therapy	TUMOR FREE			87	106	Complete Remission/Response		TCGA	YES	NO	R0	Primary Tumor	01	0.2		6th	NO	YES	NO	44	2		Lung	A	LIVING	2009	1993								TCGA-44-3917-01A-01D-A273-01	TCGA-44-3917-01B-02D-A276-05,TCGA-44-3917-01A-01D-A276-05		TCGA-44-3917-01A-01D-A273-01				TCGA-44-3917-01A-21-2190-20			b32ab08b-b364-456f-8494-46ca48fb5352				
TCGA-44-3918-01																												TCGA-44-3918-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 11	TCGA-44-3918	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO		60	L-Upper		TCGA-44-3918-F38999	TCGA-44-3918	TCGA-44-3918-01A			-22236			0	1036	511	FPPP	76						Scheduled Follow-up Submission	Stable Disease	2013-1-10	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	280	0.8	NO	90	NO				2	NO	Locoregional Recurrence	YES	20		No	M0	N0	T1	Stage IA	TCGA-44-3918.da381e6d-f69d-424f-ab84-5c300ca19435.pdf	3918	Other	WITH TUMOR			103	104	Complete Remission/Response	Biopsy with Histologic Confirmation|Convincing Imaging	TCGA	YES	NO	R0	Primary Tumor	01	0.8	1994	6th	NO	YES	NO	44	3		Lung	A	LIVING	2010	1974	TCGA-44-3918-01A-01D-1105-08		TCGA-44-3918-01	d9f5e680-b72e-4a64-942b-191154d8012a	TCGA-44-3918-01A-01R-1107-07	TCGA-44-3918-01A-01D-1104-05	TCGA-44-3918-01	TCGA-44-3918-01A-01D-A273-01	TCGA-44-3918-01B-02D-A276-05,TCGA-44-3918-01A-01D-A276-05	TCGA-44-3918-01	TCGA-44-3918-01A-01D-A273-01	TCGA-44-3918-01	d9f5e680-b72e-4a64-942b-191154d8012a		TCGA-44-3918-01A-21-2190-20	d9f5e680-b72e-4a64-942b-191154d8012a	TCGA-44-3918-01	4f270bce-0b0e-4f5d-bc5d-1524fbea5234	d9f5e680-b72e-4a64-942b-191154d8012a	TCGA-44-3918-01A-01D-1105-08		TCGA-44-3918-01
TCGA-44-3918-11																												TCGA-44-3918-11		C1-LUAD-enriched							mutation cluster 11	TCGA-44-3918	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO		60	L-Upper		TCGA-44-3918-F38999	TCGA-44-3918	TCGA-44-3918-11A			-22236			0	1036	511	FPPP	76						Scheduled Follow-up Submission	Stable Disease	2013-1-10	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	600	0.8	NO	90	NO				2	NO	Locoregional Recurrence	YES	20		No	M0	N0	T1	Stage IA		3918	Other	WITH TUMOR			103	104	Complete Remission/Response	Biopsy with Histologic Confirmation|Convincing Imaging	TCGA	YES	NO	R0	Solid Tissue Normal	11	0.8	1994	6th	NO	YES	NO	44	3		Lung	A	LIVING	2010	1974						TCGA-44-3918-11A-01D-1104-05																
TCGA-44-3919-01	1.94	0.49	none		none	none	none	N	Y	none	p.774_775insAYVM	none	0.25	Bronchioid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-3919-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation c1uster 9	TCGA-44-3919	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	71	R-Upper		TCGA-44-3919-F38530	TCGA-44-3919				-26081		1026	0	190	984		103	2					Additional New Tumor Event		2012-12-19	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO					NO	Distant Metastasis	YES			No	M0	N0	T1	Stage IA		3919	Other	WITH TUMOR			99	100	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01			7th	NO	YES	NO	44	1	Lifelong Non-smoker	Lung		DECEASED	2010		TCGA-44-3919-01	TCGA-44-3919-01A-02D-1458-08	TCGA-44-3919-01	fa3183f2-b71c-4837-8b1e-5e29336caf62	TCGA-44-3919-01A-02R-1107-07	TCGA-44-3919-01A-02D-1104-05	TCGA-44-3919-01	TCGA-44-3919-01A-02D-1877-01		TCGA-44-3919-01	TCGA-44-3919-01A-02D-1877-01	TCGA-44-3919-01	fa3183f2-b71c-4837-8b1e-5e29336caf62		TCGA-44-3919-01A-11-2190-20	fa3183f2-b71c-4837-8b1e-5e29336caf62	TCGA-44-3919-01	e72f62a3-8f58-4df4-b339-198051b6c95f	fa3183f2-b71c-4837-8b1e-5e29336caf62	TCGA-44-3919-01A-02D-1105-08,TCGA-44-3919-01A-02D-1458-08		TCGA-44-3919-01
TCGA-44-3919-11	1.94	0.49	none		none	none	none	N	Y	none	p.774_775insAYVM	none	0.25	Bronchioid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-3919-11		C1-LUAD-enriched							mutation c1uster 9	TCGA-44-3919	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	71	R-Upper		TCGA-44-3919-F38530	TCGA-44-3919	TCGA-44-3919-11A			-26081		1026	0	190	984		103	2					Additional New Tumor Event		2012-12-19	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO		NO				1.3	NO	Distant Metastasis	YES			No	M0	N0	T1	Stage IA		3919	Other	WITH TUMOR			99	100	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Solid Tissue Normal	11	0.4		7th	NO	YES	NO	44	1	Lifelong Non-smoker	Lung	A	DECEASED	2010							TCGA-44-3919-11A-01D-1104-05																
TCGA-44-4112-01	2.13	0.56	none		none	none	p.G367V	N	N	none	none	p.C304F	0.27	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-4112-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 12	TCGA-44-4112	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		60	R-Upper		TCGA-44-4112-F32266	TCGA-44-4112	TCGA-44-4112-01A			-22106		808	0	141		FPPP									2012-5-22	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	220	1	NO		NO				2			NO	30		No	M0	N0	T2a	Stage IB	TCGA-44-4112.9f214c90-f9a8-458c-8a53-ca8e8b09a2b2.pdf	4112		WITH TUMOR							TCGA	YES		R0	Primary Tumor	01	0.4	1992	6th		YES	NO	44	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2010	1972	TCGA-44-4112-01	TCGA-44-4112-01A-01D-1105-08	TCGA-44-4112-01	220d4f21-012b-4e06-aabf-a32d23f28a78	TCGA-44-4112-01A-01R-1107-07	TCGA-44-4112-01A-01D-1104-05	TCGA-44-4112-01	TCGA-44-4112-01A-01D-A273-01	TCGA-44-4112-01B-06D-A276-05,TCGA-44-4112-01A-01D-A276-05	TCGA-44-4112-01	TCGA-44-4112-01A-01D-A273-01	TCGA-44-4112-01	220d4f21-012b-4e06-aabf-a32d23f28a78		TCGA-44-4112-01A-21-2190-20	220d4f21-012b-4e06-aabf-a32d23f28a78	TCGA-44-4112-01	cc482acb-598e-44b9-86f9-c287fd6766d5	220d4f21-012b-4e06-aabf-a32d23f28a78	TCGA-44-4112-01A-01D-1105-08,TCGA-44-4112-01A-01D-1458-08		TCGA-44-4112-01
TCGA-44-4112-11	2.13	0.56	none		none	none	p.G367V	N	N	none	none	p.C304F	0.27	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-4112-11		C1-LUAD-enriched							mutation cluster 12	TCGA-44-4112	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		60	R-Upper		TCGA-44-4112-F32266	TCGA-44-4112	TCGA-44-4112-11A			-22106		808	0	141		FPPP									2012-5-22	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	520	1	NO		NO				1.5			NO	30		No	M0	N0	T2a	Stage IB		4112		WITH TUMOR							TCGA	YES		R0	Solid Tissue Normal	11	0.4	1992	6th		YES	NO	44	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2010	1972						TCGA-44-4112-11A-01D-1104-05																
TCGA-44-5643-01																												TCGA-44-5643-01	Squamous	C2-Squamous-like		Cluster 13 (HNSC-LUSC)	BRCA basal-like c6	squamous-like c4	miRNA cluster 11		mutation cluster 3	TCGA-44-5643	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		53	R-Lower		TCGA-44-5643-F39742	TCGA-44-5643	TCGA-44-5643-01A			-19426			0	1013			75	1					Scheduled Follow-up Submission	Complete Remission/Response	2013-2-25	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.8	NO						1.2	NO		NO	20		No	M0	N2	T2b	Stage IIIA	TCGA-44-5643.3117a24b-6125-47a8-a05b-4ada99e68dfa.pdf	5643	Other	TUMOR FREE			92	66				YES			Primary Tumor	01	0.8		7th		YES	NO	44	2		Lung	A	LIVING	2010		TCGA-44-5643-01A-01D-1625-08			a8ef928f-7321-4355-b136-cec50ebd9481				TCGA-44-5643-01A-01D-1624-01	TCGA-44-5643-01A-01D-1626-05	TCGA-44-5643-01	TCGA-44-5643-01A-01D-1624-01		a8ef928f-7321-4355-b136-cec50ebd9481	TCGA-44-5643-01	TCGA-44-5643-01A-41-2191-20	a8ef928f-7321-4355-b136-cec50ebd9481	TCGA-44-5643-01	65fa1532-4925-48b2-888f-3509654957e7	a8ef928f-7321-4355-b136-cec50ebd9481	TCGA-44-5643-01A-01D-1625-08	TCGA-44-5643-01	
TCGA-44-5643-11																												TCGA-44-5643-11		C2-Squamous-like							mutation cluster 3	TCGA-44-5643	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		53	R-Lower		TCGA-44-5643-F39742	TCGA-44-5643	TCGA-44-5643-11A			-19426			0	1013			75	1					Scheduled Follow-up Submission	Complete Remission/Response	2013-2-25	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.9	NO						1.9	NO		NO	20		No	M0	N2	T2b	Stage IIIA		5643	Other	TUMOR FREE			92	66				YES			Solid Tissue Normal	11	0.7		7th		YES	NO	44	2		Lung	A	LIVING	2010										TCGA-44-5643-11A-01D-1626-05													
TCGA-44-5644-01																												TCGA-44-5644-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 6			TCGA-44-5644	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		51	R-Lower		TCGA-44-5644-F38817	TCGA-44-5644	TCGA-44-5644-01A			-18644			0	863			61						Scheduled Follow-up Submission	Complete Remission/Response	2012-12-26	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1	NO						1	NO		NO	17.5		No		N0	T2a	Stage IB	TCGA-44-5644.041e212a-2fdd-42af-9326-9fb5fef07126.pdf	5644		TUMOR FREE			103	59	Complete Remission/Response			YES	NO		Primary Tumor	01	0.2		7th	NO	YES	NO	44	2		Lung	A	LIVING	2010	1975				44205bf0-b593-4c0d-9aeb-4e604314e10f				TCGA-44-5644-01A-21D-2035-01	TCGA-44-5644-01A-21D-2037-05	TCGA-44-5644-01	TCGA-44-5644-01A-21D-2035-01		44205bf0-b593-4c0d-9aeb-4e604314e10f	TCGA-44-5644-01	TCGA-44-5644-01A-41-2191-20	44205bf0-b593-4c0d-9aeb-4e604314e10f	TCGA-44-5644-01	07d9b06a-f8d3-46d8-b864-4dfd4430540b	44205bf0-b593-4c0d-9aeb-4e604314e10f	TCGA-44-5644-01A-21D-2036-08	TCGA-44-5644-01	
TCGA-44-5645-01	2.38	0.54	none		none	none	none	N	N	none	none	none	0.24	Bronchioid	none	none	none	none	none	p.H1047R	none	Lepidic predominant Adc	Lepidic predominant Adc			none	0	TCGA-44-5645-01	Iq	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 4	mutation cluster 3	TCGA-44-5645	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		61	L-Upper		TCGA-44-5645-F38800	TCGA-44-5645				-22471			0	852		FPPP	82						Scheduled Follow-up Submission	Complete Remission/Response	2012-12-24	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES										NO		NO	5		No		NX	T1	Stage IA		5645		TUMOR FREE			90	100	Complete Remission/Response		TCGA	YES	NO		Primary Tumor	01		1973	7th	NO	YES	NO	44	3	Current reformed smoker for > 15 years	Lung		LIVING	2010	1963	TCGA-44-5645-01A-01D-1625-08	TCGA-44-5645-01A-01D-1625-08		b4bbc93a-5460-476d-a663-61299fddfab2				TCGA-44-5645-01A-01D-A273-01	TCGA-44-5645-01B-04D-A276-05,TCGA-44-5645-01A-01D-A276-05,TCGA-44-5645-01A-01D-1626-05	TCGA-44-5645-01	TCGA-44-5645-01A-01D-A273-01		b4bbc93a-5460-476d-a663-61299fddfab2	TCGA-44-5645-01	TCGA-44-5645-01A-41-2191-20	b4bbc93a-5460-476d-a663-61299fddfab2	TCGA-44-5645-01	ec945497-65c8-47ca-81d7-22be0f1f8c7c	b4bbc93a-5460-476d-a663-61299fddfab2	TCGA-44-5645-01A-01D-1625-08	TCGA-44-5645-01	
TCGA-44-5645-11	2.38	0.54	none		none	none	none	N	N	none	none	none	0.24	Bronchioid	none	none	none	none	none	p.H1047R	none	Lepidic predominant Adc	Lepidic predominant Adc			none	0	TCGA-44-5645-11		C1-LUAD-enriched							mutation cluster 3	TCGA-44-5645	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		61	L-Upper		TCGA-44-5645-F38800	TCGA-44-5645	TCGA-44-5645-11A			-22471			0	852		FPPP	82						Scheduled Follow-up Submission	Complete Remission/Response	2012-12-24	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	860	1	NO						2.4	NO		NO	5		No		NX	T1	Stage IA		5645		TUMOR FREE			90	100	Complete Remission/Response		TCGA	YES	NO		Solid Tissue Normal	11	0.8	1973	7th	NO	YES	NO	44	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2010	1963				cafb7a81-9e7a-49c0-8a55-96cb32ad273e					TCGA-44-5645-11A-01D-1626-05				cafb7a81-9e7a-49c0-8a55-96cb32ad273e			cafb7a81-9e7a-49c0-8a55-96cb32ad273e			cafb7a81-9e7a-49c0-8a55-96cb32ad273e			
TCGA-44-6144-01																												TCGA-44-6144-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3		miRNA cluster 5		mutation cluster 2	TCGA-44-6144	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	NO	58	R-Upper		TCGA-44-6144-F39034	TCGA-44-6144				-21283			0	723	399		82	0					Scheduled Follow-up Submission	Progressive Disease	2013-1-9	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES				70						NO	Locoregional Recurrence|Distant Metastasis	YES	67.5		No	M0	N0	T1a	Stage IA		6144	Other	WITH TUMOR	97	77	87	63	Complete Remission/Response	Biopsy with Histologic Confirmation|Convincing Imaging		YES	NO	RX	Primary Tumor	01			7th	NO	YES	NO	44	2		Lung		LIVING	2011	1968	TCGA-44-6144-01A-11D-1753-08							TCGA-44-6144-01A-11D-1752-01	TCGA-44-6144-01A-11D-1756-05		TCGA-44-6144-01A-11D-1752-01			TCGA-44-6144-01	TCGA-44-6144-01A-13-2191-20			faa409af-7bc8-4e0e-8c38-7ab58e895727		TCGA-44-6144-01A-11D-1753-08	TCGA-44-6144-01	
TCGA-44-6144-11																												TCGA-44-6144-11		C1-LUAD-enriched							mutation cluster 2	TCGA-44-6144	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	NO	58	R-Upper		TCGA-44-6144-F39034	TCGA-44-6144				-21283			0	723	399		82	0					Scheduled Follow-up Submission	Progressive Disease	2013-1-9	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES				70						NO	Locoregional Recurrence|Distant Metastasis	YES	67.5		No	M0	N0	T1a	Stage IA		6144	Other	WITH TUMOR	97	77	87	63	Complete Remission/Response	Biopsy with Histologic Confirmation|Convincing Imaging		YES	NO	RX	Solid Tissue Normal	11			7th	NO	YES	NO	44	2		Lung		LIVING	2011	1968				e9c07b6c-0a18-44ff-90cd-d39ae6c47fd6					TCGA-44-6144-11A-01D-1756-05				e9c07b6c-0a18-44ff-90cd-d39ae6c47fd6	TCGA-44-6144-11		e9c07b6c-0a18-44ff-90cd-d39ae6c47fd6			e9c07b6c-0a18-44ff-90cd-d39ae6c47fd6		TCGA-44-6144-11	
TCGA-44-6145-01	1.66	0.31	none		none	none	none	Y	Y	none	none	none	0.16	Squamoid	none	p.G12V	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-6145-01	High	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 3	mutation cluster 11	TCGA-44-6145	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					62	R-Upper		TCGA-44-6145-F38802	TCGA-44-6145	TCGA-44-6145-01A			-22745			0	595			73	0					Scheduled Follow-up Submission	Complete Remission/Response	2012-12-24	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO		NO	NO			1.5	NO		NO	75		No	M0	N0	T1	Stage IA	TCGA-44-6145.57537882-084b-4082-bcf0-f7d297a877e6.pdf	6145	Preoperative	TUMOR FREE	91	90	77	71	Complete Remission/Response			YES	NO		Primary Tumor	01	0.5	1999	7th	NO	YES	NO	44	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2011	1963	TCGA-44-6145-01A-11D-1753-08	TCGA-44-6145-01A-11D-1753-08		2d452408-9d25-49e1-81db-542021eb28cb				TCGA-44-6145-01A-11D-1752-01	TCGA-44-6145-01A-11D-1756-05	TCGA-44-6145-01	TCGA-44-6145-01A-11D-1752-01		2d452408-9d25-49e1-81db-542021eb28cb	TCGA-44-6145-01	TCGA-44-6145-01A-13-2191-20	2d452408-9d25-49e1-81db-542021eb28cb	TCGA-44-6145-01	6dda9f9a-db50-4dfe-90e5-2c06a8f65018	2d452408-9d25-49e1-81db-542021eb28cb	TCGA-44-6145-01A-11D-1753-08	TCGA-44-6145-01	
TCGA-44-6145-11	1.66	0.31	none		none	none	none	Y	Y	none	none	none	0.16	Squamoid	none	p.G12V	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-6145-11		C1-LUAD-enriched							mutation cluster 11	TCGA-44-6145	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					62	R-Upper		TCGA-44-6145-F38802	TCGA-44-6145	TCGA-44-6145-11A			-22745			0	595			73	0					Scheduled Follow-up Submission	Complete Remission/Response	2012-12-24	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO		NO	NO			2	NO		NO	75		No	M0	N0	T1	Stage IA		6145	Preoperative	TUMOR FREE	91	90	77	71	Complete Remission/Response			YES	NO		Solid Tissue Normal	11	1	1999	7th	NO	YES	NO	44	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2011	1963				3b3948f2-e93e-4d89-8611-3cde3b962193					TCGA-44-6145-11A-01D-1756-05				3b3948f2-e93e-4d89-8611-3cde3b962193			3b3948f2-e93e-4d89-8611-3cde3b962193			3b3948f2-e93e-4d89-8611-3cde3b962193			
TCGA-44-6146-01	1.87	0.74	none		none	none	none	Y	Y	none	none	none	0.39	Bronchioid	none	p.G12V	none	none	none	none	none	Invasive mucinous	Invasive mucinous			none	0	TCGA-44-6146-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 6	cluster 1	mutation cluster 12	TCGA-44-6146	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO		64	L-Lower		TCGA-44-6146-F34551	TCGA-44-6146	TCGA-44-6146-01A			-23378			0	728	631	FPPP	76	0					Additional New Tumor Event		2012-8-22	MALE	Lung Mucinous Adenocarcinoma	No	C34.30	8480/3	C34.3	YES	420	0.8	NO						2	NO	Locoregional Recurrence	YES	15		Yes	M0	N0	T3	Stage IIB	TCGA-44-6146.51a479ab-4c21-4189-a682-e6976d509ed3.pdf	6146	Other	TUMOR FREE	95	94	88	87		Convincing Imaging	TCGA	YES			Primary Tumor	01	0.8	1980	7th		YES	NO	44	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2010		TCGA-44-6146-01A-11D-1753-08	TCGA-44-6146-01A-11D-1753-08		c18d4714-5af9-4370-8b6d-f86b0c43b285				TCGA-44-6146-01A-11D-A273-01	TCGA-44-6146-01A-11D-1756-05,TCGA-44-6146-01A-11D-A276-05,TCGA-44-6146-01B-04D-A276-05	TCGA-44-6146-01	TCGA-44-6146-01A-11D-A273-01		c18d4714-5af9-4370-8b6d-f86b0c43b285	TCGA-44-6146-01	TCGA-44-6146-01A-13-2191-20	c18d4714-5af9-4370-8b6d-f86b0c43b285	TCGA-44-6146-01	39d5ffa0-85ff-4d42-a064-1c083c1c24fd	c18d4714-5af9-4370-8b6d-f86b0c43b285	TCGA-44-6146-01A-11D-1753-08	TCGA-44-6146-01	
TCGA-44-6146-11	1.87	0.74	none		none	none	none	Y	Y	none	none	none	0.39	Bronchioid	none	p.G12V	none	none	none	none	none	Invasive mucinous	Invasive mucinous			none	0	TCGA-44-6146-11		C1-LUAD-enriched							mutation cluster 12	TCGA-44-6146	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO		64	L-Lower		TCGA-44-6146-F34551	TCGA-44-6146	TCGA-44-6146-11A			-23378			0	728	631	FPPP	76	0					Additional New Tumor Event		2012-8-22	MALE	Lung Mucinous Adenocarcinoma	No	C34.30	8480/3	C34.3	YES	400	0.9	NO						1.5	NO	Locoregional Recurrence	YES	15		Yes	M0	N0	T3	Stage IIB		6146	Other	TUMOR FREE	95	94	88	87		Convincing Imaging	TCGA	YES			Solid Tissue Normal	11	0.9	1980	7th		YES	NO	44	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2010					488285fc-5482-46b7-b97e-2f5e7330311a					TCGA-44-6146-11A-01D-1756-05				488285fc-5482-46b7-b97e-2f5e7330311a			488285fc-5482-46b7-b97e-2f5e7330311a			488285fc-5482-46b7-b97e-2f5e7330311a			
TCGA-44-6147-01	2.19	0.36	none		none	none	none	Y	Y	p.S768I, p.V769L	none	none	0.17	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-44-6147-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 5	mutation cluster 8	TCGA-44-6147	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		67	R-Upper		TCGA-44-6147-F38947	TCGA-44-6147	TCGA-44-6147-01A			-24631			0	845		FPPP	68						Scheduled Follow-up Submission	Complete Remission/Response	2013-1-4	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	80	0.8	NO	80					1	NO		NO			Yes	M0	NX	T1b	Stage IA	TCGA-44-6147.06f76ecf-14db-4228-b413-f6b4e187a1e4.pdf	6147	Other	TUMOR FREE			105	97	Complete Remission/Response		TCGA	YES	NO		Primary Tumor	01	0.6	1980	7th	NO	YES	NO	44	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2010	1976	TCGA-44-6147-01A-11D-1753-08	TCGA-44-6147-01A-11D-1753-08		29af0307-5d76-462d-beee-18e8c4f179b8				TCGA-44-6147-01A-11D-A273-01	TCGA-44-6147-01A-11D-1756-05,TCGA-44-6147-01B-06D-A276-05,TCGA-44-6147-01A-11D-A276-05	TCGA-44-6147-01	TCGA-44-6147-01A-11D-A273-01		29af0307-5d76-462d-beee-18e8c4f179b8		TCGA-44-6147-01A-13-2191-20	29af0307-5d76-462d-beee-18e8c4f179b8	TCGA-44-6147-01	af82f02d-660f-4906-9b42-be16c0615693	29af0307-5d76-462d-beee-18e8c4f179b8	TCGA-44-6147-01A-11D-1753-08		
TCGA-44-6147-11	2.19	0.36	none		none	none	none	Y	Y	p.S768I, p.V769L	none	none	0.17	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-44-6147-11		C1-LUAD-enriched							mutation cluster 8	TCGA-44-6147	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		67	R-Upper		TCGA-44-6147-F38947	TCGA-44-6147	TCGA-44-6147-11A			-24631			0	845		FPPP	68						Scheduled Follow-up Submission	Complete Remission/Response	2013-1-4	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	720	1	NO	80					2.2	NO		NO			Yes	M0	NX	T1b	Stage IA		6147	Other	TUMOR FREE			105	97	Complete Remission/Response		TCGA	YES	NO		Solid Tissue Normal	11	1	1980	7th	NO	YES	NO	44	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2010	1976				2f16ddcc-8a98-4734-9878-645ff102fb14					TCGA-44-6147-11A-01D-1756-05				2f16ddcc-8a98-4734-9878-645ff102fb14			2f16ddcc-8a98-4734-9878-645ff102fb14			2f16ddcc-8a98-4734-9878-645ff102fb14			
TCGA-44-6148-01																												TCGA-44-6148-01	Kirc+	C1-LUAD-enriched		Low purity c2	squamous c3	LUAD-like c10			mutation c1uster 9	TCGA-44-6148	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		60	L-Lower		TCGA-44-6148-F38967	TCGA-44-6148	TCGA-44-6148-01A			-22138			0	704				1					Scheduled Follow-up Submission	Complete Remission/Response	2013-1-7	MALE	Lung Mucinous Adenocarcinoma	No	C34.30	8480/3	C34.3	YES		0.8	NO		NO	NO			1.5	NO		NO	60		No	M0	N0	T1b	Stage IA	TCGA-44-6148.5407ff6d-a042-47db-998b-60e6f15109ab.pdf	6148	Preoperative	TUMOR FREE	110	77	98	74	Complete Remission/Response			YES	NO	RX	Primary Tumor	01	0.4	1994	7th	NO	YES	NO	44	3		Lung	A	LIVING	2011	1963	TCGA-44-6148-01A-11D-1753-08			472518f5-c62b-4e50-9ea9-077a44a8f117				TCGA-44-6148-01A-11D-1752-01	TCGA-44-6148-01A-11D-1756-05	TCGA-44-6148-01	TCGA-44-6148-01A-11D-1752-01		472518f5-c62b-4e50-9ea9-077a44a8f117	TCGA-44-6148-01	TCGA-44-6148-01A-13-2191-20	472518f5-c62b-4e50-9ea9-077a44a8f117	TCGA-44-6148-01	2227fc80-a405-473b-b25c-dbcfe1624040	472518f5-c62b-4e50-9ea9-077a44a8f117	TCGA-44-6148-01A-11D-1753-08	TCGA-44-6148-01	
TCGA-44-6148-11																												TCGA-44-6148-11		C1-LUAD-enriched							mutation c1uster 9	TCGA-44-6148	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		60	L-Lower		TCGA-44-6148-F38967	TCGA-44-6148	TCGA-44-6148-11A			-22138			0	704				1					Scheduled Follow-up Submission	Complete Remission/Response	2013-1-7	MALE	Lung Mucinous Adenocarcinoma	No	C34.30	8480/3	C34.3	YES		0.9	NO		NO	NO			2.3	NO		NO	60		No	M0	N0	T1b	Stage IA		6148	Preoperative	TUMOR FREE	110	77	98	74	Complete Remission/Response			YES	NO	RX	Solid Tissue Normal	11	0.9	1994	7th	NO	YES	NO	44	3		Lung	A	LIVING	2011	1963				0391cb59-6ceb-4d9a-be02-5d68b4ddafc3					TCGA-44-6148-11A-01D-1756-05				0391cb59-6ceb-4d9a-be02-5d68b4ddafc3			0391cb59-6ceb-4d9a-be02-5d68b4ddafc3			0391cb59-6ceb-4d9a-be02-5d68b4ddafc3			
TCGA-44-6774-01	2.13	0.36	none		p.N581S	none	none	N	N	none	none	none	0.18	Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-44-6774-01	High	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation cluster 13	TCGA-44-6774	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		56	L-Lower		TCGA-44-6774-F39646	TCGA-44-6774	TCGA-44-6774-01A			-20462			0	658			101	1					Scheduled Follow-up Submission	Complete Remission/Response	2013-1-28	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1	NO						1.5	NO		NO	20		No	M0	N2	T1	Stage IIIA	TCGA-44-6774.f9587269-4f32-497a-a95a-42d505af2434.pdf	6774	Other	TUMOR FREE			84	96	Complete Remission/Response			YES	YES		Primary Tumor	01	0.3		7th	YES	YES	NO	44	2	Current smoker	Lung	A	LIVING	2011	1971	TCGA-44-6774-01A-21D-1855-08	TCGA-44-6774-01A-21D-1855-08		7d27cfbf-870f-45e8-80a9-7e3848f414dc				TCGA-44-6774-01A-21D-1854-01	TCGA-44-6774-01A-21D-1856-05	TCGA-44-6774-01	TCGA-44-6774-01A-21D-1854-01		7d27cfbf-870f-45e8-80a9-7e3848f414dc	TCGA-44-6774-01	TCGA-44-6774-01A-23-2191-20	7d27cfbf-870f-45e8-80a9-7e3848f414dc	TCGA-44-6774-01	dafb8264-54ef-4fe8-b549-3c5079a42773	7d27cfbf-870f-45e8-80a9-7e3848f414dc	TCGA-44-6774-01A-21D-1855-08	TCGA-44-6774-01	
TCGA-44-6775-01	2.24	0.38	none		none	none	none	N	N	none	none	none	0.18	Squamoid	none	none	none	exon 14 skipping by RSeq	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-44-6775-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 13	TCGA-44-6775	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		72	R-Upper		TCGA-44-6775-F40408	TCGA-44-6775	TCGA-44-6775-01A			-26415			0	705	684	FPPP	66						Scheduled Follow-up Submission	Progressive Disease	2013-2-19	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	70	1.1	NO	100					1.1	NO	Locoregional Recurrence	YES	25		No	MX	N0	T2a	Stage IB	TCGA-44-6775.cd641541-f607-49de-8f57-fa54b0561721.pdf	6775	Other	WITH TUMOR	89	72	84	68	Complete Remission/Response	Convincing Imaging	TCGA	YES	NO	RX	Primary Tumor	01	0.2	2005	7th	NO	YES	NO	44	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2011	1955	TCGA-44-6775-01A-11D-1855-08	TCGA-44-6775-01A-11D-1855-08		6a4b7295-a738-4d4a-a264-72fba462e60c				TCGA-44-6775-01A-11D-A273-01	TCGA-44-6775-01A-11D-1856-05,TCGA-44-6775-01A-11D-A276-05,TCGA-44-6775-01C-02D-A276-05	TCGA-44-6775-01	TCGA-44-6775-01A-11D-A273-01		6a4b7295-a738-4d4a-a264-72fba462e60c	TCGA-44-6775-01	TCGA-44-6775-01A-13-2191-20	6a4b7295-a738-4d4a-a264-72fba462e60c	TCGA-44-6775-01	f098943b-8859-4329-b980-14784b42131f	6a4b7295-a738-4d4a-a264-72fba462e60c	TCGA-44-6775-01A-11D-1855-08	TCGA-44-6775-01	
TCGA-44-6776-01	1.95	0.64	none		none	none	none	Y	Y	none	none	none	0.33	Bronchioid	none	p.G12D	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			p.Q220*	0	TCGA-44-6776-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA c1uster 9	cluster 5	mutation cluster 7	TCGA-44-6776	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		60	R-Upper		TCGA-44-6776-F39378	TCGA-44-6776				-22150			0	2616			80						Scheduled Follow-up Submission	Complete Remission/Response	2013-1-21	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES										NO		NO	45		Yes	MX	N0	T1	Stage IA		6776		TUMOR FREE	85	82	95	74	Complete Remission/Response			YES	NO		Primary Tumor	01		2005	6th	NO	NO	YES	44	4	Current reformed smoker for < or = 15 years	Lung		LIVING	2005	1960	TCGA-44-6776-01A-11D-1855-08	TCGA-44-6776-01A-11D-1855-08		aae03245-71cc-4081-87b6-925f96bee9ef				TCGA-44-6776-01A-11D-1854-01	TCGA-44-6776-01A-11D-1856-05	TCGA-44-6776-01	TCGA-44-6776-01A-11D-1854-01		aae03245-71cc-4081-87b6-925f96bee9ef	TCGA-44-6776-01	TCGA-44-6776-01A-13-2191-20	aae03245-71cc-4081-87b6-925f96bee9ef	TCGA-44-6776-01	b08fc3a5-06b6-42af-8195-585acfcf1d4e	aae03245-71cc-4081-87b6-925f96bee9ef	TCGA-44-6776-01A-11D-1855-08	TCGA-44-6776-01	
TCGA-44-6776-11	1.95	0.64	none		none	none	none	Y	Y	none	none	none	0.33	Bronchioid	none	p.G12D	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			p.Q220*	0	TCGA-44-6776-11		C1-LUAD-enriched							mutation cluster 7	TCGA-44-6776	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		60	R-Upper		TCGA-44-6776-F39378	TCGA-44-6776				-22150			0	2616			80						Scheduled Follow-up Submission	Complete Remission/Response	2013-1-21	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES										NO		NO	45		Yes	MX	N0	T1	Stage IA		6776		TUMOR FREE	85	82	95	74	Complete Remission/Response			YES	NO		Solid Tissue Normal	11		2005	6th	NO	NO	YES	44	4	Current reformed smoker for < or = 15 years	Lung		LIVING	2005	1960				d3402ac8-0188-4fb8-8054-ba3145120952									d3402ac8-0188-4fb8-8054-ba3145120952	TCGA-44-6776-11		d3402ac8-0188-4fb8-8054-ba3145120952			d3402ac8-0188-4fb8-8054-ba3145120952		TCGA-44-6776-11	
TCGA-44-6777-01	1.91	0.34	none		none	none	none	Y	Y	none	none	p.D335Y	0.17	Squamoid	none	p.G12C	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-6777-01	High	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 2	TCGA-44-6777	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					85	L-Upper		TCGA-44-6777-F15694	TCGA-44-6777	TCGA-44-6777-01A			-31234		987	0				178	3					Scheduled Follow-up Submission		2011-8-30	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO						1.8			NO	64		No	MX	NX	T2	Stage IB	TCGA-44-6777.600a1078-21f2-4267-9d3c-03f292fa6a32.pdf	6777	Post-Adjuvant Therapy	TUMOR FREE	77	71	68	62	Complete Remission/Response			YES	YES		Primary Tumor	01	0.4	2006	6th	NO	NO	YES	44	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2006	1942	TCGA-44-6777-01A-11D-1855-08	TCGA-44-6777-01A-11D-1855-08		25f0eee1-8f38-4e75-accf-7e7bb686405c				TCGA-44-6777-01A-11D-1854-01	TCGA-44-6777-01A-11D-1856-05	TCGA-44-6777-01	TCGA-44-6777-01A-11D-1854-01		25f0eee1-8f38-4e75-accf-7e7bb686405c	TCGA-44-6777-01	TCGA-44-6777-01A-13-2191-20	25f0eee1-8f38-4e75-accf-7e7bb686405c	TCGA-44-6777-01	137825b5-a029-4638-8150-bca2c02f6ded	25f0eee1-8f38-4e75-accf-7e7bb686405c	TCGA-44-6777-01A-11D-1855-08	TCGA-44-6777-01	
TCGA-44-6777-11	1.91	0.34	none		none	none	none	Y	Y	none	none	p.D335Y	0.17	Squamoid	none	p.G12C	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-6777-11		C1-LUAD-enriched							mutation cluster 2	TCGA-44-6777	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					85	L-Upper		TCGA-44-6777-F15694	TCGA-44-6777				-31234		987	0				178	3					Scheduled Follow-up Submission		2011-8-30	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES												NO	64		No	MX	NX	T2	Stage IB		6777	Post-Adjuvant Therapy	TUMOR FREE	77	71	68	62	Complete Remission/Response			YES	YES		Solid Tissue Normal	11		2006	6th	NO	NO	YES	44	4	Current reformed smoker for < or = 15 years	Lung		DECEASED	2006	1942				f3bb69da-304f-462d-b020-f479a866381e									f3bb69da-304f-462d-b020-f479a866381e	TCGA-44-6777-11		f3bb69da-304f-462d-b020-f479a866381e			f3bb69da-304f-462d-b020-f479a866381e		TCGA-44-6777-11	
TCGA-44-6778-01																												TCGA-44-6778-01	High	C1-LUAD-enriched		Low purity c2	squamous c3	LUAD-like c10	miRNA cluster 6		mutation cluster 2	TCGA-44-6778	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					59	[Discrepancy]		TCGA-44-6778-F39376	TCGA-44-6778	TCGA-44-6778-01A			-21725			0	1864			53						Scheduled Follow-up Submission	Complete Remission/Response	2013-1-21	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES		0.9	NO						1	NO		NO	15		No	MX	N0	T1	Stage IA	TCGA-44-6778.b1f41c0e-a2a1-4945-85b3-a2ef6a994cbe.pdf	6778		TUMOR FREE			90	74	Complete Remission/Response			YES	NO		Primary Tumor	01	0.8	2004	6th	NO	NO	YES	44	4		Lung	A	LIVING	2007	1974	TCGA-44-6778-01A-11D-1855-08			ee90d7cd-4ac9-4be0-b9a8-49329890f69d				TCGA-44-6778-01A-11D-1854-01	TCGA-44-6778-01A-11D-1856-05	TCGA-44-6778-01	TCGA-44-6778-01A-11D-1854-01		ee90d7cd-4ac9-4be0-b9a8-49329890f69d	TCGA-44-6778-01	TCGA-44-6778-01A-13-2191-20	ee90d7cd-4ac9-4be0-b9a8-49329890f69d	TCGA-44-6778-01	3380c662-2c5f-4dc7-b438-5286e2984b36	ee90d7cd-4ac9-4be0-b9a8-49329890f69d	TCGA-44-6778-01A-11D-1855-08	TCGA-44-6778-01	
TCGA-44-6778-11																												TCGA-44-6778-11		C1-LUAD-enriched							mutation cluster 2	TCGA-44-6778	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					59	[Discrepancy]		TCGA-44-6778-F39376	TCGA-44-6778				-21725			0	1864			53						Scheduled Follow-up Submission	Complete Remission/Response	2013-1-21	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES										NO		NO	15		No	MX	N0	T1	Stage IA		6778		TUMOR FREE			90	74	Complete Remission/Response			YES	NO		Solid Tissue Normal	11		2004	6th	NO	NO	YES	44	4		Lung		LIVING	2007	1974				a89e4f9e-0dfe-449d-a215-6c770cc5ea55					TCGA-44-6778-11A-01D-1856-05				a89e4f9e-0dfe-449d-a215-6c770cc5ea55	TCGA-44-6778-11		a89e4f9e-0dfe-449d-a215-6c770cc5ea55			a89e4f9e-0dfe-449d-a215-6c770cc5ea55		TCGA-44-6778-11	
TCGA-44-6779-01	3.12	0.43	none		none	none	none	N	N	none	none	none	0.17	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			p.K235*	0	TCGA-44-6779-01	High	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 8	TCGA-44-6779	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO		50	[Discrepancy]		TCGA-44-6779-F15758	TCGA-44-6779	TCGA-44-6779-01A			-18469		500	0		232		44						Scheduled Follow-up Submission		2011-9-12	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES		0.7	NO						1			YES	15		No	MX	N1	T2	Stage IIB	TCGA-44-6779.7f7b5635-2f0e-4f0e-b56a-5c19cfe0593c.pdf	6779		WITH TUMOR	83	48	83	49	Progressive Disease			YES	NO		Primary Tumor	01	0.5	2008	6th	YES	NO	YES	44	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2008	1978	TCGA-44-6779-01A-11D-1855-08	TCGA-44-6779-01A-11D-1855-08		57f72fed-dcb9-4bba-8810-30c254f4635c				TCGA-44-6779-01A-11D-1854-01	TCGA-44-6779-01A-11D-1856-05	TCGA-44-6779-01	TCGA-44-6779-01A-11D-1854-01		57f72fed-dcb9-4bba-8810-30c254f4635c	TCGA-44-6779-01	TCGA-44-6779-01A-13-2191-20	57f72fed-dcb9-4bba-8810-30c254f4635c	TCGA-44-6779-01	1976e376-25dc-481c-b1b0-ba2b390944d5	57f72fed-dcb9-4bba-8810-30c254f4635c	TCGA-44-6779-01A-11D-1855-08	TCGA-44-6779-01	
TCGA-44-7659-01	2.09	0.59	none		none	none	none	Y	Y	none	none	none	0.29	Bronchioid	none	p.G12C	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-44-7659-01	Iq	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-44-7659	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		70	L-Upper		TCGA-44-7659-F39654	TCGA-44-7659	TCGA-44-7659-01A			-25730			0	691			43						Scheduled Follow-up Submission	Complete Remission/Response	2013-1-29	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO		NO				1.2	NO		NO	40		No	MX	N0	T1b	Stage IA	TCGA-44-7659.ca4281d7-0cd7-4ebc-8050-9dd81fbbefbc.pdf	7659		TUMOR FREE	60	47	55	42	Complete Remission/Response			YES	NO		Primary Tumor	01	0.4		7th	NO	YES	NO	44	2	Current smoker	Lung	A	LIVING	2010	1989		TCGA-44-7659-01A-11D-2063-08		e01db349-84f5-4e73-a356-3460d3267f03				TCGA-44-7659-01A-11D-2062-01	TCGA-44-7659-01A-11D-2064-05	TCGA-44-7659-01	TCGA-44-7659-01A-11D-2062-01		e01db349-84f5-4e73-a356-3460d3267f03	TCGA-44-7659-01	TCGA-44-7659-01A-13-2192-20	e01db349-84f5-4e73-a356-3460d3267f03	TCGA-44-7659-01	15ecd6a2-ab28-4b96-b20f-5a9163f6c14a	e01db349-84f5-4e73-a356-3460d3267f03	TCGA-44-7659-01A-11D-2063-08	TCGA-44-7659-01	
TCGA-44-7659-11	2.09	0.59	none		none	none	none	Y	Y	none	none	none	0.29	Bronchioid	none	p.G12C	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-44-7659-11		C1-LUAD-enriched								TCGA-44-7659	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		70	L-Upper		TCGA-44-7659-F39654	TCGA-44-7659				-25730			0	691			43						Scheduled Follow-up Submission	Complete Remission/Response	2013-1-29	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO					NO		NO	40		No	MX	N0	T1b	Stage IA		7659		TUMOR FREE	60	47	55	42	Complete Remission/Response			YES	NO		Solid Tissue Normal	11			7th	NO	YES	NO	44	2	Current smoker	Lung		LIVING	2010	1989														TCGA-44-7659-11							TCGA-44-7659-11	
TCGA-44-7660-01																												TCGA-44-7660-01	Squamous	C2-Squamous-like		OV-like c1	squamous c3	squamous-like c4	miRNA cluster 4			TCGA-44-7660	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		72	R-Upper		TCGA-44-7660-F40409	TCGA-44-7660				-26594			0	592			80	1					Scheduled Follow-up Submission	Stable Disease	2013-2-19	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES				70	NO					NO		NO	124		No	MX	N0	T2	Stage IB		7660	Other	WITH TUMOR	95	94	92	83	Progressive Disease			YES	NO		Primary Tumor	01			7th	YES	YES	NO	44	2		Lung		LIVING	2011	1949				bbf1f651-44f0-42c9-a519-64f3d47b42dc				TCGA-44-7660-01A-11D-2062-01	TCGA-44-7660-01A-11D-2064-05	TCGA-44-7660-01	TCGA-44-7660-01A-11D-2062-01		bbf1f651-44f0-42c9-a519-64f3d47b42dc	TCGA-44-7660-01	TCGA-44-7660-01A-13-2192-20	bbf1f651-44f0-42c9-a519-64f3d47b42dc	TCGA-44-7660-01	c423ffaa-5b81-4218-b7bb-85c8e7be4efe	bbf1f651-44f0-42c9-a519-64f3d47b42dc	TCGA-44-7660-01A-11D-2063-08	TCGA-44-7660-01	
TCGA-44-7660-11																												TCGA-44-7660-11		C2-Squamous-like								TCGA-44-7660	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		72	R-Upper		TCGA-44-7660-F40409	TCGA-44-7660				-26594			0	592			80	1					Scheduled Follow-up Submission	Stable Disease	2013-2-19	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES				70	NO					NO		NO	124		No	MX	N0	T2	Stage IB		7660	Other	WITH TUMOR	95	94	92	83	Progressive Disease			YES	NO		Solid Tissue Normal	11			7th	YES	YES	NO	44	2		Lung		LIVING	2011	1949														TCGA-44-7660-11							TCGA-44-7660-11	
TCGA-44-7661-01																												TCGA-44-7661-01	Kirc+	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5			TCGA-44-7661	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	69	R-Lower		TCGA-44-7661-F39321	TCGA-44-7661				-25483		557	0	153	335			0	YES			YES	Scheduled Follow-up Submission	Progressive Disease	2013-1-17	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES								Peripheral Lung		NO	Locoregional Recurrence	YES	22		Yes	M0	N0	T2a	Stage IB		7661	Preoperative	WITH TUMOR	95	81	92	68	Complete Remission/Response	Convincing Imaging		YES	NO		Primary Tumor	01		1976	7th	NO	YES	NO	44	3		Lung		DECEASED	2011	1961				d037d7f2-3277-4dc3-954b-503f906bc467				TCGA-44-7661-01A-11D-2062-01	TCGA-44-7661-01A-11D-2064-05	TCGA-44-7661-01	TCGA-44-7661-01A-11D-2062-01		d037d7f2-3277-4dc3-954b-503f906bc467	TCGA-44-7661-01	TCGA-44-7661-01A-13-2192-20	d037d7f2-3277-4dc3-954b-503f906bc467	TCGA-44-7661-01	ad484c0c-edb6-47f3-8e06-3adf0a4c3654	d037d7f2-3277-4dc3-954b-503f906bc467	TCGA-44-7661-01A-11D-2063-08	TCGA-44-7661-01	
TCGA-44-7661-11																												TCGA-44-7661-11		C1-LUAD-enriched								TCGA-44-7661	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	69	R-Lower		TCGA-44-7661-F39321	TCGA-44-7661				-25483		557	0	153	335			0	YES			YES	Scheduled Follow-up Submission	Progressive Disease	2013-1-17	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES								Peripheral Lung		NO	Locoregional Recurrence	YES	22		Yes	M0	N0	T2a	Stage IB		7661	Preoperative	WITH TUMOR	95	81	92	68	Complete Remission/Response	Convincing Imaging		YES	NO		Solid Tissue Normal	11		1976	7th	NO	YES	NO	44	3		Lung		DECEASED	2011	1961														TCGA-44-7661-11							TCGA-44-7661-11	
TCGA-44-7662-01	2.9	0.33	none		none	none	none	N	N	none	none	p.A828D	0.14	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-7662-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-44-7662	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	L-Upper		TCGA-44-7662-F34016	TCGA-44-7662	TCGA-44-7662-01A			-22543			0	218			57						Scheduled Follow-up Submission	Complete Remission/Response	2012-7-25	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO		NO				1	NO		NO	50		No	MX	N0	T2a	Stage IB	TCGA-44-7662.7b34e153-7bc5-4ba6-8445-bac63ca2dcc6.pdf	7662		TUMOR FREE	66	68	68	60	Complete Remission/Response			YES	NO		Primary Tumor	01	0.3		7th	NO	YES	NO	44	2	Current smoker	Lung	A	LIVING	2011	1961		TCGA-44-7662-01A-11D-2063-08		0216208c-fbbd-4370-93dd-19fbb7703568				TCGA-44-7662-01A-11D-2062-01	TCGA-44-7662-01A-11D-2064-05	TCGA-44-7662-01	TCGA-44-7662-01A-11D-2062-01		0216208c-fbbd-4370-93dd-19fbb7703568	TCGA-44-7662-01	TCGA-44-7662-01A-13-2192-20	0216208c-fbbd-4370-93dd-19fbb7703568	TCGA-44-7662-01	318204fb-9dc7-4024-b09a-5b507bf8f217	0216208c-fbbd-4370-93dd-19fbb7703568	TCGA-44-7662-01A-11D-2063-08	TCGA-44-7662-01	
TCGA-44-7662-11	2.9	0.33	none		none	none	none	N	N	none	none	p.A828D	0.14	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-7662-11		C1-LUAD-enriched								TCGA-44-7662	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	L-Upper		TCGA-44-7662-F34016	TCGA-44-7662				-22543			0	218			57						Scheduled Follow-up Submission	Complete Remission/Response	2012-7-25	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO					NO		NO	50		No	MX	N0	T2a	Stage IB		7662		TUMOR FREE	66	68	68	60	Complete Remission/Response			YES	NO		Solid Tissue Normal	11			7th	NO	YES	NO	44	2	Current smoker	Lung		LIVING	2011	1961														TCGA-44-7662-11							TCGA-44-7662-11	
TCGA-44-7667-01																												TCGA-44-7667-01	High	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 6			TCGA-44-7667	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					49	R-Lower		TCGA-44-7667-F39968	TCGA-44-7667	TCGA-44-7667-01A			-18062			0	1097			50						Scheduled Follow-up Submission	Complete Remission/Response	2013-2-7	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.8	NO		NO				1.7	NO		NO	50		No	MX	N0	T3	Stage IIB	TCGA-44-7667.9722e13c-6ac6-415b-a84f-997d301cea49.pdf	7667		TUMOR FREE			104	74	Complete Remission/Response			YES	NO		Primary Tumor	01	0.5		6th	NO	YES	NO	44	2		Lung	A	LIVING	2009	1974				7dcc9d07-9af9-405e-b75a-c0e7ffdff5c0				TCGA-44-7667-01A-31D-2062-01	TCGA-44-7667-01A-31D-2064-05	TCGA-44-7667-01	TCGA-44-7667-01A-31D-2062-01		7dcc9d07-9af9-405e-b75a-c0e7ffdff5c0	TCGA-44-7667-01	TCGA-44-7667-01A-23-2192-20	7dcc9d07-9af9-405e-b75a-c0e7ffdff5c0	TCGA-44-7667-01	6ab603ca-baa9-46a5-a40f-367048fb7cc9	7dcc9d07-9af9-405e-b75a-c0e7ffdff5c0	TCGA-44-7667-01A-31D-2063-08	TCGA-44-7667-01	
TCGA-44-7667-11																												TCGA-44-7667-11		C1-LUAD-enriched								TCGA-44-7667	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					49	R-Lower		TCGA-44-7667-F39968	TCGA-44-7667				-18062			0	1097			50						Scheduled Follow-up Submission	Complete Remission/Response	2013-2-7	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES					NO					NO		NO	50		No	MX	N0	T3	Stage IIB		7667		TUMOR FREE			104	74	Complete Remission/Response			YES	NO		Solid Tissue Normal	11			6th	NO	YES	NO	44	2		Lung		LIVING	2009	1974														TCGA-44-7667-11							TCGA-44-7667-11	
TCGA-44-7669-01																												TCGA-44-7669-01	GBM	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 6			TCGA-44-7669	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	59	R-Upper		TCGA-44-7669-F20505	TCGA-44-7669	TCGA-44-7669-01A			-21893		574	0		525		52						Additional New Tumor Event	Progressive Disease	2012-1-16	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.9	NO		NO				1.8			YES	20		No	MX	N1	T1b	Stage IIA	TCGA-44-7669.4b112ed4-a999-467d-aace-8bc2c13db1cb.pdf	7669		WITH TUMOR	84	80	80	73				YES			Primary Tumor	01	0.7		7th		YES	NO	44	2		Lung	A	DECEASED	2010	1970				109f2b77-1742-4afa-bcba-b763746fe080				TCGA-44-7669-01A-21D-2062-01	TCGA-44-7669-01A-21D-2064-05	TCGA-44-7669-01	TCGA-44-7669-01A-21D-2062-01		109f2b77-1742-4afa-bcba-b763746fe080	TCGA-44-7669-01	TCGA-44-7669-01A-23-2192-20	109f2b77-1742-4afa-bcba-b763746fe080	TCGA-44-7669-01	58a516e2-5056-4dbf-b60e-76ce109984db	109f2b77-1742-4afa-bcba-b763746fe080	TCGA-44-7669-01A-21D-2063-08	TCGA-44-7669-01	
TCGA-44-7669-11																												TCGA-44-7669-11		C1-LUAD-enriched								TCGA-44-7669	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	59	R-Upper		TCGA-44-7669-F20505	TCGA-44-7669				-21893		574	0		525		52						Additional New Tumor Event	Progressive Disease	2012-1-16	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO							YES	20		No	MX	N1	T1b	Stage IIA		7669		WITH TUMOR	84	80	80	73				YES			Solid Tissue Normal	11			7th		YES	NO	44	2		Lung		DECEASED	2010	1970														TCGA-44-7669-11							TCGA-44-7669-11	
TCGA-44-7670-01	2.76	0.68	none		none	none	none	N	N	none	none	p.R866K	0.27	Magnoid	none	none	none	none	none	p.E600K	none	Lepidic predominant Adc	Lepidic predominant Adc			none	0	TCGA-44-7670-01	High	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-44-7670	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		47	L-Upper		TCGA-44-7670-F39052	TCGA-44-7670	TCGA-44-7670-01A			-17392			0	882			50						Scheduled Follow-up Submission	Complete Remission/Response	2013-1-9	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO						1.5	NO		NO	30		Yes	M0	N1	T1b	Stage IIA	TCGA-44-7670.b93c87ac-5344-408e-a0e1-763b998a55b7.pdf	7670		TUMOR FREE	90	82	86	80	Complete Remission/Response			YES	NO		Primary Tumor	01	0.7		7th	YES	YES	NO	44	2	Current smoker	Lung	A	LIVING	2010	1980		TCGA-44-7670-01A-11D-2063-08		0b8ef0be-c6fb-4ca9-9da0-f97dd22767bf				TCGA-44-7670-01A-11D-2062-01	TCGA-44-7670-01A-11D-2064-05	TCGA-44-7670-01	TCGA-44-7670-01A-11D-2062-01		0b8ef0be-c6fb-4ca9-9da0-f97dd22767bf	TCGA-44-7670-01	TCGA-44-7670-01A-11-2192-20	0b8ef0be-c6fb-4ca9-9da0-f97dd22767bf	TCGA-44-7670-01	3a023cd3-de1f-4b19-afd9-685baf90aab7	0b8ef0be-c6fb-4ca9-9da0-f97dd22767bf	TCGA-44-7670-01A-11D-2063-08	TCGA-44-7670-01	
TCGA-44-7670-11	2.76	0.68	none		none	none	none	N	N	none	none	p.R866K	0.27	Magnoid	none	none	none	none	none	p.E600K	none	Lepidic predominant Adc	Lepidic predominant Adc			none	0	TCGA-44-7670-11		C1-LUAD-enriched								TCGA-44-7670	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		47	L-Upper		TCGA-44-7670-F39052	TCGA-44-7670				-17392			0	882			50						Scheduled Follow-up Submission	Complete Remission/Response	2013-1-9	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES										NO		NO	30		Yes	M0	N1	T1b	Stage IIA		7670		TUMOR FREE	90	82	86	80	Complete Remission/Response			YES	NO		Solid Tissue Normal	11			7th	YES	YES	NO	44	2	Current smoker	Lung		LIVING	2010	1980														TCGA-44-7670-11							TCGA-44-7670-11	
TCGA-44-7671-01	3.03	0.67	none		none	none	none	Y	Y	none	none	none	0.25	Magnoid	none	p.G12C	none	p.T660R	none	none	none	Acinar predominant Adc	Acinar predominant Adc			p.K262*	0	TCGA-44-7671-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-44-7671	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO		NO		64			TCGA-44-7671-F38982	TCGA-44-7671				-23538			0	889	883		65						Scheduled Follow-up Submission		2013-1-8	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.2	8255/3	C34.2	YES										NO	Locoregional Recurrence	YES			Yes	M0	N0	T2a	Stage IB		7671		WITH TUMOR	103	82	97	76	Complete Remission/Response	Convincing Imaging		YES	NO		Primary Tumor	01		1995	7th	NO	YES	NO	44	3	Current reformed smoker for > 15 years	Lung		LIVING	2010			TCGA-44-7671-01A-11D-2063-08		b294ae61-dd94-40a4-8cda-1001658d986f				TCGA-44-7671-01A-11D-2062-01	TCGA-44-7671-01A-11D-2064-05	TCGA-44-7671-01	TCGA-44-7671-01A-11D-2062-01		b294ae61-dd94-40a4-8cda-1001658d986f	TCGA-44-7671-01	TCGA-44-7671-01A-21-2192-20	b294ae61-dd94-40a4-8cda-1001658d986f	TCGA-44-7671-01	d73aab66-a9f7-4bf5-969a-aceb01abb8ff	b294ae61-dd94-40a4-8cda-1001658d986f	TCGA-44-7671-01A-11D-2063-08	TCGA-44-7671-01	
TCGA-44-7671-11	3.03	0.67	none		none	none	none	Y	Y	none	none	none	0.25	Magnoid	none	p.G12C	none	p.T660R	none	none	none	Acinar predominant Adc	Acinar predominant Adc			p.K262*	0	TCGA-44-7671-11		C1-LUAD-enriched								TCGA-44-7671	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO		NO		64			TCGA-44-7671-F38982	TCGA-44-7671				-23538			0	889	883		65						Scheduled Follow-up Submission		2013-1-8	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.2	8255/3	C34.2	YES										NO	Locoregional Recurrence	YES			Yes	M0	N0	T2a	Stage IB		7671		WITH TUMOR	103	82	97	76	Complete Remission/Response	Convincing Imaging		YES	NO		Solid Tissue Normal	11		1995	7th	NO	YES	NO	44	3	Current reformed smoker for > 15 years	Lung		LIVING	2010															TCGA-44-7671-11							TCGA-44-7671-11	
TCGA-44-7672-01	2.88	0.19	none		none	none	none	Y	Y	none	none	none	0.09	Squamoid	none	p.G12A	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-7672-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-44-7672	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					52	L-Upper		TCGA-44-7672-F39074	TCGA-44-7672				-19200			0	719			82						Scheduled Follow-up Submission	Complete Remission/Response	2013-1-10	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES										NO		NO	20		No	M0	N0	T1b	Stage IA		7672		TUMOR FREE			90	105	Complete Remission/Response			YES	NO		Primary Tumor	01			7th	NO	YES	NO	44	2	Current smoker	Lung		LIVING	2010	1980		TCGA-44-7672-01A-11D-2063-08		e0c25421-eda1-4204-8d86-37613a005180				TCGA-44-7672-01A-11D-2062-01	TCGA-44-7672-01A-11D-2064-05	TCGA-44-7672-01	TCGA-44-7672-01A-11D-2062-01		e0c25421-eda1-4204-8d86-37613a005180	TCGA-44-7672-01	TCGA-44-7672-01A-21-2192-20	e0c25421-eda1-4204-8d86-37613a005180	TCGA-44-7672-01	ee5f6e2a-0d90-4e2c-8631-00b3a10b0d43	e0c25421-eda1-4204-8d86-37613a005180	TCGA-44-7672-01A-11D-2063-08	TCGA-44-7672-01	
TCGA-44-7672-11	2.88	0.19	none		none	none	none	Y	Y	none	none	none	0.09	Squamoid	none	p.G12A	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-44-7672-11		C1-LUAD-enriched								TCGA-44-7672	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					52	L-Upper		TCGA-44-7672-F39074	TCGA-44-7672				-19200			0	719			82						Scheduled Follow-up Submission	Complete Remission/Response	2013-1-10	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES										NO		NO	20		No	M0	N0	T1b	Stage IA		7672		TUMOR FREE			90	105	Complete Remission/Response			YES	NO		Solid Tissue Normal	11			7th	NO	YES	NO	44	2	Current smoker	Lung		LIVING	2010	1980														TCGA-44-7672-11							TCGA-44-7672-11	
TCGA-44-8117-01																												TCGA-44-8117-01	High			Cluster 6		LUAD-like c10	miRNA cluster 4			TCGA-44-8117	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					54	R-Upper		TCGA-44-8117-F36070	TCGA-44-8117	TCGA-44-8117-01A			-19855			0	385			86	1					Scheduled Follow-up Submission	Complete Remission/Response	2012-10-18	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO						1.1	NO		NO	54		No	M0	N0	T2a	Stage IB	TCGA-44-8117.af49cbe4-eb8a-46df-bd70-4023acee6ae1.pdf	8117	Post-Adjuvant Therapy	TUMOR FREE	88	65	83	60	Complete Remission/Response			YES	NO		Primary Tumor	01	0.4	2011	7th	YES	YES	NO	44	4		Lung	A	LIVING	2011	1975				4bd54818-dbda-44f7-837e-0235716712d9				TCGA-44-8117-01A-11D-2237-01	TCGA-44-8117-01A-11D-2239-05	TCGA-44-8117-01	TCGA-44-8117-01A-11D-2237-01		4bd54818-dbda-44f7-837e-0235716712d9	TCGA-44-8117-01		4bd54818-dbda-44f7-837e-0235716712d9	TCGA-44-8117-01	5A8A836A-C37A-444B-B289-98C815E58096	4bd54818-dbda-44f7-837e-0235716712d9	TCGA-44-8117-01A-11D-2238-08	TCGA-44-8117-01	
TCGA-44-8119-01																												TCGA-44-8119-01	High			Cluster 5		LUAD-like c10	miRNA cluster 4			TCGA-44-8119	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		73	R-Upper		TCGA-44-8119-F38976	TCGA-44-8119	TCGA-44-8119-01A			-27003			0	285			40	0					Scheduled Follow-up Submission	Complete Remission/Response	2013-1-8	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO						2.6	NO		NO	50		Yes, History of Prior Malignancy	M0	N0	T3	Stage IIB	TCGA-44-8119.c40ea4c8-8cbe-4a44-96d4-ae524a916449.pdf	8119	Preoperative	TUMOR FREE	74	59	73	55	Complete Remission/Response			YES	NO		Primary Tumor	01	1		7th	NO	YES	NO	44	2		Lung	A	LIVING	2012	1961				b524809c-72a5-4e46-a3d9-7a838fbc4f02				TCGA-44-8119-01A-11D-2237-01	TCGA-44-8119-01A-11D-2239-05	TCGA-44-8119-01	TCGA-44-8119-01A-11D-2237-01		b524809c-72a5-4e46-a3d9-7a838fbc4f02	TCGA-44-8119-01		b524809c-72a5-4e46-a3d9-7a838fbc4f02	TCGA-44-8119-01	A9E94589-B427-4B44-98BB-315D8372D36C	b524809c-72a5-4e46-a3d9-7a838fbc4f02	TCGA-44-8119-01A-11D-2238-08	TCGA-44-8119-01	
TCGA-44-8120-01																												TCGA-44-8120-01	Squamous			Cluster 6		LUAD-like c10	miRNA cluster 4			TCGA-44-8120	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					58	R-Upper		TCGA-44-8120-F36757	TCGA-44-8120	TCGA-44-8120-01A			-21188			0	260				0					Scheduled Follow-up Submission	Complete Remission/Response	2012-11-13	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.9	NO						1	NO		NO	30		No	M0	N0	T2a	Stage IB	TCGA-44-8120.6996d5eb-bdfd-4b9b-9517-40c28e439834.pdf	8120	Preoperative	TUMOR FREE	100	101	98	97	Complete Remission/Response			YES	NO		Primary Tumor	01	0.4		7th	NO	YES	NO	44	5		Lung	A	LIVING	2011	1981				8af91e43-8345-432a-a758-1ce8aa55c664				TCGA-44-8120-01A-11D-2237-01	TCGA-44-8120-01A-11D-2239-05	TCGA-44-8120-01	TCGA-44-8120-01A-11D-2237-01		8af91e43-8345-432a-a758-1ce8aa55c664	TCGA-44-8120-01		8af91e43-8345-432a-a758-1ce8aa55c664	TCGA-44-8120-01		8af91e43-8345-432a-a758-1ce8aa55c664	TCGA-44-8120-01A-11D-2238-08	TCGA-44-8120-01	
TCGA-44-A479-01																												TCGA-44-A479-01										TCGA-44-A479	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	YES	NO	73	R-Upper		TCGA-44-A479-F45874	TCGA-44-A479	TCGA-44-A479-01A	437		-27024	193		0	486	437		60	0	YES			NO	Additional New Tumor Event	Complete Remission/Response	2013-8-12	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	280		NO		NO					NO	New Primary Tumor	YES	40	false	No	MX	N0	T2	Stage IB	TCGA-44-A479.FFCFD93C-1D69-4DF8-9E1B-E2A4EEA66613.pdf	A479	Preoperative	TUMOR FREE			115	102	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		2002	7th	NO	YES	NO	44	4		Lung	A	LIVING	2012	1962				9de618ee-04ff-49da-830a-f82eff981616				TCGA-44-A479-01A-31D-A24C-01	TCGA-44-A479-01A-31D-A24I-05	TCGA-44-A479-01	TCGA-44-A479-01A-31D-A24C-01		9de618ee-04ff-49da-830a-f82eff981616	TCGA-44-A479-01		9de618ee-04ff-49da-830a-f82eff981616	TCGA-44-A479-01	601BAE6B-FD1C-497B-AE9F-C6346E131BD5	9de618ee-04ff-49da-830a-f82eff981616	TCGA-44-A479-01A-31D-A24D-08	TCGA-44-A479-01	
TCGA-44-A47A-01																												TCGA-44-A47A-01										TCGA-44-A47A	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	78	R-Upper		TCGA-44-A47A-F46609	TCGA-44-A47A	TCGA-44-A47A-01A			-28782	117		0	466	397			1	NO			NO	Additional New Tumor Event		2013-8-12	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	290		NO		NO					NO	Distant Metastasis	YES	80	false	No	MX	N0	T2a	Stage IB	TCGA-44-A47A.3F92B4C0-ED5F-486D-A751-730136B1D9A8.pdf	A47A	Preoperative	WITH TUMOR					Complete Remission/Response	Convincing Imaging		NO	NO	R0	Primary Tumor	01		2010	7th	NO	YES	NO	44	4		Lung	A	LIVING	2012	1970				99268491-1400-4982-8aa4-7b8c3c815727				TCGA-44-A47A-01A-21D-A24C-01	TCGA-44-A47A-01A-21D-A24I-05	TCGA-44-A47A-01	TCGA-44-A47A-01A-21D-A24C-01		99268491-1400-4982-8aa4-7b8c3c815727	TCGA-44-A47A-01		99268491-1400-4982-8aa4-7b8c3c815727	TCGA-44-A47A-01	76C3B1B4-0866-4179-B14B-3CF3C1A50242	99268491-1400-4982-8aa4-7b8c3c815727	TCGA-44-A47A-01A-21D-A24D-08	TCGA-44-A47A-01	
TCGA-44-A47B-01																												TCGA-44-A47B-01										TCGA-44-A47B	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					79	R-Upper		TCGA-44-A47B-F41746	TCGA-44-A47B				-28869			0	287			73	0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-3-27	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO					NO		NO	4.5		No	M0	N0	T2a	Stage IB		A47B	Preoperative	TUMOR FREE	102	96	98	96	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1965	7th	NO	YES	NO	44	3		Lung		LIVING	2012	1956				ec29675b-7379-44ee-981b-458fe9aca616				TCGA-44-A47B-01A-11D-A24C-01	TCGA-44-A47B-01A-11D-A24I-05	TCGA-44-A47B-01	TCGA-44-A47B-01A-11D-A24C-01		ec29675b-7379-44ee-981b-458fe9aca616	TCGA-44-A47B-01		ec29675b-7379-44ee-981b-458fe9aca616	TCGA-44-A47B-01		ec29675b-7379-44ee-981b-458fe9aca616	TCGA-44-A47B-01A-11D-A24D-08	TCGA-44-A47B-01	
TCGA-44-A47F-01																												TCGA-44-A47F-01										TCGA-44-A47F	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	L-Upper		TCGA-44-A47F-F41750	TCGA-44-A47F	TCGA-44-A47F-01A			-27122	169		0	337				0					Scheduled Follow-up Submission	Complete Remission/Response	2013-3-27	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	370		NO	90						NO		NO	20	false	Yes, History of Prior Malignancy	M0	N1	T2b	Stage IIB	TCGA-44-A47F.FC0E596B-733C-4532-AF0D-94B4A4ECB90C.pdf	A47F	Post-Adjuvant Therapy	TUMOR FREE	127	84	122	81	Complete Remission/Response			YES	NO		Primary Tumor	01		1987	7th	YES	YES	NO	44	3		Lung	A	LIVING	2012	1955								TCGA-44-A47F-01A-11D-A24C-01	TCGA-44-A47F-01A-11D-A24I-05		TCGA-44-A47F-01A-11D-A24C-01			TCGA-44-A47F-01				19C331EE-AB15-4A56-961A-3CF1B3441CD8		TCGA-44-A47F-01A-11D-A24D-08	TCGA-44-A47F-01	
TCGA-44-A47G-01																												TCGA-44-A47G-01										TCGA-44-A47G	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					73	R-Upper		TCGA-44-A47G-F49023	TCGA-44-A47G	TCGA-44-A47G-01A			-26800	71		0	351			85	0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-9-25	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	170		NO		NO					NO		NO	28	false	No	M0	N0	T1	Stage IA	TCGA-44-A47G.103CEC27-11AE-4E7F-88F4-530A94CB5278.pdf	A47G	Preoperative	TUMOR FREE			113	100	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		2012	7th	NO	YES	NO	44	4		Lung	A	LIVING	2012	1956				64f41383-d668-489a-9fe7-f00235015442				TCGA-44-A47G-01A-21D-A24C-01	TCGA-44-A47G-01A-21D-A24I-05	TCGA-44-A47G-01	TCGA-44-A47G-01A-21D-A24C-01		64f41383-d668-489a-9fe7-f00235015442	TCGA-44-A47G-01		64f41383-d668-489a-9fe7-f00235015442	TCGA-44-A47G-01	732A0498-D142-4529-AB3C-350AB6685787	64f41383-d668-489a-9fe7-f00235015442	TCGA-44-A47G-01A-21D-A24D-08	TCGA-44-A47G-01	
TCGA-44-A4SS-01																												TCGA-44-A4SS-01										TCGA-44-A4SS	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					73	L-Upper		TCGA-44-A4SS-F49165	TCGA-44-A4SS	TCGA-44-A4SS-01A			-26991	86		0	415			54	0					Scheduled Follow-up Submission	Complete Remission/Response	2013-9-26	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	200		NO							NO		NO	90	false	No	M0	N0	T1b	Stage IA	TCGA-44-A4SS.12F30C5F-91F0-4ECD-A073-74CDEA147097.pdf	A4SS	Preoperative	TUMOR FREE	88	71	86	69	Complete Remission/Response			YES	NO		Primary Tumor	01		2012	7th	NO	YES	NO	44	4		Lung	A	LIVING	2012	1952				89b3869c-aacb-4882-8aa0-4d9058cf5625				TCGA-44-A4SS-01A-11D-A24O-01	TCGA-44-A4SS-01A-11D-A24U-05	TCGA-44-A4SS-01	TCGA-44-A4SS-01A-11D-A24O-01		89b3869c-aacb-4882-8aa0-4d9058cf5625	TCGA-44-A4SS-01		89b3869c-aacb-4882-8aa0-4d9058cf5625	TCGA-44-A4SS-01	4E72B580-DC3A-45FB-BC7E-92C092EBE4F3	89b3869c-aacb-4882-8aa0-4d9058cf5625	TCGA-44-A4SS-01A-11D-A24P-08	TCGA-44-A4SS-01	
TCGA-44-A4SU-01																												TCGA-44-A4SU-01										TCGA-44-A4SU	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		67	R-Lower		TCGA-44-A4SU-F49438	TCGA-44-A4SU	TCGA-44-A4SU-01A			-24820	55	409	0	76	260		74	3					Scheduled Follow-up Submission	Progressive Disease	2013-10-3	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	140		NO							NO	Locoregional Recurrence	YES	50	false	No	MX	N0	T1a	Stage IA	TCGA-44-A4SU.14019D02-C4EC-4EA7-8AEB-255A14EB8D07.pdf	A4SU	Other	WITH TUMOR	100	95	100	88	Complete Remission/Response	Biopsy with Histologic Confirmation|Convincing Imaging		YES	NO	R0	Primary Tumor	01		2011	7th	NO	YES	NO	44	4		Lung	A	DECEASED	2012	1961				5f83fb8f-01d8-4deb-89d1-2fe9fb69255e				TCGA-44-A4SU-01A-11D-A24O-01	TCGA-44-A4SU-01A-11D-A24U-05	TCGA-44-A4SU-01	TCGA-44-A4SU-01A-11D-A24O-01		5f83fb8f-01d8-4deb-89d1-2fe9fb69255e	TCGA-44-A4SU-01		5f83fb8f-01d8-4deb-89d1-2fe9fb69255e	TCGA-44-A4SU-01	B8370710-087D-4599-8996-C85308670455	5f83fb8f-01d8-4deb-89d1-2fe9fb69255e	TCGA-44-A4SU-01A-11D-A24P-08	TCGA-44-A4SU-01	
TCGA-49-4486-01	2.1	0.72	none		none	none	none	N	N	none	none	none	0.35	Bronchioid	none	none	none	none	none	none	none	Lepidic predominant Adc	Lepidic predominant Adc			p.N181I	1	TCGA-49-4486-01	Iq	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 7	cluster 4	mutation cluster 5	TCGA-49-4486	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	72	R-Lower		TCGA-49-4486-F58843	TCGA-49-4486	TCGA-49-4486-01A			-26415		2318	0		2045			2					Scheduled Follow-up Submission	Progressive Disease	2014-4-25	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.6	NO	60					1.6	NO	Distant Metastasis	YES	17.5		No	M0	N0	T1	Stage IA	TCGA-49-4486.30b3b92c-c810-4cf8-8342-f6e9d87bacfe.pdf	4486	Other	WITH TUMOR	69	96	77	108	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01	0.6	1967	3rd	NO	NO	YES	49	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	1992	1932	TCGA-49-4486-01A-01D-1265-08	TCGA-49-4486-01A-01D-1265-08		0c0cfdfb-107b-4a20-bfda-7922453c041e		TCGA-49-4486-01A-01D-1205-05	TCGA-49-4486-01	TCGA-49-4486-01A-01D-1204-01		TCGA-49-4486-01	TCGA-49-4486-01A-01D-1204-01		0c0cfdfb-107b-4a20-bfda-7922453c041e		TCGA-49-4486-01A-21-2190-20	0c0cfdfb-107b-4a20-bfda-7922453c041e	TCGA-49-4486-01	5c48d536-cfad-4535-a47d-08c42362aae5	0c0cfdfb-107b-4a20-bfda-7922453c041e	TCGA-49-4486-01A-01D-1265-08		TCGA-49-4486-01
TCGA-49-4486-11	2.1	0.72	none		none	none	none	N	N	none	none	none	0.35	Bronchioid	none	none	none	none	none	none	none	Lepidic predominant Adc	Lepidic predominant Adc			p.N181I	1	TCGA-49-4486-11		C1-LUAD-enriched							mutation cluster 5	TCGA-49-4486	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	72	R-Lower		TCGA-49-4486-F58843	TCGA-49-4486	TCGA-49-4486-11A			-26415		2318	0		2045			2					Scheduled Follow-up Submission	Progressive Disease	2014-4-25	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.7	NO	60					1	NO	Distant Metastasis	YES	17.5		No	M0	N0	T1	Stage IA		4486	Other	WITH TUMOR	69	96	77	108	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Solid Tissue Normal	11	0.2	1967	3rd	NO	NO	YES	49	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	1992	1932						TCGA-49-4486-11A-01D-1205-05																
TCGA-49-4487-01			none		none	none	none	N	N	none	none	none		Squamoid	none	none	none	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			p.E70*	0	TCGA-49-4487-01	High	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 11	TCGA-49-4487	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	YES	YES	72	L-Upper		TCGA-49-4487-F14693	TCGA-49-4487	TCGA-49-4487-01A	697	712	-26583		855	0		697								Scheduled Follow-up Submission	Progressive Disease	2011-8-9	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO						0.9			YES	40		No	M0	N0	T1	Stage IA	TCGA-49-4487.c67031fc-f601-4bd2-b8fd-429a0664cc65.pdf	4487		WITH TUMOR					Complete Remission/Response				YES	R0	Primary Tumor	01	0.3		3rd	NO	NO	YES	49	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	1992		TCGA-49-4487-01A-21D-1855-08	TCGA-49-4487-01A-21D-1855-08		3cc3fe41-c7e8-4dcf-99a0-a488f7763e93				TCGA-49-4487-01A-21D-1854-01	TCGA-49-4487-01A-21D-1856-05	TCGA-49-4487-01	TCGA-49-4487-01A-21D-1854-01		3cc3fe41-c7e8-4dcf-99a0-a488f7763e93	TCGA-49-4487-01	TCGA-49-4487-01A-22-2190-20	3cc3fe41-c7e8-4dcf-99a0-a488f7763e93	TCGA-49-4487-01	09b4e4df-58df-4faa-8e4d-21bc4799f467	3cc3fe41-c7e8-4dcf-99a0-a488f7763e93	TCGA-49-4487-01A-21D-1855-08	TCGA-49-4487-01	
TCGA-49-4488-01			none		none	none	none	N	N	none	none	none		Squamoid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-49-4488-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 12	cluster 5	mutation c1uster 10	TCGA-49-4488	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES			74	L-Lower		TCGA-49-4488-F14699	TCGA-49-4488	TCGA-49-4488-01A		690	-27332		869	0		634								Scheduled Follow-up Submission		2011-8-9	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.8	NO						2			YES			No	MX	N0	T1	Stage IA	TCGA-49-4488.1aae91ef-85c6-49f4-a76a-3f09d5cabcb5.pdf	4488											NO	R0	Primary Tumor	01	0.4	1964	3rd	NO	NO	YES	49	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	1992		TCGA-49-4488-01A-01D-1753-08	TCGA-49-4488-01A-01D-1753-08		94a591be-8b32-4680-b2ad-fc856f3f0c8e				TCGA-49-4488-01A-01D-1752-01	TCGA-49-4488-01A-01D-1756-05	TCGA-49-4488-01	TCGA-49-4488-01A-01D-1752-01		94a591be-8b32-4680-b2ad-fc856f3f0c8e	TCGA-49-4488-01	TCGA-49-4488-01A-21-2190-20	94a591be-8b32-4680-b2ad-fc856f3f0c8e	TCGA-49-4488-01	911a1ccb-8917-4b18-a0a4-65def5a2160b	94a591be-8b32-4680-b2ad-fc856f3f0c8e	TCGA-49-4488-01A-01D-1753-08	TCGA-49-4488-01	
TCGA-49-4488-11			none		none	none	none	N	N	none	none	none		Squamoid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-49-4488-11		C1-LUAD-enriched							mutation c1uster 10	TCGA-49-4488	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES			74	L-Lower		TCGA-49-4488-F14699	TCGA-49-4488	TCGA-49-4488-11A		690	-27332		869	0		634								Scheduled Follow-up Submission		2011-8-9	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.8	NO						1			YES			No	MX	N0	T1	Stage IA		4488											NO	R0	Solid Tissue Normal	11	0.4	1964	3rd	NO	NO	YES	49	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	1992										TCGA-49-4488-11A-01D-1756-05													
TCGA-49-4490-01			none		none	none	none	Y	Y	p.L858R	none	none		Bronchioid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-49-4490-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5		LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 8	TCGA-49-4490	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					45	L-Upper		TCGA-49-4490-F14703	TCGA-49-4490	TCGA-49-4490-01A			-16634		385	0										Scheduled Follow-up Submission		2011-8-9	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.5	NO						0.5			NO	5		No	M0	N2	T3	Stage IIIA	TCGA-49-4490.d6ec6f67-0c16-4396-be41-aaa6868a6106.pdf	4490		WITH TUMOR									YES		Primary Tumor	01	0.5		4th	YES	NO	YES	49	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	1993		TCGA-49-4490-01A-21D-1855-08	TCGA-49-4490-01A-21D-1855-08		5e45c9ab-f5fe-497b-b919-72b0d8dec83d				TCGA-49-4490-01A-21D-1854-01	TCGA-49-4490-01A-21D-1856-05	TCGA-49-4490-01	TCGA-49-4490-01A-21D-1854-01		5e45c9ab-f5fe-497b-b919-72b0d8dec83d	TCGA-49-4490-01		5e45c9ab-f5fe-497b-b919-72b0d8dec83d	TCGA-49-4490-01		5e45c9ab-f5fe-497b-b919-72b0d8dec83d	TCGA-49-4490-01A-21D-1855-08	TCGA-49-4490-01	
TCGA-49-4490-11			none		none	none	none	Y	Y	p.L858R	none	none		Bronchioid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-49-4490-11		C1-LUAD-enriched							mutation cluster 8	TCGA-49-4490	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					45	L-Upper		TCGA-49-4490-F14703	TCGA-49-4490	TCGA-49-4490-11A			-16634		385	0										Scheduled Follow-up Submission		2011-8-9	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.9	NO						1.9			NO	5		No	M0	N2	T3	Stage IIIA		4490		WITH TUMOR									YES		Solid Tissue Normal	11	0.6		4th	YES	NO	YES	49	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	1993					d0e9dd65-ec79-4eee-802a-3f5438168136									d0e9dd65-ec79-4eee-802a-3f5438168136			d0e9dd65-ec79-4eee-802a-3f5438168136			d0e9dd65-ec79-4eee-802a-3f5438168136			
TCGA-49-4494-01	4.06	0.3	none		none	none	none	Y	Y	p.T790M, p.L858R	none	none	0.11	Magnoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-49-4494-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4	mutation cluster 7	TCGA-49-4494	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					77	L-Upper		TCGA-49-4494-F58840	TCGA-49-4494	TCGA-49-4494-01A			-28387		1081	0					1					Scheduled Follow-up Submission		2014-4-25	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO	90					2.5	NO			50		No	M0	N2	T3	Stage IIIA	TCGA-49-4494.178a8648-f3cd-46ae-b90a-a45d6715c889.pdf	4494	Preoperative	WITH TUMOR					Complete Remission/Response			NO		R0	Primary Tumor	01	0.4	1955	4th		NO	YES	49	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	1995	1930	TCGA-49-4494-01A-01D-1265-08	TCGA-49-4494-01A-01D-1265-08		f338175a-fa1e-4b98-91e2-f4f0ee349e8e		TCGA-49-4494-01A-01D-1205-05	TCGA-49-4494-01	TCGA-49-4494-01A-01D-1204-01		TCGA-49-4494-01	TCGA-49-4494-01A-01D-1204-01		f338175a-fa1e-4b98-91e2-f4f0ee349e8e		TCGA-49-4494-01A-21-2190-20	f338175a-fa1e-4b98-91e2-f4f0ee349e8e	TCGA-49-4494-01	4af63e96-7fed-4a64-bf86-cdeb2dff3877	f338175a-fa1e-4b98-91e2-f4f0ee349e8e	TCGA-49-4494-01A-01D-1265-08		TCGA-49-4494-01
TCGA-49-4494-11	4.06	0.3	none		none	none	none	Y	Y	p.T790M, p.L858R	none	none	0.11	Magnoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-49-4494-11		C1-LUAD-enriched							mutation cluster 7	TCGA-49-4494	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					77	L-Upper		TCGA-49-4494-F58840	TCGA-49-4494	TCGA-49-4494-11A			-28387		1081	0					1					Scheduled Follow-up Submission		2014-4-25	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.9	NO	90					0.9	NO			50		No	M0	N2	T3	Stage IIIA		4494	Preoperative	WITH TUMOR					Complete Remission/Response			NO		R0	Solid Tissue Normal	11	0.4	1955	4th		NO	YES	49	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	1995	1930						TCGA-49-4494-11A-01D-1205-05																
TCGA-49-4501-01	2.85	0.43	none		none	none	none	Y	Y	p.ELREA746del	none	none	0.18	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-49-4501-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4	mutation cluster 14	TCGA-49-4501	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO		67	R-Upper		TCGA-49-4501-F7014	TCGA-49-4501				-24817		1421	0		545			1						Progressive Disease	2011-2-2	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES												YES			Yes	M0	N0	T2	Stage IB		4501	Other	WITH TUMOR					Complete Remission/Response				NO	R0	Primary Tumor	01				NO	NO	YES	49	1	Lifelong Non-smoker	Lung		DECEASED	1996		TCGA-49-4501-01A-01D-1265-08	TCGA-49-4501-01A-01D-1265-08		f118c45b-544d-45eb-8acd-a4c8cfcab3fd		TCGA-49-4501-01A-01D-1205-05	TCGA-49-4501-01	TCGA-49-4501-01A-01D-1204-01		TCGA-49-4501-01	TCGA-49-4501-01A-01D-1204-01		f118c45b-544d-45eb-8acd-a4c8cfcab3fd		TCGA-49-4501-01A-21-2190-20	f118c45b-544d-45eb-8acd-a4c8cfcab3fd	TCGA-49-4501-01	b9a9cb4c-96f6-47a0-adc8-55d6a6604b92	f118c45b-544d-45eb-8acd-a4c8cfcab3fd	TCGA-49-4501-01A-01D-1265-08		TCGA-49-4501-01
TCGA-49-4501-11	2.85	0.43	none		none	none	none	Y	Y	p.ELREA746del	none	none	0.18	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-49-4501-11		C1-LUAD-enriched							mutation cluster 14	TCGA-49-4501	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO		67	R-Upper		TCGA-49-4501-F7014	TCGA-49-4501	TCGA-49-4501-11A			-24817		1421	0		545			1						Progressive Disease	2011-2-2	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.9	NO						1.2			YES			Yes	M0	N0	T2	Stage IB		4501	Other	WITH TUMOR					Complete Remission/Response				NO	R0	Solid Tissue Normal	11	0.5			NO	NO	YES	49	1	Lifelong Non-smoker	Lung	A	DECEASED	1996							TCGA-49-4501-11A-01D-1205-05																
TCGA-49-4505-01			none		none	none	none	Y	Y	none	none	none		Bronchioid	none	p.G12C	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-49-4505-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 11	TCGA-49-4505	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	R-Lower		TCGA-49-4505-F58844	TCGA-49-4505	TCGA-49-4505-01A			-22628		428	0		417			1					Scheduled Follow-up Submission		2014-4-25	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.7	NO	80					1.5	NO	Distant Metastasis|New Primary Tumor	YES	74		No	M0	N1	T2	Stage IIB	TCGA-49-4505.1733d182-08f0-4426-9227-9f008893ac14.pdf	4505	Preoperative	WITH TUMOR					Complete Remission/Response	Convincing Imaging		NO	NO	R0	Primary Tumor	01	0.3	1986	4th	NO	NO	YES	49	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	1996	1949	TCGA-49-4505-01A-01D-1265-08	TCGA-49-4505-01A-01D-1265-08		cb06be5e-7c1d-49a4-9818-e1cbc52de9b6		TCGA-49-4505-01A-01D-1205-05	TCGA-49-4505-01	TCGA-49-4505-01A-01D-1204-01		TCGA-49-4505-01	TCGA-49-4505-01A-01D-1204-01		cb06be5e-7c1d-49a4-9818-e1cbc52de9b6		TCGA-49-4505-01A-21-2190-20	cb06be5e-7c1d-49a4-9818-e1cbc52de9b6	TCGA-49-4505-01	1cb8eafc-ac9d-4901-a44f-a2dbb6ee7f8b	cb06be5e-7c1d-49a4-9818-e1cbc52de9b6	TCGA-49-4505-01A-01D-1931-08		TCGA-49-4505-01
TCGA-49-4505-11			none		none	none	none	Y	Y	none	none	none		Bronchioid	none	p.G12C	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-49-4505-11		C1-LUAD-enriched							mutation cluster 11	TCGA-49-4505	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	R-Lower		TCGA-49-4505-F58844	TCGA-49-4505	TCGA-49-4505-11A			-22628		428	0		417			1					Scheduled Follow-up Submission		2014-4-25	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1.1	NO	80					1.3	NO	Distant Metastasis|New Primary Tumor	YES	74		No	M0	N1	T2	Stage IIB		4505	Preoperative	WITH TUMOR					Complete Remission/Response	Convincing Imaging		NO	NO	R0	Solid Tissue Normal	11	0.4	1986	4th	NO	NO	YES	49	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	1996	1949						TCGA-49-4505-11A-01D-1205-05																
TCGA-49-4506-01	2.69	0.25	none		none	none	none	N	N	none	none	none	0.12	Magnoid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-49-4506-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-49-4506	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		68	L-Upper		TCGA-49-4506-F58841	TCGA-49-4506	TCGA-49-4506-01A			-25132		999	0		692			2					Scheduled Follow-up Submission	Progressive Disease	2014-4-25	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.4	NO	70				Peripheral Lung	0.8	NO	Locoregional Recurrence	YES	100		No	M0	N1	T2	Stage IIB	TCGA-49-4506.09fb40cf-afb5-4dd5-a1b6-6261ef27b65e.pdf	4506	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response	Convincing Imaging		NO	YES	R1	Primary Tumor	01	0.3		4th	YES	NO	YES	49	2	Current smoker	Lung	A	DECEASED	1997		TCGA-49-4506-01A-01D-1265-08	TCGA-49-4506-01A-01D-1265-08		7ce14f35-6404-4adc-8929-4d5cd3c85697		TCGA-49-4506-01A-01D-1205-05	TCGA-49-4506-01	TCGA-49-4506-01A-01D-1204-01		TCGA-49-4506-01	TCGA-49-4506-01A-01D-1204-01		7ce14f35-6404-4adc-8929-4d5cd3c85697		TCGA-49-4506-01A-21-2190-20	7ce14f35-6404-4adc-8929-4d5cd3c85697	TCGA-49-4506-01	4a70d495-2aa6-41b6-a4b9-535fb1741255	7ce14f35-6404-4adc-8929-4d5cd3c85697	TCGA-49-4506-01A-01D-1265-08		TCGA-49-4506-01
TCGA-49-4506-11	2.69	0.25	none		none	none	none	N	N	none	none	none	0.12	Magnoid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-49-4506-11		C1-LUAD-enriched							mutation c1uster 9	TCGA-49-4506	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		68	L-Upper		TCGA-49-4506-F58841	TCGA-49-4506	TCGA-49-4506-11A			-25132		999	0		692			2					Scheduled Follow-up Submission	Progressive Disease	2014-4-25	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO	70				Peripheral Lung	2.4	NO	Locoregional Recurrence	YES	100		No	M0	N1	T2	Stage IIB		4506	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response	Convincing Imaging		NO	YES	R1	Solid Tissue Normal	11	0.5		4th	YES	NO	YES	49	2	Current smoker	Lung	A	DECEASED	1997							TCGA-49-4506-11A-01D-1205-05																
TCGA-49-4507-01	2.7	0.35	none		none	none	none	N	N	none	none	none	0.16	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			p.D176A	0	TCGA-49-4507-01	High	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation c1uster 9	TCGA-49-4507	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	NO	73	R-Middle		TCGA-49-4507-F7007	TCGA-49-4507	TCGA-49-4507-01A			-26851		268	0		158			1						Progressive Disease	2011-2-2	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.0	8140/3	C34.0	YES		0.7	NO						1			YES	78		No	M0	N1	T3	Stage IIIA	TCGA-49-4507.e37717f8-8175-4f30-a817-ae365097804a.pdf	4507	Preoperative	WITH TUMOR					Progressive Disease				YES	R0	Primary Tumor	01	0.3	1991		YES	NO	YES	49	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	1997		TCGA-49-4507-01A-01D-1265-08	TCGA-49-4507-01A-01D-1265-08		15f243f1-05de-4750-9826-d80ddc97d739		TCGA-49-4507-01A-01D-1205-05	TCGA-49-4507-01	TCGA-49-4507-01A-01D-1204-01		TCGA-49-4507-01	TCGA-49-4507-01A-01D-1204-01		15f243f1-05de-4750-9826-d80ddc97d739		TCGA-49-4507-01A-21-2190-20	15f243f1-05de-4750-9826-d80ddc97d739	TCGA-49-4507-01	bb4a85f4-2747-4228-b9fe-cc9057b6d9bd	15f243f1-05de-4750-9826-d80ddc97d739	TCGA-49-4507-01A-01D-1265-08		TCGA-49-4507-01
TCGA-49-4507-11	2.7	0.35	none		none	none	none	N	N	none	none	none	0.16	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			p.D176A	0	TCGA-49-4507-11		C1-LUAD-enriched							mutation c1uster 9	TCGA-49-4507	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	NO	73	R-Middle		TCGA-49-4507-F7007	TCGA-49-4507	TCGA-49-4507-11A			-26851		268	0		158			1						Progressive Disease	2011-2-2	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.0	8140/3	C34.0	YES		1.1	NO						1.4			YES	78		No	M0	N1	T3	Stage IIIA		4507	Preoperative	WITH TUMOR					Progressive Disease				YES	R0	Solid Tissue Normal	11	0.3	1991		YES	NO	YES	49	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	1997							TCGA-49-4507-11A-01D-1205-05																
TCGA-49-4510-01	3.39	0.63	none		none	none	none	Y	Y	none	none	none	0.22	Bronchioid	none	p.G12D	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	1	TCGA-49-4510-01	High	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 7	cluster 4	mutation cluster 12	TCGA-49-4510	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	NO	51	L-Upper		TCGA-49-4510-F58842	TCGA-49-4510	TCGA-49-4510-01A			-18762		896	0		502			1					Scheduled Follow-up Submission	Stable Disease	2014-4-25	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO	80					0.9	NO	Distant Metastasis	YES	55.5		No	M0	N1	T2	Stage IIB	TCGA-49-4510.de27239d-52ae-4979-979f-51e1ce7a43e8.pdf	4510	Post-Adjuvant Therapy	WITH TUMOR					Stable Disease	Convincing Imaging		NO	YES	R0	Primary Tumor	01	0.3		5th	YES	NO	YES	49	2	Current smoker	Lung	A	DECEASED	2001		TCGA-49-4510-01A-01D-1265-08	TCGA-49-4510-01A-01D-1265-08		3739f699-5aef-4152-a918-36dc138c432e		TCGA-49-4510-01A-01D-1205-05	TCGA-49-4510-01	TCGA-49-4510-01A-01D-1204-01		TCGA-49-4510-01	TCGA-49-4510-01A-01D-1204-01		3739f699-5aef-4152-a918-36dc138c432e		TCGA-49-4510-01A-21-2190-20	3739f699-5aef-4152-a918-36dc138c432e	TCGA-49-4510-01	b44fa59f-1f6d-4dfb-a709-c9eeb73258d8	3739f699-5aef-4152-a918-36dc138c432e	TCGA-49-4510-01A-01D-1265-08		TCGA-49-4510-01
TCGA-49-4510-11	3.39	0.63	none		none	none	none	Y	Y	none	none	none	0.22	Bronchioid	none	p.G12D	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	1	TCGA-49-4510-11		C1-LUAD-enriched							mutation cluster 12	TCGA-49-4510	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	NO	51	L-Upper		TCGA-49-4510-F58842	TCGA-49-4510	TCGA-49-4510-11A			-18762		896	0		502			1					Scheduled Follow-up Submission	Stable Disease	2014-4-25	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO	80					1.3	NO	Distant Metastasis	YES	55.5		No	M0	N1	T2	Stage IIB		4510	Post-Adjuvant Therapy	WITH TUMOR					Stable Disease	Convincing Imaging		NO	YES	R0	Solid Tissue Normal	11	0.4		5th	YES	NO	YES	49	2	Current smoker	Lung	A	DECEASED	2001							TCGA-49-4510-11A-01D-1205-05																
TCGA-49-4512-01	2.43	0.48	none		none	none	none	N	N	none	none	none	0.22	Bronchioid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-49-4512-01	High	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 3	mutation c1uster 9	TCGA-49-4512	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	R-Middle		TCGA-49-4512-F14815	TCGA-49-4512				-25502		905	0	157									Scheduled Follow-up Submission		2011-8-10	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES												NO			No	MX	N2	T2	Stage IIIA		4512		WITH TUMOR					Progressive Disease				NO	R1	Primary Tumor	01			6th	YES	NO	YES	49	1	Lifelong Non-smoker	Lung		DECEASED	2007		TCGA-49-4512-01A-21D-1855-08	TCGA-49-4512-01A-21D-1855-08		c1796b57-c5e4-45dd-931d-bf533dcb9e1a				TCGA-49-4512-01A-21D-1854-01	TCGA-49-4512-01A-21D-1856-05	TCGA-49-4512-01	TCGA-49-4512-01A-21D-1854-01		c1796b57-c5e4-45dd-931d-bf533dcb9e1a	TCGA-49-4512-01	TCGA-49-4512-01A-22-2190-20	c1796b57-c5e4-45dd-931d-bf533dcb9e1a	TCGA-49-4512-01	bd1ea6e2-9316-47f3-b830-e1ddb98e3190	c1796b57-c5e4-45dd-931d-bf533dcb9e1a	TCGA-49-4512-01A-21D-1855-08	TCGA-49-4512-01	
TCGA-49-4512-11	2.43	0.48	none		none	none	none	N	N	none	none	none	0.22	Bronchioid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-49-4512-11		C1-LUAD-enriched							mutation c1uster 9	TCGA-49-4512	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	R-Middle		TCGA-49-4512-F14815	TCGA-49-4512	TCGA-49-4512-11A			-25502		905	0	157									Scheduled Follow-up Submission		2011-8-10	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES		0.7	NO						1			NO			No	MX	N2	T2	Stage IIIA		4512		WITH TUMOR					Progressive Disease				NO	R1	Solid Tissue Normal	11	0.3		6th	YES	NO	YES	49	1	Lifelong Non-smoker	Lung	A	DECEASED	2007					a137e804-ed82-4ad8-b25e-f9dcb71331bb									a137e804-ed82-4ad8-b25e-f9dcb71331bb			a137e804-ed82-4ad8-b25e-f9dcb71331bb			a137e804-ed82-4ad8-b25e-f9dcb71331bb			
TCGA-49-4514-01	1.79	0.34	none		none	none	none	N	N	none	none	none	0.18	Magnoid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-49-4514-01	High	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 3	mutation cluster 2	TCGA-49-4514	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					79	L-Upper		TCGA-49-4514-F14817	TCGA-49-4514	TCGA-49-4514-01A			-28908			0	1700									Scheduled Follow-up Submission		2011-8-10	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES		0.8	NO						1.4			NO	65		No	M0	N0	T1	Stage IA	TCGA-49-4514.1d1c3125-05a9-4939-a296-f98d8f977ab7.pdf	4514		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.4		6th	NO	NO	YES	49	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2007		TCGA-49-4514-01A-21D-1855-08	TCGA-49-4514-01A-21D-1855-08		4b05bcbb-08b4-4cf5-bd31-798490e00f94				TCGA-49-4514-01A-21D-1854-01	TCGA-49-4514-01A-21D-1856-05	TCGA-49-4514-01	TCGA-49-4514-01A-21D-1854-01		4b05bcbb-08b4-4cf5-bd31-798490e00f94	TCGA-49-4514-01	TCGA-49-4514-01A-22-2190-20	4b05bcbb-08b4-4cf5-bd31-798490e00f94	TCGA-49-4514-01	d035e74e-e911-44a9-a749-b51b50693629	4b05bcbb-08b4-4cf5-bd31-798490e00f94	TCGA-49-4514-01A-21D-1855-08	TCGA-49-4514-01	
TCGA-49-6742-01	3.59	0.49	none		none	none	none	N	N	none	none	none	0.18	Magnoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-49-6742-01	High	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation cluster 12	TCGA-49-6742	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	YES	70	L-Upper		TCGA-49-6742-F70579	TCGA-49-6742	TCGA-49-6742-01A		214	-25839		488	0	1678	214			3					Scheduled Follow-up Submission	Progressive Disease	2015-2-25	MALE	Mucinous (Colloid) Carcinoma	No	C34.1	8480/3	C34.1	YES		0.8	NO	40	YES	NO			2.1	NO	Distant Metastasis	YES	10		Yes	M0	N1	T2a	Stage IIA	TCGA-49-6742.d9853b55-fd00-4a20-8181-5f4dad297724.pdf	6742	Post-Adjuvant Therapy	WITH TUMOR					Progressive Disease				NO	R0	Primary Tumor	01	0.4		7th	YES	NO	YES	49	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2010		TCGA-49-6742-01A-11D-1855-08	TCGA-49-6742-01A-11D-1855-08		6e3df59e-5d52-4ced-b9dd-785df1952339				TCGA-49-6742-01A-11D-1854-01	TCGA-49-6742-01A-11D-1856-05	TCGA-49-6742-01	TCGA-49-6742-01A-11D-1854-01		6e3df59e-5d52-4ced-b9dd-785df1952339	TCGA-49-6742-01	TCGA-49-6742-01A-13-2191-20	6e3df59e-5d52-4ced-b9dd-785df1952339	TCGA-49-6742-01	0dc5925e-c817-4e3a-8f07-864c4ef1df6d	6e3df59e-5d52-4ced-b9dd-785df1952339	TCGA-49-6742-01A-11D-1855-08	TCGA-49-6742-01	
TCGA-49-6742-11	3.59	0.49	none		none	none	none	N	N	none	none	none	0.18	Magnoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-49-6742-11		C1-LUAD-enriched							mutation cluster 12	TCGA-49-6742	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	YES	70	L-Upper		TCGA-49-6742-F70579	TCGA-49-6742	TCGA-49-6742-11A		214	-25839		488	0	1678	214			3					Scheduled Follow-up Submission	Progressive Disease	2015-2-25	MALE	Mucinous (Colloid) Carcinoma	No	C34.1	8480/3	C34.1	YES		0.7	NO	40	YES	NO			1	NO	Distant Metastasis	YES	10		Yes	M0	N1	T2a	Stage IIA		6742	Post-Adjuvant Therapy	WITH TUMOR					Progressive Disease				NO	R0	Solid Tissue Normal	11	0.4		7th	YES	NO	YES	49	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2010					98056d94-9c31-4cf7-9b0f-5ebe06be01bd									98056d94-9c31-4cf7-9b0f-5ebe06be01bd	TCGA-49-6742-11		98056d94-9c31-4cf7-9b0f-5ebe06be01bd			98056d94-9c31-4cf7-9b0f-5ebe06be01bd		TCGA-49-6742-11	
TCGA-49-6743-01																												TCGA-49-6743-01	Squamous	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 6	TCGA-49-6743	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					81	R-Upper		TCGA-49-6743-F71136	TCGA-49-6743	TCGA-49-6743-01A			-29807			0	1621									Scheduled Follow-up Submission	Complete Remission/Response	2015-3-18	FEMALE	Lung Clear Cell Adenocarcinoma	No	C34.1	8310/3	C34.1	YES		0.4	NO	100					1.2	NO		NO	50		No	MX	N2	T1	Stage IIIA	TCGA-49-6743.bc777cb6-8409-4a25-a22a-a398c28ef065.pdf	6743		TUMOR FREE					Complete Remission/Response				NO		Primary Tumor	01	0.4		7th	YES	NO	YES	49	4		Lung	A	LIVING	2010		TCGA-49-6743-01A-11D-1855-08			93f3f561-056a-4036-afcf-4662b45e6965				TCGA-49-6743-01A-11D-1854-01	TCGA-49-6743-01A-11D-1856-05	TCGA-49-6743-01	TCGA-49-6743-01A-11D-1854-01		93f3f561-056a-4036-afcf-4662b45e6965	TCGA-49-6743-01	TCGA-49-6743-01A-13-2191-20	93f3f561-056a-4036-afcf-4662b45e6965	TCGA-49-6743-01	f61515e3-5fb1-4313-be4a-53e182f95765	93f3f561-056a-4036-afcf-4662b45e6965	TCGA-49-6743-01A-11D-1855-08	TCGA-49-6743-01	
TCGA-49-6743-11																												TCGA-49-6743-11		C1-LUAD-enriched							mutation cluster 6	TCGA-49-6743	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					81	R-Upper		TCGA-49-6743-F71136	TCGA-49-6743	TCGA-49-6743-11A			-29807			0	1621									Scheduled Follow-up Submission	Complete Remission/Response	2015-3-18	FEMALE	Lung Clear Cell Adenocarcinoma	No	C34.1	8310/3	C34.1	YES		0.4	NO	100					1.5	NO		NO	50		No	MX	N2	T1	Stage IIIA		6743		TUMOR FREE					Complete Remission/Response				NO		Solid Tissue Normal	11	0.3		7th	YES	NO	YES	49	4		Lung	A	LIVING	2010					6eb0d705-8faf-476a-8062-afb1f927db99									6eb0d705-8faf-476a-8062-afb1f927db99	TCGA-49-6743-11		6eb0d705-8faf-476a-8062-afb1f927db99			6eb0d705-8faf-476a-8062-afb1f927db99		TCGA-49-6743-11	
TCGA-49-6744-01			none		none	none	none	N	N	none	none	none		Bronchioid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-49-6744-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 12	TCGA-49-6744	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO			64	L-Upper		TCGA-49-6744-F70580	TCGA-49-6744	TCGA-49-6744-01A			-23484			0	1683				1					Scheduled Follow-up Submission	Complete Remission/Response	2015-2-25	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.5	NO	90	YES	YES			2.1	NO		NO	20		No	MX	N1	T2a	Stage IIA	TCGA-49-6744.9a6d2cc6-3d78-42ec-b747-74bb6e96d22b.pdf	6744	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.5		7th	YES	NO	YES	49	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2010		TCGA-49-6744-01A-11D-1855-08	TCGA-49-6744-01A-11D-1855-08		d4b90c1d-0d33-4845-bec2-ceedcace2dcb				TCGA-49-6744-01A-11D-1854-01	TCGA-49-6744-01A-11D-1856-05	TCGA-49-6744-01	TCGA-49-6744-01A-11D-1854-01		d4b90c1d-0d33-4845-bec2-ceedcace2dcb	TCGA-49-6744-01	TCGA-49-6744-01A-13-2191-20	d4b90c1d-0d33-4845-bec2-ceedcace2dcb	TCGA-49-6744-01	85fe0aa0-d71a-43d8-bbb9-100597b54b04	d4b90c1d-0d33-4845-bec2-ceedcace2dcb	TCGA-49-6744-01A-11D-1855-08	TCGA-49-6744-01	
TCGA-49-6744-11			none		none	none	none	N	N	none	none	none		Bronchioid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-49-6744-11		C1-LUAD-enriched							mutation cluster 12	TCGA-49-6744	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO			64	L-Upper		TCGA-49-6744-F70580	TCGA-49-6744	TCGA-49-6744-11A			-23484			0	1683				1					Scheduled Follow-up Submission	Complete Remission/Response	2015-2-25	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.9	NO	90	YES	YES			1	NO		NO	20		No	MX	N1	T2a	Stage IIA		6744	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response				NO	R0	Solid Tissue Normal	11	0.4		7th	YES	NO	YES	49	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2010					6abcb12e-73c2-491e-b9f3-4f61f8a4e854									6abcb12e-73c2-491e-b9f3-4f61f8a4e854	TCGA-49-6744-11		6abcb12e-73c2-491e-b9f3-4f61f8a4e854			6abcb12e-73c2-491e-b9f3-4f61f8a4e854		TCGA-49-6744-11	
TCGA-49-6745-01	2.16	0.34	none		none	none	none	N	N	none	none	none	0.17	Squamoid	none	none	none	p.D1010_splice	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-49-6745-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation c1uster 9	TCGA-49-6745	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					82	L-Upper		TCGA-49-6745-F15015	TCGA-49-6745	TCGA-49-6745-01A			-30133			0	522					YES				Scheduled Follow-up Submission		2011-8-11	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8260/3	C34.1	YES		0.7	NO		YES	NO			1.1			NO	20		Yes	M0	N2	T2a	Stage IIIA	TCGA-49-6745.e291ad97-8658-435d-ae71-f0eb80bbb816.pdf	6745		TUMOR FREE									NO		Primary Tumor	01	0.3		7th	YES	NO	YES	49	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2011		TCGA-49-6745-01A-11D-1855-08	TCGA-49-6745-01A-11D-1855-08		5969b621-a81e-42aa-ac40-4849df285060				TCGA-49-6745-01A-11D-1854-01	TCGA-49-6745-01A-11D-1856-05	TCGA-49-6745-01	TCGA-49-6745-01A-11D-1854-01		5969b621-a81e-42aa-ac40-4849df285060	TCGA-49-6745-01	TCGA-49-6745-01A-13-2191-20	5969b621-a81e-42aa-ac40-4849df285060	TCGA-49-6745-01	98d5f3f8-4922-47c7-9f92-946acd7e9db8	5969b621-a81e-42aa-ac40-4849df285060	TCGA-49-6745-01A-11D-1855-08	TCGA-49-6745-01	
TCGA-49-6745-11	2.16	0.34	none		none	none	none	N	N	none	none	none	0.17	Squamoid	none	none	none	p.D1010_splice	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-49-6745-11		C1-LUAD-enriched							mutation c1uster 9	TCGA-49-6745	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					82	L-Upper		TCGA-49-6745-F15015	TCGA-49-6745	TCGA-49-6745-11A			-30133			0	522					YES				Scheduled Follow-up Submission		2011-8-11	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8260/3	C34.1	YES		0.7	NO		YES	NO			2.5			NO	20		Yes	M0	N2	T2a	Stage IIIA		6745		TUMOR FREE									NO		Solid Tissue Normal	11	0.4		7th	YES	NO	YES	49	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2011					1b4bb160-191b-4796-8759-339b11fe386d					TCGA-49-6745-11A-01D-1856-05				1b4bb160-191b-4796-8759-339b11fe386d	TCGA-49-6745-11		1b4bb160-191b-4796-8759-339b11fe386d			1b4bb160-191b-4796-8759-339b11fe386d		TCGA-49-6745-11	
TCGA-49-6761-01	3.13	0.29	none		none	none	none	Y	Y	none	none	none	0.12	Squamoid	none	p.G12D	none	p.S441C	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-49-6761-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4		TCGA-49-6761	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO			68	R-Upper		TCGA-49-6761-F22056	TCGA-49-6761	TCGA-49-6761-01A			-24849			0	354			1						Scheduled Follow-up Submission		2012-2-23	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO						2.3			NO	50		Yes	MX	N2	T1	Stage IIIA	TCGA-49-6761.73669cba-81ee-4215-a938-32556c5a211a.pdf	6761		TUMOR FREE	64	56	64	52	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.4		6th	NO	NO	YES	49	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2009			TCGA-49-6761-01A-31D-1945-08		ed630d55-aca9-4b8e-9128-f89177733bd5				TCGA-49-6761-01A-31D-1943-01	TCGA-49-6761-01A-31D-1947-05	TCGA-49-6761-01	TCGA-49-6761-01A-31D-1943-01		ed630d55-aca9-4b8e-9128-f89177733bd5	TCGA-49-6761-01	TCGA-49-6761-01A-13-2191-20	ed630d55-aca9-4b8e-9128-f89177733bd5	TCGA-49-6761-01	2ca5d0c2-9d41-40ec-95d1-ea7fb78a728c	ed630d55-aca9-4b8e-9128-f89177733bd5	TCGA-49-6761-01A-31D-1945-08	TCGA-49-6761-01	
TCGA-49-6761-11	3.13	0.29	none		none	none	none	Y	Y	none	none	none	0.12	Squamoid	none	p.G12D	none	p.S441C	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-49-6761-11		C1-LUAD-enriched								TCGA-49-6761	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO			68	R-Upper		TCGA-49-6761-F22056	TCGA-49-6761	TCGA-49-6761-11A			-24849			0	354			1						Scheduled Follow-up Submission		2012-2-23	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO						1.4			NO	50		Yes	MX	N2	T1	Stage IIIA		6761		TUMOR FREE	64	56	64	52	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11	0.4		6th	NO	NO	YES	49	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2009					0ab304f8-0976-4637-8955-199e1782ab16									0ab304f8-0976-4637-8955-199e1782ab16			0ab304f8-0976-4637-8955-199e1782ab16			0ab304f8-0976-4637-8955-199e1782ab16			
TCGA-49-6767-01	3.32	0.43	none		none	none	none	N	N	none	none	p.P645T	0.17	Squamoid	none	none	none	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-49-6767-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 8	TCGA-49-6767	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					46	R-Middle		TCGA-49-6767-F58822	TCGA-49-6767	TCGA-49-6767-01A			-17108			0	677									Scheduled Follow-up Submission		2014-4-24	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES		0.5	NO						1.5	NO			30		No	MX	N0	T3	Stage IIB	TCGA-49-6767.8e8171dc-1baa-4b81-8e05-e15714135c1f.pdf	6767		TUMOR FREE								NO		R0	Primary Tumor	01	0.4		7th		NO	YES	49	2	Current smoker	Lung	A	LIVING	2010		TCGA-49-6767-01A-11D-1855-08	TCGA-49-6767-01A-11D-1855-08		6a1b9b24-7377-4807-a876-282f9d948473				TCGA-49-6767-01A-11D-1854-01	TCGA-49-6767-01A-11D-1856-05	TCGA-49-6767-01	TCGA-49-6767-01A-11D-1854-01		6a1b9b24-7377-4807-a876-282f9d948473	TCGA-49-6767-01	TCGA-49-6767-01A-13-2191-20	6a1b9b24-7377-4807-a876-282f9d948473	TCGA-49-6767-01	dfc22417-6b41-42df-b53e-3fea9dadcd19	6a1b9b24-7377-4807-a876-282f9d948473	TCGA-49-6767-01A-11D-1855-08	TCGA-49-6767-01	
TCGA-49-AAQV-01																												TCGA-49-AAQV-01										TCGA-49-AAQV	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					63	L-Lower			TCGA-49-AAQV	TCGA-49-AAQV-01A			-23370	717	677	0				95.5	1	YES	Exon 19 Deletion	FISH	YES			2014-6-13	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	160		NO	90								YES		true	No	MX	N1	T1	Stage II	TCGA-49-AAQV.4FE4DC74-AF70-4F6C-B290-561808DD7FAE.pdf	AAQV	Preoperative	TUMOR FREE	77.29	81.7	78.80	83.3	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	NO	NO	YES	49	1		Lung	A	DECEASED	2012					a32fcc87-5473-43d5-9e4b-bad78719156c				TCGA-49-AAQV-01A-11D-A396-01	TCGA-49-AAQV-01A-11D-A398-05	TCGA-49-AAQV-01	TCGA-49-AAQV-01A-11D-A396-01		a32fcc87-5473-43d5-9e4b-bad78719156c	TCGA-49-AAQV-01		a32fcc87-5473-43d5-9e4b-bad78719156c	TCGA-49-AAQV-01	47586EA8-3CDE-46FC-A744-C016A1512530	a32fcc87-5473-43d5-9e4b-bad78719156c		TCGA-49-AAQV-01	
TCGA-49-AAR0-01																												TCGA-49-AAR0-01										TCGA-49-AAR0	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					57	R-Upper		TCGA-49-AAR0-F71576	TCGA-49-AAR0	TCGA-49-AAR0-01A			-20932	4298		0	4765			107	1					Scheduled Follow-up Submission	Complete Remission/Response	2015-4-10	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	200		NO	90						NO		NO	37	true	Yes, History of Prior Malignancy	MX	N0	T1	Stage IA	TCGA-49-AAR0.FCCE5D5B-6AB6-441F-9FBF-65B23060C95B.pdf	AAR0	Preoperative	TUMOR FREE	80	62.5	58.6	85.4	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			5th	NO	NO	YES	49	2		Lung	A	LIVING	2002					a90eef12-777c-4a46-b90e-1385807269f8				TCGA-49-AAR0-01A-21D-A396-01	TCGA-49-AAR0-01A-21D-A398-05	TCGA-49-AAR0-01	TCGA-49-AAR0-01A-21D-A396-01		a90eef12-777c-4a46-b90e-1385807269f8	TCGA-49-AAR0-01		a90eef12-777c-4a46-b90e-1385807269f8	TCGA-49-AAR0-01	B4E492F9-250C-4D37-A2BA-DAED1B3E1CE5	a90eef12-777c-4a46-b90e-1385807269f8		TCGA-49-AAR0-01	
TCGA-49-AAR2-01																												TCGA-49-AAR2-01										TCGA-49-AAR2	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					64	R-Lower		TCGA-49-AAR2-F72094	TCGA-49-AAR2	TCGA-49-AAR2-01A			-23479	1778		0	2224			105.8	1					Scheduled Follow-up Submission	Complete Remission/Response	2015-4-10	MALE	Lung Acinar Adenocarcinoma	No	C34.3	8550/3	C34.3	YES	130		NO	90						NO		NO		true	No	MX	N0	T2	Stage IB	TCGA-49-AAR2.70CAA6C7-B5DB-449A-A151-EED87511DEE5.pdf	AAR2	Preoperative	TUMOR FREE	78.2	79.5	78.6	80	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		2006	6th	YES	NO	YES	49	4		Lung	A	LIVING	2009					1c03d9f5-e222-48b2-afeb-dfdeeff246b0				TCGA-49-AAR2-01A-11D-A396-01	TCGA-49-AAR2-01A-11D-A398-05	TCGA-49-AAR2-01	TCGA-49-AAR2-01A-11D-A396-01		1c03d9f5-e222-48b2-afeb-dfdeeff246b0	TCGA-49-AAR2-01		1c03d9f5-e222-48b2-afeb-dfdeeff246b0	TCGA-49-AAR2-01	E9AF6E9A-3091-4D3C-A127-1E06A54A8B06	1c03d9f5-e222-48b2-afeb-dfdeeff246b0		TCGA-49-AAR2-01	
TCGA-49-AAR3-01																												TCGA-49-AAR3-01										TCGA-49-AAR3	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	R-Upper		TCGA-49-AAR3-F70567	TCGA-49-AAR3	TCGA-49-AAR3-01A			-25469	1927		0	1893				0					Scheduled Follow-up Submission	Complete Remission/Response	2015-2-25	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	140		NO	100						NO		NO		true	No	MX	N1	T2	Stage IIB	TCGA-49-AAR3.75D3436D-1CF9-4DC9-97EE-B93E2D6A3049.pdf	AAR3	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01			6th	YES	NO	YES	49			Lung	A	LIVING	2008					5c7d1e9d-56b8-4e54-a573-f7bd91f2afee				TCGA-49-AAR3-01A-11D-A40Z-01	TCGA-49-AAR3-01A-11D-A411-05	TCGA-49-AAR3-01	TCGA-49-AAR3-01A-11D-A40Z-01		5c7d1e9d-56b8-4e54-a573-f7bd91f2afee	TCGA-49-AAR3-01		5c7d1e9d-56b8-4e54-a573-f7bd91f2afee	TCGA-49-AAR3-01	9077B43C-C052-46E8-81D5-76043606D3DD	5c7d1e9d-56b8-4e54-a573-f7bd91f2afee		TCGA-49-AAR3-01	
TCGA-49-AAR4-01																												TCGA-49-AAR4-01										TCGA-49-AAR4	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					51	L-Upper			TCGA-49-AAR4	TCGA-49-AAR4-01A			-18939	2842	879	0				109.4	1							2014-6-18	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	200		NO	80								NO	35	true	No	MX	N2	T2	Stage IIIA	TCGA-49-AAR4.8982CE18-FA5A-4882-AAC4-F2AC6ED60C49.pdf	AAR4	Preoperative	WITH TUMOR	79.0	97.5	81.2	100.2	Stable Disease			YES	YES	R0	Primary Tumor	01			6th	YES	NO	YES	49	2		Lung	A	DECEASED	2006					653f5c38-8795-4ed9-8c4a-aaf5597eee8c				TCGA-49-AAR4-01A-12D-A40Z-01	TCGA-49-AAR4-01A-12D-A411-05	TCGA-49-AAR4-01	TCGA-49-AAR4-01A-12D-A40Z-01		653f5c38-8795-4ed9-8c4a-aaf5597eee8c	TCGA-49-AAR4-01		653f5c38-8795-4ed9-8c4a-aaf5597eee8c	TCGA-49-AAR4-01	BA9C8A6D-1668-43BB-8DDE-B9ABF414EF6F	653f5c38-8795-4ed9-8c4a-aaf5597eee8c		TCGA-49-AAR4-01	
TCGA-49-AAR9-01																												TCGA-49-AAR9-01										TCGA-49-AAR9	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	Other (please specify)	ALL 3 LOBES OF RT Lung		TCGA-49-AAR9	TCGA-49-AAR9-01A			-22510	5308	260	0					1							2014-6-18	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES	260		NO	80								NO		true	No	MX	N0	T3	Stage IIB	TCGA-49-AAR9.F2AB65ED-823F-446C-92CB-5F9DAB58D37A.pdf	AAR9	Preoperative	WITH TUMOR					Progressive Disease			NO	NO	R0	Primary Tumor	01			5th	NO	NO	YES	49	2		Lung	A	DECEASED	1999					c3a5aa9d-5b4d-4c3a-9e4c-656f174e2a6e				TCGA-49-AAR9-01A-21D-A40Z-01	TCGA-49-AAR9-01A-21D-A411-05	TCGA-49-AAR9-01	TCGA-49-AAR9-01A-21D-A40Z-01		c3a5aa9d-5b4d-4c3a-9e4c-656f174e2a6e	TCGA-49-AAR9-01		c3a5aa9d-5b4d-4c3a-9e4c-656f174e2a6e	TCGA-49-AAR9-01	707CCED4-A991-406A-A988-BDFF030229CD	c3a5aa9d-5b4d-4c3a-9e4c-656f174e2a6e		TCGA-49-AAR9-01	
TCGA-49-AARE-01																												TCGA-49-AARE-01										TCGA-49-AARE	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					51	R-Upper			TCGA-49-AARE	TCGA-49-AARE-01A			-18893	5455	1229	0				107.2	1							2014-6-19	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	180		NO	90								YES	15	true	No	MX	N0	T1	Stage IA	TCGA-49-AARE.D15D2040-F72D-4913-92FC-54741F573151.pdf	AARE	Other	WITH TUMOR	55.2	41.7	81	61.2	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1995	5th	NO	NO	YES	49	4		Lung	A	DECEASED	1999	1980				fb2e021f-ebae-4f7a-a072-d14046a20ce6				TCGA-49-AARE-01A-11D-A40Z-01	TCGA-49-AARE-01A-11D-A411-05	TCGA-49-AARE-01	TCGA-49-AARE-01A-11D-A40Z-01		fb2e021f-ebae-4f7a-a072-d14046a20ce6	TCGA-49-AARE-01		fb2e021f-ebae-4f7a-a072-d14046a20ce6	TCGA-49-AARE-01	E4D9E21A-5783-4975-89BE-D1C38B197B9E	fb2e021f-ebae-4f7a-a072-d14046a20ce6		TCGA-49-AARE-01	
TCGA-49-AARN-01																												TCGA-49-AARN-01										TCGA-49-AARN	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					56	R-Lower			TCGA-49-AARN	TCGA-49-AARN-01A			-20605	4882	1135	0				110.6	1							2014-6-19	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	210		NO	90										true	Yes, History of Synchronous/Bilateral Malignancy	MX	N0	T1	Stage IA	TCGA-49-AARN.19256999-CAE3-4D04-AA1C-758B4E80BCD1.pdf	AARN	Preoperative		85.9	101.1	80.2	94.4	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			5th	NO	NO	YES	49	5		Lung	A	DECEASED	2000					b58ffa95-5a94-4b18-b149-8a0095c53bb8				TCGA-49-AARN-01A-21D-A40Z-01	TCGA-49-AARN-01A-21D-A411-05	TCGA-49-AARN-01	TCGA-49-AARN-01A-21D-A40Z-01		b58ffa95-5a94-4b18-b149-8a0095c53bb8	TCGA-49-AARN-01		b58ffa95-5a94-4b18-b149-8a0095c53bb8	TCGA-49-AARN-01	C59E1214-7FB0-490B-9B96-5AF733AAE26B	b58ffa95-5a94-4b18-b149-8a0095c53bb8		TCGA-49-AARN-01	
TCGA-49-AARO-01																												TCGA-49-AARO-01										TCGA-49-AARO	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO		39	L-Upper		TCGA-49-AARO-F70571	TCGA-49-AARO	TCGA-49-AARO-01A			-14527	3838		0	3759	3521		103.3	3					Scheduled Follow-up Submission	Stable Disease	2015-2-25	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	170		NO	40						NO	Locoregional Recurrence	YES		true	No	MX	N0	T1a	Stage IA	TCGA-49-AARO.5E71C822-2014-431A-B050-102C4A845321.pdf	AARO	Post-Adjuvant Therapy	WITH TUMOR	84.4	83.9	83.6	83.0	Complete Remission/Response	Convincing Imaging		YES	YES	R0	Primary Tumor	01			6th	YES	NO	YES	49	2		Lung	A	LIVING	2003					51122947-fc8a-4285-b83a-4d5eabbe7c87				TCGA-49-AARO-01A-12D-A40Z-01	TCGA-49-AARO-01A-12D-A411-05	TCGA-49-AARO-01	TCGA-49-AARO-01A-12D-A40Z-01		51122947-fc8a-4285-b83a-4d5eabbe7c87	TCGA-49-AARO-01		51122947-fc8a-4285-b83a-4d5eabbe7c87	TCGA-49-AARO-01	6B18D7BD-A031-41F3-9286-44C0FAB9088B	51122947-fc8a-4285-b83a-4d5eabbe7c87		TCGA-49-AARO-01	
TCGA-49-AARQ-01																												TCGA-49-AARQ-01										TCGA-49-AARQ	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					41	R-Upper		TCGA-49-AARQ-F72093	TCGA-49-AARQ	TCGA-49-AARQ-01A			-15065	6271		0	6732			99.9	1					Scheduled Follow-up Submission	Complete Remission/Response	2015-4-10	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	60		NO	90						NO		NO	60	true	No	MX	N0	T2	Stage I	TCGA-49-AARQ.9A745E52-5B6D-4209-9A05-E30D8CE40A3E.pdf	AARQ	Preoperative	TUMOR FREE	56.8	56.1	83.2	82.2	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		2007	4th	NO	NO	YES	49	4		Lung	A	LIVING	1996					1ec3463c-c56d-4b93-9873-1e7b9d2d4fc4				TCGA-49-AARQ-01A-11D-A40Z-01	TCGA-49-AARQ-01A-11D-A411-05	TCGA-49-AARQ-01	TCGA-49-AARQ-01A-11D-A40Z-01		1ec3463c-c56d-4b93-9873-1e7b9d2d4fc4	TCGA-49-AARQ-01		1ec3463c-c56d-4b93-9873-1e7b9d2d4fc4	TCGA-49-AARQ-01		1ec3463c-c56d-4b93-9873-1e7b9d2d4fc4		TCGA-49-AARQ-01	
TCGA-49-AARR-01																												TCGA-49-AARR-01										TCGA-49-AARR	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		68	L-Upper		TCGA-49-AARR-F70574	TCGA-49-AARR	TCGA-49-AARR-01A			-24942	4634		0	4992	4812		103.5	1					Scheduled Follow-up Submission	Stable Disease	2015-2-25	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	170		NO	80						NO	Locoregional Recurrence	YES		true	No	MX	N0	T1	Stage IA	TCGA-49-AARR.55998E02-5285-4E6F-8BB8-7DB57F18C0D2.pdf	AARR	Preoperative	WITH TUMOR	76.3	78.8	77.8	80.3	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01		1987	5th	NO	NO	YES	49	3		Lung	A	LIVING	2001					367f7d8f-d11e-4cec-8df8-ab4e23e1ed0c				TCGA-49-AARR-01A-11D-A40Z-01	TCGA-49-AARR-01A-11D-A411-05	TCGA-49-AARR-01	TCGA-49-AARR-01A-11D-A40Z-01		367f7d8f-d11e-4cec-8df8-ab4e23e1ed0c	TCGA-49-AARR-01		367f7d8f-d11e-4cec-8df8-ab4e23e1ed0c	TCGA-49-AARR-01	179D0CD8-D62D-48A0-A3E5-8979901BA6A0	367f7d8f-d11e-4cec-8df8-ab4e23e1ed0c		TCGA-49-AARR-01	
TCGA-4B-A93V-01																												TCGA-4B-A93V-01										TCGA-4B-A93V	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	52	R-Lower		TCGA-4B-A93V-F67919	TCGA-4B-A93V	TCGA-4B-A93V-01A			-19035	84	300	0	254	251			0					Additional New Tumor Event	Progressive Disease	2014-11-12	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8140/3	C34.3	YES	400		NO	0				Peripheral Lung		YES	Distant Metastasis	YES	30	true	No	M0	N0	T1b	Stage IA	TCGA-4B-A93V.3723B92A-EFB6-4239-9D26-B88AF56252CE.pdf	A93V	Post-Adjuvant Therapy	WITH TUMOR					Progressive Disease	Convincing Imaging		NO	YES	R0	Primary Tumor	01		2013	7th	NO	YES	NO	4B	4		Lung	A	DECEASED	2013	1984				924c4803-0337-4423-ab6c-7aa43a5f7874				TCGA-4B-A93V-01A-11D-A396-01	TCGA-4B-A93V-01A-11D-A398-05	TCGA-4B-A93V-01	TCGA-4B-A93V-01A-11D-A396-01		924c4803-0337-4423-ab6c-7aa43a5f7874	TCGA-4B-A93V-01		924c4803-0337-4423-ab6c-7aa43a5f7874	TCGA-4B-A93V-01	B6DF0BDD-E000-4495-8C89-00F2498DEC5D	924c4803-0337-4423-ab6c-7aa43a5f7874		TCGA-4B-A93V-01	
TCGA-50-5044-01	2.03	0.21	none		p.D594H	none	none	N	Y	none	none	none	0.1	Squamoid	none	none	none	none	none	p.E542K	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-50-5044-01	Iq	C1-LUAD-enriched	cluster 2	Cluster 5	KIRC-like c1	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 14	TCGA-50-5044	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	72	R-Lower		TCGA-50-5044-F31976	TCGA-50-5044				-26567		624	0		483								Scheduled Follow-up Submission	Progressive Disease	2012-5-14	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES										NO	Distant Metastasis	YES			No	M0	N1	T4	Stage IIIB		5044		WITH TUMOR					Progressive Disease	Convincing Imaging			YES		Primary Tumor	01			5th	NO	NO	YES	50			Lung		DECEASED	2002		TCGA-50-5044-01A-21D-1855-08	TCGA-50-5044-01A-21D-1855-08		dac01b76-c2a3-4041-b704-97f1afc2c4d3				TCGA-50-5044-01A-21D-1854-01	TCGA-50-5044-01A-21D-1856-05	TCGA-50-5044-01	TCGA-50-5044-01A-21D-1854-01		dac01b76-c2a3-4041-b704-97f1afc2c4d3	TCGA-50-5044-01	TCGA-50-5044-01A-31-2190-20	dac01b76-c2a3-4041-b704-97f1afc2c4d3	TCGA-50-5044-01	fee0d27e-2ada-467b-b39e-e1ed30a27a9b	dac01b76-c2a3-4041-b704-97f1afc2c4d3	TCGA-50-5044-01A-21D-1855-08	TCGA-50-5044-01	
TCGA-50-5045-01																												TCGA-50-5045-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3		miRNA cluster 4		mutation cluster 5	TCGA-50-5045	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO		57	R-Lower		TCGA-50-5045-F32015	TCGA-50-5045	TCGA-50-5045-01A			-20961		2174	0		1433								Scheduled Follow-up Submission	Progressive Disease	2012-5-15	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1.5	NO						1.8	NO	Locoregional Recurrence	YES			No	M0	N1	T2	[Discrepancy]	TCGA-50-5045.1d5c2f0f-4203-4db9-b63c-b6d80d04207e.pdf	5045		WITH TUMOR					Progressive Disease	Biopsy with Histologic Confirmation			YES		Primary Tumor	01	0.4		6th		NO	YES	50			Lung	A	DECEASED	2004		TCGA-50-5045-01A-01D-1625-08			7a4e94fa-09fb-4483-8816-f3ff2f1b2a6f				TCGA-50-5045-01A-01D-1624-01	TCGA-50-5045-01A-01D-1626-05	TCGA-50-5045-01	TCGA-50-5045-01A-01D-1624-01		7a4e94fa-09fb-4483-8816-f3ff2f1b2a6f	TCGA-50-5045-01	TCGA-50-5045-01A-31-2190-20	7a4e94fa-09fb-4483-8816-f3ff2f1b2a6f	TCGA-50-5045-01	f5230fa4-0c05-484a-a17b-debebbcab1f4	7a4e94fa-09fb-4483-8816-f3ff2f1b2a6f	TCGA-50-5045-01A-01D-1625-08	TCGA-50-5045-01	
TCGA-50-5049-01			none		none	none	none	N	N	none	none	p.Q1126*		Squamoid	none	none	none	none	none	none	p.D551N	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-50-5049-01	High	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4	mutation cluster 11	TCGA-50-5049	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO		70	R-Upper		TCGA-50-5049-F70448	TCGA-50-5049	TCGA-50-5049-01A			-25577			0	3094	2544				YES				Scheduled Follow-up Submission		2015-2-16	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1.5	NO		YES	NO			2	NO	Locoregional Recurrence	YES			No	M0	N0	T2	Stage IA	TCGA-50-5049.3d60a219-3c2c-4e2a-ab29-5d61cd31478b.pdf	5049		WITH TUMOR					Progressive Disease	Convincing Imaging		NO	YES		Primary Tumor	01	0.3		6th	NO	NO	YES	50			Lung	A	LIVING	2006		TCGA-50-5049-01A-01D-1625-08	TCGA-50-5049-01A-01D-1625-08		299d2ad8-b54d-4ddb-b6c5-b80d8baf39f2				TCGA-50-5049-01A-01D-1624-01	TCGA-50-5049-01A-01D-1626-05	TCGA-50-5049-01	TCGA-50-5049-01A-01D-1624-01		299d2ad8-b54d-4ddb-b6c5-b80d8baf39f2	TCGA-50-5049-01	TCGA-50-5049-01A-21-2190-20	299d2ad8-b54d-4ddb-b6c5-b80d8baf39f2	TCGA-50-5049-01	db4fab65-7a1b-4386-b755-35ff900b9ca8	299d2ad8-b54d-4ddb-b6c5-b80d8baf39f2	TCGA-50-5049-01A-01D-1625-08	TCGA-50-5049-01	
TCGA-50-5051-01	2.99	0.59	none		none	none	none	Y	Y	none	none	none	0.23	Magnoid	none	p.G12C	none	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-50-5051-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 12	TCGA-50-5051	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	42	L-Upper		TCGA-50-5051-F32019	TCGA-50-5051	TCGA-50-5051-01A			-15585		478	0	455	184				YES				Scheduled Follow-up Submission	Progressive Disease	2012-5-15	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO		YES	YES	Other		1.2	NO	Distant Metastasis	YES	30		No	M0	N2	T2	Stage IIIA	TCGA-50-5051.ff5f5187-c4da-482c-b6fe-cbde5c820a80.pdf	5051		WITH TUMOR					Progressive Disease	Convincing Imaging			YES	R0	Primary Tumor	01	0.4	2006	6th	YES	NO	YES	50	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2007		TCGA-50-5051-01A-21D-1855-08	TCGA-50-5051-01A-21D-1855-08		ebbb3b0d-c092-4af4-919a-25fcb49eac69				TCGA-50-5051-01A-21D-1854-01	TCGA-50-5051-01A-21D-1856-05	TCGA-50-5051-01	TCGA-50-5051-01A-21D-1854-01		ebbb3b0d-c092-4af4-919a-25fcb49eac69	TCGA-50-5051-01	TCGA-50-5051-01A-22-2190-20	ebbb3b0d-c092-4af4-919a-25fcb49eac69	TCGA-50-5051-01	55ebc73e-1a0b-4e52-872a-e0d8a1e13226	ebbb3b0d-c092-4af4-919a-25fcb49eac69	TCGA-50-5051-01A-21D-1855-08	TCGA-50-5051-01	
TCGA-50-5055-01			none		none	none	none	N	N	none	none	none		Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-50-5055-01	GBM	C10-GBM	cluster 3	Low purity c2		LUAD-like c10	miRNA cluster 5	cluster 4	mutation c1uster 9	TCGA-50-5055	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	YES	NO	79	L-Lower		TCGA-50-5055-F32023	TCGA-50-5055	TCGA-50-5055-01A	792		-28988		1830	0	785	771				YES				Scheduled Follow-up Submission	Progressive Disease	2012-5-15	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		1.5	NO		YES	NO			1.9	NO	Locoregional Recurrence|Distant Metastasis	YES			No	M0	N1	T1	Stage IIA	TCGA-50-5055.847a0c64-cd3e-4a99-a6f7-b4ba1636ada1.pdf	5055		WITH TUMOR					Stable Disease	Biopsy with Histologic Confirmation|Convincing Imaging			NO	R0	Primary Tumor	01	0.1		6th	NO	NO	YES	50			Lung	A	DECEASED	2008		TCGA-50-5055-01A-01D-1625-08	TCGA-50-5055-01A-01D-1625-08		15be34fa-d099-42d0-98ca-e66c83a16790				TCGA-50-5055-01A-01D-1624-01	TCGA-50-5055-01A-01D-1626-05	TCGA-50-5055-01	TCGA-50-5055-01A-01D-1624-01		15be34fa-d099-42d0-98ca-e66c83a16790	TCGA-50-5055-01		15be34fa-d099-42d0-98ca-e66c83a16790	TCGA-50-5055-01		15be34fa-d099-42d0-98ca-e66c83a16790	TCGA-50-5055-01A-01D-1625-08	TCGA-50-5055-01	
TCGA-50-5066-01																												TCGA-50-5066-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 13	TCGA-50-5066	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	R-Upper		TCGA-50-5066-F70450	TCGA-50-5066	TCGA-50-5066-01A			-26385			0	1442					YES			YES	Scheduled Follow-up Submission	Complete Remission/Response	2015-2-16	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		1	NO		YES	NO			1.5	NO		NO			No	M0	N0	T2	Stage IB	TCGA-50-5066.E00CB449-F980-4829-A006-32706F041E94.pdf	5066		TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.2		6th	YES	NO	YES	50	1		Lung	A	LIVING	2009		TCGA-50-5066-01A-01D-1625-08			554a301f-fbc8-41f2-96e9-5da2ee943727				TCGA-50-5066-01A-01D-1624-01	TCGA-50-5066-01A-01D-1626-05	TCGA-50-5066-01	TCGA-50-5066-01A-01D-1624-01		554a301f-fbc8-41f2-96e9-5da2ee943727	TCGA-50-5066-01	TCGA-50-5066-01A-21-2190-20	554a301f-fbc8-41f2-96e9-5da2ee943727	TCGA-50-5066-01	125106f7-3b1d-4bd3-ab00-f8cc72798de9	554a301f-fbc8-41f2-96e9-5da2ee943727	TCGA-50-5066-01A-01D-1625-08	TCGA-50-5066-01	
TCGA-50-5066-02																												TCGA-50-5066-02		C1-LUAD-enriched		Cluster 5		LUAD-like c10	miRNA cluster 5		mutation cluster 13	TCGA-50-5066	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	R-Upper		TCGA-50-5066-F70450	TCGA-50-5066				-26385			0	1442					YES			YES	Scheduled Follow-up Submission	Complete Remission/Response	2015-2-16	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES					YES	NO				NO		NO			No	M0	N0	T2	Stage IB		5066		TUMOR FREE					Complete Remission/Response			NO	NO	R0	Recurrent Tumor	02			6th	YES	NO	YES	50	1		Lung		LIVING	2009					f274e34b-e111-47e0-8fff-5c338d387d76					TCGA-50-5066-02A-11D-2087-05				f274e34b-e111-47e0-8fff-5c338d387d76	TCGA-50-5066-02		f274e34b-e111-47e0-8fff-5c338d387d76			f274e34b-e111-47e0-8fff-5c338d387d76	TCGA-50-5066-02A-11D-2107-08	TCGA-50-5066-02	
TCGA-50-5068-01	1.62	0.38	none		none	none	none	N	N	none	none	none	0.2	Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-50-5068-01	High	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 5	TCGA-50-5068	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	YES	NO	59	R-Lower		TCGA-50-5068-F32057	TCGA-50-5068	TCGA-50-5068-01A	686		-21728		1499	0	1499	686								Scheduled Follow-up Submission	Progressive Disease	2012-5-16	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1.3	NO						1.4	NO	Distant Metastasis	YES			No	MX	N1	T2	Stage IIB	TCGA-50-5068.d8025f22-0b42-4204-bc58-56fc727c71ac.pdf	5068		WITH TUMOR					Progressive Disease	Biopsy with Histologic Confirmation|Convincing Imaging			NO		Primary Tumor	01	0.3		6th	YES	NO	YES	50			Lung	A	DECEASED	2003		TCGA-50-5068-01A-01D-1625-08	TCGA-50-5068-01A-01D-1625-08		10c6a96f-b119-43a8-8dfa-9af13bce53b9				TCGA-50-5068-01A-01D-1624-01	TCGA-50-5068-01A-01D-1626-05	TCGA-50-5068-01	TCGA-50-5068-01A-01D-1624-01		10c6a96f-b119-43a8-8dfa-9af13bce53b9	TCGA-50-5068-01	TCGA-50-5068-01A-21-2190-20	10c6a96f-b119-43a8-8dfa-9af13bce53b9	TCGA-50-5068-01	72359d96-a06f-4d72-8d58-009a5d06d25b	10c6a96f-b119-43a8-8dfa-9af13bce53b9	TCGA-50-5068-01A-01D-1625-08	TCGA-50-5068-01	
TCGA-50-5072-01	2.1	0.45	none		none	none	none	N	N	none	none	none	0.22	Magnoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			p.K97_splice	0	TCGA-50-5072-01	High	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation c1uster 9	TCGA-50-5072	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		NO	74	L-Upper		TCGA-50-5072-F32059	TCGA-50-5072	TCGA-50-5072-01A			-27036		250	0	246	213				YES			YES	Scheduled Follow-up Submission	Progressive Disease	2012-5-16	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Yes	C34.1	8140/3	C34.1	YES		0.9	NO		YES				1.2	NO	Distant Metastasis	YES	15		No	M0	N2	T2	Stage IIIA	TCGA-50-5072.0e998d45-ba74-4a11-8a14-e394299c9bba.pdf	5072		WITH TUMOR					Progressive Disease	Convincing Imaging		NO	YES		Primary Tumor	01	0.3	1974	6th	YES	NO	YES	50	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2009		TCGA-50-5072-01A-21D-1855-08	TCGA-50-5072-01A-21D-1855-08		d27e254c-1ccb-4b13-97f3-48d1e427d130				TCGA-50-5072-01A-21D-1854-01	TCGA-50-5072-01A-21D-1856-05	TCGA-50-5072-01	TCGA-50-5072-01A-21D-1854-01		d27e254c-1ccb-4b13-97f3-48d1e427d130	TCGA-50-5072-01	TCGA-50-5072-01A-22-2190-20	d27e254c-1ccb-4b13-97f3-48d1e427d130	TCGA-50-5072-01	5c0a5c7e-afab-4817-8118-46a95f8a8ae9	d27e254c-1ccb-4b13-97f3-48d1e427d130	TCGA-50-5072-01A-21D-1855-08	TCGA-50-5072-01	
TCGA-50-5930-01																												TCGA-50-5930-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3		miRNA cluster 4		mutation c1uster 9	TCGA-50-5930	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		NO	47	[Discrepancy]		TCGA-50-5930-F32064	TCGA-50-5930				-17238		282	0		177								Scheduled Follow-up Submission	Progressive Disease	2012-5-16	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES										NO	Distant Metastasis	YES			No	M0	N2	T2	Stage IIIA		5930		WITH TUMOR					Progressive Disease	Convincing Imaging			YES		Primary Tumor	01			5th	YES	NO	YES	50			Lung		DECEASED	2001		TCGA-50-5930-01A-11D-1753-08			ea55c131-97f8-49cc-a445-87523ce1f075				TCGA-50-5930-01A-11D-1752-01	TCGA-50-5930-01A-11D-1756-05	TCGA-50-5930-01	TCGA-50-5930-01A-11D-1752-01		ea55c131-97f8-49cc-a445-87523ce1f075	TCGA-50-5930-01	TCGA-50-5930-01A-31-2191-20	ea55c131-97f8-49cc-a445-87523ce1f075	TCGA-50-5930-01	d78804ea-2fb0-415f-9c69-0db95fcade3f	ea55c131-97f8-49cc-a445-87523ce1f075	TCGA-50-5930-01A-11D-1753-08	TCGA-50-5930-01	
TCGA-50-5930-11																												TCGA-50-5930-11		C1-LUAD-enriched							mutation c1uster 9	TCGA-50-5930	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		NO	47	[Discrepancy]		TCGA-50-5930-F32064	TCGA-50-5930				-17238		282	0		177								Scheduled Follow-up Submission	Progressive Disease	2012-5-16	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES										NO	Distant Metastasis	YES			No	M0	N2	T2	Stage IIIA		5930		WITH TUMOR					Progressive Disease	Convincing Imaging			YES		Solid Tissue Normal	11			5th	YES	NO	YES	50			Lung		DECEASED	2001					c019f320-2e0e-4f00-a393-2e5717d64cc0					TCGA-50-5930-11A-01D-1756-05				c019f320-2e0e-4f00-a393-2e5717d64cc0	TCGA-50-5930-11		c019f320-2e0e-4f00-a393-2e5717d64cc0			c019f320-2e0e-4f00-a393-2e5717d64cc0		TCGA-50-5930-11	
TCGA-50-5931-01	3.68	0.76	none		none	none	none	N	N	none	none	none	0.23	Magnoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-50-5931-01	Squamous	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	RNA cluster 12	miRNA cluster 5	cluster 3	mutation cluster 2	TCGA-50-5931	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO		NO	75	L-Upper		TCGA-50-5931-F32067	TCGA-50-5931	TCGA-50-5931-01A			-27733		434	0	267	425								Scheduled Follow-up Submission	Progressive Disease	2012-5-16	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO					Central Lung	1.7	NO	Distant Metastasis	YES	40		No	M0	N0	T2	Stage IB	TCGA-50-5931.396c0f5f-1b86-4aa9-88ef-ca9220f4ccf3.pdf	5931		WITH TUMOR					Progressive Disease	Convincing Imaging			NO	R0	Primary Tumor	01	0.3		5th	NO	NO	YES	50	4		Lung	A	DECEASED	2001		TCGA-50-5931-01A-11D-1753-08	TCGA-50-5931-01A-11D-1753-08		e2a7336c-5262-433a-ad52-8834eaee2e1e				TCGA-50-5931-01A-11D-1752-01	TCGA-50-5931-01A-11D-1756-05	TCGA-50-5931-01	TCGA-50-5931-01A-11D-1752-01		e2a7336c-5262-433a-ad52-8834eaee2e1e	TCGA-50-5931-01	TCGA-50-5931-01A-31-2191-20	e2a7336c-5262-433a-ad52-8834eaee2e1e	TCGA-50-5931-01	10e7fc5f-f750-4d81-8314-5efd5d7e0efa	e2a7336c-5262-433a-ad52-8834eaee2e1e	TCGA-50-5931-01A-11D-1753-08	TCGA-50-5931-01	
TCGA-50-5931-11	3.68	0.76	none		none	none	none	N	N	none	none	none	0.23	Magnoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-50-5931-11		C1-LUAD-enriched							mutation cluster 2	TCGA-50-5931	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO		NO	75	L-Upper		TCGA-50-5931-F32067	TCGA-50-5931	TCGA-50-5931-11A			-27733		434	0	267	425								Scheduled Follow-up Submission	Progressive Disease	2012-5-16	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO					Central Lung	1.2	NO	Distant Metastasis	YES	40		No	M0	N0	T2	Stage IB		5931		WITH TUMOR					Progressive Disease	Convincing Imaging			NO	R0	Solid Tissue Normal	11	0.3		5th	NO	NO	YES	50	4		Lung	A	DECEASED	2001					4cc61cbe-fa79-499b-9fd5-9b454030154c					TCGA-50-5931-11A-01D-1756-05				4cc61cbe-fa79-499b-9fd5-9b454030154c			4cc61cbe-fa79-499b-9fd5-9b454030154c			4cc61cbe-fa79-499b-9fd5-9b454030154c			
TCGA-50-5932-01	1.8	0.85	none		none	none	none	Y	Y	none	none	none	0.46	Magnoid	none	p.G12C	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			p.N181Y	0	TCGA-50-5932-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 1	mutation cluster 12	TCGA-50-5932	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	NO	75	R-Upper		TCGA-50-5932-F32080	TCGA-50-5932	TCGA-50-5932-01A			-27454		1235	0	1091	1090								Scheduled Follow-up Submission	Progressive Disease	2012-5-16	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1.3	NO					Central Lung	1.4	NO	Locoregional Recurrence	YES			Yes	M0	N1	T2	Stage IIB	TCGA-50-5932.d7713068-4d83-4242-bae2-8035c1ba9b8d.pdf	5932		WITH TUMOR					Progressive Disease	Biopsy with Histologic Confirmation|Convincing Imaging			NO		Primary Tumor	01	0.5		5th	NO	NO	YES	50			Lung	A	DECEASED	2001		TCGA-50-5932-01A-11D-1753-08	TCGA-50-5932-01A-11D-1753-08		80032260-febc-4069-9897-e36cf1118e68				TCGA-50-5932-01A-11D-1752-01	TCGA-50-5932-01A-11D-1756-05	TCGA-50-5932-01	TCGA-50-5932-01A-11D-1752-01		80032260-febc-4069-9897-e36cf1118e68	TCGA-50-5932-01	TCGA-50-5932-01A-31-2191-20	80032260-febc-4069-9897-e36cf1118e68	TCGA-50-5932-01	3bffc9f0-f53c-4f65-bdfc-9100a4d15510	80032260-febc-4069-9897-e36cf1118e68	TCGA-50-5932-01A-11D-1753-08	TCGA-50-5932-01	
TCGA-50-5932-11	1.8	0.85	none		none	none	none	Y	Y	none	none	none	0.46	Magnoid	none	p.G12C	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			p.N181Y	0	TCGA-50-5932-11		C1-LUAD-enriched							mutation cluster 12	TCGA-50-5932	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	NO	75	R-Upper		TCGA-50-5932-F32080	TCGA-50-5932	TCGA-50-5932-11A			-27454		1235	0	1091	1090								Scheduled Follow-up Submission	Progressive Disease	2012-5-16	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1.3	NO					Central Lung	2.2	NO	Locoregional Recurrence	YES			Yes	M0	N1	T2	Stage IIB		5932		WITH TUMOR					Progressive Disease	Biopsy with Histologic Confirmation|Convincing Imaging			NO		Solid Tissue Normal	11	0.5		5th	NO	NO	YES	50			Lung	A	DECEASED	2001					7284cc3a-d5a1-42b1-8b1a-89665c4bc35f					TCGA-50-5932-11A-01D-1756-05				7284cc3a-d5a1-42b1-8b1a-89665c4bc35f	TCGA-50-5932-11		7284cc3a-d5a1-42b1-8b1a-89665c4bc35f			7284cc3a-d5a1-42b1-8b1a-89665c4bc35f		TCGA-50-5932-11	
TCGA-50-5933-01	2.78	0.3	none		none	none	none	N	N	none	none	none	0.13	Squamoid	none	none	none	p.C98F	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-50-5933-01	High	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation cluster 11	TCGA-50-5933	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	L-Lower		TCGA-50-5933-F32104	TCGA-50-5933	TCGA-50-5933-01A			-26377		2393	0	2370									Scheduled Follow-up Submission	Complete Remission/Response	2012-5-17	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1	NO					Central Lung	1.7	NO		NO			No	M0	N2	T4	Stage IIIB	TCGA-50-5933.68d471f3-43c0-44cf-97ce-003ff111c35c.pdf	5933		TUMOR FREE					Complete Remission/Response				YES		Primary Tumor	01	0.5		5th	YES	NO	YES	50			Lung	A	DECEASED	2001		TCGA-50-5933-01A-11D-1753-08	TCGA-50-5933-01A-11D-1753-08		51eae0de-8f16-4093-b42e-5c34c4768459				TCGA-50-5933-01A-11D-1752-01	TCGA-50-5933-01A-11D-1756-05	TCGA-50-5933-01	TCGA-50-5933-01A-11D-1752-01		51eae0de-8f16-4093-b42e-5c34c4768459	TCGA-50-5933-01	TCGA-50-5933-01A-31-2191-20	51eae0de-8f16-4093-b42e-5c34c4768459	TCGA-50-5933-01	47959745-d225-4df7-b32c-e66bc6db4f7d	51eae0de-8f16-4093-b42e-5c34c4768459	TCGA-50-5933-01A-11D-1753-08	TCGA-50-5933-01	
TCGA-50-5933-11	2.78	0.3	none		none	none	none	N	N	none	none	none	0.13	Squamoid	none	none	none	p.C98F	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-50-5933-11		C1-LUAD-enriched							mutation cluster 11	TCGA-50-5933	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	L-Lower		TCGA-50-5933-F32104	TCGA-50-5933				-26377		2393	0	2370									Scheduled Follow-up Submission	Complete Remission/Response	2012-5-17	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES								Central Lung		NO		NO			No	M0	N2	T4	Stage IIIB		5933		TUMOR FREE					Complete Remission/Response				YES		Solid Tissue Normal	11			5th	YES	NO	YES	50			Lung		DECEASED	2001					af24ffd8-4d43-4f7a-ae49-590814d00f39					TCGA-50-5933-11A-01D-1756-05				af24ffd8-4d43-4f7a-ae49-590814d00f39	TCGA-50-5933-11		af24ffd8-4d43-4f7a-ae49-590814d00f39			af24ffd8-4d43-4f7a-ae49-590814d00f39		TCGA-50-5933-11	
TCGA-50-5935-01	3.08	0.58	none		none	none	none	N	N	none	none	none	0.22	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-50-5935-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 2	Cluster 6		LUAD-like c10	miRNA cluster 4	cluster 5	mutation cluster 12	TCGA-50-5935	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		86	L-Upper		TCGA-50-5935-F32108	TCGA-50-5935				-31610		653	0	653					YES	Other			Scheduled Follow-up Submission	Complete Remission/Response	2012-5-17	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					YES	YES				NO		NO			Yes	M0	N0	T1	Stage IA		5935		TUMOR FREE					Complete Remission/Response				YES		Primary Tumor	01			6th	NO	NO	YES	50			Lung		DECEASED	2006		TCGA-50-5935-01A-11D-1753-08	TCGA-50-5935-01A-11D-1753-08		bf999d4c-d1e6-4e8b-8aa3-becb7b734037				TCGA-50-5935-01A-11D-1752-01	TCGA-50-5935-01A-11D-1756-05	TCGA-50-5935-01	TCGA-50-5935-01A-11D-1752-01		bf999d4c-d1e6-4e8b-8aa3-becb7b734037	TCGA-50-5935-01		bf999d4c-d1e6-4e8b-8aa3-becb7b734037	TCGA-50-5935-01		bf999d4c-d1e6-4e8b-8aa3-becb7b734037	TCGA-50-5935-01A-11D-1753-08	TCGA-50-5935-01	
TCGA-50-5935-11	3.08	0.58	none		none	none	none	N	N	none	none	none	0.22	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-50-5935-11		C1-LUAD-enriched							mutation cluster 12	TCGA-50-5935	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		86	L-Upper		TCGA-50-5935-F32108	TCGA-50-5935	TCGA-50-5935-11A			-31610		653	0	653					YES	Other			Scheduled Follow-up Submission	Complete Remission/Response	2012-5-17	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1.1	NO		YES	YES			1.5	NO		NO			Yes	M0	N0	T1	Stage IA		5935		TUMOR FREE					Complete Remission/Response				YES		Solid Tissue Normal	11	0.3		6th	NO	NO	YES	50			Lung	A	DECEASED	2006					c6722ce9-8824-4721-9e95-96e9b0b09066					TCGA-50-5935-11A-01D-1756-05				c6722ce9-8824-4721-9e95-96e9b0b09066			c6722ce9-8824-4721-9e95-96e9b0b09066			c6722ce9-8824-4721-9e95-96e9b0b09066			
TCGA-50-5936-01	3.25	0.43	none		none	none	none	N	N	none	none	none	0.17	Magnoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-50-5936-01	Squamous	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 12	TCGA-50-5936	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	YES	NO	58	R-Lower		TCGA-50-5936-F32110	TCGA-50-5936	TCGA-50-5936-01A	177		-21238		257	0		150				YES				Scheduled Follow-up Submission	Progressive Disease	2012-5-17	MALE	Mucinous (Colloid) Carcinoma	No	C34.30	8480/3	C34.3	YES		0.8	NO		YES	YES	G12C		0.9	NO		YES			No	M0	N2	T2	Stage IIIA	TCGA-50-5936.8d30d2aa-bef2-4329-944b-99ad5c9d8fc6.pdf	5936		WITH TUMOR					Progressive Disease	Biopsy with Histologic Confirmation|Convincing Imaging			NO		Primary Tumor	01	0.3		6th	NO	NO	YES	50			Lung	A	DECEASED	2007		TCGA-50-5936-01A-11D-1625-08	TCGA-50-5936-01A-11D-1625-08		3bb181ee-960f-488b-b04b-c2acb7cfb127				TCGA-50-5936-01A-11D-1624-01	TCGA-50-5936-01A-11D-1626-05	TCGA-50-5936-01	TCGA-50-5936-01A-11D-1624-01		3bb181ee-960f-488b-b04b-c2acb7cfb127	TCGA-50-5936-01	TCGA-50-5936-01A-31-2191-20	3bb181ee-960f-488b-b04b-c2acb7cfb127	TCGA-50-5936-01	321627c2-4c05-4e79-ab55-5fe72402662c	3bb181ee-960f-488b-b04b-c2acb7cfb127	TCGA-50-5936-01A-11D-1625-08	TCGA-50-5936-01	
TCGA-50-5936-11	3.25	0.43	none		none	none	none	N	N	none	none	none	0.17	Magnoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-50-5936-11		C1-LUAD-enriched							mutation cluster 12	TCGA-50-5936	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	YES	NO	58	R-Lower		TCGA-50-5936-F32110	TCGA-50-5936	TCGA-50-5936-11A	177		-21238		257	0		150				YES				Scheduled Follow-up Submission	Progressive Disease	2012-5-17	MALE	Mucinous (Colloid) Carcinoma	No	C34.30	8480/3	C34.3	YES		1.4	NO		YES	YES	G12C		2.2	NO		YES			No	M0	N2	T2	Stage IIIA		5936		WITH TUMOR					Progressive Disease	Biopsy with Histologic Confirmation|Convincing Imaging			NO		Solid Tissue Normal	11	0.1		6th	NO	NO	YES	50			Lung	A	DECEASED	2007					81e8d16b-1a9b-4156-a438-07d89807f652					TCGA-50-5936-11A-01D-1626-05				81e8d16b-1a9b-4156-a438-07d89807f652			81e8d16b-1a9b-4156-a438-07d89807f652			81e8d16b-1a9b-4156-a438-07d89807f652			
TCGA-50-5939-01	1.72	0.33	none		none	none	none	N	N	none	none	none	0.17	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-50-5939-01	Squamous	C1-LUAD-enriched	cluster 3	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 5	TCGA-50-5939	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					85	R-Upper		TCGA-50-5939-F32124	TCGA-50-5939	TCGA-50-5939-01A			-31236		460	0										Scheduled Follow-up Submission	Complete Remission/Response	2012-5-17	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.8	NO						1.2			NO	15		No	M0	N0	T2	Stage IB	TCGA-50-5939.b8f00ba8-722f-4df1-bfcd-2ccfe6583abd.pdf	5939		TUMOR FREE					Complete Remission/Response				NO		Primary Tumor	01	0.4	1968	6th	NO	NO	YES	50	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2008		TCGA-50-5939-01A-11D-1625-08	TCGA-50-5939-01A-11D-1625-08		3cafb1e5-9de0-4ced-8b87-d2299a207b97				TCGA-50-5939-01A-11D-1624-01	TCGA-50-5939-01A-11D-1626-05	TCGA-50-5939-01	TCGA-50-5939-01A-11D-1624-01		3cafb1e5-9de0-4ced-8b87-d2299a207b97	TCGA-50-5939-01	TCGA-50-5939-01A-31-2191-20	3cafb1e5-9de0-4ced-8b87-d2299a207b97	TCGA-50-5939-01	a1c702d2-d557-477f-9df0-f51e18f54163	3cafb1e5-9de0-4ced-8b87-d2299a207b97	TCGA-50-5939-01A-11D-1625-08	TCGA-50-5939-01	
TCGA-50-5939-11	1.72	0.33	none		none	none	none	N	N	none	none	none	0.17	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-50-5939-11		C1-LUAD-enriched							mutation cluster 5	TCGA-50-5939	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					85	R-Upper		TCGA-50-5939-F32124	TCGA-50-5939	TCGA-50-5939-11A			-31236		460	0										Scheduled Follow-up Submission	Complete Remission/Response	2012-5-17	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		2	NO						2.5			NO	15		No	M0	N0	T2	Stage IB		5939		TUMOR FREE					Complete Remission/Response				NO		Solid Tissue Normal	11	0.2	1968	6th	NO	NO	YES	50	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2008					0569af63-9a1d-4f03-9a67-1269c7973677					TCGA-50-5939-11A-01D-1626-05				0569af63-9a1d-4f03-9a67-1269c7973677			0569af63-9a1d-4f03-9a67-1269c7973677			0569af63-9a1d-4f03-9a67-1269c7973677			
TCGA-50-5941-01			none		p.G327_splice	none	none	Y	Y	none	none	none		Squamoid	none	p.G12A	none	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-50-5941-01	High	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 3	mutation cluster 2	TCGA-50-5941	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					55	R-Upper		TCGA-50-5941-F70451	TCGA-50-5941	TCGA-50-5941-01A			-20350			0	1474									Scheduled Follow-up Submission	Complete Remission/Response	2015-2-16	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO						1	NO		NO	25		No	M0	N2	T2a	Stage IIIA	TCGA-50-5941.d49e610e-998f-4c6e-bb3d-b9c3a4221544.pdf	5941		TUMOR FREE					Complete Remission/Response			NO	NO		Primary Tumor	01	0.3		7th	YES	NO	YES	50	2	Current smoker	Lung	A	LIVING	2010		TCGA-50-5941-01A-11D-1753-08	TCGA-50-5941-01A-11D-1753-08		84138ee7-b120-4201-95b1-ccdc1c82ebda				TCGA-50-5941-01A-11D-1752-01	TCGA-50-5941-01A-11D-1756-05	TCGA-50-5941-01	TCGA-50-5941-01A-11D-1752-01		84138ee7-b120-4201-95b1-ccdc1c82ebda	TCGA-50-5941-01	TCGA-50-5941-01A-31-2191-20	84138ee7-b120-4201-95b1-ccdc1c82ebda	TCGA-50-5941-01	ac85d41b-26b4-438a-86a6-94d8cc001368	84138ee7-b120-4201-95b1-ccdc1c82ebda	TCGA-50-5941-01A-11D-1753-08	TCGA-50-5941-01	
TCGA-50-5942-01	1.95	0.7	none		p.V600E	none	none	N	Y	none	none	none	0.36	Bronchioid	none	none	none	none	none	none	none	Lepidic predominant Adc	Lepidic predominant Adc			none	0	TCGA-50-5942-01	Kirc+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation c1uster 9	TCGA-50-5942	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES			67	R-Upper		TCGA-50-5942-F70452	TCGA-50-5942	TCGA-50-5942-01A			-24781			0	1847	1378								Scheduled Follow-up Submission		2015-2-16	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO						1	NO	Locoregional Recurrence	YES	30		No	M0	N0	T1	Stage IA	TCGA-50-5942.915634e0-d38b-4a37-b96f-b9ac10507179.pdf	5942		WITH TUMOR					Stable Disease	Convincing Imaging		NO	YES	R0	Primary Tumor	01	0.3	2009	7th	NO	NO	YES	50	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2009		TCGA-50-5942-01A-21D-1753-08	TCGA-50-5942-01A-21D-1753-08		43a90c23-bff9-45ae-a5b5-c65f343d1cdc				TCGA-50-5942-01A-21D-1752-01	TCGA-50-5942-01A-21D-1756-05	TCGA-50-5942-01	TCGA-50-5942-01A-21D-1752-01		43a90c23-bff9-45ae-a5b5-c65f343d1cdc	TCGA-50-5942-01	TCGA-50-5942-01A-31-2191-20	43a90c23-bff9-45ae-a5b5-c65f343d1cdc	TCGA-50-5942-01	41451a71-047f-4417-8d68-7cc15598a207	43a90c23-bff9-45ae-a5b5-c65f343d1cdc	TCGA-50-5942-01A-21D-1753-08	TCGA-50-5942-01	
TCGA-50-5944-01	3.32	0.57	none		none	none	none	Y	Y	p.L858R	none	none	0.21	Bronchioid	none	none	none	none	none	none	none	Lepidic predominant Adc	Lepidic predominant Adc			none	0	TCGA-50-5944-01	High	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation cluster 8	TCGA-50-5944	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	R-Upper		TCGA-50-5944-F70454	TCGA-50-5944				-25440			0	1750									Scheduled Follow-up Submission	Complete Remission/Response	2015-2-16	FEMALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES										NO		NO			No	M0	N0	T1	Stage IA		5944		TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01			7th	NO	NO	YES	50			Lung		LIVING	2010		TCGA-50-5944-01A-11D-1753-08	TCGA-50-5944-01A-11D-1753-08		c1859475-12fd-47f6-887d-136d334399cd				TCGA-50-5944-01A-11D-1752-01	TCGA-50-5944-01A-11D-1756-05	TCGA-50-5944-01	TCGA-50-5944-01A-11D-1752-01		c1859475-12fd-47f6-887d-136d334399cd	TCGA-50-5944-01	TCGA-50-5944-01A-13-2191-20	c1859475-12fd-47f6-887d-136d334399cd	TCGA-50-5944-01	e17609bb-ee34-4c92-9a72-41f40b80fb45	c1859475-12fd-47f6-887d-136d334399cd	TCGA-50-5944-01A-11D-1753-08	TCGA-50-5944-01	
TCGA-50-5946-01																												TCGA-50-5946-01	High	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10			mutation cluster 5	TCGA-50-5946	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO		NO	62	R-Upper		TCGA-50-5946-F70455	TCGA-50-5946	TCGA-50-5946-01A			-22852			0	1617	811									Progressive Disease	2015-2-16	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		1.2	NO						1.5	NO	Distant Metastasis	YES			No	MX	N0	T1	Stage IA	TCGA-50-5946.E0329D21-475F-4C7D-9703-8297FF21B39F.pdf	5946		WITH TUMOR					Progressive Disease	Convincing Imaging		NO	NO		Primary Tumor	01	0.3	2009		NO	NO	YES	50	4		Lung	A	LIVING	2010		TCGA-50-5946-01A-11D-1753-08			8a5cfa5b-2dab-4775-ae08-3d7e0b36e93f				TCGA-50-5946-01A-11D-1752-01	TCGA-50-5946-01A-11D-1756-05	TCGA-50-5946-01	TCGA-50-5946-01A-11D-1752-01		8a5cfa5b-2dab-4775-ae08-3d7e0b36e93f	TCGA-50-5946-01	TCGA-50-5946-01A-13-2191-20	8a5cfa5b-2dab-4775-ae08-3d7e0b36e93f	TCGA-50-5946-01	754a4160-e44d-4f89-a135-c7400eb8badc	8a5cfa5b-2dab-4775-ae08-3d7e0b36e93f	TCGA-50-5946-01A-11D-1753-08	TCGA-50-5946-01	
TCGA-50-5946-02																												TCGA-50-5946-02		C1-LUAD-enriched		Cluster 5		LUAD-like c10	miRNA cluster 5		mutation cluster 5	TCGA-50-5946	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO		NO	62	R-Upper		TCGA-50-5946-F70455	TCGA-50-5946	TCGA-50-5946-02A			-22852			0	1617	811									Progressive Disease	2015-2-16	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.4	NO						1.9	NO	Distant Metastasis	YES			No	MX	N0	T1	Stage IA	TCGA-50-5946.E0329D21-475F-4C7D-9703-8297FF21B39F.pdf	5946		WITH TUMOR					Progressive Disease	Convincing Imaging		NO	NO		Recurrent Tumor	02	0.2	2009		NO	NO	YES	50	4		Lung	A	LIVING	2010					0bfc47d8-bd48-49e9-8d37-6a418d049aef					TCGA-50-5946-02A-11D-2087-05				0bfc47d8-bd48-49e9-8d37-6a418d049aef	TCGA-50-5946-02		0bfc47d8-bd48-49e9-8d37-6a418d049aef			0bfc47d8-bd48-49e9-8d37-6a418d049aef		TCGA-50-5946-02	
TCGA-50-6590-01																												TCGA-50-6590-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 11	TCGA-50-6590	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	R-Upper		TCGA-50-6590-F43827	TCGA-50-6590	TCGA-50-6590-01A			-26444		1288	0						YES				Scheduled Follow-up Submission	Complete Remission/Response	2013-6-4	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO						1.6	NO		NO	50		No	M0	N0	T2	Stage IB	TCGA-50-6590.13192955-ae90-4708-8f85-3b4e35781345.pdf	6590		TUMOR FREE					Complete Remission/Response				NO		Primary Tumor	01	0.3	2002	6th	YES	NO	YES	50	4		Lung	A	DECEASED	2005		TCGA-50-6590-01A-12D-1855-08			12fdf681-a6f5-4dfe-b556-d7e7f7e4d58a				TCGA-50-6590-01A-12D-1854-01	TCGA-50-6590-01A-12D-1856-05	TCGA-50-6590-01	TCGA-50-6590-01A-12D-1854-01		12fdf681-a6f5-4dfe-b556-d7e7f7e4d58a	TCGA-50-6590-01	TCGA-50-6590-01A-23-2191-20	12fdf681-a6f5-4dfe-b556-d7e7f7e4d58a	TCGA-50-6590-01	b33cf148-e9bc-473b-b51f-037b348e7e49	12fdf681-a6f5-4dfe-b556-d7e7f7e4d58a	TCGA-50-6590-01A-12D-1855-08	TCGA-50-6590-01	
TCGA-50-6591-01																												TCGA-50-6591-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3	GBM-like c6	miRNA cluster 13		mutation cluster 8	TCGA-50-6591	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					63	L-Lower		TCGA-50-6591-F43833	TCGA-50-6591	TCGA-50-6591-01A			-23067		119	0										Scheduled Follow-up Submission	Progressive Disease	2013-6-4	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.8	NO						0.9	NO		NO			No	M1	N0	T2	Stage IV	TCGA-50-6591.d1bb9feb-2cd4-40fd-a4d6-300d16b29d51.pdf	6591		WITH TUMOR					Progressive Disease				NO		Primary Tumor	01	0.7		6th	NO	NO	YES	50	1		Lung	A	DECEASED	2007		TCGA-50-6591-01A-11D-1753-08			92321ab5-8c77-4208-9daf-e6fcb01cc7a1				TCGA-50-6591-01A-11D-1752-01	TCGA-50-6591-01A-11D-1756-05	TCGA-50-6591-01	TCGA-50-6591-01A-11D-1752-01		92321ab5-8c77-4208-9daf-e6fcb01cc7a1	TCGA-50-6591-01	TCGA-50-6591-01A-13-2191-20	92321ab5-8c77-4208-9daf-e6fcb01cc7a1	TCGA-50-6591-01	4fdef60d-ba82-4b43-85b0-840c42622ab7	92321ab5-8c77-4208-9daf-e6fcb01cc7a1	TCGA-50-6591-01A-11D-1753-08	TCGA-50-6591-01	
TCGA-50-6591-11																												TCGA-50-6591-11		C1-LUAD-enriched							mutation cluster 8	TCGA-50-6591	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					63	L-Lower		TCGA-50-6591-F43833	TCGA-50-6591	TCGA-50-6591-11A			-23067		119	0										Scheduled Follow-up Submission	Progressive Disease	2013-6-4	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1.1	NO						1.8	NO		NO			No	M1	N0	T2	Stage IV		6591		WITH TUMOR					Progressive Disease				NO		Solid Tissue Normal	11	0.4		6th	NO	NO	YES	50	1		Lung	A	DECEASED	2007										TCGA-50-6591-11A-01D-1756-05													
TCGA-50-6592-01																												TCGA-50-6592-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 3	TCGA-50-6592	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	L-Lower		TCGA-50-6592-F43835	TCGA-50-6592	TCGA-50-6592-01A			-26191		777	0										Scheduled Follow-up Submission	Progressive Disease	2013-6-4	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1	NO						2	NO		NO			No	M0	N0	T2	Stage IB	TCGA-50-6592.9a5098a9-7600-4b77-9b16-d6c274affd77.pdf	6592		WITH TUMOR					Progressive Disease				YES		Primary Tumor	01	0.3		6th	NO	NO	YES	50	4		Lung	A	DECEASED	2007		TCGA-50-6592-01A-11D-1753-08			444662df-ae9b-4fec-9afc-df392ba3a88d				TCGA-50-6592-01A-11D-1752-01	TCGA-50-6592-01A-11D-1756-05	TCGA-50-6592-01	TCGA-50-6592-01A-11D-1752-01		444662df-ae9b-4fec-9afc-df392ba3a88d	TCGA-50-6592-01	TCGA-50-6592-01A-13-2191-20	444662df-ae9b-4fec-9afc-df392ba3a88d	TCGA-50-6592-01	14deca38-5943-4ef6-8735-ba83e03eb3a7	444662df-ae9b-4fec-9afc-df392ba3a88d	TCGA-50-6592-01A-11D-1753-08	TCGA-50-6592-01	
TCGA-50-6592-11																												TCGA-50-6592-11		C1-LUAD-enriched							mutation cluster 3	TCGA-50-6592	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	L-Lower		TCGA-50-6592-F43835	TCGA-50-6592	TCGA-50-6592-11A			-26191		777	0										Scheduled Follow-up Submission	Progressive Disease	2013-6-4	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1.5	NO						2	NO		NO			No	M0	N0	T2	Stage IB		6592		WITH TUMOR					Progressive Disease				YES		Solid Tissue Normal	11	0.1		6th	NO	NO	YES	50	4		Lung	A	DECEASED	2007										TCGA-50-6592-11A-01D-1756-05													
TCGA-50-6593-01	2.9	0.31	none		none	none	none	N	N	none	none	none	0.14	Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-50-6593-01	High	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation cluster 13	TCGA-50-6593	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO		NO	49	R-Upper		TCGA-50-6593-F43840	TCGA-50-6593				-18152		336	0		266				YES			YES	Scheduled Follow-up Submission	Progressive Disease	2013-6-13	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES					YES	NO				NO	Distant Metastasis	YES			No	M0	N2	T1	Stage IIIA		6593		WITH TUMOR					Progressive Disease	Convincing Imaging		NO	YES	R0	Primary Tumor	01			6th	NO	NO	YES	50	4	Current reformed smoker for < or = 15 years	Lung		DECEASED	2008		TCGA-50-6593-01A-11D-1753-08	TCGA-50-6593-01A-11D-1753-08		ace0aace-27ba-42a6-8d6b-3c29095ccbe5				TCGA-50-6593-01A-11D-1752-01	TCGA-50-6593-01A-11D-1756-05	TCGA-50-6593-01	TCGA-50-6593-01A-11D-1752-01		ace0aace-27ba-42a6-8d6b-3c29095ccbe5	TCGA-50-6593-01	TCGA-50-6593-01A-13-2191-20	ace0aace-27ba-42a6-8d6b-3c29095ccbe5	TCGA-50-6593-01	fc327353-7dfc-40e7-81ee-43307e7d12bf	ace0aace-27ba-42a6-8d6b-3c29095ccbe5	TCGA-50-6593-01A-11D-1753-08	TCGA-50-6593-01	
TCGA-50-6593-11	2.9	0.31	none		none	none	none	N	N	none	none	none	0.14	Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-50-6593-11		C1-LUAD-enriched							mutation cluster 13	TCGA-50-6593	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO		NO	49	R-Upper		TCGA-50-6593-F43840	TCGA-50-6593	TCGA-50-6593-11A			-18152		336	0		266				YES			YES	Scheduled Follow-up Submission	Progressive Disease	2013-6-13	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.6	NO		YES	NO			1.5	NO	Distant Metastasis	YES			No	M0	N2	T1	Stage IIIA		6593		WITH TUMOR					Progressive Disease	Convincing Imaging		NO	YES	R0	Solid Tissue Normal	11	0.4		6th	NO	NO	YES	50	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2008										TCGA-50-6593-11A-01D-1756-05													
TCGA-50-6594-01																												TCGA-50-6594-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 2	TCGA-50-6594	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		NO	79	L-Upper		TCGA-50-6594-F44032	TCGA-50-6594	TCGA-50-6594-01A			-28924		370	0		285							YES	Scheduled Follow-up Submission	Progressive Disease	2013-6-13	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO			NO			1.5	NO	Distant Metastasis	YES			No	M0	N2	T3	Stage IIIA	TCGA-50-6594.f0ca0fa2-8143-4d83-a82b-188c044d7071.pdf	6594		WITH TUMOR					Progressive Disease	Convincing Imaging			NO		Primary Tumor	01	0.3	1998	6th	NO	NO	YES	50	4		Lung	A	DECEASED	2009		TCGA-50-6594-01A-11D-1753-08			7326b41e-46e0-47fb-895d-43ef08c91b97				TCGA-50-6594-01A-11D-1752-01	TCGA-50-6594-01A-11D-1756-05	TCGA-50-6594-01	TCGA-50-6594-01A-11D-1752-01		7326b41e-46e0-47fb-895d-43ef08c91b97	TCGA-50-6594-01	TCGA-50-6594-01A-13-2191-20	7326b41e-46e0-47fb-895d-43ef08c91b97	TCGA-50-6594-01	1b4ed202-75b7-4591-8b58-dbb2dba7376f	7326b41e-46e0-47fb-895d-43ef08c91b97	TCGA-50-6594-01A-11D-1753-08	TCGA-50-6594-01	
TCGA-50-6594-11																												TCGA-50-6594-11		C1-LUAD-enriched							mutation cluster 2	TCGA-50-6594	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		NO	79	L-Upper		TCGA-50-6594-F44032	TCGA-50-6594	TCGA-50-6594-11A			-28924		370	0		285							YES	Scheduled Follow-up Submission	Progressive Disease	2013-6-13	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO			NO			1.5	NO	Distant Metastasis	YES			No	M0	N2	T3	Stage IIIA		6594		WITH TUMOR					Progressive Disease	Convincing Imaging			NO		Solid Tissue Normal	11	0.4	1998	6th	NO	NO	YES	50	4		Lung	A	DECEASED	2009										TCGA-50-6594-11A-01D-1756-05													
TCGA-50-6595-01			none		none	none	none	Y	Y	p.G719A, p.S768I	none	none		Squamoid	none	none	none	none	none	none	none	NSCLC, favor Adeno	NSCLC, favor Adeno			none	0	TCGA-50-6595-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	squamous-like c4	miRNA cluster 4	cluster 2	mutation cluster 8	TCGA-50-6595	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	YES	74	R-Upper		TCGA-50-6595-F44127	TCGA-50-6595	TCGA-50-6595-01A		187	-27197		189	0		182				YES			YES	Scheduled Follow-up Submission	Progressive Disease	2013-6-13	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO		YES				1.7	NO	Distant Metastasis	YES			No	M0	N2	T2	Stage IIIA	TCGA-50-6595.13f36f42-a0d4-4cf3-b8ea-8cdeff292a91.pdf	6595		WITH TUMOR					Progressive Disease	Biopsy with Histologic Confirmation		NO	YES		Primary Tumor	01	0.3	1979	6th	YES	NO	YES	50	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2009		TCGA-50-6595-01A-12D-1855-08	TCGA-50-6595-01A-12D-1855-08		cb72fb22-d492-432c-8188-82fce70c071c				TCGA-50-6595-01A-12D-1854-01	TCGA-50-6595-01A-12D-1856-05	TCGA-50-6595-01	TCGA-50-6595-01A-12D-1854-01		cb72fb22-d492-432c-8188-82fce70c071c	TCGA-50-6595-01	TCGA-50-6595-01A-23-2191-20	cb72fb22-d492-432c-8188-82fce70c071c	TCGA-50-6595-01	9425139b-c220-4c94-a144-db0ab41b827a	cb72fb22-d492-432c-8188-82fce70c071c	TCGA-50-6595-01A-12D-1855-08	TCGA-50-6595-01	
TCGA-50-6595-11			none		none	none	none	Y	Y	p.G719A, p.S768I	none	none		Squamoid	none	none	none	none	none	none	none	NSCLC, favor Adeno	NSCLC, favor Adeno			none	0	TCGA-50-6595-11		C1-LUAD-enriched							mutation cluster 8	TCGA-50-6595	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	YES	74	R-Upper		TCGA-50-6595-F44127	TCGA-50-6595	TCGA-50-6595-11A		187	-27197		189	0		182				YES			YES	Scheduled Follow-up Submission	Progressive Disease	2013-6-13	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1.1	NO		YES				1.7	NO	Distant Metastasis	YES			No	M0	N2	T2	Stage IIIA		6595		WITH TUMOR					Progressive Disease	Biopsy with Histologic Confirmation		NO	YES		Solid Tissue Normal	11	0.1	1979	6th	YES	NO	YES	50	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2009					44ffccc3-f2ba-4c7a-bc88-afbf93f63102									44ffccc3-f2ba-4c7a-bc88-afbf93f63102			44ffccc3-f2ba-4c7a-bc88-afbf93f63102			44ffccc3-f2ba-4c7a-bc88-afbf93f63102			
TCGA-50-6597-01			none		none	none	none	N	N	none	none	none		Bronchioid	none	none	none	p.D1010_splice	none	none	none	Lepidic predominant Adc	Lepidic predominant Adc			none	0	TCGA-50-6597-01	High	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation c1uster 9	TCGA-50-6597	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					79	R-Lower		TCGA-50-6597-F44134	TCGA-50-6597	TCGA-50-6597-01A			-29195		1268	0	1015					YES				Scheduled Follow-up Submission	Complete Remission/Response	2013-6-13	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.9	NO		YES	NO			2	NO		NO			No	M0	N0	T2	Stage IB	TCGA-50-6597.6ba1ee6a-b37e-4f8d-9435-3d69ad1dbfdd.pdf	6597		TUMOR FREE					Partial Remission/Response			NO	NO	R0	Primary Tumor	01	0.1		6th	NO	NO	YES	50	1	Lifelong Non-smoker	Lung	A	DECEASED	2007		TCGA-50-6597-01A-11D-1855-08	TCGA-50-6597-01A-11D-1855-08		ce74929b-eae4-4e87-9a60-90230e28dadd				TCGA-50-6597-01A-11D-1854-01	TCGA-50-6597-01A-11D-1856-05	TCGA-50-6597-01	TCGA-50-6597-01A-11D-1854-01		ce74929b-eae4-4e87-9a60-90230e28dadd	TCGA-50-6597-01	TCGA-50-6597-01A-23-2191-20	ce74929b-eae4-4e87-9a60-90230e28dadd	TCGA-50-6597-01	5971b955-c7c4-4efa-a0e5-4e27bd9abce9	ce74929b-eae4-4e87-9a60-90230e28dadd	TCGA-50-6597-01A-11D-1855-08	TCGA-50-6597-01	
TCGA-50-6673-01	3.77	0.35	none		none	none	none	Y	Y	p.773_774insH	none	none	0.13	Bronchioid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-50-6673-01	Squamous	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 7	cluster 4		TCGA-50-6673	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					84	R-Upper		TCGA-50-6673-F44135	TCGA-50-6673	TCGA-50-6673-01A			-30689		22	0										Scheduled Follow-up Submission		2013-6-13	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO						1.1	NO		NO			No	M0	N0	T1	Stage I	TCGA-50-6673.e2a03d91-afb5-4c25-99ae-e339660d7e2c.pdf	6673											YES	R0	Primary Tumor	01	0.3		6th	NO	NO	YES	50	1	Lifelong Non-smoker	Lung	A	DECEASED	2004			TCGA-50-6673-01A-11D-1945-08		5655a240-2ed7-469e-af17-9997547ea119				TCGA-50-6673-01A-11D-1943-01	TCGA-50-6673-01A-11D-1947-05	TCGA-50-6673-01	TCGA-50-6673-01A-11D-1943-01		5655a240-2ed7-469e-af17-9997547ea119	TCGA-50-6673-01	TCGA-50-6673-01A-13-2191-20	5655a240-2ed7-469e-af17-9997547ea119	TCGA-50-6673-01	bbe974cc-029f-48c4-b5d6-7f489e831af7	5655a240-2ed7-469e-af17-9997547ea119	TCGA-50-6673-01A-11D-1945-08	TCGA-50-6673-01	
TCGA-50-7109-01	2.91	0.45	none		none	none	none	N	N	none	none	none	0.19	Magnoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			p.D194Y	0	TCGA-50-7109-01	High	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-50-7109	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	60	R-Lower		TCGA-50-7109-F44136	TCGA-50-7109	TCGA-50-7109-01A			-21979		308	0	255	15								Scheduled Follow-up Submission	Progressive Disease	2013-6-13	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.9	NO						1.3	NO	Distant Metastasis	YES	120		No	M0	N0	T1	Stage IA	TCGA-50-7109.a34c2391-f021-4b46-a4e9-8d9b7ee31402.pdf	7109		WITH TUMOR					Progressive Disease	Convincing Imaging		NO	NO		Primary Tumor	01	0.2		7th	NO	NO	YES	50	2	Current smoker	Lung	A	DECEASED	2011			TCGA-50-7109-01A-11D-2036-08		330a29fe-e4ec-458b-8d1f-05f147ac98d9				TCGA-50-7109-01A-11D-2035-01	TCGA-50-7109-01A-11D-2037-05	TCGA-50-7109-01	TCGA-50-7109-01A-11D-2035-01		330a29fe-e4ec-458b-8d1f-05f147ac98d9	TCGA-50-7109-01	TCGA-50-7109-01A-13-2192-20	330a29fe-e4ec-458b-8d1f-05f147ac98d9	TCGA-50-7109-01	cd785e69-967c-4ae7-9137-aaf65ebab433	330a29fe-e4ec-458b-8d1f-05f147ac98d9	TCGA-50-7109-01A-11D-2036-08	TCGA-50-7109-01	
TCGA-50-7109-11	2.91	0.45	none		none	none	none	N	N	none	none	none	0.19	Magnoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			p.D194Y	0	TCGA-50-7109-11		C1-LUAD-enriched								TCGA-50-7109	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	60	R-Lower		TCGA-50-7109-F44136	TCGA-50-7109				-21979		308	0	255	15								Scheduled Follow-up Submission	Progressive Disease	2013-6-13	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES										NO	Distant Metastasis	YES	120		No	M0	N0	T1	Stage IA		7109		WITH TUMOR					Progressive Disease	Convincing Imaging		NO	NO		Solid Tissue Normal	11			7th	NO	NO	YES	50	2	Current smoker	Lung		DECEASED	2011															TCGA-50-7109-11							TCGA-50-7109-11	
TCGA-50-8457-01																												TCGA-50-8457-01				Cluster 5			miRNA cluster 4			TCGA-50-8457	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					63	R-Upper		TCGA-50-8457-F70409	TCGA-50-8457	TCGA-50-8457-01A			-23055			0	1125					YES		FISH	YES	Scheduled Follow-up Submission	Complete Remission/Response	2015-2-11	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.9	NO		YES	YES	G12A		1.2	NO		NO	30		No	M0	N0	T1a	Stage IA	TCGA-50-8457.21529b79-5b5b-46e6-8deb-e4e6460a4695.pdf	8457		TUMOR FREE					Complete Remission/Response			NO	NO		Primary Tumor	01	0.3	1997	7th	NO	YES	NO	50	4		Lung	A	LIVING	2011					9475bf3a-ae1b-482c-88d8-3f0c90ff18f6				TCGA-50-8457-01A-11D-2322-01	TCGA-50-8457-01A-11D-2324-05	TCGA-50-8457-01	TCGA-50-8457-01A-11D-2322-01		9475bf3a-ae1b-482c-88d8-3f0c90ff18f6	TCGA-50-8457-01		9475bf3a-ae1b-482c-88d8-3f0c90ff18f6	TCGA-50-8457-01	D9B469C0-1645-49E0-B652-C4515203021F	9475bf3a-ae1b-482c-88d8-3f0c90ff18f6	TCGA-50-8457-01A-11D-2323-08	TCGA-50-8457-01	
TCGA-50-8459-01																												TCGA-50-8459-01				Cluster 5			miRNA cluster 4			TCGA-50-8459	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					68	R-Lower		TCGA-50-8459-F70410	TCGA-50-8459	TCGA-50-8459-01A			-24859			0	1119			70		YES				Scheduled Follow-up Submission	Progressive Disease	2015-2-11	MALE	Mucinous (Colloid) Carcinoma	No	C34.30	8480/3	C34.3	YES		0.7	NO		YES	YES	G12C		1.2	NO		NO	10		No	M0	N0	T3	Stage IIB	TCGA-50-8459.be87241c-fcb4-416f-a8a4-74b09033ca0b.pdf	8459		WITH TUMOR			70	72	Progressive Disease			YES	NO		Primary Tumor	01	0.3		7th	YES	YES	NO	50	2		Lung	A	LIVING	2012					defb83d5-ba61-435f-a8bf-98daaa1c546f				TCGA-50-8459-01A-11D-2322-01	TCGA-50-8459-01A-11D-2324-05	TCGA-50-8459-01	TCGA-50-8459-01A-11D-2322-01		defb83d5-ba61-435f-a8bf-98daaa1c546f	TCGA-50-8459-01		defb83d5-ba61-435f-a8bf-98daaa1c546f	TCGA-50-8459-01	B312A3EE-242B-4B69-B4F6-265317315D2D	defb83d5-ba61-435f-a8bf-98daaa1c546f	TCGA-50-8459-01A-11D-2323-08	TCGA-50-8459-01	
TCGA-50-8460-01																												TCGA-50-8460-01				Cluster 5			miRNA cluster 4			TCGA-50-8460	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	R-Upper		TCGA-50-8460-F69335	TCGA-50-8460	TCGA-50-8460-01A			-27270			0	829					YES				Scheduled Follow-up Submission	Complete Remission/Response	2015-1-5	MALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES		0.9	NO		YES	NO			1.3	NO		NO			No	M0	N0	T1a	Stage IA	TCGA-50-8460.fc79e8c5-c79b-46d3-ab41-03399a68999a.pdf	8460		TUMOR FREE					Complete Remission/Response			NO	YES	R0	Primary Tumor	01	0.3		7th	NO	YES	NO	50			Lung	A	LIVING	2012					42a4a133-ec9d-4f5a-8b95-be83cbddb148				TCGA-50-8460-01A-11D-2322-01	TCGA-50-8460-01A-11D-2324-05	TCGA-50-8460-01	TCGA-50-8460-01A-11D-2322-01		42a4a133-ec9d-4f5a-8b95-be83cbddb148	TCGA-50-8460-01		42a4a133-ec9d-4f5a-8b95-be83cbddb148	TCGA-50-8460-01	12DA9D1D-1F9A-44E5-BB0A-7787ED4456F8	42a4a133-ec9d-4f5a-8b95-be83cbddb148	TCGA-50-8460-01A-11D-2323-08	TCGA-50-8460-01	
TCGA-53-7624-01																												TCGA-53-7624-01	High	C8-BLCA		Cluster 5	squamous c3	BLCA nonsquamous-like c1	miRNA cluster 4			TCGA-53-7624	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES		YES	40	R-Upper		TCGA-53-7624-F39722	TCGA-53-7624	TCGA-53-7624-01A		593	-14794		1043	0		400			0	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-1-31	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES			NO	0	NO			Peripheral Lung		NO	Distant Metastasis	YES	50		No	M1	N0	T2	Stage IV	TCGA-53-7624.b108a209-518b-4271-a90c-7f3857044581.pdf	7624	Post-Adjuvant Therapy	WITH TUMOR					Progressive Disease	Biopsy with Histologic Confirmation			NO	R0	Primary Tumor	01			6th	YES	NO	YES	53	2		Lung	A	DECEASED	2008	1986				50d03646-1082-4ae3-9853-f5295006f11a				TCGA-53-7624-01A-11D-2062-01	TCGA-53-7624-01A-11D-2064-05	TCGA-53-7624-01	TCGA-53-7624-01A-11D-2062-01		50d03646-1082-4ae3-9853-f5295006f11a	TCGA-53-7624-01	TCGA-53-7624-01A-13-2192-20	50d03646-1082-4ae3-9853-f5295006f11a	TCGA-53-7624-01	4ca5de57-b4b9-4bdb-8272-40b134e5f812	50d03646-1082-4ae3-9853-f5295006f11a	TCGA-53-7624-01A-11D-2063-08	TCGA-53-7624-01	
TCGA-53-7626-01	3.58	0.26	none		none	none	none	N	N	none	none	p.C589F	0.11	Bronchioid	none	none	none	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-53-7626-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 3		TCGA-53-7626	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		76	R-Upper		TCGA-53-7626-F38969	TCGA-53-7626	TCGA-53-7626-01A			-28024		929	0		865			0	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-1-15	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES			NO		NO			Peripheral Lung		NO	Locoregional Recurrence	YES	35		No	M0	N1	T1	Stage IIA	TCGA-53-7626.23a82f88-d450-4546-88e0-c26cf8de267e.pdf	7626	Post-Adjuvant Therapy	WITH TUMOR					Progressive Disease	Biopsy with Histologic Confirmation			NO	R0	Primary Tumor	01		2006	6th	YES	NO	YES	53	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2008	1971		TCGA-53-7626-01A-12D-2063-08		f3196cf4-2cda-4377-9089-e29434cbd4d4				TCGA-53-7626-01A-12D-2062-01	TCGA-53-7626-01A-12D-2064-05	TCGA-53-7626-01	TCGA-53-7626-01A-12D-2062-01		f3196cf4-2cda-4377-9089-e29434cbd4d4	TCGA-53-7626-01	TCGA-53-7626-01A-23-2192-20	f3196cf4-2cda-4377-9089-e29434cbd4d4	TCGA-53-7626-01	431635c1-f187-4a27-9013-502373adccd8	f3196cf4-2cda-4377-9089-e29434cbd4d4	TCGA-53-7626-01A-12D-2063-08	TCGA-53-7626-01	
TCGA-53-7813-01			none		none	none	none	Y	Y	none	none	none		Magnoid	none	p.G12A	none	none	none	none	none					p.Y60fs		TCGA-53-7813-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 6	cluster 1		TCGA-53-7813	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					51	R-Upper		TCGA-53-7813-F39281	TCGA-53-7813				-18875			0	424			88	1	NO			NO	Scheduled Follow-up Submission		2013-1-31	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.1	8252/3	C34.1	YES					NO					YES			35		No	M0	N0	T4	Stage IIIB		7813	Pre-Adjuvant Therapy	TUMOR FREE	69	91	67	90	Progressive Disease			YES	NO		Primary Tumor	01		2008	6th	YES	NO	YES	53	4		Lung		LIVING	2008	1973		TCGA-53-7813-01A-11D-2167-08		f8d65338-5f5e-4cf5-a119-25faf54453d4				TCGA-53-7813-01A-11D-2166-01	TCGA-53-7813-01A-11D-2168-05	TCGA-53-7813-01	TCGA-53-7813-01A-11D-2166-01		f8d65338-5f5e-4cf5-a119-25faf54453d4	TCGA-53-7813-01	TCGA-53-7813-01A-13-2192-20	f8d65338-5f5e-4cf5-a119-25faf54453d4	TCGA-53-7813-01	a9fcd075-f885-4617-b67a-11b039062e93	f8d65338-5f5e-4cf5-a119-25faf54453d4	TCGA-53-7813-01A-11D-2167-08	TCGA-53-7813-01	
TCGA-53-A4EZ-01																												TCGA-53-A4EZ-01										TCGA-53-A4EZ	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					63	L-Upper		TCGA-53-A4EZ-F61081	TCGA-53-A4EZ	TCGA-53-A4EZ-01A			-23201	163		0	1071			86	1	YES		FISH	YES	Scheduled Follow-up Submission	Complete Remission/Response	2015-3-19	MALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	120		NO	80	YES	NO		Peripheral Lung		NO		NO	40	true	No	MX	N1	T2a	Stage IIA	TCGA-53-A4EZ.E4CB6C1D-9774-47BE-989E-F9CD05D9EED8.pdf	A4EZ	Post-Adjuvant Therapy	TUMOR FREE	73	75	73	76	Stable Disease			YES	YES	RX	Primary Tumor	01		1996	7th	YES	YES	NO	53	3		Lung	A	LIVING	2012	1956				465ce132-c1f4-490f-b1f1-46300fde4441				TCGA-53-A4EZ-01A-12D-A24O-01	TCGA-53-A4EZ-01A-12D-A24U-05	TCGA-53-A4EZ-01	TCGA-53-A4EZ-01A-12D-A24O-01		465ce132-c1f4-490f-b1f1-46300fde4441	TCGA-53-A4EZ-01		465ce132-c1f4-490f-b1f1-46300fde4441	TCGA-53-A4EZ-01	8620B021-C8FD-4814-991D-71B4D1906835	465ce132-c1f4-490f-b1f1-46300fde4441	TCGA-53-A4EZ-01A-12D-A24P-08	TCGA-53-A4EZ-01	
TCGA-55-1592-01	3.24	0.49	none		none	none	none	N	N	none	none	none	0.19	Bronchioid	none	none	none	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-55-1592-01	High	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4	mutation cluster 11	TCGA-55-1592	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	65	L-Upper		TCGA-55-1592-F9167	TCGA-55-1592	TCGA-55-1592-01A					701	0		452									Progressive Disease	2011-3-15	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO						1.8			YES			Yes	M0	N0	T2	Stage IA	TCGA-55-1592.99ae36ee-bb6c-4934-8e5c-388ff5a69c46.pdf	1592		WITH TUMOR					Complete Remission/Response				NO	R0	Primary Tumor	01	0.5	1997		NO	NO	YES	55	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2005	1957	TCGA-55-1592-01	TCGA-55-1592-01A-01D-0969-08	TCGA-55-1592-01	f215665e-3c8d-4746-a18a-859ac95b2fdb	TCGA-55-1592-01A-01R-0946-07	TCGA-55-1592-01A-01D-0945-05	TCGA-55-1592-01	TCGA-55-1592-01A-01D-0944-01		TCGA-55-1592-01	TCGA-55-1592-01A-01D-0944-01	TCGA-55-1592-01	f215665e-3c8d-4746-a18a-859ac95b2fdb		TCGA-55-1592-01A-21-2190-20	f215665e-3c8d-4746-a18a-859ac95b2fdb	TCGA-55-1592-01	08e59b04-61a9-4a1b-9fd9-bb07ffe2551a	f215665e-3c8d-4746-a18a-859ac95b2fdb	TCGA-55-1592-01A-01W-0928-08,TCGA-55-1592-01A-01D-0969-08		TCGA-55-1592-01
TCGA-55-1592-11	3.24	0.49	none		none	none	none	N	N	none	none	none	0.19	Bronchioid	none	none	none	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-55-1592-11		C1-LUAD-enriched							mutation cluster 11	TCGA-55-1592	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	65	L-Upper		TCGA-55-1592-F9167	TCGA-55-1592	TCGA-55-1592-11A					701	0		452									Progressive Disease	2011-3-15	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.4	NO						1			YES			Yes	M0	N0	T2	Stage IA		1592		WITH TUMOR					Complete Remission/Response				NO	R0	Solid Tissue Normal	11	0.2	1997		NO	NO	YES	55	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2005	1957						TCGA-55-1592-11A-01D-0945-05																
TCGA-55-1594-01	3.28	0.54	none		none	none	none	N	N	none	none	none	0.2	Magnoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	1	TCGA-55-1594-01	High	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 6	cluster 1	mutation cluster 5	TCGA-55-1594	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					68	R-Lower			TCGA-55-1594	TCGA-55-1594-01A			-25008			0	1178											2010-9-14	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.5	NO						2						No	M0	N2	T2	Stage IIIA	TCGA-55-1594.bdbfef54-ca5a-4b4f-809d-4de379232a8a.pdf	1594		TUMOR FREE										R0	Primary Tumor	01	0.2				NO	YES	55	2	Current smoker	Lung	A	LIVING	2005	1965	TCGA-55-1594-01	TCGA-55-1594-01A-01D-1040-01	TCGA-55-1594-01	63b6924e-921f-4fac-9866-dd97e996d7ac	TCGA-55-1594-01A-01R-0946-07	TCGA-55-1594-01A-01D-0945-05	TCGA-55-1594-01	TCGA-55-1594-01A-01D-0944-01		TCGA-55-1594-01	TCGA-55-1594-01A-01D-0944-01	TCGA-55-1594-01	63b6924e-921f-4fac-9866-dd97e996d7ac		TCGA-55-1594-01A-21-2190-20	63b6924e-921f-4fac-9866-dd97e996d7ac	TCGA-55-1594-01	273089ef-4fc5-462c-a77e-e3076a998e4d	63b6924e-921f-4fac-9866-dd97e996d7ac	TCGA-55-1594-01A-01W-0928-08,TCGA-55-1594-01A-01D-1040-01		TCGA-55-1594-01
TCGA-55-1594-11	3.28	0.54	none		none	none	none	N	N	none	none	none	0.2	Magnoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	1	TCGA-55-1594-11		C1-LUAD-enriched							mutation cluster 5	TCGA-55-1594	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					68	R-Lower			TCGA-55-1594	TCGA-55-1594-11A			-25008			0	1178											2010-9-14	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1	NO						3						No	M0	N2	T2	Stage IIIA		1594		TUMOR FREE										R0	Solid Tissue Normal	11	0.6				NO	YES	55	2	Current smoker	Lung	A	LIVING	2005	1965						TCGA-55-1594-11A-01D-0945-05																
TCGA-55-1595-01																												TCGA-55-1595-01	High	C1-LUAD-enriched		Cluster 6		LUAD-like c10	miRNA cluster 4		mutation cluster 12	TCGA-55-1595	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	L-Lower		TCGA-55-1595-F9159	TCGA-55-1595							0	1479											2011-3-15	FEMALE	Lung Clear Cell Adenocarcinoma	No	C34.3	8310/3	C34.3	YES												NO			Yes	M0	N0	T1	Stage IA		1595		TUMOR FREE					Complete Remission/Response				NO		Primary Tumor	01		1993	6th	NO			55	4		Lung		LIVING	2004	1964	TCGA-55-1595-01A-01D-0969-08		TCGA-55-1595-01	e7db32c0-8d04-4ab7-9c64-c4590d62539b	TCGA-55-1595-01A-01R-0946-07	TCGA-55-1595-01A-01D-0945-05	TCGA-55-1595-01	TCGA-55-1595-01A-01D-0944-01		TCGA-55-1595-01	TCGA-55-1595-01A-01D-0944-01	TCGA-55-1595-01	e7db32c0-8d04-4ab7-9c64-c4590d62539b			e7db32c0-8d04-4ab7-9c64-c4590d62539b	TCGA-55-1595-01		e7db32c0-8d04-4ab7-9c64-c4590d62539b	TCGA-55-1595-01A-01D-0969-08		TCGA-55-1595-01
TCGA-55-1595-11																												TCGA-55-1595-11		C1-LUAD-enriched							mutation cluster 12	TCGA-55-1595	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	L-Lower		TCGA-55-1595-F9159	TCGA-55-1595	TCGA-55-1595-11A						0	1479											2011-3-15	FEMALE	Lung Clear Cell Adenocarcinoma	No	C34.3	8310/3	C34.3	YES		0.4	NO						0.4			NO			Yes	M0	N0	T1	Stage IA		1595		TUMOR FREE					Complete Remission/Response				NO		Solid Tissue Normal	11	0.4	1993	6th	NO			55	4		Lung	A	LIVING	2004	1964						TCGA-55-1595-11A-01D-0945-05																
TCGA-55-1596-01	3.45	0.62	none		none	none	none	N	N	none	none	none	0.21	Magnoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			p.S216F, p.G242W	1	TCGA-55-1596-01	Squamous	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 5	TCGA-55-1596	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					55	R-Upper		TCGA-55-1596-F40544	TCGA-55-1596	TCGA-55-1596-01A			-20381			0	2065									Scheduled Follow-up Submission	Complete Remission/Response	2013-2-22	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO						0.9	NO		NO	50		No	M0	N1	T2	Stage IIB	TCGA-55-1596.200ccd8b-b3dc-4e3f-8c1e-ed9fa31ae9da.pdf	1596		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.4		6th	YES	NO	YES	55	2	Current smoker	Lung	A	LIVING	2004	1979	TCGA-55-1596-01	TCGA-55-1596-01A-01D-1040-01	TCGA-55-1596-01	8b2f9a82-4c0d-496b-a46c-15d20d069e11	TCGA-55-1596-01A-01R-0946-07	TCGA-55-1596-01A-01D-0945-05	TCGA-55-1596-01	TCGA-55-1596-01A-01D-0944-01		TCGA-55-1596-01	TCGA-55-1596-01A-01D-0944-01	TCGA-55-1596-01	8b2f9a82-4c0d-496b-a46c-15d20d069e11		TCGA-55-1596-01A-21-2190-20	8b2f9a82-4c0d-496b-a46c-15d20d069e11	TCGA-55-1596-01	443a13de-0a5e-4da3-8913-e8c6fbc51aa2	8b2f9a82-4c0d-496b-a46c-15d20d069e11	TCGA-55-1596-01A-01W-0928-08,TCGA-55-1596-01A-01D-1040-01		TCGA-55-1596-01
TCGA-55-1596-11	3.45	0.62	none		none	none	none	N	N	none	none	none	0.21	Magnoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			p.S216F, p.G242W	1	TCGA-55-1596-11		C1-LUAD-enriched							mutation cluster 5	TCGA-55-1596	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					55	R-Upper		TCGA-55-1596-F40544	TCGA-55-1596	TCGA-55-1596-11A			-20381			0	2065									Scheduled Follow-up Submission	Complete Remission/Response	2013-2-22	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.5	NO						1	NO		NO	50		No	M0	N1	T2	Stage IIB		1596		TUMOR FREE					Complete Remission/Response				NO	R0	Solid Tissue Normal	11	0.2		6th	YES	NO	YES	55	2	Current smoker	Lung	A	LIVING	2004	1979						TCGA-55-1596-11A-01D-0945-05																
TCGA-55-5899-01																												TCGA-55-5899-01	Squamous	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 6		mutation cluster 3	TCGA-55-5899	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					58	R-Upper		TCGA-55-5899-F43194	TCGA-55-5899	TCGA-55-5899-01A						0	930				0					Scheduled Follow-up Submission	Complete Remission/Response	2013-5-15	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO	100					1	NO		NO			No	M0	N1	T1a	[Discrepancy]	TCGA-55-5899.8fcdc599-a63e-4774-a58d-8b1b19d13980.pdf	5899	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.3		7th	YES	NO	YES	55	2		Lung	A	LIVING	2010	1985	TCGA-55-5899-01A-11D-1625-08			f51ff2e2-bc0a-4cdd-b008-933a8f7fa8fc				TCGA-55-5899-01A-11D-1624-01	TCGA-55-5899-01A-11D-1626-05	TCGA-55-5899-01	TCGA-55-5899-01A-11D-1624-01		f51ff2e2-bc0a-4cdd-b008-933a8f7fa8fc	TCGA-55-5899-01	TCGA-55-5899-01A-21-2190-20	f51ff2e2-bc0a-4cdd-b008-933a8f7fa8fc	TCGA-55-5899-01	53a204a4-caa0-4a30-b31d-5e408a4a4df1	f51ff2e2-bc0a-4cdd-b008-933a8f7fa8fc	TCGA-55-5899-01A-11D-1625-08	TCGA-55-5899-01	
TCGA-55-6543-01	2.29	0.65	none		none	none	none	N	Y	none	none	none	0.3	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc	Y		none	0	TCGA-55-6543-01	Kirc+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation c1uster 9	TCGA-55-6543	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					60	R-Upper		TCGA-55-6543-F46659	TCGA-55-6543	TCGA-55-6543-01A						0	435									Scheduled Follow-up Submission	Complete Remission/Response	2013-8-13	FEMALE	Lung Bronchioloalveolar Carcinoma Mucinous	No	C34.1	8253/3	C34.1	YES		0.4	NO					Peripheral Lung	1	NO		NO	60		No	MX	N0	T1b	Stage IA	TCGA-55-6543.b1b81957-278c-4c30-af49-821ab7e0429c.pdf	6543		TUMOR FREE					Complete Remission/Response				NO		Primary Tumor	01	0.4	2004	7th	NO	NO	YES	55	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2010		TCGA-55-6543-01A-11D-1753-08	TCGA-55-6543-01A-11D-1753-08		991a6ea6-32cf-479b-87a6-cc930baeddfa				TCGA-55-6543-01A-11D-1752-01	TCGA-55-6543-01A-11D-1756-05	TCGA-55-6543-01	TCGA-55-6543-01A-11D-1752-01		991a6ea6-32cf-479b-87a6-cc930baeddfa	TCGA-55-6543-01	TCGA-55-6543-01A-13-2191-20	991a6ea6-32cf-479b-87a6-cc930baeddfa	TCGA-55-6543-01	094e7995-ee01-40b2-aced-0db808ad9a56	991a6ea6-32cf-479b-87a6-cc930baeddfa	TCGA-55-6543-01A-11D-1753-08	TCGA-55-6543-01	
TCGA-55-6642-01	2.66	0.36	none		none	none	none	Y	Y	none	none	none	0.16	Magnoid	none	p.G12V	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-55-6642-01	Squamous	C1-LUAD-enriched	cluster 2	Cluster 5		LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 12	TCGA-55-6642	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					63	R-Lower		TCGA-55-6642-F45614	TCGA-55-6642	TCGA-55-6642-01A			-23107			0	2449									Scheduled Follow-up Submission	Complete Remission/Response	2013-7-17	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.9	NO						1	NO		NO			No	MX	N0	T2	Stage IB	TCGA-55-6642.5d390c9f-0f12-4ed2-a7ec-d9e7c8f05320.pdf	6642		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.4		6th	NO	NO	YES	55	2	Current smoker	Lung	A	LIVING	2006	1961	TCGA-55-6642-01A-11D-1855-08	TCGA-55-6642-01A-11D-1855-08		891aefa4-e7f1-482f-a2f5-b2d5c7d9e179				TCGA-55-6642-01A-11D-1854-01	TCGA-55-6642-01A-11D-1856-05	TCGA-55-6642-01	TCGA-55-6642-01A-11D-1854-01		891aefa4-e7f1-482f-a2f5-b2d5c7d9e179	TCGA-55-6642-01		891aefa4-e7f1-482f-a2f5-b2d5c7d9e179	TCGA-55-6642-01		891aefa4-e7f1-482f-a2f5-b2d5c7d9e179	TCGA-55-6642-01A-11D-1855-08	TCGA-55-6642-01	
TCGA-55-6712-01	3.31	0.29	none		none	none	none	N	N	none	none	none	0.12	Squamoid	none	none	none	p.E1314G	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-55-6712-01	High	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 5	TCGA-55-6712	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	L-Upper		TCGA-55-6712-F46639	TCGA-55-6712	TCGA-55-6712-01A					171	0	24									Scheduled Follow-up Submission	Progressive Disease	2013-8-13	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO						0.9	NO		NO			No	MX	N1	T2a	Stage IIA	TCGA-55-6712.156f5763-3bc6-47a8-b579-6d767fa3fd00.pdf	6712		WITH TUMOR					Progressive Disease				NO	R1	Primary Tumor	01	0.4	2003	7th	YES	NO	YES	55	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2010	1970	TCGA-55-6712-01A-11D-1855-08	TCGA-55-6712-01A-11D-1855-08		f5a01f2f-247a-42a0-a713-ba6f8bb8d03e				TCGA-55-6712-01A-11D-1854-01	TCGA-55-6712-01A-11D-1856-05	TCGA-55-6712-01	TCGA-55-6712-01A-11D-1854-01		f5a01f2f-247a-42a0-a713-ba6f8bb8d03e	TCGA-55-6712-01	TCGA-55-6712-01A-13-2191-20	f5a01f2f-247a-42a0-a713-ba6f8bb8d03e	TCGA-55-6712-01	55dfe466-08c8-4196-9e3e-61851f50100e	f5a01f2f-247a-42a0-a713-ba6f8bb8d03e	TCGA-55-6712-01A-11D-1855-08	TCGA-55-6712-01	
TCGA-55-6968-01																												TCGA-55-6968-01	Squamous			Cluster 5		LUAD-like c10	miRNA cluster 6			TCGA-55-6968	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	R-Lower		TCGA-55-6968-F56247	TCGA-55-6968	TCGA-55-6968-01A			-22344		1293	0										Scheduled Follow-up Submission	Stable Disease	2014-1-30	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.4	NO						0.7	NO		NO			No	M1	N0	T1	Stage IV	TCGA-55-6968.87f5cbe6-cce1-4a8c-8189-c6feabd3b4bb.pdf	6968		WITH TUMOR					Stable Disease				YES		Primary Tumor	01	0.2		6th	YES	NO	YES	55	2		Lung	A	DECEASED	2004					09fba9fa-29d2-41a1-b3aa-4bfd97be3fc8				TCGA-55-6968-01A-11D-1943-01	TCGA-55-6968-01A-11D-1947-05	TCGA-55-6968-01	TCGA-55-6968-01A-11D-1943-01		09fba9fa-29d2-41a1-b3aa-4bfd97be3fc8	TCGA-55-6968-01		09fba9fa-29d2-41a1-b3aa-4bfd97be3fc8	TCGA-55-6968-01		09fba9fa-29d2-41a1-b3aa-4bfd97be3fc8	TCGA-55-6968-01A-11D-1945-08	TCGA-55-6968-01	
TCGA-55-6968-11																												TCGA-55-6968-11										TCGA-55-6968	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	R-Lower		TCGA-55-6968-F56247	TCGA-55-6968	TCGA-55-6968-11A			-22344		1293	0										Scheduled Follow-up Submission	Stable Disease	2014-1-30	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.9	NO						0.9	NO		NO			No	M1	N0	T1	Stage IV		6968		WITH TUMOR					Stable Disease				YES		Solid Tissue Normal	11	0.3		6th	YES	NO	YES	55	2		Lung	A	DECEASED	2004					372ec0c3-ab4c-421b-acc4-6fecf473d2fb									372ec0c3-ab4c-421b-acc4-6fecf473d2fb			372ec0c3-ab4c-421b-acc4-6fecf473d2fb			372ec0c3-ab4c-421b-acc4-6fecf473d2fb			
TCGA-55-6969-01																												TCGA-55-6969-01	High	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 7			TCGA-55-6969	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					52	L-Upper			TCGA-55-6969	TCGA-55-6969-01A			-19270			0	1239					NO			NO			2011-7-25	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.5	NO		NO				0.9						No	M0	N0	T2	Stage IB	TCGA-55-6969.96b7d4c4-6513-4249-a6d5-b5cf0bf49ab4.pdf	6969		TUMOR FREE											Primary Tumor	01	0.3	2004	6th		NO	YES	55	4		Lung	A	LIVING	2004					a4c1e9e8-a335-47b0-afc6-c2b490da4e58				TCGA-55-6969-01A-11D-1943-01	TCGA-55-6969-01A-11D-1947-05	TCGA-55-6969-01	TCGA-55-6969-01A-11D-1943-01		a4c1e9e8-a335-47b0-afc6-c2b490da4e58	TCGA-55-6969-01	TCGA-55-6969-01A-13-2191-20	a4c1e9e8-a335-47b0-afc6-c2b490da4e58	TCGA-55-6969-01	4d784c19-acc2-42e0-a078-396eeb07c20c	a4c1e9e8-a335-47b0-afc6-c2b490da4e58	TCGA-55-6969-01A-11D-1945-08	TCGA-55-6969-01	
TCGA-55-6969-11																												TCGA-55-6969-11		C1-LUAD-enriched								TCGA-55-6969	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					52	L-Upper			TCGA-55-6969	TCGA-55-6969-11A			-19270			0	1239					NO			NO			2011-7-25	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO		NO				0.9						No	M0	N0	T2	Stage IB		6969		TUMOR FREE											Solid Tissue Normal	11	0.5	2004	6th		NO	YES	55	4		Lung	A	LIVING	2004					7921e917-f743-4813-8fcf-2145dce93c37									7921e917-f743-4813-8fcf-2145dce93c37			7921e917-f743-4813-8fcf-2145dce93c37			7921e917-f743-4813-8fcf-2145dce93c37			
TCGA-55-6970-01	1.39	0.56	none		none	none	none	Y	Y	none	none	none	0.34	Magnoid	none	p.G12V	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			p.T250fs	0	TCGA-55-6970-01	High	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4		TCGA-55-6970	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		67	R-Upper		TCGA-55-6970-F57904	TCGA-55-6970	TCGA-55-6970-01A			-24773		464	0		457				NO			NO	Scheduled Follow-up Submission	Progressive Disease	2014-3-28	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES		0.8	NO		NO				1.1	NO	Locoregional Recurrence	YES			No	MX	N2	T2	Stage IIIA	TCGA-55-6970.1662fe4b-da42-444a-b7fa-4990d9e8aa9d.pdf	6970		WITH TUMOR					Stable Disease	Convincing Imaging			YES	R1	Primary Tumor	01	0.4		6th	YES	NO	YES	55	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2004			TCGA-55-6970-01A-11D-1945-08		4f5215c3-7763-49f8-afe7-b3ce3474afe2				TCGA-55-6970-01A-11D-1943-01	TCGA-55-6970-01A-11D-1947-05	TCGA-55-6970-01	TCGA-55-6970-01A-11D-1943-01		4f5215c3-7763-49f8-afe7-b3ce3474afe2	TCGA-55-6970-01	TCGA-55-6970-01A-13-2191-20	4f5215c3-7763-49f8-afe7-b3ce3474afe2	TCGA-55-6970-01	978d1436-06b6-4591-8538-a8504b820bcd	4f5215c3-7763-49f8-afe7-b3ce3474afe2	TCGA-55-6970-01A-11D-1945-08	TCGA-55-6970-01	
TCGA-55-6970-11	1.39	0.56	none		none	none	none	Y	Y	none	none	none	0.34	Magnoid	none	p.G12V	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			p.T250fs	0	TCGA-55-6970-11		C1-LUAD-enriched								TCGA-55-6970	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		67	R-Upper		TCGA-55-6970-F57904	TCGA-55-6970	TCGA-55-6970-11A			-24773		464	0		457				NO			NO	Scheduled Follow-up Submission	Progressive Disease	2014-3-28	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES		0.4	NO		NO				0.8	NO	Locoregional Recurrence	YES			No	MX	N2	T2	Stage IIIA		6970		WITH TUMOR					Stable Disease	Convincing Imaging			YES	R1	Solid Tissue Normal	11	0.4		6th	YES	NO	YES	55	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2004					fc4df3f7-2c4b-4a4d-9e5d-faac9e84fde8									fc4df3f7-2c4b-4a4d-9e5d-faac9e84fde8			fc4df3f7-2c4b-4a4d-9e5d-faac9e84fde8			fc4df3f7-2c4b-4a4d-9e5d-faac9e84fde8			
TCGA-55-6971-01	3.34	0.22	none		none	none	none	N	N	none	none	none	0.1	Magnoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			p.G251F	0	TCGA-55-6971-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4		TCGA-55-6971	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					59	L-Lower		TCGA-55-6971-F56190	TCGA-55-6971	TCGA-55-6971-01A			-21734			0	1400					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-1-29	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.5	NO		NO				1.1	NO		NO	60		No	MX	N0	T2	Stage IB	TCGA-55-6971.c270e56a-dfc6-41a5-9cfc-3c302c4ccc13.pdf	6971		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.2	2010	7th	NO	NO	YES	55	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2010	1970		TCGA-55-6971-01A-11D-1945-08		50b1d328-57c8-44ab-9c1a-a2bdbc40c6a4				TCGA-55-6971-01A-11D-1943-01	TCGA-55-6971-01A-11D-1947-05	TCGA-55-6971-01	TCGA-55-6971-01A-11D-1943-01		50b1d328-57c8-44ab-9c1a-a2bdbc40c6a4	TCGA-55-6971-01	TCGA-55-6971-01A-13-2191-20	50b1d328-57c8-44ab-9c1a-a2bdbc40c6a4	TCGA-55-6971-01	324f133e-3269-4bea-939d-2c5ebac520cf	50b1d328-57c8-44ab-9c1a-a2bdbc40c6a4	TCGA-55-6971-01A-11D-1945-08	TCGA-55-6971-01	
TCGA-55-6971-11	3.34	0.22	none		none	none	none	N	N	none	none	none	0.1	Magnoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			p.G251F	0	TCGA-55-6971-11		C1-LUAD-enriched								TCGA-55-6971	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					59	L-Lower		TCGA-55-6971-F56190	TCGA-55-6971	TCGA-55-6971-11A			-21734			0	1400					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-1-29	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.5	NO		NO				1	NO		NO	60		No	MX	N0	T2	Stage IB		6971		TUMOR FREE					Complete Remission/Response				NO	R0	Solid Tissue Normal	11	0.4	2010	7th	NO	NO	YES	55	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2010	1970				0b78c265-393c-4e3a-a53e-3ba76556c506									0b78c265-393c-4e3a-a53e-3ba76556c506			0b78c265-393c-4e3a-a53e-3ba76556c506			0b78c265-393c-4e3a-a53e-3ba76556c506			
TCGA-55-6972-01			none		none	none	none	N	N	none	none	none		Magnoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-55-6972-01	High		cluster 3	Low purity c2		LUAD-like c10	miRNA cluster 7	cluster 4		TCGA-55-6972	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	R-Upper		TCGA-55-6972-F56187	TCGA-55-6972	TCGA-55-6972-01A			-26625		1632	0	1475					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-1-29	MALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES		0.4	NO		NO				0.6	NO		NO			No	M0	N0	T2	Stage IB	TCGA-55-6972.7d2c5e22-45d5-404c-97c5-5523ea656d75.pdf	6972		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.2		6th	NO	NO	YES	55	2	Current smoker	Lung	A	DECEASED	2005			TCGA-55-6972-01A-11D-1945-08		13e20aec-d506-4fa0-a6e1-121e76dcedc4				TCGA-55-6972-01A-11D-1943-01	TCGA-55-6972-01A-11D-1947-05	TCGA-55-6972-01	TCGA-55-6972-01A-11D-1943-01		13e20aec-d506-4fa0-a6e1-121e76dcedc4	TCGA-55-6972-01		13e20aec-d506-4fa0-a6e1-121e76dcedc4	TCGA-55-6972-01		13e20aec-d506-4fa0-a6e1-121e76dcedc4	TCGA-55-6972-01A-11D-1945-08	TCGA-55-6972-01	
TCGA-55-6972-11			none		none	none	none	N	N	none	none	none		Magnoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-55-6972-11										TCGA-55-6972	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	R-Upper		TCGA-55-6972-F56187	TCGA-55-6972	TCGA-55-6972-11A			-26625		1632	0	1475					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-1-29	MALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES		0.7	NO		NO				0.7	NO		NO			No	M0	N0	T2	Stage IB		6972		TUMOR FREE					Complete Remission/Response				NO	R0	Solid Tissue Normal	11	0.4		6th	NO	NO	YES	55	2	Current smoker	Lung	A	DECEASED	2005					e448d6d2-be85-4164-be3f-fd7e5a0c53ec									e448d6d2-be85-4164-be3f-fd7e5a0c53ec			e448d6d2-be85-4164-be3f-fd7e5a0c53ec			e448d6d2-be85-4164-be3f-fd7e5a0c53ec			
TCGA-55-6975-01																												TCGA-55-6975-01	Squamous			Cluster 5		LUAD-like c10				TCGA-55-6975	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	L-Lower		TCGA-55-6975-F45635	TCGA-55-6975	TCGA-55-6975-01A					118	0						NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-7-17	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.2	NO		NO				0.2	NO		NO			No	M0	N1	T2	Stage IIB	TCGA-55-6975.7c03cf6a-c871-4c53-af4d-cb931f6d8b72.pdf	6975		WITH TUMOR					Progressive Disease				NO		Primary Tumor	01	0.1	2004	6th	NO	NO	YES	55	4		Lung	A	DECEASED	2004					7ee4963f-9682-46b1-8946-4c726fd81c39				TCGA-55-6975-01A-11D-1943-01	TCGA-55-6975-01A-11D-1947-05	TCGA-55-6975-01	TCGA-55-6975-01A-11D-1943-01		7ee4963f-9682-46b1-8946-4c726fd81c39			7ee4963f-9682-46b1-8946-4c726fd81c39	TCGA-55-6975-01		7ee4963f-9682-46b1-8946-4c726fd81c39	TCGA-55-6975-01A-11D-1945-08		
TCGA-55-6975-11																												TCGA-55-6975-11										TCGA-55-6975	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	L-Lower		TCGA-55-6975-F45635	TCGA-55-6975	TCGA-55-6975-11A					118	0						NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-7-17	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.9	NO		NO				0.9	NO		NO			No	M0	N1	T2	Stage IIB		6975		WITH TUMOR					Progressive Disease				NO		Solid Tissue Normal	11	0.8	2004	6th	NO	NO	YES	55	4		Lung	A	DECEASED	2004					9ae0702d-672e-44c0-b548-25e11c198887									9ae0702d-672e-44c0-b548-25e11c198887			9ae0702d-672e-44c0-b548-25e11c198887			9ae0702d-672e-44c0-b548-25e11c198887			
TCGA-55-6978-01			none		none	none	none	N	N	none	none	none		Squamoid	none	none	none	none	none	none	none	NSCLC, favor Adeno	NSCLC, favor Adeno			none	0	TCGA-55-6978-01	Squamous	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-55-6978	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	81	R-Middle		TCGA-55-6978-F45607	TCGA-55-6978	TCGA-55-6978-01A					176	0		42				NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-7-17	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES		0.6	NO		NO				0.7	NO		YES			Yes	MX	N0	T2b	Stage IIA	TCGA-55-6978.3e3c1e82-ee09-4eeb-873a-9b6580274f97.pdf	6978		WITH TUMOR					Progressive Disease				NO		Primary Tumor	01	0.2		7th	NO	NO	YES	55	1	Lifelong Non-smoker	Lung	A	DECEASED	2010			TCGA-55-6978-01A-11D-1945-08		7a25f591-c475-4bc4-a0ad-85f41e072608				TCGA-55-6978-01A-11D-1943-01	TCGA-55-6978-01A-11D-1947-05	TCGA-55-6978-01	TCGA-55-6978-01A-11D-1943-01		7a25f591-c475-4bc4-a0ad-85f41e072608	TCGA-55-6978-01	TCGA-55-6978-01A-13-2191-20	7a25f591-c475-4bc4-a0ad-85f41e072608	TCGA-55-6978-01	d49d649a-ddee-4f58-b56f-2e0fe6bf220e	7a25f591-c475-4bc4-a0ad-85f41e072608	TCGA-55-6978-01A-11D-1945-08	TCGA-55-6978-01	
TCGA-55-6978-11			none		none	none	none	N	N	none	none	none		Squamoid	none	none	none	none	none	none	none	NSCLC, favor Adeno	NSCLC, favor Adeno			none	0	TCGA-55-6978-11		C1-LUAD-enriched								TCGA-55-6978	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	81	R-Middle		TCGA-55-6978-F45607	TCGA-55-6978	TCGA-55-6978-11A					176	0		42				NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-7-17	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES		0.7	NO		NO				1.1	NO		YES			Yes	MX	N0	T2b	Stage IIA		6978		WITH TUMOR					Progressive Disease				NO		Solid Tissue Normal	11	0.5		7th	NO	NO	YES	55	1	Lifelong Non-smoker	Lung	A	DECEASED	2010					b3b1d4f3-1511-40a5-bf62-0ddf0893eac5									b3b1d4f3-1511-40a5-bf62-0ddf0893eac5			b3b1d4f3-1511-40a5-bf62-0ddf0893eac5			b3b1d4f3-1511-40a5-bf62-0ddf0893eac5			
TCGA-55-6979-01	3.35	0.18	none		p.P367R	none	none	N	N	none	none	none	0.08	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-55-6979-01	High	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 7	cluster 4		TCGA-55-6979	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES		NO	59	L-Upper		TCGA-55-6979-F37057	TCGA-55-6979	TCGA-55-6979-01A			-21780		237	0		195				NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-2-22	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO		NO				1	NO	Distant Metastasis	YES			Yes	M0	N1	T2	Stage IIB	TCGA-55-6979.c7896f40-c1a5-4e4c-bfea-7e80c94c66ad.pdf	6979		WITH TUMOR					Progressive Disease	Convincing Imaging			NO		Primary Tumor	01	0.4		6th	YES	NO	YES	55	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2006			TCGA-55-6979-01A-11D-1945-08		a7a6d133-a7d0-44ea-bac5-3a8b7ddd9cd8				TCGA-55-6979-01A-11D-1943-01	TCGA-55-6979-01A-11D-1947-05	TCGA-55-6979-01	TCGA-55-6979-01A-11D-1943-01		a7a6d133-a7d0-44ea-bac5-3a8b7ddd9cd8	TCGA-55-6979-01	TCGA-55-6979-01A-13-2191-20	a7a6d133-a7d0-44ea-bac5-3a8b7ddd9cd8	TCGA-55-6979-01	4283cc72-754c-4dec-b8c3-93b5cbaf6a95	a7a6d133-a7d0-44ea-bac5-3a8b7ddd9cd8	TCGA-55-6979-01A-11D-1945-08	TCGA-55-6979-01	
TCGA-55-6979-11	3.35	0.18	none		p.P367R	none	none	N	N	none	none	none	0.08	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-55-6979-11		C1-LUAD-enriched								TCGA-55-6979	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES		NO	59	L-Upper		TCGA-55-6979-F37057	TCGA-55-6979	TCGA-55-6979-11A			-21780		237	0		195				NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-2-22	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.5	NO		NO				1	NO	Distant Metastasis	YES			Yes	M0	N1	T2	Stage IIB		6979		WITH TUMOR					Progressive Disease	Convincing Imaging			NO		Solid Tissue Normal	11	0.1		6th	YES	NO	YES	55	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2006					3d563365-c563-4fba-b67b-8aad1af89eab									3d563365-c563-4fba-b67b-8aad1af89eab			3d563365-c563-4fba-b67b-8aad1af89eab			3d563365-c563-4fba-b67b-8aad1af89eab			
TCGA-55-6980-01	2.15	0.3	none		none	none	none	Y	Y	p.709_710ET>D	none	none	0.15	Bronchioid	none	none	none	none	none	none	none	Other see comment	Acinar predominant Adc			none	0	TCGA-55-6980-01	High		cluster 3	Cluster 5		LUAD-like c10	miRNA cluster 4	cluster 5		TCGA-55-6980	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					56	R-Lower		TCGA-55-6980-F46642	TCGA-55-6980	TCGA-55-6980-01A						0	2109					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-13	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES		0.3	NO		NO				0.7	NO		NO			No	M0	N0	T1	Stage IA	TCGA-55-6980.e73aad2d-83d3-46b2-b2e9-cc93c5fbd670.pdf	6980		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.1		6th	NO	NO	YES	55	1	Lifelong Non-smoker	Lung	A	LIVING	2006			TCGA-55-6980-01A-11D-1945-08		5eae1d0f-5ca1-499b-963f-2fce4807ccc6				TCGA-55-6980-01A-11D-1943-01	TCGA-55-6980-01A-11D-1947-05	TCGA-55-6980-01	TCGA-55-6980-01A-11D-1943-01		5eae1d0f-5ca1-499b-963f-2fce4807ccc6	TCGA-55-6980-01		5eae1d0f-5ca1-499b-963f-2fce4807ccc6	TCGA-55-6980-01		5eae1d0f-5ca1-499b-963f-2fce4807ccc6	TCGA-55-6980-01A-11D-1945-08	TCGA-55-6980-01	
TCGA-55-6980-11	2.15	0.3	none		none	none	none	Y	Y	p.709_710ET>D	none	none	0.15	Bronchioid	none	none	none	none	none	none	none	Other see comment	Acinar predominant Adc			none	0	TCGA-55-6980-11										TCGA-55-6980	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					56	R-Lower		TCGA-55-6980-F46642	TCGA-55-6980	TCGA-55-6980-11A						0	2109					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-13	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES		0.9	NO		NO				1	NO		NO			No	M0	N0	T1	Stage IA		6980		TUMOR FREE					Complete Remission/Response				NO	R0	Solid Tissue Normal	11	0.2		6th	NO	NO	YES	55	1	Lifelong Non-smoker	Lung	A	LIVING	2006					cdc81d17-1d85-42e5-a3ec-f458e6ab83f6									cdc81d17-1d85-42e5-a3ec-f458e6ab83f6			cdc81d17-1d85-42e5-a3ec-f458e6ab83f6			cdc81d17-1d85-42e5-a3ec-f458e6ab83f6			
TCGA-55-6981-01	3.42	0.27	none		none	none	none	Y	Y	p.LREAT747del	none	none	0.11	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-55-6981-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 5		TCGA-55-6981	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					53	L-Upper		TCGA-55-6981-F56243	TCGA-55-6981	TCGA-55-6981-01A			-19497		1379	0						NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-1-30	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO		NO				0.8	NO		NO			No	M0	N2	T1	Stage IIIA	TCGA-55-6981.84738cad-3b17-456c-a9a0-21f6e044a688.pdf	6981		TUMOR FREE					Complete Remission/Response				YES	R0	Primary Tumor	01	0.4		6th	YES	NO	YES	55	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2005			TCGA-55-6981-01A-11D-1945-08		af2f26d9-617a-42f3-a083-352d5e576460				TCGA-55-6981-01A-11D-1943-01	TCGA-55-6981-01A-11D-1947-05	TCGA-55-6981-01	TCGA-55-6981-01A-11D-1943-01		af2f26d9-617a-42f3-a083-352d5e576460	TCGA-55-6981-01	TCGA-55-6981-01A-13-2191-20	af2f26d9-617a-42f3-a083-352d5e576460	TCGA-55-6981-01	1ee6ed8b-3ce5-4565-9948-33bdc5e40c92	af2f26d9-617a-42f3-a083-352d5e576460	TCGA-55-6981-01A-11D-1945-08	TCGA-55-6981-01	
TCGA-55-6981-11	3.42	0.27	none		none	none	none	Y	Y	p.LREAT747del	none	none	0.11	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-55-6981-11		C1-LUAD-enriched								TCGA-55-6981	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					53	L-Upper		TCGA-55-6981-F56243	TCGA-55-6981	TCGA-55-6981-11A			-19497		1379	0						NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-1-30	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO		NO				1.1	NO		NO			No	M0	N2	T1	Stage IIIA		6981		TUMOR FREE					Complete Remission/Response				YES	R0	Solid Tissue Normal	11	0.4		6th	YES	NO	YES	55	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2005					988e9e29-398e-45af-a4da-b6e7d119b776									988e9e29-398e-45af-a4da-b6e7d119b776			988e9e29-398e-45af-a4da-b6e7d119b776			988e9e29-398e-45af-a4da-b6e7d119b776			
TCGA-55-6982-01	2.7	0.25	none		none	none	none	N	N	none	none	none	0.11	Squamoid	none	none	none	p.D1010_splice	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-55-6982-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4		TCGA-55-6982	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	YES	79	R-Lower		TCGA-55-6982-F46626	TCGA-55-6982	TCGA-55-6982-01A		183			995	0		183				NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-8-13	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.3	NO		NO				0.5	NO	Distant Metastasis	YES			No	M0	N1	T2	Stage IIB	TCGA-55-6982.54e65072-9bea-41d0-b976-5f5723379c51.pdf	6982		WITH TUMOR					Progressive Disease	Convincing Imaging			NO		Primary Tumor	01	0.1		6th	NO	NO	YES	55	1	Lifelong Non-smoker	Lung	A	DECEASED	2004			TCGA-55-6982-01A-11D-1945-08		681fbd5b-5bff-434d-8ff4-d995fc517e93				TCGA-55-6982-01A-11D-1943-01	TCGA-55-6982-01A-11D-1947-05	TCGA-55-6982-01	TCGA-55-6982-01A-11D-1943-01		681fbd5b-5bff-434d-8ff4-d995fc517e93	TCGA-55-6982-01	TCGA-55-6982-01A-13-2191-20	681fbd5b-5bff-434d-8ff4-d995fc517e93	TCGA-55-6982-01	1615fbef-fcaa-4509-a01f-0f00f69c6106	681fbd5b-5bff-434d-8ff4-d995fc517e93	TCGA-55-6982-01A-11D-1945-08	TCGA-55-6982-01	
TCGA-55-6982-11	2.7	0.25	none		none	none	none	N	N	none	none	none	0.11	Squamoid	none	none	none	p.D1010_splice	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-55-6982-11		C1-LUAD-enriched								TCGA-55-6982	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	YES	79	R-Lower		TCGA-55-6982-F46626	TCGA-55-6982	TCGA-55-6982-11A		183			995	0		183				NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-8-13	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.7	NO		NO				0.8	NO	Distant Metastasis	YES			No	M0	N1	T2	Stage IIB		6982		WITH TUMOR					Progressive Disease	Convincing Imaging			NO		Solid Tissue Normal	11	0.5		6th	NO	NO	YES	55	1	Lifelong Non-smoker	Lung	A	DECEASED	2004					2b7e9552-e34f-4c68-96af-1c01a605df60									2b7e9552-e34f-4c68-96af-1c01a605df60			2b7e9552-e34f-4c68-96af-1c01a605df60			2b7e9552-e34f-4c68-96af-1c01a605df60			
TCGA-55-6983-01			none		none	none	none	Y	Y	none	none	none		Magnoid	none	p.G12C	none	none	none	none	none	Colloid adenoca	Colloid adenoca			p.R75fs	0	TCGA-55-6983-01	Iq		cluster 2	Cluster 6		LUAD-like c10	miRNA cluster 6	cluster 1		TCGA-55-6983	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					81	L-Lower		TCGA-55-6983-F47805	TCGA-55-6983	TCGA-55-6983-01A						0	2823					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-28	MALE	Mucinous (Colloid) Carcinoma	No	C34.30	8480/3	C34.3	YES		0.3	NO		NO				0.5	NO		NO	60		No	M0	N1	T2	Stage IIB	TCGA-55-6983.5428a18c-8db6-4dbc-bec0-b55658f3302b.pdf	6983		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.2		6th	YES	NO	YES	55	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2005			TCGA-55-6983-01A-11D-1945-08		3f4a27fd-378a-4d74-91c1-eda773c26b79				TCGA-55-6983-01A-11D-1943-01	TCGA-55-6983-01A-11D-1947-05	TCGA-55-6983-01	TCGA-55-6983-01A-11D-1943-01		3f4a27fd-378a-4d74-91c1-eda773c26b79	TCGA-55-6983-01		3f4a27fd-378a-4d74-91c1-eda773c26b79	TCGA-55-6983-01		3f4a27fd-378a-4d74-91c1-eda773c26b79	TCGA-55-6983-01A-11D-1945-08	TCGA-55-6983-01	
TCGA-55-6983-11			none		none	none	none	Y	Y	none	none	none		Magnoid	none	p.G12C	none	none	none	none	none	Colloid adenoca	Colloid adenoca			p.R75fs	0	TCGA-55-6983-11										TCGA-55-6983	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					81	L-Lower		TCGA-55-6983-F47805	TCGA-55-6983	TCGA-55-6983-11A						0	2823					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-28	MALE	Mucinous (Colloid) Carcinoma	No	C34.30	8480/3	C34.3	YES		0.9	NO		NO				1.1	NO		NO	60		No	M0	N1	T2	Stage IIB		6983		TUMOR FREE					Complete Remission/Response				NO	R0	Solid Tissue Normal	11	0.4		6th	YES	NO	YES	55	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2005					97a84c2b-7832-479c-8d01-a9ff610e7bf4									97a84c2b-7832-479c-8d01-a9ff610e7bf4			97a84c2b-7832-479c-8d01-a9ff610e7bf4			97a84c2b-7832-479c-8d01-a9ff610e7bf4			
TCGA-55-6984-01																												TCGA-55-6984-01	BRCA-LUAD+			BRCA non-CIMP c9		LUAD-like c10	miRNA cluster 4			TCGA-55-6984	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	NO	71	L-Lower		TCGA-55-6984-F45632	TCGA-55-6984						760	0		724				NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-7-17	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES					NO					NO		YES			No	M0	N1	T2	Stage IIB		6984		WITH TUMOR					Complete Remission/Response				NO		Primary Tumor	01			6th	YES	NO	YES	55			Lung		DECEASED	2006					bf920e10-514e-4623-b92e-c83a3e32485f				TCGA-55-6984-01A-11D-1943-01	TCGA-55-6984-01A-11D-1947-05	TCGA-55-6984-01	TCGA-55-6984-01A-11D-1943-01		bf920e10-514e-4623-b92e-c83a3e32485f	TCGA-55-6984-01		bf920e10-514e-4623-b92e-c83a3e32485f	TCGA-55-6984-01		bf920e10-514e-4623-b92e-c83a3e32485f	TCGA-55-6984-01A-11D-1945-08	TCGA-55-6984-01	
TCGA-55-6984-11																												TCGA-55-6984-11										TCGA-55-6984	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	NO	71	L-Lower		TCGA-55-6984-F45632	TCGA-55-6984	TCGA-55-6984-11A					760	0		724				NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-7-17	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.6	NO		NO				1	NO		YES			No	M0	N1	T2	Stage IIB		6984		WITH TUMOR					Complete Remission/Response				NO		Solid Tissue Normal	11	0.4		6th	YES	NO	YES	55			Lung	A	DECEASED	2006					d777ced1-c519-4281-b0c0-9e9188303e87									d777ced1-c519-4281-b0c0-9e9188303e87			d777ced1-c519-4281-b0c0-9e9188303e87			d777ced1-c519-4281-b0c0-9e9188303e87			
TCGA-55-6985-01			none		none	none	none	N	N	none	none	none		Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-55-6985-01	Squamous		cluster 2	Cluster 6		LUAD-like c10	miRNA cluster 4	cluster 5		TCGA-55-6985	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					58	L-Upper		TCGA-55-6985-F37056	TCGA-55-6985				-21381			0	1233					NO			NO	Scheduled Follow-up Submission		2013-2-22	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO					YES		NO	50		No	MX	N0	T2	Stage IB		6985		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01		2004	6th	NO	NO	YES	55	4	Current reformed smoker for < or = 15 years	Lung		LIVING	2004			TCGA-55-6985-01A-11D-1945-08		fc852193-d692-4a36-83bd-30f49df5f973				TCGA-55-6985-01A-11D-1943-01	TCGA-55-6985-01A-11D-1947-05	TCGA-55-6985-01	TCGA-55-6985-01A-11D-1943-01		fc852193-d692-4a36-83bd-30f49df5f973	TCGA-55-6985-01		fc852193-d692-4a36-83bd-30f49df5f973	TCGA-55-6985-01		fc852193-d692-4a36-83bd-30f49df5f973	TCGA-55-6985-01A-11D-1945-08	TCGA-55-6985-01	
TCGA-55-6985-11			none		none	none	none	N	N	none	none	none		Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-55-6985-11										TCGA-55-6985	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					58	L-Upper		TCGA-55-6985-F37056	TCGA-55-6985	TCGA-55-6985-11A			-21381			0	1233					NO			NO	Scheduled Follow-up Submission		2013-2-22	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.9	NO		NO				1.2	YES		NO	50		No	MX	N0	T2	Stage IB		6985		TUMOR FREE					Complete Remission/Response				NO	R0	Solid Tissue Normal	11	0.4	2004	6th	NO	NO	YES	55	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2004					6cc31d25-1d4e-4f17-9321-2474befc3232									6cc31d25-1d4e-4f17-9321-2474befc3232			6cc31d25-1d4e-4f17-9321-2474befc3232			6cc31d25-1d4e-4f17-9321-2474befc3232			
TCGA-55-6986-01	1.96	0.39	none		none	none	none	N	Y	none	none	none	0.2	Bronchioid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc		Y	none	0	TCGA-55-6986-01	Kirc+		cluster 2	Cluster 6		LUAD-like c10	miRNA c1uster 9	cluster 4		TCGA-55-6986	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	R-Lower		TCGA-55-6986-F45606	TCGA-55-6986							0	3261					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-7-17	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES					NO					NO		NO			No	M0	N0	T2	Stage IB		6986		TUMOR FREE					Complete Remission/Response				NO		Primary Tumor	01			6th	NO	NO	YES	55	1	Lifelong Non-smoker	Lung		LIVING	2004			TCGA-55-6986-01A-11D-1945-08		c2711074-5019-4c8f-a5d7-7bf4654f5647				TCGA-55-6986-01A-11D-1943-01	TCGA-55-6986-01A-11D-1947-05	TCGA-55-6986-01	TCGA-55-6986-01A-11D-1943-01		c2711074-5019-4c8f-a5d7-7bf4654f5647	TCGA-55-6986-01		c2711074-5019-4c8f-a5d7-7bf4654f5647	TCGA-55-6986-01		c2711074-5019-4c8f-a5d7-7bf4654f5647	TCGA-55-6986-01A-11D-1945-08	TCGA-55-6986-01	
TCGA-55-6986-11	1.96	0.39	none		none	none	none	N	Y	none	none	none	0.2	Bronchioid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc		Y	none	0	TCGA-55-6986-11										TCGA-55-6986	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	R-Lower		TCGA-55-6986-F45606	TCGA-55-6986	TCGA-55-6986-11A						0	3261					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-7-17	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES		0.6	NO		NO				0.7	NO		NO			No	M0	N0	T2	Stage IB		6986		TUMOR FREE					Complete Remission/Response				NO		Solid Tissue Normal	11	0.5		6th	NO	NO	YES	55	1	Lifelong Non-smoker	Lung	A	LIVING	2004					e1adae95-dfa9-4279-8fc1-2f899f432360									e1adae95-dfa9-4279-8fc1-2f899f432360			e1adae95-dfa9-4279-8fc1-2f899f432360			e1adae95-dfa9-4279-8fc1-2f899f432360			
TCGA-55-6987-01																												TCGA-55-6987-01	High			Cluster 5		LUAD-like c10	miRNA cluster 7			TCGA-55-6987	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					77	L-Lower		TCGA-55-6987-F47803	TCGA-55-6987	TCGA-55-6987-01A			-28382			0	2137					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-28	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.1	NO		NO				0.2	NO		NO			No	M0	N0	T1	Stage IA	TCGA-55-6987.345eb11f-9520-4463-8a84-07aeb26ce559.pdf	6987		TUMOR FREE					Complete Remission/Response				NO		Primary Tumor	01	0.1	2006	6th	NO	NO	YES	55	4		Lung	A	LIVING	2006					779acc52-4279-4249-b993-88ed032ccefa				TCGA-55-6987-01A-11D-1943-01	TCGA-55-6987-01A-11D-1947-05	TCGA-55-6987-01	TCGA-55-6987-01A-11D-1943-01		779acc52-4279-4249-b993-88ed032ccefa	TCGA-55-6987-01		779acc52-4279-4249-b993-88ed032ccefa	TCGA-55-6987-01		779acc52-4279-4249-b993-88ed032ccefa	TCGA-55-6987-01A-11D-1945-08	TCGA-55-6987-01	
TCGA-55-7227-01																												TCGA-55-7227-01	Kirc+			Cluster 6		LUAD-like c10	miRNA cluster 4			TCGA-55-7227	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO		77	R-Lower		TCGA-55-7227-F65704	TCGA-55-7227	TCGA-55-7227-01A			-28458		952	0	53	255								Scheduled Follow-up Submission	Progressive Disease	2014-9-26	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.3	NO						0.5	NO	Locoregional Recurrence	YES			No	MX	N1	T3	Stage IIIA	TCGA-55-7227.7910979d-a635-4ef5-ab00-84df0455df66.pdf	7227		WITH TUMOR					Complete Remission/Response	Convincing Imaging			NO	R0	Primary Tumor	01	0.1	1993	7th	NO	YES	NO	55	3		Lung	A	DECEASED	2011	1953				987c7eea-648f-4feb-8239-0b9151a74331					TCGA-55-7227-01A-11D-2037-05				987c7eea-648f-4feb-8239-0b9151a74331	TCGA-55-7227-01		987c7eea-648f-4feb-8239-0b9151a74331	TCGA-55-7227-01		987c7eea-648f-4feb-8239-0b9151a74331	TCGA-55-7227-01A-11D-2036-08	TCGA-55-7227-01	
TCGA-55-7281-01	1.85	0.59	none		none	none	none	Y	Y	none	none	none	0.31	Bronchioid	none	p.G12C	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-55-7281-01	BRCA-LUAD+		cluster 2	Cluster 6		LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-55-7281	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	70	R-Middle		TCGA-55-7281-F47807	TCGA-55-7281				-25870			0	872	339								Scheduled Follow-up Submission	Partial Remission/Response	2013-8-28	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES					NO					NO	Distant Metastasis	YES	20		No	M0	N0	T1b	Stage IA		7281		WITH TUMOR					Complete Remission/Response	Convincing Imaging			NO	R0	Primary Tumor	01			7th	NO	YES	NO	55	4	Current reformed smoker for < or = 15 years	Lung		LIVING	2011			TCGA-55-7281-01A-11D-2036-08		b4a82c9e-4b14-42ed-8d33-6494ec475827				TCGA-55-7281-01A-11D-2035-01	TCGA-55-7281-01A-11D-2037-05	TCGA-55-7281-01	TCGA-55-7281-01A-11D-2035-01		b4a82c9e-4b14-42ed-8d33-6494ec475827	TCGA-55-7281-01		b4a82c9e-4b14-42ed-8d33-6494ec475827	TCGA-55-7281-01		b4a82c9e-4b14-42ed-8d33-6494ec475827	TCGA-55-7281-01A-11D-2036-08	TCGA-55-7281-01	
TCGA-55-7283-01			p.D323Y		none	none	none	Y	Y	none	none	none		Bronchioid	none	p.G12S	none	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-55-7283-01	BRCA-LUAD+		cluster 1	Cluster 6		LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-55-7283	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					76	R-Upper		TCGA-55-7283-F46988	TCGA-55-7283	TCGA-55-7283-01A			-27946			0	609			64	0	NO			NO	Scheduled Follow-up Submission	Partial Remission/Response	2013-8-21	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.1	8252/3	C34.1	YES		0.1	NO	100	NO			Central Lung	0.1	NO		NO	5		No	MX	N2	T3	Stage IIIA	TCGA-55-7283.39929fe3-b87c-413c-8613-f5a15b407b28.pdf	7283	Preoperative	WITH TUMOR			105	82	Partial Remission/Response			YES	NO		Primary Tumor	01	0.1	1961	7th	YES	YES	NO	55	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2011	1950		TCGA-55-7283-01A-11D-2036-08		91449ec2-a03f-4cc8-8738-4819564d9dae				TCGA-55-7283-01A-11D-2035-01	TCGA-55-7283-01A-11D-2037-05	TCGA-55-7283-01	TCGA-55-7283-01A-11D-2035-01		91449ec2-a03f-4cc8-8738-4819564d9dae	TCGA-55-7283-01		91449ec2-a03f-4cc8-8738-4819564d9dae	TCGA-55-7283-01		91449ec2-a03f-4cc8-8738-4819564d9dae	TCGA-55-7283-01A-11D-2036-08	TCGA-55-7283-01	
TCGA-55-7283-11			p.D323Y		none	none	none	Y	Y	none	none	none		Bronchioid	none	p.G12S	none	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-55-7283-11										TCGA-55-7283	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					76	R-Upper		TCGA-55-7283-F46988	TCGA-55-7283				-27946			0	609			64	0	NO			NO	Scheduled Follow-up Submission	Partial Remission/Response	2013-8-21	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.1	8252/3	C34.1	YES				100	NO			Central Lung		NO		NO	5		No	MX	N2	T3	Stage IIIA		7283	Preoperative	WITH TUMOR			105	82	Partial Remission/Response			YES	NO		Solid Tissue Normal	11		1961	7th	YES	YES	NO	55	3	Current reformed smoker for > 15 years	Lung		LIVING	2011	1950														TCGA-55-7283-11							TCGA-55-7283-11	
TCGA-55-7284-01																												TCGA-55-7284-01	Iq			Cluster 5		LUAD-like c10	miRNA cluster 4			TCGA-55-7284	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	74	R-Lower		TCGA-55-7284-F61486	TCGA-55-7284	TCGA-55-7284-01B			-27087		243	0	121	231		89						Scheduled Follow-up Submission	Progressive Disease	2014-6-30	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.8	8252/3	C34.8	YES		0.5	NO						0.9	NO	Distant Metastasis	YES			Yes, History of Synchronous/Bilateral Malignancy	MX	N0	T3	Stage IIB	TCGA-55-7284.ca201579-79b6-4a03-a982-9f43bf16471b.pdf	7284		WITH TUMOR	102	70	108	74	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01	0.3		7th	NO	YES	NO	55	3		Lung	B	DECEASED	2011					43d4cf00-5ed1-4f50-a2a4-31ee7c387eb9				TCGA-55-7284-01B-11D-2237-01	TCGA-55-7284-01B-11D-2239-05	TCGA-55-7284-01	TCGA-55-7284-01B-11D-2237-01		43d4cf00-5ed1-4f50-a2a4-31ee7c387eb9	TCGA-55-7284-01		43d4cf00-5ed1-4f50-a2a4-31ee7c387eb9	TCGA-55-7284-01		43d4cf00-5ed1-4f50-a2a4-31ee7c387eb9	TCGA-55-7284-01B-11D-2238-08	TCGA-55-7284-01	
TCGA-55-7570-01																												TCGA-55-7570-01	Squamous			Cluster 5		RNA cluster 3	miRNA cluster 4			TCGA-55-7570	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					60	R-Upper		TCGA-55-7570-F56185	TCGA-55-7570	TCGA-55-7570-01A			-22218			0	824									Scheduled Follow-up Submission	Complete Remission/Response	2014-1-29	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.2	NO						0.3	NO		NO			No	MX	N0	T1a	Stage IA	TCGA-55-7570.95cb32d6-2999-44eb-a93f-31aa65a6c51c.pdf	7570		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.2		7th	NO	YES	NO	55	2		Lung	A	LIVING	2011	1971				56982118-0f10-47b2-af05-18b037c73f22				TCGA-55-7570-01A-11D-2035-01	TCGA-55-7570-01A-11D-2037-05	TCGA-55-7570-01	TCGA-55-7570-01A-11D-2035-01		56982118-0f10-47b2-af05-18b037c73f22	TCGA-55-7570-01		56982118-0f10-47b2-af05-18b037c73f22	TCGA-55-7570-01		56982118-0f10-47b2-af05-18b037c73f22	TCGA-55-7570-01A-11D-2036-08	TCGA-55-7570-01	
TCGA-55-7570-11																												TCGA-55-7570-11										TCGA-55-7570	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					60	R-Upper		TCGA-55-7570-F56185	TCGA-55-7570				-22218			0	824									Scheduled Follow-up Submission	Complete Remission/Response	2014-1-29	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES										NO		NO			No	MX	N0	T1a	Stage IA		7570		TUMOR FREE					Complete Remission/Response				NO	R0	Solid Tissue Normal	11			7th	NO	YES	NO	55	2		Lung		LIVING	2011	1971														TCGA-55-7570-11							TCGA-55-7570-11	
TCGA-55-7573-01	3.2	0.33	none		none	none	none	Y	Y	p.K754E, p.ELR746del	none	none	0.14	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-55-7573-01	Iq	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-55-7573	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	R-Upper		TCGA-55-7573-F46657	TCGA-55-7573	TCGA-55-7573-01A			-26302			0	487			51	1	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-13	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO	90	NO			Central Lung	0.9	NO		NO			Yes	MX	N0	T1b	Stage IA	TCGA-55-7573.3eda2065-31da-49d1-8974-9d004ed26113.pdf	7573	Preoperative	TUMOR FREE	119	134	115	130	Complete Remission/Response			YES	NO		Primary Tumor	01	0.2	1983	7th	NO	YES	NO	55	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2011			TCGA-55-7573-01A-11D-2036-08		f9faf081-c497-44a3-9df1-da2be95e41d0				TCGA-55-7573-01A-11D-2035-01	TCGA-55-7573-01A-11D-2037-05	TCGA-55-7573-01	TCGA-55-7573-01A-11D-2035-01		f9faf081-c497-44a3-9df1-da2be95e41d0	TCGA-55-7573-01	TCGA-55-7573-01A-11-2192-20	f9faf081-c497-44a3-9df1-da2be95e41d0	TCGA-55-7573-01	8a3614c0-ea67-4f95-97af-e64ef9de981a	f9faf081-c497-44a3-9df1-da2be95e41d0	TCGA-55-7573-01A-11D-2036-08	TCGA-55-7573-01	
TCGA-55-7574-01	2.12	0.16	none		none	none	none	N	N	none	none	none	0.08	Bronchioid	none	none	none	none	none	p.R87T	none	Solid predominant Adc	Solid predominant Adc			p.K97_splice	0	TCGA-55-7574-01	Squamous	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-55-7574	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	64	R-Upper		TCGA-55-7574-F64279	TCGA-55-7574	TCGA-55-7574-01A			-23703		995	0	95	478			3					Scheduled Follow-up Submission	Progressive Disease	2014-8-28	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO	50	NO				0.9	NO	Distant Metastasis	YES	2		No	M0	N0	T2a	Stage IB	TCGA-55-7574.7bf6ed4b-a0da-4bcd-ba62-211d2d2a86e7.pdf	7574	Post-Adjuvant Therapy	WITH TUMOR					Complete Remission/Response	Convincing Imaging			YES	R1	Primary Tumor	01	0.4	2011	7th	YES	YES	NO	55	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2011	1971		TCGA-55-7574-01A-11D-2036-08		bbf4c600-a4c5-4ad6-8842-d90639aab690				TCGA-55-7574-01A-11D-2035-01	TCGA-55-7574-01A-11D-2037-05	TCGA-55-7574-01	TCGA-55-7574-01A-11D-2035-01		bbf4c600-a4c5-4ad6-8842-d90639aab690	TCGA-55-7574-01	TCGA-55-7574-01A-11-2192-20	bbf4c600-a4c5-4ad6-8842-d90639aab690	TCGA-55-7574-01	253ddce6-582d-4108-9c27-1575e415d37f	bbf4c600-a4c5-4ad6-8842-d90639aab690	TCGA-55-7574-01A-11D-2036-08	TCGA-55-7574-01	
TCGA-55-7574-11	2.12	0.16	none		none	none	none	N	N	none	none	none	0.08	Bronchioid	none	none	none	none	none	p.R87T	none	Solid predominant Adc	Solid predominant Adc			p.K97_splice	0	TCGA-55-7574-11		C1-LUAD-enriched								TCGA-55-7574	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	64	R-Upper		TCGA-55-7574-F64279	TCGA-55-7574				-23703		995	0	95	478			3					Scheduled Follow-up Submission	Progressive Disease	2014-8-28	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES				50	NO					NO	Distant Metastasis	YES	2		No	M0	N0	T2a	Stage IB		7574	Post-Adjuvant Therapy	WITH TUMOR					Complete Remission/Response	Convincing Imaging			YES	R1	Solid Tissue Normal	11		2011	7th	YES	YES	NO	55	4	Current reformed smoker for < or = 15 years	Lung		DECEASED	2011	1971														TCGA-55-7574-11							TCGA-55-7574-11	
TCGA-55-7576-01	2.86	0.47	none		none	none	none	Y	Y	none	none	none	0.2	Squamoid	none	p.G12S	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-55-7576-01	Squamous		cluster 1	Cluster 6		LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-55-7576	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					54	R-Upper		TCGA-55-7576-F45603	TCGA-55-7576	TCGA-55-7576-01A			-19917			0	670									Scheduled Follow-up Submission	Complete Remission/Response	2013-7-17	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.5	NO						0.5	NO		NO			No	M0	N0	T2a	Stage IB	TCGA-55-7576.feac18c2-ce79-4092-ad5a-98143981a24e.pdf	7576		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.2		7th	YES	YES	NO	55	2	Current smoker	Lung	A	LIVING	2011	1972		TCGA-55-7576-01A-11D-2063-08		829b31ba-7ab2-475e-bad9-1d1a9b6ab13f				TCGA-55-7576-01A-11D-2062-01	TCGA-55-7576-01A-11D-2064-05	TCGA-55-7576-01	TCGA-55-7576-01A-11D-2062-01		829b31ba-7ab2-475e-bad9-1d1a9b6ab13f	TCGA-55-7576-01		829b31ba-7ab2-475e-bad9-1d1a9b6ab13f	TCGA-55-7576-01		829b31ba-7ab2-475e-bad9-1d1a9b6ab13f	TCGA-55-7576-01A-11D-2063-08	TCGA-55-7576-01	
TCGA-55-7576-11	2.86	0.47	none		none	none	none	Y	Y	none	none	none	0.2	Squamoid	none	p.G12S	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-55-7576-11										TCGA-55-7576	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					54	R-Upper		TCGA-55-7576-F45603	TCGA-55-7576				-19917			0	670									Scheduled Follow-up Submission	Complete Remission/Response	2013-7-17	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES										NO		NO			No	M0	N0	T2a	Stage IB		7576		TUMOR FREE					Complete Remission/Response				NO	R0	Solid Tissue Normal	11			7th	YES	YES	NO	55	2	Current smoker	Lung		LIVING	2011	1972														TCGA-55-7576-11							TCGA-55-7576-11	
TCGA-55-7724-01			p.E17K		none	none	none	N	Y	none	none	none		Squamoid	none	none	none	none	none	p.E542K	none	Solid predominant Adc	Solid predominant Adc			none		TCGA-55-7724-01	Squamous		cluster 3	Cluster 5		squamous-like c4	miRNA cluster 5	cluster 3		TCGA-55-7724	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					76	L-Upper		TCGA-55-7724-F56186	TCGA-55-7724	TCGA-55-7724-01A			-27891			0	705			49						Scheduled Follow-up Submission	Complete Remission/Response	2014-1-29	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.4	NO						0.7	NO		NO	50		Yes	MX	N0	T2a	Stage IB	TCGA-55-7724.2d61169f-eaf9-4a67-afef-0dd4c2ffe0c5.pdf	7724		TUMOR FREE			36	33	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.2	2008	7th	NO	YES	NO	55	4		Lung	A	LIVING	2011	1958		TCGA-55-7724-01A-11D-2167-08		4be7594c-c6ff-47c3-bb57-22ba6489b0f4				TCGA-55-7724-01A-11D-2166-01	TCGA-55-7724-01A-11D-2168-05	TCGA-55-7724-01	TCGA-55-7724-01A-11D-2166-01		4be7594c-c6ff-47c3-bb57-22ba6489b0f4	TCGA-55-7724-01		4be7594c-c6ff-47c3-bb57-22ba6489b0f4	TCGA-55-7724-01		4be7594c-c6ff-47c3-bb57-22ba6489b0f4	TCGA-55-7724-01A-11D-2167-08	TCGA-55-7724-01	
TCGA-55-7724-11			p.E17K		none	none	none	N	Y	none	none	none		Squamoid	none	none	none	none	none	p.E542K	none	Solid predominant Adc	Solid predominant Adc			none		TCGA-55-7724-11										TCGA-55-7724	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					76	L-Upper		TCGA-55-7724-F56186	TCGA-55-7724				-27891			0	705			49						Scheduled Follow-up Submission	Complete Remission/Response	2014-1-29	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES										NO		NO	50		Yes	MX	N0	T2a	Stage IB		7724		TUMOR FREE			36	33	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11		2008	7th	NO	YES	NO	55	4		Lung		LIVING	2011	1958														TCGA-55-7724-11							TCGA-55-7724-11	
TCGA-55-7725-01			none		none	none	none	Y	Y	none	none	none		Bronchioid	none	p.G12V	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-55-7725-01	Kirc+		cluster 2	Cluster 5		LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-55-7725	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					68	R-Lower		TCGA-55-7725-F46647	TCGA-55-7725	TCGA-55-7725-01A			-24848			0	442				0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-13	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.4	NO	100	NO			Central Lung	0.5	NO		NO	16		Yes	MX	N0	T1a	Stage IA	TCGA-55-7725.e25ffd17-6064-4eef-acd4-5e26475cd842.pdf	7725	Post-Adjuvant Therapy	TUMOR FREE	88	64	89	61	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.2	1994	7th	NO	YES	NO	55	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2011	1963		TCGA-55-7725-01A-11D-2167-08		8b1695b3-8abd-4bfc-98e4-7d0ad20a5acc				TCGA-55-7725-01A-11D-2166-01	TCGA-55-7725-01A-11D-2168-05	TCGA-55-7725-01	TCGA-55-7725-01A-11D-2166-01		8b1695b3-8abd-4bfc-98e4-7d0ad20a5acc	TCGA-55-7725-01		8b1695b3-8abd-4bfc-98e4-7d0ad20a5acc	TCGA-55-7725-01		8b1695b3-8abd-4bfc-98e4-7d0ad20a5acc	TCGA-55-7725-01A-11D-2167-08	TCGA-55-7725-01	
TCGA-55-7725-11			none		none	none	none	Y	Y	none	none	none		Bronchioid	none	p.G12V	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-55-7725-11										TCGA-55-7725	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					68	R-Lower		TCGA-55-7725-F46647	TCGA-55-7725				-24848			0	442				0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-13	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES				100	NO			Central Lung		NO		NO	16		Yes	MX	N0	T1a	Stage IA		7725	Post-Adjuvant Therapy	TUMOR FREE	88	64	89	61	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11		1994	7th	NO	YES	NO	55	3	Current reformed smoker for > 15 years	Lung		LIVING	2011	1963														TCGA-55-7725-11							TCGA-55-7725-11	
TCGA-55-7726-01			none		none	none	none	Y	Y	none	none	none		Squamoid	none	p.G12C	none	none	none	none	none					none		TCGA-55-7726-01	BRCA-LUAD+		cluster 3	Cluster 5		squamous-like c4	miRNA cluster 5	cluster 3		TCGA-55-7726	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	L-Lower		TCGA-55-7726-F47844	TCGA-55-7726				-26451			0	652			72						Scheduled Follow-up Submission	Complete Remission/Response	2013-8-29	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES										NO		NO	30		Yes	MX	N0	T1b	Stage IA		7726		TUMOR FREE	59	61	55	49	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1979	7th	NO	YES	NO	55	3		Lung		LIVING	2011	1955		TCGA-55-7726-01A-11D-2167-08		b2d849d8-f837-43e4-b06c-051f041172ae				TCGA-55-7726-01A-11D-2166-01	TCGA-55-7726-01A-11D-2168-05	TCGA-55-7726-01	TCGA-55-7726-01A-11D-2166-01		b2d849d8-f837-43e4-b06c-051f041172ae	TCGA-55-7726-01		b2d849d8-f837-43e4-b06c-051f041172ae	TCGA-55-7726-01		b2d849d8-f837-43e4-b06c-051f041172ae	TCGA-55-7726-01A-11D-2167-08	TCGA-55-7726-01	
TCGA-55-7726-11			none		none	none	none	Y	Y	none	none	none		Squamoid	none	p.G12C	none	none	none	none	none					none		TCGA-55-7726-11										TCGA-55-7726	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	L-Lower		TCGA-55-7726-F47844	TCGA-55-7726				-26451			0	652			72						Scheduled Follow-up Submission	Complete Remission/Response	2013-8-29	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES										NO		NO	30		Yes	MX	N0	T1b	Stage IA		7726		TUMOR FREE	59	61	55	49	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11		1979	7th	NO	YES	NO	55	3		Lung		LIVING	2011	1955														TCGA-55-7726-11							TCGA-55-7726-11	
TCGA-55-7727-01			none		none	none	none	N	N	none	none	none		Magnoid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-55-7727-01	BRCA-LUAD+		cluster 1	Cluster 6		LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-55-7727	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	L-Upper		TCGA-55-7727-F66030	TCGA-55-7727				-25929			0	119			86						Scheduled Follow-up Submission	Complete Remission/Response	2014-10-1	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES										YES		NO			No	MX	N2	T1a	Stage IIIA		7727		TUMOR FREE	48	73	49	74	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	YES	YES	NO	55	2	Current smoker	Lung		LIVING	2011			TCGA-55-7727-01A-11D-2167-08		d4349207-30b1-44ad-b460-14db8ea58cc4				TCGA-55-7727-01A-11D-2166-01	TCGA-55-7727-01A-11D-2168-05	TCGA-55-7727-01	TCGA-55-7727-01A-11D-2166-01		d4349207-30b1-44ad-b460-14db8ea58cc4	TCGA-55-7727-01		d4349207-30b1-44ad-b460-14db8ea58cc4	TCGA-55-7727-01		d4349207-30b1-44ad-b460-14db8ea58cc4	TCGA-55-7727-01A-11D-2167-08	TCGA-55-7727-01	
TCGA-55-7728-01			none		none	none	none	Y	Y	none	none	p.H841Q		Bronchioid	none	p.G12V	none	none	none	none	none	Invasive mucinous	Invasive mucinous			none	0	TCGA-55-7728-01	Kirc+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-55-7728	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					64	L-Upper		TCGA-55-7728-F47841	TCGA-55-7728	TCGA-55-7728-01A			-23505			0	704			64		NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-29	FEMALE	Mucinous (Colloid) Carcinoma	No	C34.1	8480/3	C34.1	YES		0.8	NO		NO				1	NO		NO	30		No	MX	N0	T2a	Stage IB	TCGA-55-7728.d12721b3-53dc-47e8-a9c2-03343ec7a4bb.pdf	7728		TUMOR FREE		74		67	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.5	1996	7th	NO	YES	NO	55	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2011	1980		TCGA-55-7728-01A-11D-2184-08		d54aa159-e398-4fd4-bd2c-a437e7766582				TCGA-55-7728-01A-11D-2183-01	TCGA-55-7728-01A-11D-2185-05	TCGA-55-7728-01	TCGA-55-7728-01A-11D-2183-01		d54aa159-e398-4fd4-bd2c-a437e7766582	TCGA-55-7728-01	TCGA-55-7728-01A-13-2192-20	d54aa159-e398-4fd4-bd2c-a437e7766582	TCGA-55-7728-01	95cddb98-de35-4aa2-898f-427b5d9c34bf	d54aa159-e398-4fd4-bd2c-a437e7766582	TCGA-55-7728-01A-11D-2184-08	TCGA-55-7728-01	
TCGA-55-7815-01			none		none	none	none	Y	Y	none	none	none		Magnoid	none	p.G12V	none	none	none	none	none					none		TCGA-55-7815-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-55-7815	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	76	R-Lower		TCGA-55-7815-F61497	TCGA-55-7815				-28119			0	773	592		59						Additional New Tumor Event	Progressive Disease	2014-6-30	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES										NO	Distant Metastasis	YES			No	MX	N0	T2a	Stage IB		7815		WITH TUMOR		76		72	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	NO	YES	NO	55	1		Lung		LIVING	2011			TCGA-55-7815-01A-11D-2167-08		ea6af137-a116-4a32-9436-a9470abb3b10				TCGA-55-7815-01A-11D-2166-01	TCGA-55-7815-01A-11D-2168-05	TCGA-55-7815-01	TCGA-55-7815-01A-11D-2166-01		ea6af137-a116-4a32-9436-a9470abb3b10	TCGA-55-7815-01	TCGA-55-7815-01A-13-2192-20	ea6af137-a116-4a32-9436-a9470abb3b10	TCGA-55-7815-01	dc4e6e89-07fb-418a-b96c-14825cd8bca2	ea6af137-a116-4a32-9436-a9470abb3b10	TCGA-55-7815-01A-11D-2167-08	TCGA-55-7815-01	
TCGA-55-7816-01																												TCGA-55-7816-01				Low purity c2			miRNA cluster 5			TCGA-55-7816	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					49	R-Upper		TCGA-55-7816-F60131	TCGA-55-7816	TCGA-55-7816-01A			-18170		468	0	44									Scheduled Follow-up Submission	Progressive Disease	2014-5-29	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.3	NO						0.3	NO		NO			No	MX	NX	TX	Stage IV	TCGA-55-7816.ca0d6f7a-fee3-49c5-8239-8a2583cecdd1.pdf	7816		WITH TUMOR					Progressive Disease			NO	NO		Primary Tumor	01	0.2		7th	NO	YES	NO	55	1		Lung	A	DECEASED	2011					94beac77-4ba2-4465-9f42-813e7de4df3e					TCGA-55-7816-01A-11D-2168-05				94beac77-4ba2-4465-9f42-813e7de4df3e	TCGA-55-7816-01		94beac77-4ba2-4465-9f42-813e7de4df3e	TCGA-55-7816-01		94beac77-4ba2-4465-9f42-813e7de4df3e	TCGA-55-7816-01A-11D-2167-08	TCGA-55-7816-01	
TCGA-55-7903-01			none		p.R146W, p.V600E	none	none	N	Y	none	none	none		Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-55-7903-01	BRCA-LUAD+		cluster 1	Cluster 6		LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-55-7903	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					64	R-Lower		TCGA-55-7903-F47840	TCGA-55-7903	TCGA-55-7903-01A			-23509			0	567			83		NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-29	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.2	NO		NO				0.5	NO		NO	40		No	MX	N0	T1b	Stage IA	TCGA-55-7903.f044afa0-43c8-4047-a6bf-d46bfb42433c.pdf	7903		TUMOR FREE			63	66	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.2		7th	NO	YES	NO	55	2	Current smoker	Lung	A	LIVING	2011			TCGA-55-7903-01A-11D-2167-08		514e90fa-113f-48d7-9166-41096e0ad209				TCGA-55-7903-01A-11D-2166-01	TCGA-55-7903-01A-11D-2168-05	TCGA-55-7903-01	TCGA-55-7903-01A-11D-2166-01		514e90fa-113f-48d7-9166-41096e0ad209	TCGA-55-7903-01		514e90fa-113f-48d7-9166-41096e0ad209	TCGA-55-7903-01		514e90fa-113f-48d7-9166-41096e0ad209	TCGA-55-7903-01A-11D-2167-08	TCGA-55-7903-01	
TCGA-55-7903-11			none		p.R146W, p.V600E	none	none	N	Y	none	none	none		Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-55-7903-11										TCGA-55-7903	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					64	R-Lower		TCGA-55-7903-F47840	TCGA-55-7903				-23509			0	567			83		NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-29	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES					NO					NO		NO	40		No	MX	N0	T1b	Stage IA		7903		TUMOR FREE			63	66	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11			7th	NO	YES	NO	55	2	Current smoker	Lung		LIVING	2011															TCGA-55-7903-11							TCGA-55-7903-11	
TCGA-55-7907-01			none		none	none	none	Y	Y	none	none	p.L805V		Squamoid	none	p.G12C	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-55-7907-01	High		cluster 1	Cluster 6		LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-55-7907	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO		NO	77	L-Upper		TCGA-55-7907-F60132	TCGA-55-7907	TCGA-55-7907-01A			-28201		343	0	16	294		75						Scheduled Follow-up Submission	Progressive Disease	2014-5-29	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.3	NO						0.3	NO	Distant Metastasis	YES	80		No	MX	N1	T2a	Stage IIA	TCGA-55-7907.233ef961-8050-47e5-bb53-260a7de4174d.pdf	7907		WITH TUMOR	80	87	75	76	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01	0.1	1994	7th	NO	YES	NO	55	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2011	1954		TCGA-55-7907-01A-11D-2167-08		0168f22b-6d11-4492-9aea-5ffa451bff3e				TCGA-55-7907-01A-11D-2166-01	TCGA-55-7907-01A-11D-2168-05	TCGA-55-7907-01	TCGA-55-7907-01A-11D-2166-01		0168f22b-6d11-4492-9aea-5ffa451bff3e	TCGA-55-7907-01		0168f22b-6d11-4492-9aea-5ffa451bff3e	TCGA-55-7907-01		0168f22b-6d11-4492-9aea-5ffa451bff3e	TCGA-55-7907-01A-11D-2167-08	TCGA-55-7907-01	
TCGA-55-7910-01																												TCGA-55-7910-01	High	C1-LUAD-enriched		Low purity c2	squamous c3	LUAD-like c10	miRNA cluster 5			TCGA-55-7910	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES			50	L-Lower		TCGA-55-7910-F66140	TCGA-55-7910	TCGA-55-7910-01A			-18289			0	1040	1018		44	1					Scheduled Follow-up Submission		2014-10-3	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.6	NO	80				Peripheral Lung	0.9	NO		YES	15		No	M0	N0	T2b	Stage IIA	TCGA-55-7910.c205abda-dfe0-43b1-a265-4c41125216fe.pdf	7910	Preoperative	WITH TUMOR	91	91	97	86	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.5	2011	7th	YES	YES	NO	55	4		Lung	A	LIVING	2011	1996				4ff760c4-074e-4876-b63f-71098942c780				TCGA-55-7910-01A-11D-2166-01	TCGA-55-7910-01A-11D-2168-05	TCGA-55-7910-01	TCGA-55-7910-01A-11D-2166-01		4ff760c4-074e-4876-b63f-71098942c780	TCGA-55-7910-01	TCGA-55-7910-01A-13-2192-20	4ff760c4-074e-4876-b63f-71098942c780	TCGA-55-7910-01	8454f2fd-cc01-4eb8-b206-9499ed8f7bbb	4ff760c4-074e-4876-b63f-71098942c780	TCGA-55-7910-01A-11D-2167-08	TCGA-55-7910-01	
TCGA-55-7910-11																												TCGA-55-7910-11		C1-LUAD-enriched								TCGA-55-7910	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES			50	L-Lower		TCGA-55-7910-F66140	TCGA-55-7910				-18289			0	1040	1018		44	1					Scheduled Follow-up Submission		2014-10-3	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES				80				Peripheral Lung		NO		YES	15		No	M0	N0	T2b	Stage IIA		7910	Preoperative	WITH TUMOR	91	91	97	86	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11		2011	7th	YES	YES	NO	55	4		Lung		LIVING	2011	1996														TCGA-55-7910-11							TCGA-55-7910-11	
TCGA-55-7911-01			none		none	none	none	Y	Y	none	none	none		Squamoid	none	p.G12V, p.K88*	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-55-7911-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-55-7911	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	70	R-Middle		TCGA-55-7911-F48785	TCGA-55-7911	TCGA-55-7911-01A			-25746			0	537	515				NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES		0.5	NO		NO				0.8	NO	New Primary Tumor	YES	96		No	MX	N0	T1a	Stage IA	TCGA-55-7911.0c8ea3a9-23b7-4c43-8972-3660048b8537.pdf	7911		TUMOR FREE		86		64	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.4	1981	7th	NO	YES	NO	55	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2011	1959		TCGA-55-7911-01A-11D-2167-08		9142e848-c5cb-41c1-b80f-5f7674f9a1cb				TCGA-55-7911-01A-11D-2166-01	TCGA-55-7911-01A-11D-2168-05	TCGA-55-7911-01	TCGA-55-7911-01A-11D-2166-01		9142e848-c5cb-41c1-b80f-5f7674f9a1cb	TCGA-55-7911-01	TCGA-55-7911-01A-13-2192-20	9142e848-c5cb-41c1-b80f-5f7674f9a1cb	TCGA-55-7911-01	75ec6f61-ec15-409e-a0a6-e4b5618375e5	9142e848-c5cb-41c1-b80f-5f7674f9a1cb	TCGA-55-7911-01A-11D-2167-08	TCGA-55-7911-01	
TCGA-55-7911-11			none		none	none	none	Y	Y	none	none	none		Squamoid	none	p.G12V, p.K88*	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-55-7911-11		C1-LUAD-enriched								TCGA-55-7911	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	70	R-Middle		TCGA-55-7911-F48785	TCGA-55-7911				-25746			0	537	515				NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES					NO					NO	New Primary Tumor	YES	96		No	MX	N0	T1a	Stage IA		7911		TUMOR FREE		86		64	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11		1981	7th	NO	YES	NO	55	3	Current reformed smoker for > 15 years	Lung		LIVING	2011	1959														TCGA-55-7911-11							TCGA-55-7911-11	
TCGA-55-7913-01																												TCGA-55-7913-01	BRCA-LUAD+			Cluster 5		LUAD-like c10	miRNA cluster 6			TCGA-55-7913	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		NO	61	L-Lower		TCGA-55-7913-F57911	TCGA-55-7913	TCGA-55-7913-01B			-22326		561	0	62	480			1	YES		FISH	YES	Scheduled Follow-up Submission	Progressive Disease	2014-3-28	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.4	NO	90	YES	NO		Central Lung	0.7	NO	Distant Metastasis	YES	40		No	MX	N0	T1b	Stage IA	TCGA-55-7913.7ce361fa-ad56-4e0e-95e3-ea977a513e98.pdf	7913	Preoperative	WITH TUMOR					Complete Remission/Response	Convincing Imaging			NO	R0	Primary Tumor	01	0.2		7th	NO	YES	NO	55	2		Lung	B	DECEASED	2011	1971				168efb85-ed48-4e77-ba13-90674218c506				TCGA-55-7913-01B-11D-2237-01	TCGA-55-7913-01B-11D-2239-05	TCGA-55-7913-01	TCGA-55-7913-01B-11D-2237-01		168efb85-ed48-4e77-ba13-90674218c506	TCGA-55-7913-01		168efb85-ed48-4e77-ba13-90674218c506	TCGA-55-7913-01		168efb85-ed48-4e77-ba13-90674218c506	TCGA-55-7913-01B-11D-2238-08	TCGA-55-7913-01	
TCGA-55-7914-01			none		none	none	none	Y	Y	none	none	none		Bronchioid	none	p.G12C	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-55-7914-01	Squamous		cluster 1	Cluster 6		LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-55-7914	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	R-Upper		TCGA-55-7914-F59091	TCGA-55-7914	TCGA-55-7914-01A			-26105		187	0	3			56	1	YES		FISH	YES	Scheduled Follow-up Submission	Progressive Disease	2014-4-30	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.2	NO	80	YES	YES	G12C	Central Lung	0.4	NO		NO	5		Yes	MX	N1	T1b	Stage IIA	TCGA-55-7914.eaabadac-ea5e-47c3-9db7-d2c0c77b7b68.pdf	7914	Preoperative	WITH TUMOR			88	73	Progressive Disease			YES	NO	R0	Primary Tumor	01	0.2		7th	YES	YES	NO	55	2	Current smoker	Lung	A	DECEASED	2011	1990		TCGA-55-7914-01A-11D-2167-08		5bfe179e-eae2-4d2a-9f2a-b4af4602a2b5				TCGA-55-7914-01A-11D-2166-01	TCGA-55-7914-01A-11D-2168-05	TCGA-55-7914-01	TCGA-55-7914-01A-11D-2166-01		5bfe179e-eae2-4d2a-9f2a-b4af4602a2b5	TCGA-55-7914-01		5bfe179e-eae2-4d2a-9f2a-b4af4602a2b5	TCGA-55-7914-01		5bfe179e-eae2-4d2a-9f2a-b4af4602a2b5	TCGA-55-7914-01A-11D-2167-08	TCGA-55-7914-01	
TCGA-55-7914-11			none		none	none	none	Y	Y	none	none	none		Bronchioid	none	p.G12C	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-55-7914-11										TCGA-55-7914	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	R-Upper		TCGA-55-7914-F59091	TCGA-55-7914				-26105		187	0	3			56	1	YES		FISH	YES	Scheduled Follow-up Submission	Progressive Disease	2014-4-30	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES				80	YES	YES	G12C	Central Lung		NO		NO	5		Yes	MX	N1	T1b	Stage IIA		7914	Preoperative	WITH TUMOR			88	73	Progressive Disease			YES	NO	R0	Solid Tissue Normal	11			7th	YES	YES	NO	55	2	Current smoker	Lung		DECEASED	2011	1990														TCGA-55-7914-11							TCGA-55-7914-11	
TCGA-55-7994-01																												TCGA-55-7994-01	Squamous			Cluster 6		LUAD-like c10	miRNA cluster 4			TCGA-55-7994	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					81	R-Upper		TCGA-55-7994-F47823	TCGA-55-7994				-29858			0	603					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-28	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO					NO		NO	28		No	MX	N0	T3	Stage IIB		7994		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01			7th	YES	YES	NO	55	2		Lung		LIVING	2011					c857b341-4021-48e6-a9e7-fff0525cdb96				TCGA-55-7994-01A-11D-2183-01	TCGA-55-7994-01A-11D-2185-05	TCGA-55-7994-01	TCGA-55-7994-01A-11D-2183-01		c857b341-4021-48e6-a9e7-fff0525cdb96	TCGA-55-7994-01		c857b341-4021-48e6-a9e7-fff0525cdb96	TCGA-55-7994-01		c857b341-4021-48e6-a9e7-fff0525cdb96	TCGA-55-7994-01A-11D-2184-08	TCGA-55-7994-01	
TCGA-55-7995-01																												TCGA-55-7995-01	High			BRCA basal-like c8		LUAD-like c10	miRNA cluster 4			TCGA-55-7995	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO		73	L-Upper		TCGA-55-7995-F65700	TCGA-55-7995	TCGA-55-7995-01A			-26837			0	889	468		51	1	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-9-26	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO	80				Peripheral Lung	0.8	NO	Locoregional Recurrence	YES	60		No	M0	N0	T1b	Stage IA	TCGA-55-7995.3f3f4bdf-75f6-4b5b-988e-cebc4f098cbd.pdf	7995	Post-Adjuvant Therapy	TUMOR FREE			71	77	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01	0.2	2002	7th	NO	YES	NO	55	4		Lung	A	LIVING	2012					956590e9-4962-497b-a59f-81ee0a1c0caf				TCGA-55-7995-01A-11D-2183-01	TCGA-55-7995-01A-11D-2185-05	TCGA-55-7995-01	TCGA-55-7995-01A-11D-2183-01		956590e9-4962-497b-a59f-81ee0a1c0caf	TCGA-55-7995-01		956590e9-4962-497b-a59f-81ee0a1c0caf	TCGA-55-7995-01		956590e9-4962-497b-a59f-81ee0a1c0caf	TCGA-55-7995-01A-11D-2184-08	TCGA-55-7995-01	
TCGA-55-8085-01																												TCGA-55-8085-01	BRCA-LUAD+			Cluster 5		LUAD-like c10	miRNA cluster 7			TCGA-55-8085	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					64	L-Lower		TCGA-55-8085-F65697	TCGA-55-8085	TCGA-55-8085-01A			-23596			0	904			51	1					Scheduled Follow-up Submission	Complete Remission/Response	2014-9-26	MALE	Lung Papillary Adenocarcinoma	No	C34.3	8260/3	C34.3	YES		0.5	NO						0.7	NO		NO			No	M0	N0	T1b	Stage IA	TCGA-55-8085.16f4298e-d5f3-4503-bdad-a15531c3635c.pdf	8085		TUMOR FREE	46	45	39	35	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.3		7th	NO	YES	NO	55	2		Lung	A	LIVING	2011					04104d50-dcf7-4e77-9038-8fed73db6a12				TCGA-55-8085-01A-11D-2237-01	TCGA-55-8085-01A-11D-2239-05	TCGA-55-8085-01	TCGA-55-8085-01A-11D-2237-01		04104d50-dcf7-4e77-9038-8fed73db6a12	TCGA-55-8085-01		04104d50-dcf7-4e77-9038-8fed73db6a12	TCGA-55-8085-01		04104d50-dcf7-4e77-9038-8fed73db6a12	TCGA-55-8085-01A-11D-2238-08	TCGA-55-8085-01	
TCGA-55-8087-01																												TCGA-55-8087-01	Iq			Cluster 5		LUAD-like c10	miRNA c1uster 9			TCGA-55-8087	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					59	R-Upper		TCGA-55-8087-F47822	TCGA-55-8087				-21655			0	462			142		NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-28	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO					NO		NO			No	MX	N0	T2a	Stage IB		8087		TUMOR FREE				126	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	NO	YES	NO	55	1		Lung		LIVING	2011					ce03cab8-df0a-433b-bc39-96203ab061a1				TCGA-55-8087-01A-11D-2237-01	TCGA-55-8087-01A-11D-2239-05	TCGA-55-8087-01	TCGA-55-8087-01A-11D-2237-01		ce03cab8-df0a-433b-bc39-96203ab061a1	TCGA-55-8087-01		ce03cab8-df0a-433b-bc39-96203ab061a1	TCGA-55-8087-01		ce03cab8-df0a-433b-bc39-96203ab061a1	TCGA-55-8087-01A-11D-2238-08	TCGA-55-8087-01	
TCGA-55-8089-01																												TCGA-55-8089-01	High			Cluster 6		LUAD-like c10	miRNA cluster 4			TCGA-55-8089	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					56	R-Upper		TCGA-55-8089-F59075	TCGA-55-8089	TCGA-55-8089-01A			-20576		702	0	100			90	0	YES			YES	Scheduled Follow-up Submission	Complete Remission/Response	2014-4-30	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.2	NO	100	YES	NO		Peripheral Lung	0.2	NO		NO	97		No	M0	N0	T1a	Stage IA	TCGA-55-8089.af442cea-76df-4233-b3d6-134b1e91c607.pdf	8089	Preoperative	TUMOR FREE			85	70	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.1		7th	NO	YES	NO	55	2		Lung	A	DECEASED	2011	1973				671a4dd5-cb2a-4d9b-aec7-c5963d50f2ab				TCGA-55-8089-01A-11D-2237-01	TCGA-55-8089-01A-11D-2239-05	TCGA-55-8089-01	TCGA-55-8089-01A-11D-2237-01		671a4dd5-cb2a-4d9b-aec7-c5963d50f2ab	TCGA-55-8089-01		671a4dd5-cb2a-4d9b-aec7-c5963d50f2ab	TCGA-55-8089-01		671a4dd5-cb2a-4d9b-aec7-c5963d50f2ab	TCGA-55-8089-01A-11D-2238-08	TCGA-55-8089-01	
TCGA-55-8090-01																												TCGA-55-8090-01	BRCA-LUAD+			Cluster 6		LUAD-like c10	miRNA c1uster 9			TCGA-55-8090	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO		NO	80	R-Lower		TCGA-55-8090-F56189	TCGA-55-8090	TCGA-55-8090-01A			-29235		598	0	6	548		58						Scheduled Follow-up Submission	Progressive Disease	2014-1-29	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.4	NO						1	NO	Distant Metastasis	YES			Yes, History of Synchronous/Bilateral Malignancy	M0	N0	T1a	Stage IA	TCGA-55-8090.8f75f207-fe12-44ba-86b2-444ab5578d45.pdf	8090		WITH TUMOR	4	6	103	83	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01	0.2		7th	NO	YES	NO	55	2		Lung	A	DECEASED	2011					5877248b-dff8-494d-a5c1-7721072ec225				TCGA-55-8090-01A-11D-2237-01	TCGA-55-8090-01A-11D-2239-05	TCGA-55-8090-01	TCGA-55-8090-01A-11D-2237-01		5877248b-dff8-494d-a5c1-7721072ec225	TCGA-55-8090-01		5877248b-dff8-494d-a5c1-7721072ec225	TCGA-55-8090-01		5877248b-dff8-494d-a5c1-7721072ec225	TCGA-55-8090-01A-11D-2238-08	TCGA-55-8090-01	
TCGA-55-8091-01																												TCGA-55-8091-01	Kirc+			Cluster 5		LUAD-like c10	miRNA c1uster 9			TCGA-55-8091	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	R-Lower		TCGA-55-8091-F47820	TCGA-55-8091	TCGA-55-8091-01A			-27385			0	600			65		NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-28	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.8	NO		NO				1.1	NO		NO			Yes, History of Prior Malignancy	MX	N0	T2	Stage IB	TCGA-55-8091.33902b19-5be6-47ff-81a7-b945ae674a2f.pdf	8091		TUMOR FREE			79	82	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.6	1985	7th	NO	YES	NO	55	3		Lung	A	LIVING	2011					40adb8fd-ac1d-4f5d-98a4-3bb5256626c4				TCGA-55-8091-01A-11D-2237-01	TCGA-55-8091-01A-11D-2239-05	TCGA-55-8091-01	TCGA-55-8091-01A-11D-2237-01		40adb8fd-ac1d-4f5d-98a4-3bb5256626c4	TCGA-55-8091-01		40adb8fd-ac1d-4f5d-98a4-3bb5256626c4	TCGA-55-8091-01		40adb8fd-ac1d-4f5d-98a4-3bb5256626c4	TCGA-55-8091-01A-11D-2238-08	TCGA-55-8091-01	
TCGA-55-8092-01																												TCGA-55-8092-01	High			Cluster 6		LUAD-like c10	miRNA cluster 7			TCGA-55-8092	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		75	R-Upper		TCGA-55-8092-F46643	TCGA-55-8092				-27597		154	0	26	127		19						Scheduled Follow-up Submission	Progressive Disease	2013-8-13	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES										NO	Locoregional Recurrence	YES	40		No	MX	N0	T3	Stage IIB		8092		WITH TUMOR	2	19	66	68	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01		2012	7th	NO	YES	NO	55	4		Lung		DECEASED	2012	1972				add23090-21e1-4cc2-a833-539b1db1e05f				TCGA-55-8092-01A-11D-2237-01	TCGA-55-8092-01A-11D-2239-05	TCGA-55-8092-01	TCGA-55-8092-01A-11D-2237-01		add23090-21e1-4cc2-a833-539b1db1e05f	TCGA-55-8092-01		add23090-21e1-4cc2-a833-539b1db1e05f	TCGA-55-8092-01		add23090-21e1-4cc2-a833-539b1db1e05f	TCGA-55-8092-01A-11D-2238-08	TCGA-55-8092-01	
TCGA-55-8094-01																												TCGA-55-8094-01	High			Cluster 5		LUAD-like c10	miRNA cluster 6			TCGA-55-8094	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					51	L-Upper		TCGA-55-8094-F66029	TCGA-55-8094				-18903			0	541					YES		FISH	YES	Scheduled Follow-up Submission	Partial Remission/Response	2014-10-1	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO			Peripheral Lung		NO		NO	70		No	M1b	N0	T2b	Stage IV		8094		WITH TUMOR					Progressive Disease				YES	R0	Primary Tumor	01		2011	7th	YES	YES	NO	55	4		Lung		LIVING	2012	1976				b08923df-9b70-48eb-bc2b-023d1e1b0eeb				TCGA-55-8094-01A-11D-2237-01	TCGA-55-8094-01A-11D-2239-05	TCGA-55-8094-01	TCGA-55-8094-01A-11D-2237-01		b08923df-9b70-48eb-bc2b-023d1e1b0eeb	TCGA-55-8094-01		b08923df-9b70-48eb-bc2b-023d1e1b0eeb	TCGA-55-8094-01		b08923df-9b70-48eb-bc2b-023d1e1b0eeb	TCGA-55-8094-01A-11D-2238-08	TCGA-55-8094-01	
TCGA-55-8096-01																												TCGA-55-8096-01	High			Low purity c2		LUAD-like c10	miRNA cluster 4			TCGA-55-8096	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		NO	67	L-Upper		TCGA-55-8096-F59097	TCGA-55-8096	TCGA-55-8096-01A			-24684		719	0	47	566			2	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2014-4-30	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.9	NO	70	NO			Central Lung	0.9	NO	Distant Metastasis	YES	104		No	MX	N0	T2a	Stage IB	TCGA-55-8096.d27900ae-8cf6-4d92-84e8-5247df7d46b4.pdf	8096	Preoperative	WITH TUMOR			77	55	Complete Remission/Response	Convincing Imaging		YES	NO		Primary Tumor	01	0.4		7th	NO	YES	NO	55	2		Lung	A	DECEASED	2011	1959				22366c3f-bf63-421e-b086-0ffb87945bf9				TCGA-55-8096-01A-11D-2237-01	TCGA-55-8096-01A-11D-2239-05	TCGA-55-8096-01	TCGA-55-8096-01A-11D-2237-01		22366c3f-bf63-421e-b086-0ffb87945bf9	TCGA-55-8096-01		22366c3f-bf63-421e-b086-0ffb87945bf9	TCGA-55-8096-01		22366c3f-bf63-421e-b086-0ffb87945bf9	TCGA-55-8096-01A-11D-2238-08	TCGA-55-8096-01	
TCGA-55-8097-01																												TCGA-55-8097-01	COAD-READ			Cluster 5		LUAD-like c10	miRNA cluster 4			TCGA-55-8097	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					60	R-Upper		TCGA-55-8097-F47821	TCGA-55-8097	TCGA-55-8097-01A			-22260			0	476			74		NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-28	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.4	NO		NO				0.5	NO		NO	35		No	MX	N0	T1a	Stage IA	TCGA-55-8097.3e2989f4-213d-4f64-be03-9b967f1fcc08.pdf	8097		TUMOR FREE		87		79	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.1	2008	7th	NO	YES	NO	55	4		Lung	A	LIVING	2012	1973				6191a9e8-7ed1-49d0-b582-e38b29c61649				TCGA-55-8097-01A-11D-2237-01	TCGA-55-8097-01A-11D-2239-05	TCGA-55-8097-01	TCGA-55-8097-01A-11D-2237-01		6191a9e8-7ed1-49d0-b582-e38b29c61649	TCGA-55-8097-01		6191a9e8-7ed1-49d0-b582-e38b29c61649	TCGA-55-8097-01		6191a9e8-7ed1-49d0-b582-e38b29c61649	TCGA-55-8097-01A-11D-2238-08	TCGA-55-8097-01	
TCGA-55-8203-01																												TCGA-55-8203-01	BRCA-LUAD+			Cluster 6		LUAD-like c10	miRNA cluster 6			TCGA-55-8203	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	R-Lower		TCGA-55-8203-F47819	TCGA-55-8203	TCGA-55-8203-01A			-25477			0	547			39		NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-28	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.3	NO		NO				0.4	NO		NO	50		Yes, History of Prior Malignancy	M0	N0	T1b	Stage IA	TCGA-55-8203.079475a1-b61d-4cb3-b1e1-a5a890d3073b.pdf	8203		TUMOR FREE	50	48	52	49	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.2		7th	NO	YES	NO	55	2		Lung	A	LIVING	2011					26900eb0-165e-463e-84ad-51321287d2c3				TCGA-55-8203-01A-11D-2237-01	TCGA-55-8203-01A-11D-2239-05	TCGA-55-8203-01	TCGA-55-8203-01A-11D-2237-01		26900eb0-165e-463e-84ad-51321287d2c3	TCGA-55-8203-01		26900eb0-165e-463e-84ad-51321287d2c3	TCGA-55-8203-01		26900eb0-165e-463e-84ad-51321287d2c3	TCGA-55-8203-01A-11D-2238-08	TCGA-55-8203-01	
TCGA-55-8204-01																												TCGA-55-8204-01	Squamous			Cluster 5		squamous-like c4	miRNA cluster 4			TCGA-55-8204	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					87	L-Upper		TCGA-55-8204-F47802	TCGA-55-8204				-31818			0	515			101						Scheduled Follow-up Submission	Complete Remission/Response	2013-8-28	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES										NO		NO			Yes, History of Prior Malignancy	MX	N0	T2a	Stage IB		8204		TUMOR FREE			88	85	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	NO	YES	NO	55	3		Lung		LIVING	2011					cfa04d49-cec6-4454-b10e-8b4600485f12				TCGA-55-8204-01A-11D-2237-01	TCGA-55-8204-01A-11D-2239-05	TCGA-55-8204-01	TCGA-55-8204-01A-11D-2237-01		cfa04d49-cec6-4454-b10e-8b4600485f12	TCGA-55-8204-01		cfa04d49-cec6-4454-b10e-8b4600485f12	TCGA-55-8204-01		cfa04d49-cec6-4454-b10e-8b4600485f12	TCGA-55-8204-01A-11D-2238-08	TCGA-55-8204-01	
TCGA-55-8205-01																												TCGA-55-8205-01	Squamous			Cluster 6		LUAD-like c10	miRNA cluster 4			TCGA-55-8205	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES		NO	76	R-Lower		TCGA-55-8205-F59040	TCGA-55-8205	TCGA-55-8205-01A			-28063			0	599	495			0	YES			NO	Scheduled Follow-up Submission	Progressive Disease	2014-4-30	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1	NO	100	YES	NO		Central Lung	1.1	NO	Distant Metastasis	YES	30		Yes, History of Prior Malignancy	M0	N0	T2b	Stage IIA	TCGA-55-8205.7a632c9d-4215-4d85-83df-30ce645d4e0c.pdf	8205	Preoperative	WITH TUMOR			73	42	Progressive Disease	Convincing Imaging		YES	NO	R0	Primary Tumor	01	0.6	2012	7th	YES	YES	NO	55	4		Lung	A	LIVING	2012	1951				96b3c91a-389e-48cc-9347-ed65fa70f3de				TCGA-55-8205-01A-11D-2237-01	TCGA-55-8205-01A-11D-2239-05	TCGA-55-8205-01	TCGA-55-8205-01A-11D-2237-01		96b3c91a-389e-48cc-9347-ed65fa70f3de	TCGA-55-8205-01		96b3c91a-389e-48cc-9347-ed65fa70f3de	TCGA-55-8205-01		96b3c91a-389e-48cc-9347-ed65fa70f3de	TCGA-55-8205-01A-11D-2238-08	TCGA-55-8205-01	
TCGA-55-8206-01																												TCGA-55-8206-01	BRCA-LUAD+			Cluster 5		LUAD-like c10	miRNA cluster 5			TCGA-55-8206	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					56	R-Upper		TCGA-55-8206-F65698	TCGA-55-8206				-20690			0	888			98						Scheduled Follow-up Submission	Complete Remission/Response	2014-9-26	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES										NO		NO			No	M0	N0	T1b	Stage IA		8206		TUMOR FREE			104	84	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	NO	YES	NO	55	1		Lung		LIVING	2012					e6817dfb-7634-4321-9627-ce94feb46011				TCGA-55-8206-01A-11D-2237-01	TCGA-55-8206-01A-11D-2239-05	TCGA-55-8206-01	TCGA-55-8206-01A-11D-2237-01		e6817dfb-7634-4321-9627-ce94feb46011	TCGA-55-8206-01		e6817dfb-7634-4321-9627-ce94feb46011	TCGA-55-8206-01		e6817dfb-7634-4321-9627-ce94feb46011	TCGA-55-8206-01A-11D-2238-08	TCGA-55-8206-01	
TCGA-55-8207-01																												TCGA-55-8207-01	High			Cluster 6		LUAD-like c10	miRNA cluster 4			TCGA-55-8207	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					73	L-Lower		TCGA-55-8207-F65849	TCGA-55-8207	TCGA-55-8207-01A			-26897			0	977			48						Scheduled Follow-up Submission	Complete Remission/Response	2014-9-30	MALE	Lung Acinar Adenocarcinoma	No	C34.3	8550/3	C34.3	YES		0.5	NO						0.9	NO		NO			Yes, History of Synchronous/Bilateral Malignancy	MX	N0	T2a	Stage IB	TCGA-55-8207.bf8af6e0-1ea5-4281-a00d-42aa138d781f.pdf	8207		TUMOR FREE	84	83	86	84	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.4		7th	NO	YES	NO	55	3		Lung	A	LIVING	2011					7f0fe109-7153-46a8-81d7-2f132ee513f5				TCGA-55-8207-01A-11D-2237-01	TCGA-55-8207-01A-11D-2239-05	TCGA-55-8207-01	TCGA-55-8207-01A-11D-2237-01		7f0fe109-7153-46a8-81d7-2f132ee513f5	TCGA-55-8207-01		7f0fe109-7153-46a8-81d7-2f132ee513f5	TCGA-55-8207-01		7f0fe109-7153-46a8-81d7-2f132ee513f5	TCGA-55-8207-01A-11D-2238-08	TCGA-55-8207-01	
TCGA-55-8208-01																												TCGA-55-8208-01	High			Cluster 5		LUAD-like c10	miRNA cluster 7			TCGA-55-8208	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung		YES		YES	73	R-Upper		TCGA-55-8208-F59045	TCGA-55-8208			536	-26716			0	674	511		50	0					Scheduled Follow-up Submission	Stable Disease	2014-4-30	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES				100				Peripheral Lung		YES	Distant Metastasis	YES	50		No	M0	N0	T1b	Stage IA		8208	Preoperative	WITH TUMOR	68	151	72	156	Complete Remission/Response	Biopsy with Histologic Confirmation|Convincing Imaging		YES	NO	R0	Primary Tumor	01			7th	NO	YES	NO	55	2		Lung		LIVING	2012					dbeac9fe-cb6a-464c-9a96-d586797b1da0				TCGA-55-8208-01A-11D-2237-01	TCGA-55-8208-01A-11D-2239-05	TCGA-55-8208-01	TCGA-55-8208-01A-11D-2237-01		dbeac9fe-cb6a-464c-9a96-d586797b1da0	TCGA-55-8208-01		dbeac9fe-cb6a-464c-9a96-d586797b1da0	TCGA-55-8208-01		dbeac9fe-cb6a-464c-9a96-d586797b1da0	TCGA-55-8208-01A-11D-2238-08	TCGA-55-8208-01	
TCGA-55-8299-01																												TCGA-55-8299-01	Quiet			Low purity c2		LUAD-like c10	miRNA cluster 4			TCGA-55-8299	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	61	R-Upper		TCGA-55-8299-F57915	TCGA-55-8299				-22626		469	0	216	274								Scheduled Follow-up Submission	Progressive Disease	2014-3-28	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES										NO	Distant Metastasis	YES	20		No	MX	N0	T1b	Stage IA		8299		WITH TUMOR			75	74	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01		2012	7th	NO	YES	NO	55	4		Lung		DECEASED	2012	1971				f835bdde-2b5e-4013-a8d4-0074f66c9317				TCGA-55-8299-01A-11D-2283-01	TCGA-55-8299-01A-11D-2285-05	TCGA-55-8299-01	TCGA-55-8299-01A-11D-2283-01		f835bdde-2b5e-4013-a8d4-0074f66c9317	TCGA-55-8299-01		f835bdde-2b5e-4013-a8d4-0074f66c9317	TCGA-55-8299-01		f835bdde-2b5e-4013-a8d4-0074f66c9317	TCGA-55-8299-01A-11D-2284-08	TCGA-55-8299-01	
TCGA-55-8301-01																												TCGA-55-8301-01	High			Cluster 5		LUAD-like c10	miRNA cluster 4			TCGA-55-8301	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	58	R-Lower		TCGA-55-8301-F56261	TCGA-55-8301				-21535			0	534	238								Scheduled Follow-up Submission	Partial Remission/Response	2014-1-30	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES										NO	Locoregional Recurrence	YES	100		No	MX	N0	T2a	Stage IB		8301		WITH TUMOR					Complete Remission/Response	Convincing Imaging			NO	R0	Primary Tumor	01			7th	NO	YES	NO	55	2		Lung		LIVING	2012	1962				aca30642-6479-4cfb-bcac-b9b5e45c5686				TCGA-55-8301-01A-11D-2283-01	TCGA-55-8301-01A-11D-2285-05	TCGA-55-8301-01	TCGA-55-8301-01A-11D-2283-01		aca30642-6479-4cfb-bcac-b9b5e45c5686	TCGA-55-8301-01		aca30642-6479-4cfb-bcac-b9b5e45c5686	TCGA-55-8301-01		aca30642-6479-4cfb-bcac-b9b5e45c5686	TCGA-55-8301-01A-11D-2284-08	TCGA-55-8301-01	
TCGA-55-8302-01																												TCGA-55-8302-01				Cluster 6			miRNA cluster 4			TCGA-55-8302	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					54	R-Lower		TCGA-55-8302-F56188	TCGA-55-8302				-20011			0	478									Scheduled Follow-up Submission	Complete Remission/Response	2014-1-29	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES										NO		NO	59		No	MX	N0	T2	Stage IB		8302		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01			7th	NO	YES	NO	55	2		Lung		LIVING	2012	1965				db0d3ef1-a8d7-4a5e-863e-f9e2717dee54				TCGA-55-8302-01A-11D-2322-01	TCGA-55-8302-01A-11D-2324-05	TCGA-55-8302-01	TCGA-55-8302-01A-11D-2322-01		db0d3ef1-a8d7-4a5e-863e-f9e2717dee54	TCGA-55-8302-01		db0d3ef1-a8d7-4a5e-863e-f9e2717dee54	TCGA-55-8302-01		db0d3ef1-a8d7-4a5e-863e-f9e2717dee54	TCGA-55-8302-01A-11D-2323-08	TCGA-55-8302-01	
TCGA-55-8505-01																												TCGA-55-8505-01										TCGA-55-8505	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					62	R-Lower		TCGA-55-8505-F47798	TCGA-55-8505	TCGA-55-8505-01A			-22676			0	440									Scheduled Follow-up Submission	Complete Remission/Response	2013-8-28	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.7	NO						1.2	NO		NO			No	MX	N2	T1a	Stage IIIA	TCGA-55-8505.401f1ed0-5da9-442f-ac17-6394e72e88ae.pdf	8505		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.4		7th	YES	YES	NO	55	1		Lung	A	LIVING	2012					865eece0-5e69-4878-b504-af3eb071273d				TCGA-55-8505-01A-11D-2389-01	TCGA-55-8505-01A-11D-2398-05	TCGA-55-8505-01	TCGA-55-8505-01A-11D-2389-01		865eece0-5e69-4878-b504-af3eb071273d	TCGA-55-8505-01		865eece0-5e69-4878-b504-af3eb071273d	TCGA-55-8505-01	B6E226D1-F5A3-4547-9CAA-0DC89085EFC6	865eece0-5e69-4878-b504-af3eb071273d	TCGA-55-8505-01A-11D-2393-08	TCGA-55-8505-01	
TCGA-55-8506-01																												TCGA-55-8506-01										TCGA-55-8506	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					62	R-Upper			TCGA-55-8506	TCGA-55-8506-01A			-22850			0	11											2012-12-28	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO					Peripheral Lung	1.1			NO			No	MX	N0	T3	Stage IIB	TCGA-55-8506.448de79c-d662-4783-a7c8-32a224ee5375.pdf	8506												R0	Primary Tumor	01	0.4		7th		YES	NO	55	2		Lung	A	LIVING	2012	1972				db1370cf-7ca5-45ed-bba6-751f28e39825				TCGA-55-8506-01A-11D-2389-01	TCGA-55-8506-01A-11D-2398-05	TCGA-55-8506-01	TCGA-55-8506-01A-11D-2389-01		db1370cf-7ca5-45ed-bba6-751f28e39825	TCGA-55-8506-01		db1370cf-7ca5-45ed-bba6-751f28e39825	TCGA-55-8506-01	D0E66396-D304-41F3-86F4-96D2CED6FFC6	db1370cf-7ca5-45ed-bba6-751f28e39825	TCGA-55-8506-01A-11D-2393-08	TCGA-55-8506-01	
TCGA-55-8507-01																												TCGA-55-8507-01										TCGA-55-8507	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					53	R-Upper		TCGA-55-8507-F48792	TCGA-55-8507	TCGA-55-8507-01A			-19390			0	418				3					Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO	40				Peripheral Lung	1	NO		NO	120		No	MX	N0	T1a	Stage IA	TCGA-55-8507.2658f9b1-c419-42f1-944c-8148b00e13b0.pdf	8507	Other	TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.4		7th	NO	YES	NO	55	2		Lung	A	LIVING	2012	1972				758f95a1-8aca-43d0-aff2-39566606f88d				TCGA-55-8507-01A-11D-2389-01	TCGA-55-8507-01A-11D-2398-05	TCGA-55-8507-01	TCGA-55-8507-01A-11D-2389-01		758f95a1-8aca-43d0-aff2-39566606f88d	TCGA-55-8507-01		758f95a1-8aca-43d0-aff2-39566606f88d	TCGA-55-8507-01	B44F82B6-93CE-409D-9C12-B7AB7364C200	758f95a1-8aca-43d0-aff2-39566606f88d	TCGA-55-8507-01A-11D-2393-08	TCGA-55-8507-01	
TCGA-55-8508-01																												TCGA-55-8508-01										TCGA-55-8508	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					60	R-Upper		TCGA-55-8508-F66137	TCGA-55-8508	TCGA-55-8508-01A			-22159			0	617				2					Scheduled Follow-up Submission	Complete Remission/Response	2014-10-3	FEMALE	Mucinous (Colloid) Carcinoma	No	C34.1	8480/3	C34.1	YES		0.7	NO	60				Central Lung	1	NO		NO			No	MX	N1	T2a	Stage IIA	TCGA-55-8508.c5d96896-7988-469a-b521-39affeab8f95.pdf	8508	Preoperative	TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.5		7th	YES	YES	NO	55	2		Lung	A	LIVING	2012					5a4f0f21-a774-46cd-a5ba-525029761d94				TCGA-55-8508-01A-11D-2389-01	TCGA-55-8508-01A-11D-2398-05	TCGA-55-8508-01	TCGA-55-8508-01A-11D-2389-01		5a4f0f21-a774-46cd-a5ba-525029761d94	TCGA-55-8508-01		5a4f0f21-a774-46cd-a5ba-525029761d94	TCGA-55-8508-01		5a4f0f21-a774-46cd-a5ba-525029761d94	TCGA-55-8508-01A-11D-2393-08	TCGA-55-8508-01	
TCGA-55-8510-01																												TCGA-55-8510-01										TCGA-55-8510	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					55	R-Lower		TCGA-55-8510-F57923	TCGA-55-8510	TCGA-55-8510-01A			-20410			0	539			54						Scheduled Follow-up Submission	Complete Remission/Response	2014-3-28	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1	NO						1.2	NO		NO			No	MX	N0	T2a	Stage IB	TCGA-55-8510.54ad9f1a-326f-4cc6-991a-6717bfbaed35.pdf	8510		TUMOR FREE	90	70	98	70	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.4		7th	NO	YES	NO	55	2		Lung	A	LIVING	2012					3088dac7-68b6-42f3-82eb-ff2bd451d7c5				TCGA-55-8510-01A-11D-2389-01	TCGA-55-8510-01A-11D-2398-05	TCGA-55-8510-01	TCGA-55-8510-01A-11D-2389-01		3088dac7-68b6-42f3-82eb-ff2bd451d7c5	TCGA-55-8510-01		3088dac7-68b6-42f3-82eb-ff2bd451d7c5	TCGA-55-8510-01		3088dac7-68b6-42f3-82eb-ff2bd451d7c5	TCGA-55-8510-01A-11D-2393-08	TCGA-55-8510-01	
TCGA-55-8511-01																												TCGA-55-8511-01										TCGA-55-8511	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO	NO	73	R-Upper		TCGA-55-8511-F66028	TCGA-55-8511				-26986			0	552	460		31	2					Scheduled Follow-up Submission	Progressive Disease	2014-10-1	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES				70						NO		YES	58		Yes, History of Prior Malignancy	MX	N0	T2a	Stage IB		8511	Preoperative	WITH TUMOR			82	53	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	NO	YES	NO	55	2		Lung		LIVING	2012	1953				db0a4e20-b5ad-4034-ae70-1e3747cdaa1f				TCGA-55-8511-01A-11D-2389-01	TCGA-55-8511-01A-11D-2398-05	TCGA-55-8511-01	TCGA-55-8511-01A-11D-2389-01		db0a4e20-b5ad-4034-ae70-1e3747cdaa1f	TCGA-55-8511-01		db0a4e20-b5ad-4034-ae70-1e3747cdaa1f	TCGA-55-8511-01		db0a4e20-b5ad-4034-ae70-1e3747cdaa1f	TCGA-55-8511-01A-11D-2393-08	TCGA-55-8511-01	
TCGA-55-8512-01																												TCGA-55-8512-01										TCGA-55-8512	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					41	R-Lower		TCGA-55-8512-F64286	TCGA-55-8512				-15266		607	0	3				1					Scheduled Follow-up Submission	Progressive Disease	2014-8-28	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES				90						NO		NO	19		No	M1b	N1	T1a	Stage IV		8512	Preoperative	WITH TUMOR					Progressive Disease			NO	NO	R0	Primary Tumor	01			7th	NO	YES	NO	55	2		Lung		DECEASED	2012	1989				e776b3c7-2afe-4f44-8596-4c0de62fd46d				TCGA-55-8512-01A-11D-2389-01	TCGA-55-8512-01A-11D-2398-05	TCGA-55-8512-01	TCGA-55-8512-01A-11D-2389-01		e776b3c7-2afe-4f44-8596-4c0de62fd46d	TCGA-55-8512-01		e776b3c7-2afe-4f44-8596-4c0de62fd46d	TCGA-55-8512-01		e776b3c7-2afe-4f44-8596-4c0de62fd46d	TCGA-55-8512-01A-11D-2393-08	TCGA-55-8512-01	
TCGA-55-8513-01																												TCGA-55-8513-01										TCGA-55-8513	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	NO	77	L-Lower		TCGA-55-8513-F64283	TCGA-55-8513	TCGA-55-8513-01A			-28284			0	791	317		65	2	YES			YES	Scheduled Follow-up Submission	Stable Disease	2014-8-28	FEMALE	Mucinous (Colloid) Carcinoma	No	C34.30	8480/3	C34.3	YES		0.9	NO	60					1	NO	Distant Metastasis	YES			No	MX	N0	T3	Stage IIB	TCGA-55-8513.a93a99a9-075c-4bc4-9cf8-2d7fbc3e8d80.pdf	8513	Other	WITH TUMOR			108	87	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01	0.4		7th	NO	YES	NO	55	1		Lung	A	LIVING	2012					518328ff-5705-456f-b71a-a194fc526653				TCGA-55-8513-01A-11D-2389-01	TCGA-55-8513-01A-11D-2398-05	TCGA-55-8513-01	TCGA-55-8513-01A-11D-2389-01		518328ff-5705-456f-b71a-a194fc526653	TCGA-55-8513-01		518328ff-5705-456f-b71a-a194fc526653	TCGA-55-8513-01		518328ff-5705-456f-b71a-a194fc526653	TCGA-55-8513-01A-11D-2393-08	TCGA-55-8513-01	
TCGA-55-8514-01																												TCGA-55-8514-01										TCGA-55-8514	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	R-Upper		TCGA-55-8514-F57917	TCGA-55-8514				-25608			0	520			90						Scheduled Follow-up Submission	Complete Remission/Response	2014-3-28	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES										NO		NO	20		No	MX	N0	T2a	Stage IB		8514		TUMOR FREE			114	85	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		2011	7th	NO	YES	NO	55	4		Lung		LIVING	2012	1971				bdaceebb-1720-4ed0-b4e2-e3dec1d2335b				TCGA-55-8514-01A-11D-2389-01	TCGA-55-8514-01A-11D-2398-05	TCGA-55-8514-01	TCGA-55-8514-01A-11D-2389-01		bdaceebb-1720-4ed0-b4e2-e3dec1d2335b	TCGA-55-8514-01		bdaceebb-1720-4ed0-b4e2-e3dec1d2335b	TCGA-55-8514-01		bdaceebb-1720-4ed0-b4e2-e3dec1d2335b	TCGA-55-8514-01A-11D-2393-08	TCGA-55-8514-01	
TCGA-55-8614-01																												TCGA-55-8614-01										TCGA-55-8614	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					76	L-Upper		TCGA-55-8614-F47843	TCGA-55-8614	TCGA-55-8614-01A			-27924			0	536			113						Scheduled Follow-up Submission	Complete Remission/Response	2013-8-29	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.4	NO						0.7	NO		NO	40		No	MX	N0	T2a	Stage IB	TCGA-55-8614.f443d31b-ee7f-4285-9529-6f04a8dad0d5.pdf	8614		TUMOR FREE				94	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.3	1995	7th	NO	YES	NO	55	3		Lung	A	LIVING	2011					80c995f9-48bf-49a7-82ac-27d646b93e81				TCGA-55-8614-01A-11D-2389-01	TCGA-55-8614-01A-11D-2398-05	TCGA-55-8614-01	TCGA-55-8614-01A-11D-2389-01		80c995f9-48bf-49a7-82ac-27d646b93e81	TCGA-55-8614-01		80c995f9-48bf-49a7-82ac-27d646b93e81	TCGA-55-8614-01		80c995f9-48bf-49a7-82ac-27d646b93e81	TCGA-55-8614-01A-11D-2393-08	TCGA-55-8614-01	
TCGA-55-8615-01																												TCGA-55-8615-01										TCGA-55-8615	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	67	R-Middle		TCGA-55-8615-F56254	TCGA-55-8615	TCGA-55-8615-01A			-24786			0	446	224		83						Scheduled Follow-up Submission	Progressive Disease	2014-1-30	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES		0.9	NO						0.9	NO	Distant Metastasis	YES	67		No	MX	N2	T3	Stage IIIA	TCGA-55-8615.37b4238a-1aea-4670-8c43-b24525b94cdd.pdf	8615		WITH TUMOR				88	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01	0.6		7th	YES	YES	NO	55	2		Lung	A	LIVING	2012	1966				50d1ad39-3545-422e-b8fa-440e68eeebf3				TCGA-55-8615-01A-11D-2389-01	TCGA-55-8615-01A-11D-2398-05	TCGA-55-8615-01	TCGA-55-8615-01A-11D-2389-01		50d1ad39-3545-422e-b8fa-440e68eeebf3	TCGA-55-8615-01		50d1ad39-3545-422e-b8fa-440e68eeebf3	TCGA-55-8615-01		50d1ad39-3545-422e-b8fa-440e68eeebf3	TCGA-55-8615-01A-11D-2393-08	TCGA-55-8615-01	
TCGA-55-8616-01																												TCGA-55-8616-01										TCGA-55-8616	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					58	R-Upper			TCGA-55-8616	TCGA-55-8616-01A			-21225			0	48				0							2012-12-28	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.4	NO						0.5			NO			No	M0	N0	T2a	Stage IB	TCGA-55-8616.4506aced-56d2-4297-9a5c-40539f20be87.pdf	8616	Preoperative	TUMOR FREE										R0	Primary Tumor	01	0.2	1999	7th		YES	NO	55	4		Lung	A	LIVING	2012					78dd0304-d459-4d26-b0ba-39a8078c59d0				TCGA-55-8616-01A-11D-2389-01	TCGA-55-8616-01A-11D-2398-05	TCGA-55-8616-01	TCGA-55-8616-01A-11D-2389-01		78dd0304-d459-4d26-b0ba-39a8078c59d0	TCGA-55-8616-01		78dd0304-d459-4d26-b0ba-39a8078c59d0	TCGA-55-8616-01		78dd0304-d459-4d26-b0ba-39a8078c59d0	TCGA-55-8616-01A-11D-2393-08	TCGA-55-8616-01	
TCGA-55-8619-01																												TCGA-55-8619-01										TCGA-55-8619	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	R-Lower		TCGA-55-8619-F57919	TCGA-55-8619	TCGA-55-8619-01A			-26616			0	416									Scheduled Follow-up Submission	Complete Remission/Response	2014-3-28	FEMALE	Mucinous (Colloid) Carcinoma	No	C34.30	8480/3	C34.3	YES		0.8	NO	90					1.2	NO		NO			Yes, History of Prior Malignancy	MX	N0	T3	Stage IIB	TCGA-55-8619.dcbc1e01-c61a-4d30-b741-965c99418ecf.pdf	8619	Preoperative	TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.6		7th	NO	YES	NO	55	1		Lung	A	LIVING	2012					9d7459be-af93-4bf3-8d54-df569a16ee12				TCGA-55-8619-01A-11D-2389-01	TCGA-55-8619-01A-11D-2398-05	TCGA-55-8619-01	TCGA-55-8619-01A-11D-2389-01		9d7459be-af93-4bf3-8d54-df569a16ee12	TCGA-55-8619-01		9d7459be-af93-4bf3-8d54-df569a16ee12	TCGA-55-8619-01		9d7459be-af93-4bf3-8d54-df569a16ee12	TCGA-55-8619-01A-11D-2393-08	TCGA-55-8619-01	
TCGA-55-8620-01																												TCGA-55-8620-01										TCGA-55-8620	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					60	L-Upper		TCGA-55-8620-F59081	TCGA-55-8620	TCGA-55-8620-01A			-22091		375	0	66			64	2	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2014-4-30	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO	70	NO			Central Lung	1	NO		NO	154		No	M1b	N1	T1a	Stage IV	TCGA-55-8620.d74a185a-8e07-46ca-861e-14b0012ddf22.pdf	8620	Preoperative	WITH TUMOR			73	76	Progressive Disease			YES	YES	R0	Primary Tumor	01	0.5	2012	7th	NO	YES	NO	55	4		Lung	A	DECEASED	2012	1965				777c61bc-aa43-4661-a1d3-7a2f07dc055a				TCGA-55-8620-01A-11D-2389-01	TCGA-55-8620-01A-11D-2398-05	TCGA-55-8620-01	TCGA-55-8620-01A-11D-2389-01		777c61bc-aa43-4661-a1d3-7a2f07dc055a	TCGA-55-8620-01		777c61bc-aa43-4661-a1d3-7a2f07dc055a	TCGA-55-8620-01	07DE1409-5B24-4603-B9E0-E53E42D4CEA1	777c61bc-aa43-4661-a1d3-7a2f07dc055a	TCGA-55-8620-01A-11D-2393-08	TCGA-55-8620-01	
TCGA-55-8621-01																												TCGA-55-8621-01										TCGA-55-8621	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					75	L-Lower		TCGA-55-8621-F48791	TCGA-55-8621	TCGA-55-8621-01A			-27485			0	515				1					Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.6	NO	90					0.7	NO		NO	30		Yes, History of Prior Malignancy	MX	N0	T1a	Stage IA	TCGA-55-8621.22990911-a16f-4607-8722-c610ed1c590b.pdf	8621	Other	TUMOR FREE	112	105	110	105	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.6	2010	7th	NO	YES	NO	55	4		Lung	A	LIVING	2012	1980				7eb83c83-31e0-435b-8866-9d2764098800				TCGA-55-8621-01A-11D-2389-01	TCGA-55-8621-01A-11D-2398-05	TCGA-55-8621-01	TCGA-55-8621-01A-11D-2389-01		7eb83c83-31e0-435b-8866-9d2764098800	TCGA-55-8621-01		7eb83c83-31e0-435b-8866-9d2764098800	TCGA-55-8621-01		7eb83c83-31e0-435b-8866-9d2764098800	TCGA-55-8621-01A-11D-2393-08	TCGA-55-8621-01	
TCGA-55-A48X-01																												TCGA-55-A48X-01										TCGA-55-A48X	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	YES		63	L-Lower		TCGA-55-A48X-F61500	TCGA-55-A48X	TCGA-55-A48X-01A	615		-23341	111		0	689	615		79						Scheduled Follow-up Submission	Complete Remission/Response	2014-6-30	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	30		NO							NO	New Primary Tumor	YES	36	false	Yes, History of Prior Malignancy	M0	N1	T1b	Stage IIA	TCGA-55-A48X.4D06D10F-60F5-4417-BD8E-F2BBCA84BEEB.pdf	A48X		TUMOR FREE				57	Complete Remission/Response	Biopsy with Histologic Confirmation		YES	NO	R0	Primary Tumor	01		1999	7th	YES	YES	NO	55	4		Lung	A	LIVING	2012	1963				439804ec-6110-4628-b3ea-fa807c346846				TCGA-55-A48X-01A-11D-A24C-01	TCGA-55-A48X-01A-11D-A24I-05	TCGA-55-A48X-01	TCGA-55-A48X-01A-11D-A24C-01		439804ec-6110-4628-b3ea-fa807c346846	TCGA-55-A48X-01		439804ec-6110-4628-b3ea-fa807c346846	TCGA-55-A48X-01		439804ec-6110-4628-b3ea-fa807c346846	TCGA-55-A48X-01A-11D-A24D-08	TCGA-55-A48X-01	
TCGA-55-A48Y-01																												TCGA-55-A48Y-01										TCGA-55-A48Y	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	L-Lower		TCGA-55-A48Y-F59057	TCGA-55-A48Y	TCGA-55-A48Y-01A			-25384	107		0	630			42						Scheduled Follow-up Submission	Complete Remission/Response	2014-4-30	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	10		NO							NO		NO	50	false	No	M0	N0	T2b	Stage IIA	TCGA-55-A48Y.3542521A-EA16-4CD1-A61A-1FB3AE928FC9.pdf	A48Y		TUMOR FREE				38	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	YES	YES	NO	55	2		Lung	A	LIVING	2012	1962				3b576c81-9276-4177-90e9-355f641f734c				TCGA-55-A48Y-01A-11D-A24C-01	TCGA-55-A48Y-01A-11D-A24I-05	TCGA-55-A48Y-01	TCGA-55-A48Y-01A-11D-A24C-01		3b576c81-9276-4177-90e9-355f641f734c	TCGA-55-A48Y-01		3b576c81-9276-4177-90e9-355f641f734c	TCGA-55-A48Y-01		3b576c81-9276-4177-90e9-355f641f734c	TCGA-55-A48Y-01A-11D-A24D-08	TCGA-55-A48Y-01	
TCGA-55-A48Z-01																												TCGA-55-A48Z-01										TCGA-55-A48Z	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	60	R-Upper		TCGA-55-A48Z-F59061	TCGA-55-A48Z	TCGA-55-A48Z-01A			-22056	64		0	651	536		110	2	YES	Other	FISH	YES	Scheduled Follow-up Submission		2014-4-30	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	70		NO	70	YES	NO		Central Lung		NO	Distant Metastasis	YES	40	false	No	MX	N3	T1a	Stage IIIB	TCGA-55-A48Z.74C5526C-5300-4AEA-B2BB-1B78F9B536D9.pdf	A48Z	Preoperative	WITH TUMOR			85	87	Stable Disease	Convincing Imaging		YES	YES	R0	Primary Tumor	01		2012	7th	YES	YES	NO	55	4		Lung	A	LIVING	2012	1972				6499ffb8-c649-4881-8ca1-95d84842083b				TCGA-55-A48Z-01A-12D-A24O-01	TCGA-55-A48Z-01A-12D-A24U-05	TCGA-55-A48Z-01	TCGA-55-A48Z-01A-12D-A24O-01		6499ffb8-c649-4881-8ca1-95d84842083b	TCGA-55-A48Z-01		6499ffb8-c649-4881-8ca1-95d84842083b	TCGA-55-A48Z-01		6499ffb8-c649-4881-8ca1-95d84842083b	TCGA-55-A48Z-01A-12D-A24P-08	TCGA-55-A48Z-01	
TCGA-55-A490-01																												TCGA-55-A490-01										TCGA-55-A490	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					78	R-Upper		TCGA-55-A490-F59076	TCGA-55-A490				-28728		99	0	48			40	1	YES		FISH	YES	Scheduled Follow-up Submission		2014-4-30	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES				80	YES	YES	G12C	Peripheral Lung		NO		NO	34		No	MX	N0	T2b	Stage IIA		A490	Preoperative	TUMOR FREE			60	56				YES	NO	R0	Primary Tumor	01		1985	7th	YES	YES	NO	55	3		Lung		DECEASED	2012	1951				abbff93f-d9f6-4db6-b769-6b4e36a7de0d				TCGA-55-A490-01A-11D-A24C-01	TCGA-55-A490-01A-11D-A24I-05	TCGA-55-A490-01	TCGA-55-A490-01A-11D-A24C-01		abbff93f-d9f6-4db6-b769-6b4e36a7de0d	TCGA-55-A490-01		abbff93f-d9f6-4db6-b769-6b4e36a7de0d	TCGA-55-A490-01		abbff93f-d9f6-4db6-b769-6b4e36a7de0d	TCGA-55-A490-01A-11D-A24D-08	TCGA-55-A490-01	
TCGA-55-A491-01																												TCGA-55-A491-01										TCGA-55-A491	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					81	L-Lower		TCGA-55-A491-F60134	TCGA-55-A491	TCGA-55-A491-01A			-29593	31		0	626			68	2	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-5-29	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	10		NO	80	NO					NO		NO	45	false	Yes, History of Prior Malignancy	MX	N0	T1b	Stage IA	TCGA-55-A491.EE286E94-9CDB-4E6C-A768-BB35DA870736.pdf	A491	Other	TUMOR FREE	73	68	72	64	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1982	7th	NO	YES	NO	55	3		Lung	A	LIVING	2012	1952				768f6ac0-d742-4dda-a695-c75070a5511a				TCGA-55-A491-01A-11D-A24C-01	TCGA-55-A491-01A-11D-A24I-05	TCGA-55-A491-01	TCGA-55-A491-01A-11D-A24C-01		768f6ac0-d742-4dda-a695-c75070a5511a	TCGA-55-A491-01		768f6ac0-d742-4dda-a695-c75070a5511a	TCGA-55-A491-01		768f6ac0-d742-4dda-a695-c75070a5511a	TCGA-55-A491-01A-11D-A24D-08	TCGA-55-A491-01	
TCGA-55-A492-01																												TCGA-55-A492-01										TCGA-55-A492	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	R-Upper		TCGA-55-A492-F60135	TCGA-55-A492				-25719			0	596			52	2	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-5-29	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES				80	NO					NO		NO	35		Yes, History of Prior Malignancy	MX	N0	T1a	Stage IA		A492	Other	TUMOR FREE		92		95	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1995	7th	NO	YES	NO	55	3		Lung		LIVING	2012	1962				ba477731-a4c6-4e1c-b44c-1964672a777c				TCGA-55-A492-01A-11D-A24C-01	TCGA-55-A492-01A-11D-A24I-05	TCGA-55-A492-01	TCGA-55-A492-01A-11D-A24C-01		ba477731-a4c6-4e1c-b44c-1964672a777c	TCGA-55-A492-01		ba477731-a4c6-4e1c-b44c-1964672a777c	TCGA-55-A492-01		ba477731-a4c6-4e1c-b44c-1964672a777c	TCGA-55-A492-01A-11D-A24D-08	TCGA-55-A492-01	
TCGA-55-A493-01																												TCGA-55-A493-01										TCGA-55-A493	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					54	R-Upper			TCGA-55-A493				-20027			0	28			102		NO			NO			2013-2-21	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO							NO	53		No	M0	N0	T2a	Stage IB		A493		TUMOR FREE	71	2	65	2				NO		R0	Primary Tumor	01			7th		YES	NO	55	2		Lung		LIVING	2012	1977				ca04916e-5edc-4481-81d0-b0cc56925005				TCGA-55-A493-01A-11D-A24C-01	TCGA-55-A493-01A-11D-A24I-05	TCGA-55-A493-01	TCGA-55-A493-01A-11D-A24C-01		ca04916e-5edc-4481-81d0-b0cc56925005	TCGA-55-A493-01		ca04916e-5edc-4481-81d0-b0cc56925005	TCGA-55-A493-01		ca04916e-5edc-4481-81d0-b0cc56925005	TCGA-55-A493-01A-11D-A24D-08	TCGA-55-A493-01	
TCGA-55-A494-01																												TCGA-55-A494-01										TCGA-55-A494	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	R-Lower		TCGA-55-A494-F59038	TCGA-55-A494	TCGA-55-A494-01A			-22540	28		0	481			76	1	YES		FISH	YES	Scheduled Follow-up Submission	Complete Remission/Response	2014-4-30	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	60		NO	80	YES	YES	G12D	Peripheral Lung		NO		NO	7	false	No	MX	N0	T2a	Stage IB	TCGA-55-A494.6FB7C18D-27D8-4C04-B8F8-AA7EA16F8C8A.pdf	A494	Preoperative	TUMOR FREE			95	77	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1980	7th	NO	YES	NO	55	3		Lung	A	LIVING	2012	1967				5e532c06-5ffc-4f37-9792-2ce23146d15e				TCGA-55-A494-01A-11D-A24O-01	TCGA-55-A494-01A-11D-A24U-05	TCGA-55-A494-01	TCGA-55-A494-01A-11D-A24O-01		5e532c06-5ffc-4f37-9792-2ce23146d15e	TCGA-55-A494-01		5e532c06-5ffc-4f37-9792-2ce23146d15e	TCGA-55-A494-01	2A3F818A-CFBA-413A-948F-95D2D0274C5A	5e532c06-5ffc-4f37-9792-2ce23146d15e	TCGA-55-A494-01A-11D-A24P-08	TCGA-55-A494-01	
TCGA-55-A4DF-01																												TCGA-55-A4DF-01										TCGA-55-A4DF	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	88	R-Lower		TCGA-55-A4DF-F59072	TCGA-55-A4DF				-32432		614	0	47	515		82						Scheduled Follow-up Submission	Progressive Disease	2014-4-30	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES										NO	Distant Metastasis	YES	60		Yes, History of Synchronous/Bilateral Malignancy	MX	N0	T1b	Stage IA		A4DF		WITH TUMOR		58		47	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01		1984	7th	NO	YES	NO	55	3		Lung		DECEASED	2012					bf1fd845-aa87-49e7-8bd9-1443d6a3799c				TCGA-55-A4DF-01A-11D-A24C-01	TCGA-55-A4DF-01A-11D-A24I-05	TCGA-55-A4DF-01	TCGA-55-A4DF-01A-11D-A24C-01		bf1fd845-aa87-49e7-8bd9-1443d6a3799c	TCGA-55-A4DF-01		bf1fd845-aa87-49e7-8bd9-1443d6a3799c	TCGA-55-A4DF-01		bf1fd845-aa87-49e7-8bd9-1443d6a3799c	TCGA-55-A4DF-01A-11D-A24D-08	TCGA-55-A4DF-01	
TCGA-55-A4DG-01																												TCGA-55-A4DG-01										TCGA-55-A4DG	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	R-Upper		TCGA-55-A4DG-F59047	TCGA-55-A4DG	TCGA-55-A4DG-01A			-26044	229		0	608			61						Scheduled Follow-up Submission	Complete Remission/Response	2014-4-30	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	50		NO							NO		NO	100	false	No	MX	N0	T1b	Stage IA	TCGA-55-A4DG.E1EA2600-CEEE-4009-A2E7-D845153DB167.pdf	A4DG		TUMOR FREE			73		Complete Remission/Response			YES	NO	R0	Primary Tumor	01		2012	7th	NO	YES	NO	55	4		Lung	A	LIVING	2012					1dd50bb6-84d4-4e07-ba01-802f470b46dd				TCGA-55-A4DG-01A-11D-A24C-01	TCGA-55-A4DG-01A-11D-A24I-05	TCGA-55-A4DG-01	TCGA-55-A4DG-01A-11D-A24C-01		1dd50bb6-84d4-4e07-ba01-802f470b46dd	TCGA-55-A4DG-01		1dd50bb6-84d4-4e07-ba01-802f470b46dd	TCGA-55-A4DG-01		1dd50bb6-84d4-4e07-ba01-802f470b46dd	TCGA-55-A4DG-01A-11D-A24D-08	TCGA-55-A4DG-01	
TCGA-55-A57B-01																												TCGA-55-A57B-01										TCGA-55-A57B	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					80	L-Upper		TCGA-55-A57B-F60133	TCGA-55-A57B	TCGA-55-A57B-01A			-29452	64		0	546			77	0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-5-29	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	70		NO	90	NO			Peripheral Lung		NO		NO		false	No	M0	N0	T1b	Stage IA	TCGA-55-A57B.8231F2AB-F7AC-4866-BFA0-F902E2EC18B4.pdf	A57B	Preoperative	TUMOR FREE			99	114	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	NO	YES	NO	55	1		Lung	A	LIVING	2012					9c08d387-1d4f-4aee-a985-04cb01fc2b07				TCGA-55-A57B-01A-12D-A396-01	TCGA-55-A57B-01A-12D-A398-05	TCGA-55-A57B-01	TCGA-55-A57B-01A-12D-A396-01		9c08d387-1d4f-4aee-a985-04cb01fc2b07	TCGA-55-A57B-01		9c08d387-1d4f-4aee-a985-04cb01fc2b07	TCGA-55-A57B-01		9c08d387-1d4f-4aee-a985-04cb01fc2b07		TCGA-55-A57B-01	
TCGA-62-8394-01																												TCGA-62-8394-01				Cluster 5			miRNA cluster 4			TCGA-62-8394	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					65	L-Lower			TCGA-62-8394	TCGA-62-8394-01A			-23758		139	0						NO			NO			2012-7-5	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.6	NO	100	NO			Central Lung	0.7			NO			No	M0	N2	T4	Stage IIIB	TCGA-62-8394.ffcaea73-0146-4b42-aa1d-e032f6944e3d.pdf	8394	Preoperative	TUMOR FREE			74	115	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.3		6th	YES	NO	YES	62	1		Lung	A	DECEASED	2008					9713f322-bae0-47aa-88d5-e2c50a7bd687				TCGA-62-8394-01A-11D-2322-01	TCGA-62-8394-01A-11D-2324-05	TCGA-62-8394-01	TCGA-62-8394-01A-11D-2322-01		9713f322-bae0-47aa-88d5-e2c50a7bd687	TCGA-62-8394-01		9713f322-bae0-47aa-88d5-e2c50a7bd687	TCGA-62-8394-01	44C9E47E-2ED2-4F88-A818-0525053D2D7C	9713f322-bae0-47aa-88d5-e2c50a7bd687	TCGA-62-8394-01A-11D-2323-08	TCGA-62-8394-01	
TCGA-62-8395-01																												TCGA-62-8395-01				Cluster 6			miRNA cluster 4			TCGA-62-8395	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO		80	R-Upper		TCGA-62-8395-F42099	TCGA-62-8395	TCGA-62-8395-01A			-29311			0	1216	395			0	YES			NO	Scheduled Follow-up Submission	Progressive Disease	2013-5-15	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.6	NO	100	NO			Central Lung	1	NO	Locoregional Recurrence	YES			No	M0	N0	T3	Stage IIB	TCGA-62-8395.d30859b7-5af5-4579-854b-bab436e3ae9a.pdf	8395	Preoperative	WITH TUMOR			86	130	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01	0.5		6th	NO	NO	YES	62	1		Lung	A	LIVING	2009					69b5d608-a290-4534-ada5-59055c352fac				TCGA-62-8395-01A-11D-2322-01	TCGA-62-8395-01A-11D-2324-05	TCGA-62-8395-01	TCGA-62-8395-01A-11D-2322-01		69b5d608-a290-4534-ada5-59055c352fac	TCGA-62-8395-01		69b5d608-a290-4534-ada5-59055c352fac	TCGA-62-8395-01	E405D3EB-1B7B-494A-8268-7A889BEB4B7D	69b5d608-a290-4534-ada5-59055c352fac	TCGA-62-8395-01A-11D-2323-08	TCGA-62-8395-01	
TCGA-62-8397-01																												TCGA-62-8397-01				Cluster 5			miRNA cluster 4			TCGA-62-8397	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	R-Lower		TCGA-62-8397-F42100	TCGA-62-8397	TCGA-62-8397-01A			-25728			0	1289				0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-5-15	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.5	NO	90	NO			Peripheral Lung	0.6	NO		NO			No	M0	N0	T3	Stage IIB	TCGA-62-8397.129e57ab-653d-4b31-8777-0fdd6d01a89d.pdf	8397	Preoperative	TUMOR FREE			64	86	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.4		6th	NO	NO	YES	62	1		Lung	A	LIVING	2008					360f4431-8dc9-4bc0-a388-c88bd46766c7				TCGA-62-8397-01A-11D-2322-01	TCGA-62-8397-01A-11D-2324-05	TCGA-62-8397-01	TCGA-62-8397-01A-11D-2322-01		360f4431-8dc9-4bc0-a388-c88bd46766c7	TCGA-62-8397-01		360f4431-8dc9-4bc0-a388-c88bd46766c7	TCGA-62-8397-01		360f4431-8dc9-4bc0-a388-c88bd46766c7	TCGA-62-8397-01A-11D-2323-08	TCGA-62-8397-01	
TCGA-62-8398-01																												TCGA-62-8398-01				Cluster 5			miRNA cluster 4			TCGA-62-8398	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					55	R-Lower			TCGA-62-8398	TCGA-62-8398-01A			-20197		444	0						NO			NO			2012-7-4	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.6	NO	100	NO			Central Lung	1			NO	20		No	M0	N2	T2	Stage IIIA	TCGA-62-8398.49359dce-0df1-4d52-87e8-aba44fd43363.pdf	8398	Preoperative	TUMOR FREE			72	64	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.3	1999	6th	YES	NO	YES	62	4		Lung	A	DECEASED	2007	1970				82de5dc9-2d34-4395-ae7c-430b5632ed24				TCGA-62-8398-01A-11D-2322-01	TCGA-62-8398-01A-11D-2324-05	TCGA-62-8398-01	TCGA-62-8398-01A-11D-2322-01		82de5dc9-2d34-4395-ae7c-430b5632ed24	TCGA-62-8398-01		82de5dc9-2d34-4395-ae7c-430b5632ed24	TCGA-62-8398-01	D52B4AD3-D7AE-4398-B34C-DC0FD9D3173A	82de5dc9-2d34-4395-ae7c-430b5632ed24	TCGA-62-8398-01A-11D-2323-08	TCGA-62-8398-01	
TCGA-62-8399-01																												TCGA-62-8399-01				Cluster 5			miRNA cluster 4			TCGA-62-8399	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					62	L-Upper		TCGA-62-8399-F52545	TCGA-62-8399				-22952			0	2696					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-12-4	MALE	Lung Papillary Adenocarcinoma	No	C34.1	8255/3	C34.1	YES				100	NO			Peripheral Lung		NO		NO	70		No	M0	N2	T2	Stage IIIA		8399	Preoperative	TUMOR FREE			48	32	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			6th	NO	NO	YES	62	4		Lung		LIVING	2006					b1235878-9ab0-4335-befc-869ffa79cfab				TCGA-62-8399-01A-21D-2322-01	TCGA-62-8399-01A-21D-2324-05	TCGA-62-8399-01	TCGA-62-8399-01A-21D-2322-01		b1235878-9ab0-4335-befc-869ffa79cfab	TCGA-62-8399-01		b1235878-9ab0-4335-befc-869ffa79cfab	TCGA-62-8399-01		b1235878-9ab0-4335-befc-869ffa79cfab	TCGA-62-8399-01A-21D-2323-08	TCGA-62-8399-01	
TCGA-62-8402-01																												TCGA-62-8402-01				Cluster 5			miRNA cluster 4			TCGA-62-8402	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES		NO	73	R-Upper		TCGA-62-8402-F52547	TCGA-62-8402	TCGA-62-8402-01A			-26934		1498	0	1445	772			0	YES	Exon 19 Deletion		NO	Scheduled Follow-up Submission	Progressive Disease	2013-12-4	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.6	NO	100	NO			Peripheral Lung	0.7	NO	Distant Metastasis	YES			No	M0	N2	T2	Stage IIIA	TCGA-62-8402.c5ebd021-924a-48b4-a401-b7802f7acf92.pdf	8402	Preoperative	WITH TUMOR			80	134	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01	0.2		6th	NO	NO	YES	62	1		Lung	A	DECEASED	2008					21e0230a-8314-4d80-afca-9326c34d1299				TCGA-62-8402-01A-11D-2322-01	TCGA-62-8402-01A-11D-2324-05	TCGA-62-8402-01	TCGA-62-8402-01A-11D-2322-01		21e0230a-8314-4d80-afca-9326c34d1299	TCGA-62-8402-01		21e0230a-8314-4d80-afca-9326c34d1299	TCGA-62-8402-01		21e0230a-8314-4d80-afca-9326c34d1299	TCGA-62-8402-01A-11D-2323-08	TCGA-62-8402-01	
TCGA-62-A46O-01																												TCGA-62-A46O-01										TCGA-62-A46O	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					65	R-Lower			TCGA-62-A46O	TCGA-62-A46O-01A			-24050	2349	1454	0						NO			NO			2012-10-29	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	70		NO	100	NO			Central Lung				YES	48	true	No	M0	N0	T2	Stage IB	TCGA-62-A46O.C1EAC8C9-2538-4FEB-9DFF-FF9AE7A20F42.pdf	A46O	Preoperative	WITH TUMOR			65	106	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			6th	NO	NO	YES	62	2		Lung	A	DECEASED	2006					a5105fe6-6ba9-4977-a976-49d9a1b6f164				TCGA-62-A46O-01A-11D-A24C-01	TCGA-62-A46O-01A-11D-A24I-05	TCGA-62-A46O-01	TCGA-62-A46O-01A-11D-A24C-01		a5105fe6-6ba9-4977-a976-49d9a1b6f164	TCGA-62-A46O-01		a5105fe6-6ba9-4977-a976-49d9a1b6f164	TCGA-62-A46O-01	7F7753FD-B329-443F-8F4D-2C7559742EB5	a5105fe6-6ba9-4977-a976-49d9a1b6f164	TCGA-62-A46O-01A-11D-A24D-08	TCGA-62-A46O-01	
TCGA-62-A46P-01																												TCGA-62-A46P-01										TCGA-62-A46P	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					65	L-Upper			TCGA-62-A46P	TCGA-62-A46P-01A			-23993	2254	594	0						NO			NO			2012-10-29	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	90		NO	100	NO			Central Lung				YES	40	true	No	M0	N0	T2	Stage IB	TCGA-62-A46P.1520ADC4-F5A7-4412-B2E7-A26326EE0074.pdf	A46P	Preoperative	TUMOR FREE			66	78	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			6th	NO	NO	YES	62	4		Lung	A	DECEASED	2006					ddf657f3-c764-4003-9de5-3384931c711b				TCGA-62-A46P-01A-11D-A24C-01	TCGA-62-A46P-01A-11D-A24I-05	TCGA-62-A46P-01	TCGA-62-A46P-01A-11D-A24C-01		ddf657f3-c764-4003-9de5-3384931c711b	TCGA-62-A46P-01		ddf657f3-c764-4003-9de5-3384931c711b	TCGA-62-A46P-01	489229C9-5E0B-43F3-BFE7-903140052B6E	ddf657f3-c764-4003-9de5-3384931c711b	TCGA-62-A46P-01A-11D-A24D-08	TCGA-62-A46P-01	
TCGA-62-A46R-01																												TCGA-62-A46R-01										TCGA-62-A46R	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					54	L-Lower			TCGA-62-A46R	TCGA-62-A46R-01A			-20063	2071	1725	0						NO			NO			2012-10-29	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	100		NO	100	NO			Central Lung				NO	25	true	No	M0	N0	T2	Stage IB	TCGA-62-A46R.7AF85E19-CD80-40FD-B0BE-CFFF4B252C0D.pdf	A46R	Preoperative	TUMOR FREE			73	74	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			6th	NO	NO	YES	62	4		Lung	A	DECEASED	2006					fae54004-1d4e-414e-a85e-667fc2cb89b5				TCGA-62-A46R-01A-11D-A24C-01	TCGA-62-A46R-01A-11D-A24I-05	TCGA-62-A46R-01	TCGA-62-A46R-01A-11D-A24C-01		fae54004-1d4e-414e-a85e-667fc2cb89b5	TCGA-62-A46R-01		fae54004-1d4e-414e-a85e-667fc2cb89b5	TCGA-62-A46R-01	B902BF89-CAB7-4771-A55A-7127BD5A6A70	fae54004-1d4e-414e-a85e-667fc2cb89b5	TCGA-62-A46R-01A-11D-A24D-08	TCGA-62-A46R-01	
TCGA-62-A46S-01																												TCGA-62-A46S-01										TCGA-62-A46S	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					73	L-Upper			TCGA-62-A46S	TCGA-62-A46S-01A			-26825	1936	1653	0					0	NO			NO			2012-10-29	MALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	150		NO	100	NO			Peripheral Lung				YES	40	true	No	M0	N0	T2	Stage IB	TCGA-62-A46S.56821636-8883-494F-A808-61AD827CE524.pdf	A46S	Preoperative	WITH TUMOR			66	72	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			6th	YES	NO	YES	62	4		Lung	A	DECEASED	2007					cc85d7b0-8421-4ea1-b647-92d3d0bbe550				TCGA-62-A46S-01A-11D-A24C-01	TCGA-62-A46S-01A-11D-A24I-05	TCGA-62-A46S-01	TCGA-62-A46S-01A-11D-A24C-01		cc85d7b0-8421-4ea1-b647-92d3d0bbe550	TCGA-62-A46S-01		cc85d7b0-8421-4ea1-b647-92d3d0bbe550	TCGA-62-A46S-01	DFC753AE-689E-40B7-AB75-C61B65EFE49A	cc85d7b0-8421-4ea1-b647-92d3d0bbe550	TCGA-62-A46S-01A-11D-A24D-08	TCGA-62-A46S-01	
TCGA-62-A46U-01																												TCGA-62-A46U-01										TCGA-62-A46U	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	R-Lower		TCGA-62-A46U-F51441	TCGA-62-A46U	TCGA-62-A46U-01A			-25998	1834		0	2067					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-11-19	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	70		NO	100	NO			Central Lung		NO		NO		true	No	M0	N1	T2	Stage IIB	TCGA-62-A46U.15C4143C-779A-44D7-B75F-867E5E0F7671.pdf	A46U	Preoperative	TUMOR FREE			81	131	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			6th	YES	NO	YES	62	1		Lung	A	LIVING	2007					83ca9e67-060b-45ec-9ea9-076a64ae8062				TCGA-62-A46U-01A-11D-A24C-01	TCGA-62-A46U-01A-11D-A24I-05	TCGA-62-A46U-01	TCGA-62-A46U-01A-11D-A24C-01		83ca9e67-060b-45ec-9ea9-076a64ae8062	TCGA-62-A46U-01		83ca9e67-060b-45ec-9ea9-076a64ae8062	TCGA-62-A46U-01		83ca9e67-060b-45ec-9ea9-076a64ae8062	TCGA-62-A46U-01A-11D-A24D-08	TCGA-62-A46U-01	
TCGA-62-A46V-01																												TCGA-62-A46V-01										TCGA-62-A46V	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					78	L-Lower		TCGA-62-A46V-F51440	TCGA-62-A46V	TCGA-62-A46V-01A			-28495	1751		0	2199					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-11-19	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	100		NO	90	NO			Peripheral Lung		NO		NO		true	No	M0	N0	T2	Stage IB	TCGA-62-A46V.FC6490C8-996A-4FD9-B0B5-65ED9E0AE6C7.pdf	A46V	Preoperative	TUMOR FREE			51	100	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			6th	NO	NO	YES	62	3		Lung	A	LIVING	2007					fc475e1d-25de-46e4-9191-9e5ee16f0371				TCGA-62-A46V-01A-11D-A24C-01	TCGA-62-A46V-01A-11D-A24I-05	TCGA-62-A46V-01	TCGA-62-A46V-01A-11D-A24C-01		fc475e1d-25de-46e4-9191-9e5ee16f0371	TCGA-62-A46V-01		fc475e1d-25de-46e4-9191-9e5ee16f0371	TCGA-62-A46V-01	A3AEAAFD-CF26-443D-A68C-360267DAECC8	fc475e1d-25de-46e4-9191-9e5ee16f0371	TCGA-62-A46V-01A-11D-A24D-08	TCGA-62-A46V-01	
TCGA-62-A46Y-01																												TCGA-62-A46Y-01										TCGA-62-A46Y	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	R-Lower			TCGA-62-A46Y	TCGA-62-A46Y-01A			-25905	1608	414	0						NO			NO			2012-10-30	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	80		NO	90	NO			Peripheral Lung				YES		true	No	M0	N2	T2	Stage IIIA	TCGA-62-A46Y.284FE692-BC27-4E0E-A92A-2DF64FF33405.pdf	A46Y	Preoperative	WITH TUMOR			84	88	Complete Remission/Response			YES	YES	R0	Primary Tumor	01			6th	YES	NO	YES	62	1		Lung	A	DECEASED	2008					085abecb-d625-44e2-b699-34f9863a9b28				TCGA-62-A46Y-01A-11D-A24C-01	TCGA-62-A46Y-01A-11D-A24I-05	TCGA-62-A46Y-01	TCGA-62-A46Y-01A-11D-A24C-01		085abecb-d625-44e2-b699-34f9863a9b28	TCGA-62-A46Y-01		085abecb-d625-44e2-b699-34f9863a9b28	TCGA-62-A46Y-01		085abecb-d625-44e2-b699-34f9863a9b28	TCGA-62-A46Y-01A-11D-A24D-08	TCGA-62-A46Y-01	
TCGA-62-A470-01																												TCGA-62-A470-01										TCGA-62-A470	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					84	R-Upper			TCGA-62-A470	TCGA-62-A470-01A			-30689	1310	1194	0					0	NO			NO			2012-10-30	MALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	80		NO	100	NO			Central Lung				YES	30	true	No	M0	N0	T2	Stage IB	TCGA-62-A470.C0136855-AF03-4065-8563-5C2B232D7070.pdf	A470	Preoperative	WITH TUMOR			74	111	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			6th	NO	NO	YES	62	3		Lung	A	DECEASED	2009					4f8a59d0-d4e5-4015-9bec-46fccd7d139e				TCGA-62-A470-01A-11D-A24C-01	TCGA-62-A470-01A-11D-A24I-05	TCGA-62-A470-01	TCGA-62-A470-01A-11D-A24C-01		4f8a59d0-d4e5-4015-9bec-46fccd7d139e	TCGA-62-A470-01		4f8a59d0-d4e5-4015-9bec-46fccd7d139e	TCGA-62-A470-01		4f8a59d0-d4e5-4015-9bec-46fccd7d139e	TCGA-62-A470-01A-11D-A24D-08	TCGA-62-A470-01	
TCGA-62-A471-01																												TCGA-62-A471-01										TCGA-62-A471	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					64	L-Upper		TCGA-62-A471-F51439	TCGA-62-A471	TCGA-62-A471-01A			-23689	951		0	1246				0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-11-19	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	130		NO	100	NO			Peripheral Lung		NO		NO	30	true	No	M0	N1	T2b	Stage IIB	TCGA-62-A471.5F2495BD-2398-4C97-8F3E-76E979F22691.pdf	A471	Preoperative	TUMOR FREE			75	104	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		2006	7th	YES	NO	YES	62	4		Lung	A	LIVING	2010					d0979d89-4efa-4e30-8510-8aa96a7c2f3d				TCGA-62-A471-01A-12D-A24C-01	TCGA-62-A471-01A-12D-A24I-05	TCGA-62-A471-01	TCGA-62-A471-01A-12D-A24C-01		d0979d89-4efa-4e30-8510-8aa96a7c2f3d	TCGA-62-A471-01		d0979d89-4efa-4e30-8510-8aa96a7c2f3d	TCGA-62-A471-01	5D921A12-A1EC-4265-9198-1896A5054016	d0979d89-4efa-4e30-8510-8aa96a7c2f3d	TCGA-62-A471-01A-12D-A24D-08	TCGA-62-A471-01	
TCGA-62-A472-01																												TCGA-62-A472-01										TCGA-62-A472	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO		70	R-Lower		TCGA-62-A472-F51442	TCGA-62-A472	TCGA-62-A472-01A			-25893	498		0	910	290			1	NO			NO	Scheduled Follow-up Submission	Partial Remission/Response	2013-11-19	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	80		NO	80	NO			Central Lung		NO	Locoregional Recurrence	YES	60	true	No	M0	N0	T3	Stage IIB	TCGA-62-A472.1C47AD8C-F1EB-4B7E-9633-3260EF8CEAE4.pdf	A472	Preoperative	WITH TUMOR			70	87	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01			7th	NO	NO	YES	62	2		Lung	A	LIVING	2011					17a290d7-8577-4d11-8842-86c2f48e1cac				TCGA-62-A472-01A-11D-A24C-01	TCGA-62-A472-01A-11D-A24I-05	TCGA-62-A472-01	TCGA-62-A472-01A-11D-A24C-01		17a290d7-8577-4d11-8842-86c2f48e1cac	TCGA-62-A472-01		17a290d7-8577-4d11-8842-86c2f48e1cac	TCGA-62-A472-01		17a290d7-8577-4d11-8842-86c2f48e1cac	TCGA-62-A472-01A-11D-A24D-08	TCGA-62-A472-01	
TCGA-64-1676-01	3.41	0.36	none		none	none	none	N	N	none	none	none	0.14	Squamoid	none	none	p.C121S	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-64-1676-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 11	TCGA-64-1676	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					58	R-Lower		TCGA-64-1676-F4366	TCGA-64-1676	TCGA-64-1676-01A			-21428			0	1728										Complete Remission/Response	2010-11-15	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.5	NO					Central Lung	1.5			NO	60		No	M0	N0	T1a	Stage IA	TCGA-64-1676.516b08af-72b5-4b4a-b208-3c874abe63ad.pdf	1676		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.3			NO	NO	YES	64	2	Current smoker	Lung	A	LIVING	2005		TCGA-64-1676-01	TCGA-64-1676-01A-01D-0969-08	TCGA-64-1676-01	6447a7cf-ae7a-4896-b00f-10c357eb8c8b	TCGA-64-1676-01A-01R-0946-07	TCGA-64-1676-01A-01D-0945-05	TCGA-64-1676-01	TCGA-64-1676-01A-01D-0944-01		TCGA-64-1676-01	TCGA-64-1676-01A-01D-0944-01	TCGA-64-1676-01	6447a7cf-ae7a-4896-b00f-10c357eb8c8b		TCGA-64-1676-01A-21-2190-20	6447a7cf-ae7a-4896-b00f-10c357eb8c8b	TCGA-64-1676-01	390c2548-0e2b-4b46-9bfb-2993a7570bc9	6447a7cf-ae7a-4896-b00f-10c357eb8c8b	TCGA-64-1676-01A-01W-0928-08,TCGA-64-1676-01A-01D-0969-08		TCGA-64-1676-01
TCGA-64-1677-01	2.68	0.32	none		none	none	none	N	N	none	none	none	0.14	Magnoid	none	none	none	none	none	p.E545K	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-64-1677-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 7	cluster 4	mutation cluster 2	TCGA-64-1677	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	77	R-Lower		TCGA-64-1677-F8691	TCGA-64-1677	TCGA-64-1677-01A			-28482		628	0		360										2011-2-18	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.5	NO	0					1			YES	50		Yes	M0	N2	T2	Stage IIIA	TCGA-64-1677.31f047f0-df34-44d4-b0d1-a3b43833f560.pdf	1677											NO	R0	Primary Tumor	01	0.4			YES	NO	YES	64	2	Current smoker	Lung	A	DECEASED	2005	1955	TCGA-64-1677-01A-01W-0928-08	TCGA-64-1677-01A-01W-0928-08	TCGA-64-1677-01	900735b7-3870-421e-8c87-3f4e86fc8dae	TCGA-64-1677-01A-01R-0946-07	TCGA-64-1677-01A-01D-0945-05	TCGA-64-1677-01	TCGA-64-1677-01A-01D-0944-01		TCGA-64-1677-01	TCGA-64-1677-01A-01D-0944-01	TCGA-64-1677-01	900735b7-3870-421e-8c87-3f4e86fc8dae		TCGA-64-1677-01A-21-2190-20	900735b7-3870-421e-8c87-3f4e86fc8dae	TCGA-64-1677-01	b3712c9a-2e1b-4cb2-8f49-f69cec4c5ca9	900735b7-3870-421e-8c87-3f4e86fc8dae	TCGA-64-1677-01A-01W-0928-08		TCGA-64-1677-01
TCGA-64-1678-01	3.11	0.57	none		none	none	none	N	Y	none	none	none	0.22	Magnoid	none	none	p.K57N	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	1	TCGA-64-1678-01	High	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 6	cluster 1	mutation cluster 5	TCGA-64-1678	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	R-Middle		TCGA-64-1678-F4371	TCGA-64-1678	TCGA-64-1678-01A			-25931			0	1189										Complete Remission/Response	2010-11-15	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO						1			NO	20		No	M0	N0	T2b	[Discrepancy]	TCGA-64-1678.5b49e9b0-c7f5-43a2-9d48-34c1537c148d.pdf	1678		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.3	1990	6th	YES	NO	YES	64	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2006	1970	TCGA-64-1678-01A-01W-0928-08	TCGA-64-1678-01A-01W-0928-08	TCGA-64-1678-01	37f38cd6-6b65-4646-8ee1-d86ccc02fa75	TCGA-64-1678-01A-01R-0946-07	TCGA-64-1678-01A-01D-0945-05	TCGA-64-1678-01	TCGA-64-1678-01A-01D-0944-01		TCGA-64-1678-01	TCGA-64-1678-01A-01D-0944-01	TCGA-64-1678-01	37f38cd6-6b65-4646-8ee1-d86ccc02fa75		TCGA-64-1678-01A-21-2190-20	37f38cd6-6b65-4646-8ee1-d86ccc02fa75	TCGA-64-1678-01	011bb13f-e0e8-4f4b-b7a5-4867bbe3b30a	37f38cd6-6b65-4646-8ee1-d86ccc02fa75	TCGA-64-1678-01A-01W-0928-08		TCGA-64-1678-01
TCGA-64-1679-01	1.73	0.42	none		none	none	none	N	N	none	none	none	0.22	Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-64-1679-01	Squamous	C2-Squamous-like	cluster 3	Low purity c2	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-64-1679	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					58	R-Upper		TCGA-64-1679-F66261	TCGA-64-1679	TCGA-64-1679-01A			-21310			0	2488				0					Scheduled Follow-up Submission	Complete Remission/Response	2014-10-7	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.5	NO		NO				1	NO		NO	40		No	M0	N2	T1	Stage IIIA	TCGA-64-1679.dd4816b8-a99f-4f95-94b1-75b011509c2d.pdf	1679	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.4		6th	YES	NO	YES	64	2	Current smoker	Lung	A	LIVING	2007			TCGA-64-1679-01A-21D-2063-08		7c6ef5e6-8116-4a21-ae62-88a5e420bcc1				TCGA-64-1679-01A-21D-2062-01	TCGA-64-1679-01A-21D-2064-05	TCGA-64-1679-01	TCGA-64-1679-01A-21D-2062-01		7c6ef5e6-8116-4a21-ae62-88a5e420bcc1	TCGA-64-1679-01	TCGA-64-1679-01A-11-2190-20	7c6ef5e6-8116-4a21-ae62-88a5e420bcc1	TCGA-64-1679-01	112ea78d-4339-4119-bc19-7f011fee944d	7c6ef5e6-8116-4a21-ae62-88a5e420bcc1	TCGA-64-1679-01A-21D-2063-08	TCGA-64-1679-01	
TCGA-64-1680-01	3.41	0.63	none		none	none	none	N	Y	none	none	none	0.22	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc		Y	none	1	TCGA-64-1680-01	Kirc+	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 14	TCGA-64-1680	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					63	R-Middle		TCGA-64-1680-F4387	TCGA-64-1680	TCGA-64-1680-01A			-23267			0	1126											2010-11-16	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.8	8255/3	C34.8	YES		0.4	NO						1.2			NO	50		No	M1	N2	T2a	Stage IV	TCGA-64-1680.8daa91a5-773c-4c8b-ab17-b270aa75ec18.pdf	1680		TUMOR FREE					Complete Remission/Response				YES	R0	Primary Tumor	01	0.3	1982	6th	YES	NO	YES	64	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2007	1962	TCGA-64-1680-01	TCGA-64-1680-01A-02D-0969-08	TCGA-64-1680-01	1cade122-820d-4d68-8508-7a6c0f2b4852	TCGA-64-1680-01A-02R-0946-07	TCGA-64-1680-01A-02D-0945-05	TCGA-64-1680-01	TCGA-64-1680-01A-02D-0944-01		TCGA-64-1680-01	TCGA-64-1680-01A-02D-0944-01	TCGA-64-1680-01	1cade122-820d-4d68-8508-7a6c0f2b4852		TCGA-64-1680-01A-11-2190-20	1cade122-820d-4d68-8508-7a6c0f2b4852	TCGA-64-1680-01	9a98e01f-f8aa-4b09-856a-572743a2db89	1cade122-820d-4d68-8508-7a6c0f2b4852	TCGA-64-1680-01A-02W-0928-08,TCGA-64-1680-01A-02D-0969-08		TCGA-64-1680-01
TCGA-64-1681-01	2.97	0.44	none		none	none	none	Y	Y	p.L858R	none	none	0.18	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-64-1681-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-64-1681	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO		61	R-Upper		TCGA-64-1681-F20365	TCGA-64-1681	TCGA-64-1681-01A			-22525		1167	0		439				YES	Exon 19 Deletion			Additional New Tumor Event		2011-12-21	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES		0.4	NO	0	YES	NO			0.8			YES			No	M0	N0	T1	Stage IA	TCGA-64-1681.de31291a-ced6-458b-8fb7-ad47ae581b64.pdf	1681											NO	R0	Primary Tumor	01	0.4	1988	6th	NO	NO	YES	64	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2008	1968		TCGA-64-1681-01A-11D-2063-08		4f0fbd7c-4768-4bf2-b6f4-372f28b1953f				TCGA-64-1681-01A-11D-2062-01	TCGA-64-1681-01A-11D-2064-05	TCGA-64-1681-01	TCGA-64-1681-01A-11D-2062-01		4f0fbd7c-4768-4bf2-b6f4-372f28b1953f	TCGA-64-1681-01	TCGA-64-1681-01A-21-2190-20	4f0fbd7c-4768-4bf2-b6f4-372f28b1953f	TCGA-64-1681-01	6fc61107-6515-4cc3-a63e-5e1fe083c3eb	4f0fbd7c-4768-4bf2-b6f4-372f28b1953f	TCGA-64-1681-01A-11D-2063-08	TCGA-64-1681-01	
TCGA-64-5774-01	2.84	0.76	none		none	none	none	Y	Y	none	none	none	0.29	Magnoid	none	p.G12C	p.G279fs	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-64-5774-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 6	cluster 1	mutation cluster 12	TCGA-64-5774	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO		YES	60	R-Middle		TCGA-64-5774-F31478	TCGA-64-5774	TCGA-64-5774-01A			-22059			0	2676	277		95						Additional New Tumor Event		2012-5-3	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.0	8140/3	C34.0	YES		0.6	NO					Central Lung	1.4		Distant Metastasis	YES	45		No	M0	N0	T2	Stage IB	TCGA-64-5774.d8d1fecd-1290-4d5a-a98b-3c29f789bde6.pdf	5774		TUMOR FREE			71	72				YES	NO	R0	Primary Tumor	01	0.2	2004	6th	NO	NO	YES	64	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2004	1959	TCGA-64-5774-01A-01D-1625-08	TCGA-64-5774-01A-01D-1625-08		9ea59622-ed8d-48aa-aa45-665a670928a0				TCGA-64-5774-01A-01D-1624-01	TCGA-64-5774-01A-01D-1626-05	TCGA-64-5774-01	TCGA-64-5774-01A-01D-1624-01		9ea59622-ed8d-48aa-aa45-665a670928a0	TCGA-64-5774-01	TCGA-64-5774-01A-41-2191-20	9ea59622-ed8d-48aa-aa45-665a670928a0	TCGA-64-5774-01	2bb2dd1a-8bd9-45d0-9c34-9bf98476b90a	9ea59622-ed8d-48aa-aa45-665a670928a0	TCGA-64-5774-01A-01D-1625-08	TCGA-64-5774-01	
TCGA-64-5775-01	3.39	0.71	none		none	none	none	Y	Y	none	none	none	0.24	Squamoid	none	p.Q61L	none	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-64-5775-01	Kirc+	C12-small-various	cluster 1	Cluster 6		RNA cluster 2	miRNA c1uster 9	cluster 2	mutation cluster 2	TCGA-64-5775	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	L-Upper		TCGA-64-5775-F11418	TCGA-64-5775	TCGA-64-5775-01A			-26058		62	0											Progressive Disease	2011-5-2	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Yes	C34.1	8140/3	C34.1	YES		1.2	NO	0					1.3			NO	110		No	M0	N0	T4	Stage IIIA	TCGA-64-5775.eb576e3d-fa59-42b7-af77-416013a9bc90.pdf	5775		WITH TUMOR					Progressive Disease				NO	R0	Primary Tumor	01	0.4			NO	NO	YES	64	2	Current smoker	Lung	A	DECEASED	2005	1950	TCGA-64-5775-01A-01D-1625-08	TCGA-64-5775-01A-01D-1625-08		6cf7d085-d60c-4456-9266-5031628f687c				TCGA-64-5775-01A-01D-1624-01	TCGA-64-5775-01A-01D-1626-05	TCGA-64-5775-01	TCGA-64-5775-01A-01D-1624-01		6cf7d085-d60c-4456-9266-5031628f687c	TCGA-64-5775-01		6cf7d085-d60c-4456-9266-5031628f687c	TCGA-64-5775-01		6cf7d085-d60c-4456-9266-5031628f687c	TCGA-64-5775-01A-01D-1625-08	TCGA-64-5775-01	
TCGA-64-5778-01	3.45	0.42	none		none	none	none	Y	Y	none	none	p.G640C	0.16	Squamoid	none	p.G12C	none	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-64-5778-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 2	TCGA-64-5778	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	NO	60	R-Upper		TCGA-64-5778-F31471	TCGA-64-5778	TCGA-64-5778-01A			-21927			0	1305	1168			1					Additional New Tumor Event	Progressive Disease	2012-5-3	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.1	8252/3	C34.1	YES		0.4	NO	0				Central Lung	1.2	NO		YES	68		No	M0	N0	T2	Stage IB	TCGA-64-5778.36cf9846-5ec1-4d43-8b66-80a802c6b4e7.pdf	5778	Other	WITH TUMOR					Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.4	2000	6th	NO	NO	YES	64	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2008	1966	TCGA-64-5778-01A-01D-1625-08	TCGA-64-5778-01A-01D-1625-08		b549484e-cce0-4f6f-994c-910b458de4de				TCGA-64-5778-01A-01D-1624-01	TCGA-64-5778-01A-01D-1626-05	TCGA-64-5778-01	TCGA-64-5778-01A-01D-1624-01		b549484e-cce0-4f6f-994c-910b458de4de	TCGA-64-5778-01	TCGA-64-5778-01A-41-2191-20	b549484e-cce0-4f6f-994c-910b458de4de	TCGA-64-5778-01	423b6125-bdf6-483c-8aad-4f0c5c2703bc	b549484e-cce0-4f6f-994c-910b458de4de	TCGA-64-5778-01A-01D-1625-08	TCGA-64-5778-01	
TCGA-64-5779-01																												TCGA-64-5779-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 7		mutation cluster 12	TCGA-64-5779	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		YES	61	L-Lower		TCGA-64-5779-F31473	TCGA-64-5779	TCGA-64-5779-01A		797	-22305			0	864	795		100	0					Additional New Tumor Event		2012-5-3	MALE	Lung Acinar Adenocarcinoma	No	C34.3	8550/3	C34.3	YES		1	NO					Central Lung	1.3		Distant Metastasis	YES	40		No	M0	N2	T2	Stage IIIA	TCGA-64-5779.74ed3c2e-6708-48d7-bc21-5fc04999614f.pdf	5779	Post-Adjuvant Therapy	TUMOR FREE			94	100	[Discrepancy]			YES	YES	R0	Primary Tumor	01	0.4	2009	6th	YES	NO	YES	64	4		Lung	A	LIVING	2009	1969	TCGA-64-5779-01A-01D-1625-08			0f61b005-3643-4a6b-a075-bffb7320a2f3				TCGA-64-5779-01A-01D-1624-01	TCGA-64-5779-01A-01D-1626-05	TCGA-64-5779-01	TCGA-64-5779-01A-01D-1624-01		0f61b005-3643-4a6b-a075-bffb7320a2f3	TCGA-64-5779-01	TCGA-64-5779-01A-41-2191-20	0f61b005-3643-4a6b-a075-bffb7320a2f3	TCGA-64-5779-01	5e3fb226-21a1-4b99-948a-55d119066615	0f61b005-3643-4a6b-a075-bffb7320a2f3	TCGA-64-5779-01A-01D-1625-08	TCGA-64-5779-01	
TCGA-64-5781-01	1.9	0.38	none		none	none	none	N	N	none	none	none	0.19	Squamoid	none	none	none	p.Y1235H	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-64-5781-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 1	TCGA-64-5781	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	YES	55	R-Upper		TCGA-64-5781-F31490	TCGA-64-5781	TCGA-64-5781-01A		112	-20219			0	1559	96		73	0					Additional New Tumor Event	Complete Remission/Response	2012-5-3	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.8	NO					Central Lung	1		Distant Metastasis	YES	25		No	M0	N0	T2	Stage IB	TCGA-64-5781.988a550c-800e-4ba9-9c6a-de986969753b.pdf	5781	Post-Adjuvant Therapy	TUMOR FREE			61	77	Progressive Disease			YES	NO	R0	Primary Tumor	01	0.4	2007	6th	NO	NO	YES	64	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2007	1982	TCGA-64-5781-01A-01D-1625-08	TCGA-64-5781-01A-01D-1625-08		55228174-5562-47b2-a9f1-f9f5216f8c8c				TCGA-64-5781-01A-01D-1624-01	TCGA-64-5781-01A-01D-1626-05	TCGA-64-5781-01	TCGA-64-5781-01A-01D-1624-01		55228174-5562-47b2-a9f1-f9f5216f8c8c	TCGA-64-5781-01	TCGA-64-5781-01A-41-2191-20	55228174-5562-47b2-a9f1-f9f5216f8c8c	TCGA-64-5781-01	d161ad96-a846-4f14-b954-316e4dfaffcd	55228174-5562-47b2-a9f1-f9f5216f8c8c	TCGA-64-5781-01A-01D-1625-08	TCGA-64-5781-01	
TCGA-64-5815-01																												TCGA-64-5815-01	Kirc+	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 12	TCGA-64-5815	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	R-Upper		TCGA-64-5815-F31480	TCGA-64-5815				-27280			0	866			87	1	YES				Scheduled Follow-up Submission		2012-5-3	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES					YES			Central Lung					30		No	M0	N1	T2	Stage IIB		5815	Post-Adjuvant Therapy	TUMOR FREE			76	89	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1985	6th	YES	NO	YES	64	3		Lung		LIVING	2009		TCGA-64-5815-01A-01D-1625-08			a07caf79-5856-4f7d-ae48-7fa82c36cf4d				TCGA-64-5815-01A-01D-1624-01	TCGA-64-5815-01A-01D-1626-05	TCGA-64-5815-01	TCGA-64-5815-01A-01D-1624-01		a07caf79-5856-4f7d-ae48-7fa82c36cf4d	TCGA-64-5815-01	TCGA-64-5815-01A-41-2191-20	a07caf79-5856-4f7d-ae48-7fa82c36cf4d	TCGA-64-5815-01	c1fc598f-efaa-4a42-a646-a7bac6f73085	a07caf79-5856-4f7d-ae48-7fa82c36cf4d	TCGA-64-5815-01A-01D-1625-08	TCGA-64-5815-01	
TCGA-67-3770-01																												TCGA-67-3770-01	BRCA-LUAD+					LUAD-like c10	miRNA cluster 7		mutation cluster 11	TCGA-67-3770	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	R-Upper			TCGA-67-3770	TCGA-67-3770-01A			-25658			0	610					NO			NO			2010-12-00	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO		NO			Central Lung	0.9						No	M0	N0	T1	Stage IA	TCGA-67-3770.93f88ca0-8ac7-486f-a253-d258a0744c77.pdf	3770		TUMOR FREE										R0	Primary Tumor	01	0.2				YES	NO	67	3		Lung	A	LIVING	2009		TCGA-67-3770-01		TCGA-67-3770-01	69180b6c-8fef-4453-812d-212730a35ea7	TCGA-67-3770-01A-01R-0946-07		TCGA-67-3770-01	TCGA-67-3770-01A-01D-0944-01		TCGA-67-3770-01	TCGA-67-3770-01A-01D-0944-01	TCGA-67-3770-01	69180b6c-8fef-4453-812d-212730a35ea7			69180b6c-8fef-4453-812d-212730a35ea7	TCGA-67-3770-01		69180b6c-8fef-4453-812d-212730a35ea7	TCGA-67-3770-01A-01W-0928-08,TCGA-67-3770-01A-01D-0969-08		TCGA-67-3770-01
TCGA-67-3771-01	2.87	0.46	none		none	p.E894*	p.S37C	N	N	none	none	none	0.19	Magnoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	1	TCGA-67-3771-01	High	C1-LUAD-enriched		OV-like c1	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4	mutation cluster 8	TCGA-67-3771	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					77	L-Upper			TCGA-67-3771	TCGA-67-3771-01A			-28406			0	610					NO			NO			2011-1-21	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO		NO			Central Lung	1.1						No	M0	N0	T1	Stage IA	TCGA-67-3771.4bcfc5f3-136c-46b5-8e90-6be1abe3a9d8.pdf	3771		TUMOR FREE										R0	Primary Tumor	01	0.7		6th		YES	NO	67	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2009		TCGA-67-3771-01	TCGA-67-3771-01A-01D-1040-01	TCGA-67-3771-01	a1022e37-586a-4c6a-a754-01709bad7a43	TCGA-67-3771-01A-01R-0946-07	TCGA-67-3771-01A-01D-0945-05	TCGA-67-3771-01	TCGA-67-3771-01A-01D-0944-01		TCGA-67-3771-01	TCGA-67-3771-01A-01D-0944-01	TCGA-67-3771-01	a1022e37-586a-4c6a-a754-01709bad7a43		TCGA-67-3771-01A-21-2190-20	a1022e37-586a-4c6a-a754-01709bad7a43	TCGA-67-3771-01	15deae70-aafb-4ace-8e1c-7d694473d742	a1022e37-586a-4c6a-a754-01709bad7a43	TCGA-67-3771-01A-01W-0928-08,TCGA-67-3771-01A-01D-1040-01		TCGA-67-3771-01
TCGA-67-3772-01	1.89	0.43	none		none	none	none	Y	Y	p.L858R	none	none	0.22	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	1	TCGA-67-3772-01	BRCA-LUAD+	C1-LUAD-enriched		Low purity c2		LUAD-like c10	miRNA cluster 7	cluster 4	mutation cluster 14	TCGA-67-3772	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					82	R-Upper			TCGA-67-3772	TCGA-67-3772-01A			-29989			0	573					NO			NO			2011-3-3	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.9	NO		NO				0.9						No	M0	N0	T2	Stage IB	TCGA-67-3772.1b3a5b8e-7469-4fd6-b314-ad1fd7a2b957.pdf	3772		TUMOR FREE											Primary Tumor	01	0.2		6th		YES	NO	67	1	Lifelong Non-smoker	Lung	A	LIVING	2009		TCGA-67-3772-01A-01W-0928-08	TCGA-67-3772-01A-01W-0928-08	TCGA-67-3772-01	4722db5d-698c-4847-b4b7-31d4a3634f59	TCGA-67-3772-01A-01R-0946-07	TCGA-67-3772-01A-01D-0945-05	TCGA-67-3772-01	TCGA-67-3772-01A-01D-0944-01		TCGA-67-3772-01	TCGA-67-3772-01A-01D-0944-01	TCGA-67-3772-01	4722db5d-698c-4847-b4b7-31d4a3634f59			4722db5d-698c-4847-b4b7-31d4a3634f59	TCGA-67-3772-01		4722db5d-698c-4847-b4b7-31d4a3634f59	TCGA-67-3772-01A-01W-0928-08		TCGA-67-3772-01
TCGA-67-3773-01	1.96	0.69	none		none	none	none	Y	Y	none	none	none	0.35	Bronchioid	none	p.G12V	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-67-3773-01	Kirc+	C1-LUAD-enriched		Cluster 6		LUAD-like c10	miRNA cluster 4	cluster 4	mutation cluster 12	TCGA-67-3773	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					84	L-Lower			TCGA-67-3773	TCGA-67-3773-01A			-30706			0	427					NO			NO			2011-1-21	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.4	NO		NO			Central Lung	1						No	M0	N0	T2	Stage IB	TCGA-67-3773.e5b82f07-698e-4dff-9d33-748790e40811.pdf	3773		TUMOR FREE										R0	Primary Tumor	01	0.2		6th		YES	NO	67	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2009		TCGA-67-3773-01	TCGA-67-3773-01A-01D-1040-01	TCGA-67-3773-01	17a5a6af-dca6-47dc-912a-7ac0c226da89	TCGA-67-3773-01A-01R-0946-07	TCGA-67-3773-01A-01D-0945-05	TCGA-67-3773-01	TCGA-67-3773-01A-01D-0944-01		TCGA-67-3773-01	TCGA-67-3773-01A-01D-0944-01	TCGA-67-3773-01	17a5a6af-dca6-47dc-912a-7ac0c226da89			17a5a6af-dca6-47dc-912a-7ac0c226da89	TCGA-67-3773-01		17a5a6af-dca6-47dc-912a-7ac0c226da89	TCGA-67-3773-01A-01D-1040-01		TCGA-67-3773-01
TCGA-67-3774-01	1.89	0.48	none		none	none	none	Y	Y	none	none	none	0.25	Bronchioid	none	p.G12F	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-67-3774-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5		LUAD-like c10	miRNA cluster 4	cluster 4	mutation cluster 7	TCGA-67-3774	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					73	L-Lower			TCGA-67-3774	TCGA-67-3774-01A			-26704			0	385					NO			NO			2011-3-3	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.4	NO		NO				0.5						No	M0	N0	T2	Stage IB	TCGA-67-3774.a1d72b00-7384-4a8f-b335-5beb9ae078fc.pdf	3774		TUMOR FREE										RX	Primary Tumor	01	0.2		6th		YES	NO	67	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2009		TCGA-67-3774-01	TCGA-67-3774-01A-01D-1040-01	TCGA-67-3774-01	0621fd32-18bd-4720-846b-4bf47453d296	TCGA-67-3774-01A-01R-0946-07	TCGA-67-3774-01A-01D-0945-05	TCGA-67-3774-01	TCGA-67-3774-01A-01D-0944-01		TCGA-67-3774-01	TCGA-67-3774-01A-01D-0944-01	TCGA-67-3774-01	0621fd32-18bd-4720-846b-4bf47453d296			0621fd32-18bd-4720-846b-4bf47453d296	TCGA-67-3774-01		0621fd32-18bd-4720-846b-4bf47453d296	TCGA-67-3774-01A-01W-0928-08,TCGA-67-3774-01A-01D-1040-01		TCGA-67-3774-01
TCGA-67-4679-01																												TCGA-67-4679-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 6		LUAD-like c10	miRNA cluster 5		mutation cluster 7	TCGA-67-4679	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	R-Lower			TCGA-67-4679	TCGA-67-4679-01B			-25202			0	448					NO			NO			2011-1-21	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.5	NO		NO			Central Lung	0.9						No	M0	N0	T3	[Discrepancy]	TCGA-67-4679.3528ccec-afff-4212-97aa-1d4f7af79856.pdf	4679		TUMOR FREE										R0	Primary Tumor	01	0.2				YES	NO	67	4		Lung	B	LIVING	2009		TCGA-67-4679-01B-01D-1753-08			2613a946-0689-4c1b-99f6-30cfaa0ac3f9				TCGA-67-4679-01B-01D-1752-01	TCGA-67-4679-01B-01D-1756-05	TCGA-67-4679-01	TCGA-67-4679-01B-01D-1752-01		2613a946-0689-4c1b-99f6-30cfaa0ac3f9	TCGA-67-4679-01		2613a946-0689-4c1b-99f6-30cfaa0ac3f9	TCGA-67-4679-01		2613a946-0689-4c1b-99f6-30cfaa0ac3f9	TCGA-67-4679-01B-01D-1753-08	TCGA-67-4679-01	
TCGA-67-6215-01	2.24	0.71	none	Y	none	none	none	Y	Y	none	none	none	0.33	Bronchioid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-67-6215-01	High	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation c1uster 9	TCGA-67-6215	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					52	R-Lower		TCGA-67-6215-F13585	TCGA-67-6215	TCGA-67-6215-01A			-19310			0	174				2	NO			NO	Scheduled Follow-up Submission		2011-7-6	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.5	NO		NO			Central Lung	0.6			NO			No	M0	N0	T2a	Stage IB	TCGA-67-6215.bdaf595f-ae8e-451f-83d2-3a79ef06b2a3.pdf	6215	Adjuvant therapy	TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.2		7th	YES	YES	NO	67	1	Lifelong Non-smoker	Lung	A	LIVING	2010		TCGA-67-6215-01A-11D-1753-08	TCGA-67-6215-01A-11D-1753-08		d4f590d7-626c-4c70-b170-1ad19d2ff6eb				TCGA-67-6215-01A-11D-1752-01	TCGA-67-6215-01A-11D-1756-05	TCGA-67-6215-01	TCGA-67-6215-01A-11D-1752-01		d4f590d7-626c-4c70-b170-1ad19d2ff6eb	TCGA-67-6215-01	TCGA-67-6215-01A-13-2191-20	d4f590d7-626c-4c70-b170-1ad19d2ff6eb	TCGA-67-6215-01	72400518-bc32-4d05-9abd-9233e7cbff29	d4f590d7-626c-4c70-b170-1ad19d2ff6eb	TCGA-67-6215-01A-11D-1753-08	TCGA-67-6215-01	
TCGA-67-6216-01	3.89	0.39	none	Y	none	none	none	Y	Y	none	none	none	0.14	Bronchioid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-67-6216-01	Kirc+	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-67-6216	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					57	R-Middle		TCGA-67-6216-F13587	TCGA-67-6216	TCGA-67-6216-01A			-20967			0	141					NO			NO	Scheduled Follow-up Submission		2011-7-6	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES		0.6	NO		NO			Central Lung	1.2			NO			No	M0	N0	T1a	Stage IA	TCGA-67-6216.9f6ac234-e3d8-44a9-b82d-0552e49224be.pdf	6216		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.4		7th	NO	YES	NO	67	1	Lifelong Non-smoker	Lung	A	LIVING	2010		TCGA-67-6216-01A-11D-1753-08	TCGA-67-6216-01A-11D-1753-08		abcd4b7e-f4f0-4be5-9769-3c889a078717				TCGA-67-6216-01A-11D-1752-01	TCGA-67-6216-01A-11D-1756-05	TCGA-67-6216-01	TCGA-67-6216-01A-11D-1752-01		abcd4b7e-f4f0-4be5-9769-3c889a078717	TCGA-67-6216-01	TCGA-67-6216-01A-13-2191-20	abcd4b7e-f4f0-4be5-9769-3c889a078717	TCGA-67-6216-01	5fd7748f-8145-4251-a040-26d19aef9c87	abcd4b7e-f4f0-4be5-9769-3c889a078717	TCGA-67-6216-01A-11D-1753-08	TCGA-67-6216-01	
TCGA-67-6217-01			none		none	none	none	Y	Y	p.L858R	none	none		Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-67-6217-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation cluster 14	TCGA-67-6217	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES		NO	NO	73	L-Upper		TCGA-67-6217-F13566	TCGA-67-6217	TCGA-67-6217-01A			-26920			0	422	296				YES	L858R	RT-PCR	YES	Scheduled Follow-up Submission	Progressive Disease	2011-7-5	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO		YES	NO		Central Lung	1.1			YES			Yes	M0	N1	T2a	Stage IIA	TCGA-67-6217.f03e4cad-5322-4068-b986-dd98892e1c85.pdf	6217		WITH TUMOR					Progressive Disease				NO	R0	Primary Tumor	01	0.4	1965	7th	NO	YES	NO	67	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2010		TCGA-67-6217-01A-11D-1753-08	TCGA-67-6217-01A-11D-1753-08		5a47770e-3ebf-4390-ab03-e128fd9ac507				TCGA-67-6217-01A-11D-1752-01	TCGA-67-6217-01A-11D-1756-05	TCGA-67-6217-01	TCGA-67-6217-01A-11D-1752-01		5a47770e-3ebf-4390-ab03-e128fd9ac507	TCGA-67-6217-01	TCGA-67-6217-01A-13-2191-20	5a47770e-3ebf-4390-ab03-e128fd9ac507	TCGA-67-6217-01	e34ffd31-b15e-42f7-aa41-414b5cd519b1	5a47770e-3ebf-4390-ab03-e128fd9ac507	TCGA-67-6217-01A-11D-1753-08	TCGA-67-6217-01	
TCGA-69-7760-01			none		none	none	none	Y	Y	p.709_710ET>D	none	none		Magnoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-69-7760-01	Squamous	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-69-7760	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					73	R-Lower		TCGA-69-7760-F29247	TCGA-69-7760	TCGA-69-7760-01A			-26777			0	202			125		YES			NO	Scheduled Follow-up Submission		2012-3-13	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.7	NO		NO			Peripheral Lung	1.1			NO			No	M0	N0	T3	Stage IIB	TCGA-69-7760.e5c9b2ce-2e5a-4127-8ee4-c6bd4ad99fa0.pdf	7760	Post-Adjuvant Therapy	TUMOR FREE			91	83				YES	NO		Primary Tumor	01	0.3		7th	YES	YES	NO	69	1	Lifelong Non-smoker	Lung	A	LIVING	2011			TCGA-69-7760-01A-11D-2167-08		877fb28c-fcdd-4e75-8057-029c9ff31d26				TCGA-69-7760-01A-11D-2166-01	TCGA-69-7760-01A-11D-2168-05	TCGA-69-7760-01	TCGA-69-7760-01A-11D-2166-01		877fb28c-fcdd-4e75-8057-029c9ff31d26	TCGA-69-7760-01	TCGA-69-7760-01A-21-2192-20	877fb28c-fcdd-4e75-8057-029c9ff31d26	TCGA-69-7760-01	aea6b973-08b3-429f-bc71-0977e6a86960	877fb28c-fcdd-4e75-8057-029c9ff31d26	TCGA-69-7760-01A-11D-2167-08	TCGA-69-7760-01	
TCGA-69-7761-01			none		none	none	none	N	N	none	none	none		Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-69-7761-01	Squamous	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-69-7761	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					84	L-Lower		TCGA-69-7761-F29252	TCGA-69-7761	TCGA-69-7761-01A			-31041			0	186			80	1	YES	Other			Scheduled Follow-up Submission		2012-3-13	MALE	Lung Acinar Adenocarcinoma	No	C34.3	8550/3	C34.3	YES		0.7	NO					Peripheral Lung	1.3			NO	20		No	MX	N0	T2a	Stage IB	TCGA-69-7761.1148daaf-0315-4639-92dd-f17ff727c6cc.pdf	7761	Adjuvant therapy	TUMOR FREE			91	98				YES	NO		Primary Tumor	01	0.3	1975	7th	YES	NO	YES	69	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2011	1955		TCGA-69-7761-01A-11D-2167-08		167ca59a-5b32-4d99-8f91-2244b723dd87				TCGA-69-7761-01A-11D-2166-01	TCGA-69-7761-01A-11D-2168-05	TCGA-69-7761-01	TCGA-69-7761-01A-11D-2166-01		167ca59a-5b32-4d99-8f91-2244b723dd87	TCGA-69-7761-01	TCGA-69-7761-01A-31-2192-20	167ca59a-5b32-4d99-8f91-2244b723dd87	TCGA-69-7761-01	63dc187d-2053-4f13-ab84-7053b9f2baa5	167ca59a-5b32-4d99-8f91-2244b723dd87	TCGA-69-7761-01A-11D-2167-08	TCGA-69-7761-01	
TCGA-69-7763-01			none		none	none	none	N	N	none	none	none		Bronchioid	none	none	none	none	none	none	none	Lepidic predominant Adc	Lepidic predominant Adc			p.Y60fs	0	TCGA-69-7763-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-69-7763	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	R-Middle		TCGA-69-7763-F20990	TCGA-69-7763				-25316			0	690			72	1	NO			NO	Scheduled Follow-up Submission		2012-1-26	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.2	8550/3	C34.2	YES					NO			Peripheral Lung				NO	7.5		No	M0	N0	T1b	Stage IA		7763	Other				93	89				YES	NO		Primary Tumor	01		2004	7th	NO	NO	YES	69	4	Current reformed smoker for < or = 15 years	Lung		LIVING	2010	1959		TCGA-69-7763-01A-11D-2167-08		c9376fb2-9938-4516-88da-3fc03deeb6ee				TCGA-69-7763-01A-11D-2166-01	TCGA-69-7763-01A-11D-2168-05	TCGA-69-7763-01	TCGA-69-7763-01A-11D-2166-01		c9376fb2-9938-4516-88da-3fc03deeb6ee	TCGA-69-7763-01	TCGA-69-7763-01A-13-2192-20	c9376fb2-9938-4516-88da-3fc03deeb6ee	TCGA-69-7763-01	e5fc0052-b756-4073-b7b7-b4f5d78c16ed	c9376fb2-9938-4516-88da-3fc03deeb6ee	TCGA-69-7763-01A-11D-2167-08	TCGA-69-7763-01	
TCGA-69-7764-01			none		none	none	none	N	N	none	none	none		Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-69-7764-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 3		TCGA-69-7764	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					75	R-Upper		TCGA-69-7764-F20992	TCGA-69-7764	TCGA-69-7764-01A			-27693			0	414				0	YES			NO	Scheduled Follow-up Submission		2012-1-26	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.6	NO		NO			Peripheral Lung	0.6			NO	30		No	M0	N0	T1b	Stage IA	TCGA-69-7764.3518ba0e-79fc-4a98-a308-ecee684e0439.pdf	7764	Other	TUMOR FREE			94	106				YES	NO		Primary Tumor	01	0.2	1991	7th	NO	NO	YES	69	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2010	1977		TCGA-69-7764-01A-11D-2167-08		6deb91e8-110b-444d-93c8-72cd04e4746a				TCGA-69-7764-01A-11D-2166-01	TCGA-69-7764-01A-11D-2168-05	TCGA-69-7764-01	TCGA-69-7764-01A-11D-2166-01		6deb91e8-110b-444d-93c8-72cd04e4746a	TCGA-69-7764-01	TCGA-69-7764-01A-13-2192-20	6deb91e8-110b-444d-93c8-72cd04e4746a	TCGA-69-7764-01	f1fe363c-ae3d-4fab-bc18-d16a781851ed	6deb91e8-110b-444d-93c8-72cd04e4746a	TCGA-69-7764-01A-11D-2167-08	TCGA-69-7764-01	
TCGA-69-7765-01			none		p.G469V	none	none	N	Y	p.Q486*	none	none		Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-69-7765-01	Iq	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-69-7765	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					56	R-Upper		TCGA-69-7765-F29244	TCGA-69-7765				-20625			0	165			45		NO	Other		NO	Scheduled Follow-up Submission		2012-3-13	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES					NO			Peripheral Lung				NO			No	MX	N0	T4	[Discrepancy]		7765					86	84				YES	NO		Primary Tumor	01		2011	7th	YES	YES	NO	69	4	Current reformed smoker for < or = 15 years	Lung		LIVING	2011	1981		TCGA-69-7765-01A-11D-2167-08		a660dca3-d4cd-4d7e-93fd-6be7a622cc59				TCGA-69-7765-01A-11D-2166-01	TCGA-69-7765-01A-11D-2168-05	TCGA-69-7765-01	TCGA-69-7765-01A-11D-2166-01		a660dca3-d4cd-4d7e-93fd-6be7a622cc59	TCGA-69-7765-01	TCGA-69-7765-01A-13-2192-20	a660dca3-d4cd-4d7e-93fd-6be7a622cc59	TCGA-69-7765-01	c579c28f-8254-4e78-be5e-c673baf0f14b	a660dca3-d4cd-4d7e-93fd-6be7a622cc59	TCGA-69-7765-01A-11D-2167-08	TCGA-69-7765-01	
TCGA-69-7973-01																												TCGA-69-7973-01	High			Cluster 5		LUAD-like c10	miRNA cluster 6			TCGA-69-7973	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	42	R-Middle		TCGA-69-7973-F30347	TCGA-69-7973	TCGA-69-7973-01A			-15355			0	230				1	YES				Scheduled Follow-up Submission	Complete Remission/Response	2012-4-9	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.2	8255/3	C34.2	YES		0.6	NO					Central Lung	0.9			NO	25		No	M0	N0	T2a	Stage IB	TCGA-69-7973.fd1b94d4-d5b9-47fe-96ad-4e3d781a638a.pdf	7973	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response			NO	NO		Primary Tumor	01	0.5	2011	7th	YES	NO	YES	69	4		Lung	A	LIVING	2011					47b76d43-afa5-4540-b129-64c997d726b4				TCGA-69-7973-01A-11D-2183-01	TCGA-69-7973-01A-11D-2185-05	TCGA-69-7973-01	TCGA-69-7973-01A-11D-2183-01		47b76d43-afa5-4540-b129-64c997d726b4	TCGA-69-7973-01		47b76d43-afa5-4540-b129-64c997d726b4	TCGA-69-7973-01		47b76d43-afa5-4540-b129-64c997d726b4	TCGA-69-7973-01A-11D-2184-08	TCGA-69-7973-01	
TCGA-69-7974-01																												TCGA-69-7974-01	Kirc+			Cluster 6		LUAD-like c10	miRNA cluster 4			TCGA-69-7974	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					54	L-Upper		TCGA-69-7974-F30365	TCGA-69-7974				-20021			0	184					YES	Other			Scheduled Follow-up Submission	Progressive Disease	2012-4-9	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES				80				Peripheral Lung				NO	30		No	MX	N2	T2a	Stage IIIA		7974	Post-Adjuvant Therapy	WITH TUMOR			58	47	Progressive Disease			YES	YES		Primary Tumor	01		2011	7th	YES	NO	YES	69	4		Lung		LIVING	2011	1981				a237a685-c274-4cc9-ae4d-64398d2ba92e				TCGA-69-7974-01A-11D-2183-01	TCGA-69-7974-01A-11D-2185-05	TCGA-69-7974-01	TCGA-69-7974-01A-11D-2183-01		a237a685-c274-4cc9-ae4d-64398d2ba92e	TCGA-69-7974-01		a237a685-c274-4cc9-ae4d-64398d2ba92e	TCGA-69-7974-01		a237a685-c274-4cc9-ae4d-64398d2ba92e	TCGA-69-7974-01A-11D-2184-08	TCGA-69-7974-01	
TCGA-69-7978-01																												TCGA-69-7978-01	BRCA-LUAD+			Cluster 6		LUAD-like c10	miRNA cluster 4			TCGA-69-7978	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		59	R-Upper		TCGA-69-7978-F39911	TCGA-69-7978				-21785			0	134					YES	Other			Scheduled Follow-up Submission	Stable Disease	2013-2-11	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES								Peripheral Lung		NO		NO	80		No	MX	N1	T2b	Stage IIB		7978		[Discrepancy]	91	75	88	67				YES	NO		Primary Tumor	01			7th	NO	NO	YES	69	2		Lung		LIVING	2011					c2972973-dec9-4723-8fc6-af9db22e1cde				TCGA-69-7978-01A-11D-2183-01	TCGA-69-7978-01A-11D-2185-05	TCGA-69-7978-01	TCGA-69-7978-01A-11D-2183-01		c2972973-dec9-4723-8fc6-af9db22e1cde	TCGA-69-7978-01		c2972973-dec9-4723-8fc6-af9db22e1cde	TCGA-69-7978-01		c2972973-dec9-4723-8fc6-af9db22e1cde	TCGA-69-7978-01A-11D-2184-08	TCGA-69-7978-01	
TCGA-69-7979-01																												TCGA-69-7979-01	High			Cluster 6		LUAD-like c10	miRNA cluster 12			TCGA-69-7979	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	R-Upper		TCGA-69-7979-F40026	TCGA-69-7979				-26180			0	408					NO			NO			2014-3-19	FEMALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES					NO								28		No	MX	N0	T2a	Stage IB		7979			71	64	70	59				YES			Primary Tumor	01			7th		NO	YES	69	2		Lung		LIVING	2011	1955				e9b4a714-487c-40e5-943d-11301e5bc54c				TCGA-69-7979-01A-11D-2183-01	TCGA-69-7979-01A-11D-2185-05	TCGA-69-7979-01	TCGA-69-7979-01A-11D-2183-01		e9b4a714-487c-40e5-943d-11301e5bc54c	TCGA-69-7979-01		e9b4a714-487c-40e5-943d-11301e5bc54c	TCGA-69-7979-01		e9b4a714-487c-40e5-943d-11301e5bc54c	TCGA-69-7979-01A-11D-2184-08	TCGA-69-7979-01	
TCGA-69-7980-01			none		none	p.R86L	none	Y	Y	none	none	p.L420M, p.L868F		Bronchioid	none	p.G12A	none	none	none	none	none	0	Acinar predominant Adc			none		TCGA-69-7980-01	High		cluster 2	Cluster 6		LUAD-like c10	miRNA c1uster 9	cluster 2		TCGA-69-7980	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	R-Upper		TCGA-69-7980-F57659	TCGA-69-7980	TCGA-69-7980-01A			-25583			0	362			71		YES	Other		NO	Scheduled Follow-up Submission		2014-3-19	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8550/3	C34.1	YES		1.2	NO		NO				1.6	NO		NO	80		No	M0	N0	T1b	Stage I	TCGA-69-7980.a4a32cf5-43b8-4387-9873-d90f7000b134.pdf	7980		TUMOR FREE			86	92	Complete Remission/Response			YES	NO		Primary Tumor	01	0.4	2001	7th	NO	YES	NO	69	4		Lung	A	LIVING	2011			TCGA-69-7980-01A-11D-2184-08		16b48e8d-f339-45b2-8182-fe27212bc8da				TCGA-69-7980-01A-11D-2183-01	TCGA-69-7980-01A-11D-2185-05	TCGA-69-7980-01	TCGA-69-7980-01A-11D-2183-01		16b48e8d-f339-45b2-8182-fe27212bc8da	TCGA-69-7980-01		16b48e8d-f339-45b2-8182-fe27212bc8da	TCGA-69-7980-01		16b48e8d-f339-45b2-8182-fe27212bc8da	TCGA-69-7980-01A-11D-2184-08	TCGA-69-7980-01	
TCGA-69-8253-01																												TCGA-69-8253-01	Iq			Cluster 5		LUAD-like c10	miRNA cluster 4			TCGA-69-8253	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					59	R-Lower		TCGA-69-8253-F41949	TCGA-69-8253	TCGA-69-8253-01A			-21771			0	426				1	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-4-5	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.6	NO		NO				1.2	NO		NO	7.8		No	MX	N1	T1a	Stage IIA	TCGA-69-8253.8148140f-8b78-4c05-a2fa-59a25cc6c9d8.pdf	8253	Preoperative	TUMOR FREE				87	Complete Remission/Response			YES	NO		Primary Tumor	01	0.5	2011	7th	YES	YES	NO	69	4		Lung	A	LIVING	2012	1972				2acc6f62-4829-4c3d-a813-951ec8136ae7				TCGA-69-8253-01A-11D-2283-01	TCGA-69-8253-01A-11D-2285-05	TCGA-69-8253-01	TCGA-69-8253-01A-11D-2283-01		2acc6f62-4829-4c3d-a813-951ec8136ae7	TCGA-69-8253-01		2acc6f62-4829-4c3d-a813-951ec8136ae7	TCGA-69-8253-01		2acc6f62-4829-4c3d-a813-951ec8136ae7	TCGA-69-8253-01A-11D-2284-08	TCGA-69-8253-01	
TCGA-69-8254-01																												TCGA-69-8254-01	Kirc+			Cluster 6		LUAD-like c10	miRNA cluster 6			TCGA-69-8254	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					85	R-Lower		TCGA-69-8254-F41950	TCGA-69-8254	TCGA-69-8254-01A			-31134			0	409				0	YES	Other		NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-4-5	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.7	NO	80	NO				1.4	NO		NO	40		No			T2b		TCGA-69-8254.3edeafc6-1876-4547-82b2-90e18240061d.pdf	8254	Preoperative	TUMOR FREE				62	Complete Remission/Response			YES	NO		Primary Tumor	01	0.3	1989	7th	NO	YES	NO	69	3		Lung	A	LIVING	2012					8fabb97c-5921-4156-98c0-86bdd642c612				TCGA-69-8254-01A-11D-2283-01	TCGA-69-8254-01A-11D-2285-05	TCGA-69-8254-01	TCGA-69-8254-01A-11D-2283-01		8fabb97c-5921-4156-98c0-86bdd642c612	TCGA-69-8254-01		8fabb97c-5921-4156-98c0-86bdd642c612	TCGA-69-8254-01		8fabb97c-5921-4156-98c0-86bdd642c612	TCGA-69-8254-01A-11D-2284-08	TCGA-69-8254-01	
TCGA-69-8255-01																												TCGA-69-8255-01	Squamous			Cluster 5		LAML-like c13				TCGA-69-8255	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	R-Upper		TCGA-69-8255-F32611	TCGA-69-8255	TCGA-69-8255-01A			-26289			0	129			60		YES	Other		NO	Scheduled Follow-up Submission		2012-6-4	MALE	Lung Solid Pattern Predominant Adenocarcinoma	No	C34.1	8230/3	C34.1	YES		0.8	NO		NO				1	NO		NO	40		No	M0	N0	T1a	Stage IA	TCGA-69-8255.d807cbcd-b72d-47f5-975b-347782728e94.pdf	8255				60		57				YES	NO		Primary Tumor	01	0.7		7th	NO	YES	NO	69	2		Lung	A	LIVING	2011	1971				ea0be0ea-2959-435e-a1c6-c5a3b4c52f51				TCGA-69-8255-01A-11D-2283-01	TCGA-69-8255-01A-11D-2285-05	TCGA-69-8255-01	TCGA-69-8255-01A-11D-2283-01		ea0be0ea-2959-435e-a1c6-c5a3b4c52f51	TCGA-69-8255-01		ea0be0ea-2959-435e-a1c6-c5a3b4c52f51	TCGA-69-8255-01	7AB70020-1031-446E-AB4B-B39C89B35DE3	ea0be0ea-2959-435e-a1c6-c5a3b4c52f51	TCGA-69-8255-01A-11D-2284-08	TCGA-69-8255-01	
TCGA-69-8453-01																												TCGA-69-8453-01				Cluster 5			miRNA c1uster 9			TCGA-69-8453	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					77	R-Lower		TCGA-69-8453-F58885	TCGA-69-8453				-28413			0	813			52	1					Scheduled Follow-up Submission		2014-4-25	MALE	Mucinous (Colloid) Carcinoma	No	C34.30	8480/3	C34.3	YES								Peripheral Lung		NO		NO	12		No	MX	N0	T3	Stage IIB		8453	Preoperative	WITH TUMOR	87	85	86	85	Stable Disease			YES	NO		Primary Tumor	01		1974	7th	YES	YES	NO	69	3		Lung		LIVING	2012					c58f01fe-6249-49fe-93ab-dd0f7af94df3				TCGA-69-8453-01A-12D-2322-01	TCGA-69-8453-01A-12D-2324-05	TCGA-69-8453-01	TCGA-69-8453-01A-12D-2322-01		c58f01fe-6249-49fe-93ab-dd0f7af94df3	TCGA-69-8453-01		c58f01fe-6249-49fe-93ab-dd0f7af94df3	TCGA-69-8453-01		c58f01fe-6249-49fe-93ab-dd0f7af94df3		TCGA-69-8453-01	
TCGA-69-A59K-01																												TCGA-69-A59K-01										TCGA-69-A59K	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					60	R-Upper		TCGA-69-A59K-F57660	TCGA-69-A59K	TCGA-69-A59K-01A			-22093	130		0	522			75	2	YES			NO	Scheduled Follow-up Submission		2014-3-19	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	140		NO							NO		NO	25	true	No	M0	N0	T3	Stage IIB	TCGA-69-A59K.6EF9E448-6E2D-499D-8EC0-7F03B7A10FC8.pdf	A59K	Pre-Adjuvant Therapy	TUMOR FREE		120		118	Stable Disease			YES	NO		Primary Tumor	01		2012	7th	YES	YES	NO	69	4		Lung	A	LIVING	2012	1999				0a8dbb5b-77b8-4eda-a67c-8cf842c12d53				TCGA-69-A59K-01A-11D-A25M-01	TCGA-69-A59K-01A-11D-A25R-05	TCGA-69-A59K-01	TCGA-69-A59K-01A-11D-A25M-01		0a8dbb5b-77b8-4eda-a67c-8cf842c12d53	TCGA-69-A59K-01		0a8dbb5b-77b8-4eda-a67c-8cf842c12d53	TCGA-69-A59K-01	F46C35CA-FFC7-44EA-A8F8-C1D6A53CE45C	0a8dbb5b-77b8-4eda-a67c-8cf842c12d53	TCGA-69-A59K-01A-11D-A25L-08	TCGA-69-A59K-01	
TCGA-71-6725-01	2.69	0.63	none		none	none	none	N	N	none	none	none	0.26	Bronchioid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-71-6725-01	High	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation c1uster 9	TCGA-71-6725	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO		48	R-Upper		TCGA-71-6725-F70928	TCGA-71-6725	TCGA-71-6725-01A			-17793			0	256	164			2					Scheduled Follow-up Submission	Progressive Disease	2015-3-10	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES		1	NO	60					2	NO	Locoregional Recurrence	YES			No	M0	N0	T2	Stage IB	TCGA-71-6725.0d31265b-d292-4550-81cb-509a2ab9a4ce.pdf	6725	Post-Adjuvant Therapy	WITH TUMOR					Progressive Disease				NO	RX	Primary Tumor	01	0.8		6th	YES	YES	NO	71	2	Current smoker	Lung	A	LIVING	2011		TCGA-71-6725-01A-11D-1855-08	TCGA-71-6725-01A-11D-1855-08		9680a78d-59ab-4cf0-bd92-e6ecbc640e04				TCGA-71-6725-01A-11D-1854-01	TCGA-71-6725-01A-11D-1856-05	TCGA-71-6725-01	TCGA-71-6725-01A-11D-1854-01		9680a78d-59ab-4cf0-bd92-e6ecbc640e04	TCGA-71-6725-01	TCGA-71-6725-01A-13-2191-20	9680a78d-59ab-4cf0-bd92-e6ecbc640e04	TCGA-71-6725-01	c40a352a-a90e-4015-9049-4dda961025ae	9680a78d-59ab-4cf0-bd92-e6ecbc640e04	TCGA-71-6725-01A-11D-1855-08	TCGA-71-6725-01	
TCGA-71-8520-01																												TCGA-71-8520-01										TCGA-71-8520	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		60	L-Upper		TCGA-71-8520-F70925	TCGA-71-8520	TCGA-71-8520-01A			-21921		210	0	3	179								Scheduled Follow-up Submission	Progressive Disease	2015-3-10	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO	40	YES	NO			0.9	NO	Locoregional Recurrence	YES			No	M0	N0	T2	Stage IB	TCGA-71-8520.3ead80d6-5b6e-49ff-87a2-aed7abb8e2e7.pdf	8520	Preoperative	WITH TUMOR					Complete Remission/Response			NO	YES	R0	Primary Tumor	01	0.5		7th	NO	YES	NO	71	1		Lung	A	DECEASED	2011					2fe33b61-8a00-424b-b881-e2808b099022					TCGA-71-8520-01A-11D-2398-05				2fe33b61-8a00-424b-b881-e2808b099022	TCGA-71-8520-01		2fe33b61-8a00-424b-b881-e2808b099022	TCGA-71-8520-01	AB00BC04-B343-4DF6-876A-84A2199ED592	2fe33b61-8a00-424b-b881-e2808b099022	TCGA-71-8520-01A-11D-2393-08	TCGA-71-8520-01	
TCGA-73-4658-01	2.01	0.32	none		none	none	none	N	N	none	none	none	0.16	Squamoid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-73-4658-01	High	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation cluster 4	TCGA-73-4658	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					80	L-Lower		TCGA-73-4658-F12975	TCGA-73-4658	TCGA-73-4658-01A			-29508		1600	0	1600					NO					Complete Remission/Response	2011-6-15	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1	NO		NO			Central Lung	1.4			NO	25		Yes	M0	N0	T2	Stage IB	TCGA-73-4658.37bb6a7b-4f9e-4690-b904-4eebc3189562.pdf	4658		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.3		6th	NO	NO	YES	73	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2004		TCGA-73-4658-01A-01D-1753-08	TCGA-73-4658-01A-01D-1753-08		8090b818-81f9-4bd6-aed2-7a721432cdc8				TCGA-73-4658-01A-01D-1752-01	TCGA-73-4658-01A-01D-1756-05	TCGA-73-4658-01	TCGA-73-4658-01A-01D-1752-01		8090b818-81f9-4bd6-aed2-7a721432cdc8	TCGA-73-4658-01	TCGA-73-4658-01A-21-2190-20	8090b818-81f9-4bd6-aed2-7a721432cdc8	TCGA-73-4658-01	8ac764a5-e8cc-4992-b647-9b07d95e7b70	8090b818-81f9-4bd6-aed2-7a721432cdc8		TCGA-73-4658-01	
TCGA-73-4658-11	2.01	0.32	none		none	none	none	N	N	none	none	none	0.16	Squamoid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-73-4658-11		C1-LUAD-enriched							mutation cluster 4	TCGA-73-4658	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					80	L-Lower		TCGA-73-4658-F12975	TCGA-73-4658	TCGA-73-4658-11A			-29508		1600	0	1600					NO					Complete Remission/Response	2011-6-15	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.6	NO		NO			Central Lung	1.1			NO	25		Yes	M0	N0	T2	Stage IB		4658		TUMOR FREE					Complete Remission/Response				NO	R0	Solid Tissue Normal	11	0.5		6th	NO	NO	YES	73	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2004										TCGA-73-4658-11A-01D-1756-05													
TCGA-73-4659-01	3.54	0.33	none		none	none	none	Y	Y	none	none	none	0.13	Magnoid	none	p.G12V	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	1	TCGA-73-4659-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 6	cluster 1	mutation cluster 12	TCGA-73-4659	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		NO	66	R-Upper		TCGA-73-4659-F42024	TCGA-73-4659				-24253		711	0	711	316			0	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-4-9	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES				0	NO			Central Lung		NO	Distant Metastasis	YES	12		No	M0	N2	T2	Stage IIIA		4659	Other	WITH TUMOR					Progressive Disease	Convincing Imaging			NO	R0	Primary Tumor	01		1986	6th	NO	NO	YES	73	3	Current reformed smoker for > 15 years	Lung		DECEASED	2006	1974	TCGA-73-4659-01A-01D-1265-08	TCGA-73-4659-01A-01D-1265-08		dc1b5145-85ca-4e21-9896-2216924019bb		TCGA-73-4659-01A-01D-1205-05	TCGA-73-4659-01	TCGA-73-4659-01A-01D-1204-01		TCGA-73-4659-01	TCGA-73-4659-01A-01D-1204-01		dc1b5145-85ca-4e21-9896-2216924019bb		TCGA-73-4659-01A-21-2190-20	dc1b5145-85ca-4e21-9896-2216924019bb	TCGA-73-4659-01	b4bf2bd5-e32e-4f30-973b-72fc8a2f426b	dc1b5145-85ca-4e21-9896-2216924019bb	TCGA-73-4659-01A-01D-1265-08		TCGA-73-4659-01
TCGA-73-4659-11	3.54	0.33	none		none	none	none	Y	Y	none	none	none	0.13	Magnoid	none	p.G12V	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	1	TCGA-73-4659-11		C1-LUAD-enriched							mutation cluster 12	TCGA-73-4659	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		NO	66	R-Upper		TCGA-73-4659-F42024	TCGA-73-4659	TCGA-73-4659-11A			-24253		711	0	711	316			0	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-4-9	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES		2.2	NO	0	NO			Central Lung	2.5	NO	Distant Metastasis	YES	12		No	M0	N2	T2	Stage IIIA		4659	Other	WITH TUMOR					Progressive Disease	Convincing Imaging			NO	R0	Solid Tissue Normal	11	0.6	1986	6th	NO	NO	YES	73	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2006	1974						TCGA-73-4659-11A-01D-1205-05																
TCGA-73-4662-01	3	0.49	none		none	none	none	Y	Y	none	none	none	0.2	Bronchioid	none	p.G12C	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-73-4662-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 6		LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 12	TCGA-73-4662	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					65	L-Upper		TCGA-73-4662-F71029	TCGA-73-4662				-23762			0	2515			116	0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2015-3-18	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES				100	NO			Peripheral Lung		NO		NO	10		No	M0	N0	T1	Stage IA		4662	Preoperative	TUMOR FREE			115	111	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1972	6th	NO	NO	YES	73	3	Current reformed smoker for > 15 years	Lung		LIVING	2007	1955	TCGA-73-4662-01A-01D-1265-08	TCGA-73-4662-01A-01D-1265-08		fce05b98-e717-4364-8c8d-c15759e1170a		TCGA-73-4662-01A-01D-1205-05	TCGA-73-4662-01	TCGA-73-4662-01A-01D-1204-01		TCGA-73-4662-01	TCGA-73-4662-01A-01D-1204-01		fce05b98-e717-4364-8c8d-c15759e1170a			fce05b98-e717-4364-8c8d-c15759e1170a	TCGA-73-4662-01		fce05b98-e717-4364-8c8d-c15759e1170a	TCGA-73-4662-01A-01D-1265-08		TCGA-73-4662-01
TCGA-73-4662-11	3	0.49	none		none	none	none	Y	Y	none	none	none	0.2	Bronchioid	none	p.G12C	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-73-4662-11		C1-LUAD-enriched							mutation cluster 12	TCGA-73-4662	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					65	L-Upper		TCGA-73-4662-F71029	TCGA-73-4662	TCGA-73-4662-11A			-23762			0	2515			116	0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2015-3-18	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO	100	NO			Peripheral Lung	1.5	NO		NO	10		No	M0	N0	T1	Stage IA		4662	Preoperative	TUMOR FREE			115	111	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11	0.7	1972	6th	NO	NO	YES	73	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2007	1955						TCGA-73-4662-11A-01D-1205-05																
TCGA-73-4666-01																												TCGA-73-4666-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 6		LUAD-like c10			mutation cluster 2	TCGA-73-4666	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	YES	52	R-Upper		TCGA-73-4666-F12865	TCGA-73-4666			-43	-19074			0	800				1	NO			NO		Complete Remission/Response	2011-6-10	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES				80	NO			Central Lung				YES	10		No	M1	N0	T1	Stage IV		4666	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response				YES	R0	Primary Tumor	01		2002		YES	NO	YES	73	4		Lung		LIVING	2009	1982	TCGA-73-4666-01A-01D-1265-08			f66bb574-487a-426d-9b17-799718300e1e		TCGA-73-4666-01A-01D-1205-05		TCGA-73-4666-01A-01D-1204-01		TCGA-73-4666-01	TCGA-73-4666-01A-01D-1204-01		f66bb574-487a-426d-9b17-799718300e1e			f66bb574-487a-426d-9b17-799718300e1e	TCGA-73-4666-01		f66bb574-487a-426d-9b17-799718300e1e	TCGA-73-4666-01A-01D-1265-08		
TCGA-73-4666-11																												TCGA-73-4666-11		C1-LUAD-enriched							mutation cluster 2	TCGA-73-4666	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	YES	52	R-Upper		TCGA-73-4666-F12865	TCGA-73-4666	TCGA-73-4666-11A		-43	-19074			0	800				1	NO			NO		Complete Remission/Response	2011-6-10	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO	80	NO			Central Lung	1.2			YES	10		No	M1	N0	T1	Stage IV		4666	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response				YES	R0	Solid Tissue Normal	11	0.2	2002		YES	NO	YES	73	4		Lung	A	LIVING	2009	1982						TCGA-73-4666-11A-01D-1205-05																
TCGA-73-4668-01																												TCGA-73-4668-01	High	C1-LUAD-enriched		Cluster 6		LUAD-like c10			mutation c1uster 10	TCGA-73-4668	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	66	L-Upper		TCGA-73-4668-F7958	TCGA-73-4668	TCGA-73-4668-01A			-24255			0	467	282			0	NO			NO		Stable Disease	2011-1-6	FEMALE	Lung Micropapillary Adenocarcinoma	No	C34.1	8507/3	C34.1	YES		0.3	NO	80	NO			Peripheral Lung	0.6			YES	55		No	M0	N1	T2	Stage IIB	TCGA-73-4668.9177e909-f92c-4b50-a256-a4f840a05140.pdf	4668	Post-Adjuvant Therapy	WITH TUMOR									NO	R0	Primary Tumor	01	0.1	2005			NO	YES	73	4		Lung	A	LIVING	2009	1968	TCGA-73-4668-01A-01D-1265-08			297fecfd-e9b8-4882-8a55-312f2a04c3f6		TCGA-73-4668-01A-01D-1205-05		TCGA-73-4668-01A-01D-1204-01		TCGA-73-4668-01	TCGA-73-4668-01A-01D-1204-01		297fecfd-e9b8-4882-8a55-312f2a04c3f6			297fecfd-e9b8-4882-8a55-312f2a04c3f6	TCGA-73-4668-01		297fecfd-e9b8-4882-8a55-312f2a04c3f6	TCGA-73-4668-01A-01D-1265-08		
TCGA-73-4668-11																												TCGA-73-4668-11		C1-LUAD-enriched							mutation c1uster 10	TCGA-73-4668	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	66	L-Upper		TCGA-73-4668-F7958	TCGA-73-4668	TCGA-73-4668-11A			-24255			0	467	282			0	NO			NO		Stable Disease	2011-1-6	FEMALE	Lung Micropapillary Adenocarcinoma	No	C34.1	8507/3	C34.1	YES		0.5	NO	80	NO			Peripheral Lung	0.8			YES	55		No	M0	N1	T2	Stage IIB		4668	Post-Adjuvant Therapy	WITH TUMOR									NO	R0	Solid Tissue Normal	11	0.2	2005			NO	YES	73	4		Lung	A	LIVING	2009	1968						TCGA-73-4668-11A-01D-1205-05																
TCGA-73-4670-01																												TCGA-73-4670-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10			mutation cluster 11	TCGA-73-4670	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	L-Upper		TCGA-73-4670-F12983	TCGA-73-4670	TCGA-73-4670-01A			-25526			0	131				2	NO			NO			2011-6-15	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO	50	NO			Peripheral Lung	1.2			NO	30		No	M1	N0	T2	Stage IV	TCGA-73-4670.a9349f65-0980-427e-af86-1af3c747926b.pdf	4670	Adjuvant therapy	WITH TUMOR					Stable Disease				NO	R0	Primary Tumor	01	0.2	2009		YES	NO	YES	73	4		Lung	A	LIVING	2010	1979	TCGA-73-4670-01A-01D-1265-08			1671e6a6-1c3a-4ec7-b6b8-bd88f5ffcc60		TCGA-73-4670-01A-01D-1205-05		TCGA-73-4670-01A-01D-1204-01		TCGA-73-4670-01	TCGA-73-4670-01A-01D-1204-01		1671e6a6-1c3a-4ec7-b6b8-bd88f5ffcc60		TCGA-73-4670-01A-21-2190-20	1671e6a6-1c3a-4ec7-b6b8-bd88f5ffcc60	TCGA-73-4670-01	c58a6915-0ec4-4525-b15e-ad20f3f427d8	1671e6a6-1c3a-4ec7-b6b8-bd88f5ffcc60	TCGA-73-4670-01A-01D-1265-08		
TCGA-73-4670-11																												TCGA-73-4670-11		C1-LUAD-enriched							mutation cluster 11	TCGA-73-4670	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	L-Upper		TCGA-73-4670-F12983	TCGA-73-4670	TCGA-73-4670-11A			-25526			0	131				2	NO			NO			2011-6-15	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.4	NO	50	NO			Peripheral Lung	1.1			NO	30		No	M1	N0	T2	Stage IV		4670	Adjuvant therapy	WITH TUMOR					Stable Disease				NO	R0	Solid Tissue Normal	11	0.2	2009		YES	NO	YES	73	4		Lung	A	LIVING	2010	1979						TCGA-73-4670-11A-01D-1205-05																
TCGA-73-4675-01	3.47	0.58	none		none	none	none	N	N	none	none	none	0.2	Magnoid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-73-4675-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-73-4675	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO		59	L-Lower		TCGA-73-4675-F71055	TCGA-73-4675	TCGA-73-4675-01A			-21614		922	0	40	361		69	0	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2015-3-17	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1.1	NO		NO			Peripheral Lung	1.6	NO	Locoregional Recurrence	YES	41		No	M0	N1	T3	Stage IIIA	TCGA-73-4675.73be3e61-573d-43a3-a055-e86786e126f3.pdf	4675	Pre-Adjuvant Therapy	TUMOR FREE			55	66	Progressive Disease	Convincing Imaging		YES	NO	RX	Primary Tumor	01	0.4	2010	7th	YES	NO	YES	73	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2010	1969	TCGA-73-4675-01A-01D-1265-08	TCGA-73-4675-01A-01D-1265-08		928e4b3e-0664-4f05-b971-4c7ce6a318e4		TCGA-73-4675-01A-01D-1205-05	TCGA-73-4675-01	TCGA-73-4675-01A-01D-1204-01		TCGA-73-4675-01	TCGA-73-4675-01A-01D-1204-01		928e4b3e-0664-4f05-b971-4c7ce6a318e4		TCGA-73-4675-01A-21-2190-20	928e4b3e-0664-4f05-b971-4c7ce6a318e4	TCGA-73-4675-01	bb338195-b226-4ce4-a231-92bca76edd63	928e4b3e-0664-4f05-b971-4c7ce6a318e4	TCGA-73-4675-01A-01D-1265-08		TCGA-73-4675-01
TCGA-73-4675-11	3.47	0.58	none		none	none	none	N	N	none	none	none	0.2	Magnoid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-73-4675-11		C1-LUAD-enriched							mutation c1uster 9	TCGA-73-4675	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO		59	L-Lower		TCGA-73-4675-F71055	TCGA-73-4675	TCGA-73-4675-11A			-21614		922	0	40	361		69	0	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2015-3-17	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.8	NO		NO			Peripheral Lung	1.2	NO	Locoregional Recurrence	YES	41		No	M0	N1	T3	Stage IIIA		4675	Pre-Adjuvant Therapy	TUMOR FREE			55	66	Progressive Disease	Convincing Imaging		YES	NO	RX	Solid Tissue Normal	11	0.5	2010	7th	YES	NO	YES	73	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2010	1969						TCGA-73-4675-11A-01D-1205-05																
TCGA-73-4676-01	2.57	0.52	none		none	none	none	N	N	none	none	none	0.23	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-73-4676-01	High	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation cluster 5	TCGA-73-4676	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					45	R-Upper		TCGA-73-4676-F71022	TCGA-73-4676	TCGA-73-4676-01A			-16746		281	0	122			86	1	NO			NO	Scheduled Follow-up Submission		2015-3-18	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Yes	C34.1	8140/3	C34.1	YES		0.7	NO	70	NO			Peripheral Lung	1.5	NO			48		No	M0	N1	T2a	Stage IIA	TCGA-73-4676.d93488a2-e8a9-4775-8d8a-9622b237ba9d.pdf	4676	Preoperative	WITH TUMOR			67	78				YES	YES	R0	Primary Tumor	01	0.3	2009	7th	YES	NO	YES	73	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2010	1977	TCGA-73-4676-01A-01D-1753-08	TCGA-73-4676-01A-01D-1753-08		c54cd39c-c7fc-4a0c-9d33-9c1f78c80871				TCGA-73-4676-01A-01D-1752-01	TCGA-73-4676-01A-01D-1756-05	TCGA-73-4676-01	TCGA-73-4676-01A-01D-1752-01		c54cd39c-c7fc-4a0c-9d33-9c1f78c80871	TCGA-73-4676-01	TCGA-73-4676-01A-21-2190-20	c54cd39c-c7fc-4a0c-9d33-9c1f78c80871	TCGA-73-4676-01	94a6f867-15a8-41a7-b9e1-5853e970678a	c54cd39c-c7fc-4a0c-9d33-9c1f78c80871	TCGA-73-4676-01A-01D-1753-08	TCGA-73-4676-01	
TCGA-73-4676-11	2.57	0.52	none		none	none	none	N	N	none	none	none	0.23	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-73-4676-11		C1-LUAD-enriched							mutation cluster 5	TCGA-73-4676	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					45	R-Upper		TCGA-73-4676-F71022	TCGA-73-4676	TCGA-73-4676-11A			-16746		281	0	122			86	1	NO			NO	Scheduled Follow-up Submission		2015-3-18	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Yes	C34.1	8140/3	C34.1	YES		0.5	NO	70	NO			Peripheral Lung	1.5	NO			48		No	M0	N1	T2a	Stage IIA		4676	Preoperative	WITH TUMOR			67	78				YES	YES	R0	Solid Tissue Normal	11	0.2	2009	7th	YES	NO	YES	73	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2010	1977				6c12591a-55fa-4a7e-8eed-da9d698afb35					TCGA-73-4676-11A-01D-1756-05				6c12591a-55fa-4a7e-8eed-da9d698afb35			6c12591a-55fa-4a7e-8eed-da9d698afb35			6c12591a-55fa-4a7e-8eed-da9d698afb35			
TCGA-73-4677-01																												TCGA-73-4677-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5		LUAD-like c10			mutation cluster 7	TCGA-73-4677	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	R-Upper		TCGA-73-4677-F12744	TCGA-73-4677	TCGA-73-4677-01A			-27381		38	0					1	NO			NO			2011-6-1	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO	80	NO			Peripheral Lung	0.9			NO			No	M0	N0	T2a	[Discrepancy]	TCGA-73-4677.13109adb-64f8-462a-b0c1-af0723ad9aff.pdf	4677	Adjuvant therapy	WITH TUMOR					Stable Disease				NO	R0	Primary Tumor	01	0.3	1985		NO	NO	YES	73	3		Lung	A	DECEASED	2010		TCGA-73-4677-01A-01D-1265-08			0f8cdcd1-bcf6-4591-97f1-43202071326b		TCGA-73-4677-01A-01D-1205-05		TCGA-73-4677-01A-01D-1204-01		TCGA-73-4677-01	TCGA-73-4677-01A-01D-1204-01		0f8cdcd1-bcf6-4591-97f1-43202071326b			0f8cdcd1-bcf6-4591-97f1-43202071326b	TCGA-73-4677-01		0f8cdcd1-bcf6-4591-97f1-43202071326b	TCGA-73-4677-01A-01D-1265-08		
TCGA-73-4677-11																												TCGA-73-4677-11		C1-LUAD-enriched							mutation cluster 7	TCGA-73-4677	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	R-Upper		TCGA-73-4677-F12744	TCGA-73-4677	TCGA-73-4677-11A			-27381		38	0					1	NO			NO			2011-6-1	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO	80	NO			Peripheral Lung	1.2			NO			No	M0	N0	T2a	[Discrepancy]		4677	Adjuvant therapy	WITH TUMOR					Stable Disease				NO	R0	Solid Tissue Normal	11	0.3	1985		NO	NO	YES	73	3		Lung	A	DECEASED	2010							TCGA-73-4677-11A-01D-1205-05																
TCGA-73-7498-01			none		none	none	none	Y	Y	none	none	none		Bronchioid	none	p.G12C	none	none	none	none	none	0	Acinar predominant Adc			p.M51fs		TCGA-73-7498-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 1		TCGA-73-7498	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					58	R-Lower		TCGA-73-7498-F48755	TCGA-73-7498	TCGA-73-7498-01A			-21527			0	1189			74.0	0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-9-20	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES		0.6	NO	100	NO			Peripheral Lung	1	NO		NO	28		Yes, History of Synchronous/Bilateral Malignancy	M0	N0	T1b	Stage IA	TCGA-73-7498.c60ca2d8-4981-406a-9b8d-8efde4976001.pdf	7498	Pre-Adjuvant Therapy	TUMOR FREE	89.6	60.1	91.9	61.2	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.3	1997	7th	YES	NO	YES	73	4		Lung	A	LIVING	2010	1969		TCGA-73-7498-01A-12D-2184-08		71772580-ecde-4cbb-a3b5-d58b50b496c5				TCGA-73-7498-01A-12D-2183-01	TCGA-73-7498-01A-12D-2185-05	TCGA-73-7498-01	TCGA-73-7498-01A-12D-2183-01		71772580-ecde-4cbb-a3b5-d58b50b496c5	TCGA-73-7498-01	TCGA-73-7498-01A-23-2192-20	71772580-ecde-4cbb-a3b5-d58b50b496c5	TCGA-73-7498-01	29736b88-08c0-4418-bfde-9f7ea3b7e8be	71772580-ecde-4cbb-a3b5-d58b50b496c5	TCGA-73-7498-01A-12D-2184-08	TCGA-73-7498-01	
TCGA-73-7499-01			none		none	none	none	N	N	none	none	none		Squamoid	none	none	none	none	none	p.123_124MP>IA	none	0	Acinar predominant Adc			none		TCGA-73-7499-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-73-7499	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO		YES	81	R-Upper		TCGA-73-7499-F69827	TCGA-73-7499	TCGA-73-7499-01A		1451	-29683		1531	0	519	1447		54	3	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2015-1-21	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.9	NO	40	NO			Peripheral Lung	2.3	NO	Distant Metastasis	YES			No	M0	N0	T2a	Stage IB	TCGA-73-7499.8d4f6d68-7f74-4def-a235-a36a70f83ebe.pdf	7499	Other	TUMOR FREE			103.7	91.5	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.7		7th	NO	NO	YES	73	1		Lung	A	DECEASED	2010			TCGA-73-7499-01A-11D-2184-08		0d423ac2-0d64-4956-a897-d7bc6e1293c2				TCGA-73-7499-01A-11D-2183-01	TCGA-73-7499-01A-11D-2185-05	TCGA-73-7499-01	TCGA-73-7499-01A-11D-2183-01		0d423ac2-0d64-4956-a897-d7bc6e1293c2	TCGA-73-7499-01	TCGA-73-7499-01A-13-2192-20	0d423ac2-0d64-4956-a897-d7bc6e1293c2	TCGA-73-7499-01	f5f257c7-0d45-4305-a9eb-388dccb46c7a	0d423ac2-0d64-4956-a897-d7bc6e1293c2	TCGA-73-7499-01A-11D-2184-08	TCGA-73-7499-01	
TCGA-73-A9RS-01																												TCGA-73-A9RS-01										TCGA-73-A9RS	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					41	R-Upper		TCGA-73-A9RS-F64487	TCGA-73-A9RS	TCGA-73-A9RS-01A			-15162	162	340	0	305				1	YES		FISH	YES	Scheduled Follow-up Submission	Progressive Disease	2014-9-3	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8480/3	C34.1	YES	160		NO	80	YES	NO		Peripheral Lung		NO		NO	11	true	No	M0	N0	T3	Stage IIB	TCGA-73-A9RS.7E029394-80EC-4B53-829E-8F1DA476D648.pdf	A9RS	Preoperative	WITH TUMOR	81.9	60.2	81.5	59.6	Progressive Disease			YES	YES	R0	Primary Tumor	01			7th	NO	NO	YES	73	2		Lung	A	DECEASED	2013	1990				02bb3468-c1a4-405e-b721-68569b1b70d2				TCGA-73-A9RS-01A-11D-A40Z-01	TCGA-73-A9RS-01A-11D-A411-05	TCGA-73-A9RS-01	TCGA-73-A9RS-01A-11D-A40Z-01		02bb3468-c1a4-405e-b721-68569b1b70d2	TCGA-73-A9RS-01		02bb3468-c1a4-405e-b721-68569b1b70d2	TCGA-73-A9RS-01	53165A6D-C5C1-46A4-BA07-353BF652A1E6	02bb3468-c1a4-405e-b721-68569b1b70d2		TCGA-73-A9RS-01	
TCGA-75-5122-01	3.52	0.17	none		none	none	none	N	N	none	none	none	0.08	Squamoid	none	none	none	p.D1010_splice	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-75-5122-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation c1uster 10	TCGA-75-5122	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO		NO		L-Upper		TCGA-75-5122-F11750	TCGA-75-5122	TCGA-75-5122-01A												NO			NO		Progressive Disease	2011-3-31	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO	0	NO			Peripheral Lung	0.8			YES	20		No	M0	N0	T2	Stage IB	TCGA-75-5122.a664b87c-a7ef-4f18-9e4d-d37d0ccaaf70.pdf	5122	Adjuvant therapy	WITH TUMOR					Complete Remission/Response				NO	R0	Primary Tumor	01	0.5	1985		NO	NO	YES	75	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2005		TCGA-75-5122-01A-01D-1753-08	TCGA-75-5122-01A-01D-1753-08		7540edef-3853-4293-bb00-41f790f27840				TCGA-75-5122-01A-01D-1752-01	TCGA-75-5122-01A-01D-1756-05	TCGA-75-5122-01	TCGA-75-5122-01A-01D-1752-01		7540edef-3853-4293-bb00-41f790f27840	TCGA-75-5122-01	TCGA-75-5122-01A-21-2190-20	7540edef-3853-4293-bb00-41f790f27840	TCGA-75-5122-01	3b21e011-4b11-4ef6-978f-391c837ccbc5	7540edef-3853-4293-bb00-41f790f27840	TCGA-75-5122-01A-01D-1753-08	TCGA-75-5122-01	
TCGA-75-5125-01																												TCGA-75-5125-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 13	TCGA-75-5125	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO			R-Upper		TCGA-75-5125-F72028	TCGA-75-5125	TCGA-75-5125-01A					2027			1752				NO			NO	Scheduled Follow-up Submission	Progressive Disease	2015-4-2	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO		NO			Peripheral Lung	1.6	NO		YES	25		No	M0	N1	T2	Stage IIB	TCGA-75-5125.a0af0de5-9022-4354-8b9b-fc80e9508889.pdf	5125	Other	WITH TUMOR					Complete Remission/Response				NO	R0	Primary Tumor	01	0.4	1987	6th	NO	NO	YES	75	3		Lung	A	DECEASED			TCGA-75-5125-01A-01D-1753-08			dbe34afe-ea16-4faa-adab-9106a92dfde6				TCGA-75-5125-01A-01D-1752-01	TCGA-75-5125-01A-01D-1756-05	TCGA-75-5125-01	TCGA-75-5125-01A-01D-1752-01		dbe34afe-ea16-4faa-adab-9106a92dfde6	TCGA-75-5125-01	TCGA-75-5125-01A-21-2190-20	dbe34afe-ea16-4faa-adab-9106a92dfde6	TCGA-75-5125-01	8a8e4b62-7ad5-4108-a6f3-e38c47fec526	dbe34afe-ea16-4faa-adab-9106a92dfde6	TCGA-75-5125-01A-01D-1753-08	TCGA-75-5125-01	
TCGA-75-5126-01	2.01	0.27	none		none	none	none	Y	Y	none	none	none	0.13	Squamoid	none	p.G12C	none	none	none	none	none	NSCLC, favor Adeno	NSCLC, favor Adeno			none	0	TCGA-75-5126-01	Kirc+	C1-LUAD-enriched	cluster 2	Cluster 5		LUAD-like c10	miRNA cluster 5	cluster 3	mutation cluster 12	TCGA-75-5126	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO			L-Upper		TCGA-75-5126-F11746	TCGA-75-5126	TCGA-75-5126-01A											1	NO			NO		Progressive Disease	2011-4-4	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES		0.7	NO		NO			Peripheral Lung	1.2			YES	40		No	M0	N2	T3	Stage IIIA	TCGA-75-5126.ed7f326c-d2f5-46ef-bd92-ed2d0f81be26.pdf	5126	Adjuvant therapy	WITH TUMOR					Partial Remission/Response				NO	R2	Primary Tumor	01	0.2	2007		NO	NO	YES	75	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2007		TCGA-75-5126-01A-01D-1753-08	TCGA-75-5126-01A-01D-1753-08		6047b848-8fe8-4aab-81a7-2df3f31f7392				TCGA-75-5126-01A-01D-1752-01	TCGA-75-5126-01A-01D-1756-05	TCGA-75-5126-01	TCGA-75-5126-01A-01D-1752-01		6047b848-8fe8-4aab-81a7-2df3f31f7392	TCGA-75-5126-01		6047b848-8fe8-4aab-81a7-2df3f31f7392	TCGA-75-5126-01		6047b848-8fe8-4aab-81a7-2df3f31f7392	TCGA-75-5126-01A-01D-1753-08	TCGA-75-5126-01	
TCGA-75-5146-01	1.8	0.57	none		p.G469V	none	none	N	Y	none	none	none	0.3	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			p.W239C	0	TCGA-75-5146-01	Squamous	C1-LUAD-enriched	cluster 3	Cluster 5		LUAD-like c10	miRNA cluster 5	cluster 3	mutation cluster 8	TCGA-75-5146	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO				R-Lower		TCGA-75-5146-F72030	TCGA-75-5146								2368	1773				NO			NO	Scheduled Follow-up Submission		2015-4-2	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8252/3	C34.3	YES					NO			Peripheral Lung		NO	New Primary Tumor	YES			No	M0	N0	T2	Stage IB		5146	Other	TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01		1987	6th	NO	NO	YES	75	3	Current reformed smoker for > 15 years	Lung		LIVING			TCGA-75-5146-01A-01D-1625-08	TCGA-75-5146-01A-01D-1625-08		aa7b5f63-ac8e-45bf-80e9-be4a576426a5				TCGA-75-5146-01A-01D-1624-01	TCGA-75-5146-01A-01D-1626-05	TCGA-75-5146-01	TCGA-75-5146-01A-01D-1624-01		aa7b5f63-ac8e-45bf-80e9-be4a576426a5	TCGA-75-5146-01		aa7b5f63-ac8e-45bf-80e9-be4a576426a5	TCGA-75-5146-01		aa7b5f63-ac8e-45bf-80e9-be4a576426a5	TCGA-75-5146-01A-01D-1625-08	TCGA-75-5146-01	
TCGA-75-5147-01	3.27	0.4	none		none	none	none	N	N	none	none	none	0.16	Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-75-5147-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5		LUAD-like c10	miRNA cluster 5	cluster 3	mutation cluster 5	TCGA-75-5147	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung						R-Upper		TCGA-75-5147-F72031	TCGA-75-5147								1333					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2015-4-2	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8252/3	C34.1	YES					NO			Peripheral Lung		NO		NO			No	M0	N0	T2	Stage IB		5147	Other	TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01			6th	NO	NO	YES	75	1	Lifelong Non-smoker	Lung		LIVING			TCGA-75-5147-01A-01D-1625-08	TCGA-75-5147-01A-01D-1625-08		dea6072e-021d-4984-87ba-2c624e07fa18				TCGA-75-5147-01A-01D-1624-01	TCGA-75-5147-01A-01D-1626-05	TCGA-75-5147-01	TCGA-75-5147-01A-01D-1624-01		dea6072e-021d-4984-87ba-2c624e07fa18	TCGA-75-5147-01		dea6072e-021d-4984-87ba-2c624e07fa18	TCGA-75-5147-01		dea6072e-021d-4984-87ba-2c624e07fa18	TCGA-75-5147-01A-01D-1625-08	TCGA-75-5147-01	
TCGA-75-6203-01	2.21	0.26	none		none	none	none	N	Y	none	none	none	0.13	Bronchioid	none	none	none	none	none	none	none	Invasive mucinous	Invasive mucinous	Y - unknown binding partner		none	0	TCGA-75-6203-01	Kirc+	C1-LUAD-enriched	cluster 3	Low purity c2	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation c1uster 9	TCGA-75-6203	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung						L-Lower		TCGA-75-6203-F15862	TCGA-75-6203																		Complete Remission/Response	2011-8-15	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES															No	M0	N2	T2	Stage IIIA		6203		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01			6th	YES	NO	YES	75	1	Lifelong Non-smoker	Lung		LIVING	2008		TCGA-75-6203-01A-11D-1753-08	TCGA-75-6203-01A-11D-1753-08		ccf84703-a5c7-4995-a1c2-b3e4e15d99b7				TCGA-75-6203-01A-11D-1752-01	TCGA-75-6203-01A-11D-1756-05	TCGA-75-6203-01	TCGA-75-6203-01A-11D-1752-01		ccf84703-a5c7-4995-a1c2-b3e4e15d99b7	TCGA-75-6203-01	TCGA-75-6203-01A-13-2191-20	ccf84703-a5c7-4995-a1c2-b3e4e15d99b7	TCGA-75-6203-01	b8ce0a35-56d2-4294-881d-63f96342f51b	ccf84703-a5c7-4995-a1c2-b3e4e15d99b7	TCGA-75-6203-01A-11D-1753-08	TCGA-75-6203-01	
TCGA-75-6205-01			none		none	none	none	N	N	none	none	none		Squamoid	none	none	none	p.Y1003*	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-75-6205-01	Squamous	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation c1uster 9	TCGA-75-6205	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO		L-Upper		TCGA-75-6205-F15083	TCGA-75-6205	TCGA-75-6205-01A																		2011-7-21	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.5	NO					Peripheral Lung	0.7			YES			No	M0	N0	T2a	Stage IB	TCGA-75-6205.50af99e1-fe4a-4d65-86c0-59fd699433e3.pdf	6205	Adjuvant therapy	WITH TUMOR					Complete Remission/Response				NO	R0	Primary Tumor	01	0.3		7th	NO	NO	YES	75	1	Lifelong Non-smoker	Lung	A	DECEASED	2006		TCGA-75-6205-01A-11D-1753-08	TCGA-75-6205-01A-11D-1753-08		2e8a5454-24d7-4059-ac17-595dcfccaf0b				TCGA-75-6205-01A-11D-1752-01	TCGA-75-6205-01A-11D-1756-05	TCGA-75-6205-01	TCGA-75-6205-01A-11D-1752-01		2e8a5454-24d7-4059-ac17-595dcfccaf0b	TCGA-75-6205-01	TCGA-75-6205-01A-13-2191-20	2e8a5454-24d7-4059-ac17-595dcfccaf0b	TCGA-75-6205-01	d5765a3d-3aa3-4076-ac67-bb67763af157	2e8a5454-24d7-4059-ac17-595dcfccaf0b	TCGA-75-6205-01A-11D-1753-08	TCGA-75-6205-01	
TCGA-75-6206-01																												TCGA-75-6206-01	BRCA-LUAD+	C1-LUAD-enriched			squamous c3	LUAD-like c10	miRNA cluster 5		mutation cluster 12	TCGA-75-6206	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung						R-Upper		TCGA-75-6206-F72036	TCGA-75-6206	TCGA-75-6206-01A							2590									Scheduled Follow-up Submission	Complete Remission/Response	2015-4-2	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO					Peripheral Lung	0.7	NO		NO	20		No	M0	N0	T2	Stage IB	TCGA-75-6206.ad913d82-cb95-477f-8eeb-dba23f5c85c8.pdf	6206		TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.3	1962	6th	NO	NO	YES	75	3		Lung	A	LIVING			TCGA-75-6206-01A-11D-1753-08			b74b611d-7090-4beb-ae34-13086884a7e3				TCGA-75-6206-01A-11D-1752-01	TCGA-75-6206-01A-11D-1756-05	TCGA-75-6206-01	TCGA-75-6206-01A-11D-1752-01		b74b611d-7090-4beb-ae34-13086884a7e3	TCGA-75-6206-01	TCGA-75-6206-01A-13-2191-20	b74b611d-7090-4beb-ae34-13086884a7e3	TCGA-75-6206-01	40123d1f-93e7-4182-a279-66c8cbb2d6c3	b74b611d-7090-4beb-ae34-13086884a7e3	TCGA-75-6206-01A-11D-1753-08	TCGA-75-6206-01	
TCGA-75-6207-01	1.94	0.64	none		none	none	none	Y	Y	p.ELREA746del	none	none	0.33	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-75-6207-01	Squamous	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 8	TCGA-75-6207	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO				R-Upper		TCGA-75-6207-F15092	TCGA-75-6207	TCGA-75-6207-01A																		2011-7-21	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES		0.4	NO					Peripheral Lung	1				10		No	M0	N2	T2	Stage IIIA	TCGA-75-6207.46e1c8e2-5603-41c4-8b84-552ba6537ff1.pdf	6207							Complete Remission/Response				NO	R0	Primary Tumor	01	0.2	1972	6th	NO	NO	YES	75	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2007		TCGA-75-6207-01A-11D-1753-08	TCGA-75-6207-01A-11D-1753-08		4b57bac2-6b38-435f-b935-8eb6a3369d1c				TCGA-75-6207-01A-11D-1752-01	TCGA-75-6207-01A-11D-1756-05	TCGA-75-6207-01	TCGA-75-6207-01A-11D-1752-01		4b57bac2-6b38-435f-b935-8eb6a3369d1c	TCGA-75-6207-01	TCGA-75-6207-01A-13-2191-20	4b57bac2-6b38-435f-b935-8eb6a3369d1c	TCGA-75-6207-01	6ba7b19d-fe29-467f-ba50-78ac47ad8a4d	4b57bac2-6b38-435f-b935-8eb6a3369d1c	TCGA-75-6207-01A-11D-1753-08	TCGA-75-6207-01	
TCGA-75-6211-01	3.1	0.39	none		none	none	none	N	N	none	none	none	0.16	Magnoid	none	none	p.F53L	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-75-6211-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA c1uster 10	cluster 5	mutation cluster 11	TCGA-75-6211	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		NO		Bronchial		TCGA-75-6211-F15095	TCGA-75-6211	TCGA-75-6211-01A																	Progressive Disease	2011-7-21	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.9	YES		0.6	NO						0.8			YES	34		No	M0	N0	T2	Stage IB	TCGA-75-6211.7dff638f-e4c9-495b-95a0-00bb2a753378.pdf	6211	Adjuvant therapy	WITH TUMOR					Complete Remission/Response				NO	R0	Primary Tumor	01	0.4		6th	NO	NO	YES	75	2	Current smoker	Lung	A	DECEASED	2009		TCGA-75-6211-01A-11D-1753-08	TCGA-75-6211-01A-11D-1753-08		9a28482f-36a7-490f-9d22-a69f82fbfc05				TCGA-75-6211-01A-11D-1752-01	TCGA-75-6211-01A-11D-1756-05	TCGA-75-6211-01	TCGA-75-6211-01A-11D-1752-01		9a28482f-36a7-490f-9d22-a69f82fbfc05	TCGA-75-6211-01	TCGA-75-6211-01A-13-2191-20	9a28482f-36a7-490f-9d22-a69f82fbfc05	TCGA-75-6211-01	7510fd86-91a5-47ed-88bc-64b774eebc6c	9a28482f-36a7-490f-9d22-a69f82fbfc05	TCGA-75-6211-01A-11D-1753-08	TCGA-75-6211-01	
TCGA-75-6212-01	2.76	0.41	none		none	none	none	Y	Y	p.ELR746del	none	none	0.18	Bronchioid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-75-6212-01	Kirc+	C1-LUAD-enriched	cluster 3	KIRC-like c17	squamous c3	LUAD-like c10	miRNA cluster 7	cluster 4	mutation cluster 14	TCGA-75-6212	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO				L-Lower		TCGA-75-6212-F72037	TCGA-75-6212	TCGA-75-6212-01A					1516			1340			0					Scheduled Follow-up Submission	Progressive Disease	2015-4-2	FEMALE	Lung Micropapillary Adenocarcinoma	No	C34.3	8507/3	C34.3	YES		0.8	NO					Peripheral Lung	2.5	NO	New Primary Tumor	YES			No	M0	N1	T2	Stage IIB	TCGA-75-6212.6749d901-d37c-4ef9-b0a0-0ee0ee1d7f0e.pdf	6212	Post-Adjuvant Therapy	WITH TUMOR					Complete Remission/Response				NO	R0	Primary Tumor	01	0.2		6th	YES	NO	YES	75	1	Lifelong Non-smoker	Lung	A	DECEASED			TCGA-75-6212-01A-11D-1753-08	TCGA-75-6212-01A-11D-1753-08		69d106c0-b3e7-4918-a442-d142dce3adab				TCGA-75-6212-01A-11D-1752-01	TCGA-75-6212-01A-11D-1756-05	TCGA-75-6212-01	TCGA-75-6212-01A-11D-1752-01		69d106c0-b3e7-4918-a442-d142dce3adab	TCGA-75-6212-01	TCGA-75-6212-01A-13-2191-20	69d106c0-b3e7-4918-a442-d142dce3adab	TCGA-75-6212-01	5383ef0c-7d86-4025-93f5-71098359a488	69d106c0-b3e7-4918-a442-d142dce3adab	TCGA-75-6212-01A-11D-1753-08	TCGA-75-6212-01	
TCGA-75-6214-01			none		none	none	p.E55K	N	N	none	none	none		Magnoid	none	none	none	none	none	p.E545K	p.M82V	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-75-6214-01	COAD-READ	C2-Squamous-like	cluster 3	Cluster 5	squamous c3	squamous-like c4	miRNA cluster 11	cluster 5		TCGA-75-6214	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		YES		R-Upper		TCGA-75-6214-F72038	TCGA-75-6214	TCGA-75-6214-01A		524			1115			419			0					Scheduled Follow-up Submission	Progressive Disease	2015-4-2	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO					Peripheral Lung	1.9	NO	Distant Metastasis	YES	40		No	M0	N2	T2	Stage IIIA	TCGA-75-6214.e3473dc5-927a-466f-ac60-0ac0771a8b1f.pdf	6214	Post-Adjuvant Therapy	WITH TUMOR					Complete Remission/Response				NO	R0	Primary Tumor	01	0.2		6th	NO	NO	YES	75	2	Current smoker	Lung	A	DECEASED		1970		TCGA-75-6214-01A-41D-1945-08		f398c31b-c947-4ba7-84c0-6d3b36daaf3f				TCGA-75-6214-01A-41D-1943-01	TCGA-75-6214-01A-41D-1947-05	TCGA-75-6214-01	TCGA-75-6214-01A-41D-1943-01		f398c31b-c947-4ba7-84c0-6d3b36daaf3f	TCGA-75-6214-01	TCGA-75-6214-01A-23-2192-20	f398c31b-c947-4ba7-84c0-6d3b36daaf3f	TCGA-75-6214-01	85c494c4-bc37-424f-bae2-c374c44b8da9	f398c31b-c947-4ba7-84c0-6d3b36daaf3f	TCGA-75-6214-01A-41D-1945-08	TCGA-75-6214-01	
TCGA-75-7025-01	3.66	0.34	none		none	none	none	Y	Y	p.ELREA746del	none	none	0.13	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-75-7025-01	BRCA-LUAD+		cluster 3	Cluster 5		LUAD-like c10	miRNA c1uster 9	cluster 4		TCGA-75-7025	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	YES	YES		L-Lower		TCGA-75-7025-F72041	TCGA-75-7025	TCGA-75-7025-01A	1481	2092					3305	1481			0					Scheduled Follow-up Submission	Complete Remission/Response	2015-4-2	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.5	NO					Peripheral Lung	0.6	NO	Locoregional Recurrence|Distant Metastasis	YES			No	M0	N0	T2	Stage IB	TCGA-75-7025.6d05110b-1a5f-4002-b140-00a36c5c102b.pdf	7025	Preoperative	TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.2	1986	6th	NO	NO	YES	75	3	Current reformed smoker for > 15 years	Lung	A	LIVING		1967		TCGA-75-7025-01A-12D-1945-08		8966f44c-9452-4e21-9fad-142ea03c9bff				TCGA-75-7025-01A-12D-1943-01	TCGA-75-7025-01A-12D-1947-05	TCGA-75-7025-01	TCGA-75-7025-01A-12D-1943-01		8966f44c-9452-4e21-9fad-142ea03c9bff	TCGA-75-7025-01		8966f44c-9452-4e21-9fad-142ea03c9bff	TCGA-75-7025-01		8966f44c-9452-4e21-9fad-142ea03c9bff	TCGA-75-7025-01A-12D-1945-08	TCGA-75-7025-01	
TCGA-75-7027-01	3.09	0.62	none		none	none	none	Y	Y	none	none	none	0.23	Magnoid	none	p.G12V	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-75-7027-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 1		TCGA-75-7027	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO			L-Lower		TCGA-75-7027-F72040	TCGA-75-7027	TCGA-75-7027-01A							3059	2949			0					Scheduled Follow-up Submission		2015-4-2	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.7	NO					Peripheral Lung	1.4	NO	Locoregional Recurrence	YES	50		No	M0	N0	T2	Stage IB	TCGA-75-7027.04803f1d-6cb8-44ec-b4f1-11f1308dc840.pdf	7027	Preoperative	TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.7		6th	NO	NO	YES	75	2	Current smoker	Lung	A	LIVING		1956		TCGA-75-7027-01A-11D-1945-08		ef16aead-4eec-4c97-a393-dc7a54ce5264				TCGA-75-7027-01A-11D-1943-01	TCGA-75-7027-01A-11D-1947-05	TCGA-75-7027-01	TCGA-75-7027-01A-11D-1943-01		ef16aead-4eec-4c97-a393-dc7a54ce5264	TCGA-75-7027-01	TCGA-75-7027-01A-13-2191-20	ef16aead-4eec-4c97-a393-dc7a54ce5264	TCGA-75-7027-01	5f83ce7b-d3b2-4053-8d30-753fd9820a93	ef16aead-4eec-4c97-a393-dc7a54ce5264	TCGA-75-7027-01A-11D-1945-08	TCGA-75-7027-01	
TCGA-75-7030-01	2.01	0.17	none		none	none	none	Y	Y	none	none	none	0.08	Bronchioid	none	p.G12D	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-75-7030-01	Quiet	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4		TCGA-75-7030	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO		R-Lower		TCGA-75-7030-F15878	TCGA-75-7030	TCGA-75-7030-01A											0						Complete Remission/Response	2011-8-16	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.6	NO					Peripheral Lung	0.6			NO			No	M0	N0	T3	Stage IIB	TCGA-75-7030.34fb09ff-9b3b-4197-8fb7-91fe66981ac2.pdf	7030	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.5		6th	YES	NO	YES	75	1	Lifelong Non-smoker	Lung	A	LIVING	2007			TCGA-75-7030-01A-11D-1945-08		aa1dfe29-6e97-4b20-b439-1d06455dfc56				TCGA-75-7030-01A-11D-1943-01	TCGA-75-7030-01A-11D-1947-05	TCGA-75-7030-01	TCGA-75-7030-01A-11D-1943-01		aa1dfe29-6e97-4b20-b439-1d06455dfc56	TCGA-75-7030-01	TCGA-75-7030-01A-13-2191-20	aa1dfe29-6e97-4b20-b439-1d06455dfc56	TCGA-75-7030-01	7b85c15a-ee62-464b-a28c-03499ea5d340	aa1dfe29-6e97-4b20-b439-1d06455dfc56	TCGA-75-7030-01A-11D-1945-08	TCGA-75-7030-01	
TCGA-75-7031-01	4.01	0.48	none		none	none	none	N	N	none	none	none	0.16	Magnoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			p.W239C	0	TCGA-75-7031-01	High	C4-BRCA/Basal	cluster 3	Low purity c2	BRCA basal-like c6	LUAD-like c10	miRNA cluster 4	cluster 1		TCGA-75-7031	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO		R-Upper		TCGA-75-7031-F15880	TCGA-75-7031	TCGA-75-7031-01A											0							2011-8-16	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO					Peripheral Lung	0.9			NO	5		No	M0	N0	T2	Stage IB	TCGA-75-7031.0f516d64-bec9-42ff-9432-d626193c3dd2.pdf	7031	Preoperative	TUMOR FREE									NO	R0	Primary Tumor	01	0.3	1975	6th	NO	NO	YES	75	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2008	1965		TCGA-75-7031-01A-11D-1945-08		66b0fb5a-0587-4d01-8960-29c19c0b0b20				TCGA-75-7031-01A-11D-1943-01	TCGA-75-7031-01A-11D-1947-05	TCGA-75-7031-01	TCGA-75-7031-01A-11D-1943-01		66b0fb5a-0587-4d01-8960-29c19c0b0b20	TCGA-75-7031-01	TCGA-75-7031-01A-13-2192-20	66b0fb5a-0587-4d01-8960-29c19c0b0b20	TCGA-75-7031-01	1ae37e42-5c58-4388-89da-a30726493ed1	66b0fb5a-0587-4d01-8960-29c19c0b0b20	TCGA-75-7031-01A-11D-1945-08	TCGA-75-7031-01	
TCGA-78-7143-01			none		none	none	none	N	N	none	none	none		Bronchioid	none	none	none	p.D963_splice	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-78-7143-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-78-7143	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	62	L-Upper		TCGA-78-7143-F16669	TCGA-78-7143	TCGA-78-7143-01A			-22673		4961	0		4608			0	NO			NO	Additional New Tumor Event		2011-9-23	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.1	8252/3	C34.1	YES		1	NO		NO			Central Lung	1.1			YES			No	M0	N0	T2	Stage IB	TCGA-78-7143.083bd90a-b596-4a8b-84f5-97ca17cee7fa.pdf	7143	Preoperative	TUMOR FREE										R0	Primary Tumor	01	0.7		6th		NO	YES	78	1	Lifelong Non-smoker	Lung	A	DECEASED	1992			TCGA-78-7143-01A-11D-2036-08		274a99f3-1b61-48f3-afab-11088c63f488				TCGA-78-7143-01A-11D-2035-01	TCGA-78-7143-01A-11D-2037-05	TCGA-78-7143-01	TCGA-78-7143-01A-11D-2035-01		274a99f3-1b61-48f3-afab-11088c63f488	TCGA-78-7143-01	TCGA-78-7143-01A-13-2192-20	274a99f3-1b61-48f3-afab-11088c63f488	TCGA-78-7143-01	de7019fd-493c-4c57-a720-3b20049d5e82	274a99f3-1b61-48f3-afab-11088c63f488		TCGA-78-7143-01	
TCGA-78-7145-01	2.04	0.78	none		none	none	none	Y	Y	none	none	none	0.38	Squamoid	none	p.G12Y	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-78-7145-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-78-7145	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	52	R-Middle		TCGA-78-7145-F16671	TCGA-78-7145	TCGA-78-7145-01A			-19080		826	0		422			1	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2011-9-23	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES		1	NO		NO			Peripheral Lung	1.4			YES	25		No	M1	N1	T4	Stage IV	TCGA-78-7145.b9516a4e-5bc3-47f6-8ca3-f1e5abf71b34.pdf	7145	Preoperative	WITH TUMOR									NO	R1	Primary Tumor	01	0.6	1998	6th	YES	NO	YES	78	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2000	1973		TCGA-78-7145-01A-11D-2036-08		29f0cffb-22a7-40a7-964d-9b84d7c5b442				TCGA-78-7145-01A-11D-2035-01	TCGA-78-7145-01A-11D-2037-05	TCGA-78-7145-01	TCGA-78-7145-01A-11D-2035-01		29f0cffb-22a7-40a7-964d-9b84d7c5b442	TCGA-78-7145-01	TCGA-78-7145-01A-13-2192-20	29f0cffb-22a7-40a7-964d-9b84d7c5b442	TCGA-78-7145-01	470c8ea8-5563-4fa6-8ae2-e44d589a0de2	29f0cffb-22a7-40a7-964d-9b84d7c5b442	TCGA-78-7145-01A-11D-2036-08	TCGA-78-7145-01	
TCGA-78-7146-01																												TCGA-78-7146-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4			TCGA-78-7146	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	L-Lower		TCGA-78-7146-F16969	TCGA-78-7146	TCGA-78-7146-01A			-26272		173	0					1	NO			NO	Scheduled Follow-up Submission		2011-9-28	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.8	NO		NO			Peripheral Lung	0.8				6		No	M0	N2	T2	Stage IIIA	TCGA-78-7146.3ff87253-3d93-4283-8052-499cd0edea85.pdf	7146	Preoperative										NO	R0	Primary Tumor	01	0.6	1998	6th	NO	NO	YES	78	4		Lung	A	DECEASED	1999	1988				6a45204a-96c6-4617-a4cc-27f71c05170b				TCGA-78-7146-01A-11D-2035-01	TCGA-78-7146-01A-11D-2037-05	TCGA-78-7146-01	TCGA-78-7146-01A-11D-2035-01		6a45204a-96c6-4617-a4cc-27f71c05170b	TCGA-78-7146-01	TCGA-78-7146-01A-13-2192-20	6a45204a-96c6-4617-a4cc-27f71c05170b	TCGA-78-7146-01	067d2d3a-828e-426a-87bf-86018e3bc83b	6a45204a-96c6-4617-a4cc-27f71c05170b	TCGA-78-7146-01A-11D-2036-08	TCGA-78-7146-01	
TCGA-78-7147-01	1.9	0.77	none		none	none	none	Y	Y	p.L387M, p.L861Q, p.D1083fs	none	none	0.4	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-78-7147-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 3		TCGA-78-7147	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	67	R-Upper		TCGA-78-7147-F16971	TCGA-78-7147	TCGA-78-7147-01A			-24809		586	0		578			1	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2011-9-28	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO		NO			Peripheral Lung	0.9			YES	50		No	M0	N1	T2	Stage IIB	TCGA-78-7147.0f5ad63e-a072-4f02-8f88-1d75fabd3a4b.pdf	7147	Preoperative	WITH TUMOR									NO	R0	Primary Tumor	01	0.8		6th	NO	NO	YES	78	2	Current smoker	Lung	A	DECEASED	2001	1950		TCGA-78-7147-01A-11D-2036-08		8c957960-d5a3-4d07-a3aa-6c13b16fff0e				TCGA-78-7147-01A-11D-2035-01	TCGA-78-7147-01A-11D-2037-05	TCGA-78-7147-01	TCGA-78-7147-01A-11D-2035-01		8c957960-d5a3-4d07-a3aa-6c13b16fff0e	TCGA-78-7147-01	TCGA-78-7147-01A-13-2192-20	8c957960-d5a3-4d07-a3aa-6c13b16fff0e	TCGA-78-7147-01	86f70a35-27ae-46fe-bae0-152228134cd1	8c957960-d5a3-4d07-a3aa-6c13b16fff0e	TCGA-78-7147-01A-11D-2036-08	TCGA-78-7147-01	
TCGA-78-7148-01			none		none	none	none	Y	Y	none	none	p.R1304L		Magnoid	none	p.G12C	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			p.E265fs	0	TCGA-78-7148-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-78-7148	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO	YES	71	L-Upper		TCGA-78-7148-F17170	TCGA-78-7148	TCGA-78-7148-01A		182	-25990		626	0		182			0	NO			NO	Scheduled Follow-up Submission		2011-10-4	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.8	NO		NO			Peripheral Lung	0.9			YES	57		No	M0	N1	T2	Stage IIB	TCGA-78-7148.5c97d03f-3dfc-4876-ab9e-ad2f4606d62b.pdf	7148	Preoperative										NO	R0	Primary Tumor	01	0.6		6th	NO	NO	YES	78	2	Current smoker	Lung	A	DECEASED	2001	1944		TCGA-78-7148-01A-11D-2036-08		614ad2cf-7744-4ce1-b684-b6a57827e8c8				TCGA-78-7148-01A-11D-2035-01	TCGA-78-7148-01A-11D-2037-05	TCGA-78-7148-01	TCGA-78-7148-01A-11D-2035-01		614ad2cf-7744-4ce1-b684-b6a57827e8c8	TCGA-78-7148-01	TCGA-78-7148-01A-13-2192-20	614ad2cf-7744-4ce1-b684-b6a57827e8c8	TCGA-78-7148-01	3c3ea12a-d4d9-48b5-a19e-552c41a626c4	614ad2cf-7744-4ce1-b684-b6a57827e8c8	TCGA-78-7148-01A-11D-2036-08	TCGA-78-7148-01	
TCGA-78-7149-01	1.89	0.74	none		none	none	none	N	N	none	none	none	0.39	Magnoid	none	none	none	p.P1322H	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-78-7149-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-78-7149	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	R-Lower		TCGA-78-7149-F46148	TCGA-78-7149	TCGA-78-7149-01A			-26285			0	3940				1	NO			NO	Scheduled Follow-up Submission		2013-8-23	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.9	NO		NO			Central Lung	1	NO			115		No	M0	N0	T4	Stage IIIB	TCGA-78-7149.2211dcab-03dd-493c-9131-684a9accea7a.pdf	7149	Preoperative						Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.5		6th	NO	NO	YES	78	2	Current smoker	Lung	A	LIVING	2002	1950		TCGA-78-7149-01A-11D-2036-08		02e43817-47d3-4436-bcfa-37dd510eec4c				TCGA-78-7149-01A-11D-2035-01	TCGA-78-7149-01A-11D-2037-05	TCGA-78-7149-01	TCGA-78-7149-01A-11D-2035-01		02e43817-47d3-4436-bcfa-37dd510eec4c	TCGA-78-7149-01	TCGA-78-7149-01A-13-2192-20	02e43817-47d3-4436-bcfa-37dd510eec4c	TCGA-78-7149-01	71dc1546-3861-4b65-9151-152972f6872e	02e43817-47d3-4436-bcfa-37dd510eec4c	TCGA-78-7149-01A-11D-2036-08	TCGA-78-7149-01	
TCGA-78-7150-01	3	0.46	none		none	none	none	N	N	none	none	none	0.19	Magnoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-78-7150-01	Squamous	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-78-7150	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	YES	59	L-Lower		TCGA-78-7150-F16962	TCGA-78-7150	TCGA-78-7150-01A		164	-21891		666	0		139			0	NO			NO	Scheduled Follow-up Submission		2011-9-28	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.8	NO		NO			Central Lung	0.9			YES	37		No	M0	N1	T2	Stage IIB	TCGA-78-7150.99bec792-e05e-49fd-8601-5f51e876e614.pdf	7150	Preoperative	WITH TUMOR									NO	R0	Primary Tumor	01	0.6	2000	6th	NO	NO	YES	78	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2002	1963		TCGA-78-7150-01A-21D-2036-08		fb59e5ad-650a-4620-af05-9e8cb6c402ea				TCGA-78-7150-01A-21D-2035-01	TCGA-78-7150-01A-21D-2037-05	TCGA-78-7150-01	TCGA-78-7150-01A-21D-2035-01		fb59e5ad-650a-4620-af05-9e8cb6c402ea	TCGA-78-7150-01	TCGA-78-7150-01A-23-2192-20	fb59e5ad-650a-4620-af05-9e8cb6c402ea	TCGA-78-7150-01	67bbd18a-fc5c-472d-9203-cf91078210d5	fb59e5ad-650a-4620-af05-9e8cb6c402ea	TCGA-78-7150-01A-21D-2036-08	TCGA-78-7150-01	
TCGA-78-7152-01	1.99	0.56	none		none	none	none	N	N	none	none	none	0.28	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			p.I29fs	0	TCGA-78-7152-01	Kirc+	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-78-7152	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		NO	65	R-Upper		TCGA-78-7152-F46144	TCGA-78-7152	TCGA-78-7152-01A			-23782		1215	0	1202	1202			1	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-8-4	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.7	NO		NO			Peripheral Lung	0.9	NO	Distant Metastasis	YES	40		No	M0	N0	T2	Stage IB	TCGA-78-7152.4ee9aa80-a04b-4220-8657-0b05af9da97c.pdf	7152	Preoperative	WITH TUMOR					Complete Remission/Response	Biopsy with Histologic Confirmation|Convincing Imaging		NO	NO	R0	Primary Tumor	01	0.7	1999	6th	NO	NO	YES	78	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2003	1959		TCGA-78-7152-01A-11D-2036-08		5a775e87-c4e5-4875-bc64-e2e2a59376e8				TCGA-78-7152-01A-11D-2035-01	TCGA-78-7152-01A-11D-2037-05	TCGA-78-7152-01	TCGA-78-7152-01A-11D-2035-01		5a775e87-c4e5-4875-bc64-e2e2a59376e8	TCGA-78-7152-01	TCGA-78-7152-01A-13-2192-20	5a775e87-c4e5-4875-bc64-e2e2a59376e8	TCGA-78-7152-01	fd44c328-915d-40a6-a1de-3ac0b666cca9	5a775e87-c4e5-4875-bc64-e2e2a59376e8	TCGA-78-7152-01A-11D-2036-08	TCGA-78-7152-01	
TCGA-78-7153-01	2.12	0.74	none		p.G466A	p.IVVD429del	p.S33N	N	Y	none	none	none	0.35	Magnoid	none	none	none	none	none	p.Q296E	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-78-7153-01	Iq	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-78-7153	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					65	R-Upper		TCGA-78-7153-F46077	TCGA-78-7153				-23922			0	3635				0	NO			NO	Scheduled Follow-up Submission		2013-8-23	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.8	8255/3	C34.8	YES					NO			Peripheral Lung		NO			20		No	M0	N0	T2	Stage IB		7153	Preoperative						Complete Remission/Response			NO	NO	R0	Primary Tumor	01		1988	6th	NO	NO	YES	78	4	Current reformed smoker for < or = 15 years	Lung		LIVING	2003	1948		TCGA-78-7153-01A-11D-2036-08		e1bbe3cc-e58e-45d6-82a7-57e8d202e7e6				TCGA-78-7153-01A-11D-2035-01	TCGA-78-7153-01A-11D-2037-05	TCGA-78-7153-01	TCGA-78-7153-01A-11D-2035-01		e1bbe3cc-e58e-45d6-82a7-57e8d202e7e6	TCGA-78-7153-01	TCGA-78-7153-01A-13-2192-20	e1bbe3cc-e58e-45d6-82a7-57e8d202e7e6	TCGA-78-7153-01	bbd8169d-89fa-476d-b097-eeedd8a977e8	e1bbe3cc-e58e-45d6-82a7-57e8d202e7e6	TCGA-78-7153-01A-11D-2036-08	TCGA-78-7153-01	
TCGA-78-7154-01	2.17	0.68	none		none	none	none	N	N	none	none	none	0.32	Magnoid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-78-7154-01	High	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 5		TCGA-78-7154	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	L-Upper		TCGA-78-7154-F16951	TCGA-78-7154				-26481		593	0					1	NO			NO	Scheduled Follow-up Submission		2011-9-28	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO			Peripheral Lung					112.5		No	M0	N2	T3	Stage IIIA		7154	Preoperative											R0	Primary Tumor	01		1993	6th		NO	YES	78	4	Current reformed smoker for < or = 15 years	Lung		DECEASED	2003	1948		TCGA-78-7154-01A-11D-2036-08		dbe8b05d-9b51-4d93-9e04-9609a5dd4cb8				TCGA-78-7154-01A-11D-2035-01	TCGA-78-7154-01A-11D-2037-05	TCGA-78-7154-01	TCGA-78-7154-01A-11D-2035-01		dbe8b05d-9b51-4d93-9e04-9609a5dd4cb8	TCGA-78-7154-01	TCGA-78-7154-01A-13-2192-20	dbe8b05d-9b51-4d93-9e04-9609a5dd4cb8	TCGA-78-7154-01	d4d06599-d87f-4cf3-bb74-288516ccedee	dbe8b05d-9b51-4d93-9e04-9609a5dd4cb8	TCGA-78-7154-01A-11D-2036-08	TCGA-78-7154-01	
TCGA-78-7155-01	2.53	0.81	none		none	none	none	N	N	p.Q432H, p.K754I, p.G901V	none	none	0.33	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-78-7155-01	High	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	RNA cluster 14	miRNA cluster 12	cluster 5		TCGA-78-7155	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO	NO	68	L-Upper		TCGA-78-7155-F16958	TCGA-78-7155	TCGA-78-7155-01A			-24863		1171	0		209			0	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2011-9-28	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO		NO			Peripheral Lung	0.9			YES	48		No	M0	N0	T2	Stage IB	TCGA-78-7155.0a07b1a2-095d-4da1-ba4f-112169b62971.pdf	7155	Preoperative											R0	Primary Tumor	01	0.7	2005	6th		NO	YES	78	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2005	1957		TCGA-78-7155-01A-11D-2036-08		ddb17f24-f233-40dc-bbbd-731e50d4fce4				TCGA-78-7155-01A-11D-2035-01	TCGA-78-7155-01A-11D-2037-05	TCGA-78-7155-01	TCGA-78-7155-01A-11D-2035-01		ddb17f24-f233-40dc-bbbd-731e50d4fce4	TCGA-78-7155-01	TCGA-78-7155-01A-13-2192-20	ddb17f24-f233-40dc-bbbd-731e50d4fce4	TCGA-78-7155-01	815f2443-e1d3-43e0-ac43-6fab6279696c	ddb17f24-f233-40dc-bbbd-731e50d4fce4	TCGA-78-7155-01A-11D-2036-08	TCGA-78-7155-01	
TCGA-78-7156-01	1.98	0.8	none		none	none	none	N	N	none	none	none	0.4	Magnoid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			p.G279fs	0	TCGA-78-7156-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-78-7156	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					62			TCGA-78-7156-F16982	TCGA-78-7156	TCGA-78-7156-01A			-22720		976	0					1	NO			NO	Scheduled Follow-up Submission		2011-9-29	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.9	8255/3	C34.9	YES		0.7	NO		NO			Peripheral Lung	1.1				84		No	M1	N1	T4	Stage IV	TCGA-78-7156.28b28933-7e87-4a7b-a17b-170e494d1a30.pdf	7156	Preoperative										NO	R0	Primary Tumor	01	0.6	1989	6th	NO	NO	YES	78	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2006	1961		TCGA-78-7156-01A-11D-2036-08		e6aecb65-29f2-48de-a8a0-55b25fbafef1				TCGA-78-7156-01A-11D-2035-01	TCGA-78-7156-01A-11D-2037-05	TCGA-78-7156-01	TCGA-78-7156-01A-11D-2035-01		e6aecb65-29f2-48de-a8a0-55b25fbafef1	TCGA-78-7156-01	TCGA-78-7156-01A-13-2192-20	e6aecb65-29f2-48de-a8a0-55b25fbafef1	TCGA-78-7156-01	45d51359-305c-4ee3-b02d-b88154ee3e47	e6aecb65-29f2-48de-a8a0-55b25fbafef1	TCGA-78-7156-01A-11D-2036-08	TCGA-78-7156-01	
TCGA-78-7158-01	2.09	0.92	none		none	none	p.S37F	N	N	p.L907M	none	none	0.44	Bronchioid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-78-7158-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 3	cluster 1		TCGA-78-7158	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO	NO	59	L-Lower		TCGA-78-7158-F16166	TCGA-78-7158	TCGA-78-7158-01A			-21742		179	0		132			1	NO			NO	Scheduled Follow-up Submission		2011-9-15	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.9	NO		NO			Peripheral Lung	1.1			YES	14		No	M0	N2	T4	Stage IIIB	TCGA-78-7158.1ac638bd-3da2-472d-90bf-1e100bfcdb19.pdf	7158	Preoperative	WITH TUMOR					Progressive Disease				NO	R1	Primary Tumor	01	0.5	2005	6th	YES	NO	YES	78	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2007	1963		TCGA-78-7158-01A-11D-2036-08		cc748956-075e-4433-9640-274ee42bdba8				TCGA-78-7158-01A-11D-2035-01	TCGA-78-7158-01A-11D-2037-05	TCGA-78-7158-01	TCGA-78-7158-01A-11D-2035-01		cc748956-075e-4433-9640-274ee42bdba8	TCGA-78-7158-01	TCGA-78-7158-01A-13-2192-20	cc748956-075e-4433-9640-274ee42bdba8	TCGA-78-7158-01	85bf5bc8-7e43-4cb3-a654-152c901477ea	cc748956-075e-4433-9640-274ee42bdba8	TCGA-78-7158-01A-11D-2036-08	TCGA-78-7158-01	
TCGA-78-7159-01	2.13	0.71	none		none	none	none	N	N	none	none	none	0.34	Magnoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			p.N259fs	0	TCGA-78-7159-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 6	cluster 1		TCGA-78-7159	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					60	L-Upper		TCGA-78-7159-F46103	TCGA-78-7159	TCGA-78-7159-01A			-22261			0	1974				1	NO			NO	Scheduled Follow-up Submission		2013-8-4	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		1	NO		NO			Peripheral Lung	1.1	NO			21		No	M0	NX	T1	Stage IA	TCGA-78-7159.abb2f0e8-b167-4ffb-a52d-2116d4a919c6.pdf	7159	Preoperative						Complete Remission/Response				NO	R0	Primary Tumor	01	0.7	2007	6th	NO	NO	YES	78	4	Current smoker	Lung	A	LIVING	2008	1965		TCGA-78-7159-01A-11D-2036-08		cc6ff65b-c9fe-4992-971c-3c9a61caeec1				TCGA-78-7159-01A-11D-2035-01	TCGA-78-7159-01A-11D-2037-05	TCGA-78-7159-01	TCGA-78-7159-01A-11D-2035-01		cc6ff65b-c9fe-4992-971c-3c9a61caeec1	TCGA-78-7159-01	TCGA-78-7159-01A-13-2192-20	cc6ff65b-c9fe-4992-971c-3c9a61caeec1	TCGA-78-7159-01	9cd6f033-15cc-4a73-97d9-38bc5c99fdd7	cc6ff65b-c9fe-4992-971c-3c9a61caeec1	TCGA-78-7159-01A-11D-2036-08	TCGA-78-7159-01	
TCGA-78-7160-01	3.23	0.17	none		none	none	none	Y	Y	none	none	p.P1240H	0.08	Magnoid	none	p.G12D	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			p.M51fs	0	TCGA-78-7160-01	Squamous	C1-LUAD-enriched	cluster 3	Low purity c2	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-78-7160	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	R-Lower		TCGA-78-7160-F46139	TCGA-78-7160				-22385		697	0	678				1	NO			NO	Scheduled Follow-up Submission		2013-8-4	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES					NO			Central Lung		NO			43.8		No	M1	N2	T4	Stage IV		7160	Preoperative						Complete Remission/Response			NO	NO	R0	Primary Tumor	01		1998	6th	YES	NO	YES	78	4	Current reformed smoker for < or = 15 years	Lung		DECEASED	2008	1963		TCGA-78-7160-01A-11D-2036-08		d41fd6e3-f45d-40df-86bc-7fb9d2e3cdd3				TCGA-78-7160-01A-11D-2035-01	TCGA-78-7160-01A-11D-2037-05	TCGA-78-7160-01	TCGA-78-7160-01A-11D-2035-01		d41fd6e3-f45d-40df-86bc-7fb9d2e3cdd3	TCGA-78-7160-01	TCGA-78-7160-01A-13-2192-20	d41fd6e3-f45d-40df-86bc-7fb9d2e3cdd3	TCGA-78-7160-01	d370d747-9c80-4bba-af93-4aa5db7c587c	d41fd6e3-f45d-40df-86bc-7fb9d2e3cdd3	TCGA-78-7160-01A-11D-2036-08	TCGA-78-7160-01	
TCGA-78-7161-01			none		none	none	none	Y	Y	none	none	none		Magnoid	none	p.G12V	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			p.G155_splice	0	TCGA-78-7161-01	High	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 6	cluster 1		TCGA-78-7161	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		69	L-Upper		TCGA-78-7161-F46153	TCGA-78-7161	TCGA-78-7161-01A			-25294		291	0	215	162			1	YES			NO	Scheduled Follow-up Submission	Progressive Disease	2013-8-23	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.6	NO		NO			Peripheral Lung	1	NO	Locoregional Recurrence	YES	27.8		No	M0	N0	T3	Stage IIB	TCGA-78-7161.0a86e747-a5e2-4d91-8ebd-6ef80e11cbc8.pdf	7161	Preoperative	WITH TUMOR					Progressive Disease	Biopsy with Histologic Confirmation		NO	NO	R1	Primary Tumor	01	0.5	1998	7th	YES	NO	YES	78	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2011	1961		TCGA-78-7161-01A-11D-2036-08		3bc1fe5d-5eff-46f2-adf6-e6bc8b7e8f90				TCGA-78-7161-01A-11D-2035-01	TCGA-78-7161-01A-11D-2037-05	TCGA-78-7161-01	TCGA-78-7161-01A-11D-2035-01		3bc1fe5d-5eff-46f2-adf6-e6bc8b7e8f90	TCGA-78-7161-01	TCGA-78-7161-01A-13-2192-20	3bc1fe5d-5eff-46f2-adf6-e6bc8b7e8f90	TCGA-78-7161-01	7dfad617-4921-46ff-9151-2b34915859e7	3bc1fe5d-5eff-46f2-adf6-e6bc8b7e8f90	TCGA-78-7161-01A-11D-2036-08	TCGA-78-7161-01	
TCGA-78-7162-01			none		none	none	none	N	N	none	none	none		Bronchioid	none	none	none	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-78-7162-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-78-7162	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	NO	75	L-Upper		TCGA-78-7162-F17127	TCGA-78-7162	TCGA-78-7162-01A			-27593		3169	0		2740			0	NO			NO	Additional New Tumor Event		2011-10-3	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.6	NO		NO			Peripheral Lung	0.7			YES	12		No	M0	N0	T1	Stage IA	TCGA-78-7162.41e3d123-0a90-43e4-80b7-7be47de9fd16.pdf	7162	Preoperative										NO	R0	Primary Tumor	01	0.5		6th	NO	NO	YES	78	2	Current smoker	Lung	A	DECEASED	1991	1940		TCGA-78-7162-01A-21D-2063-08		01a75809-bb4e-42f3-a3ca-25e4d1ca37a3				TCGA-78-7162-01A-21D-2062-01	TCGA-78-7162-01A-21D-2064-05	TCGA-78-7162-01	TCGA-78-7162-01A-21D-2062-01		01a75809-bb4e-42f3-a3ca-25e4d1ca37a3	TCGA-78-7162-01	TCGA-78-7162-01A-23-2192-20	01a75809-bb4e-42f3-a3ca-25e4d1ca37a3	TCGA-78-7162-01	78e8850d-ff5b-4199-b9ac-f098ddf67561	01a75809-bb4e-42f3-a3ca-25e4d1ca37a3	TCGA-78-7162-01A-21D-2063-08	TCGA-78-7162-01	
TCGA-78-7163-01	2.56	0.7	none	Y	none	none	none	Y	Y	none	none	none	0.29	Bronchioid	none	none	none	none	none	none	none	Invasive mucinous	Invasive mucinous			none	0	TCGA-78-7163-01	Kirc+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 1		TCGA-78-7163	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					60	R-Lower		TCGA-78-7163-F46140	TCGA-78-7163	TCGA-78-7163-01A			-22002			0	7248				1	NO			NO	Scheduled Follow-up Submission		2013-8-4	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.7	NO		NO			Peripheral Lung	1.2	NO			41		No	M0	N0	T2	Stage IB	TCGA-78-7163.40948ca8-3075-47ef-a679-94ea5dc29a08.pdf	7163	Preoperative	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.4	1991	6th	NO	NO	YES	78	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	1992	1950		TCGA-78-7163-01A-12D-2063-08		5deb51ff-a271-4fc4-90b6-3bdb0c508967				TCGA-78-7163-01A-12D-2062-01	TCGA-78-7163-01A-12D-2064-05	TCGA-78-7163-01	TCGA-78-7163-01A-12D-2062-01		5deb51ff-a271-4fc4-90b6-3bdb0c508967	TCGA-78-7163-01	TCGA-78-7163-01A-23-2192-20	5deb51ff-a271-4fc4-90b6-3bdb0c508967	TCGA-78-7163-01	1a4d9a2b-2eaf-4e8e-a463-2a9060163096	5deb51ff-a271-4fc4-90b6-3bdb0c508967	TCGA-78-7163-01A-12D-2063-08	TCGA-78-7163-01	
TCGA-78-7163-11	2.56	0.7	none	Y	none	none	none	Y	Y	none	none	none	0.29	Bronchioid	none	none	none	none	none	none	none	Invasive mucinous	Invasive mucinous			none	0	TCGA-78-7163-11		C1-LUAD-enriched								TCGA-78-7163	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					60	R-Lower		TCGA-78-7163-F46140	TCGA-78-7163				-22002			0	7248				1	NO			NO	Scheduled Follow-up Submission		2013-8-4	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES					NO			Peripheral Lung		NO			41		No	M0	N0	T2	Stage IB		7163	Preoperative	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Solid Tissue Normal	11		1991	6th	NO	NO	YES	78	4	Current reformed smoker for < or = 15 years	Lung		LIVING	1992	1950														TCGA-78-7163-11							TCGA-78-7163-11	
TCGA-78-7166-01	2.04	0.63	none		none	none	none	Y	Y	none	none	none	0.31	Magnoid	none	p.G12C	none	none	none	none	none	Invasive mucinous	Invasive mucinous			p.G56V, p.K78E	0	TCGA-78-7166-01	Iq	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-78-7166	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO			84	L-Lower		TCGA-78-7166-F16954	TCGA-78-7166	TCGA-78-7166-01A			-30869		258	0					2	NO			NO	Scheduled Follow-up Submission		2011-9-28	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.6	NO		NO			Central Lung	0.9			NO	38		Yes	M0	N1	T2	Stage IIB	TCGA-78-7166.e2ddc3ba-8151-4f3e-9219-cd3147ea5029.pdf	7166	Preoperative										YES	R0	Primary Tumor	01	0.4	1972	6th	NO	NO	YES	78	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2002	1934		TCGA-78-7166-01A-12D-2063-08		3d86f6ec-741c-4da5-836e-28b029b32706				TCGA-78-7166-01A-12D-2062-01	TCGA-78-7166-01A-12D-2064-05	TCGA-78-7166-01	TCGA-78-7166-01A-12D-2062-01		3d86f6ec-741c-4da5-836e-28b029b32706	TCGA-78-7166-01	TCGA-78-7166-01A-23-2192-20	3d86f6ec-741c-4da5-836e-28b029b32706	TCGA-78-7166-01	bbde7e4b-5d2e-4fa1-8548-7b4f87d96cfb	3d86f6ec-741c-4da5-836e-28b029b32706	TCGA-78-7166-01A-12D-2063-08	TCGA-78-7166-01	
TCGA-78-7167-01			none		none	none	none	Y	Y	none	none	none		Magnoid	none	p.G12F	none	none	none	none	none	Lepidic predominant Adc	Lepidic predominant Adc			p.R331fs	0	TCGA-78-7167-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 6	cluster 1		TCGA-78-7167	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	77			TCGA-78-7167-F17172	TCGA-78-7167	TCGA-78-7167-01A			-28295		2681	0		726			1	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2011-10-4	MALE	Lung Papillary Adenocarcinoma	No	C34.9	8260/3	C34.9	YES		0.6	NO		NO			Peripheral Lung	0.7			YES	64		No	M1	N0	T2	Stage IV	TCGA-78-7167.a164a9ae-8f90-4deb-83ce-8f111897e5d6.pdf	7167	Preoperative	WITH TUMOR									NO	R0	Primary Tumor	01	0.6		6th	NO	NO	YES	78	2	Current smoker	Lung	A	DECEASED	2002	1937		TCGA-78-7167-01A-11D-2063-08		30642287-a06f-46e0-8e37-839935a2d3dc				TCGA-78-7167-01A-11D-2062-01	TCGA-78-7167-01A-11D-2064-05	TCGA-78-7167-01	TCGA-78-7167-01A-11D-2062-01		30642287-a06f-46e0-8e37-839935a2d3dc	TCGA-78-7167-01	TCGA-78-7167-01A-13-2192-20	30642287-a06f-46e0-8e37-839935a2d3dc	TCGA-78-7167-01	07fd6c8a-3e19-45c8-9a15-b46cb4365d43	30642287-a06f-46e0-8e37-839935a2d3dc	TCGA-78-7167-01A-11D-2063-08	TCGA-78-7167-01	
TCGA-78-7220-01																												TCGA-78-7220-01	High			Cluster 5		LUAD-like c10	miRNA cluster 4			TCGA-78-7220	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	53	L-Upper		TCGA-78-7220-F19298	TCGA-78-7220				-19480		807	0		531			0	NO			NO	Scheduled Follow-up Submission		2011-12-8	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES					NO			Peripheral Lung				YES	35		No	M0	N2	T2	Stage IIIA		7220	Preoperative	WITH TUMOR									YES	R0	Primary Tumor	01			6th	NO	NO	YES	78	2		Lung		DECEASED	2000	1965				aa29c7b0-8641-4a59-8b17-c007b3cb8726				TCGA-78-7220-01A-11D-2035-01	TCGA-78-7220-01A-11D-2037-05	TCGA-78-7220-01	TCGA-78-7220-01A-11D-2035-01		aa29c7b0-8641-4a59-8b17-c007b3cb8726	TCGA-78-7220-01		aa29c7b0-8641-4a59-8b17-c007b3cb8726	TCGA-78-7220-01		aa29c7b0-8641-4a59-8b17-c007b3cb8726	TCGA-78-7220-01A-11D-2036-08	TCGA-78-7220-01	
TCGA-78-7535-01	1.53	0.75	none		none	none	none	N	N	none	none	none	0.46	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			p.L245_splice	0	TCGA-78-7535-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-78-7535	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	YES	45	L-Upper		TCGA-78-7535-F20633	TCGA-78-7535	TCGA-78-7535-01A		809	-16571		949	0		809			0	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2012-1-19	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO		NO				1.2			YES	35		No	M0	N0	T2	Stage IB	TCGA-78-7535.217e5c9a-950f-46c0-a022-5ece5205d9d4.pdf	7535	Preoperative	WITH TUMOR					Stable Disease				NO	R0	Primary Tumor	01	0.6		6th	YES	NO	YES	78	2	Current smoker	Lung	A	DECEASED	2000	1972		TCGA-78-7535-01A-11D-2063-08		2cbd77bd-dece-4177-ace2-98d9d545b575				TCGA-78-7535-01A-11D-2062-01	TCGA-78-7535-01A-11D-2064-05	TCGA-78-7535-01	TCGA-78-7535-01A-11D-2062-01		2cbd77bd-dece-4177-ace2-98d9d545b575	TCGA-78-7535-01	TCGA-78-7535-01A-13-2192-20	2cbd77bd-dece-4177-ace2-98d9d545b575	TCGA-78-7535-01	ff5b1536-6edf-4479-b3f2-50d59414eae6	2cbd77bd-dece-4177-ace2-98d9d545b575	TCGA-78-7535-01A-11D-2063-08	TCGA-78-7535-01	
TCGA-78-7536-01	3.07	0.78	none		none	none	none	N	N	none	none	none	0.28	Magnoid	none	none	none	none	none	none	p.E313*	Solid predominant Adc	Solid predominant Adc			p.G279fs	0	TCGA-78-7536-01	High	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 1		TCGA-78-7536	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	69	R-Upper		TCGA-78-7536-F20631	TCGA-78-7536	TCGA-78-7536-01A			-25558		244	0		231			0	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2012-1-19	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO		NO				1.1			YES	44		No	M0	N2	T2	Stage IIIA	TCGA-78-7536.543b5396-e92f-436e-93c5-1324b9171598.pdf	7536	Preoperative	WITH TUMOR					Progressive Disease				YES	R0	Primary Tumor	01	0.6	1993	6th	NO	NO	YES	78	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2001	1949		TCGA-78-7536-01A-11D-2063-08		9334a61d-eb4f-4504-9f4d-b9d55a8733de				TCGA-78-7536-01A-11D-2062-01	TCGA-78-7536-01A-11D-2064-05	TCGA-78-7536-01	TCGA-78-7536-01A-11D-2062-01		9334a61d-eb4f-4504-9f4d-b9d55a8733de	TCGA-78-7536-01	TCGA-78-7536-01A-13-2192-20	9334a61d-eb4f-4504-9f4d-b9d55a8733de	TCGA-78-7536-01	a35de618-0eec-4f5b-afbc-7111491df9b8	9334a61d-eb4f-4504-9f4d-b9d55a8733de	TCGA-78-7536-01A-11D-2063-08	TCGA-78-7536-01	
TCGA-78-7537-01	2.08	0.74	none		p.G466V	none	none	N	Y	none	none	none	0.36	Bronchioid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			p.K175fs	0	TCGA-78-7537-01	Iq	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA c1uster 9	cluster 4		TCGA-78-7537	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	R-Upper		TCGA-78-7537-F20455	TCGA-78-7537				-26610		1622	0					1	NO			NO	Scheduled Follow-up Submission		2012-1-13	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES					NO								20		No	M0	N0	T2	Stage IB		7537	Preoperative										NO	R0	Primary Tumor	01		1984	6th	NO	YES	NO	78	3	Current reformed smoker for > 15 years	Lung		DECEASED	2002	1944		TCGA-78-7537-01A-11D-2063-08		a91960e0-f237-419e-aa57-f90ceb12fcde				TCGA-78-7537-01A-11D-2062-01	TCGA-78-7537-01A-11D-2064-05	TCGA-78-7537-01	TCGA-78-7537-01A-11D-2062-01		a91960e0-f237-419e-aa57-f90ceb12fcde	TCGA-78-7537-01	TCGA-78-7537-01A-13-2192-20	a91960e0-f237-419e-aa57-f90ceb12fcde	TCGA-78-7537-01	d853bbc6-ad3a-4e47-8387-91d27e06d8bc	a91960e0-f237-419e-aa57-f90ceb12fcde	TCGA-78-7537-01A-11D-2063-08	TCGA-78-7537-01	
TCGA-78-7539-01	2.1	0.69	none		none	none	none	Y	Y	none	none	none	0.33	Bronchioid	none	p.G12C	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-78-7539-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-78-7539	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung		YES		YES	75	R-Upper		TCGA-78-7539-F46143	TCGA-78-7539	TCGA-78-7539-01A		688	-27445			0	791	688			1	NO			NO	Scheduled Follow-up Submission		2013-8-4	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.8	NO		NO				0.9	NO	Distant Metastasis	YES	2.2		No	M0	N0	T2b	Stage IIA	TCGA-78-7539.686bc9a9-71b6-4c27-a76d-4ca9713fbdbe.pdf	7539	Preoperative						Complete Remission/Response	Biopsy with Histologic Confirmation		NO	NO	R0	Primary Tumor	01	0.7	1981	7th	YES	NO	YES	78	3	Current smoker	Lung	A	LIVING	2011	1953		TCGA-78-7539-01A-11D-2063-08		479528a6-12ed-4e7b-8ca6-cf9fe6baa6de				TCGA-78-7539-01A-11D-2062-01	TCGA-78-7539-01A-11D-2064-05	TCGA-78-7539-01	TCGA-78-7539-01A-11D-2062-01		479528a6-12ed-4e7b-8ca6-cf9fe6baa6de	TCGA-78-7539-01	TCGA-78-7539-01A-13-2192-20	479528a6-12ed-4e7b-8ca6-cf9fe6baa6de	TCGA-78-7539-01	d9129bfe-b2b1-4c6c-bf9a-249921abce2b	479528a6-12ed-4e7b-8ca6-cf9fe6baa6de	TCGA-78-7539-01A-11D-2063-08	TCGA-78-7539-01	
TCGA-78-7540-01	2.02	0.58	none		none	none	none	Y	Y	none	none	none	0.29	Bronchioid	none	p.G12V	none	none	none	none	none	Invasive mucinous	Invasive mucinous			none	0	TCGA-78-7540-01	GBM	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-78-7540	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					66	L-Lower		TCGA-78-7540-F46104	TCGA-78-7540	TCGA-78-7540-01A			-24440		1197	0	881				0	NO			NO	Scheduled Follow-up Submission		2013-8-2	FEMALE	Lung Bronchioloalveolar Carcinoma Mucinous	No	C34.3	8253/3	C34.3	YES		0.8	NO		NO				1.3	NO					No	M0	N0	T2	Stage IB	TCGA-78-7540.95cad21d-0a35-4ac7-9163-f5b7bb21e18d.pdf	7540	Preoperative						Complete Remission/Response					R0	Primary Tumor	01	0.5		6th		NO	YES	78	1	Lifelong Non-smoker	Lung	A	DECEASED	1999			TCGA-78-7540-01A-11D-2063-08		193873d4-f0ad-4e8d-918b-9beb83965483				TCGA-78-7540-01A-11D-2062-01	TCGA-78-7540-01A-11D-2064-05	TCGA-78-7540-01	TCGA-78-7540-01A-11D-2062-01		193873d4-f0ad-4e8d-918b-9beb83965483	TCGA-78-7540-01	TCGA-78-7540-01A-13-2192-20	193873d4-f0ad-4e8d-918b-9beb83965483	TCGA-78-7540-01	9e24367f-3036-45d3-85fe-46808f92fe25	193873d4-f0ad-4e8d-918b-9beb83965483	TCGA-78-7540-01A-11D-2063-08	TCGA-78-7540-01	
TCGA-78-7540-11	2.02	0.58	none		none	none	none	Y	Y	none	none	none	0.29	Bronchioid	none	p.G12V	none	none	none	none	none	Invasive mucinous	Invasive mucinous			none	0	TCGA-78-7540-11		C1-LUAD-enriched								TCGA-78-7540	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					66	L-Lower		TCGA-78-7540-F46104	TCGA-78-7540				-24440		1197	0	881				0	NO			NO	Scheduled Follow-up Submission		2013-8-2	FEMALE	Lung Bronchioloalveolar Carcinoma Mucinous	No	C34.3	8253/3	C34.3	YES					NO					NO					No	M0	N0	T2	Stage IB		7540	Preoperative						Complete Remission/Response					R0	Solid Tissue Normal	11			6th		NO	YES	78	1	Lifelong Non-smoker	Lung		DECEASED	1999															TCGA-78-7540-11							TCGA-78-7540-11	
TCGA-78-7542-01	3.49	0.44	none		none	none	none	N	N	none	none	none	0.17	Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-78-7542-01	High	C2-Squamous-like	cluster 2	Cluster 6	squamous c3	squamous-like c4	miRNA c1uster 9	cluster 3		TCGA-78-7542	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					56	R-Upper		TCGA-78-7542-F20456	TCGA-78-7542				-20763		321	0					0	NO			NO	Scheduled Follow-up Submission		2012-1-13	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO								60		No	M0	N0	T2	Stage IB		7542	Preoperative											R0	Primary Tumor	01			6th		NO	YES	78	2	Current smoker	Lung		DECEASED	1993	1952		TCGA-78-7542-01A-21D-2063-08		ff74b4c6-e938-4a40-ab1a-84525349a62e				TCGA-78-7542-01A-21D-2062-01	TCGA-78-7542-01A-21D-2064-05	TCGA-78-7542-01	TCGA-78-7542-01A-21D-2062-01		ff74b4c6-e938-4a40-ab1a-84525349a62e	TCGA-78-7542-01	TCGA-78-7542-01A-23-2192-20	ff74b4c6-e938-4a40-ab1a-84525349a62e	TCGA-78-7542-01	ed42ee40-c1b5-4241-98ca-ed13a0bf8861	ff74b4c6-e938-4a40-ab1a-84525349a62e	TCGA-78-7542-01A-21D-2063-08	TCGA-78-7542-01	
TCGA-78-7633-01	2.19	0.75	none		p.G469L	none	none	N	Y	none	none	none	0.35	Magnoid	none	none	none	none	none	none	none	Papillary predominant Adc	Papillary predominant Adc			none	0	TCGA-78-7633-01	Iq	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-78-7633	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					67	L-Upper		TCGA-78-7633-F46157	TCGA-78-7633	TCGA-78-7633-01A			-24713		1528	0	994	1450		57	0	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2013-8-29	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.9	NO		NO				1	NO	Locoregional Recurrence	YES	94		Yes	M0	N0	T2	Stage IB	TCGA-78-7633.b1031a29-f3af-4f4f-a3d2-1be59c524222.pdf	7633	Preoperative	WITH TUMOR				100	Complete Remission/Response	Biopsy with Histologic Confirmation		YES		R0	Primary Tumor	01	0.5	2002	6th		NO	YES	78	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2009	1955		TCGA-78-7633-01A-11D-2063-08		006eb1bc-b058-49b9-8c2d-3c50f2427d95				TCGA-78-7633-01A-11D-2062-01	TCGA-78-7633-01A-11D-2064-05	TCGA-78-7633-01	TCGA-78-7633-01A-11D-2062-01		006eb1bc-b058-49b9-8c2d-3c50f2427d95	TCGA-78-7633-01	TCGA-78-7633-01A-13-2192-20	006eb1bc-b058-49b9-8c2d-3c50f2427d95	TCGA-78-7633-01	46727f4d-0ce9-401f-ac87-531f1ea3dc11	006eb1bc-b058-49b9-8c2d-3c50f2427d95	TCGA-78-7633-01A-11D-2063-08	TCGA-78-7633-01	
TCGA-78-8640-01																												TCGA-78-8640-01										TCGA-78-8640	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					59	L-Upper		TCGA-78-8640-F70500	TCGA-78-8640	TCGA-78-8640-01A			-21832			0	7062				0	NO			NO	Scheduled Follow-up Submission		2015-3-25	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO		NO			Peripheral Lung	0.8	NO		NO	45		No	M0	N1	T1	Stage IIA	TCGA-78-8640.b39fa23e-bac4-49c9-919b-6e6d4cb8d90d.pdf	8640	Preoperative	TUMOR FREE			73	66	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.3		6th	NO	NO	YES	78	2		Lung	A	LIVING	1994	1949				5cb476d8-eae8-453c-8157-fdb71b4d5efa				TCGA-78-8640-01A-11D-2389-01	TCGA-78-8640-01A-11D-2398-05	TCGA-78-8640-01	TCGA-78-8640-01A-11D-2389-01		5cb476d8-eae8-453c-8157-fdb71b4d5efa	TCGA-78-8640-01		5cb476d8-eae8-453c-8157-fdb71b4d5efa	TCGA-78-8640-01		5cb476d8-eae8-453c-8157-fdb71b4d5efa	TCGA-78-8640-01A-11D-2393-08	TCGA-78-8640-01	
TCGA-78-8648-01																												TCGA-78-8648-01										TCGA-78-8648	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					58	R-Upper			TCGA-78-8648	TCGA-78-8648-01A			-21443		1209	0				69	2	NO			NO			2012-10-23	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO		NO			Peripheral Lung	1.2			YES	45		No	M0	N0	T3	Stage IIB	TCGA-78-8648.a439594e-b536-4bd3-a77a-fb50304de9a2.pdf	8648	Preoperative				83	70				YES	NO	R0	Primary Tumor	01	0.4		6th	NO	NO	YES	78	2		Lung	A	DECEASED	2002	1971				42ab0bc6-16cb-43e4-9729-9b947f2e6432				TCGA-78-8648-01A-11D-2389-01	TCGA-78-8648-01A-11D-2398-05	TCGA-78-8648-01	TCGA-78-8648-01A-11D-2389-01		42ab0bc6-16cb-43e4-9729-9b947f2e6432	TCGA-78-8648-01		42ab0bc6-16cb-43e4-9729-9b947f2e6432	TCGA-78-8648-01		42ab0bc6-16cb-43e4-9729-9b947f2e6432	TCGA-78-8648-01A-11D-2393-08	TCGA-78-8648-01	
TCGA-78-8655-01																												TCGA-78-8655-01										TCGA-78-8655	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					77	L-Lower		TCGA-78-8655-F46154	TCGA-78-8655				-28379			0	2360			93	0	NO			NO	Scheduled Follow-up Submission		2013-8-28	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES					NO			Peripheral Lung		YES			10		No	M0	N0	T1	Stage IA		8655	Preoperative				70	128	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		2001	6th	NO	NO	YES	78	4		Lung		LIVING	2003	1981				a0e0a895-ce81-44a6-a21e-453e727acdbb				TCGA-78-8655-01A-11D-2389-01	TCGA-78-8655-01A-11D-2398-05	TCGA-78-8655-01	TCGA-78-8655-01A-11D-2389-01		a0e0a895-ce81-44a6-a21e-453e727acdbb	TCGA-78-8655-01		a0e0a895-ce81-44a6-a21e-453e727acdbb	TCGA-78-8655-01		a0e0a895-ce81-44a6-a21e-453e727acdbb	TCGA-78-8655-01A-11D-2393-08	TCGA-78-8655-01	
TCGA-78-8660-01																												TCGA-78-8660-01										TCGA-78-8660	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	R-Lower			TCGA-78-8660	TCGA-78-8660-01A			-25422		321	0				87	1	NO			NO			2012-10-23	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.8	NO		NO			Peripheral Lung	1.1			YES	11		Yes, History of Prior Malignancy	M0	N1	T2	Stage IIB	TCGA-78-8660.2c53d65a-d792-41bc-a6c3-cd2d079a5386.pdf	8660	Preoperative	WITH TUMOR			72	108				YES	YES	R0	Primary Tumor	01	0.5	2005	6th	NO	NO	YES	78	4		Lung	A	DECEASED	2005	1954				664ffa40-4508-40ae-9505-84a10136b362				TCGA-78-8660-01A-11D-2389-01	TCGA-78-8660-01A-11D-2398-05	TCGA-78-8660-01	TCGA-78-8660-01A-11D-2389-01		664ffa40-4508-40ae-9505-84a10136b362	TCGA-78-8660-01		664ffa40-4508-40ae-9505-84a10136b362	TCGA-78-8660-01		664ffa40-4508-40ae-9505-84a10136b362	TCGA-78-8660-01A-11D-2393-08	TCGA-78-8660-01	
TCGA-78-8662-01																												TCGA-78-8662-01										TCGA-78-8662	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					53	R-Upper			TCGA-78-8662	TCGA-78-8662-01A			-19563		3361	0				76	0	NO			NO			2012-10-23	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES			NO		NO			Peripheral Lung				YES	45		No	M0	N0	T2	Stage IB	TCGA-78-8662.fb1023d3-d221-4dbb-80f9-0c3dd7b0750f.pdf	8662	Preoperative				64	96	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			6th	NO	NO	YES	78	2		Lung	A	DECEASED	2000	1964				4c893780-d86b-4b01-a423-ca099e4fc007				TCGA-78-8662-01A-11D-2389-01	TCGA-78-8662-01A-11D-2398-05	TCGA-78-8662-01	TCGA-78-8662-01A-11D-2389-01		4c893780-d86b-4b01-a423-ca099e4fc007	TCGA-78-8662-01		4c893780-d86b-4b01-a423-ca099e4fc007	TCGA-78-8662-01	A93B8E14-B557-46DC-B1D5-7BD46458C569	4c893780-d86b-4b01-a423-ca099e4fc007	TCGA-78-8662-01A-11D-2393-08	TCGA-78-8662-01	
TCGA-80-5607-01	2.02	0.49	none		p.V600E	none	none	N	Y	none	none	none	0.24	Bronchioid	none	none	none	none	none	p.E545K	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-80-5607-01	Kirc+	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4		TCGA-80-5607	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO		L-Upper		TCGA-80-5607-F15867	TCGA-80-5607	TCGA-80-5607-01A											1							2011-8-15	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO					Peripheral Lung	1.4			YES	15		Yes	M0	N1	T2	Stage IIB	TCGA-80-5607.6c775590-55a2-4e85-b511-afd2fa76cabc.pdf	5607	Preoperative	WITH TUMOR									NO	R0	Primary Tumor	01	0.6	1985	6th	NO	NO	YES	80	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2007	1965		TCGA-80-5607-01A-31D-1945-08		0ddf256d-70a4-4dfc-ade0-1f51a4c115a3				TCGA-80-5607-01A-31D-1943-01	TCGA-80-5607-01A-31D-1947-05	TCGA-80-5607-01	TCGA-80-5607-01A-31D-1943-01		0ddf256d-70a4-4dfc-ade0-1f51a4c115a3	TCGA-80-5607-01	TCGA-80-5607-01A-11-2190-20	0ddf256d-70a4-4dfc-ade0-1f51a4c115a3	TCGA-80-5607-01	aa426968-088a-443a-862c-171fdc182ca9	0ddf256d-70a4-4dfc-ade0-1f51a4c115a3	TCGA-80-5607-01A-31D-1945-08	TCGA-80-5607-01	
TCGA-80-5608-01	3.11	0.48	none		none	none	none	Y	Y	none	none	p.H1303Q	0.19	Magnoid	none	p.G12A	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			p.K62*	0	TCGA-80-5608-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 6	cluster 1		TCGA-80-5608	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung						R-Upper		TCGA-80-5608-F72033	TCGA-80-5608	TCGA-80-5608-01A							2832				1					Scheduled Follow-up Submission		2015-4-2	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO					Peripheral Lung	1.2	NO		NO	26		No	M0	N0	T1	Stage IA	TCGA-80-5608.a4f3469b-1aae-424f-9135-7e6bfcc08d03.pdf	5608	Preoperative	TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.5		6th	NO	NO	YES	80	2	Current smoker	Lung	A	LIVING		1972		TCGA-80-5608-01A-31D-1945-08		b93762e1-ee51-4768-8343-f49e241fd397				TCGA-80-5608-01A-31D-1943-01	TCGA-80-5608-01A-31D-1947-05	TCGA-80-5608-01	TCGA-80-5608-01A-31D-1943-01		b93762e1-ee51-4768-8343-f49e241fd397	TCGA-80-5608-01	TCGA-80-5608-01A-11-2190-20	b93762e1-ee51-4768-8343-f49e241fd397	TCGA-80-5608-01	1e6ecda8-bdc5-4133-adf1-99b849623c7e	b93762e1-ee51-4768-8343-f49e241fd397	TCGA-80-5608-01A-31D-1945-08	TCGA-80-5608-01	
TCGA-80-5611-01																												TCGA-80-5611-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4		mutation c1uster 9	TCGA-80-5611	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung						L-Upper		TCGA-80-5611-F72034	TCGA-80-5611	TCGA-80-5611-01A							2595				0					Scheduled Follow-up Submission		2015-4-2	MALE	Lung Solid Pattern Predominant Adenocarcinoma	No	C34.1	8230/3	C34.1	YES		0.8	NO					Peripheral Lung	1.2	NO		NO	60		Yes	M0	N0	T2	Stage IB	TCGA-80-5611.42e15634-a742-4e7c-a795-e5fe6fd7b9aa.pdf	5611	Preoperative	TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.6	2008	6th	NO	NO	YES	80	4		Lung	A	LIVING			TCGA-80-5611-01A-01D-1625-08			7f12f566-ca68-4528-b704-b3ef4cb9ba09				TCGA-80-5611-01A-01D-1624-01	TCGA-80-5611-01A-01D-1626-05	TCGA-80-5611-01	TCGA-80-5611-01A-01D-1624-01		7f12f566-ca68-4528-b704-b3ef4cb9ba09	TCGA-80-5611-01	TCGA-80-5611-01A-31-2191-20	7f12f566-ca68-4528-b704-b3ef4cb9ba09	TCGA-80-5611-01	0829a330-1be5-44b1-80ac-2a426e24bac3	7f12f566-ca68-4528-b704-b3ef4cb9ba09	TCGA-80-5611-01A-01D-1625-08	TCGA-80-5611-01	
TCGA-83-5908-01																												TCGA-83-5908-01	Squamous	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4			TCGA-83-5908	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	59	L-Upper		TCGA-83-5908-F12196	TCGA-83-5908	TCGA-83-5908-01A			-21760			0	824				1	NO			NO		Stable Disease	2011-5-25	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1	NO	90	NO				1.9			NO	69		No	M0	N0	T1	Stage IA	TCGA-83-5908.bf81e5a3-26db-4476-b553-38d4f6897309.pdf	5908	Other	TUMOR FREE					Stable Disease				NO	R0	Primary Tumor	01	0.6	2007	6th	NO	YES	NO	83	4		Lung	A	LIVING	2009	1962				772f9a82-9a03-4bf0-b7ce-877b15e3d017				TCGA-83-5908-01A-21D-2283-01	TCGA-83-5908-01A-21D-2285-05	TCGA-83-5908-01	TCGA-83-5908-01A-21D-2283-01		772f9a82-9a03-4bf0-b7ce-877b15e3d017	TCGA-83-5908-01	TCGA-83-5908-01A-31-2191-20	772f9a82-9a03-4bf0-b7ce-877b15e3d017	TCGA-83-5908-01	bd5509b4-f8fb-4e68-a735-c42b23cdbbf8	772f9a82-9a03-4bf0-b7ce-877b15e3d017	TCGA-83-5908-01A-21D-2284-08	TCGA-83-5908-01	
TCGA-86-6562-01	3.43	0.45	none		none	none	none	N	Y	none	p.776_776G>VC	none	0.17	Squamoid	none	none	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-86-6562-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 5	mutation c1uster 9	TCGA-86-6562	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		52	R-Upper		TCGA-86-6562-F29765	TCGA-86-6562	TCGA-86-6562-01A			-19301		376	0	0	274								Scheduled Follow-up Submission	Progressive Disease	2012-3-28	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1.4	NO	0	NO			Central Lung	1.9			YES			No	M0	N1	T2a	Stage IIA	TCGA-86-6562.b0e49ac9-6b9c-4e70-a4a9-10e0686e61aa.pdf	6562		WITH TUMOR					Progressive Disease			NO	NO	R0	Primary Tumor	01	0.4		7th	YES	YES	NO	86	1	Lifelong Non-smoker	Lung	A	DECEASED	2011		TCGA-86-6562-01A-11D-1753-08	TCGA-86-6562-01A-11D-1753-08		a0c2dedc-803a-4097-8225-653262fbf394				TCGA-86-6562-01A-11D-1752-01	TCGA-86-6562-01A-11D-1756-05	TCGA-86-6562-01	TCGA-86-6562-01A-11D-1752-01		a0c2dedc-803a-4097-8225-653262fbf394	TCGA-86-6562-01	TCGA-86-6562-01A-13-2191-20	a0c2dedc-803a-4097-8225-653262fbf394	TCGA-86-6562-01	1534f1f0-bd71-43e0-8185-ec0809746d2f	a0c2dedc-803a-4097-8225-653262fbf394	TCGA-86-6562-01A-11D-1753-08	TCGA-86-6562-01	
TCGA-86-6851-01	3.34	0.32	none		none	none	none	N	N	none	none	none	0.13	Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-86-6851-01	Squamous	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 7	cluster 4		TCGA-86-6851	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					73	L-Upper		TCGA-86-6851-F53594	TCGA-86-6851	TCGA-86-6851-01A			-26808			0	179				0					Scheduled Follow-up Submission	Complete Remission/Response	2013-12-12	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.7	NO	100					1	YES		NO	52		No	M0	N1	T1b	Stage IIA	TCGA-86-6851.519253c3-7e47-4c66-9149-65e622f1ba29.pdf	6851	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response			NO	NO		Primary Tumor	01	0.4		7th	NO	YES	NO	86	2	Current smoker	Lung	A	LIVING	2011	1959		TCGA-86-6851-01A-11D-1945-08		9214caa3-2ad2-41ff-ab77-cf22c4ccce97				TCGA-86-6851-01A-11D-1943-01	TCGA-86-6851-01A-11D-1947-05	TCGA-86-6851-01	TCGA-86-6851-01A-11D-1943-01		9214caa3-2ad2-41ff-ab77-cf22c4ccce97	TCGA-86-6851-01	TCGA-86-6851-01A-13-2191-20	9214caa3-2ad2-41ff-ab77-cf22c4ccce97	TCGA-86-6851-01	be82da85-37a8-4c75-9cf7-ef9ec0acddba	9214caa3-2ad2-41ff-ab77-cf22c4ccce97	TCGA-86-6851-01A-11D-1945-08	TCGA-86-6851-01	
TCGA-86-7701-01																												TCGA-86-7701-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 6			TCGA-86-7701	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES		NO	66	R-Upper		TCGA-86-7701-F58406	TCGA-86-7701	TCGA-86-7701-01A			-24209			0	947	900			2					Scheduled Follow-up Submission	Progressive Disease	2014-4-9	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1.7	NO	80				Peripheral Lung	1.8	NO	Distant Metastasis	YES			No	M1	N0	T2	Stage IV	TCGA-86-7701.711a97e9-ac1d-4f62-b488-a3eb8370841e.pdf	7701	Post-Adjuvant Therapy	WITH TUMOR					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.2		7th	YES	YES	NO	86	1		Lung	A	LIVING	2011					7524ebc8-c57e-44d5-9a4e-b5ccce93bf55				TCGA-86-7701-01A-11D-2166-01	TCGA-86-7701-01A-11D-2168-05	TCGA-86-7701-01	TCGA-86-7701-01A-11D-2166-01		7524ebc8-c57e-44d5-9a4e-b5ccce93bf55	TCGA-86-7701-01	TCGA-86-7701-01A-13-2192-20	7524ebc8-c57e-44d5-9a4e-b5ccce93bf55	TCGA-86-7701-01	e2450111-6105-461c-bf1f-70106b4eb4e5	7524ebc8-c57e-44d5-9a4e-b5ccce93bf55	TCGA-86-7701-01A-11D-2167-08	TCGA-86-7701-01	
TCGA-86-7711-01																												TCGA-86-7711-01	High	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4			TCGA-86-7711	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	R-Lower		TCGA-86-7711-F41203	TCGA-86-7711	TCGA-86-7711-01A			-25719		1046	0	27				2					Scheduled Follow-up Submission	Progressive Disease	2013-3-13	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1.5	NO	80	NO			Peripheral Lung	1.8	NO		NO	50		No	M0	N1	T2a	Stage IIA	TCGA-86-7711.5a85d8a6-3533-4ac8-9fc9-437a81b436d6.pdf	7711		WITH TUMOR					Progressive Disease			NO	NO	R0	Primary Tumor	01	0.4		7th	YES	YES	NO	86	2		Lung	A	DECEASED	2011	1960				597e959c-bab8-4234-b57b-1b8413de7955				TCGA-86-7711-01A-11D-2062-01	TCGA-86-7711-01A-11D-2064-05	TCGA-86-7711-01	TCGA-86-7711-01A-11D-2062-01		597e959c-bab8-4234-b57b-1b8413de7955	TCGA-86-7711-01	TCGA-86-7711-01A-13-2192-20	597e959c-bab8-4234-b57b-1b8413de7955	TCGA-86-7711-01	12e8ae79-b62d-4a85-a4f9-30fadb5e0dc0	597e959c-bab8-4234-b57b-1b8413de7955	TCGA-86-7711-01A-11D-2063-08	TCGA-86-7711-01	
TCGA-86-7711-11																												TCGA-86-7711-11		C1-LUAD-enriched								TCGA-86-7711	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	R-Lower		TCGA-86-7711-F41203	TCGA-86-7711				-25719		1046	0	27				2					Scheduled Follow-up Submission	Progressive Disease	2013-3-13	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES				80	NO			Peripheral Lung		NO		NO	50		No	M0	N1	T2a	Stage IIA		7711		WITH TUMOR					Progressive Disease			NO	NO	R0	Solid Tissue Normal	11			7th	YES	YES	NO	86	2		Lung		DECEASED	2011	1960														TCGA-86-7711-11							TCGA-86-7711-11	
TCGA-86-7713-01	2.14	0.79	none		none	none	none	Y	Y	none	none	none	0.37	Magnoid	none	p.G12C	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			p.L245F	0	TCGA-86-7713-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-86-7713	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	R-Middle		TCGA-86-7713-F63513	TCGA-86-7713	TCGA-86-7713-01A			-25791			0	1157				0					Scheduled Follow-up Submission	Complete Remission/Response	2014-8-12	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES		1.2	NO	100	NO			Peripheral Lung	3	NO		NO			No	M0	N0	T2b	Stage IIA	TCGA-86-7713.0ec59eb0-0640-4d6b-b191-76bad8bb38d8.pdf	7713	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.5		7th	YES	YES	NO	86	1	Lifelong Non-smoker	Lung	A	LIVING	2011			TCGA-86-7713-01A-11D-2063-08		2d1f10dd-a834-4c64-919c-2d9eea15c37a				TCGA-86-7713-01A-11D-2062-01	TCGA-86-7713-01A-11D-2064-05	TCGA-86-7713-01	TCGA-86-7713-01A-11D-2062-01		2d1f10dd-a834-4c64-919c-2d9eea15c37a	TCGA-86-7713-01	TCGA-86-7713-01A-13-2192-20	2d1f10dd-a834-4c64-919c-2d9eea15c37a	TCGA-86-7713-01	3aed5efc-311a-4163-a44d-6f2972340d19	2d1f10dd-a834-4c64-919c-2d9eea15c37a	TCGA-86-7713-01A-11D-2063-08	TCGA-86-7713-01	
TCGA-86-7713-11	2.14	0.79	none		none	none	none	Y	Y	none	none	none	0.37	Magnoid	none	p.G12C	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			p.L245F	0	TCGA-86-7713-11		C1-LUAD-enriched								TCGA-86-7713	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	R-Middle		TCGA-86-7713-F63513	TCGA-86-7713				-25791			0	1157				0					Scheduled Follow-up Submission	Complete Remission/Response	2014-8-12	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES				100	NO			Peripheral Lung		NO		NO			No	M0	N0	T2b	Stage IIA		7713	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Solid Tissue Normal	11			7th	YES	YES	NO	86	1	Lifelong Non-smoker	Lung		LIVING	2011															TCGA-86-7713-11							TCGA-86-7713-11	
TCGA-86-7714-01			none		p.V600E	none	none	N	Y	none	none	none		Bronchioid	none	none	none	none	none	p.E726K	none	Lepidic predominant Adc	Lepidic predominant Adc			none	0	TCGA-86-7714-01	Kirc+		cluster 2	Cluster 6		LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-86-7714	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	R-Lower		TCGA-86-7714-F53595	TCGA-86-7714				-22619		625	0	0				0	NO				Scheduled Follow-up Submission	Progressive Disease	2013-12-12	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES				0	NO			Peripheral Lung		NO		NO	43		No	M0	N2	T1b	Stage IIIA		7714	Post-Adjuvant Therapy	WITH TUMOR					Stable Disease			NO	NO	R0	Primary Tumor	01			7th	NO	YES	NO	86	2	Current smoker	Lung		DECEASED	2011	1968		TCGA-86-7714-01A-12D-2167-08		a6af2ef5-6774-422c-99d1-826a686334d0				TCGA-86-7714-01A-12D-2166-01	TCGA-86-7714-01A-12D-2168-05	TCGA-86-7714-01	TCGA-86-7714-01A-12D-2166-01		a6af2ef5-6774-422c-99d1-826a686334d0	TCGA-86-7714-01		a6af2ef5-6774-422c-99d1-826a686334d0	TCGA-86-7714-01		a6af2ef5-6774-422c-99d1-826a686334d0	TCGA-86-7714-01A-12D-2167-08	TCGA-86-7714-01	
TCGA-86-7953-01																												TCGA-86-7953-01	BRCA-LUAD+	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4			TCGA-86-7953	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	L-Upper		TCGA-86-7953-F66262	TCGA-86-7953	TCGA-86-7953-01A			-25315			0	997				1	NO				Scheduled Follow-up Submission	Complete Remission/Response	2014-10-7	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8250/3	C34.1	YES		1.2	NO	90				Peripheral Lung	3	NO		NO			No	M0	N0	T1b	Stage IA	TCGA-86-7953.1af715d0-9b4b-444f-b93e-53478cde8e58.pdf	7953	Preoperative	TUMOR FREE					Complete Remission/Response			NO	NO	RX	Primary Tumor	01	0.2		7th	NO	YES	NO	86	1		Lung	A	LIVING	2011					90865a55-659d-409f-a865-bae9e46c4a7c				TCGA-86-7953-01A-11D-2183-01	TCGA-86-7953-01A-11D-2185-05	TCGA-86-7953-01	TCGA-86-7953-01A-11D-2183-01		90865a55-659d-409f-a865-bae9e46c4a7c	TCGA-86-7953-01	TCGA-86-7953-01A-13-2192-20	90865a55-659d-409f-a865-bae9e46c4a7c	TCGA-86-7953-01	2b5c0a28-53db-48a3-8f06-2878f99f42b3	90865a55-659d-409f-a865-bae9e46c4a7c	TCGA-86-7953-01A-11D-2184-08	TCGA-86-7953-01	
TCGA-86-7954-01																												TCGA-86-7954-01	High	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA c1uster 10			TCGA-86-7954	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					68	R-Lower		TCGA-86-7954-F57948	TCGA-86-7954	TCGA-86-7954-01A			-25062			0	605				0	NO				Scheduled Follow-up Submission	Complete Remission/Response	2014-3-28	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8250/3	C34.3	YES		1	NO	100	NO			Peripheral Lung	1.1	NO		NO	8		No	M0	N0	T2	Stage IB	TCGA-86-7954.6a0c9a64-8c57-412a-8b3c-efb8e0b184ea.pdf	7954	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.3	1971	7th	YES	YES	NO	86	3		Lung	A	LIVING	2011	1963				f84c748d-1296-44aa-b7b1-0795939a88fe				TCGA-86-7954-01A-11D-2183-01	TCGA-86-7954-01A-11D-2185-05	TCGA-86-7954-01	TCGA-86-7954-01A-11D-2183-01		f84c748d-1296-44aa-b7b1-0795939a88fe	TCGA-86-7954-01	TCGA-86-7954-01A-13-2192-20	f84c748d-1296-44aa-b7b1-0795939a88fe	TCGA-86-7954-01	478cc583-9ef7-409b-9cda-4d1f64f447a4	f84c748d-1296-44aa-b7b1-0795939a88fe	TCGA-86-7954-01A-11D-2184-08	TCGA-86-7954-01	
TCGA-86-7955-01																												TCGA-86-7955-01	High	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4			TCGA-86-7955	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO		62	R-Lower		TCGA-86-7955-F63517	TCGA-86-7955	TCGA-86-7955-01A			-22772			0	1072	820			0	NO				Scheduled Follow-up Submission	Complete Remission/Response	2014-8-12	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		1.5	NO	100	NO			Peripheral Lung	2.1	NO	Locoregional Recurrence	YES			No	M0	N0	T2a	Stage IB	TCGA-86-7955.d6a25f15-9117-43b7-bbd4-132914a24d16.pdf	7955	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response			NO	YES	RX	Primary Tumor	01	0.4		7th	YES	YES	NO	86	1		Lung	A	LIVING	2011					937a163b-b469-46a0-87b8-6d7c7e6105d7				TCGA-86-7955-01A-11D-2183-01	TCGA-86-7955-01A-11D-2185-05	TCGA-86-7955-01	TCGA-86-7955-01A-11D-2183-01		937a163b-b469-46a0-87b8-6d7c7e6105d7	TCGA-86-7955-01	TCGA-86-7955-01A-21-2192-20	937a163b-b469-46a0-87b8-6d7c7e6105d7	TCGA-86-7955-01	a7ef7d69-1adb-4014-82ef-d078c1121456	937a163b-b469-46a0-87b8-6d7c7e6105d7	TCGA-86-7955-01A-11D-2184-08	TCGA-86-7955-01	
TCGA-86-8054-01																												TCGA-86-8054-01	BRCA-LUAD+			Cluster 5		LUAD-like c10	miRNA cluster 6			TCGA-86-8054	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	R-Upper		TCGA-86-8054-F65792	TCGA-86-8054	TCGA-86-8054-01A			-22584			0	1148				2	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-9-30	MALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES		1.1	NO	80	NO			Central Lung	1.7	NO		NO	9		No	M0	N1	T2b	Stage IIB	TCGA-86-8054.a47b8835-2314-4631-b55d-f99af91ad5e7.pdf	8054	Preoperative	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.4		7th	YES	YES	NO	86	2		Lung	A	LIVING	2011	1994				ed7e5789-ce06-4213-beda-f0892b103ce4				TCGA-86-8054-01A-11D-2237-01	TCGA-86-8054-01A-11D-2239-05	TCGA-86-8054-01	TCGA-86-8054-01A-11D-2237-01		ed7e5789-ce06-4213-beda-f0892b103ce4	TCGA-86-8054-01		ed7e5789-ce06-4213-beda-f0892b103ce4	TCGA-86-8054-01	12254A12-4508-4B07-A365-E1D133723141	ed7e5789-ce06-4213-beda-f0892b103ce4	TCGA-86-8054-01A-11D-2238-08	TCGA-86-8054-01	
TCGA-86-8055-01																												TCGA-86-8055-01	BRCA-LUAD+			Cluster 5		LUAD-like c10	miRNA c1uster 9			TCGA-86-8055	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		79	L-Upper		TCGA-86-8055-F40636	TCGA-86-8055	TCGA-86-8055-01A			-29124		124	0	10				2	NO				Scheduled Follow-up Submission	Complete Remission/Response	2013-2-26	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1.3	NO	80	NO			Peripheral Lung	3.2	NO		NO	60		No	M0	N1	T2a	Stage IIA	TCGA-86-8055.b0f478a2-7696-4fc2-bdc9-839142556b6f.pdf	8055	Preoperative	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.4		7th	NO	YES	NO	86	2		Lung	A	DECEASED	2011	1955				b0b8fd4b-d725-417b-b17b-4cb6a7136459				TCGA-86-8055-01A-11D-2237-01	TCGA-86-8055-01A-11D-2239-05	TCGA-86-8055-01	TCGA-86-8055-01A-11D-2237-01		b0b8fd4b-d725-417b-b17b-4cb6a7136459	TCGA-86-8055-01		b0b8fd4b-d725-417b-b17b-4cb6a7136459	TCGA-86-8055-01	D64A8265-A17C-4EB4-B35B-F050A7BA32A5	b0b8fd4b-d725-417b-b17b-4cb6a7136459	TCGA-86-8055-01A-11D-2238-08	TCGA-86-8055-01	
TCGA-86-8056-01																												TCGA-86-8056-01	BRCA-LUAD+			Cluster 6		LUAD-like c10	miRNA cluster 4			TCGA-86-8056	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					63	Other (please specify)	Right upper, lower	TCGA-86-8056-F57951	TCGA-86-8056	TCGA-86-8056-01A			-23369			0	139				0	NO			NO	Scheduled Follow-up Submission		2014-3-28	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		1.1	NO	100	NO			Peripheral Lung	1.4	YES		NO	36		No	M0	N0	T4	Stage IIIA	TCGA-86-8056.b372fd6d-8c36-4642-b660-d353efb0bd89.pdf	8056	Preoperative	TUMOR FREE					Complete Remission/Response			NO		R0	Primary Tumor	01	0.4	1975	7th		YES	NO	86	3		Lung	A	LIVING	2011	1963				8684c13a-9445-45a8-b37f-ce2b04b218bf				TCGA-86-8056-01A-11D-2237-01	TCGA-86-8056-01A-11D-2239-05	TCGA-86-8056-01	TCGA-86-8056-01A-11D-2237-01		8684c13a-9445-45a8-b37f-ce2b04b218bf	TCGA-86-8056-01		8684c13a-9445-45a8-b37f-ce2b04b218bf	TCGA-86-8056-01	EC2B7FF4-EB02-4503-9320-7438E8ECA695	8684c13a-9445-45a8-b37f-ce2b04b218bf	TCGA-86-8056-01A-11D-2238-08	TCGA-86-8056-01	
TCGA-86-8073-01																												TCGA-86-8073-01	High			Cluster 6		LUAD-like c10	miRNA c1uster 9			TCGA-86-8073	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					58	L-Upper		TCGA-86-8073-F66082	TCGA-86-8073	TCGA-86-8073-01A			-21214			0	740				0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-10-2	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.1	8250/3	C34.1	YES		1.5	NO	100	NO			Peripheral Lung	1.8	NO		NO	40		No	M0	N0	T2a	Stage IB	TCGA-86-8073.2ae8592b-aa83-476a-b77f-dc53e8eb802b.pdf	8073	Other	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.4		7th	NO	YES	NO	86	2		Lung	A	LIVING	2011	1970				97c75ab2-4b91-4c26-992e-ed1252805aac				TCGA-86-8073-01A-11D-2237-01	TCGA-86-8073-01A-11D-2239-05	TCGA-86-8073-01	TCGA-86-8073-01A-11D-2237-01		97c75ab2-4b91-4c26-992e-ed1252805aac	TCGA-86-8073-01		97c75ab2-4b91-4c26-992e-ed1252805aac	TCGA-86-8073-01	9DE79452-B65C-4691-ACE1-291B310376FC	97c75ab2-4b91-4c26-992e-ed1252805aac	TCGA-86-8073-01A-11D-2238-08	TCGA-86-8073-01	
TCGA-86-8074-01																												TCGA-86-8074-01	BRCA-LUAD+			Cluster 6		LUAD-like c10	miRNA cluster 4			TCGA-86-8074	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					62	L-Lower		TCGA-86-8074-F41667	TCGA-86-8074	TCGA-86-8074-01A			-22862			0	24				2	NO			NO	Scheduled Follow-up Submission		2013-3-26	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8260/3	C34.3	YES		1.3	NO	80	NO			Peripheral Lung	2.3	YES			40		No	M0	N1	T1b	Stage IIA	TCGA-86-8074.a1e9569b-0254-4be6-adb2-3a842e23613f.pdf	8074		TUMOR FREE								NO		R0	Primary Tumor	01	0.3		7th		YES	NO	86	2		Lung	A	LIVING	2011	1970				13549fc9-6145-4853-88a6-39c78cb3ab0a				TCGA-86-8074-01A-11D-2237-01	TCGA-86-8074-01A-11D-2239-05	TCGA-86-8074-01	TCGA-86-8074-01A-11D-2237-01		13549fc9-6145-4853-88a6-39c78cb3ab0a	TCGA-86-8074-01		13549fc9-6145-4853-88a6-39c78cb3ab0a	TCGA-86-8074-01	39CEF057-7CC2-48A2-835F-9BEED0BB5265	13549fc9-6145-4853-88a6-39c78cb3ab0a	TCGA-86-8074-01A-11D-2238-08	TCGA-86-8074-01	
TCGA-86-8075-01																												TCGA-86-8075-01	BRCA-LUAD+			Cluster 5		LUAD-like c10	miRNA cluster 4			TCGA-86-8075	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					66	L-Upper		TCGA-86-8075-F63521	TCGA-86-8075	TCGA-86-8075-01A			-24402		694	0	43				1	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-8-12	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1.6	NO	90	NO			Peripheral Lung	1.8	NO		NO			No	M0	N0	T2	Stage IB	TCGA-86-8075.7988f9a9-584e-4ce9-b12c-f3e289af1d6d.pdf	8075	Preoperative	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.4		7th	NO	YES	NO	86	1		Lung	A	DECEASED	2011					fa3d0703-ce5e-49a9-96a6-0777f8e81cd3				TCGA-86-8075-01A-11D-2237-01	TCGA-86-8075-01A-11D-2239-05	TCGA-86-8075-01	TCGA-86-8075-01A-11D-2237-01		fa3d0703-ce5e-49a9-96a6-0777f8e81cd3	TCGA-86-8075-01		fa3d0703-ce5e-49a9-96a6-0777f8e81cd3	TCGA-86-8075-01	2CC15F30-6AD7-4295-A3AE-B1B4F2851F76	fa3d0703-ce5e-49a9-96a6-0777f8e81cd3	TCGA-86-8075-01A-11D-2238-08	TCGA-86-8075-01	
TCGA-86-8076-01																												TCGA-86-8076-01	Iq			Cluster 5		LUAD-like c10	miRNA c1uster 9			TCGA-86-8076	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					42	R-Upper		TCGA-86-8076-F63522	TCGA-86-8076	TCGA-86-8076-01A			-15605			0	993				0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-8-12	MALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES		1.2	NO	100	NO			Peripheral Lung	1.7	NO		NO			No	M0	N0	T1	Stage IA	TCGA-86-8076.c282d817-b99a-4bda-8073-9de1cac074f9.pdf	8076	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.4		7th	YES	YES	NO	86	1		Lung	A	LIVING	2011					c9cf5f5f-30de-4062-99c3-dcb9cfd55870				TCGA-86-8076-01A-31D-2237-01	TCGA-86-8076-01A-31D-2239-05	TCGA-86-8076-01	TCGA-86-8076-01A-31D-2237-01		c9cf5f5f-30de-4062-99c3-dcb9cfd55870	TCGA-86-8076-01		c9cf5f5f-30de-4062-99c3-dcb9cfd55870	TCGA-86-8076-01	45139A07-3CD0-4EC6-AE37-442BDA160BFE	c9cf5f5f-30de-4062-99c3-dcb9cfd55870	TCGA-86-8076-01A-31D-2238-08	TCGA-86-8076-01	
TCGA-86-8278-01																												TCGA-86-8278-01	Kirc+			Cluster 6			miRNA c1uster 9			TCGA-86-8278	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					63	L-Lower		TCGA-86-8278-F59732	TCGA-86-8278	TCGA-86-8278-01A			-23117			0	944				1					Scheduled Follow-up Submission	Stable Disease	2014-5-20	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.30	8480/3	C34.3	YES		1.2	NO	90	NO			Peripheral Lung	2	NO		NO			No	M0	N1	T2	Stage IIB	TCGA-86-8278.75c05d77-d3b7-4cd1-9e6f-d8a18fc23f6c.pdf	8278	Preoperative	WITH TUMOR					Complete Remission/Response				NO	R0	Primary Tumor	01	0.3		7th	NO	YES	NO	86	1		Lung	A	LIVING	2011					8719f9af-0876-4ec6-a4dc-4178ad964349				TCGA-86-8278-01A-11D-2283-01	TCGA-86-8278-01A-11D-2285-05	TCGA-86-8278-01	TCGA-86-8278-01A-11D-2283-01		8719f9af-0876-4ec6-a4dc-4178ad964349	TCGA-86-8278-01		8719f9af-0876-4ec6-a4dc-4178ad964349	TCGA-86-8278-01	23B1CC79-FF71-43C3-9903-CA3C6202D1DC	8719f9af-0876-4ec6-a4dc-4178ad964349	TCGA-86-8278-01A-11D-2284-08	TCGA-86-8278-01	
TCGA-86-8279-01																												TCGA-86-8279-01	High			Cluster 5		LUAD-like c10	miRNA cluster 4			TCGA-86-8279	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					46	R-Upper		TCGA-86-8279-F59731	TCGA-86-8279	TCGA-86-8279-01A			-17032			0	949				1					Scheduled Follow-up Submission	Complete Remission/Response	2014-5-20	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1.5	NO	90	NO			Peripheral Lung	1.8	NO		NO			No	M0	N1	T2a	Stage IIA	TCGA-86-8279.e7e4b4fd-f47d-4aab-826c-0ef1f620a739.pdf	8279	Preoperative	TUMOR FREE					Complete Remission/Response			NO	YES	R0	Primary Tumor	01	0.3		7th	YES	YES	NO	86	1		Lung	A	LIVING	2011					87e51ccb-9ded-43c6-bb1a-a8a85d2d9fa6				TCGA-86-8279-01A-11D-2283-01	TCGA-86-8279-01A-11D-2285-05	TCGA-86-8279-01	TCGA-86-8279-01A-11D-2283-01		87e51ccb-9ded-43c6-bb1a-a8a85d2d9fa6	TCGA-86-8279-01		87e51ccb-9ded-43c6-bb1a-a8a85d2d9fa6	TCGA-86-8279-01	55B45160-BCC0-4545-A462-9D452A192EAB	87e51ccb-9ded-43c6-bb1a-a8a85d2d9fa6	TCGA-86-8279-01A-11D-2284-08	TCGA-86-8279-01	
TCGA-86-8280-01																												TCGA-86-8280-01	BRCA-LUAD+			Cluster 5		LUAD-like c10	miRNA cluster 7			TCGA-86-8280	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					54	L-Lower		TCGA-86-8280-F66079	TCGA-86-8280	TCGA-86-8280-01A			-19977			0	701				0					Scheduled Follow-up Submission	Complete Remission/Response	2014-10-2	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES		1.4	NO	100	NO			Peripheral Lung	2.8	NO		NO			No	M0	N0	T2b	Stage IIA	TCGA-86-8280.49459cae-eee4-4e46-a8fc-efbeb6cb1f5d.pdf	8280	Other	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.4		7th	YES	YES	NO	86	1		Lung	A	LIVING	2011					974f4223-c166-4ea2-a061-25e3f4b415e7				TCGA-86-8280-01A-11D-2283-01	TCGA-86-8280-01A-11D-2285-05	TCGA-86-8280-01	TCGA-86-8280-01A-11D-2283-01		974f4223-c166-4ea2-a061-25e3f4b415e7	TCGA-86-8280-01		974f4223-c166-4ea2-a061-25e3f4b415e7	TCGA-86-8280-01	9F0028D2-E480-470D-B5A5-01A5754BB4ED	974f4223-c166-4ea2-a061-25e3f4b415e7	TCGA-86-8280-01A-11D-2284-08	TCGA-86-8280-01	
TCGA-86-8281-01																												TCGA-86-8281-01	BRCA-LUAD+			Cluster 5		LUAD-like c10	miRNA cluster 4			TCGA-86-8281	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					75	R-Lower		TCGA-86-8281-F57953	TCGA-86-8281	TCGA-86-8281-01A			-27409			0	0				0					Scheduled Follow-up Submission		2014-4-21	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.6	NO	100	NO			Peripheral Lung	1.6	YES		NO	30		No	M0	NX	T1	Stage IA	TCGA-86-8281.775debd9-a338-412e-86da-5c132df883c1.pdf	8281	Preoperative	TUMOR FREE					Complete Remission/Response			NO			Primary Tumor	01	0.4	1985	7th		YES	NO	86	3		Lung	A	LIVING	2011	1955				f9e17a94-37a3-4bac-bbfe-0128fc3a644b				TCGA-86-8281-01A-11D-2283-01	TCGA-86-8281-01A-11D-2285-05	TCGA-86-8281-01	TCGA-86-8281-01A-11D-2283-01		f9e17a94-37a3-4bac-bbfe-0128fc3a644b	TCGA-86-8281-01		f9e17a94-37a3-4bac-bbfe-0128fc3a644b	TCGA-86-8281-01	D255BC28-A2F1-4B69-9447-749D5BCD7288	f9e17a94-37a3-4bac-bbfe-0128fc3a644b	TCGA-86-8281-01A-11D-2284-08	TCGA-86-8281-01	
TCGA-86-8358-01																												TCGA-86-8358-01				Cluster 6			miRNA cluster 6			TCGA-86-8358	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					44	R-Upper		TCGA-86-8358-F58410	TCGA-86-8358	TCGA-86-8358-01A			-16409			0	653				0					Scheduled Follow-up Submission	Complete Remission/Response	2014-4-9	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1.4	NO	100	NO			Peripheral Lung	1.7	NO		NO	20		No	M0	N0	T2a	Stage IB	TCGA-86-8358.bdfc4ca3-ce4f-4206-b3ff-3733df596e9d.pdf	8358	Other	TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.5		7th	NO	YES	NO	86	2		Lung	A	LIVING	2012	1992				6addf668-7b4d-4e3d-9086-b95818648be2				TCGA-86-8358-01A-11D-2322-01	TCGA-86-8358-01A-11D-2324-05	TCGA-86-8358-01	TCGA-86-8358-01A-11D-2322-01		6addf668-7b4d-4e3d-9086-b95818648be2	TCGA-86-8358-01		6addf668-7b4d-4e3d-9086-b95818648be2	TCGA-86-8358-01	4FAE672F-FA96-42B1-9A49-ADA69B980562	6addf668-7b4d-4e3d-9086-b95818648be2	TCGA-86-8358-01A-11D-2323-08	TCGA-86-8358-01	
TCGA-86-8359-01																												TCGA-86-8359-01				Cluster 5			miRNA cluster 4			TCGA-86-8359	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					52	L-Lower		TCGA-86-8359-F43296	TCGA-86-8359	TCGA-86-8359-01A			-19088		444	0	26				4					Scheduled Follow-up Submission		2013-5-16	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		2	NO	20				Peripheral Lung	2.5	NO			36		No	M0	N2	T3	Stage IIIA	TCGA-86-8359.7525adb2-550a-4d65-beed-5fb0fef0b36d.pdf	8359	Post-Adjuvant Therapy	TUMOR FREE								NO		R0	Primary Tumor	01	0.5		7th		YES	NO	86	2		Lung	A	DECEASED	2012	1982				1ed6d4b1-0a36-4515-9475-709ad876ffa9				TCGA-86-8359-01A-11D-2322-01	TCGA-86-8359-01A-11D-2324-05	TCGA-86-8359-01	TCGA-86-8359-01A-11D-2322-01		1ed6d4b1-0a36-4515-9475-709ad876ffa9	TCGA-86-8359-01		1ed6d4b1-0a36-4515-9475-709ad876ffa9	TCGA-86-8359-01	F28DE85D-791C-4A84-A056-647DACAE5046	1ed6d4b1-0a36-4515-9475-709ad876ffa9	TCGA-86-8359-01A-11D-2323-08	TCGA-86-8359-01	
TCGA-86-8585-01																												TCGA-86-8585-01										TCGA-86-8585	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					57	L-Upper		TCGA-86-8585-F46400	TCGA-86-8585	TCGA-86-8585-01A			-20918			0	353					NO				Scheduled Follow-up Submission	Complete Remission/Response	2013-9-19	MALE	Lung Solid Pattern Predominant Adenocarcinoma	No	C34.1	8230/3	C34.1	YES		2	NO		NO			Peripheral Lung	2.2	YES		NO			No	M0	N0	T2a	Stage IB	TCGA-86-8585.6c3d5577-390c-4a80-8c02-dee4901c2a16.pdf	8585		TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.4		7th	NO	YES	NO	86	1		Lung	A	LIVING	2012					5642f9d8-a84b-4ab6-b841-910ac4010e16				TCGA-86-8585-01A-11D-2389-01	TCGA-86-8585-01A-11D-2398-05	TCGA-86-8585-01	TCGA-86-8585-01A-11D-2389-01		5642f9d8-a84b-4ab6-b841-910ac4010e16	TCGA-86-8585-01		5642f9d8-a84b-4ab6-b841-910ac4010e16	TCGA-86-8585-01	9493BA2A-E810-46D1-B99D-7EA76B68BCDB	5642f9d8-a84b-4ab6-b841-910ac4010e16	TCGA-86-8585-01A-11D-2393-08	TCGA-86-8585-01	
TCGA-86-8668-01																												TCGA-86-8668-01										TCGA-86-8668	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	L-Lower		TCGA-86-8668-F66084	TCGA-86-8668	TCGA-86-8668-01A			-22383			0	423				0					Scheduled Follow-up Submission	Complete Remission/Response	2014-10-2	FEMALE	Lung Bronchioloalveolar Carcinoma Mucinous	No	C34.3	8253/3	C34.3	YES		1.6	NO	100	NO			Peripheral Lung	2	NO		NO			No	M0	N0	T1b	Stage IA	TCGA-86-8668.be6c4ce2-4c88-41a7-bff6-e5bb157ad3ad.pdf	8668	Other	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.5		7th	NO	YES	NO	86	1		Lung	A	LIVING	2012					ae6e4491-f510-41b0-9279-d4887504a637				TCGA-86-8668-01A-11D-2389-01	TCGA-86-8668-01A-11D-2398-05	TCGA-86-8668-01	TCGA-86-8668-01A-11D-2389-01		ae6e4491-f510-41b0-9279-d4887504a637	TCGA-86-8668-01		ae6e4491-f510-41b0-9279-d4887504a637	TCGA-86-8668-01	DDD67F62-BE18-4F27-A2E1-41782D30BC7B	ae6e4491-f510-41b0-9279-d4887504a637	TCGA-86-8668-01A-11D-2393-08	TCGA-86-8668-01	
TCGA-86-8669-01																												TCGA-86-8669-01										TCGA-86-8669	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO		NO	64	R-Upper		TCGA-86-8669-F66085	TCGA-86-8669	TCGA-86-8669-01A			-23443			0	938	849			0					Scheduled Follow-up Submission	Complete Remission/Response	2014-10-15	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1.5	NO	100	NO			Peripheral Lung	2.2	NO	Distant Metastasis	YES	47		No	M0	N0	T1b	Stage IA	TCGA-86-8669.6c8d6319-a235-4757-be34-79286a8da60f.pdf	8669	Preoperative	TUMOR FREE					Complete Remission/Response	Convincing Imaging		NO	NO	R0	Primary Tumor	01	0.4		7th	NO	YES	NO	86	2		Lung	A	LIVING	2012	1965				b363949d-cc43-4480-8afd-9f4693fe43cc				TCGA-86-8669-01A-11D-2389-01	TCGA-86-8669-01A-11D-2398-05	TCGA-86-8669-01	TCGA-86-8669-01A-11D-2389-01		b363949d-cc43-4480-8afd-9f4693fe43cc	TCGA-86-8669-01		b363949d-cc43-4480-8afd-9f4693fe43cc	TCGA-86-8669-01	5B0FD5E1-D603-431F-A843-EEDDD0B0488C	b363949d-cc43-4480-8afd-9f4693fe43cc	TCGA-86-8669-01A-11D-2393-08	TCGA-86-8669-01	
TCGA-86-8671-01																												TCGA-86-8671-01										TCGA-86-8671	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	R-Upper		TCGA-86-8671-F66089	TCGA-86-8671	TCGA-86-8671-01A			-26448			0	839				0					Scheduled Follow-up Submission	Complete Remission/Response	2014-10-2	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES		0.8	NO	100				Peripheral Lung	0.9	NO		NO			No	M0	N1	T2b	Stage IIB	TCGA-86-8671.94c08fb3-35a3-494e-90ee-b8df1d8cf34f.pdf	8671	Other	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.4		7th	YES	YES	NO	86	1		Lung	A	LIVING	2012					00c7a308-6add-457c-9003-784d4e65c318				TCGA-86-8671-01A-11D-2389-01	TCGA-86-8671-01A-11D-2398-05	TCGA-86-8671-01	TCGA-86-8671-01A-11D-2389-01		00c7a308-6add-457c-9003-784d4e65c318	TCGA-86-8671-01		00c7a308-6add-457c-9003-784d4e65c318	TCGA-86-8671-01	AEE7F089-32C7-436C-9F88-A6E8E7379A13	00c7a308-6add-457c-9003-784d4e65c318	TCGA-86-8671-01A-11D-2393-08	TCGA-86-8671-01	
TCGA-86-8672-01																												TCGA-86-8672-01										TCGA-86-8672	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					59	R-Upper		TCGA-86-8672-F46401	TCGA-86-8672	TCGA-86-8672-01A			-21682		19	0	15									Scheduled Follow-up Submission		2013-8-7	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1.7	NO		NO			Central Lung	2.2	NO		NO			No	M0	N0	T3	Stage IIB	TCGA-86-8672.df3d9fe7-a56c-4100-9fdb-9fe3e7b11b2a.pdf	8672		TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.4		7th	NO	YES	NO	86	1		Lung	A	DECEASED	2012					764bce37-06d7-41e7-83d9-ce803dabd5f0				TCGA-86-8672-01A-21D-2389-01	TCGA-86-8672-01A-21D-2398-05	TCGA-86-8672-01	TCGA-86-8672-01A-21D-2389-01		764bce37-06d7-41e7-83d9-ce803dabd5f0	TCGA-86-8672-01		764bce37-06d7-41e7-83d9-ce803dabd5f0	TCGA-86-8672-01		764bce37-06d7-41e7-83d9-ce803dabd5f0	TCGA-86-8672-01A-21D-2393-08	TCGA-86-8672-01	
TCGA-86-8673-01																												TCGA-86-8673-01										TCGA-86-8673	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	YES		61	L-Upper		TCGA-86-8673-F59092	TCGA-86-8673	TCGA-86-8673-01A	639		-22571			0	862	636								Scheduled Follow-up Submission	Complete Remission/Response	2014-4-30	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.1	8252/3	C34.1	YES		1.8	NO						2.9	NO	Locoregional Recurrence	YES	54		No	M0	N0	T2	Stage IB	TCGA-86-8673.0e5c5229-2b1d-45d6-8fae-02a32fb84988.pdf	8673		TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.5		7th	NO	YES	NO	86	2		Lung	A	LIVING	2011	1968				ab39e99f-8967-4068-b1e2-49e1fe2298ff				TCGA-86-8673-01A-11D-2389-01	TCGA-86-8673-01A-11D-2398-05	TCGA-86-8673-01	TCGA-86-8673-01A-11D-2389-01		ab39e99f-8967-4068-b1e2-49e1fe2298ff	TCGA-86-8673-01		ab39e99f-8967-4068-b1e2-49e1fe2298ff	TCGA-86-8673-01	E813BA5F-3E01-4FD6-AFA0-DECE1B2B3E83	ab39e99f-8967-4068-b1e2-49e1fe2298ff	TCGA-86-8673-01A-11D-2393-08	TCGA-86-8673-01	
TCGA-86-8674-01																												TCGA-86-8674-01										TCGA-86-8674	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					50	R-Middle		TCGA-86-8674-F59096	TCGA-86-8674	TCGA-86-8674-01A			-18479			0	806									Scheduled Follow-up Submission	Complete Remission/Response	2014-4-30	MALE	Lung Papillary Adenocarcinoma	No	C34.2	8260/3	C34.2	YES		1.5	NO					Peripheral Lung	2.5	NO		NO	37.5		No	M0	N1	T2a	Stage IIA	TCGA-86-8674.463cd118-45ef-4e2f-aca3-39ce953dcb09.pdf	8674		TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.5	2012	7th	YES	YES	NO	86	4		Lung	A	LIVING	2012	1982				81be01d3-ad98-495f-910c-c33a7b100b53				TCGA-86-8674-01A-21D-2389-01	TCGA-86-8674-01A-21D-2398-05	TCGA-86-8674-01	TCGA-86-8674-01A-21D-2389-01		81be01d3-ad98-495f-910c-c33a7b100b53	TCGA-86-8674-01		81be01d3-ad98-495f-910c-c33a7b100b53	TCGA-86-8674-01		81be01d3-ad98-495f-910c-c33a7b100b53	TCGA-86-8674-01A-21D-2393-08	TCGA-86-8674-01	
TCGA-86-A456-01																												TCGA-86-A456-01										TCGA-86-A456	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					78	L-Upper		TCGA-86-A456-F67789	TCGA-86-A456	TCGA-86-A456-01A			-28533	90		0	896									Scheduled Follow-up Submission	Complete Remission/Response	2014-11-11	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES	580		NO	80				Peripheral Lung		NO		NO		true	No	M0	N0	T1a	Stage IA	TCGA-86-A456.56606792-5083-4F1E-ABEF-711BACF546E6.pdf	A456	Post-Adjuvant Therapy	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01		2009	7th		YES	NO	86	4		Lung	A	LIVING	2012	1974				46749725-ef75-479b-9af9-1cb898682e1c				TCGA-86-A456-01A-11D-A24C-01	TCGA-86-A456-01A-11D-A24I-05	TCGA-86-A456-01	TCGA-86-A456-01A-11D-A24C-01		46749725-ef75-479b-9af9-1cb898682e1c	TCGA-86-A456-01		46749725-ef75-479b-9af9-1cb898682e1c	TCGA-86-A456-01	A75F6121-F3AB-4794-923B-9F2B4AFA0395	46749725-ef75-479b-9af9-1cb898682e1c	TCGA-86-A456-01A-11D-A24D-08	TCGA-86-A456-01	
TCGA-86-A4D0-01																												TCGA-86-A4D0-01										TCGA-86-A4D0	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					48	R-Upper		TCGA-86-A4D0-F52852	TCGA-86-A4D0	TCGA-86-A4D0-01A			-17607	133	116	0	30				1	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-12-6	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	920		NO	90	NO					NO		NO		true	No	M0	N0	T2b	Stage IIA	TCGA-86-A4D0.80C129A3-A5B6-4B1C-9979-44A307867744.pdf	A4D0	Preoperative	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01			7th	YES	YES	NO	86	2		Lung	A	DECEASED	2012	1983				ae82fe73-dc4c-403b-af98-1d01ad87e732				TCGA-86-A4D0-01A-11D-A24C-01	TCGA-86-A4D0-01A-11D-A24I-05	TCGA-86-A4D0-01	TCGA-86-A4D0-01A-11D-A24C-01		ae82fe73-dc4c-403b-af98-1d01ad87e732	TCGA-86-A4D0-01		ae82fe73-dc4c-403b-af98-1d01ad87e732	TCGA-86-A4D0-01	11425CD6-20A7-424C-8B84-C3BE4E5CA3A3	ae82fe73-dc4c-403b-af98-1d01ad87e732		TCGA-86-A4D0-01	
TCGA-86-A4JF-01																												TCGA-86-A4JF-01										TCGA-86-A4JF	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					56	R-Upper		TCGA-86-A4JF-F70857	TCGA-86-A4JF	TCGA-86-A4JF-01A			-20491	140	737	0	0				4	NO			NO	Scheduled Follow-up Submission	Progressive Disease	2015-3-10	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	940		NO	20	NO			Central Lung		NO		NO		true	No	M0	N0	T3	Stage IIB	TCGA-86-A4JF.5D7BD5E2-4575-4169-B07F-DBF4C2307A13.pdf	A4JF	Post-Adjuvant Therapy	WITH TUMOR					Complete Remission/Response			NO	NO	R0	Primary Tumor	01		2012	7th	YES	YES	NO	86	4		Lung	A	DECEASED	2012					b30fef8e-9736-4f6d-9547-cfd9163ebbb9				TCGA-86-A4JF-01A-11D-A24O-01	TCGA-86-A4JF-01A-11D-A24U-05	TCGA-86-A4JF-01	TCGA-86-A4JF-01A-11D-A24O-01		b30fef8e-9736-4f6d-9547-cfd9163ebbb9	TCGA-86-A4JF-01		b30fef8e-9736-4f6d-9547-cfd9163ebbb9	TCGA-86-A4JF-01	5F5878C1-9358-4021-8CAA-67BDED439B59	b30fef8e-9736-4f6d-9547-cfd9163ebbb9	TCGA-86-A4JF-01A-11D-A24P-08	TCGA-86-A4JF-01	
TCGA-86-A4P7-01																												TCGA-86-A4P7-01										TCGA-86-A4P7	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					63	L-Lower		TCGA-86-A4P7-F66092	TCGA-86-A4P7	TCGA-86-A4P7-01A			-23330	220		0	415				0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-10-2	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	350		NO	100	NO			Peripheral Lung		NO		NO		true	No	M0	N0	T2a	Stage IB	TCGA-86-A4P7.E6FEB175-8903-47D5-BBD4-3BF2E95C3B15.pdf	A4P7	Other	TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01			7th	NO	YES	NO	86	1		Lung	A	LIVING	2012					3a401a11-c977-45b6-9900-87c6adb7dc09				TCGA-86-A4P7-01A-11D-A24O-01	TCGA-86-A4P7-01A-11D-A24U-05	TCGA-86-A4P7-01	TCGA-86-A4P7-01A-11D-A24O-01		3a401a11-c977-45b6-9900-87c6adb7dc09	TCGA-86-A4P7-01		3a401a11-c977-45b6-9900-87c6adb7dc09	TCGA-86-A4P7-01	6EC60F08-C9CA-41DA-A6F0-E40A02482619	3a401a11-c977-45b6-9900-87c6adb7dc09	TCGA-86-A4P7-01A-11D-A24P-08	TCGA-86-A4P7-01	
TCGA-86-A4P8-01																												TCGA-86-A4P8-01										TCGA-86-A4P8	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					59	R-Lower		TCGA-86-A4P8-F65331	TCGA-86-A4P8	TCGA-86-A4P8-01A			-21738	98		0	805			85	0	YES		FISH	YES	Scheduled Follow-up Submission	Complete Remission/Response	2014-9-22	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	360		NO		NO					NO		NO		true	No	MX	N2	T1b	Stage IIIA	TCGA-86-A4P8.72828D6C-9995-42E2-ABE7-D4BA29B8A987.pdf	A4P8	Post-Adjuvant Therapy	TUMOR FREE	78	89	74	84	Complete Remission/Response			YES	YES		Primary Tumor	01			7th	YES	YES	NO	86	1		Lung	A	LIVING	2012					fe82fe98-0116-4657-acb0-36b2093fb639				TCGA-86-A4P8-01A-11D-A24O-01	TCGA-86-A4P8-01A-11D-A24U-05	TCGA-86-A4P8-01	TCGA-86-A4P8-01A-11D-A24O-01		fe82fe98-0116-4657-acb0-36b2093fb639	TCGA-86-A4P8-01		fe82fe98-0116-4657-acb0-36b2093fb639	TCGA-86-A4P8-01	6796D8BC-0520-49A2-8650-782E9EC339CB	fe82fe98-0116-4657-acb0-36b2093fb639	TCGA-86-A4P8-01A-11D-A24P-08	TCGA-86-A4P8-01	
TCGA-91-6828-01			none		none	none	none	Y	Y	none	none	none		Magnoid	none	p.G12V	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-91-6828-01	High	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 6	cluster 1	mutation cluster 12	TCGA-91-6828	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	L-Lower		TCGA-91-6828-F21014	TCGA-91-6828	TCGA-91-6828-01A			-25870			0	323			71	2					Scheduled Follow-up Submission		2012-5-8	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.8	NO		NO				1.5			NO			No	M0	N0	T1a	Stage IA	TCGA-91-6828.8b494f5f-5e6f-43bb-8748-0cb2d36eab37.pdf	6828	Preoperative	TUMOR FREE				81	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.4	1993	7th	NO	YES	NO	91	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2011		TCGA-91-6828-01A-11D-1855-08	TCGA-91-6828-01A-11D-1855-08		e3958992-3206-4cdd-8bc9-38fd43853800				TCGA-91-6828-01A-11D-1854-01	TCGA-91-6828-01A-11D-1856-05	TCGA-91-6828-01	TCGA-91-6828-01A-11D-1854-01		e3958992-3206-4cdd-8bc9-38fd43853800	TCGA-91-6828-01	TCGA-91-6828-01A-13-2191-20	e3958992-3206-4cdd-8bc9-38fd43853800	TCGA-91-6828-01	868a423e-7b37-44b0-af6a-7331066e88d3	e3958992-3206-4cdd-8bc9-38fd43853800	TCGA-91-6828-01A-11D-1855-08	TCGA-91-6828-01	
TCGA-91-6828-11			none		none	none	none	Y	Y	none	none	none		Magnoid	none	p.G12V	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-91-6828-11		C1-LUAD-enriched							mutation cluster 12	TCGA-91-6828	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	L-Lower		TCGA-91-6828-F21014	TCGA-91-6828	TCGA-91-6828-11A			-25870			0	323			71	2					Scheduled Follow-up Submission		2012-5-8	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.9	NO		NO				1.4			NO			No	M0	N0	T1a	Stage IA		6828	Preoperative	TUMOR FREE				81	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11	0.3	1993	7th	NO	YES	NO	91	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2011					e7e90370-f414-4668-910c-c556613be671									e7e90370-f414-4668-910c-c556613be671			e7e90370-f414-4668-910c-c556613be671			e7e90370-f414-4668-910c-c556613be671			
TCGA-91-6829-01	2.78	0.48	none		none	none	none	N	N	none	none	none	0.2	Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-91-6829-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3	mutation cluster 8	TCGA-91-6829	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					78	R-Lower		TCGA-91-6829-F32591	TCGA-91-6829	TCGA-91-6829-01A			-28841		1258	0					3					Scheduled Follow-up Submission	Progressive Disease	2012-6-4	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES		0.5	NO	0	NO				0.9	NO		NO	94.5		No	MX	N0	T2	Stage IB	TCGA-91-6829.d21d20d3-a384-417a-aa95-11f4b6930af0.pdf	6829	Other	TUMOR FREE					Progressive Disease				NO	R0	Primary Tumor	01	0.4	2003	5th	NO	NO	YES	91	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2001	1940	TCGA-91-6829-01A-21D-1855-08	TCGA-91-6829-01A-21D-1855-08		b4e31dbe-0923-401e-a664-e779914254b8				TCGA-91-6829-01A-21D-1854-01	TCGA-91-6829-01A-21D-1856-05	TCGA-91-6829-01	TCGA-91-6829-01A-21D-1854-01		b4e31dbe-0923-401e-a664-e779914254b8	TCGA-91-6829-01	TCGA-91-6829-01A-23-2191-20	b4e31dbe-0923-401e-a664-e779914254b8	TCGA-91-6829-01	36a9dbe9-dfd6-41d7-9f76-04dcf1c93755	b4e31dbe-0923-401e-a664-e779914254b8	TCGA-91-6829-01A-21D-1855-08	TCGA-91-6829-01	
TCGA-91-6829-11	2.78	0.48	none		none	none	none	N	N	none	none	none	0.2	Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-91-6829-11		C1-LUAD-enriched							mutation cluster 8	TCGA-91-6829	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					78	R-Lower		TCGA-91-6829-F32591	TCGA-91-6829	TCGA-91-6829-11A			-28841		1258	0					3					Scheduled Follow-up Submission	Progressive Disease	2012-6-4	MALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES		0.8	NO	0	NO				1.1	NO		NO	94.5		No	MX	N0	T2	Stage IB		6829	Other	TUMOR FREE					Progressive Disease				NO	R0	Solid Tissue Normal	11	0.4	2003	5th	NO	NO	YES	91	4	Current reformed smoker for < or = 15 years	Lung	A	DECEASED	2001	1940				d3b983d1-2665-4cdd-893e-4f120dc43346									d3b983d1-2665-4cdd-893e-4f120dc43346			d3b983d1-2665-4cdd-893e-4f120dc43346			d3b983d1-2665-4cdd-893e-4f120dc43346			
TCGA-91-6830-01																												TCGA-91-6830-01	Squamous	C1-LUAD-enriched		Low purity c2	squamous c3	LUAD-like c10	miRNA c1uster 9			TCGA-91-6830	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		YES	65	L-Upper		TCGA-91-6830-F32595	TCGA-91-6830			18	-23922			0	60	18								Scheduled Follow-up Submission		2012-6-4	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO					YES	Distant Metastasis	YES	12		No	MX	N1	T1	Stage IIA		6830		WITH TUMOR						Biopsy with Histologic Confirmation			NO		Primary Tumor	01		2002	5th	NO	NO	YES	91	4		Lung		LIVING	2002	1990				f61ba831-745d-468c-a3b0-0229000926f5				TCGA-91-6830-01A-11D-1943-01	TCGA-91-6830-01A-11D-1947-05	TCGA-91-6830-01	TCGA-91-6830-01A-11D-1943-01		f61ba831-745d-468c-a3b0-0229000926f5	TCGA-91-6830-01	TCGA-91-6830-01A-13-2191-20	f61ba831-745d-468c-a3b0-0229000926f5	TCGA-91-6830-01	a05658f0-5ddb-449d-b36a-383e17b9b95b	f61ba831-745d-468c-a3b0-0229000926f5	TCGA-91-6830-01A-11D-1945-08	TCGA-91-6830-01	
TCGA-91-6831-01																												TCGA-91-6831-01	High	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 2	TCGA-91-6831	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					66	R-Middle		TCGA-91-6831-F32636	TCGA-91-6831	TCGA-91-6831-01A			-24436			0	310									Scheduled Follow-up Submission	Complete Remission/Response	2012-6-5	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES		0.6	NO		NO				0.6	YES		NO			No	MX	N0	T2	Stage IB	TCGA-91-6831.21f30ab4-751e-4ef5-bffa-75d5086ea1cb.pdf	6831		TUMOR FREE					Complete Remission/Response			NO	NO		Primary Tumor	01	0.4		5th	NO	NO	YES	91	2		Lung	A	LIVING	2001		TCGA-91-6831-01A-11D-1855-08			860fa33f-75d9-480d-92e7-2a5a45b35433				TCGA-91-6831-01A-11D-1854-01	TCGA-91-6831-01A-11D-1856-05	TCGA-91-6831-01	TCGA-91-6831-01A-11D-1854-01		860fa33f-75d9-480d-92e7-2a5a45b35433	TCGA-91-6831-01	TCGA-91-6831-01A-13-2191-20	860fa33f-75d9-480d-92e7-2a5a45b35433	TCGA-91-6831-01	71cf2558-e5c1-4a83-bdec-6c3d8b3de2c1	860fa33f-75d9-480d-92e7-2a5a45b35433	TCGA-91-6831-01A-11D-1855-08	TCGA-91-6831-01	
TCGA-91-6831-11																												TCGA-91-6831-11		C1-LUAD-enriched							mutation cluster 2	TCGA-91-6831	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					66	R-Middle		TCGA-91-6831-F32636	TCGA-91-6831	TCGA-91-6831-11A			-24436			0	310									Scheduled Follow-up Submission	Complete Remission/Response	2012-6-5	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES		0.6	NO		NO				1.3	YES		NO			No	MX	N0	T2	Stage IB		6831		TUMOR FREE					Complete Remission/Response			NO	NO		Solid Tissue Normal	11	0.4		5th	NO	NO	YES	91	2		Lung	A	LIVING	2001					292dfcd4-8c49-4348-9622-87b52f593ac3									292dfcd4-8c49-4348-9622-87b52f593ac3			292dfcd4-8c49-4348-9622-87b52f593ac3			292dfcd4-8c49-4348-9622-87b52f593ac3			
TCGA-91-6835-01			none		none	none	none	Y	Y	p.L858R	none	none		Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-91-6835-01	High	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2	mutation cluster 14	TCGA-91-6835	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					81	R-Lower		TCGA-91-6835-F32643	TCGA-91-6835	TCGA-91-6835-01A			-29887			0	79			78		NO				Scheduled Follow-up Submission	Complete Remission/Response	2012-6-5	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.5	NO		NO				1.1	YES		NO	25		No	M0	N0	T1	Stage IA	TCGA-91-6835.bb4510c1-addd-42a3-9439-dfc7e43078d3.pdf	6835		TUMOR FREE		91		75	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.4	1976	7th	NO	NO	YES	91	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2010		TCGA-91-6835-01A-11D-1855-08	TCGA-91-6835-01A-11D-1855-08		4502921a-1650-4721-b814-c9435fe6042d				TCGA-91-6835-01A-11D-1854-01	TCGA-91-6835-01A-11D-1856-05	TCGA-91-6835-01	TCGA-91-6835-01A-11D-1854-01		4502921a-1650-4721-b814-c9435fe6042d	TCGA-91-6835-01	TCGA-91-6835-01A-13-2191-20	4502921a-1650-4721-b814-c9435fe6042d	TCGA-91-6835-01	9fc7b7be-5f60-4b40-adc9-b54df34d01cd	4502921a-1650-4721-b814-c9435fe6042d	TCGA-91-6835-01A-11D-1855-08	TCGA-91-6835-01	
TCGA-91-6835-11			none		none	none	none	Y	Y	p.L858R	none	none		Squamoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-91-6835-11		C1-LUAD-enriched							mutation cluster 14	TCGA-91-6835	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					81	R-Lower		TCGA-91-6835-F32643	TCGA-91-6835	TCGA-91-6835-11A			-29887			0	79			78		NO				Scheduled Follow-up Submission	Complete Remission/Response	2012-6-5	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.5	NO		NO				1.5	YES		NO	25		No	M0	N0	T1	Stage IA		6835		TUMOR FREE		91		75	Complete Remission/Response			YES	NO	R0	Solid Tissue Normal	11	0.4	1976	7th	NO	NO	YES	91	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2010					183b2543-2665-403a-a8c0-7ae668082f2d									183b2543-2665-403a-a8c0-7ae668082f2d	TCGA-91-6835-11		183b2543-2665-403a-a8c0-7ae668082f2d			183b2543-2665-403a-a8c0-7ae668082f2d		TCGA-91-6835-11	
TCGA-91-6836-01																												TCGA-91-6836-01	High	C1-LUAD-enriched		Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4		mutation cluster 11	TCGA-91-6836	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					52	R-Upper		TCGA-91-6836-F32646	TCGA-91-6836	TCGA-91-6836-01A			-19216			0	417			97		NO				Scheduled Follow-up Submission	Complete Remission/Response	2012-6-5	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO		NO				0.9	NO		NO	50		Yes	MX	N0	T2	Stage IB	TCGA-91-6836.89441c7c-1e09-4b73-8cc3-27cba26f3bd3.pdf	6836		TUMOR FREE	101	109		108	Complete Remission/Response			YES	NO		Primary Tumor	01	0.4		7th	NO	NO	YES	91	2		Lung	A	LIVING	2010	1973	TCGA-91-6836-01A-21D-1855-08			8ccc7a37-a9a4-4d77-9126-c8513c20bb29				TCGA-91-6836-01A-21D-1854-01	TCGA-91-6836-01A-21D-1856-05	TCGA-91-6836-01	TCGA-91-6836-01A-21D-1854-01		8ccc7a37-a9a4-4d77-9126-c8513c20bb29	TCGA-91-6836-01	TCGA-91-6836-01A-23-2191-20	8ccc7a37-a9a4-4d77-9126-c8513c20bb29	TCGA-91-6836-01	8534a1e1-144d-4978-b452-dffe629915fa	8ccc7a37-a9a4-4d77-9126-c8513c20bb29	TCGA-91-6836-01A-21D-1855-08	TCGA-91-6836-01	
TCGA-91-6836-11																												TCGA-91-6836-11		C1-LUAD-enriched							mutation cluster 11	TCGA-91-6836	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					52	R-Upper		TCGA-91-6836-F32646	TCGA-91-6836				-19216			0	417			97		NO				Scheduled Follow-up Submission	Complete Remission/Response	2012-6-5	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES					NO					NO		NO	50		Yes	MX	N0	T2	Stage IB		6836		TUMOR FREE	101	109		108	Complete Remission/Response			YES	NO		Solid Tissue Normal	11			7th	NO	NO	YES	91	2		Lung		LIVING	2010	1973				de68950c-3885-4bfe-b23e-2d218787ca15									de68950c-3885-4bfe-b23e-2d218787ca15	TCGA-91-6836-11		de68950c-3885-4bfe-b23e-2d218787ca15			de68950c-3885-4bfe-b23e-2d218787ca15		TCGA-91-6836-11	
TCGA-91-6840-01	2.83	0.62	none		none	none	none	N	N	none	none	none	0.25	Magnoid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-91-6840-01	High	C1-LUAD-enriched	cluster 3	Low purity c2	squamous c3	LUAD-like c10	miRNA cluster 2	cluster 5		TCGA-91-6840	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					59	R-Upper		TCGA-91-6840-F21664	TCGA-91-6840	TCGA-91-6840-01A			-21854			0	372									Scheduled Follow-up Submission		2012-5-8	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.5	NO		NO				0.7			NO	50		No	M0	N0	T1b	Stage IA	TCGA-91-6840.2f5322c3-f57f-4252-8e17-e5a964e81793.pdf	6840		TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01	0.4	1996	7th	NO	YES	NO	91	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2011	1971		TCGA-91-6840-01A-11D-1945-08		64f425a9-2260-4cd3-8ddd-c43ac410b1a4				TCGA-91-6840-01A-11D-1943-01	TCGA-91-6840-01A-11D-1947-05	TCGA-91-6840-01	TCGA-91-6840-01A-11D-1943-01		64f425a9-2260-4cd3-8ddd-c43ac410b1a4	TCGA-91-6840-01	TCGA-91-6840-01A-13-2191-20	64f425a9-2260-4cd3-8ddd-c43ac410b1a4	TCGA-91-6840-01	461b2f41-f117-4d06-93b3-5654fb4af5fa	64f425a9-2260-4cd3-8ddd-c43ac410b1a4	TCGA-91-6840-01A-11D-1945-08	TCGA-91-6840-01	
TCGA-91-6847-01	3.86	0.86	none		none	none	none	Y	Y	p.L861Q	none	none	0.24	Squamoid	none	none	none	p.Y321H	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-91-6847-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	RNA cluster 14	miRNA cluster 12	cluster 5		TCGA-91-6847	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		NO	62	R-Lower		TCGA-91-6847-F32637	TCGA-91-6847	TCGA-91-6847-01A			-22862			0	842	772								Scheduled Follow-up Submission	Stable Disease	2012-6-5	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.4	NO		NO				1.1	YES	Distant Metastasis	YES			No	MX	N0	T2	Stage IB	TCGA-91-6847.4e40d97c-ca3c-41ec-b5c5-eb2f85ee29b3.pdf	6847		WITH TUMOR					Progressive Disease	Convincing Imaging			YES		Primary Tumor	01	0.3	1967	5th	NO	NO	YES	91	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2002			TCGA-91-6847-01A-11D-1945-08		0c96bb0f-11f1-421c-b2c5-55458ba95d97				TCGA-91-6847-01A-11D-1943-01	TCGA-91-6847-01A-11D-1947-05	TCGA-91-6847-01	TCGA-91-6847-01A-11D-1943-01		0c96bb0f-11f1-421c-b2c5-55458ba95d97	TCGA-91-6847-01	TCGA-91-6847-01A-13-2191-20	0c96bb0f-11f1-421c-b2c5-55458ba95d97	TCGA-91-6847-01	c9e583e9-c014-4508-acdc-11a8b46c6034	0c96bb0f-11f1-421c-b2c5-55458ba95d97	TCGA-91-6847-01A-11D-1945-08	TCGA-91-6847-01	
TCGA-91-6847-11	3.86	0.86	none		none	none	none	Y	Y	p.L861Q	none	none	0.24	Squamoid	none	none	none	p.Y321H	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-91-6847-11		C1-LUAD-enriched								TCGA-91-6847	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		NO	62	R-Lower		TCGA-91-6847-F32637	TCGA-91-6847	TCGA-91-6847-11A			-22862			0	842	772								Scheduled Follow-up Submission	Stable Disease	2012-6-5	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.5	NO		NO				1.2	YES	Distant Metastasis	YES			No	MX	N0	T2	Stage IB		6847		WITH TUMOR					Progressive Disease	Convincing Imaging			YES		Solid Tissue Normal	11	0.3	1967	5th	NO	NO	YES	91	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2002					32f582db-018c-4134-9998-79138bf301f2									32f582db-018c-4134-9998-79138bf301f2			32f582db-018c-4134-9998-79138bf301f2			32f582db-018c-4134-9998-79138bf301f2			
TCGA-91-6848-01																												TCGA-91-6848-01	BRCA-LUAD+	C12-small-various		BRCA CIMP c7	squamous c3	RNA cluster 2	miRNA c1uster 9			TCGA-91-6848	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					59	L-Upper		TCGA-91-6848-F32641	TCGA-91-6848	TCGA-91-6848-01A			-21829			0	224									Scheduled Follow-up Submission	Complete Remission/Response	2012-6-5	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO		YES	NO			1.1	YES		NO			No	MX	N2	T2	Stage IIIA	TCGA-91-6848.a790e051-b741-4913-aff6-5a48c9e8e8cd.pdf	6848		TUMOR FREE					Complete Remission/Response				NO		Primary Tumor	01	0.6	2007	6th	YES	NO	YES	91	4		Lung	A	LIVING	2009					0cfbefba-24ff-474b-8bfa-b44a1f71b48c				TCGA-91-6848-01A-11D-1943-01	TCGA-91-6848-01A-11D-1947-05	TCGA-91-6848-01	TCGA-91-6848-01A-11D-1943-01		0cfbefba-24ff-474b-8bfa-b44a1f71b48c	TCGA-91-6848-01	TCGA-91-6848-01A-13-2191-20	0cfbefba-24ff-474b-8bfa-b44a1f71b48c	TCGA-91-6848-01	46b0370f-a666-4cce-a746-8701a344a36e	0cfbefba-24ff-474b-8bfa-b44a1f71b48c	TCGA-91-6848-01A-11D-1945-08	TCGA-91-6848-01	
TCGA-91-6849-01	1.93	0.6	none		none	none	none	Y	Y	none	none	p.G240*	0.31	Bronchioid	none	p.G12C	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			p.G288_splice	0	TCGA-91-6849-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA c1uster 9	cluster 4		TCGA-91-6849	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					75	L-Upper		TCGA-91-6849-F32642	TCGA-91-6849	TCGA-91-6849-01A			-27676			0	35			66		YES				Scheduled Follow-up Submission		2012-6-5	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.5	NO	90	NO				1.5	YES			30		No	MX	N2	T2	Stage IIIA	TCGA-91-6849.910d922e-8180-48ba-9e13-0f177dc71b2d.pdf	6849	Preoperative		75	86	76	88				YES			Primary Tumor	01	0.4	1976	6th		NO	YES	91	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2009	1946		TCGA-91-6849-01A-11D-1945-08		821a5315-e4a2-4005-b5fc-572b32a2386a				TCGA-91-6849-01A-11D-1943-01	TCGA-91-6849-01A-11D-1947-05	TCGA-91-6849-01	TCGA-91-6849-01A-11D-1943-01		821a5315-e4a2-4005-b5fc-572b32a2386a	TCGA-91-6849-01	TCGA-91-6849-01A-13-2191-20	821a5315-e4a2-4005-b5fc-572b32a2386a	TCGA-91-6849-01	0f7b0379-6a78-482e-909f-c85766abcb9d	821a5315-e4a2-4005-b5fc-572b32a2386a	TCGA-91-6849-01A-11D-1945-08	TCGA-91-6849-01	
TCGA-91-6849-11	1.93	0.6	none		none	none	none	Y	Y	none	none	p.G240*	0.31	Bronchioid	none	p.G12C	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			p.G288_splice	0	TCGA-91-6849-11		C1-LUAD-enriched								TCGA-91-6849	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					75	L-Upper		TCGA-91-6849-F32642	TCGA-91-6849	TCGA-91-6849-11A			-27676			0	35			66		YES				Scheduled Follow-up Submission		2012-6-5	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO	90	NO				0.7	YES			30		No	MX	N2	T2	Stage IIIA		6849	Preoperative		75	86	76	88				YES			Solid Tissue Normal	11	0.6	1976	6th		NO	YES	91	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2009	1946				9aec6b23-f6a0-4400-b72c-d7c3d16293f4									9aec6b23-f6a0-4400-b72c-d7c3d16293f4			9aec6b23-f6a0-4400-b72c-d7c3d16293f4			9aec6b23-f6a0-4400-b72c-d7c3d16293f4			
TCGA-91-7771-01			none		none	none	none	N	N	none	none	p.R47G		Bronchioid	none	none	none	none	none	none	none	Solid predominant Adc	Solid predominant Adc			none	0	TCGA-91-7771-01	High	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-91-7771	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					62	R-Upper		TCGA-91-7771-F37916	TCGA-91-7771	TCGA-91-7771-01A			-22926			0	492					NO				Scheduled Follow-up Submission	Complete Remission/Response	2012-12-6	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.9	NO		NO				3	NO		NO	75		Yes	MX	N0	T3	Stage IIB	TCGA-91-7771.a8247167-a991-441b-b60a-9f69f4c5d9da.pdf	7771		TUMOR FREE					Complete Remission/Response			NO	NO		Primary Tumor	01	0.6	2011	7th	YES	YES	NO	91	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2011			TCGA-91-7771-01A-11D-2167-08		6f2e3098-e76b-411f-9d8e-cd8594ed1175				TCGA-91-7771-01A-11D-2166-01	TCGA-91-7771-01A-11D-2168-05	TCGA-91-7771-01	TCGA-91-7771-01A-11D-2166-01		6f2e3098-e76b-411f-9d8e-cd8594ed1175	TCGA-91-7771-01	TCGA-91-7771-01A-13-2192-20	6f2e3098-e76b-411f-9d8e-cd8594ed1175	TCGA-91-7771-01	6a99d37c-55d6-4316-9280-f852f974a786	6f2e3098-e76b-411f-9d8e-cd8594ed1175	TCGA-91-7771-01A-11D-2167-08	TCGA-91-7771-01	
TCGA-91-8496-01																												TCGA-91-8496-01										TCGA-91-8496	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					63	L-Lower		TCGA-91-8496-F45467	TCGA-91-8496	TCGA-91-8496-01A			-23358			0	505				0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-7-15	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES		0.4	NO		NO				2	NO		NO			No	MX	NX	T2a	Stage IB	TCGA-91-8496.d513e826-62f5-4e2d-95ef-7b48fea0643a.pdf	8496	Preoperative	TUMOR FREE					Complete Remission/Response			NO	NO		Primary Tumor	01	0.3		7th	NO	YES	NO	91	1		Lung	A	LIVING	2011					0a85f2bd-d169-44e4-bde3-c92ff92ddc94				TCGA-91-8496-01A-11D-2389-01	TCGA-91-8496-01A-11D-2398-05	TCGA-91-8496-01	TCGA-91-8496-01A-11D-2389-01		0a85f2bd-d169-44e4-bde3-c92ff92ddc94	TCGA-91-8496-01		0a85f2bd-d169-44e4-bde3-c92ff92ddc94	TCGA-91-8496-01	DBDBC88F-6B74-4A76-B4F5-2307572A8633	0a85f2bd-d169-44e4-bde3-c92ff92ddc94	TCGA-91-8496-01A-11D-2393-08	TCGA-91-8496-01	
TCGA-91-8497-01																												TCGA-91-8497-01										TCGA-91-8497	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					75	R-Upper		TCGA-91-8497-F58334	TCGA-91-8497	TCGA-91-8497-01A			-27632		434	0	174									Scheduled Follow-up Submission	Complete Remission/Response	2014-4-7	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO		NO				1.8	NO		NO			No	MX	N0	T1a	Stage IA	TCGA-91-8497.e393a314-6d4d-41f4-a9d3-7d67ab25713b.pdf	8497		TUMOR FREE					Complete Remission/Response			NO	NO		Primary Tumor	01	0.4		7th	NO	YES	NO	91	1		Lung	A	DECEASED	2012					f5c78889-7c7f-4b88-8660-6560b49b7be4				TCGA-91-8497-01A-11D-2389-01	TCGA-91-8497-01A-11D-2398-05	TCGA-91-8497-01	TCGA-91-8497-01A-11D-2389-01		f5c78889-7c7f-4b88-8660-6560b49b7be4	TCGA-91-8497-01		f5c78889-7c7f-4b88-8660-6560b49b7be4	TCGA-91-8497-01	DE5D87CD-E176-49F0-8401-CF364136CEF5	f5c78889-7c7f-4b88-8660-6560b49b7be4	TCGA-91-8497-01A-11D-2393-08	TCGA-91-8497-01	
TCGA-91-8499-01																												TCGA-91-8499-01										TCGA-91-8499	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					76	L-Lower		TCGA-91-8499-F37976	TCGA-91-8499	TCGA-91-8499-01A			-27853			0	36					YES				Scheduled Follow-up Submission		2012-12-7	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.6	NO		NO				1.2	YES		NO	90		No	MX	N0	T1b	Stage IA	TCGA-91-8499.99ab423d-db99-4ef1-bf1f-a8dddb94e788.pdf	8499			49							YES	NO		Primary Tumor	01	0.4		7th	NO	YES	NO	91	2		Lung	A	LIVING	2011	1945				9cf68c53-c1a5-4102-aeba-a2083335954e				TCGA-91-8499-01A-11D-2389-01	TCGA-91-8499-01A-11D-2398-05	TCGA-91-8499-01	TCGA-91-8499-01A-11D-2389-01		9cf68c53-c1a5-4102-aeba-a2083335954e	TCGA-91-8499-01		9cf68c53-c1a5-4102-aeba-a2083335954e	TCGA-91-8499-01	552D8E51-111D-471C-90B4-3E6E9B1D1BFE	9cf68c53-c1a5-4102-aeba-a2083335954e	TCGA-91-8499-01A-11D-2393-08	TCGA-91-8499-01	
TCGA-91-A4BC-01																												TCGA-91-A4BC-01										TCGA-91-A4BC	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					59	R-Upper		TCGA-91-A4BC-F45192	TCGA-91-A4BC	TCGA-91-A4BC-01A			-21565	225		0	44			44		NO				Scheduled Follow-up Submission		2013-7-10	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	280		NO		NO					YES			30	false	Yes, History of Synchronous/Bilateral Malignancy	MX	N0	T2b	Stage IIA	TCGA-91-A4BC.6C586925-8FAC-4A75-8A67-574B24B9D0BA.pdf	A4BC				69						YES			Primary Tumor	01		2001	7th		YES	NO	91	4		Lung	A	LIVING	2012	1976				439820e6-1011-461e-8002-5af1470a7827				TCGA-91-A4BC-01A-11D-A24C-01	TCGA-91-A4BC-01A-11D-A24I-05	TCGA-91-A4BC-01	TCGA-91-A4BC-01A-11D-A24C-01		439820e6-1011-461e-8002-5af1470a7827	TCGA-91-A4BC-01		439820e6-1011-461e-8002-5af1470a7827	TCGA-91-A4BC-01	333255BF-9870-4B6A-999B-6B7AD02954DD	439820e6-1011-461e-8002-5af1470a7827	TCGA-91-A4BC-01A-11D-A24D-08	TCGA-91-A4BC-01	
TCGA-91-A4BD-01																												TCGA-91-A4BD-01										TCGA-91-A4BD	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					78	L-Lower		TCGA-91-A4BD-F58335	TCGA-91-A4BD	TCGA-91-A4BD-01A			-28544	162		0	603			94	1	NO				Scheduled Follow-up Submission	Complete Remission/Response	2014-4-7	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	220		NO		NO					NO		NO		false	No	MX	N1	T1b	Stage IIA	TCGA-91-A4BD.5767AA19-6B73-4FC8-BC3E-930044E249A3.pdf	A4BD	Other	TUMOR FREE	70	92			Complete Remission/Response			YES	NO	RX	Primary Tumor	01		1981	7th	NO	YES	NO	91	3		Lung	A	LIVING	2012					883fcc6f-4ef3-4c93-872a-a096b87bd85b				TCGA-91-A4BD-01A-11D-A24C-01	TCGA-91-A4BD-01A-11D-A24I-05	TCGA-91-A4BD-01	TCGA-91-A4BD-01A-11D-A24C-01		883fcc6f-4ef3-4c93-872a-a096b87bd85b	TCGA-91-A4BD-01		883fcc6f-4ef3-4c93-872a-a096b87bd85b	TCGA-91-A4BD-01	0AB8A055-9D78-4772-8086-652384CBEE0D	883fcc6f-4ef3-4c93-872a-a096b87bd85b	TCGA-91-A4BD-01A-11D-A24D-08	TCGA-91-A4BD-01	
TCGA-93-7347-01			none		none	none	none	Y	Y	none	none	none		Bronchioid	none	p.G12C	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-93-7347-01	Kirc+		cluster 3	Cluster 5		LUAD-like c10	miRNA cluster 4	cluster 4		TCGA-93-7347	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					76	R-Upper		TCGA-93-7347-F43155	TCGA-93-7347	TCGA-93-7347-01A			-27949			0	683			70		NO			NO	Scheduled Follow-up Submission		2013-5-14	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		1	NO		NO			Central Lung	1	NO		NO	11		No	MX	N0	T1a	Stage IA	TCGA-93-7347.a89ef8ab-8af7-4906-844e-eb216316f584.pdf	7347		TUMOR FREE	61	84	62	84	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.2	1967	7th	NO	YES	NO	93	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2011	1952		TCGA-93-7347-01A-11D-2184-08		2cb8a95d-20c3-4623-9b4d-b06b2a494b18				TCGA-93-7347-01A-11D-2183-01	TCGA-93-7347-01A-11D-2185-05	TCGA-93-7347-01	TCGA-93-7347-01A-11D-2183-01		2cb8a95d-20c3-4623-9b4d-b06b2a494b18	TCGA-93-7347-01		2cb8a95d-20c3-4623-9b4d-b06b2a494b18	TCGA-93-7347-01		2cb8a95d-20c3-4623-9b4d-b06b2a494b18	TCGA-93-7347-01A-11D-2184-08	TCGA-93-7347-01	
TCGA-93-7348-01	1.76	0.35	none		none	none	none	N	N	none	none	none	0.18	Bronchioid	none	none	none	p.D1010_splice	none	p.E542K	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-93-7348-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-93-7348	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					75	R-Upper		TCGA-93-7348-F43154	TCGA-93-7348	TCGA-93-7348-01A			-27456			0	531				0	NO			NO	Scheduled Follow-up Submission		2013-5-14	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		1.2	NO	100	NO			Central Lung	1.5	NO		NO	42		No	MX	N0	T1a	Stage IA	TCGA-93-7348.2ad907ad-1005-4e89-91b8-d09a173bcd4d.pdf	7348	Preoperative	TUMOR FREE					Complete Remission/Response				NO	R0	Primary Tumor	01	0.4	1999	7th	NO	YES	NO	93	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2011	1957		TCGA-93-7348-01A-21D-2036-08		6d1614e8-67cb-4551-a447-ae3b94990d70				TCGA-93-7348-01A-21D-2035-01	TCGA-93-7348-01A-21D-2037-05	TCGA-93-7348-01	TCGA-93-7348-01A-21D-2035-01		6d1614e8-67cb-4551-a447-ae3b94990d70	TCGA-93-7348-01	TCGA-93-7348-01A-23-2192-20	6d1614e8-67cb-4551-a447-ae3b94990d70	TCGA-93-7348-01	048615c7-c08c-4199-b394-c59160337d67	6d1614e8-67cb-4551-a447-ae3b94990d70	TCGA-93-7348-01A-21D-2036-08	TCGA-93-7348-01	
TCGA-93-7348-11	1.76	0.35	none		none	none	none	N	N	none	none	none	0.18	Bronchioid	none	none	none	p.D1010_splice	none	p.E542K	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-93-7348-11		C1-LUAD-enriched								TCGA-93-7348	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					75	R-Upper		TCGA-93-7348-F43154	TCGA-93-7348				-27456			0	531				0	NO			NO	Scheduled Follow-up Submission		2013-5-14	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES				100	NO			Central Lung		NO		NO	42		No	MX	N0	T1a	Stage IA		7348	Preoperative	TUMOR FREE					Complete Remission/Response				NO	R0	Solid Tissue Normal	11		1999	7th	NO	YES	NO	93	4	Current reformed smoker for < or = 15 years	Lung		LIVING	2011	1957														TCGA-93-7348-11							TCGA-93-7348-11	
TCGA-93-8067-01																												TCGA-93-8067-01	High			Cluster 6		LUAD-like c10	miRNA c1uster 9			TCGA-93-8067	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					77	L-Lower		TCGA-93-8067-F32193	TCGA-93-8067				-28453			0	186			47	2	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2012-5-18	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES				80	NO			Peripheral Lung		NO		NO	20		Yes, History of Prior Malignancy	MX	N0	T2a	Stage IB		8067	Preoperative	TUMOR FREE	94	103	89	94	Complete Remission/Response			YES	NO	RX	FFPE Scrolls	01		2001	7th	NO	YES	NO	93	4		Lung		LIVING	2011	1961				bf359688-8652-4266-b4fd-e2f8f2782a97				TCGA-93-8067-01A-11D-2283-01	TCGA-93-8067-01A-11D-2285-05	TCGA-93-8067-01	TCGA-93-8067-01A-11D-2283-01		bf359688-8652-4266-b4fd-e2f8f2782a97	TCGA-93-8067-01		bf359688-8652-4266-b4fd-e2f8f2782a97	TCGA-93-8067-01		bf359688-8652-4266-b4fd-e2f8f2782a97	TCGA-93-8067-01A-11D-2284-08	TCGA-93-8067-01	
TCGA-93-A4JN-01																												TCGA-93-A4JN-01										TCGA-93-A4JN	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	L-Upper		TCGA-93-A4JN-F56980	TCGA-93-A4JN	TCGA-93-A4JN-01A			-26273	209		0	718				1	YES		FISH	YES	Scheduled Follow-up Submission	Stable Disease	2014-2-27	MALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	330		NO	90	YES	NO				NO		NO	40	true	No	M1a	N0	T2a	Stage IV	TCGA-93-A4JN.BA9DB454-6107-4F98-8646-89129230D602.pdf	A4JN	Preoperative	WITH TUMOR					Stable Disease			NO	NO	RX	Primary Tumor	01		1991	7th	YES	YES	NO	93	3		Lung	A	LIVING	2012	1971				b31f6ff5-bd06-43d7-966e-426b787222e8				TCGA-93-A4JN-01A-11D-A24O-01	TCGA-93-A4JN-01A-11D-A24U-05	TCGA-93-A4JN-01	TCGA-93-A4JN-01A-11D-A24O-01		b31f6ff5-bd06-43d7-966e-426b787222e8	TCGA-93-A4JN-01		b31f6ff5-bd06-43d7-966e-426b787222e8	TCGA-93-A4JN-01	ACA6A642-9885-4013-BB03-09ABD1DF957E	b31f6ff5-bd06-43d7-966e-426b787222e8	TCGA-93-A4JN-01A-11D-A24P-08	TCGA-93-A4JN-01	
TCGA-93-A4JO-01																												TCGA-93-A4JO-01										TCGA-93-A4JO	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	R-Lower			TCGA-93-A4JO	TCGA-93-A4JO-01A			-25898	230	33	0				81	1	NO			NO			2014-2-27	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	390		NO	90	NO							NO	50	true	No	MX	N0	T1a	Stage IA	TCGA-93-A4JO.54D7BAFD-D766-4EE6-A769-F57A858B5F44.pdf	A4JO	Preoperative	TUMOR FREE	126	97	125	98				YES	NO	RX	Primary Tumor	01		2006	7th	NO	YES	NO	93	4		Lung	A	DECEASED	2012	1956				993626ac-469c-4d9d-8278-63fda45598c0				TCGA-93-A4JO-01A-21D-A24O-01	TCGA-93-A4JO-01A-21D-A24U-05	TCGA-93-A4JO-01	TCGA-93-A4JO-01A-21D-A24O-01		993626ac-469c-4d9d-8278-63fda45598c0	TCGA-93-A4JO-01		993626ac-469c-4d9d-8278-63fda45598c0	TCGA-93-A4JO-01	63D18EA0-CC63-461C-809B-D583F4632D86	993626ac-469c-4d9d-8278-63fda45598c0	TCGA-93-A4JO-01A-21D-A24P-08	TCGA-93-A4JO-01	
TCGA-93-A4JP-01																												TCGA-93-A4JP-01										TCGA-93-A4JP	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES		NO	64	R-Lower		TCGA-93-A4JP-F56970	TCGA-93-A4JP	TCGA-93-A4JP-01A			-23620	72		0	578	497			1	YES	L861Q		NO	Scheduled Follow-up Submission	Progressive Disease	2014-2-28	MALE	Lung Papillary Adenocarcinoma	No	C34.3	8260/3	C34.3	YES	450		NO		NO					NO	Distant Metastasis	YES		true	No	M1b	NX	TX	Stage IV	TCGA-93-A4JP.3AFDF9A9-8D19-4060-86E0-B24AE8C83A82.pdf	A4JP	Post-Adjuvant Therapy	WITH TUMOR					Partial Remission/Response	Convincing Imaging		NO	NO	RX	Primary Tumor	01			7th	YES	YES	NO	93	1		Lung	A	LIVING	2012					51705e9c-8423-4eb8-8839-09206d4d115b				TCGA-93-A4JP-01A-11D-A24O-01	TCGA-93-A4JP-01A-11D-A24U-05	TCGA-93-A4JP-01	TCGA-93-A4JP-01A-11D-A24O-01		51705e9c-8423-4eb8-8839-09206d4d115b	TCGA-93-A4JP-01		51705e9c-8423-4eb8-8839-09206d4d115b	TCGA-93-A4JP-01	F636C8C6-1BE2-4C2F-8557-6E507284657A	51705e9c-8423-4eb8-8839-09206d4d115b	TCGA-93-A4JP-01A-11D-A24P-08	TCGA-93-A4JP-01	
TCGA-93-A4JQ-01																												TCGA-93-A4JQ-01										TCGA-93-A4JQ	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					49	R-Upper		TCGA-93-A4JQ-F57022	TCGA-93-A4JQ	TCGA-93-A4JQ-01A			-17951	57		0	526			83	0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-2-28	MALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	290		NO		NO					NO		NO		true	Yes, History of Prior Malignancy	MX	N0	T1b	Stage IA	TCGA-93-A4JQ.B9CE532C-BACD-4123-B560-6671CABC5132.pdf	A4JQ	Preoperative	TUMOR FREE	97	100	94	93	Complete Remission/Response			YES	NO	RX	Primary Tumor	01		1993	7th	NO	YES	NO	93	3		Lung	A	LIVING	2012	1973				7c22c18e-b357-4f5d-a3c0-d947d9b95c15				TCGA-93-A4JQ-01A-11D-A24O-01	TCGA-93-A4JQ-01A-11D-A24U-05	TCGA-93-A4JQ-01	TCGA-93-A4JQ-01A-11D-A24O-01		7c22c18e-b357-4f5d-a3c0-d947d9b95c15	TCGA-93-A4JQ-01		7c22c18e-b357-4f5d-a3c0-d947d9b95c15	TCGA-93-A4JQ-01	85A3C8F3-775D-4804-B703-8B0B7FF963B1	7c22c18e-b357-4f5d-a3c0-d947d9b95c15	TCGA-93-A4JQ-01A-11D-A24P-08	TCGA-93-A4JQ-01	
TCGA-95-7039-01	5.71	0.42	none		p.D565_splice	none	none	N	N	p.S921R	none	none	0.12	Squamoid	none	p.D33E	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-95-7039-01	High	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-95-7039	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO		54	R-Upper		TCGA-95-7039-F67192	TCGA-95-7039	TCGA-95-7039-01A			-19981			0	1272	1258			1					Additional New Tumor Event	Progressive Disease	2014-10-31	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO						0.8	NO	Locoregional Recurrence	YES	34		No	MX	N0	T3	Stage IIB	TCGA-95-7039.8bb3ec39-1368-448f-8f75-36bac5f19f02.pdf	7039	Preoperative	WITH TUMOR					Complete Remission/Response	Biopsy with Histologic Confirmation|Convincing Imaging|Positive Biomarker(s)			NO		Primary Tumor	01	0.2		7th	NO	YES	NO	95	2	Current smoker	Lung	A	LIVING	2011			TCGA-95-7039-01A-11D-1945-08		a017b3e8-6e27-4f0c-aff2-166b73743991				TCGA-95-7039-01A-11D-1943-01	TCGA-95-7039-01A-11D-1947-05	TCGA-95-7039-01	TCGA-95-7039-01A-11D-1943-01		a017b3e8-6e27-4f0c-aff2-166b73743991	TCGA-95-7039-01	TCGA-95-7039-01A-13-2192-20	a017b3e8-6e27-4f0c-aff2-166b73743991	TCGA-95-7039-01	89356e0b-28f3-4115-9a1a-ba5788b848b8	a017b3e8-6e27-4f0c-aff2-166b73743991	TCGA-95-7039-01A-11D-1945-08	TCGA-95-7039-01	
TCGA-95-7043-01	3.72	0.77	none		none	none	none	N	N	none	none	none	0.23	Magnoid	none	none	none	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-95-7043-01	Squamous	C1-LUAD-enriched	cluster 3	Cluster 6	BRCA basal-like c6	LUAD-like c10	miRNA c1uster 10	cluster 5		TCGA-95-7043	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					63	R-Upper		TCGA-95-7043-F67188	TCGA-95-7043	TCGA-95-7043-01A			-23165		503	0	2									Scheduled Follow-up Submission	Progressive Disease	2014-10-31	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.6	NO						0.6	NO			40		Yes	MX	N0	T1a	Stage IA	TCGA-95-7043.a30ed7ec-19a9-4d15-b405-86132271a652.pdf	7043		WITH TUMOR					Complete Remission/Response			NO			Primary Tumor	01	0.1	2003	7th	YES	YES	NO	95	4	Current reformed smoker for > 15 years	Lung	A	DECEASED	2011	1964		TCGA-95-7043-01A-11D-1945-08		8a8e816b-8067-4ffe-ac37-f3ac2e0a29c4				TCGA-95-7043-01A-11D-1943-01	TCGA-95-7043-01A-11D-1947-05	TCGA-95-7043-01	TCGA-95-7043-01A-11D-1943-01		8a8e816b-8067-4ffe-ac37-f3ac2e0a29c4	TCGA-95-7043-01	TCGA-95-7043-01A-13-2192-20	8a8e816b-8067-4ffe-ac37-f3ac2e0a29c4	TCGA-95-7043-01	e4b22dc8-a344-4b20-a743-9af3e4308605	8a8e816b-8067-4ffe-ac37-f3ac2e0a29c4	TCGA-95-7043-01A-11D-1945-08	TCGA-95-7043-01	
TCGA-95-7562-01																												TCGA-95-7562-01	BRCA-LUAD+			Cluster 6		LUAD-like c10	miRNA cluster 12			TCGA-95-7562	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	R-Lower		TCGA-95-7562-F32832	TCGA-95-7562				-26000		87	0				57	1					Scheduled Follow-up Submission		2012-6-13	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES										NO		NO	10		Yes, History of Prior Malignancy	M0	N1	T2a	Stage IIA		7562	Post-Adjuvant Therapy	TUMOR FREE	72	90	76	80				YES	NO	RX	Primary Tumor	01		1983	7th	YES	YES	NO	95	3		Lung		DECEASED	2011	1973				c2842301-c4ec-41c6-96f7-53701541d93c				TCGA-95-7562-01A-11D-2237-01	TCGA-95-7562-01A-11D-2239-05	TCGA-95-7562-01	TCGA-95-7562-01A-11D-2237-01		c2842301-c4ec-41c6-96f7-53701541d93c	TCGA-95-7562-01		c2842301-c4ec-41c6-96f7-53701541d93c	TCGA-95-7562-01		c2842301-c4ec-41c6-96f7-53701541d93c	TCGA-95-7562-01A-11D-2238-08	TCGA-95-7562-01	
TCGA-95-7567-01	2.66	0.53	none		none	none	none	Y	Y	none	p.R1230fs	p.A888T	0.23	Squamoid	none	p.G12V	none	none	none	none	none	Adenocarcinoma, NOS	Adenocarcinoma, NOS			none	0	TCGA-95-7567-01	High	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-95-7567	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	R-Upper		TCGA-95-7567-F40935	TCGA-95-7567	TCGA-95-7567-01A			-22437			0	568				0					Scheduled Follow-up Submission	Complete Remission/Response	2013-3-6	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.7	NO	100					1	NO		NO			No	M0	N1	T2b	Stage IIB	TCGA-95-7567.7b2574cb-ff02-4e3e-b64b-9d0265ef9335.pdf	7567	Post-Adjuvant Therapy	TUMOR FREE					Stable Disease			NO	NO		Primary Tumor	01	0.2	2011	7th	YES	YES	NO	95	4	Current reformed smoker for > 15 years	Lung	A	LIVING	2011	1970		TCGA-95-7567-01A-11D-2063-08		84c8990e-7656-4c48-8e5a-b03e2013013d				TCGA-95-7567-01A-11D-2062-01	TCGA-95-7567-01A-11D-2064-05	TCGA-95-7567-01	TCGA-95-7567-01A-11D-2062-01		84c8990e-7656-4c48-8e5a-b03e2013013d	TCGA-95-7567-01	TCGA-95-7567-01A-13-2192-20	84c8990e-7656-4c48-8e5a-b03e2013013d	TCGA-95-7567-01	b1812676-0dc7-4038-937b-1e11d9f3a8eb	84c8990e-7656-4c48-8e5a-b03e2013013d	TCGA-95-7567-01A-11D-2063-08	TCGA-95-7567-01	
TCGA-95-7944-01																												TCGA-95-7944-01	GBM	C1-LUAD-enriched		Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 4			TCGA-95-7944	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	L-Lower		TCGA-95-7944-F40938	TCGA-95-7944	TCGA-95-7944-01A			-26003			0	377			60						Scheduled Follow-up Submission	Complete Remission/Response	2013-3-7	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES		0.7	NO						1.3	NO		NO	50		No	M0	N0	T1a	Stage IA	TCGA-95-7944.567e989f-6896-4faf-84bb-8ef786461228.pdf	7944		TUMOR FREE		87		86	Stable Disease			YES	NO	R0	Primary Tumor	01	0.2		7th	NO	YES	NO	95	2		Lung	A	LIVING	2011	1961				f842dd09-8bea-47d4-8489-a9ac06ca5172				TCGA-95-7944-01A-11D-2183-01	TCGA-95-7944-01A-11D-2185-05	TCGA-95-7944-01	TCGA-95-7944-01A-11D-2183-01		f842dd09-8bea-47d4-8489-a9ac06ca5172	TCGA-95-7944-01	TCGA-95-7944-01A-12-2192-20	f842dd09-8bea-47d4-8489-a9ac06ca5172	TCGA-95-7944-01	4e9e76ae-0854-4d55-8ac1-1e156220d369	f842dd09-8bea-47d4-8489-a9ac06ca5172	TCGA-95-7944-01A-11D-2184-08	TCGA-95-7944-01	
TCGA-95-7947-01			none		none	none	none	N	N	p.I91V, p.R1052I	none	none		Squamoid	none	none	none	none	none	p.E453Q	none	0	Acinar predominant Adc			none		TCGA-95-7947-01	High	C1-LUAD-enriched	cluster 3	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 4		TCGA-95-7947	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					67	L-Upper		TCGA-95-7947-F40940	TCGA-95-7947	TCGA-95-7947-01A			-24752			0	477									Scheduled Follow-up Submission	Complete Remission/Response	2013-3-7	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES		0.6	NO						1.2	NO		NO	100		Yes	M0	N0	T1a	Stage IA	TCGA-95-7947.003c68cb-72ea-44c9-80e3-f62224ab3ee2.pdf	7947		TUMOR FREE		37		37	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.3	2006	7th	NO	YES	NO	95	4		Lung	A	LIVING	2011	1956		TCGA-95-7947-01A-11D-2184-08		5893078d-d8cd-4c74-b0e2-d412e367710b				TCGA-95-7947-01A-11D-2183-01	TCGA-95-7947-01A-11D-2185-05	TCGA-95-7947-01	TCGA-95-7947-01A-11D-2183-01		5893078d-d8cd-4c74-b0e2-d412e367710b	TCGA-95-7947-01	TCGA-95-7947-01A-13-2192-20	5893078d-d8cd-4c74-b0e2-d412e367710b	TCGA-95-7947-01	394b67ed-76b7-4d7a-9d58-bf5a790b05d4	5893078d-d8cd-4c74-b0e2-d412e367710b	TCGA-95-7947-01A-11D-2184-08	TCGA-95-7947-01	
TCGA-95-7948-01			none		none	none	none	N	N	none	none	none		Squamoid	none	none	none	none	none	p.E545K	none	0	Micropapillary predom Adc			none		TCGA-95-7948-01	Squamous	C1-LUAD-enriched	cluster 2	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 12	cluster 5		TCGA-95-7948	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					42	R-Lower		TCGA-95-7948-F40945	TCGA-95-7948	TCGA-95-7948-01A			-15363			0	476			87						Scheduled Follow-up Submission	Complete Remission/Response	2013-3-7	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.7	NO						1.3	NO		NO	.15		Yes	M0	N0	T2a	Stage IB	TCGA-95-7948.1cee5f67-bdcc-41cb-8764-5e0d8e09ed61.pdf	7948		TUMOR FREE		79		72	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.3	1995	7th	NO	YES	NO	95	3		Lung	A	LIVING	2011	1993		TCGA-95-7948-01A-11D-2184-08		a5e6acbf-7027-4837-85d7-aacfe707900d				TCGA-95-7948-01A-11D-2183-01	TCGA-95-7948-01A-11D-2185-05	TCGA-95-7948-01	TCGA-95-7948-01A-11D-2183-01		a5e6acbf-7027-4837-85d7-aacfe707900d	TCGA-95-7948-01	TCGA-95-7948-01A-13-2192-20	a5e6acbf-7027-4837-85d7-aacfe707900d	TCGA-95-7948-01	32138cac-7e19-47d7-9a9a-c7270643ea2f	a5e6acbf-7027-4837-85d7-aacfe707900d	TCGA-95-7948-01A-11D-2184-08	TCGA-95-7948-01	
TCGA-95-8039-01																												TCGA-95-8039-01	BRCA-LUAD+			Cluster 6		LUAD-like c10	miRNA cluster 4			TCGA-95-8039	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	NO		72	R-Upper		TCGA-95-8039-F61691	TCGA-95-8039	TCGA-95-8039-01A			-26317			0	830	228		98	0					Scheduled Follow-up Submission	Complete Remission/Response	2014-7-3	MALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES		0.5	NO						0.9	NO	Locoregional Recurrence	YES			No	MX	N0	T1	Stage IA	TCGA-95-8039.2bc3d5a2-7341-44a1-a625-fbfdef9bba6c.pdf	8039	Post-Adjuvant Therapy	TUMOR FREE	70	2.54	67	2.40	Complete Remission/Response	Biopsy with Histologic Confirmation|Convincing Imaging		YES	NO	RX	Primary Tumor	01	0.4		7th	NO	YES	NO	95	1		Lung	A	LIVING	2012					8deed508-4b81-4573-afc1-a3da5ca52c60				TCGA-95-8039-01A-11D-2237-01	TCGA-95-8039-01A-11D-2239-05	TCGA-95-8039-01	TCGA-95-8039-01A-11D-2237-01		8deed508-4b81-4573-afc1-a3da5ca52c60	TCGA-95-8039-01		8deed508-4b81-4573-afc1-a3da5ca52c60	TCGA-95-8039-01		8deed508-4b81-4573-afc1-a3da5ca52c60	TCGA-95-8039-01A-11D-2238-08	TCGA-95-8039-01	
TCGA-95-8494-01																												TCGA-95-8494-01				Cluster 6			miRNA cluster 4			TCGA-95-8494	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					67	R-Middle		TCGA-95-8494-F58476	TCGA-95-8494				-24773			0	84					NO			NO	Scheduled Follow-up Submission		2014-4-10	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES					NO					YES		NO			No	M0	N1	T2a	Stage IIA		8494							Complete Remission/Response			NO	NO		Primary Tumor	01			7th	NO	YES	NO	95	5		Lung		LIVING	2012					af100535-eaf2-49a6-b4bb-5a2b85a2d2c9				TCGA-95-8494-01A-11D-2322-01	TCGA-95-8494-01A-11D-2324-05	TCGA-95-8494-01	TCGA-95-8494-01A-11D-2322-01		af100535-eaf2-49a6-b4bb-5a2b85a2d2c9	TCGA-95-8494-01		af100535-eaf2-49a6-b4bb-5a2b85a2d2c9	TCGA-95-8494-01		af100535-eaf2-49a6-b4bb-5a2b85a2d2c9	TCGA-95-8494-01A-11D-2323-08	TCGA-95-8494-01	
TCGA-95-A4VK-01																												TCGA-95-A4VK-01										TCGA-95-A4VK	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		NO	74	R-Upper		TCGA-95-A4VK-F58477	TCGA-95-A4VK	TCGA-95-A4VK-01A			-27040	155		0	651	496		81	1	YES			NO	Scheduled Follow-up Submission	Stable Disease	2014-4-10	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	140		NO		NO					NO	Distant Metastasis	YES	45	true	Yes, History of Prior Malignancy	M0	N2	T2b	Stage IIIA	TCGA-95-A4VK.0B713E19-EE67-4C3B-8319-4C69019C00D0.pdf	A4VK	Post-Adjuvant Therapy	WITH TUMOR	72	99	67	99	Stable Disease	Convincing Imaging		YES	YES	RX	Primary Tumor	01		1986	7th	YES	YES	NO	95	3		Lung	A	LIVING	2012	1956				f1a2ff30-bc18-4a82-b1a6-69f4b827fddd				TCGA-95-A4VK-01A-11D-A25M-01	TCGA-95-A4VK-01A-11D-A25R-05	TCGA-95-A4VK-01	TCGA-95-A4VK-01A-11D-A25M-01		f1a2ff30-bc18-4a82-b1a6-69f4b827fddd	TCGA-95-A4VK-01		f1a2ff30-bc18-4a82-b1a6-69f4b827fddd	TCGA-95-A4VK-01	C1C311E9-B955-4217-BA53-CF6C58126835	f1a2ff30-bc18-4a82-b1a6-69f4b827fddd	TCGA-95-A4VK-01A-11D-A25L-08	TCGA-95-A4VK-01	
TCGA-95-A4VN-01																												TCGA-95-A4VN-01										TCGA-95-A4VN	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					62	R-Lower		TCGA-95-A4VN-F58501	TCGA-95-A4VN	TCGA-95-A4VN-01A			-22927	23		0	553			50	1	YES			NO	Scheduled Follow-up Submission	Stable Disease	2014-4-11	FEMALE	Lung Solid Pattern Predominant Adenocarcinoma	No	C34.3	8140/3	C34.3	YES	150		NO		NO					NO		NO	42	true	Yes, History of Prior Malignancy	M0	N1	T2a	Stage IIA	TCGA-95-A4VN.D348711A-FD65-4771-A604-D761C96F5C48.pdf	A4VN	Pre-Adjuvant Therapy	TUMOR FREE	65	67	60	58	Stable Disease			YES	NO	R0	Primary Tumor	01		2007	7th	NO	YES	NO	95	4		Lung	A	LIVING	2012	1965				dd53f806-9971-4f03-960c-7753d6b29904				TCGA-95-A4VN-01A-11D-A25M-01	TCGA-95-A4VN-01A-11D-A25R-05	TCGA-95-A4VN-01	TCGA-95-A4VN-01A-11D-A25M-01		dd53f806-9971-4f03-960c-7753d6b29904	TCGA-95-A4VN-01		dd53f806-9971-4f03-960c-7753d6b29904	TCGA-95-A4VN-01	001668FF-E11D-415F-981E-E67389912B4E	dd53f806-9971-4f03-960c-7753d6b29904	TCGA-95-A4VN-01A-11D-A25L-08	TCGA-95-A4VN-01	
TCGA-95-A4VP-01																												TCGA-95-A4VP-01										TCGA-95-A4VP	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES		NO	66	L-Lower		TCGA-95-A4VP-F58502	TCGA-95-A4VP	TCGA-95-A4VP-01A			-24130	68		0	605	216			1	NO			NO	Scheduled Follow-up Submission	Stable Disease	2014-4-11	FEMALE	Lung Acinar Adenocarcinoma	No	C34.3	8550/3	C34.3	YES	640		NO		NO					NO	Distant Metastasis	YES	20	true	No	M0	N2	T2b	Stage IIIA	TCGA-95-A4VP.8892002E-D9B2-47FA-9540-A19E4A35B6C7.pdf	A4VP	Post-Adjuvant Therapy	WITH TUMOR					Stable Disease	Biopsy with Histologic Confirmation|Convincing Imaging		NO	NO		Primary Tumor	01		2012	7th	YES	YES	NO	95	4		Lung	A	LIVING	2012	1972				680579c1-690f-444a-9b6e-f76f5cdd1ae8				TCGA-95-A4VP-01A-21D-A25M-01	TCGA-95-A4VP-01A-21D-A25R-05	TCGA-95-A4VP-01	TCGA-95-A4VP-01A-21D-A25M-01		680579c1-690f-444a-9b6e-f76f5cdd1ae8	TCGA-95-A4VP-01		680579c1-690f-444a-9b6e-f76f5cdd1ae8	TCGA-95-A4VP-01	155C7377-148B-47D4-8BC7-3DFA092A6CB7	680579c1-690f-444a-9b6e-f76f5cdd1ae8	TCGA-95-A4VP-01A-21D-A25L-08	TCGA-95-A4VP-01	
TCGA-97-7546-01	1.8	0.57	none		none	none	none	N	N	none	none	none	0.3	Bronchioid	none	none	none	none	none	none	none	Lepidic predominant Adc	Lepidic predominant Adc			none	0	TCGA-97-7546-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-97-7546	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES			76	L-Upper		TCGA-97-7546-F31995	TCGA-97-7546	TCGA-97-7546-01A			-27913			0	1285	1255		60						Additional New Tumor Event		2012-5-15	FEMALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES		0.6	NO						1.2	NO	New Primary Tumor	YES	25		No	MX	N0	T1	Stage IA	TCGA-97-7546.6d3d1827-e313-45ab-a388-406a3b26b427.pdf	7546		WITH TUMOR	96	84	100	85	Progressive Disease	Convincing Imaging		YES	YES	R0	Primary Tumor	01	0.6	1983	6th	YES	NO	YES	97	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2008	1963		TCGA-97-7546-01A-11D-2036-08		46ba6b5d-e758-4c4d-bbbf-8ec31fdd24e7				TCGA-97-7546-01A-11D-2035-01	TCGA-97-7546-01A-11D-2037-05	TCGA-97-7546-01	TCGA-97-7546-01A-11D-2035-01		46ba6b5d-e758-4c4d-bbbf-8ec31fdd24e7	TCGA-97-7546-01	TCGA-97-7546-01A-13-2192-20	46ba6b5d-e758-4c4d-bbbf-8ec31fdd24e7	TCGA-97-7546-01	936aa67d-90fe-464a-876e-74c37cd2d9bb	46ba6b5d-e758-4c4d-bbbf-8ec31fdd24e7	TCGA-97-7546-01A-11D-2036-08	TCGA-97-7546-01	
TCGA-97-7547-01																												TCGA-97-7547-01	Iq			Cluster 5		LUAD-like c10	miRNA cluster 5			TCGA-97-7547	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	YES		67	R-Upper		TCGA-97-7547-F37177	TCGA-97-7547	TCGA-97-7547-01A	1894		-24737			0	1965	1147		94						Scheduled Follow-up Submission	Progressive Disease	2012-11-29	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES		0.2	NO						0.7	NO	Locoregional Recurrence	YES	30		No	MX	N0	T2	Stage IB	TCGA-97-7547.4a96b27c-c641-4db1-abb2-d2f5ec4a404d.pdf	7547		WITH TUMOR	83	101	82	106	Progressive Disease	Biopsy with Histologic Confirmation		YES	NO		Primary Tumor	01	0.1	1986	6th	YES	NO	YES	97	3		Lung	A	LIVING	2007					2680c851-cb71-4c87-a789-6448b1f66faf				TCGA-97-7547-01A-11D-2035-01	TCGA-97-7547-01A-11D-2037-05	TCGA-97-7547-01	TCGA-97-7547-01A-11D-2035-01		2680c851-cb71-4c87-a789-6448b1f66faf	TCGA-97-7547-01		2680c851-cb71-4c87-a789-6448b1f66faf	TCGA-97-7547-01		2680c851-cb71-4c87-a789-6448b1f66faf	TCGA-97-7547-01A-11D-2036-08	TCGA-97-7547-01	
TCGA-97-7552-01	1.95	0.18	none		none	none	none	N	N	none	none	none	0.09	Bronchioid	none	none	none	none	none	none	none	Invasive mucinous	Invasive mucinous			none	0	TCGA-97-7552-01	Kirc+	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-97-7552	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO			70	L-Lower		TCGA-97-7552-F37174	TCGA-97-7552				-25578			0	1932	798								Scheduled Follow-up Submission	Complete Remission/Response	2012-11-29	MALE	Lung Bronchioloalveolar Carcinoma Mucinous	No	C34.3	8253/3	C34.3	YES										NO	New Primary Tumor	YES	40		No	MX	N0	T2	Stage IB		7552		TUMOR FREE			82	81	Stable Disease			YES	NO		Primary Tumor	01		1985	6th	NO	NO	YES	97	3	Current reformed smoker for > 15 years	Lung		LIVING	2007			TCGA-97-7552-01A-11D-2036-08		a8873600-a0a6-4880-b933-2cbcfb274233				TCGA-97-7552-01A-11D-2035-01	TCGA-97-7552-01A-11D-2037-05	TCGA-97-7552-01	TCGA-97-7552-01A-11D-2035-01		a8873600-a0a6-4880-b933-2cbcfb274233	TCGA-97-7552-01	TCGA-97-7552-01A-13-2192-20	a8873600-a0a6-4880-b933-2cbcfb274233	TCGA-97-7552-01	ae55fdf1-f35a-4930-a339-0c51f52b791a	a8873600-a0a6-4880-b933-2cbcfb274233	TCGA-97-7552-01A-11D-2036-08	TCGA-97-7552-01	
TCGA-97-7553-01	1.47	0.3	none		none	none	none	N	N	none	none	none	0.16	Bronchioid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-97-7553-01	High	C1-LUAD-enriched	cluster 3	Low purity c2	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-97-7553	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					58	L-Lower		TCGA-97-7553-F31865	TCGA-97-7553	TCGA-97-7553-01A			-21518			0	1870			64						Scheduled Follow-up Submission		2012-5-14	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES		1	NO					Central Lung	1.5	NO		NO	20		No	MX	N0	T1	Stage IA	TCGA-97-7553.85eedad8-21be-4b10-910b-5b71802ae52f.pdf	7553		TUMOR FREE	70	99	70	99	Complete Remission/Response			YES	NO		Primary Tumor	01	0.4		6th	NO	NO	YES	97	2	Current smoker	Lung	A	LIVING	2007	1967		TCGA-97-7553-01A-21D-2036-08		4af52410-54ab-4307-96a0-b80579d18e0b				TCGA-97-7553-01A-21D-2035-01	TCGA-97-7553-01A-21D-2037-05	TCGA-97-7553-01	TCGA-97-7553-01A-21D-2035-01		4af52410-54ab-4307-96a0-b80579d18e0b	TCGA-97-7553-01	TCGA-97-7553-01A-23-2192-20	4af52410-54ab-4307-96a0-b80579d18e0b	TCGA-97-7553-01	45376060-6ebe-467c-ac0c-af4b2f3a9670	4af52410-54ab-4307-96a0-b80579d18e0b	TCGA-97-7553-01A-21D-2036-08	TCGA-97-7553-01	
TCGA-97-7554-01	2.28	0.49	none		none	none	none	Y	Y	none	none	none	0.23	Squamoid	none	p.G12V	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-97-7554-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 4	cluster 2		TCGA-97-7554	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					83	L-Lower		TCGA-97-7554-F20552	TCGA-97-7554				-30327			0	775			53	1					Scheduled Follow-up Submission		2012-1-17	FEMALE	Lung Papillary Adenocarcinoma	No	C34.3	8260/3	C34.3	YES					YES	YES	G12V					NO	30		No	M0	N2	T2a	Stage IIIA		7554	Post-Adjuvant Therapy	TUMOR FREE	75	75	76	68	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1983	7th	YES	NO	YES	97	3	Current reformed smoker for > 15 years	Lung		LIVING	2010	1945		TCGA-97-7554-01A-11D-2036-08		db278ebc-bf83-43c0-8a60-a863786ea973				TCGA-97-7554-01A-11D-2035-01	TCGA-97-7554-01A-11D-2037-05	TCGA-97-7554-01	TCGA-97-7554-01A-11D-2035-01		db278ebc-bf83-43c0-8a60-a863786ea973	TCGA-97-7554-01	TCGA-97-7554-01A-13-2192-20	db278ebc-bf83-43c0-8a60-a863786ea973	TCGA-97-7554-01	b2825831-dc98-4443-9963-3f8399f86ea9	db278ebc-bf83-43c0-8a60-a863786ea973	TCGA-97-7554-01A-11D-2036-08	TCGA-97-7554-01	
TCGA-97-7937-01			none		none	p.C401F	none	N	N	none	none	none		Squamoid	none	none	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-97-7937-01	High	C1-LUAD-enriched	cluster 1	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-97-7937	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung			NO		65	L-Upper		TCGA-97-7937-F33767	TCGA-97-7937	TCGA-97-7937-01A			-23919			0	564			89	0	YES		FISH	YES	Scheduled Follow-up Submission		2012-9-12	MALE	Lung Micropapillary Adenocarcinoma	No	C34.1	8507/3	C34.1	YES		1.1	NO		YES	NO			1.1	NO		NO	35		No	MX	N0	T2a	Stage IB	TCGA-97-7937.c52adb5c-9ab3-475b-b21c-c817ea5209f2.pdf	7937	Preoperative	TUMOR FREE			77	120	Stable Disease			YES	NO		Primary Tumor	01	0.5	1994	7th	NO	YES	NO	97	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2011			TCGA-97-7937-01A-11D-2167-08		4b847934-8dcb-451a-a0f1-a5f59bbd33db				TCGA-97-7937-01A-11D-2166-01	TCGA-97-7937-01A-11D-2168-05	TCGA-97-7937-01	TCGA-97-7937-01A-11D-2166-01		4b847934-8dcb-451a-a0f1-a5f59bbd33db	TCGA-97-7937-01	TCGA-97-7937-01A-13-2192-20	4b847934-8dcb-451a-a0f1-a5f59bbd33db	TCGA-97-7937-01	c239f617-19b3-4f8e-933e-492103f7ee83	4b847934-8dcb-451a-a0f1-a5f59bbd33db	TCGA-97-7937-01A-11D-2167-08	TCGA-97-7937-01	
TCGA-97-7938-01			none		none	none	none	Y	Y	none	none	none		Bronchioid	none	p.G12C	none	none	none	none	none	Lepidic predominant Adc	Lepidic predominant Adc			none	0	TCGA-97-7938-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 3	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-97-7938	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					76	R-Upper		TCGA-97-7938-F57460	TCGA-97-7938	TCGA-97-7938-01A			-27980		18	0				53		YES			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-3-11	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.1	8252/3	C34.1	YES		0.8	NO		YES	YES	G12C		1.2	NO		NO	40		No	MX	N0	T1a	Stage IA	TCGA-97-7938.c1b81542-c8ad-43d1-a963-1584868e7fe7.pdf	7938		TUMOR FREE	59	54	58	50	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.2	1996	7th	NO	YES	NO	97	3	Current reformed smoker for > 15 years	Lung	A	DECEASED	2011			TCGA-97-7938-01A-11D-2167-08		3163dcdb-7a0f-428d-94be-9fc140cca0ca				TCGA-97-7938-01A-11D-2166-01	TCGA-97-7938-01A-11D-2168-05	TCGA-97-7938-01	TCGA-97-7938-01A-11D-2166-01		3163dcdb-7a0f-428d-94be-9fc140cca0ca	TCGA-97-7938-01	TCGA-97-7938-01A-13-2192-20	3163dcdb-7a0f-428d-94be-9fc140cca0ca	TCGA-97-7938-01	4bfded3e-651d-476f-a780-b8345171b8cc	3163dcdb-7a0f-428d-94be-9fc140cca0ca	TCGA-97-7938-01A-11D-2167-08	TCGA-97-7938-01	
TCGA-97-7941-01			none		none	none	none	Y	Y	none	none	none		Bronchioid	none	p.G12A	none	none	none	none	none	Acinar predominant Adc	Acinar predominant Adc			none	0	TCGA-97-7941-01	Kirc+	C1-LUAD-enriched	cluster 3	Cluster 6	squamous c3	LUAD-like c10	miRNA cluster 14	cluster 4		TCGA-97-7941	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	L-Upper		TCGA-97-7941-F33765	TCGA-97-7941	TCGA-97-7941-01A			-26298			0	484			57	0	YES			NO	Scheduled Follow-up Submission		2012-8-13	FEMALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES		1	NO		YES	YES	G12A		1.3	NO		NO	22.5		No	MX	N0	T1b	Stage IA	TCGA-97-7941.f95131f4-d721-441f-86ee-d9981befc2a7.pdf	7941	Preoperative	TUMOR FREE	81	98	94	97	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.2	1985	7th	NO	YES	NO	97	3	Current reformed smoker for > 15 years	Lung	A	LIVING	2011	1960		TCGA-97-7941-01A-11D-2184-08		8f52d9f9-9077-4203-ac3a-d64b6589b536				TCGA-97-7941-01A-11D-2183-01	TCGA-97-7941-01A-11D-2185-05	TCGA-97-7941-01	TCGA-97-7941-01A-11D-2183-01		8f52d9f9-9077-4203-ac3a-d64b6589b536	TCGA-97-7941-01	TCGA-97-7941-01A-13-2192-20	8f52d9f9-9077-4203-ac3a-d64b6589b536	TCGA-97-7941-01	803df9cc-873d-4ea2-8895-3090f505e2fd	8f52d9f9-9077-4203-ac3a-d64b6589b536	TCGA-97-7941-01A-11D-2184-08	TCGA-97-7941-01	
TCGA-97-8171-01																												TCGA-97-8171-01	BRCA-LUAD+			Cluster 5		LUAD-like c10	miRNA cluster 7			TCGA-97-8171	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO		YES	81	Other (please specify)	RUL and RML	TCGA-97-8171-F44232	TCGA-97-8171	TCGA-97-8171-01A		441	-29627			0	568	441		110	1	YES	Exon 19 Deletion		NO	Scheduled Follow-up Submission	Progressive Disease	2013-6-19	MALE	Lung Papillary Adenocarcinoma	No	C34.8	8260/3	C34.8	YES		0.8	NO		YES	NO			1.9	NO	Distant Metastasis	YES	65		No	M1a	N2	T2a	Stage IV	TCGA-97-8171.71aa5cff-eda0-47d0-97d8-caf4c02f5626.pdf	8171	Preoperative	WITH TUMOR	55	104	55	99	Progressive Disease	Biopsy with Histologic Confirmation		YES	NO		Primary Tumor	01	0.5		7th	YES	YES	NO	97	2		Lung	A	LIVING	2011	1946				8dedea58-fb63-44cc-860c-56e66b52d11b				TCGA-97-8171-01A-11D-2283-01	TCGA-97-8171-01A-11D-2285-05	TCGA-97-8171-01	TCGA-97-8171-01A-11D-2283-01		8dedea58-fb63-44cc-860c-56e66b52d11b	TCGA-97-8171-01		8dedea58-fb63-44cc-860c-56e66b52d11b	TCGA-97-8171-01		8dedea58-fb63-44cc-860c-56e66b52d11b	TCGA-97-8171-01A-11D-2284-08	TCGA-97-8171-01	
TCGA-97-8172-01																												TCGA-97-8172-01	Kirc+			Cluster 6		LUAD-like c10	miRNA c1uster 9			TCGA-97-8172	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					75	R-Upper		TCGA-97-8172-F44230	TCGA-97-8172	TCGA-97-8172-01A			-27416			0	545			64.98	1	YES			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-6-19	FEMALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES		1.2	NO		YES	YES	G12V		1.7	NO		NO	20		Yes, History of Prior Malignancy	M0	N0	T2a	Stage IB	TCGA-97-8172.ef65fdd5-820a-4029-a667-56b5200276a7.pdf	8172	Preoperative	TUMOR FREE	105.10	107.25	93.27	104.64	Complete Remission/Response			YES	NO		Primary Tumor	01	0.5	1981	7th	NO	YES	NO	97	3		Lung	A	LIVING	2011	1961				9b1118f0-743f-4186-b6cb-571ddb72bc74				TCGA-97-8172-01A-11D-2283-01	TCGA-97-8172-01A-11D-2285-05	TCGA-97-8172-01	TCGA-97-8172-01A-11D-2283-01		9b1118f0-743f-4186-b6cb-571ddb72bc74	TCGA-97-8172-01		9b1118f0-743f-4186-b6cb-571ddb72bc74	TCGA-97-8172-01		9b1118f0-743f-4186-b6cb-571ddb72bc74	TCGA-97-8172-01A-11D-2284-08	TCGA-97-8172-01	
TCGA-97-8174-01																												TCGA-97-8174-01	BRCA-LUAD+			Cluster 5		LUAD-like c10	miRNA c1uster 9			TCGA-97-8174	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					67	R-Upper			TCGA-97-8174	TCGA-97-8174-01A			-24725		164	0				90	0	YES		FISH	YES			2012-6-13	MALE	Lung Papillary Adenocarcinoma	No	C34.1	8260/3	C34.1	YES		1.5	NO		YES	NO			1.5			NO	40		No	M0	N0	T2b	Stage IIA	TCGA-97-8174.f71782a0-0d9f-486e-9e17-cd5ff92d44d7.pdf	8174	Preoperative		86	99	81	91				YES	NO		Primary Tumor	01	0.5	1985	7th	YES	YES	NO	97	3		Lung	A	DECEASED	2011	1965				076c0fa3-ca40-4362-9ba4-5d31fc27af41				TCGA-97-8174-01A-11D-2283-01	TCGA-97-8174-01A-11D-2285-05	TCGA-97-8174-01	TCGA-97-8174-01A-11D-2283-01		076c0fa3-ca40-4362-9ba4-5d31fc27af41	TCGA-97-8174-01		076c0fa3-ca40-4362-9ba4-5d31fc27af41	TCGA-97-8174-01		076c0fa3-ca40-4362-9ba4-5d31fc27af41	TCGA-97-8174-01A-11D-2284-08	TCGA-97-8174-01	
TCGA-97-8175-01																												TCGA-97-8175-01	GBM			Cluster 6		LUAD-like c10	miRNA cluster 4			TCGA-97-8175	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES	YES		55	L-Upper		TCGA-97-8175-F44234	TCGA-97-8175	TCGA-97-8175-01A	294		-20206			0	551	294				YES		FISH	YES	Scheduled Follow-up Submission	Complete Remission/Response	2013-6-19	FEMALE	Lung Solid Pattern Predominant Adenocarcinoma	No	C34.1	8230/3	C34.1	YES		1	NO		YES	NO		Peripheral Lung	2	NO	Locoregional Recurrence	YES			No	M0	N0	T2a	Stage IB	TCGA-97-8175.19c71bba-794d-4245-bbd8-536740912c9f.pdf	8175		TUMOR FREE					Complete Remission/Response	Biopsy with Histologic Confirmation		NO	NO		Primary Tumor	01	0.4	1981	7th	NO	YES	NO	97	3		Lung	A	LIVING	2011					708e83be-4726-4eb6-a72c-ad855942551c				TCGA-97-8175-01A-11D-2283-01	TCGA-97-8175-01A-11D-2285-05	TCGA-97-8175-01	TCGA-97-8175-01A-11D-2283-01		708e83be-4726-4eb6-a72c-ad855942551c	TCGA-97-8175-01		708e83be-4726-4eb6-a72c-ad855942551c	TCGA-97-8175-01		708e83be-4726-4eb6-a72c-ad855942551c	TCGA-97-8175-01A-11D-2284-08	TCGA-97-8175-01	
TCGA-97-8176-01																												TCGA-97-8176-01										TCGA-97-8176	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					63	R-Lower		TCGA-97-8176-F49542	TCGA-97-8176				-23170		468	0	252			61	0	YES			NO	Scheduled Follow-up Submission	Progressive Disease	2013-10-11	MALE	Lung Acinar Adenocarcinoma	No	C34.3	8550/3	C34.3	YES					YES	YES	G12S			NO		NO	40		No	M0	N1	T3	Stage IIIA		8176	Preoperative	TUMOR FREE	68	104	67	100	Stable Disease			YES	YES	R0	Primary Tumor	01		2011	7th	YES	YES	NO	97	4		Lung		DECEASED	2012	1971				a49c5cb5-9a31-456d-b55d-904081633729				TCGA-97-8176-01A-11D-2389-01	TCGA-97-8176-01A-11D-2398-05	TCGA-97-8176-01	TCGA-97-8176-01A-11D-2389-01		a49c5cb5-9a31-456d-b55d-904081633729	TCGA-97-8176-01		a49c5cb5-9a31-456d-b55d-904081633729	TCGA-97-8176-01		a49c5cb5-9a31-456d-b55d-904081633729	TCGA-97-8176-01A-11D-2393-08	TCGA-97-8176-01	
TCGA-97-8177-01																												TCGA-97-8177-01	Kirc+			Cluster 5		LUAD-like c10	miRNA cluster 4			TCGA-97-8177	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					59	L-Lower		TCGA-97-8177-F44243	TCGA-97-8177	TCGA-97-8177-01A			-21648			0	499			97	0	YES	L858R		NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-6-19	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		1.7	NO		YES	NO			2.4	NO		NO			No	M0	N0	T2a	Stage IB	TCGA-97-8177.addbe4e2-114d-4e38-aa21-c3e9695da8fa.pdf	8177	Preoperative	TUMOR FREE	82	109	80	106	Complete Remission/Response			YES	NO		Primary Tumor	01	0.3		7th	YES	YES	NO	97	1		Lung	A	LIVING	2012					61e0c561-bf01-400c-843a-7c63e5a74b9f				TCGA-97-8177-01A-11D-2283-01	TCGA-97-8177-01A-11D-2285-05	TCGA-97-8177-01	TCGA-97-8177-01A-11D-2283-01		61e0c561-bf01-400c-843a-7c63e5a74b9f	TCGA-97-8177-01		61e0c561-bf01-400c-843a-7c63e5a74b9f	TCGA-97-8177-01		61e0c561-bf01-400c-843a-7c63e5a74b9f	TCGA-97-8177-01A-11D-2284-08	TCGA-97-8177-01	
TCGA-97-8179-01																												TCGA-97-8179-01	High			Cluster 6		LUAD-like c10	miRNA cluster 4			TCGA-97-8179	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	R-Upper		TCGA-97-8179-F44247	TCGA-97-8179	TCGA-97-8179-01A			-26305			0	435			73	0	YES		FISH	YES	Scheduled Follow-up Submission	Complete Remission/Response	2013-6-19	MALE	Lung Acinar Adenocarcinoma	No	C34.1	8550/3	C34.1	YES		0.6	NO		YES	NO			0.8	NO		NO	60		No	M0	N0	T1a	Stage IA	TCGA-97-8179.8ed138ef-c9fe-45dd-870a-a438f6f22214.pdf	8179	Preoperative	TUMOR FREE	91	95	86	90	Complete Remission/Response			YES	NO		Primary Tumor	01	0.2	1988	7th	NO	YES	NO	97	3		Lung	A	LIVING	2012	1958				1a331a89-0666-49c2-8f5c-915568d8cb31				TCGA-97-8179-01A-11D-2283-01	TCGA-97-8179-01A-11D-2285-05	TCGA-97-8179-01	TCGA-97-8179-01A-11D-2283-01		1a331a89-0666-49c2-8f5c-915568d8cb31	TCGA-97-8179-01		1a331a89-0666-49c2-8f5c-915568d8cb31	TCGA-97-8179-01	C33AD4AF-80A5-4078-883D-CE6D93BA29C6	1a331a89-0666-49c2-8f5c-915568d8cb31	TCGA-97-8179-01A-11D-2284-08	TCGA-97-8179-01	
TCGA-97-8547-01																												TCGA-97-8547-01										TCGA-97-8547	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					78	R-Lower		TCGA-97-8547-F49559	TCGA-97-8547				-28801			0	657			87		YES	Exon 19 Deletion		NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-10-3	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8550/3	C34.3	YES					YES	NO				NO		NO			No	MX	N2	T2a	Stage IIIA		8547		TUMOR FREE				136	Complete Remission/Response			YES	NO		Primary Tumor	01			7th	YES	YES	NO	97	1		Lung		LIVING	2012					c11b849f-04dd-4599-8073-e2431bd68dd1				TCGA-97-8547-01A-11D-2389-01	TCGA-97-8547-01A-11D-2398-05	TCGA-97-8547-01	TCGA-97-8547-01A-11D-2389-01		c11b849f-04dd-4599-8073-e2431bd68dd1	TCGA-97-8547-01		c11b849f-04dd-4599-8073-e2431bd68dd1	TCGA-97-8547-01		c11b849f-04dd-4599-8073-e2431bd68dd1	TCGA-97-8547-01A-11D-2393-08	TCGA-97-8547-01	
TCGA-97-8552-01																												TCGA-97-8552-01										TCGA-97-8552	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					55	L-Lower		TCGA-97-8552-F49557	TCGA-97-8552	TCGA-97-8552-01A			-20331			0	626			75	0	YES	Exon 19 Deletion		NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-10-3	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES		1.1	NO		YES	NO			1.6	NO		NO			No	MX	N0	T1a	Stage I	TCGA-97-8552.0bfe6dee-7584-4803-be3e-5201cd5ad412.pdf	8552	Other	TUMOR FREE			77	95	Complete Remission/Response			YES	NO		Primary Tumor	01	0.4		7th	NO	YES	NO	97	1		Lung	A	LIVING	2012					7d16518c-7da4-4b50-ae77-a708eccf5db0				TCGA-97-8552-01A-11D-2389-01	TCGA-97-8552-01A-11D-2398-05	TCGA-97-8552-01	TCGA-97-8552-01A-11D-2389-01		7d16518c-7da4-4b50-ae77-a708eccf5db0	TCGA-97-8552-01		7d16518c-7da4-4b50-ae77-a708eccf5db0	TCGA-97-8552-01		7d16518c-7da4-4b50-ae77-a708eccf5db0	TCGA-97-8552-01A-11D-2393-08	TCGA-97-8552-01	
TCGA-97-A4LX-01																												TCGA-97-A4LX-01										TCGA-97-A4LX	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					81	Other (please specify)	Lingula	TCGA-97-A4LX-F57384	TCGA-97-A4LX	TCGA-97-A4LX-01A			-29915	127		0	614			61	0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-3-10	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	50		NO		YES	YES	G12A			NO		NO	120	true	Yes, History of Synchronous/Bilateral Malignancy	M0	N0	T2a	Stage IB	TCGA-97-A4LX.1D7E3689-7B7F-4916-BCD9-04C5A98F09DE.pdf	A4LX	Other	TUMOR FREE	96	90	91	91	Complete Remission/Response			YES	NO		Primary Tumor	01		1985	7th	NO	YES	NO	97	3		Lung	A	LIVING	2012	1945				7d313d92-13f0-49f2-bff6-20e4fdd09337				TCGA-97-A4LX-01A-11D-A24O-01	TCGA-97-A4LX-01A-11D-A24U-05	TCGA-97-A4LX-01	TCGA-97-A4LX-01A-11D-A24O-01		7d313d92-13f0-49f2-bff6-20e4fdd09337	TCGA-97-A4LX-01		7d313d92-13f0-49f2-bff6-20e4fdd09337	TCGA-97-A4LX-01		7d313d92-13f0-49f2-bff6-20e4fdd09337	TCGA-97-A4LX-01A-11D-A24P-08	TCGA-97-A4LX-01	
TCGA-97-A4M0-01																												TCGA-97-A4M0-01										TCGA-97-A4M0	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					60	R-Upper		TCGA-97-A4M0-F57385	TCGA-97-A4M0	TCGA-97-A4M0-01A			-22206	136		0	652				0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-3-10	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	150		NO		YES	YES	G12C			NO		NO	34	true	No	M0	N0	T2a	Stage IB	TCGA-97-A4M0.0ACA9251-2F21-49E1-9E56-4D7359EF614F.pdf	A4M0	Other	TUMOR FREE			90	97	Complete Remission/Response			YES	NO		Primary Tumor	01		2004	7th	NO	YES	NO	97	4		Lung	A	LIVING	2012	1970				91128d24-c61a-47cf-938b-00ff80e4d0e7				TCGA-97-A4M0-01A-11D-A24O-01	TCGA-97-A4M0-01A-11D-A24U-05	TCGA-97-A4M0-01	TCGA-97-A4M0-01A-11D-A24O-01		91128d24-c61a-47cf-938b-00ff80e4d0e7	TCGA-97-A4M0-01		91128d24-c61a-47cf-938b-00ff80e4d0e7	TCGA-97-A4M0-01	321ABB1E-B7E7-4CA9-B1AC-6364EBEE1CE0	91128d24-c61a-47cf-938b-00ff80e4d0e7	TCGA-97-A4M0-01A-11D-A24P-08	TCGA-97-A4M0-01	
TCGA-97-A4M1-01																												TCGA-97-A4M1-01										TCGA-97-A4M1	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					52	R-Upper		TCGA-97-A4M1-F57386	TCGA-97-A4M1				-19272			0	601			111	0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-3-10	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES					NO					NO		NO	3		No	M0	N0	T1a	Stage IA		A4M1	Other	TUMOR FREE	92	105	87	100	Complete Remission/Response			YES	NO		Primary Tumor	01		1975	7th	NO	YES	NO	97	3		Lung		LIVING	2012	1972				da823ce3-fb4c-4626-824d-deef668836cf				TCGA-97-A4M1-01A-11D-A24O-01	TCGA-97-A4M1-01A-11D-A24U-05	TCGA-97-A4M1-01	TCGA-97-A4M1-01A-11D-A24O-01		da823ce3-fb4c-4626-824d-deef668836cf	TCGA-97-A4M1-01		da823ce3-fb4c-4626-824d-deef668836cf	TCGA-97-A4M1-01		da823ce3-fb4c-4626-824d-deef668836cf	TCGA-97-A4M1-01A-11D-A24P-08	TCGA-97-A4M1-01	
TCGA-97-A4M2-01																												TCGA-97-A4M2-01										TCGA-97-A4M2	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					66	R-Middle		TCGA-97-A4M2-F57453	TCGA-97-A4M2	TCGA-97-A4M2-01A			-24313	93		0	624			91	1	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-3-12	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.2	8255/3	C34.2	YES	180		NO		YES	NO				NO		NO	100	true	Yes, History of Prior Malignancy	M0	N0	T1a	Stage IA	TCGA-97-A4M2.0D5976EC-5D41-44A2-AC0A-CBE90F2A908E.pdf	A4M2	Preoperative	TUMOR FREE	89	103	96	102	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	NO	YES	NO	97	2		Lung	A	LIVING	2012	1972				dc3f6cbd-8bf0-4b8e-bce8-eada0768499d				TCGA-97-A4M2-01A-12D-A24O-01	TCGA-97-A4M2-01A-12D-A24U-05	TCGA-97-A4M2-01	TCGA-97-A4M2-01A-12D-A24O-01		dc3f6cbd-8bf0-4b8e-bce8-eada0768499d	TCGA-97-A4M2-01		dc3f6cbd-8bf0-4b8e-bce8-eada0768499d	TCGA-97-A4M2-01	8BF45AB6-A183-4187-9AE7-82E2C9DD83CA	dc3f6cbd-8bf0-4b8e-bce8-eada0768499d	TCGA-97-A4M2-01A-12D-A24P-08	TCGA-97-A4M2-01	
TCGA-97-A4M3-01																												TCGA-97-A4M3-01										TCGA-97-A4M3	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO			69	R-Upper		TCGA-97-A4M3-F57436	TCGA-97-A4M3				-25384			0	540	54		106	1	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-3-11	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES					YES	NO				NO	New Primary Tumor	YES	37.5		Yes, History of Prior Malignancy	M0	N0	T1b	Stage IA		A4M3	Other	TUMOR FREE	69	73	61	61	Complete Remission/Response	Biopsy with Histologic Confirmation		YES	NO		Primary Tumor	01		1984	7th	NO	YES	NO	97	3		Lung		LIVING	2012	1959				cb8f5c13-0ae8-4ec2-9249-3322ff220fff				TCGA-97-A4M3-01A-11D-A24O-01	TCGA-97-A4M3-01A-11D-A24U-05	TCGA-97-A4M3-01	TCGA-97-A4M3-01A-11D-A24O-01		cb8f5c13-0ae8-4ec2-9249-3322ff220fff	TCGA-97-A4M3-01		cb8f5c13-0ae8-4ec2-9249-3322ff220fff	TCGA-97-A4M3-01		cb8f5c13-0ae8-4ec2-9249-3322ff220fff	TCGA-97-A4M3-01A-11D-A24P-08	TCGA-97-A4M3-01	
TCGA-97-A4M5-01																												TCGA-97-A4M5-01										TCGA-97-A4M5	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					83	R-Upper		TCGA-97-A4M5-F57443	TCGA-97-A4M5	TCGA-97-A4M5-01A			-30665	104		0	634			51		NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-3-12	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	200		NO		YES	YES	G12C			NO		NO	6	true	No	M0	N0	T1b	Stage IA	TCGA-97-A4M5.BD386F47-1CDC-46D5-A14D-F7D27F70982F.pdf	A4M5		TUMOR FREE	84	94	85	98	Complete Remission/Response			YES	NO		Primary Tumor	01		1982	7th	NO	YES	NO	97	3		Lung	A	LIVING	2012	1952				a9b0abf6-d818-4aa0-a1bc-3e3c1cf2ff59				TCGA-97-A4M5-01A-11D-A24O-01	TCGA-97-A4M5-01A-11D-A24U-05	TCGA-97-A4M5-01	TCGA-97-A4M5-01A-11D-A24O-01		a9b0abf6-d818-4aa0-a1bc-3e3c1cf2ff59	TCGA-97-A4M5-01		a9b0abf6-d818-4aa0-a1bc-3e3c1cf2ff59	TCGA-97-A4M5-01	D9F235CC-55EF-4AC4-98B3-B69F92DCE4CB	a9b0abf6-d818-4aa0-a1bc-3e3c1cf2ff59	TCGA-97-A4M5-01A-11D-A24P-08	TCGA-97-A4M5-01	
TCGA-97-A4M6-01																												TCGA-97-A4M6-01										TCGA-97-A4M6	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					45	R-Lower		TCGA-97-A4M6-F57434	TCGA-97-A4M6	TCGA-97-A4M6-01A			-16764	115		0	568			92	0	YES	Exon 19 Deletion		NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-3-11	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	180		NO		YES	NO				NO		NO		true	No	M0	N0	T1a	Stage IA	TCGA-97-A4M6.E697A53A-C377-4BC8-8D3F-79562DFF6F0A.pdf	A4M6	Other	TUMOR FREE	95	116	95	110	Complete Remission/Response			YES	NO		Primary Tumor	01			7th	NO	YES	NO	97	1		Lung	A	LIVING	2012					39408ce7-3fca-4e7e-8016-e8586b7bafad				TCGA-97-A4M6-01A-11D-A24O-01	TCGA-97-A4M6-01A-11D-A24U-05	TCGA-97-A4M6-01	TCGA-97-A4M6-01A-11D-A24O-01		39408ce7-3fca-4e7e-8016-e8586b7bafad	TCGA-97-A4M6-01		39408ce7-3fca-4e7e-8016-e8586b7bafad	TCGA-97-A4M6-01	182BCA7C-1999-4ACE-A36C-DF0C597D67FE	39408ce7-3fca-4e7e-8016-e8586b7bafad	TCGA-97-A4M6-01A-11D-A24P-08	TCGA-97-A4M6-01	
TCGA-97-A4M7-01																												TCGA-97-A4M7-01										TCGA-97-A4M7	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	R-Middle		TCGA-97-A4M7-F57383	TCGA-97-A4M7	TCGA-97-A4M7-01A			-27062	132		0	629			99	0	YES	L858R		NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-3-10	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.2	8255/3	C34.2	YES	160		NO		YES	NO				NO		NO	40	true	Yes, History of Synchronous/Bilateral Malignancy	M0	N0	T1b	Stage IA	TCGA-97-A4M7.6E901848-BA21-4D4A-9CB5-0A5786D2843B.pdf	A4M7	Other	TUMOR FREE	82	101	74	91	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1978	7th	NO	YES	NO	97	3		Lung	A	LIVING	2012	1958				038898c8-e2f3-4bd9-9b8e-da45b86ea2ea				TCGA-97-A4M7-01A-11D-A24O-01	TCGA-97-A4M7-01A-11D-A24U-05	TCGA-97-A4M7-01	TCGA-97-A4M7-01A-11D-A24O-01		038898c8-e2f3-4bd9-9b8e-da45b86ea2ea	TCGA-97-A4M7-01		038898c8-e2f3-4bd9-9b8e-da45b86ea2ea	TCGA-97-A4M7-01	8AEEDABD-261B-43F1-B68E-0CE7B0F3E74A	038898c8-e2f3-4bd9-9b8e-da45b86ea2ea	TCGA-97-A4M7-01A-11D-A24P-08	TCGA-97-A4M7-01	
TCGA-99-7458-01	1.79	0.36	none		none	none	none	Y	Y	none	none	none	0.19	Bronchioid	none	p.G12R	none	none	none	none	none	Micropapillary predom Adc	Micropapillary predom Adc			none	0	TCGA-99-7458-01	BRCA-LUAD+	C1-LUAD-enriched	cluster 2	Cluster 5	squamous c3	LUAD-like c10	miRNA cluster 5	cluster 3		TCGA-99-7458	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	R-Lower		TCGA-99-7458-F40777	TCGA-99-7458	TCGA-99-7458-01A			-27359			0	747				1	YES		RT-PCR	YES	Scheduled Follow-up Submission	Stable Disease	2013-4-17	FEMALE	Lung Bronchioloalveolar Carcinoma Nonmucinous	No	C34.3	8252/3	C34.3	YES		0.7	NO	90	YES	YES	G12A		1.2	NO		NO	52		No	M0	N0	T4	Stage IIIA	TCGA-99-7458.d17d08c5-429b-413f-8ed6-984bc2021392.pdf	7458	Preoperative	WITH TUMOR					Stable Disease				NO	R0	Primary Tumor	01	0.7	2010	7th	YES	NO	YES	99	4	Current reformed smoker for < or = 15 years	Lung	A	LIVING	2010	1958		TCGA-99-7458-01A-11D-2036-08		38574f35-5845-4a7d-8657-da3d8757a0eb				TCGA-99-7458-01A-11D-2035-01	TCGA-99-7458-01A-11D-2037-05	TCGA-99-7458-01	TCGA-99-7458-01A-11D-2035-01		38574f35-5845-4a7d-8657-da3d8757a0eb	TCGA-99-7458-01	TCGA-99-7458-01A-13-2192-20	38574f35-5845-4a7d-8657-da3d8757a0eb	TCGA-99-7458-01	603528a1-05bf-43b5-a90b-1b8266f2a925	38574f35-5845-4a7d-8657-da3d8757a0eb	TCGA-99-7458-01A-11D-2036-08	TCGA-99-7458-01	
TCGA-99-8025-01																												TCGA-99-8025-01	High			Cluster 6		LUAD-like c10	miRNA cluster 4			TCGA-99-8025	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	R-Upper		TCGA-99-8025-F57698	TCGA-99-8025	TCGA-99-8025-01A			-26634			0	1060			87	1	YES			YES	Scheduled Follow-up Submission	Complete Remission/Response	2014-5-23	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.8	NO		YES	NO		Central Lung	1.2	NO		NO	20		No	M0	N2	T3	Stage IIIA	TCGA-99-8025.42373413-46df-4837-a01f-2659d92888cd.pdf	8025	Preoperative	TUMOR FREE				111	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.4	1998	7th	YES	NO	YES	99	4		Lung	A	LIVING	2010	1958				36c6906f-7f3e-4bb4-9813-246dc7669fc6				TCGA-99-8025-01A-11D-2237-01	TCGA-99-8025-01A-11D-2239-05	TCGA-99-8025-01	TCGA-99-8025-01A-11D-2237-01		36c6906f-7f3e-4bb4-9813-246dc7669fc6	TCGA-99-8025-01		36c6906f-7f3e-4bb4-9813-246dc7669fc6	TCGA-99-8025-01		36c6906f-7f3e-4bb4-9813-246dc7669fc6	TCGA-99-8025-01A-11D-2238-08	TCGA-99-8025-01	
TCGA-99-8028-01																												TCGA-99-8028-01	Kirc+			Cluster 5		LUAD-like c10	miRNA c1uster 9			TCGA-99-8028	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					50	L-Upper		TCGA-99-8028-F57699	TCGA-99-8028	TCGA-99-8028-01A			-18542			0	1118			71	0	YES		RT-PCR	YES	Scheduled Follow-up Submission	Complete Remission/Response	2014-4-17	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO		YES	YES	G12C		1.3	NO		NO	30		No	M0	N0	T1a	Stage IA	TCGA-99-8028.c5b3fd4e-8e81-4b8f-b38d-e2a6bbded1ee.pdf	8028	Preoperative	TUMOR FREE	91	98	91	94	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.5	2011	7th	NO	NO	YES	99	4		Lung	A	LIVING	2011	1981				e4ac001e-f87e-4c46-8e0e-cee8a4f80965				TCGA-99-8028-01A-11D-2237-01	TCGA-99-8028-01A-11D-2239-05	TCGA-99-8028-01	TCGA-99-8028-01A-11D-2237-01		e4ac001e-f87e-4c46-8e0e-cee8a4f80965	TCGA-99-8028-01		e4ac001e-f87e-4c46-8e0e-cee8a4f80965	TCGA-99-8028-01	990284E7-6075-4B31-AABB-499539FCBBDF	e4ac001e-f87e-4c46-8e0e-cee8a4f80965	TCGA-99-8028-01A-11D-2238-08	TCGA-99-8028-01	
TCGA-99-8032-01																												TCGA-99-8032-01	BRCA-LUAD+			Cluster 5		LUAD-like c10	miRNA cluster 6			TCGA-99-8032	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	R-Upper			TCGA-99-8032	TCGA-99-8032-01A			-22635			0	44			54	0	YES			NO			2012-6-15	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO		YES	YES	G12C		1.3				90		No	M0	N0	T1a	Stage IA	TCGA-99-8032.376597ef-e750-4f66-b744-2b042c0df836.pdf	8032	Preoperative	TUMOR FREE			55	59	Complete Remission/Response			YES	NO	R0	Primary Tumor	01	0.5		7th	NO	YES	NO	99	2		Lung	A	LIVING	2011	1966				179cc9f5-4583-4c7c-945b-a2754234716f				TCGA-99-8032-01A-11D-2237-01	TCGA-99-8032-01A-11D-2239-05	TCGA-99-8032-01	TCGA-99-8032-01A-11D-2237-01		179cc9f5-4583-4c7c-945b-a2754234716f	TCGA-99-8032-01		179cc9f5-4583-4c7c-945b-a2754234716f	TCGA-99-8032-01		179cc9f5-4583-4c7c-945b-a2754234716f	TCGA-99-8032-01A-11D-2238-08	TCGA-99-8032-01	
TCGA-99-8033-01																												TCGA-99-8033-01	High			Cluster 5		LUAD-like c10	miRNA cluster 4			TCGA-99-8033	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	R-Upper		TCGA-99-8033-F58623	TCGA-99-8033	TCGA-99-8033-01A			-27342		656	0	170				2	YES			NO	Scheduled Follow-up Submission		2015-3-30	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.6	NO		YES	NO		Peripheral Lung	0.6	NO		NO			No	M1	NX	TX	Stage IV	TCGA-99-8033.a7f10fd8-ab32-4adb-94a9-31632e286b11.pdf	8033	Post-Adjuvant Therapy	WITH TUMOR					Progressive Disease			NO	YES	R0	Primary Tumor	01	0.5		7th	YES	YES	NO	99	1		Lung	A	DECEASED	2011					1fd32c7c-73dd-4c17-a0ac-7b33f610976e				TCGA-99-8033-01A-11D-2237-01	TCGA-99-8033-01A-11D-2239-05	TCGA-99-8033-01	TCGA-99-8033-01A-11D-2237-01		1fd32c7c-73dd-4c17-a0ac-7b33f610976e	TCGA-99-8033-01		1fd32c7c-73dd-4c17-a0ac-7b33f610976e	TCGA-99-8033-01		1fd32c7c-73dd-4c17-a0ac-7b33f610976e	TCGA-99-8033-01A-11D-2238-08	TCGA-99-8033-01	
TCGA-99-AA5R-01																												TCGA-99-AA5R-01										TCGA-99-AA5R	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	L-Lower		TCGA-99-AA5R-F69298	TCGA-99-AA5R	TCGA-99-AA5R-01A			-25778	323		0	658			47	1	YES		IHC	YES	Scheduled Follow-up Submission		2014-12-31	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	90		NO		YES	YES	G12C			NO		NO	46	true	No	M0	N0	T1a	Stage IA	TCGA-99-AA5R.5541B103-6FD2-4767-B914-8A5B58E86D0A.pdf	AA5R	Preoperative	TUMOR FREE			65	64	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	NO	YES	NO	99	2		Lung	A	LIVING	2013	1967				07f7b453-5716-466f-affd-74a24c4d5c53				TCGA-99-AA5R-01A-11D-A396-01	TCGA-99-AA5R-01A-11D-A398-05	TCGA-99-AA5R-01	TCGA-99-AA5R-01A-11D-A396-01		07f7b453-5716-466f-affd-74a24c4d5c53	TCGA-99-AA5R-01		07f7b453-5716-466f-affd-74a24c4d5c53	TCGA-99-AA5R-01		07f7b453-5716-466f-affd-74a24c4d5c53		TCGA-99-AA5R-01	
TCGA-J2-8192-01																												TCGA-J2-8192-01	Kirc+			Cluster 5		LUAD-like c10	miRNA cluster 4			TCGA-J2-8192	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	NO	65	L-Upper		TCGA-J2-8192-F55390	TCGA-J2-8192	TCGA-J2-8192-01A			-23892			0	739	482		112		YES	Exon 19 Deletion		NO	Scheduled Follow-up Submission		2014-2-18	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES		0.7	NO		YES	NO			1	NO	Locoregional Recurrence	YES			Yes, History of Prior Malignancy	MX	N1	T2a	Stage IIA	TCGA-J2-8192.ab6bb598-f1a2-4691-90c4-e8d63dea8772.pdf	8192		TUMOR FREE	100	89	97	77	Progressive Disease	Biopsy with Histologic Confirmation		YES	NO		Primary Tumor	01	0.3		7th	YES	YES	NO	J2	1		Lung	A	LIVING	2011					54e59fdb-a377-4f69-84aa-8aa21312d270				TCGA-J2-8192-01A-11D-2237-01	TCGA-J2-8192-01A-11D-2239-05	TCGA-J2-8192-01	TCGA-J2-8192-01A-11D-2237-01		54e59fdb-a377-4f69-84aa-8aa21312d270	TCGA-J2-8192-01		54e59fdb-a377-4f69-84aa-8aa21312d270	TCGA-J2-8192-01	7C2B57F4-354C-48E0-98D4-98686E0F435D	54e59fdb-a377-4f69-84aa-8aa21312d270	TCGA-J2-8192-01A-11D-2238-08	TCGA-J2-8192-01	
TCGA-J2-8194-01																												TCGA-J2-8194-01	BRCA-LUAD+			Cluster 5		LUAD-like c10	miRNA cluster 4			TCGA-J2-8194	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	NO	NO	YES	69	R-Lower		TCGA-J2-8194-F55317	TCGA-J2-8194	TCGA-J2-8194-01A		518	-25441			0	724	470		59						Scheduled Follow-up Submission	Partial Remission/Response	2014-1-3	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES		0.6	NO						0.8	NO	Distant Metastasis	YES	20		Yes, History of Prior Malignancy	MX	N0	T3	Stage IIB	TCGA-J2-8194.9604f23f-f09c-480e-828f-5760b5fcdae4.pdf	8194		WITH TUMOR	2.04	83	2.04	83	Progressive Disease	Biopsy with Histologic Confirmation|Convincing Imaging		YES	YES		Primary Tumor	01	0.4	1982	7th	YES	YES	NO	J2	3		Lung	A	LIVING	2011	1956				c0639498-dcbb-432b-816a-1aa025c5ad60				TCGA-J2-8194-01A-11D-2237-01	TCGA-J2-8194-01A-11D-2239-05	TCGA-J2-8194-01	TCGA-J2-8194-01A-11D-2237-01		c0639498-dcbb-432b-816a-1aa025c5ad60	TCGA-J2-8194-01		c0639498-dcbb-432b-816a-1aa025c5ad60	TCGA-J2-8194-01	8A3CA32A-7352-4CD6-9B49-F0D1C13B27E7	c0639498-dcbb-432b-816a-1aa025c5ad60	TCGA-J2-8194-01A-11D-2238-08	TCGA-J2-8194-01	
TCGA-J2-A4AD-01																												TCGA-J2-A4AD-01										TCGA-J2-A4AD	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO			61	L-Upper		TCGA-J2-A4AD-F55524	TCGA-J2-A4AD	TCGA-J2-A4AD-01A			-22414	178	550	0	287	524				NO			NO	Scheduled Follow-up Submission		2014-1-8	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	110		NO		NO					NO	Locoregional Recurrence|Distant Metastasis	YES	120	true	No	MX	N0	T1a	Stage IA	TCGA-J2-A4AD.C7D2CA13-F82C-4B95-9161-E9D8C8D958E0.pdf	A4AD		WITH TUMOR				1.95		Convincing Imaging		YES	NO	RX	Primary Tumor	01			7th	NO	YES	NO	J2	2		Lung	A	DECEASED	2012	1970				2d6005de-b9ad-48ab-bfc9-60995838a002				TCGA-J2-A4AD-01A-11D-A24C-01	TCGA-J2-A4AD-01A-11D-A24I-05	TCGA-J2-A4AD-01	TCGA-J2-A4AD-01A-11D-A24C-01		2d6005de-b9ad-48ab-bfc9-60995838a002	TCGA-J2-A4AD-01		2d6005de-b9ad-48ab-bfc9-60995838a002	TCGA-J2-A4AD-01	ABFCA382-3B85-4597-B9A4-ECC64E6894EA	2d6005de-b9ad-48ab-bfc9-60995838a002	TCGA-J2-A4AD-01A-11D-A24D-08	TCGA-J2-A4AD-01	
TCGA-J2-A4AE-01																												TCGA-J2-A4AE-01										TCGA-J2-A4AE	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					77	L-Upper		TCGA-J2-A4AE-F70639	TCGA-J2-A4AE	TCGA-J2-A4AE-01A			-28163	177		0	1079			89		NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2015-2-27	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	90		NO		NO					NO		NO		true	No	MX	N0	T1a	Stage IA	TCGA-J2-A4AE.DF9C8900-3277-481F-82BD-335744EABD7A.pdf	A4AE		TUMOR FREE			0.72	92	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	NO	YES	NO	J2	1		Lung	A	LIVING	2012					25b7445f-2f62-4303-b983-cdde19c12256				TCGA-J2-A4AE-01A-21D-A24C-01	TCGA-J2-A4AE-01A-21D-A24I-05	TCGA-J2-A4AE-01	TCGA-J2-A4AE-01A-21D-A24C-01		25b7445f-2f62-4303-b983-cdde19c12256	TCGA-J2-A4AE-01		25b7445f-2f62-4303-b983-cdde19c12256	TCGA-J2-A4AE-01		25b7445f-2f62-4303-b983-cdde19c12256	TCGA-J2-A4AE-01A-21D-A24D-08	TCGA-J2-A4AE-01	
TCGA-J2-A4AG-01																												TCGA-J2-A4AG-01										TCGA-J2-A4AG	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					66	L-Upper		TCGA-J2-A4AG-F70848	TCGA-J2-A4AG	TCGA-J2-A4AG-01A			-24224	129		0	988					NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2015-3-10	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	280		NO		NO					NO		NO	25	true	No	MX	N0	T1b	Stage IA	TCGA-J2-A4AG.E56191DA-873E-4506-8591-A6989706F8CB.pdf	A4AG		TUMOR FREE					Complete Remission/Response			NO	NO	R0	Primary Tumor	01		1981	7th	NO	YES	NO	J2	3		Lung	A	LIVING	2012	1956				34c74991-850e-4794-9603-a7212905e13b				TCGA-J2-A4AG-01A-11D-A24C-01	TCGA-J2-A4AG-01A-11D-A24I-05	TCGA-J2-A4AG-01	TCGA-J2-A4AG-01A-11D-A24C-01		34c74991-850e-4794-9603-a7212905e13b	TCGA-J2-A4AG-01		34c74991-850e-4794-9603-a7212905e13b	TCGA-J2-A4AG-01	EBC840C6-D38B-46E7-A2DA-98BF4D76EECF	34c74991-850e-4794-9603-a7212905e13b	TCGA-J2-A4AG-01A-11D-A24D-08	TCGA-J2-A4AG-01	
TCGA-L4-A4E5-01																												TCGA-L4-A4E5-01										TCGA-L4-A4E5	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					48	L-Upper		TCGA-L4-A4E5-F49031	TCGA-L4-A4E5	TCGA-L4-A4E5-01A			-17680	227		0	578			93	1	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-9-25	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	160		NO		NO			Central Lung		NO		NO	33	true	No	M0	N0	T1	Stage I	TCGA-L4-A4E5.22CFA28A-0CE4-4806-97B0-32635D6DCE3F.pdf	A4E5	Other	TUMOR FREE	94	82	94	82	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		2012	7th	NO	NO	YES	L4	4		Lung	A	LIVING	2012	1979				00481f66-1aad-4885-9162-bf802b1ed7f5				TCGA-L4-A4E5-01A-11D-A24O-01	TCGA-L4-A4E5-01A-11D-A24U-05	TCGA-L4-A4E5-01	TCGA-L4-A4E5-01A-11D-A24O-01		00481f66-1aad-4885-9162-bf802b1ed7f5	TCGA-L4-A4E5-01		00481f66-1aad-4885-9162-bf802b1ed7f5	TCGA-L4-A4E5-01	331399DA-7E57-4B25-9877-30C156C27CCA	00481f66-1aad-4885-9162-bf802b1ed7f5	TCGA-L4-A4E5-01A-11D-A24P-08	TCGA-L4-A4E5-01	
TCGA-L4-A4E6-01																												TCGA-L4-A4E6-01										TCGA-L4-A4E6	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					67	R-Upper		TCGA-L4-A4E6-F51277	TCGA-L4-A4E6	TCGA-L4-A4E6-01A			-24631	22		0	435			98		NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-11-14	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	210		NO		NO			Peripheral Lung		NO		NO	30	true	No	M0	N0	T1	Stage IA	TCGA-L4-A4E6.A6FC7AD1-BE0E-4B6C-A71C-CBDC7CD58968.pdf	A4E6		TUMOR FREE	82	85	84	69	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1984	7th	NO	NO	YES	L4	3		Lung	A	LIVING	2012	1954				ff0e31ac-ee03-495a-97e0-a5283fd1c3ae				TCGA-L4-A4E6-01A-11D-A24C-01	TCGA-L4-A4E6-01A-11D-A24I-05	TCGA-L4-A4E6-01	TCGA-L4-A4E6-01A-11D-A24C-01		ff0e31ac-ee03-495a-97e0-a5283fd1c3ae	TCGA-L4-A4E6-01		ff0e31ac-ee03-495a-97e0-a5283fd1c3ae	TCGA-L4-A4E6-01	22C2601E-1B91-4320-8DA2-0605B8E2680C	ff0e31ac-ee03-495a-97e0-a5283fd1c3ae	TCGA-L4-A4E6-01A-11D-A24D-08	TCGA-L4-A4E6-01	
TCGA-L9-A443-01																												TCGA-L9-A443-01										TCGA-L9-A443	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					63	L-Lower		TCGA-L9-A443-F46410	TCGA-L9-A443	TCGA-L9-A443-01A			-23062	50	193	0	116			61	1	NO			NO	Scheduled Follow-up Submission		2013-8-7	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	230		NO		NO			Central Lung		NO		NO	90	false	Yes, History of Prior Malignancy	MX	N0	T1a	Stage IA	TCGA-L9-A443.4D3DD711-7FC9-4CC8-B297-48036F42DCE7.pdf	A443	Preoperative	TUMOR FREE	74	69			Complete Remission/Response			YES	NO	R0	Primary Tumor	01		2005	7th	NO	YES	NO	L9	4		Lung	A	DECEASED	2012	1960				12922017-4f50-4d3d-9bf9-8d9bf7a3b8d4				TCGA-L9-A443-01A-12D-A24C-01	TCGA-L9-A443-01A-12D-A24I-05	TCGA-L9-A443-01	TCGA-L9-A443-01A-12D-A24C-01		12922017-4f50-4d3d-9bf9-8d9bf7a3b8d4	TCGA-L9-A443-01		12922017-4f50-4d3d-9bf9-8d9bf7a3b8d4	TCGA-L9-A443-01	B966DC18-9A95-46B3-AB90-841345077266	12922017-4f50-4d3d-9bf9-8d9bf7a3b8d4	TCGA-L9-A443-01A-12D-A24D-08	TCGA-L9-A443-01	
TCGA-L9-A444-01																												TCGA-L9-A444-01										TCGA-L9-A444	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					60	R-Upper		TCGA-L9-A444-F46270	TCGA-L9-A444	TCGA-L9-A444-01A			-22202	8		0	307			57	0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2013-8-5	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	150		NO		NO			Central Lung		NO		NO	10	false	Yes, History of Prior Malignancy	MX	N0	T1a	Stage IA	TCGA-L9-A444.7356DDFB-ADA7-4809-85EC-1C6D51D5B32D.pdf	A444	Preoperative	TUMOR FREE	62	54	58	49	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	NO	YES	NO	L9	2		Lung	A	LIVING	2012	1972				a3b81644-c1b8-4d12-b6f8-6160533758cc				TCGA-L9-A444-01A-21D-A24C-01	TCGA-L9-A444-01A-21D-A24I-05	TCGA-L9-A444-01	TCGA-L9-A444-01A-21D-A24C-01		a3b81644-c1b8-4d12-b6f8-6160533758cc	TCGA-L9-A444-01		a3b81644-c1b8-4d12-b6f8-6160533758cc	TCGA-L9-A444-01	DE878A76-48F1-498B-B170-8472576EEF51	a3b81644-c1b8-4d12-b6f8-6160533758cc	TCGA-L9-A444-01A-21D-A24D-08	TCGA-L9-A444-01	
TCGA-L9-A50W-01																												TCGA-L9-A50W-01										TCGA-L9-A50W	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	NO	NO	75	L-Lower		TCGA-L9-A50W-F50396	TCGA-L9-A50W	TCGA-L9-A50W-01A			-27414	205	442	0	266	389			0	YES	T790M	FISH	YES	Scheduled Follow-up Submission	Progressive Disease	2013-10-23	MALE	Lung Adenocarcinoma Mixed Subtype	No	C34.3	8255/3	C34.3	YES	240		NO		NO					NO	Distant Metastasis	YES	19	false	No	MX	N1	T1b	Stage IIA	TCGA-L9-A50W.ADB0E9E3-62E7-4461-9254-14DC15DCB877.pdf	A50W	Preoperative	WITH TUMOR			103	81	Stable Disease	Biopsy with Histologic Confirmation|Convincing Imaging		YES	NO	R0	Primary Tumor	01		1986	7th	NO	YES	NO	L9	3		Lung	A	DECEASED	2012	1967				717093f1-916b-4d01-a74c-18af938563c0				TCGA-L9-A50W-01A-12D-A396-01	TCGA-L9-A50W-01A-12D-A398-05	TCGA-L9-A50W-01	TCGA-L9-A50W-01A-12D-A396-01		717093f1-916b-4d01-a74c-18af938563c0	TCGA-L9-A50W-01		717093f1-916b-4d01-a74c-18af938563c0	TCGA-L9-A50W-01	BABAEBD1-66FA-47EB-B655-5122162A0ECA	717093f1-916b-4d01-a74c-18af938563c0		TCGA-L9-A50W-01	
TCGA-L9-A5IP-01																												TCGA-L9-A5IP-01										TCGA-L9-A5IP	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					40	R-Upper			TCGA-L9-A5IP	TCGA-L9-A5IP-01A			-14681	94	58	0						YES		FISH	YES			2013-5-14	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	140		NO		NO							YES		false	No	M1b	N2	T3	Stage IV	TCGA-L9-A5IP.0C79A75F-E3B3-4984-8406-2532E4A68D96.pdf	A5IP		WITH TUMOR					Progressive Disease			NO	NO	R1	Primary Tumor	01		2012	7th	NO	YES	NO	L9	4		Lung	A	DECEASED	2012					07cf4544-6ba1-4535-8bf5-18d5bf9e4123				TCGA-L9-A5IP-01A-21D-A396-01	TCGA-L9-A5IP-01A-21D-A398-05	TCGA-L9-A5IP-01	TCGA-L9-A5IP-01A-21D-A396-01		07cf4544-6ba1-4535-8bf5-18d5bf9e4123	TCGA-L9-A5IP-01		07cf4544-6ba1-4535-8bf5-18d5bf9e4123	TCGA-L9-A5IP-01	F7F211F5-D699-415B-87F2-15ED8BA97EE0	07cf4544-6ba1-4535-8bf5-18d5bf9e4123		TCGA-L9-A5IP-01	
TCGA-L9-A743-01																												TCGA-L9-A743-01										TCGA-L9-A743	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					56	L-Upper		TCGA-L9-A743-F66554	TCGA-L9-A743	TCGA-L9-A743-01A			-20780	97		0	664			45	0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-10-20	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	520		NO		NO			Central Lung		NO		NO	40.5	false	Yes, History of Prior Malignancy	M0	N1	T2a	Stage IIA	TCGA-L9-A743.58EBD3CE-DB70-4A6C-A267-AEC8E50B6BD3.pdf	A743	Preoperative	TUMOR FREE	81	78	85	88	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	YES	YES	NO	L9	2		Lung	A	LIVING	2013	1986				a16a9fdf-3aa3-431b-a680-082e1bde6aab				TCGA-L9-A743-01A-43D-A396-01	TCGA-L9-A743-01A-43D-A398-05	TCGA-L9-A743-01	TCGA-L9-A743-01A-43D-A396-01		a16a9fdf-3aa3-431b-a680-082e1bde6aab	TCGA-L9-A743-01		a16a9fdf-3aa3-431b-a680-082e1bde6aab	TCGA-L9-A743-01	4341B69A-5F22-40E4-B8E5-014FE0D1B8F9	a16a9fdf-3aa3-431b-a680-082e1bde6aab		TCGA-L9-A743-01	
TCGA-L9-A7SV-01																												TCGA-L9-A7SV-01										TCGA-L9-A7SV	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	L-Lower		TCGA-L9-A7SV-F65116	TCGA-L9-A7SV	TCGA-L9-A7SV-01A			-25298	42		0	565			55	0	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-9-18	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	220		NO		NO					NO		NO	93	false	No	M0	N1	T2a	Stage IIA	TCGA-L9-A7SV.C6014F3D-A7C4-455E-9DC8-A59244C81DF7.pdf	A7SV	Preoperative	TUMOR FREE	40	45	38	40	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1990	7th	YES	YES	NO	L9	3		Lung	A	LIVING	2013	1959				52592aa6-979e-4671-bc5a-4c6d31c3e8e1				TCGA-L9-A7SV-01A-11D-A396-01	TCGA-L9-A7SV-01A-11D-A398-05	TCGA-L9-A7SV-01	TCGA-L9-A7SV-01A-11D-A396-01		52592aa6-979e-4671-bc5a-4c6d31c3e8e1	TCGA-L9-A7SV-01		52592aa6-979e-4671-bc5a-4c6d31c3e8e1	TCGA-L9-A7SV-01	1C560CC9-A5FC-4E86-AF64-38C40110783A	52592aa6-979e-4671-bc5a-4c6d31c3e8e1		TCGA-L9-A7SV-01	
TCGA-L9-A8F4-01																												TCGA-L9-A8F4-01										TCGA-L9-A8F4	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					64	L-Upper		TCGA-L9-A8F4-F64972	TCGA-L9-A8F4	TCGA-L9-A8F4-01A			-23617	93		0	476			35	0	NO			NO	Scheduled Follow-up Submission		2014-9-16	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	190		NO		NO					NO		NO	14	false	No	MX	N0	T2a	Stage IB	TCGA-L9-A8F4.FB592A19-E23C-465D-AEF4-55B9BBF7D486.pdf	A8F4	Preoperative	TUMOR FREE	48	54	45	53				YES	YES	R0	Primary Tumor	01			7th	NO	YES	NO	L9	2		Lung	A	LIVING	2013	1973				8fa61a97-acaa-4d5d-bc19-b1767afa356a				TCGA-L9-A8F4-01A-11D-A396-01	TCGA-L9-A8F4-01A-11D-A398-05	TCGA-L9-A8F4-01	TCGA-L9-A8F4-01A-11D-A396-01		8fa61a97-acaa-4d5d-bc19-b1767afa356a	TCGA-L9-A8F4-01		8fa61a97-acaa-4d5d-bc19-b1767afa356a	TCGA-L9-A8F4-01	89418185-FE92-4730-99DA-DC68D7B4644E	8fa61a97-acaa-4d5d-bc19-b1767afa356a		TCGA-L9-A8F4-01	
TCGA-MN-A4N1-01																												TCGA-MN-A4N1-01										TCGA-MN-A4N1	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					60	R-Upper		TCGA-MN-A4N1-F56662	TCGA-MN-A4N1	TCGA-MN-A4N1-01A			-21939	330		0	827			55	0	YES		IHC	YES	Scheduled Follow-up Submission	Complete Remission/Response	2014-2-17	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	140		NO	100	NO					NO		NO		true	Yes, History of Prior Malignancy	M0	N1	T2a	Stage IIA	TCGA-MN-A4N1.F6E1C257-EE3E-4564-8DE9-445C60D78AB8.pdf	A4N1	Preoperative	TUMOR FREE			74	117	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	NO	NO	YES	MN	2		Lung	A	LIVING	2011	1967				38843819-bf57-4c30-ae2f-408653860739				TCGA-MN-A4N1-01A-11D-A24O-01	TCGA-MN-A4N1-01A-11D-A24U-05	TCGA-MN-A4N1-01	TCGA-MN-A4N1-01A-11D-A24O-01		38843819-bf57-4c30-ae2f-408653860739	TCGA-MN-A4N1-01		38843819-bf57-4c30-ae2f-408653860739	TCGA-MN-A4N1-01	0A23E69F-43EC-4242-BD62-E04899F8C238	38843819-bf57-4c30-ae2f-408653860739	TCGA-MN-A4N1-01A-11D-A24P-08	TCGA-MN-A4N1-01	
TCGA-MN-A4N4-01																												TCGA-MN-A4N4-01										TCGA-MN-A4N4	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					57	L-Upper		TCGA-MN-A4N4-F56667	TCGA-MN-A4N4	TCGA-MN-A4N4-01A			-20888	664		0	1175				1	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-2-17	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	120		NO	100	NO					NO		NO		true	No	M0	N0	T1b	Stage IA	TCGA-MN-A4N4.4D754ACD-90C1-4268-8E84-6A8A647A29C5.pdf	A4N4	Preoperative	TUMOR FREE	75	82	70	77	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			7th	NO	NO	YES	MN	2		Lung	A	LIVING	2010	1980				0d7719a9-58ac-4c27-99d3-0a6321c03ef6				TCGA-MN-A4N4-01A-12D-A24O-01	TCGA-MN-A4N4-01A-12D-A24U-05	TCGA-MN-A4N4-01	TCGA-MN-A4N4-01A-12D-A24O-01		0d7719a9-58ac-4c27-99d3-0a6321c03ef6	TCGA-MN-A4N4-01		0d7719a9-58ac-4c27-99d3-0a6321c03ef6	TCGA-MN-A4N4-01	28498EC3-F478-474D-B361-75EC6D6F9FA4	0d7719a9-58ac-4c27-99d3-0a6321c03ef6	TCGA-MN-A4N4-01A-12D-A24P-08	TCGA-MN-A4N4-01	
TCGA-MN-A4N5-01																												TCGA-MN-A4N5-01										TCGA-MN-A4N5	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					63	L-Upper		TCGA-MN-A4N5-F56665	TCGA-MN-A4N5	TCGA-MN-A4N5-01A			-23257	408		0	84			82	0	YES		IHC	YES	Scheduled Follow-up Submission		2014-2-17	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	80		NO	100	NO					YES		NO		true	No	M0	N0	T1a	Stage IA	TCGA-MN-A4N5.3F2359D8-9958-485B-B00F-BD8ADD34FB1E.pdf	A4N5	Preoperative	TUMOR FREE			77	105	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		2011	7th	NO	NO	YES	MN	4		Lung	A	LIVING	2011	1971				6b636016-1b27-4977-8632-85ce773f7db9				TCGA-MN-A4N5-01A-11D-A24O-01	TCGA-MN-A4N5-01A-11D-A24U-05	TCGA-MN-A4N5-01	TCGA-MN-A4N5-01A-11D-A24O-01		6b636016-1b27-4977-8632-85ce773f7db9	TCGA-MN-A4N5-01		6b636016-1b27-4977-8632-85ce773f7db9	TCGA-MN-A4N5-01		6b636016-1b27-4977-8632-85ce773f7db9	TCGA-MN-A4N5-01A-11D-A24P-08	TCGA-MN-A4N5-01	
TCGA-MP-A4SV-01																												TCGA-MP-A4SV-01										TCGA-MP-A4SV	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					67	L-Lower			TCGA-MP-A4SV	TCGA-MP-A4SV-01A			-24516	3964	2620	0				48		NO			NO			2013-4-2	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	160		NO		NO								110	true	No	M0	N0	T2	Stage IB	TCGA-MP-A4SV.8E809652-9783-4B7A-B92D-8C393A2940AB.pdf	A4SV				78		62	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			5th	NO	NO	YES	MP	2		Lung	A	DECEASED	2001	1946				27a878b3-d7eb-49e3-9e1f-a12fcc33d67d				TCGA-MP-A4SV-01A-11D-A24O-01	TCGA-MP-A4SV-01A-11D-A24U-05	TCGA-MP-A4SV-01	TCGA-MP-A4SV-01A-11D-A24O-01		27a878b3-d7eb-49e3-9e1f-a12fcc33d67d	TCGA-MP-A4SV-01		27a878b3-d7eb-49e3-9e1f-a12fcc33d67d	TCGA-MP-A4SV-01	AC6EC310-4C35-49E9-8817-C070C136A907	27a878b3-d7eb-49e3-9e1f-a12fcc33d67d	TCGA-MP-A4SV-01A-11D-A24P-08	TCGA-MP-A4SV-01	
TCGA-MP-A4SW-01																												TCGA-MP-A4SW-01										TCGA-MP-A4SW	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					53	L-Upper			TCGA-MP-A4SW	TCGA-MP-A4SW-01A			-19640	3723	1778	0				102		NO			NO			2013-4-2	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	130		NO		NO								15	true	No	M0	N1	T2	Stage IIB	TCGA-MP-A4SW.2A3C5E05-A4B8-4C01-B61D-3C46E9614707.pdf	A4SW				101		90	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1982	5th	NO	NO	YES	MP	3		Lung	A	DECEASED	2002	1967				f7301b53-0d6b-47ea-a7c4-6191ed59d3cb				TCGA-MP-A4SW-01A-21D-A24O-01	TCGA-MP-A4SW-01A-21D-A24U-05	TCGA-MP-A4SW-01	TCGA-MP-A4SW-01A-21D-A24O-01		f7301b53-0d6b-47ea-a7c4-6191ed59d3cb	TCGA-MP-A4SW-01		f7301b53-0d6b-47ea-a7c4-6191ed59d3cb	TCGA-MP-A4SW-01	CDD79E0C-6487-421E-9543-1307A0C8DAD7	f7301b53-0d6b-47ea-a7c4-6191ed59d3cb	TCGA-MP-A4SW-01A-21D-A24P-08	TCGA-MP-A4SW-01	
TCGA-MP-A4SY-01																												TCGA-MP-A4SY-01										TCGA-MP-A4SY	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					61	R-Lower			TCGA-MP-A4SY	TCGA-MP-A4SY-01A			-22448	3620	1501	0				73	0	NO			NO			2013-4-2	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	130		NO		NO			Central Lung				YES	40	true	No	M0	N1	T2	Stage IIB	TCGA-MP-A4SY.C7A34958-C69B-4EDC-A4D6-503F52BA5330.pdf	A4SY	Pre-Adjuvant Therapy	TUMOR FREE		74		54	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		2002	5th	NO	NO	YES	MP	4		Lung	A	DECEASED	2002					b695df40-ae14-490c-9d67-acda17494a35				TCGA-MP-A4SY-01A-21D-A24O-01	TCGA-MP-A4SY-01A-21D-A24U-05	TCGA-MP-A4SY-01	TCGA-MP-A4SY-01A-21D-A24O-01		b695df40-ae14-490c-9d67-acda17494a35	TCGA-MP-A4SY-01		b695df40-ae14-490c-9d67-acda17494a35	TCGA-MP-A4SY-01	811635C2-6BBD-4E84-A80A-10B3A9AA4864	b695df40-ae14-490c-9d67-acda17494a35	TCGA-MP-A4SY-01A-21D-A24P-08	TCGA-MP-A4SY-01	
TCGA-MP-A4T2-01																												TCGA-MP-A4T2-01										TCGA-MP-A4T2	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	YES	NO	NO	71	L-Lower		TCGA-MP-A4T2-F41327	TCGA-MP-A4T2	TCGA-MP-A4T2-01A			-26010	3237	1136	0		1110		46		NO			NO	Additional New Tumor Event	Progressive Disease	2013-3-14	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	240		NO		NO					NO	Locoregional Recurrence|Distant Metastasis	YES	75	true	No	M0	N0	T1	Stage IA	TCGA-MP-A4T2.EC30FFC5-3C51-49E7-8996-18D9BCFC8552.pdf	A4T2		WITH TUMOR		51		31	Complete Remission/Response	Biopsy with Histologic Confirmation		YES	NO	R0	Primary Tumor	01		2001	6th	NO	NO	YES	MP	4		Lung	A	DECEASED	2003	1951								TCGA-MP-A4T2-01A-11D-A24O-01	TCGA-MP-A4T2-01A-11D-A24U-05		TCGA-MP-A4T2-01A-11D-A24O-01			TCGA-MP-A4T2-01				BC635972-7BD2-4AC0-9025-A9EE61F23022		TCGA-MP-A4T2-01A-11D-A24P-08	TCGA-MP-A4T2-01	
TCGA-MP-A4T4-01																												TCGA-MP-A4T4-01										TCGA-MP-A4T4	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					68	R-Lower			TCGA-MP-A4T4	TCGA-MP-A4T4-01A			-25052	2982	2617	0				53	0	NO			NO			2013-4-2	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	440		NO		NO								50	true	No	M0	N1	T2	Stage IIB	TCGA-MP-A4T4.30003377-8D42-4189-BCCA-C04AB0669EBC.pdf	A4T4	Preoperative			110		113	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			6th	NO	NO	YES	MP	2		Lung	A	DECEASED	2004	1954				fd1831a1-568b-4292-8d70-1450c392825f				TCGA-MP-A4T4-01A-11D-A25M-01	TCGA-MP-A4T4-01A-11D-A25R-05	TCGA-MP-A4T4-01	TCGA-MP-A4T4-01A-11D-A25M-01		fd1831a1-568b-4292-8d70-1450c392825f	TCGA-MP-A4T4-01		fd1831a1-568b-4292-8d70-1450c392825f	TCGA-MP-A4T4-01	76113143-7458-4B3D-A466-4648AD6ADC27	fd1831a1-568b-4292-8d70-1450c392825f	TCGA-MP-A4T4-01A-11D-A25L-08	TCGA-MP-A4T4-01	
TCGA-MP-A4T6-01																												TCGA-MP-A4T6-01										TCGA-MP-A4T6	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					76	L-Lower			TCGA-MP-A4T6	TCGA-MP-A4T6-01A			-27993	2778	1790	0				63		NO			NO			2013-4-2	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	220		NO		NO			Peripheral Lung				NO	50	true	No	MX	N2	T1	Stage IIIA	TCGA-MP-A4T6.2FAB9F3E-DD9B-45AF-9160-D23ECCA95A2D.pdf	A4T6		TUMOR FREE		79		77	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1989	6th	NO	NO	YES	MP	3		Lung	A	DECEASED	2005					225d40a7-eb72-4ee2-8a58-293a05df95e8				TCGA-MP-A4T6-01A-32D-A25M-01	TCGA-MP-A4T6-01A-32D-A25R-05	TCGA-MP-A4T6-01	TCGA-MP-A4T6-01A-32D-A25M-01		225d40a7-eb72-4ee2-8a58-293a05df95e8	TCGA-MP-A4T6-01		225d40a7-eb72-4ee2-8a58-293a05df95e8	TCGA-MP-A4T6-01	BF6C9558-7E31-40ED-A449-4DAD978060BD	225d40a7-eb72-4ee2-8a58-293a05df95e8	TCGA-MP-A4T6-01A-32D-A25L-08	TCGA-MP-A4T6-01	
TCGA-MP-A4T7-01																												TCGA-MP-A4T7-01										TCGA-MP-A4T7	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					75	R-Lower			TCGA-MP-A4T7	TCGA-MP-A4T7-01A			-27603	2710	167	0				57		NO			NO			2013-4-2	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	280		NO		NO								50	true	No	M1	N0	T2	Stage IV	TCGA-MP-A4T7.D973F9E7-74DB-4880-B8F0-03E3887BDC36.pdf	A4T7				91		87				YES	NO	R0	Primary Tumor	01		2004	6th	NO	NO	YES	MP	4		Lung	A	DECEASED	2005	1954				fc674e5c-f387-421e-9dc8-04272b876858				TCGA-MP-A4T7-01A-11D-A24O-01	TCGA-MP-A4T7-01A-11D-A24U-05	TCGA-MP-A4T7-01	TCGA-MP-A4T7-01A-11D-A24O-01		fc674e5c-f387-421e-9dc8-04272b876858	TCGA-MP-A4T7-01		fc674e5c-f387-421e-9dc8-04272b876858	TCGA-MP-A4T7-01	6BD8942F-05C6-4894-8469-A0DAF99D724E	fc674e5c-f387-421e-9dc8-04272b876858	TCGA-MP-A4T7-01A-11D-A24P-08	TCGA-MP-A4T7-01	
TCGA-MP-A4T8-01																												TCGA-MP-A4T8-01										TCGA-MP-A4T8	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					68	L-Upper			TCGA-MP-A4T8	TCGA-MP-A4T8-01A			-25069	2352	161	0				102	1	NO			NO			2013-4-2	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	130		NO		NO								25	true	Yes, History of Prior Malignancy	M0	N2	T2	Stage IIIA	TCGA-MP-A4T8.11D12F13-E03D-43D1-B0B1-AD9168960EE0.pdf	A4T8	Pre-Adjuvant Therapy			72		60				YES	NO	R0	Primary Tumor	01		1972	6th	YES	NO	YES	MP	3		Lung	A	DECEASED	2006	1957				2ea1224b-66aa-48a4-a605-4d1262e84303				TCGA-MP-A4T8-01A-11D-A24O-01	TCGA-MP-A4T8-01A-11D-A24U-05	TCGA-MP-A4T8-01	TCGA-MP-A4T8-01A-11D-A24O-01		2ea1224b-66aa-48a4-a605-4d1262e84303	TCGA-MP-A4T8-01		2ea1224b-66aa-48a4-a605-4d1262e84303	TCGA-MP-A4T8-01	CF31121E-7B77-4290-883A-84590F96E6D8	2ea1224b-66aa-48a4-a605-4d1262e84303	TCGA-MP-A4T8-01A-11D-A24P-08	TCGA-MP-A4T8-01	
TCGA-MP-A4T9-01																												TCGA-MP-A4T9-01										TCGA-MP-A4T9	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	NO	NO	YES		54	L-Upper		TCGA-MP-A4T9-F41357	TCGA-MP-A4T9	TCGA-MP-A4T9-01A	1255		-19767	2332	1265	0		1248		106		NO			NO	Additional New Tumor Event	Progressive Disease	2013-3-15	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	230		NO		NO					NO	Locoregional Recurrence	YES	24	true	No	MX	N2	T2	Stage IIIA	TCGA-MP-A4T9.FE06303C-736B-43C5-B692-FECA9A173EF6.pdf	A4T9		WITH TUMOR		105		99	Complete Remission/Response	Biopsy with Histologic Confirmation		YES	YES	RX	Primary Tumor	01		2004	6th	YES	NO	YES	MP	4		Lung	A	DECEASED	2006	1980				da2c0992-74c0-4380-8c6c-c9ffa73767f6				TCGA-MP-A4T9-01A-11D-A24O-01	TCGA-MP-A4T9-01A-11D-A24U-05	TCGA-MP-A4T9-01	TCGA-MP-A4T9-01A-11D-A24O-01		da2c0992-74c0-4380-8c6c-c9ffa73767f6	TCGA-MP-A4T9-01		da2c0992-74c0-4380-8c6c-c9ffa73767f6	TCGA-MP-A4T9-01	894C5741-75C4-439A-B4C6-C4D00C369FA3	da2c0992-74c0-4380-8c6c-c9ffa73767f6	TCGA-MP-A4T9-01A-11D-A24P-08	TCGA-MP-A4T9-01	
TCGA-MP-A4TA-01																												TCGA-MP-A4TA-01										TCGA-MP-A4TA	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					75	R-Upper			TCGA-MP-A4TA	TCGA-MP-A4TA-01A			-27513	2159	950	0				46	1	NO			NO			2013-4-2	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	120		NO		NO			Peripheral Lung				YES	55	true	Yes, History of Prior Malignancy	M0	N0	T1	Stage IA	TCGA-MP-A4TA.B8573F06-EEC4-49A8-943E-7F2EFF3AFBEE.pdf	A4TA	Pre-Adjuvant Therapy	WITH TUMOR		74		65	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		2006	6th	NO	NO	YES	MP	4		Lung	A	DECEASED	2006	1951				38534c34-666f-4319-86b8-8243ab76cb40				TCGA-MP-A4TA-01A-21D-A24O-01	TCGA-MP-A4TA-01A-21D-A24U-05	TCGA-MP-A4TA-01	TCGA-MP-A4TA-01A-21D-A24O-01		38534c34-666f-4319-86b8-8243ab76cb40	TCGA-MP-A4TA-01		38534c34-666f-4319-86b8-8243ab76cb40	TCGA-MP-A4TA-01	A1C04D1A-3D2B-429C-9112-30753164138D	38534c34-666f-4319-86b8-8243ab76cb40	TCGA-MP-A4TA-01A-21D-A24P-08	TCGA-MP-A4TA-01	
TCGA-MP-A4TC-01																												TCGA-MP-A4TC-01										TCGA-MP-A4TC	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					77	R-Middle			TCGA-MP-A4TC	TCGA-MP-A4TC-01A			-28471	1604	74	0				68		NO			NO			2013-4-2	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.2	8140/3	C34.2	YES	230		NO		NO							NO	125	true	Yes, History of Prior Malignancy	M0	N2	T1	Stage IIIA	TCGA-MP-A4TC.556F6F07-52C6-4FFA-AB6B-46FD9614EB0C.pdf	A4TC		TUMOR FREE		76		83	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1976	6th	YES	NO	YES	MP	3		Lung	A	DECEASED	2008	1944				f2510b83-536a-4d29-bca7-ff3ca3ca9e44				TCGA-MP-A4TC-01A-11D-A24O-01	TCGA-MP-A4TC-01A-11D-A24U-05	TCGA-MP-A4TC-01	TCGA-MP-A4TC-01A-11D-A24O-01		f2510b83-536a-4d29-bca7-ff3ca3ca9e44	TCGA-MP-A4TC-01		f2510b83-536a-4d29-bca7-ff3ca3ca9e44	TCGA-MP-A4TC-01	C78DED8D-D70D-4874-8EA7-BD5D882DC36D	f2510b83-536a-4d29-bca7-ff3ca3ca9e44	TCGA-MP-A4TC-01A-11D-A24P-08	TCGA-MP-A4TC-01	
TCGA-MP-A4TD-01																												TCGA-MP-A4TD-01										TCGA-MP-A4TD	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					71	L-Lower			TCGA-MP-A4TD	TCGA-MP-A4TD-01A			-25983	1471	307	0				61	0	NO			NO			2013-5-8	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	230		NO		NO			Peripheral Lung				YES	20	true	Yes, History of Prior Malignancy	M0	N2	T2	Stage IIIA	TCGA-MP-A4TD.12D870FD-E7C7-470B-9303-63495911A5FE.pdf	A4TD	Post-Adjuvant Therapy			92		93	Complete Remission/Response			YES	NO	RX	Primary Tumor	01		1990	6th	YES	NO	YES	MP	3		Lung	A	DECEASED	2008					53aaf8ed-546d-493a-bde3-bead91b7691f				TCGA-MP-A4TD-01A-32D-A25M-01	TCGA-MP-A4TD-01A-32D-A25R-05	TCGA-MP-A4TD-01	TCGA-MP-A4TD-01A-32D-A25M-01		53aaf8ed-546d-493a-bde3-bead91b7691f	TCGA-MP-A4TD-01		53aaf8ed-546d-493a-bde3-bead91b7691f	TCGA-MP-A4TD-01	66E4093D-2BEA-4887-A720-36CA6476AC2F	53aaf8ed-546d-493a-bde3-bead91b7691f	TCGA-MP-A4TD-01A-32D-A25L-08	TCGA-MP-A4TD-01	
TCGA-MP-A4TE-01																												TCGA-MP-A4TE-01										TCGA-MP-A4TE	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung				NO	56	L-Lower		TCGA-MP-A4TE-F41405	TCGA-MP-A4TE	TCGA-MP-A4TE-01A			-20627	1009	896	0		845				NO			NO	Additional New Tumor Event		2013-3-18	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	270		NO		YES	YES	G12C	Peripheral Lung		NO	Distant Metastasis	YES	40	true	No	MX	N0	T2b	Stage IIA	TCGA-MP-A4TE.3AC0F53B-A612-484B-9589-699F583F4F1D.pdf	A4TE		WITH TUMOR					Complete Remission/Response	Convincing Imaging		NO	NO	RX	Primary Tumor	01		2010	7th	NO	NO	YES	MP	4		Lung	A	DECEASED	2010	1970				686d6738-e29a-4039-8d97-b2f25b87a795				TCGA-MP-A4TE-01A-22D-A25M-01	TCGA-MP-A4TE-01A-22D-A25R-05	TCGA-MP-A4TE-01	TCGA-MP-A4TE-01A-22D-A25M-01		686d6738-e29a-4039-8d97-b2f25b87a795	TCGA-MP-A4TE-01		686d6738-e29a-4039-8d97-b2f25b87a795	TCGA-MP-A4TE-01	C0561CFD-92CF-467B-B6E5-7A0CF1BC21D9	686d6738-e29a-4039-8d97-b2f25b87a795	TCGA-MP-A4TE-01A-22D-A25L-08	TCGA-MP-A4TE-01	
TCGA-MP-A4TF-01																												TCGA-MP-A4TF-01										TCGA-MP-A4TF	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					58	R-Upper			TCGA-MP-A4TF	TCGA-MP-A4TF-01A			-21387	784	336	0				77		NO			NO			2013-4-2	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	240		NO		NO			Peripheral Lung				YES	40	true	No	M0	N0	T2b	Stage IIA	TCGA-MP-A4TF.04511D30-B6E2-46F1-93B9-033B78257F1F.pdf	A4TF		WITH TUMOR		108		109	Partial Remission/Response			YES	NO	R0	Primary Tumor	01		2010	7th	YES	NO	YES	MP	4		Lung	A	DECEASED	2010	1970				6028a290-48e8-400f-9ab6-39beda6051cd				TCGA-MP-A4TF-01A-11D-A25M-01	TCGA-MP-A4TF-01A-11D-A25R-05	TCGA-MP-A4TF-01	TCGA-MP-A4TF-01A-11D-A25M-01		6028a290-48e8-400f-9ab6-39beda6051cd	TCGA-MP-A4TF-01		6028a290-48e8-400f-9ab6-39beda6051cd	TCGA-MP-A4TF-01	33FA8A68-0877-4CC0-9B60-B34FACACF3B5	6028a290-48e8-400f-9ab6-39beda6051cd	TCGA-MP-A4TF-01A-11D-A25L-08	TCGA-MP-A4TF-01	
TCGA-MP-A4TH-01																												TCGA-MP-A4TH-01										TCGA-MP-A4TH	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					70	L-Lower		TCGA-MP-A4TH-F69949	TCGA-MP-A4TH	TCGA-MP-A4TH-01A			-25759	78		0	741			73		NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2015-1-22	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	200		NO		NO			Peripheral Lung		NO		NO	20	true	No	M0	N0	T1a	Stage IA	TCGA-MP-A4TH.842ADC9F-9FEE-49DC-A95D-37FCBF8FB764.pdf	A4TH		TUMOR FREE	117	115	110	115	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1982	7th	NO	YES	NO	MP	3		Lung	A	LIVING	2012	1962				9b4f4156-947b-4c34-9153-021bc670a093				TCGA-MP-A4TH-01A-31D-A25M-01	TCGA-MP-A4TH-01A-31D-A25R-05	TCGA-MP-A4TH-01	TCGA-MP-A4TH-01A-31D-A25M-01		9b4f4156-947b-4c34-9153-021bc670a093	TCGA-MP-A4TH-01		9b4f4156-947b-4c34-9153-021bc670a093	TCGA-MP-A4TH-01	456D68F5-BBCD-4CBF-A42E-60A5205432EF	9b4f4156-947b-4c34-9153-021bc670a093	TCGA-MP-A4TH-01A-31D-A25L-08	TCGA-MP-A4TH-01	
TCGA-MP-A4TI-01																												TCGA-MP-A4TI-01										TCGA-MP-A4TI	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					72	R-Lower			TCGA-MP-A4TI	TCGA-MP-A4TI-01A			-26565	780	429	0						YES			NO			2013-4-2	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	200		NO		YES	YES	G12C					YES	35	true	No	M0	N1	T2a	Stage IIA	TCGA-MP-A4TI.FE74F98E-3131-4F7F-9899-AF5259B3A8C5.pdf	A4TI		WITH TUMOR								NO		R0	Primary Tumor	01		1990	7th		NO	YES	MP	3		Lung	A	DECEASED	2010	1955				a117b181-a01e-49a7-a82b-13f4a385dd45				TCGA-MP-A4TI-01A-21D-A24O-01	TCGA-MP-A4TI-01A-21D-A24U-05	TCGA-MP-A4TI-01	TCGA-MP-A4TI-01A-21D-A24O-01		a117b181-a01e-49a7-a82b-13f4a385dd45	TCGA-MP-A4TI-01		a117b181-a01e-49a7-a82b-13f4a385dd45	TCGA-MP-A4TI-01	64296FB2-BF3D-4DB2-8216-C6F47D1FDC13	a117b181-a01e-49a7-a82b-13f4a385dd45	TCGA-MP-A4TI-01A-21D-A24P-08	TCGA-MP-A4TI-01	
TCGA-MP-A4TJ-01																												TCGA-MP-A4TJ-01										TCGA-MP-A4TJ	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					62	R-Upper			TCGA-MP-A4TJ	TCGA-MP-A4TJ-01A			-22875	2204	339	0				29		NO			NO			2013-4-2	FEMALE	Lung Signet Ring Adenocarcinoma	No	C34.1	8490/3	C34.1	YES	270		NO		NO			Central Lung						true	No	M0	N0	T1	Stage IA	TCGA-MP-A4TJ.23EC6DA5-7109-4E11-B2BC-F1EDC7DF0ED3.pdf	A4TJ			30.1	36	29.7	27	Complete Remission/Response			YES	NO	R0	Primary Tumor	01			6th	NO	NO	YES	MP	2		Lung	A	DECEASED	2006					eaf5ff83-0419-4f44-bec0-93f8517a56c9				TCGA-MP-A4TJ-01A-51D-A25M-01	TCGA-MP-A4TJ-01A-51D-A25R-05	TCGA-MP-A4TJ-01	TCGA-MP-A4TJ-01A-51D-A25M-01		eaf5ff83-0419-4f44-bec0-93f8517a56c9	TCGA-MP-A4TJ-01		eaf5ff83-0419-4f44-bec0-93f8517a56c9	TCGA-MP-A4TJ-01	1E357A4A-08C6-48E0-A9B5-B63A8B8EF339	eaf5ff83-0419-4f44-bec0-93f8517a56c9		TCGA-MP-A4TJ-01	
TCGA-MP-A4TK-01																												TCGA-MP-A4TK-01										TCGA-MP-A4TK	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung	YES	YES		NO	56	R-Lower		TCGA-MP-A4TK-F41426	TCGA-MP-A4TK	TCGA-MP-A4TK-01A			-20581	3744	582	0		545		88		NO			NO	Additional New Tumor Event	Progressive Disease	2013-3-18	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	170		NO		NO					NO	Distant Metastasis	YES	28	true	No	MX	N1	T2	Stage IIB	TCGA-MP-A4TK.D590727D-0D9F-4986-A41F-A5031C432967.pdf	A4TK		WITH TUMOR		64		57	Complete Remission/Response	Convincing Imaging		YES	NO	R0	Primary Tumor	01		1999	5th	NO	NO	YES	MP	4		Lung	A	DECEASED	2002	1971				704d2001-9501-4426-b751-af5fc74a6378				TCGA-MP-A4TK-01A-11D-A24O-01	TCGA-MP-A4TK-01A-11D-A24U-05	TCGA-MP-A4TK-01	TCGA-MP-A4TK-01A-11D-A24O-01		704d2001-9501-4426-b751-af5fc74a6378	TCGA-MP-A4TK-01		704d2001-9501-4426-b751-af5fc74a6378	TCGA-MP-A4TK-01	DED08840-92E6-4E29-A007-5D97A06CC224	704d2001-9501-4426-b751-af5fc74a6378	TCGA-MP-A4TK-01A-11D-A24P-08	TCGA-MP-A4TK-01	
TCGA-MP-A5C7-01																												TCGA-MP-A5C7-01										TCGA-MP-A5C7	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					76	L-Upper		TCGA-MP-A5C7-F67079	TCGA-MP-A5C7	TCGA-MP-A5C7-01A			-28015	1555		0	2248			105	1	NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-10-30	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	170		NO		NO			Central Lung		NO		NO	15	true	No	M0	N0	T2	Stage IB	TCGA-MP-A5C7.656F0756-05CC-437B-98D4-C2AED4B77DAB.pdf	A5C7	Other	TUMOR FREE		93		89	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1968	6th	NO	NO	YES	MP	3		Lung	A	LIVING	2008	1953				d793a609-add1-4029-87fe-1e5c8cf0e173				TCGA-MP-A5C7-01A-11D-A25M-01	TCGA-MP-A5C7-01A-11D-A25R-05	TCGA-MP-A5C7-01	TCGA-MP-A5C7-01A-11D-A25M-01		d793a609-add1-4029-87fe-1e5c8cf0e173	TCGA-MP-A5C7-01		d793a609-add1-4029-87fe-1e5c8cf0e173	TCGA-MP-A5C7-01	CA388905-28E3-4183-ACB6-C462B736BEBE	d793a609-add1-4029-87fe-1e5c8cf0e173	TCGA-MP-A5C7-01A-11D-A25L-08	TCGA-MP-A5C7-01	
TCGA-NJ-A4YF-01																												TCGA-NJ-A4YF-01										TCGA-NJ-A4YF	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					50	R-Upper		TCGA-NJ-A4YF-F50858	TCGA-NJ-A4YF	TCGA-NJ-A4YF-01A			-18584	1819		0	2161			77.5		NO			NO	Scheduled Follow-up Submission	Stable Disease	2013-11-1	FEMALE	Lung Adenocarcinoma Mixed Subtype	No	C34.1	8255/3	C34.1	YES	90		NO		NO					NO		NO	30	true	No	M0	N0	T1	Stage IA	TCGA-NJ-A4YF.1C272E41-4BE4-4E8A-BD33-A5EC5C33149C.pdf	A4YF		TUMOR FREE	95.1	83.9	96	80.7	Stable Disease			YES	NO		Primary Tumor	01			6th	NO	NO	YES	NJ	3		Lung	A	LIVING	2007					dc1f01da-cff9-4b61-b743-0452e023e2a1				TCGA-NJ-A4YF-01A-12D-A25M-01	TCGA-NJ-A4YF-01A-12D-A25R-05	TCGA-NJ-A4YF-01	TCGA-NJ-A4YF-01A-12D-A25M-01		dc1f01da-cff9-4b61-b743-0452e023e2a1	TCGA-NJ-A4YF-01		dc1f01da-cff9-4b61-b743-0452e023e2a1	TCGA-NJ-A4YF-01	4811C6C9-CAC7-403C-8C32-AE289B407C86	dc1f01da-cff9-4b61-b743-0452e023e2a1	TCGA-NJ-A4YF-01A-12D-A25L-08	TCGA-NJ-A4YF-01	
TCGA-NJ-A4YG-01																												TCGA-NJ-A4YG-01										TCGA-NJ-A4YG	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					65	L-Upper		TCGA-NJ-A4YG-F70643	TCGA-NJ-A4YG	TCGA-NJ-A4YG-01A			-23812	1691		0	2261									Scheduled Follow-up Submission	Stable Disease	2015-2-27	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8255/3	C34.1	YES	280		NO							NO		NO	104	true	No	M0	N0	T2	Stage IB	TCGA-NJ-A4YG.6A90E23E-9E8F-4282-837C-120E3AE994D7.pdf	A4YG		TUMOR FREE					Stable Disease			NO	NO		Primary Tumor	01		2007	6th	NO	NO	YES	NJ	4		Lung	A	LIVING	2008	1955				b7989e5f-032a-478c-a882-b4db35bdd42c				TCGA-NJ-A4YG-01A-22D-A25M-01	TCGA-NJ-A4YG-01A-22D-A25R-05	TCGA-NJ-A4YG-01	TCGA-NJ-A4YG-01A-22D-A25M-01		b7989e5f-032a-478c-a882-b4db35bdd42c	TCGA-NJ-A4YG-01		b7989e5f-032a-478c-a882-b4db35bdd42c	TCGA-NJ-A4YG-01	D0BD3C4F-37E1-4168-8AD9-409263FEA49D	b7989e5f-032a-478c-a882-b4db35bdd42c	TCGA-NJ-A4YG-01A-22D-A25L-08	TCGA-NJ-A4YG-01	
TCGA-NJ-A4YI-01																												TCGA-NJ-A4YI-01										TCGA-NJ-A4YI	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					87	R-Upper		TCGA-NJ-A4YI-F50887	TCGA-NJ-A4YI	TCGA-NJ-A4YI-01A			-31867	1385	4	0				52						Scheduled Follow-up Submission	Stable Disease	2013-11-1	FEMALE	Lung Papillary Adenocarcinoma	No	C34.1	8550/3	C34.1	YES	200		NO							NO		NO	3	true	No	M0	N2	T2	Stage IIIA	TCGA-NJ-A4YI.DEFC8FAD-A129-40CA-B0CF-E3773377D8A6.pdf	A4YI				94		89				YES	NO		Primary Tumor	01		1976	6th	NO	NO	YES	NJ	3		Lung	A	DECEASED	2009	1936				628fb2b6-09b2-4460-8815-fda9b89ac0c2				TCGA-NJ-A4YI-01A-11D-A25M-01	TCGA-NJ-A4YI-01A-11D-A25R-05	TCGA-NJ-A4YI-01	TCGA-NJ-A4YI-01A-11D-A25M-01		628fb2b6-09b2-4460-8815-fda9b89ac0c2	TCGA-NJ-A4YI-01		628fb2b6-09b2-4460-8815-fda9b89ac0c2	TCGA-NJ-A4YI-01	82422992-2C68-4B57-BAF5-B4AC14ED6347	628fb2b6-09b2-4460-8815-fda9b89ac0c2	TCGA-NJ-A4YI-01A-11D-A25L-08	TCGA-NJ-A4YI-01	
TCGA-NJ-A4YP-01																												TCGA-NJ-A4YP-01										TCGA-NJ-A4YP	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					52	R-Lower		TCGA-NJ-A4YP-F50888	TCGA-NJ-A4YP	TCGA-NJ-A4YP-01A			-19106	615		0	50					NO			NO	Scheduled Follow-up Submission	Stable Disease	2013-11-1	MALE	Lung Papillary Adenocarcinoma	No	C34.3	8255/3	C34.3	YES	70		NO		NO					YES		NO	60	true	No	M0	N0	T2a	Stage IB	TCGA-NJ-A4YP.13552F62-0795-453F-A597-54B3214C6F24.pdf	A4YP		TUMOR FREE					Stable Disease			NO	NO		Primary Tumor	01			7th	NO			NJ	5		Lung	A	LIVING	2011					364051c3-87fd-4f4a-b2ae-8cc6cf883407				TCGA-NJ-A4YP-01A-11D-A25M-01	TCGA-NJ-A4YP-01A-11D-A25R-05	TCGA-NJ-A4YP-01	TCGA-NJ-A4YP-01A-11D-A25M-01		364051c3-87fd-4f4a-b2ae-8cc6cf883407	TCGA-NJ-A4YP-01		364051c3-87fd-4f4a-b2ae-8cc6cf883407	TCGA-NJ-A4YP-01		364051c3-87fd-4f4a-b2ae-8cc6cf883407	TCGA-NJ-A4YP-01A-11D-A25L-08	TCGA-NJ-A4YP-01	
TCGA-NJ-A4YQ-01																												TCGA-NJ-A4YQ-01										TCGA-NJ-A4YQ	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					69	L-Upper		TCGA-NJ-A4YQ-F70646	TCGA-NJ-A4YQ	TCGA-NJ-A4YQ-01A			-25427	592		0	1432					NO			NO	Scheduled Follow-up Submission	Stable Disease	2015-2-27	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8255/3	C34.1	YES	80		NO		NO					NO		NO	40	true	No	M0	N0	T1b	Stage IA	TCGA-NJ-A4YQ.232A989B-38EA-4BAC-8B08-075913ADA7EF.pdf	A4YQ		TUMOR FREE					Stable Disease			NO	NO	RX	Primary Tumor	01		2011	7th	NO			NJ	4		Lung	A	LIVING	2011					72cad61d-c9cf-4507-b79a-9ecf459a119d				TCGA-NJ-A4YQ-01A-11D-A25M-01	TCGA-NJ-A4YQ-01A-11D-A25R-05	TCGA-NJ-A4YQ-01	TCGA-NJ-A4YQ-01A-11D-A25M-01		72cad61d-c9cf-4507-b79a-9ecf459a119d	TCGA-NJ-A4YQ-01		72cad61d-c9cf-4507-b79a-9ecf459a119d	TCGA-NJ-A4YQ-01		72cad61d-c9cf-4507-b79a-9ecf459a119d	TCGA-NJ-A4YQ-01A-11D-A25L-08	TCGA-NJ-A4YQ-01	
TCGA-NJ-A55A-01																												TCGA-NJ-A55A-01										TCGA-NJ-A55A	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					76	R-Lower		TCGA-NJ-A55A-F70649	TCGA-NJ-A55A	TCGA-NJ-A55A-01A			-28022	1199		0	15					NO			NO	Scheduled Follow-up Submission	Stable Disease	2015-2-27	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8550/3	C34.3	YES	160		NO		NO					YES		NO	25	true	No	M0	N0	T2	Stage IB	TCGA-NJ-A55A.9D29FA79-BE75-4FA6-933E-4185C0B5D03C.pdf	A55A		TUMOR FREE					Stable Disease			NO	NO		Primary Tumor	01		1983	6th	NO			NJ	3		Lung	A	LIVING	2009					b964538d-a322-4632-8b32-b64b9ee66244				TCGA-NJ-A55A-01A-11D-A25M-01	TCGA-NJ-A55A-01A-11D-A25R-05	TCGA-NJ-A55A-01	TCGA-NJ-A55A-01A-11D-A25M-01		b964538d-a322-4632-8b32-b64b9ee66244	TCGA-NJ-A55A-01		b964538d-a322-4632-8b32-b64b9ee66244	TCGA-NJ-A55A-01	F67248A2-11AB-4A41-B702-7ED39A01B760	b964538d-a322-4632-8b32-b64b9ee66244	TCGA-NJ-A55A-01A-11D-A25L-08	TCGA-NJ-A55A-01	
TCGA-NJ-A55O-01																												TCGA-NJ-A55O-01										TCGA-NJ-A55O	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					56	R-Upper		TCGA-NJ-A55O-F50898	TCGA-NJ-A55O	TCGA-NJ-A55O-01A			-20628	428		0	13					NO			NO	Scheduled Follow-up Submission	Stable Disease	2013-11-1	FEMALE	Mucinous (Colloid) Carcinoma	No	C34.1	8480/3	C34.1	YES	150		NO		NO					YES		NO	30	true	No	M0	N1	T1b	Stage IIA	TCGA-NJ-A55O.FBB218E1-EB67-4C9D-8149-EE276C1E9BCE.pdf	A55O		TUMOR FREE					Stable Disease			NO	NO		Primary Tumor	01		2000	7th	NO			NJ	4		Lung	A	LIVING	2011					a5c91562-e870-451a-8255-9620fa5f8977				TCGA-NJ-A55O-01A-11D-A25M-01	TCGA-NJ-A55O-01A-11D-A25R-05	TCGA-NJ-A55O-01	TCGA-NJ-A55O-01A-11D-A25M-01		a5c91562-e870-451a-8255-9620fa5f8977	TCGA-NJ-A55O-01		a5c91562-e870-451a-8255-9620fa5f8977	TCGA-NJ-A55O-01	07F8E95D-8A94-40E0-924F-2EEF25702F78	a5c91562-e870-451a-8255-9620fa5f8977	TCGA-NJ-A55O-01A-11D-A25L-08	TCGA-NJ-A55O-01	
TCGA-NJ-A55R-01																												TCGA-NJ-A55R-01										TCGA-NJ-A55R	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					67	L-Upper		TCGA-NJ-A55R-F70652	TCGA-NJ-A55R	TCGA-NJ-A55R-01A			-24738	499		0	603					NO			NO	Scheduled Follow-up Submission	Stable Disease	2015-2-27	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8230/3	C34.1	YES	200		NO		NO					YES		NO	5	true	No	MX	N0	T1b	Stage IA	TCGA-NJ-A55R.726A5F6E-4592-49AA-976F-556CABABDD3D.pdf	A55R		TUMOR FREE					Stable Disease			NO	NO		Primary Tumor	01		1986	7th	NO			NJ	3		Lung	A	LIVING	2011					71937412-13b3-4584-8b61-8a83e762e2d7				TCGA-NJ-A55R-01A-11D-A25M-01	TCGA-NJ-A55R-01A-11D-A25R-05	TCGA-NJ-A55R-01	TCGA-NJ-A55R-01A-11D-A25M-01		71937412-13b3-4584-8b61-8a83e762e2d7	TCGA-NJ-A55R-01		71937412-13b3-4584-8b61-8a83e762e2d7	TCGA-NJ-A55R-01	7F27BC0A-2F99-435F-8717-B9976FB4C9DA	71937412-13b3-4584-8b61-8a83e762e2d7	TCGA-NJ-A55R-01A-11D-A25L-08	TCGA-NJ-A55R-01	
TCGA-NJ-A7XG-01																												TCGA-NJ-A7XG-01										TCGA-NJ-A7XG	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					49	L-Upper		TCGA-NJ-A7XG-F71390	TCGA-NJ-A7XG	TCGA-NJ-A7XG-01A			-18127	72		0	617					YES	Other			Scheduled Follow-up Submission	Stable Disease	2015-3-25	MALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.1	8140/3	C34.1	YES	140		NO		YES	NO				NO		NO		true	No	M0	N1	T4	Stage IIIA	TCGA-NJ-A7XG.8EFDF414-12F3-4DF8-BB21-9E8876B727E8.pdf	A7XG		WITH TUMOR					Stable Disease			NO	NO		Primary Tumor	01			7th	YES			NJ	3		Lung	A	LIVING	2013					885e59fd-b9e5-4c5a-85cc-c979232b1e77				TCGA-NJ-A7XG-01A-12D-A396-01	TCGA-NJ-A7XG-01A-12D-A398-05	TCGA-NJ-A7XG-01	TCGA-NJ-A7XG-01A-12D-A396-01		885e59fd-b9e5-4c5a-85cc-c979232b1e77	TCGA-NJ-A7XG-01		885e59fd-b9e5-4c5a-85cc-c979232b1e77	TCGA-NJ-A7XG-01	9D10E64C-AC93-44A9-A81D-B6D307824D95	885e59fd-b9e5-4c5a-85cc-c979232b1e77		TCGA-NJ-A7XG-01	
TCGA-O1-A52J-01																												TCGA-O1-A52J-01										TCGA-O1-A52J	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					74	L-Lower			TCGA-O1-A52J	TCGA-O1-A52J-01A			-27223	2000	1798	0					1	NO			NO			2013-4-11	FEMALE	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	No	C34.3	8140/3	C34.3	YES	50		NO		NO							YES	45	true	No	MX	N0	T1	Stage IA	TCGA-O1-A52J.E5C54019-F404-4F8D-847A-80CF65F65E19.pdf	A52J		WITH TUMOR								NO	NO		Primary Tumor	01		1980	6th	NO	NO	YES	O1	3		Lung	A	DECEASED	2007	1950				ca467949-9170-4c3f-8e67-5b7762d31d4a				TCGA-O1-A52J-01A-11D-A25M-01	TCGA-O1-A52J-01A-11D-A25R-05	TCGA-O1-A52J-01	TCGA-O1-A52J-01A-11D-A25M-01		ca467949-9170-4c3f-8e67-5b7762d31d4a	TCGA-O1-A52J-01		ca467949-9170-4c3f-8e67-5b7762d31d4a	TCGA-O1-A52J-01	7CA1E6EE-521F-46AF-83F6-D9B12FD1C567	ca467949-9170-4c3f-8e67-5b7762d31d4a	TCGA-O1-A52J-01A-11D-A25L-08	TCGA-O1-A52J-01	
TCGA-S2-AA1A-01																												TCGA-S2-AA1A-01										TCGA-S2-AA1A	TCGA Lung Adenocarcinoma (LUAD)	lung adenocarcinoma	Lung					68	R-Upper		TCGA-S2-AA1A-F67520	TCGA-S2-AA1A	TCGA-S2-AA1A-01A			-24903	95		0	513			65		NO			NO	Scheduled Follow-up Submission	Complete Remission/Response	2014-11-7	FEMALE	Lung Bronchioloalveolar Carcinoma Mucinous	No	C34.1	8253/3	C34.1	YES	170		NO		NO					NO		NO	95	true	No	M0	N0	T1b	Stage IA	TCGA-S2-AA1A.83A6F838-3F30-411F-9982-B8985C7FA52E.pdf	AA1A		TUMOR FREE	83	2.16	79	2.01	Complete Remission/Response			YES	NO	R0	Primary Tumor	01		1995	7th	NO	YES	NO	S2	3		Lung	A	LIVING	2013	1957				b129c3f7-a2ff-40ba-91b0-a9c96f1e2b00				TCGA-S2-AA1A-01A-12D-A396-01	TCGA-S2-AA1A-01A-12D-A398-05	TCGA-S2-AA1A-01	TCGA-S2-AA1A-01A-12D-A396-01		b129c3f7-a2ff-40ba-91b0-a9c96f1e2b00	TCGA-S2-AA1A-01		b129c3f7-a2ff-40ba-91b0-a9c96f1e2b00	TCGA-S2-AA1A-01	76952263-FC42-4F1C-AB20-02FBA6F877EA	b129c3f7-a2ff-40ba-91b0-a9c96f1e2b00		TCGA-S2-AA1A-01